QueryID	SubjectID	RawScore	%coverage	PBSscore	BioSample	Title
L11079.1	SRR15276854	131.58	90.54	90.67	SAMN20362767	AMR target-enriched metagenomic and 16S rRNA reads from cows raised in conventional or organic setting
L11079.1	SRR4101320	131.32	90.54	90.49	SAMN05715927	food contamination metagenome Metagenome
L11079.1	SRR4101312	130.32	89.86	89.81	SAMN05715927	food contamination metagenome Metagenome
L11079.1	SRR4101319	129.48	89.19	89.23	SAMN05715927	food contamination metagenome Metagenome
L11079.1	SRR6667573	128.48	88.51	88.54	SAMN08457752	Metagenomes of produce spiked with E.coli
L11079.1	SRR12711160	127.50	87.84	87.87	SAMN15871213	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	ERR4083947	126.51	87.16	87.18	SAMEA6809521	Large scale metagenome assembly reveals novel animal-associated microbial diversity
L11079.1	ERR3085829	124.52	85.81	85.81	SAMEA104403803	RLBUHT_Cdiff
L11079.1	SRR4101321	122.58	84.46	84.48	SAMN05715928	food contamination metagenome Metagenome
L11079.1	SRR6514656	122.51	84.46	84.42	SAMN08379451	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	SRR15276870	121.79	83.78	83.93	SAMN20362750	AMR target-enriched metagenomic and 16S rRNA reads from cows raised in conventional or organic setting
L11079.1	SRR4101323	121.60	83.78	83.80	SAMN05715928	food contamination metagenome Metagenome
L11079.1	SRR4101324	121.39	83.78	83.65	SAMN05715929	food contamination metagenome Metagenome
L11079.1	SRR4101309	121.39	83.78	83.65	SAMN05715935	food contamination metagenome Metagenome
L11079.1	ERR321622	120.60	83.11	83.11	SAMEA2145815	Richness of human gut microbiome correlates with metabolic markers
L11079.1	SRR4101322	120.60	83.11	83.11	SAMN05715928	food contamination metagenome Metagenome
L11079.1	SRR15276868	119.79	82.43	82.55	SAMN20362769	AMR target-enriched metagenomic and 16S rRNA reads from cows raised in conventional or organic setting
L11079.1	SRR12711225	119.62	82.43	82.43	SAMN15870981	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR8353651	118.64	81.76	81.76	SAMN10615590	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	ERR3153744	118.40	81.76	81.59	SAMEA5335518	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	SRR8353652	116.81	80.41	80.50	SAMN10615591	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR17241854	115.54	79.73	79.63	SAMN23969020	Gut microbiome in obese children treated with butyrate
L11079.1	SRR4101311	114.87	79.05	79.16	SAMN05715935	food contamination metagenome Metagenome
L11079.1	SRR4101314	114.83	79.05	79.14	SAMN05715936	food contamination metagenome Metagenome
L11079.1	SRR8856338	114.82	79.05	79.13	SAMN11345975	Breccia  Pipe U Claim Borehole WT-29A subsurface metagenome
L11079.1	SRR4101313	114.68	79.05	79.03	SAMN05715936	food contamination metagenome Metagenome
L11079.1	ERR738547	114.45	79.05	78.87	SAMEA3216839	Benchmark of metagenome analysis tools
L11079.1	SRR2177286	114.42	79.05	78.85	SAMN04001584	STEC-spiked spinach Metagenome
L11079.1	SRR4101315	113.69	78.38	78.34	SAMN05715936	food contamination metagenome Metagenome
L11079.1	ERR2270961	113.42	78.38	78.16	SAMEA104549058	Metagenomic characterization of the human intestinal microbiota in faecal samples from STEC-infected patients
L11079.1	SRR14780121	113.41	78.38	78.16	SAMN15504563	Metagenomics MinION and Flongle sequencing of spiked beef
L11079.1	SRR12326571	113.41	78.38	78.16	SAMN15637147	Cassava leaf microbiome and ions
L11079.1	SRR12326569	112.67	77.70	77.65	SAMN15637149	Cassava leaf microbiome and ions
L11079.1	SRR12326570	112.67	77.70	77.65	SAMN15637148	Cassava leaf microbiome and ions
L11079.1	SRR6869086	112.46	77.70	77.50	SAMN08738623	Bovine Fecal Metagenomics During Early Life
L11079.1	SRR2177285	112.44	77.70	77.49	SAMN04001583	STEC-spiked spinach Metagenome
L11079.1	SRR4101310	111.88	77.03	77.10	SAMN05715935	food contamination metagenome Metagenome
L11079.1	SRR6482687	111.70	77.03	76.98	SAMN08017836	Collection of 3,087 bacterial metagenome-assembled genomes recovered from metagenomes available from the Sequence Read Archive.
L11079.1	ERR738549	111.67	77.03	76.96	SAMEA3216841	Benchmark of metagenome analysis tools
L11079.1	SRR4101294	111.55	77.03	76.87	SAMN05715930	food contamination metagenome Metagenome
L11079.1	SRR4101295	110.55	76.35	76.19	SAMN05715930	food contamination metagenome Metagenome
L11079.1	SRR2177280	110.45	76.35	76.11	SAMN04001579	STEC-spiked spinach Metagenome
L11079.1	SRR11435978	110.45	76.35	76.11	SAMN14475164	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR11435988	110.43	76.35	76.10	SAMN14475172	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR4101296	110.43	76.35	76.10	SAMN05715931	food contamination metagenome Metagenome
L11079.1	SRR4101297	110.43	76.35	76.10	SAMN05715931	food contamination metagenome Metagenome
L11079.1	SRR4101293	109.71	75.68	75.60	SAMN05715930	food contamination metagenome Metagenome
L11079.1	ERR2270960	109.69	75.68	75.59	SAMEA104549057	Metagenomic characterization of the human intestinal microbiota in faecal samples from STEC-infected patients
L11079.1	SRR4101307	109.69	75.68	75.59	SAMN05715934	food contamination metagenome Metagenome
L11079.1	SRR2177357	109.45	75.68	75.43	SAMN04001591	STEC-spiked spinach Metagenome
L11079.1	SRR4101289	109.45	75.68	75.43	SAMN05715926	food contamination metagenome Metagenome
L11079.1	SRR4101298	109.43	75.68	75.41	SAMN05715931	food contamination metagenome Metagenome
L11079.1	SRR4101306	109.43	75.68	75.41	SAMN05715934	food contamination metagenome Metagenome
L11079.1	SRR6486880	109.43	75.68	75.41	SAMN08375885	Evaluation of Enriched Background Microflora of Wheat flour Spiked with E. coli O157 and E. coli O121 through metagenomics
L11079.1	SRR12710916	108.89	75.00	75.04	SAMN15870962	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR15276860	108.84	75.00	75.00	SAMN20362752	AMR target-enriched metagenomic and 16S rRNA reads from cows raised in conventional or organic setting
L11079.1	SRR2164314	108.70	75.00	74.91	SAMN03983345	Fecal suspension - 2011 E coli outbreak Raw sequence reads
L11079.1	SRR4101308	108.70	75.00	74.91	SAMN05715934	food contamination metagenome Metagenome
L11079.1	SRR12195334	108.61	75.00	74.84	SAMN15504566	STEC-spiked food
L11079.1	SRR11435966	108.60	75.00	74.84	SAMN14475168	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR4101299	108.59	75.00	74.83	SAMN05715932	food contamination metagenome Metagenome
L11079.1	SRR11435987	108.45	75.00	74.74	SAMN14475173	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR2177282	108.45	75.00	74.74	SAMN04001583	STEC-spiked spinach Metagenome
L11079.1	SRR11435963	108.45	75.00	74.74	SAMN14475171	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR6486879	108.44	75.00	74.73	SAMN08375886	Evaluation of Enriched Background Microflora of Wheat flour Spiked with E. coli O157 and E. coli O121 through metagenomics
L11079.1	SRR8784357	107.73	74.32	74.24	SAMN11252265	Metagenomic sequencing of stool samples from Ethiopian individuals
L11079.1	SRR2177250	107.61	74.32	74.16	SAMN04001579	STEC-spiked spinach Metagenome
L11079.1	SRR2177288	107.61	74.32	74.16	SAMN04001591	STEC-spiked spinach Metagenome
L11079.1	SRR6486883	107.59	74.32	74.15	SAMN08375884	Evaluation of Enriched Background Microflora of Wheat flour Spiked with E. coli O157 and E. coli O121 through metagenomics
L11079.1	SRR11435969	107.46	74.32	74.05	SAMN14475165	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR4101301	107.46	74.32	74.05	SAMN05715926	food contamination metagenome Metagenome
L11079.1	ERR3413876	107.46	74.32	74.05	SAMEA5735801	The study compares 16S rDNA amplicon and metagenomics sequencing for Pathogen detection in Food safety
L11079.1	ERR3413877	107.46	74.32	74.05	SAMEA5735802	The study compares 16S rDNA amplicon and metagenomics sequencing for Pathogen detection in Food safety
L11079.1	ERR3413878	107.46	74.32	74.05	SAMEA5735803	The study compares 16S rDNA amplicon and metagenomics sequencing for Pathogen detection in Food safety
L11079.1	ERR3413879	107.46	74.32	74.05	SAMEA5735804	The study compares 16S rDNA amplicon and metagenomics sequencing for Pathogen detection in Food safety
L11079.1	SRR11435968	107.46	74.32	74.05	SAMN14475166	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR4101292	107.46	74.32	74.05	SAMN05715929	food contamination metagenome Metagenome
L11079.1	SRR11435985	107.46	74.32	74.05	SAMN14475175	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	ERR1992808	106.87	73.65	73.65	SAMEA103954398	Semi-synthetic marine metagenomes for metagenomic pipeline assessment
L11079.1	ERR2185279	106.87	73.65	73.65	SAMEA104351855	Semi-synthetic marine metagenomes for metagenomic pipeline assessment
L11079.1	ERR2182604	106.86	73.65	73.64	SAMEA104359694	Metagenomic characterization of the human intestinal microbiota in faecal samples from STEC-infected patients
L11079.1	SRR12711214	106.83	73.65	73.62	SAMN15870991	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR11435989	106.61	73.65	73.47	SAMN14475163	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR12195333	106.61	73.65	73.47	SAMN15504567	STEC-spiked food
L11079.1	SRR6486889	106.61	73.65	73.47	SAMN08375880	Evaluation of Enriched Background Microflora of Wheat flour Spiked with E. coli O157 and E. coli O121 through metagenomics
L11079.1	SRR11435964	106.46	73.65	73.37	SAMN14475170	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR12195335	106.46	73.65	73.37	SAMN15504565	STEC-spiked food
L11079.1	SRR2177283	106.46	73.65	73.37	SAMN04001575	STEC-spiked spinach Metagenome
L11079.1	SRR4101291	106.46	73.65	73.37	SAMN05715929	food contamination metagenome Metagenome
L11079.1	SRR8354042	106.46	73.65	73.37	SAMN10615885	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR12710959	105.93	72.97	73.00	SAMN15870917	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR2177287	105.69	72.97	72.84	SAMN04001591	STEC-spiked spinach Metagenome
L11079.1	SRR11435965	105.62	72.97	72.79	SAMN14475169	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR12195329	105.62	72.97	72.79	SAMN15504571	STEC-spiked food
L11079.1	SRR12195330	105.62	72.97	72.79	SAMN15504570	STEC-spiked food
L11079.1	SRR12195331	105.62	72.97	72.79	SAMN15504569	STEC-spiked food
L11079.1	SRR12195332	105.62	72.97	72.79	SAMN15504568	STEC-spiked food
L11079.1	SRR12195343	105.62	72.97	72.79	SAMN15504564	STEC-spiked food
L11079.1	SRR12195344	105.62	72.97	72.79	SAMN15504563	STEC-spiked food
L11079.1	SRR1523528	105.62	72.97	72.79	SAMN02929927	Human saliva, creek water, and synthetic metagenomic samples used in selective DNA isolation using restriction enzymes
L11079.1	SRR4101290	105.62	72.97	72.79	SAMN05715926	food contamination metagenome Metagenome
L11079.1	SRR6486887	105.62	72.97	72.79	SAMN08375878	Evaluation of Enriched Background Microflora of Wheat flour Spiked with E. coli O157 and E. coli O121 through metagenomics
L11079.1	SRR6486890	105.62	72.97	72.79	SAMN08375879	Evaluation of Enriched Background Microflora of Wheat flour Spiked with E. coli O157 and E. coli O121 through metagenomics
L11079.1	SRR7229774	105.62	72.97	72.79	SAMN09269258	Complete Genome Sequence of New Type Shiga toxin-producing Escherichia coli O157:H7 Phage vB_EcoM-Sa157w3YLVW
L11079.1	SRR6869083	104.95	72.30	72.33	SAMN08738620	Bovine Fecal Metagenomics During Early Life
L11079.1	ERR738548	104.71	72.30	72.16	SAMEA3216840	Benchmark of metagenome analysis tools
L11079.1	SRR12711224	103.95	71.62	71.63	SAMN15870982	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12711477	103.95	71.62	71.63	SAMN15870925	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR4018490	103.90	71.62	71.60	SAMN05442508	freshwater metagenome Raw sequence reads
L11079.1	SRR6514663	103.65	71.62	71.43	SAMN08379458	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	SRR11391800	102.10	70.27	70.36	SAMN14418854	Metagenomic Sequencing for cattle manure and E. coli library from cattle manure
L11079.1	SRR11435990	101.69	70.27	70.08	SAMN14475162	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR2000383	100.97	69.59	69.58	SAMN03569081	Fecal suspension - 2011 E coli outbreak Raw sequence reads
L11079.1	SRR7658622	98.78	68.24	68.07	SAMN09781734	Metagenomic sequencing of stool samples from rural communities from north-eastern Madagascar
L11079.1	SRR4101302	98.74	68.24	68.04	SAMN05715932	food contamination metagenome Metagenome
L11079.1	SRR6514664	97.90	67.57	67.47	SAMN08379457	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	SRR11435986	96.92	66.89	66.79	SAMN14475174	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR12711466	96.90	66.89	66.78	SAMN15870926	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR6514655	96.79	66.89	66.70	SAMN08379452	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	SRR11391801	96.19	66.22	66.29	SAMN14418853	Metagenomic Sequencing for cattle manure and E. coli library from cattle manure
L11079.1	SRR10692160	96.12	66.22	66.24	SAMN13246266	human gut metagenome Metagenome
L11079.1	SRR5377209	95.23	65.54	65.63	SAMN06624502	human gut metagenome Raw sequence reads
L11079.1	SRR11435967	94.83	65.54	65.35	SAMN14475167	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR11391799	92.35	63.51	63.64	SAMN14418855	Metagenomic Sequencing for cattle manure and E. coli library from cattle manure
L11079.1	SRR15276864	92.11	63.51	63.47	SAMN20362773	AMR target-enriched metagenomic and 16S rRNA reads from cows raised in conventional or organic setting
L11079.1	SRR2177251	91.84	63.51	63.29	SAMN04001579	STEC-spiked spinach Metagenome
L11079.1	SRR12217733	90.86	62.84	62.61	SAMN15503819	Bovine fecal metagenome from dairy veal calves
L11079.1	SRR5866502	89.99	62.16	62.02	SAMN07414389	Whole-Grain rich diet cross-over study
L11079.1	SRR2177360	89.75	62.16	61.85	SAMN04001593	STEC-spiked spinach Metagenome
L11079.1	SRR6514657	89.08	61.49	61.39	SAMN08379450	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	SRR2177358	88.93	61.49	61.28	SAMN04001592	STEC-spiked spinach Metagenome
L11079.1	SRR15276869	88.35	60.81	60.89	SAMN20362768	AMR target-enriched metagenomic and 16S rRNA reads from cows raised in conventional or organic setting
L11079.1	SRR4018489	87.36	60.14	60.21	SAMN05442507	freshwater metagenome Raw sequence reads
L11079.1	ERR3525314	86.16	59.46	59.38	SAMEA5961691	Metagenomic sequencing of the rumen of cattle (Bos Taurus), sheep (Ovis aries), reindeer (Rangifer tarandus) and red deer (Cervus elaphus)
L11079.1	ERR4083585	84.34	58.11	58.12	SAMEA6809520	Large scale metagenome assembly reveals novel animal-associated microbial diversity
L11079.1	SRR13236686	83.96	58.11	57.86	SAMN16807469	Cellulolytic microbial consortium Genome sequencing and assembly
L11079.1	SRR2177359	82.07	56.76	56.56	SAMN04001592	STEC-spiked spinach Metagenome
L11079.1	SRR14842352	81.38	56.08	56.08	SAMN19735668	Global Canine Shotgun Microbiomes
L11079.1	SRR14780119	81.35	56.08	56.06	SAMN15504563	Metagenomics MinION and Flongle sequencing of spiked beef
L11079.1	SRR3181139	80.93	56.08	55.77	SAMN04450471	Cattle feces Metagenome
L11079.1	ERR738545	80.27	55.41	55.32	SAMEA3216837	Benchmark of metagenome analysis tools
L11079.1	SRR2177361	78.33	54.05	53.98	SAMN04001593	STEC-spiked spinach Metagenome
L11079.1	SRR13855170	78.32	54.05	53.97	SAMN18090719	Development of standard protocols for shotgun metagenomics analyses of human fecal microbiota (raw sequencing reads)
L11079.1	SRR4425658	78.28	54.05	53.94	SAMN05597113	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR6869094	77.59	53.38	53.47	SAMN08738635	Bovine Fecal Metagenomics During Early Life
L11079.1	ERR4298353	75.49	52.03	52.02	SAMEA7020081	Proficiency testing of metagenomics-based detection of food-borne pathogens using a complex artificial sequencing dataset
L11079.1	ERR3525309	75.20	52.03	51.82	SAMEA5961686	Metagenomic sequencing of the rumen of cattle (Bos Taurus), sheep (Ovis aries), reindeer (Rangifer tarandus) and red deer (Cervus elaphus)
L11079.1	SRR4018491	74.46	51.35	51.31	SAMN05442509	freshwater metagenome Raw sequence reads
L11079.1	ERR589506	73.59	50.68	50.71	SAMEA2737661	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	SRR4101318	73.50	50.68	50.65	SAMN05715937	food contamination metagenome Metagenome
L11079.1	ERR3393547	73.12	50.68	50.39	SAMEA5733050	Animal gut microbiome
L11079.1	SRR4101317	72.50	50.00	49.97	SAMN05715937	food contamination metagenome Metagenome
L11079.1	SRR2177281	72.50	50.00	49.96	SAMN04001575	STEC-spiked spinach Metagenome
L11079.1	SRR11236200	71.60	49.32	49.34	SAMN14270949	Human gut microbiome Raw sequence reads
L11079.1	SRR7428413	71.46	49.32	49.25	SAMN09355640	Human Fecal Metagenome Metagenome
L11079.1	SRR11435977	71.45	49.32	49.24	SAMN14475182	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	ERR1620344	71.13	49.32	49.02	SAMEA4431957	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	SRR10403548	71.13	49.32	49.02	SAMN13221638	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR11462833	71.13	49.32	49.02	SAMN14514676	Alteration in gut microbiota composition and functional relevance in subclinical carotid atherosclerosis in the general popolation
L11079.1	SRR13236684	71.13	49.32	49.02	SAMN16991297	Cellulolytic microbial consortium Genome sequencing and assembly
L11079.1	SRR7351778	71.13	49.32	49.02	SAMN09278138	Probiotics in Pregnancy study
L11079.1	SRR7351897	71.13	49.32	49.02	SAMN09278319	Probiotics in Pregnancy study
L11079.1	ERR3218128	70.44	48.65	48.55	SAMEA104500607	PATCH_MICROBIOME
L11079.1	SRR13355226	70.38	48.65	48.50	SAMN17091845	Mock community containing 99% human DNA and 1% E. coli DNA.
L11079.1	SRR17284332	70.28	48.65	48.43	SAMN23963220	Transmission and formation of microbiota in the ealry life
L11079.1	SRR12158991	70.15	48.65	48.34	SAMN15422813	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR2083222	66.68	45.95	45.95	SAMN03801314	Freshwater Viruses Metagenomic assembly
L11079.1	SRR10499594	65.81	45.27	45.35	SAMN13292994	human gut metagenome Metagenome
L11079.1	SRR14842407	64.69	44.59	44.58	SAMN19735663	Global Canine Shotgun Microbiomes
L11079.1	SRR12710906	64.62	44.59	44.53	SAMN15870971	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR7110579	64.32	44.59	44.32	SAMN08776114	Enriched fungal communities from goat fecal pellet, Isla Vista, California, United States - Alfalfa, Gen10, Rep 1, Penicillin and Streptomycin metagenome
L11079.1	SRR8845319	64.31	44.59	44.32	SAMN11311500	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	ERR738544	63.67	43.92	43.88	SAMEA3216836	Benchmark of metagenome analysis tools
L11079.1	SRR10692412	63.63	43.92	43.85	SAMN13246275	human gut metagenome Metagenome
L11079.1	SRR10692766	63.32	43.92	43.63	SAMN13247019	human gut metagenome Metagenome
L11079.1	SRR4018499	61.58	42.57	42.44	SAMN05442516	freshwater metagenome Raw sequence reads
L11079.1	SRR12711033	59.71	41.22	41.15	SAMN15871266	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR1747032	58.88	40.54	40.58	SAMN03275585	Baboon feces Metagenome
L11079.1	SRR15276862	58.80	40.54	40.52	SAMN20362775	AMR target-enriched metagenomic and 16S rRNA reads from cows raised in conventional or organic setting
L11079.1	SRR12159420	58.35	40.54	40.21	SAMN15422427	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR6514659	57.78	39.86	39.82	SAMN08379456	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	SRR6869091	54.99	37.84	37.89	SAMN08738632	Bovine Fecal Metagenomics During Early Life
L11079.1	ERR5310767	54.77	37.84	37.74	SAMEA8082447	The TrackCattle Study
L11079.1	SRR12710912	52.96	36.49	36.50	SAMN15870965	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR7287333	51.99	35.81	35.83	SAMN09223217	Viral metagenome in feces from yaks in China
L11079.1	SRR11435981	51.99	35.81	35.83	SAMN14475179	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR4018493	51.94	35.81	35.79	SAMN05442511	freshwater metagenome Raw sequence reads
L11079.1	SRR10692116	50.83	35.14	35.03	SAMN13246425	human gut metagenome Metagenome
L11079.1	SRR11435976	49.94	34.46	34.42	SAMN14475183	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR2177284	48.94	33.78	33.73	SAMN04001575	STEC-spiked spinach Metagenome
L11079.1	SRR13434630	48.62	33.78	33.51	SAMN17312157	Primate phageomes are structured by superhost phylogeny and environment
L11079.1	SRR13217252	46.58	32.43	32.10	SAMN17026885	Manure metagenome from Ceftiofur-treated dairy cow
L11079.1	SRR10098309	46.23	31.76	31.86	SAMN12692666	Bovine composite fecal metagenome from pre-weaned dairy calves and lactating cows
L11079.1	SRR13855169	45.61	31.76	31.43	SAMN18090719	Development of standard protocols for shotgun metagenomics analyses of human fecal microbiota (raw sequencing reads)
L11079.1	SRR5678929	44.57	31.08	30.71	SAMN06685608	Farm metagenomes conventional and organic
L11079.1	SRR4425718	43.23	29.73	29.79	SAMN05597097	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	ERR4083577	43.23	29.73	29.79	SAMEA6809531	Large scale metagenome assembly reveals novel animal-associated microbial diversity
L11079.1	SRR4444801	42.24	29.05	29.11	SAMN05545021	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR11435980	41.27	28.38	28.44	SAMN14475180	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR8289515	41.20	28.38	28.39	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR10692023	40.69	28.38	28.04	SAMN13246444	human gut metagenome Metagenome
L11079.1	ERR4398810	40.25	27.70	27.74	SAMEA7112149	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	SRR14842348	39.98	27.70	27.55	SAMN19735734	Global Canine Shotgun Microbiomes
L11079.1	SRR13694787	39.98	27.70	27.55	SAMN17884110	Vaginal seeding in babies born by caesarean section (ECOBABe trial) - shotgun metagenomics data
L11079.1	SRR13694830	39.98	27.70	27.55	SAMN17884072	Vaginal seeding in babies born by caesarean section (ECOBABe trial) - shotgun metagenomics data
L11079.1	SRR11830715	39.72	27.70	27.38	SAMN14511597	Metatranscriptome of enriched fungal communities from goat fecal pellet, Isla Vista, California, United States - Bagasse, Gen9, Rep 1, Penicillin and Streptomycin
L11079.1	SRR7031287	39.59	27.70	27.28	SAMN08779031	Goat fecal pellet enrichment culture fungal communities from Isla Vista, California, USA - Xylan, Gen0, Rep 1 metagenome
L11079.1	SRR6915177	39.23	27.03	27.03	SAMN08813928	Whole-metagenome shotgun sequencing of two Italian fecal CRC cohorts
L11079.1	SRR2938207	39.18	27.03	27.00	SAMN04261292	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR1524754	39.00	27.03	26.88	SAMN02929926	Human saliva, creek water, and synthetic metagenomic samples used in selective DNA isolation using restriction enzymes
L11079.1	ERR525753	38.60	27.03	26.60	SAMEA2579970	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	SRR11941643	38.60	27.03	26.60	SAMN15156483	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	ERR738546	38.36	26.35	26.44	SAMEA3216838	Benchmark of metagenome analysis tools
L11079.1	SRR13826014	38.23	26.35	26.34	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099390	38.23	26.35	26.34	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR4018502	38.18	26.35	26.31	SAMN05442519	freshwater metagenome Raw sequence reads
L11079.1	ERR589505	38.08	26.35	26.24	SAMEA2737660	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	SRR11830676	38.01	26.35	26.19	SAMN14511341	Metatranscriptome of enriched fungal communities from goat fecal pellet, Isla Vista, California, United States - Bagasse, Gen6, Rep 1, Penicillin and Streptomycin
L11079.1	ERR4616331	37.87	26.35	26.09	SAMEA7332299	TwinUK cohort
L11079.1	SRR9844162	37.35	25.68	25.74	SAMN12371673	Gut microbiome for the MORDOR I study.
L11079.1	SRR6869085	37.27	25.68	25.68	SAMN08738622	Bovine Fecal Metagenomics During Early Life
L11079.1	ERR4398767	37.23	25.68	25.66	SAMEA7112106	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	ERR2855824	37.19	25.68	25.63	SAMEA4968242	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR4616330	36.88	25.68	25.42	SAMEA7332299	TwinUK cohort
L11079.1	SRR15276865	36.00	25.00	24.81	SAMN20362772	AMR target-enriched metagenomic and 16S rRNA reads from cows raised in conventional or organic setting
L11079.1	SRR17317416	35.94	25.00	24.77	SAMN24337964	The difference between diarrhea piglets and normal piglets
L11079.1	SRR17317415	35.80	25.00	24.67	SAMN24337962	The difference between diarrhea piglets and normal piglets
L11079.1	SRR5371471	35.14	24.32	24.22	SAMN06117809	bovine fecal metagenome raw sequence reads
L11079.1	SRR5273912	34.95	24.32	24.09	SAMN06350202	Mother-infant microbiome vertical transmission
L11079.1	ERR3450712	34.93	24.32	24.07	SAMEA5814004	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3153881	34.56	23.65	23.82	SAMEA5335642	gut microbiota of wild-living fish (V1-3 region, 454 pyrosequencing)
L11079.1	SRR12710909	34.31	23.65	23.64	SAMN15870968	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR4425697	34.22	23.65	23.58	SAMN05597123	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR7532988	34.22	23.65	23.58	SAMN09641552	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR4101316	34.06	23.65	23.47	SAMN05715937	food contamination metagenome Metagenome
L11079.1	ERR4564087	33.94	23.65	23.39	SAMEA7288503	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR3004221	33.94	23.65	23.39	SAMEA4813778	KOALA cohort metagenome study
L11079.1	ERR3153848	33.84	23.65	23.32	SAMEA5335622	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR710432	33.71	23.65	23.23	SAMEA3178943	Gut microbiome development along the colorectal adenoma-carcinoma sequence
L11079.1	SRR12875514	33.71	23.65	23.23	SAMN16513441	Gut microbiome is associated with exercise tolerance of resected early-stage lung cancer patients
L11079.1	SRR7723001	33.71	23.65	23.23	SAMN09863745	Influence of early environmental factors on the establishment and development of gut microbiome composition and function and metabolomics profiles in infants at-risk of celiac disease
L11079.1	ERR4571217	33.70	23.65	23.22	SAMEA7294535	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	ERR4571477	33.70	23.65	23.22	SAMEA7294535	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	SRR7227920	33.70	23.65	23.22	SAMN09272168	Effect of bariatric surgery on the faecal metagenome
L11079.1	SRR3181109	33.43	22.97	23.04	SAMN04450441	Cattle feces Metagenome
L11079.1	SRR2083213	33.34	22.97	22.97	SAMN03801324	Freshwater Viruses Metagenomic assembly
L11079.1	SRR15511266	33.28	22.97	22.94	SAMN20837616	Differential effects of western and mediterranean-type diets on gut microbiota: a metagenomics and metabolomics approach
L11079.1	ERR1135379	33.24	22.97	22.90	SAMEA3663206	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR1135382	33.24	22.97	22.90	SAMEA3663209	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR1135388	33.24	22.97	22.90	SAMEA3663215	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	SRR11412775	33.22	22.97	22.90	SAMN14445732	human gut metagenome Metagenome
L11079.1	SRR12710915	33.22	22.97	22.89	SAMN15870963	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR4425662	33.10	22.97	22.81	SAMN05597107	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR7532989	33.10	22.97	22.81	SAMN09641551	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR17317414	32.99	22.97	22.73	SAMN24337966	The difference between diarrhea piglets and normal piglets
L11079.1	ERR912057	32.73	22.97	22.56	SAMEA3449252	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	SRR13855168	32.40	22.30	22.33	SAMN18090720	Development of standard protocols for shotgun metagenomics analyses of human fecal microbiota (raw sequencing reads)
L11079.1	ERR1135385	32.25	22.30	22.23	SAMEA3663212	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR1135386	32.25	22.30	22.23	SAMEA3663213	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR3393539	32.25	22.30	22.23	SAMEA5733042	Animal gut microbiome
L11079.1	SRR13826161	32.25	22.30	22.23	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099373	32.25	22.30	22.23	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR5866558	31.75	22.30	21.88	SAMN07414360	Whole-Grain rich diet cross-over study
L11079.1	SRR16681855	31.75	22.30	21.88	SAMN22567060	Metagenomic analysis of gut microbiota of people with depression disorders for determination of the composition of the marker genes.
L11079.1	SRR12390981	31.72	22.30	21.86	SAMN15733940	Metagenome of wastewater-derived enrichment cultures with different culture media
L11079.1	ERR2020037	31.29	21.62	21.56	SAMEA104144127	We studied the effect of different zinc sources on the intestinal microbiome in weaned pigs
L11079.1	SRR17317413	31.27	21.62	21.55	SAMN24337968	The difference between diarrhea piglets and normal piglets
L11079.1	ERR3003428	31.04	21.62	21.39	SAMEA4813845	KOALA cohort metagenome study
L11079.1	ERR3406244	30.92	21.62	21.31	SAMEA5616932	Early_life_microbiota_colonisation
L11079.1	SRR5371465	30.84	21.62	21.25	SAMN06117812	bovine fecal metagenome raw sequence reads
L11079.1	ERR3451055	30.76	21.62	21.20	SAMEA5814699	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	SRR12711219	30.37	20.95	20.93	SAMN15870986	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12711444	30.15	20.95	20.78	SAMN15870928	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR5866559	29.92	20.95	20.62	SAMN07414361	Whole-Grain rich diet cross-over study
L11079.1	ERR4571347	29.80	20.95	20.53	SAMEA7294535	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	SRR15930985	29.66	20.27	20.44	SAMN21398251	human fecal and saliva metagenome Raw sequence reads
L11079.1	SRR15276861	29.45	20.27	20.30	SAMN20362751	AMR target-enriched metagenomic and 16S rRNA reads from cows raised in conventional or organic setting
L11079.1	SRR13263841	29.45	20.27	20.29	SAMN17083963	Soil microbial community Generation
L11079.1	SRR6514658	29.38	20.27	20.24	SAMN08379449	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	SRR8289456	29.34	20.27	20.22	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR1135383	29.31	20.27	20.20	SAMEA3663210	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR1135221	29.30	20.27	20.19	SAMEA3663048	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR3218092	29.10	20.27	20.05	SAMEA104500565	PATCH_MICROBIOME
L11079.1	SRR7030480	28.83	20.27	19.87	SAMN08778355	Goat fecal pellet enrichment culture fungal communities from Isla Vista, California, USA - Alfalfa, Gen0, Rep 3 metagenome
L11079.1	SRR7642179	28.48	19.59	19.62	SAMN09762372	Rural and Urban infant''s fecal microbiota study
L11079.1	SRR8289504	28.42	19.59	19.58	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR14780120	28.38	19.59	19.56	SAMN15504563	Metagenomics MinION and Flongle sequencing of spiked beef
L11079.1	SRR8289132	28.23	19.59	19.45	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR13517648	28.21	19.59	19.44	SAMN17521793	Metagenomics of antimicrobial and heavy metal resistance in the cecal microbiome of fattening pigs raised without antibiotics
L11079.1	ERR4616332	28.21	19.59	19.44	SAMEA7332299	TwinUK cohort
L11079.1	ERR6170276	27.87	19.59	19.20	SAMEA8945704	VEGA Human Gut Metagenomics
L11079.1	ERR3857638	27.83	19.59	19.18	SAMEA6512880	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	SRR6202091	27.48	18.92	18.93	SAMN07811858	Metagenomic sequencing of the gut microbiomes of bats with different diets
L11079.1	ERR3941303	27.26	18.92	18.79	SAMEA6577303	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	SRR7533038	27.15	18.92	18.71	SAMN09641623	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR14346537	26.89	18.92	18.53	SAMN18880775	The role of maternal exposures on commensal microbes
L11079.1	SRR8289526	26.47	18.24	18.24	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR11650009	26.40	18.24	18.19	SAMN14582974	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR12711455	26.40	18.24	18.19	SAMN15870927	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	ERR3393526	26.39	18.24	18.19	SAMEA5733029	Animal gut microbiome
L11079.1	SRR10691957	26.34	18.24	18.15	SAMN13246730	human gut metagenome Metagenome
L11079.1	SRR8289130	26.24	18.24	18.08	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289462	26.20	18.24	18.05	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR3053183	26.12	18.24	18.00	SAMN04362349	Beef Production Metagenome Raw sequence reads
L11079.1	ERR4571087	26.11	18.24	17.99	SAMEA7294535	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	SRR8288641	26.08	18.24	17.97	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR7030503	25.91	18.24	17.85	SAMN08778356	Goat fecal pellet enrichment culture fungal communities from Isla Vista, California, USA - Reed Canary Grass, Gen0, Rep 3 metagenome
L11079.1	ERR1600724	25.49	17.57	17.56	SAMEA4385582	Using WTP diet to modulate gut microbiota to alleviate human type 2 diabetes
L11079.1	SRR10692252	25.45	17.57	17.54	SAMN13246551	human gut metagenome Metagenome
L11079.1	SRR7228016	25.44	17.57	17.53	SAMN09272179	Effect of bariatric surgery on the faecal metagenome
L11079.1	ERR1135389	25.39	17.57	17.50	SAMEA3663216	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR589513	25.17	17.57	17.35	SAMEA2737668	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	SRR6877525	25.05	17.57	17.26	SAMN08765503	Healthy human bile Metagenome
L11079.1	SRR3181138	24.93	17.57	17.18	SAMN04450470	Cattle feces Metagenome
L11079.1	ERR3245383	24.59	16.89	16.95	SAMEA5532660	Functional description of microbial communities  from biochemical passive reactors treating synthetic Acide Mine Drainage
L11079.1	SRR8289129	24.53	16.89	16.91	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR1600642	24.50	16.89	16.88	SAMEA4385500	Using WTP diet to modulate gut microbiota to alleviate human type 2 diabetes
L11079.1	SRR13180940	24.47	16.89	16.87	SAMN16976311	Fecogenome
L11079.1	SRR8299362	24.42	16.89	16.83	SAMN10561989	Viral diversity in river catchment area
L11079.1	SRR13979576	24.31	16.89	16.75	SAMN18315996	Metagenomic analysis reveals the signature of gut microbiota associated with human chronotypes
L11079.1	ERR912002	24.27	16.89	16.73	SAMEA3449197	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	SRR8890836	24.26	16.89	16.72	SAMN11407866	Gut microbiome differences between wild and captive black rhinoceros – implications for rhino health
L11079.1	ERR4682411	24.19	16.89	16.67	SAMEA7428318	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	SRR8288631	24.16	16.89	16.65	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR4101300	23.60	16.22	16.27	SAMN05715932	food contamination metagenome Metagenome
L11079.1	ERR527133	23.59	16.22	16.26	SAMEA2581964	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	SRR6474258	23.59	16.22	16.26	SAMN08366201	human gut Metagenome
L11079.1	SRR13318207	23.54	16.22	16.23	SAMN17171336	Netherland Travelers
L11079.1	SRR14812346	23.47	16.22	16.17	SAMN19686914	Piglet gut and in-barn manure from farms on Raised Without Antibiotics program display a reduced antimicrobial resistance but an increased prevalence of pathogens
L11079.1	ERR1135387	23.46	16.22	16.17	SAMEA3663214	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR2597391	23.45	16.22	16.16	SAMEA4688905	VETII samples
L11079.1	SRR5270854	23.44	16.22	16.16	SAMN06267770	Arabidopsis thaliana rhizosphere microbial communities from the Joint Genome Institute, USA, that affect carbon cycling - Inoculated plant M1 S PM metagenome
L11079.1	ERR4398765	23.20	16.22	15.99	SAMEA7112104	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	ERR1135248	22.60	15.54	15.57	SAMEA3663075	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	SRR8288629	22.54	15.54	15.53	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR1135378	22.47	15.54	15.48	SAMEA3663205	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR4398798	22.13	15.54	15.25	SAMEA7112137	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	ERR3857640	22.12	15.54	15.24	SAMEA6512880	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	SRR14346583	22.11	15.54	15.24	SAMN18880782	The role of maternal exposures on commensal microbes
L11079.1	ERR3857610	21.94	15.54	15.12	SAMEA6512902	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	ERR7439212	21.67	14.86	14.93	SAMEA10813641	Long-term effects of diet on human gut microbiota composition employing shotgun metagenomics data analysis
L11079.1	ERR4682403	21.60	14.86	14.88	SAMEA7428310	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	SRR5371469	21.55	14.86	14.85	SAMN06117810	bovine fecal metagenome raw sequence reads
L11079.1	ERR2597327	21.48	14.86	14.80	SAMEA4688841	VETII samples
L11079.1	ERR4682857	21.16	14.86	14.58	SAMEA7428499	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682358	20.73	14.19	14.29	SAMEA7428265	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	SRR5679022	20.66	14.19	14.24	SAMN06685517	Farm metagenomes conventional and organic
L11079.1	ERR2241884	20.63	14.19	14.22	SAMEA104467387	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR4678562	20.61	14.19	14.20	SAMEA7426262	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	SRR12710908	20.57	14.19	14.18	SAMN15870969	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	ERR3502022	20.50	14.19	14.13	SAMEA5925635	A cross-sectional study of compositional and functional profiles of gut microbiota in Sardinian centenarians
L11079.1	ERR1620360	20.24	14.19	13.95	SAMEA4431973	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	SRR6059975	20.19	14.19	13.91	SAMN07632032	Fecal eukaryotic communites from dung pellets of Tule Elk in California, USA - Elk Dung F16 Day 16 Metagenome metagenome
L11079.1	SRR9218142	20.14	14.19	13.88	SAMN10877829	Metagenomic Reconstructions of Gut Microbiome in Weanling Pigs
L11079.1	ERR4398749	19.69	13.51	13.57	SAMEA7112088	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	SRR14842351	19.64	13.51	13.53	SAMN19735731	Global Canine Shotgun Microbiomes
L11079.1	SRR6325481	19.63	13.51	13.53	SAMN08097993	iron plaque metagenome Raw sequence reads
L11079.1	ERR2835560	19.54	13.51	13.46	SAMEA4968994	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	SRR11185243	19.52	13.51	13.45	SAMN11098509	Pig microbiome
L11079.1	ERR3656893	19.52	13.51	13.45	SAMEA6168775	Analysis of freeze-dried faecal samples collected from individuals between 1974 and 1980
L11079.1	ERR4290620	19.24	13.51	13.26	SAMEA7014618	Microbiome signature in post-treatment Lyme disease syndrome patients
L11079.1	ERR4564517	19.18	13.51	13.22	SAMEA7288884	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR3941325	18.73	12.84	12.91	SAMEA6577325	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	DRR171333	18.68	12.84	12.87	SAMD00162318	Comparison of sequencing bias for library preparation kit
L11079.1	ERR4086544	18.68	12.84	12.87	SAMEA6811483	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	SRR6869093	18.67	12.84	12.87	SAMN08738634	Bovine Fecal Metagenomics During Early Life
L11079.1	SRR15276859	18.65	12.84	12.85	SAMN20362753	AMR target-enriched metagenomic and 16S rRNA reads from cows raised in conventional or organic setting
L11079.1	ERR3450919	18.64	12.84	12.85	SAMEA5814098	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	SRR10682144	18.64	12.84	12.85	SAMN13252422	viral metagenome Metagenome
L11079.1	ERR3986553	18.64	12.84	12.84	SAMEA6618425	Identifying frailty-associated markers in Elderly Irish Individuals
L11079.1	SRR4423065	18.64	12.84	12.84	SAMN05891542	Shotgun sequencing of the gut microbiome to look at vitamin K biosynthesis
L11079.1	SRR15276858	18.59	12.84	12.81	SAMN20362754	AMR target-enriched metagenomic and 16S rRNA reads from cows raised in conventional or organic setting
L11079.1	ERR1655291	18.57	12.84	12.80	SAMEA4462218	The Diet and Exercise-Microbiome Paradigm: Distinct Functional Profiles of the Athlete Microbiome Revealed by Metagenomic and Metabolomic  Analysis
L11079.1	ERR3451257	18.56	12.84	12.79	SAMEA5814543	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	SRR14842324	18.55	12.84	12.78	SAMN19735756	Global Canine Shotgun Microbiomes
L11079.1	SRR7193049	18.55	12.84	12.78	SAMN09235249	Evaluation of porcine fecal microbiomes after exposure to ceftriaxone
L11079.1	SRR14489481	18.53	12.84	12.77	SAMN19068589	Study of microbial community from mixed cow-dung and plant sample
L11079.1	SRR12710910	18.49	12.84	12.74	SAMN15870967	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR6869080	18.44	12.84	12.71	SAMN08738625	Bovine Fecal Metagenomics During Early Life
L11079.1	SRR2566049	18.26	12.84	12.59	SAMN04126100	Intestinal microbiota dynamics in hospitalized patients
L11079.1	SRR7031257	18.21	12.84	12.55	SAMN08777589	Goat fecal pellet enrichment culture fungal communities from Isla Vista, California, USA - Xylan, Gen0, Rep 2 metagenome
L11079.1	SRR2566060	18.20	12.84	12.54	SAMN04126101	Intestinal microbiota dynamics in hospitalized patients
L11079.1	SRR2155332	18.10	12.84	12.47	SAMN03922488	Characterization of the distal gut microbiota in obese patients following a weight-loss intervention using whole metagenome shotgun sequencing
L11079.1	ERR3857613	18.03	12.84	12.42	SAMEA6512902	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	ERR2193828	17.68	12.16	12.19	SAMEA104378596	BBSRC Main Experiment Shotgun Study
L11079.1	SRR2083217	17.67	12.16	12.17	SAMN03801319	Freshwater Viruses Metagenomic assembly
L11079.1	ERR3574885	17.66	12.16	12.17	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3097513	17.64	12.16	12.16	SAMEA5245476	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3211921	17.56	12.16	12.10	SAMEA5414566	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	SRR8289332	17.53	12.16	12.08	SAMN10508885	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR13855167	17.50	12.16	12.06	SAMN18090720	Development of standard protocols for shotgun metagenomics analyses of human fecal microbiota (raw sequencing reads)
L11079.1	SRR8925811	17.46	12.16	12.03	SAMN11458248	Metagenome of feedstock samples for 56 full-scale biogas plants in China
L11079.1	SRR12390982	17.09	12.16	11.78	SAMN15733939	Metagenome of wastewater-derived enrichment cultures with different culture media
L11079.1	ERR3451502	17.06	12.16	11.76	SAMEA5814182	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	SRR10572878	16.72	11.49	11.52	SAMN13451461	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR8289530	16.71	11.49	11.51	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR589512	16.70	11.49	11.51	SAMEA2737667	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	SRR8890822	16.63	11.49	11.46	SAMN11407850	Gut microbiome differences between wild and captive black rhinoceros – implications for rhino health
L11079.1	SRR17284133	16.63	11.49	11.46	SAMN23963225	Transmission and formation of microbiota in the ealry life
L11079.1	SRR9866666	16.59	11.49	11.43	SAMN12283821	Metagenomic sequencing of Lawsonia intracellularis
L11079.1	SRR12529378	16.58	11.49	11.43	SAMN15829943	An integrated gene catalog and over 10,000 metagenome-assembled genomes from the gastrointestinal microbiome of ruminants
L11079.1	SRR14474040	16.58	11.49	11.43	SAMN19078916	Metagenome of pig fecal bacteria
L11079.1	SRR12711024	16.54	11.49	11.40	SAMN15870914	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR11236188	16.50	11.49	11.37	SAMN14270960	Human gut microbiome Raw sequence reads
L11079.1	SRR8289527	16.50	11.49	11.37	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR3574525	16.46	11.49	11.34	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR2835366	16.43	11.49	11.32	SAMEA4968800	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2683237	16.33	11.49	11.25	SAMEA4777494	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	SRR16178815	16.21	11.49	11.17	SAMN22025967	Metagenomic analysis towards biomarkers and prediction models between intestinal polyp patients and colorectal cancer patients
L11079.1	SRR3181119	15.74	10.81	10.85	SAMN04450451	Cattle feces Metagenome
L11079.1	SRR8784392	15.70	10.81	10.82	SAMN11252296	Metagenomic sequencing of stool samples from Ethiopian individuals
L11079.1	SRR14307655	15.69	10.81	10.81	SAMN18790488	Research on diversity of gut microbes
L11079.1	SRR8289131	15.66	10.81	10.79	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR3574523	15.65	10.81	10.79	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3097525	15.65	10.81	10.78	SAMEA5245488	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	SRR10209667	15.64	10.81	10.78	SAMN12867438	pig gut metagenome Targeted loci environmental
L11079.1	ERR2816258	15.63	10.81	10.77	SAMEA4947584	The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy
L11079.1	SRR10098752	15.42	10.81	10.63	SAMN12727813	Characterization of antimicrobial resistance genes in the enriched Enterobacteriaceae community of suburban mesocarnivores, stray dogs and owned dogs.
L11079.1	ERR3857641	15.27	10.81	10.53	SAMEA6512880	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	SRR4425696	15.27	10.81	10.52	SAMN05597075	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR7030482	15.16	10.81	10.45	SAMN08777591	Goat fecal pellet enrichment culture fungal communities from Isla Vista, California, USA - Bagasse, Gen0, Rep 2 metagenome
L11079.1	ERR3451222	14.81	10.14	10.21	SAMEA5814285	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	SRR10692490	14.80	10.14	10.20	SAMN13246271	human gut metagenome Metagenome
L11079.1	SRR6784537	14.77	10.14	10.18	SAMN06619283	MECFS metagenomics
L11079.1	SRR4425664	14.73	10.14	10.15	SAMN05597109	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR3181133	14.73	10.14	10.15	SAMN04450465	Cattle feces Metagenome
L11079.1	SRR6847361	14.71	10.14	10.14	SAMN04330478	Vaginal Microbiome of Pregnancy
L11079.1	ERR1992810	14.71	10.14	10.14	SAMEA103954417	Semi-synthetic marine metagenomes for metagenomic pipeline assessment
L11079.1	SRR6058008	14.70	10.14	10.13	SAMN07679372	Impacts of florfenicol on the antimicrobial resistance and community composition of microbiome in aquaculture ecosystem as revealed by metagenomics sequencing
L11079.1	SRR8289379	14.68	10.14	10.11	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8925792	14.65	10.14	10.10	SAMN11458256	Metagenome of feedstock samples for 56 full-scale biogas plants in China
L11079.1	ERR3211920	14.65	10.14	10.09	SAMEA5414565	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR3211898	14.63	10.14	10.08	SAMEA5414543	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	SRR12447099	14.63	10.14	10.08	SAMN15805260	Swine Feedlot Wastewater metagenome (bacterial and phages)
L11079.1	SRR4018508	14.60	10.14	10.06	SAMN05442496	freshwater metagenome Raw sequence reads
L11079.1	SRR8288596	14.56	10.14	10.03	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289505	14.56	10.14	10.03	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR3404907	14.53	10.14	10.01	SAMEA5616681	Early_life_microbiota_colonisation
L11079.1	SRR8288996	14.52	10.14	10.01	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289516	14.48	10.14	9.98	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR4425705	13.85	9.46	9.55	SAMN05597115	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR7521201	13.81	9.46	9.51	SAMN09572469	bird metagenome Metagenome
L11079.1	SRR8288642	13.77	9.46	9.49	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289459	13.72	9.46	9.46	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR3563064	13.72	9.46	9.45	SAMEA5982337	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR1137262	13.69	9.46	9.43	SAMEA3664936	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR2596699	13.69	9.46	9.43	SAMEA4527656	COMPARE global sewage snapshot virome sequencing part
L11079.1	ERR1135238	13.67	9.46	9.42	SAMEA3663065	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR3211917	13.67	9.46	9.42	SAMEA5414562	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	SRR12619562	13.66	9.46	9.41	SAMN16091599	Manure-associated resistomes in soil column experiment
L11079.1	ERR4682459	13.64	9.46	9.40	SAMEA7428366	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	SRR4018503	13.63	9.46	9.39	SAMN05442520	freshwater metagenome Raw sequence reads
L11079.1	SRR8288628	13.49	9.46	9.30	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR4678623	13.48	9.46	9.29	SAMEA7426323	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	SRR8289128	13.47	9.46	9.28	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR10692476	12.86	8.78	8.86	SAMN13246286	human gut metagenome Metagenome
L11079.1	SRR9037495	12.84	8.78	8.85	SAMN11282390	Bovine Fecal Metagenome
L11079.1	SRR8845571	12.81	8.78	8.83	SAMN11311713	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR12710919	12.81	8.78	8.83	SAMN15870959	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR4425719	12.80	8.78	8.82	SAMN05597096	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR8289463	12.78	8.78	8.81	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR6058009	12.78	8.78	8.81	SAMN07679367	Impacts of florfenicol on the antimicrobial resistance and community composition of microbiome in aquaculture ecosystem as revealed by metagenomics sequencing
L11079.1	SRR10572917	12.77	8.78	8.80	SAMN13451426	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR8288633	12.75	8.78	8.79	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289126	12.75	8.78	8.78	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289500	12.74	8.78	8.78	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR7587241	12.74	8.78	8.78	SAMN09710141	The role of Parmesan cheese in vectoring bovine microbiota's engraftment in the human gut.
L11079.1	ERR6995237	12.71	8.78	8.76	SAMEA10313695	iMSMS Baranzini data
L11079.1	ERR2597541	12.70	8.78	8.75	SAMEA4689055	VETII samples
L11079.1	SRR12459640	12.70	8.78	8.75	SAMN15824903	PROMISE Cohort Metagenome sequence data
L11079.1	ERR3211788	12.68	8.78	8.74	SAMEA5414433	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR2597490	12.68	8.78	8.74	SAMEA4689004	VETII samples
L11079.1	SRR12459394	12.68	8.78	8.74	SAMN15824809	PROMISE Cohort Metagenome sequence data
L11079.1	ERR2241648	12.68	8.78	8.74	SAMEA104467151	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR3212041	12.67	8.78	8.73	SAMEA5414687	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	SRR8289529	12.59	8.78	8.68	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR4398806	12.53	8.78	8.64	SAMEA7112145	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	SRR7060083	12.50	8.78	8.61	SAMN08976422	Colorado Natural Cattle SCFP Trial
L11079.1	SRR8289528	12.48	8.78	8.60	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8288898	12.47	8.78	8.60	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR4678686	12.37	8.78	8.53	SAMEA7426386	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	SRR10499620	12.35	8.78	8.51	SAMN13292787	human gut metagenome Metagenome
L11079.1	ERR3857639	12.22	8.78	8.42	SAMEA6512880	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	ERR4571535	12.22	8.78	8.42	SAMEA7294522	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	ERR6170198	11.85	8.11	8.16	SAMEA8945632	VEGA Human Gut Metagenomics
L11079.1	ERR4083789	11.82	8.11	8.14	SAMEA6809531	Large scale metagenome assembly reveals novel animal-associated microbial diversity
L11079.1	SRR3053214	11.79	8.11	8.13	SAMN04362352	Beef Production Metagenome Raw sequence reads
L11079.1	ERR3941150	11.78	8.11	8.12	SAMEA6577141	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	SRR4018500	11.77	8.11	8.11	SAMN05442517	freshwater metagenome Raw sequence reads
L11079.1	SRR13517627	11.75	8.11	8.10	SAMN17521794	Metagenomics of antimicrobial and heavy metal resistance in the cecal microbiome of fattening pigs raised without antibiotics
L11079.1	SRR6514665	11.75	8.11	8.10	SAMN08379464	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	ERR1135380	11.75	8.11	8.09	SAMEA3663207	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR321065	11.73	8.11	8.08	SAMEA2155030	Richness of human gut microbiome correlates with metabolic markers
L11079.1	ERR912028	11.73	8.11	8.08	SAMEA3449223	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	DRR195290	11.73	8.11	8.08	SAMD00191348	Megaviridae metabarcoding diversity analysis data
L11079.1	ERR2241683	11.72	8.11	8.08	SAMEA104467186	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	SRR10499466	11.72	8.11	8.08	SAMN13292914	human gut metagenome Metagenome
L11079.1	ERR3574516	11.71	8.11	8.07	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR2597350	11.71	8.11	8.07	SAMEA4688864	VETII samples
L11079.1	SRR7521185	11.71	8.11	8.07	SAMN09572438	bird metagenome Metagenome
L11079.1	ERR4564347	11.70	8.11	8.07	SAMEA7288568	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	SRR12459598	11.70	8.11	8.06	SAMN15824768	PROMISE Cohort Metagenome sequence data
L11079.1	ERR4564349	11.69	8.11	8.06	SAMEA7288568	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	SRR13517650	11.69	8.11	8.06	SAMN17521793	Metagenomics of antimicrobial and heavy metal resistance in the cecal microbiome of fattening pigs raised without antibiotics
L11079.1	ERR4086539	11.66	8.11	8.04	SAMEA6811483	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4678559	11.66	8.11	8.03	SAMEA7426259	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4682384	11.66	8.11	8.03	SAMEA7428291	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	SRR10692670	11.66	8.11	8.03	SAMN13246244	human gut metagenome Metagenome
L11079.1	SRR8299373	11.66	8.11	8.03	SAMN10564369	Viral diversity in river catchment area
L11079.1	SRR9264587	11.65	8.11	8.03	SAMN12011462	human gut metagenome Metagenome
L11079.1	SRR8289386	11.59	8.11	7.99	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR4398803	11.43	8.11	7.88	SAMEA7112142	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	SRR10682712	10.86	7.43	7.49	SAMN13253017	viral metagenome Metagenome
L11079.1	SRR12710904	10.84	7.43	7.47	SAMN15870973	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	ERR1713346	10.83	7.43	7.47	SAMEA4527614	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR2607427	10.83	7.43	7.47	SAMEA4700748	Global surveillance of antimicrobial resistance
L11079.1	ERR2597481	10.83	7.43	7.46	SAMEA4688995	VETII samples
L11079.1	ERR4398763	10.82	7.43	7.46	SAMEA7112102	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	ERR4398709	10.82	7.43	7.46	SAMEA7112048	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	DRR019506	10.81	7.43	7.45	SAMD00011361	Whole genome sequencing of Digital Dermatitis
L11079.1	SRR8289503	10.81	7.43	7.45	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR4425712	10.81	7.43	7.45	SAMN05597099	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	ERR2855875	10.79	7.43	7.44	SAMEA4968179	A causal role of the gut microbiome in schizophrenia
L11079.1	SRR10209685	10.79	7.43	7.44	SAMN12867437	pig gut metagenome Targeted loci environmental
L11079.1	SRR15725430	10.79	7.43	7.44	SAMN21220124	Exploring the possible link between the gut microbiome and fat deposition in pigs
L11079.1	ERR3574814	10.79	7.43	7.44	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3525313	10.78	7.43	7.43	SAMEA5961690	Metagenomic sequencing of the rumen of cattle (Bos Taurus), sheep (Ovis aries), reindeer (Rangifer tarandus) and red deer (Cervus elaphus)
L11079.1	SRR12711154	10.77	7.43	7.42	SAMN15871218	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR7227919	10.77	7.43	7.42	SAMN09272165	Effect of bariatric surgery on the faecal metagenome
L11079.1	SRR7755066	10.72	7.43	7.39	SAMN09908174	Water meter biofilm Raw sequence reads
L11079.1	ERR2182603	10.72	7.43	7.38	SAMEA104359672	Metagenomic characterization of the human intestinal microbiota in faecal samples from STEC-infected patients
L11079.1	SRR12529043	10.72	7.43	7.38	SAMN15829913	An integrated gene catalog and over 10,000 metagenome-assembled genomes from the gastrointestinal microbiome of ruminants
L11079.1	SRR8289502	10.69	7.43	7.37	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289400	10.65	7.43	7.34	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR6996584	10.65	7.43	7.34	SAMEA10314797	iMSMS Baranzini data
L11079.1	SRR8925784	10.61	7.43	7.31	SAMN11458266	Metagenome of feedstock samples for 56 full-scale biogas plants in China
L11079.1	ERR4330119	10.60	7.43	7.31	SAMEA7041226	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	SRR8288627	10.58	7.43	7.29	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR4398800	10.42	7.43	7.18	SAMEA7112139	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	SRR2938218	10.24	7.43	7.06	SAMN04262598	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR10572851	9.90	6.76	6.82	SAMN13451478	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10692415	9.88	6.76	6.81	SAMN13246503	human gut metagenome Metagenome
L11079.1	SRR13436280	9.87	6.76	6.80	SAMN17006404	human gut microbiome predicts response to MTX treatment
L11079.1	SRR6869084	9.86	6.76	6.79	SAMN08738621	Bovine Fecal Metagenomics During Early Life
L11079.1	ERR6040857	9.85	6.76	6.79	SAMEA8909752	Double-stranded RNA meta-transcriptomes from the gut microbiome of calves treated or untreated with florfenicol.
L11079.1	SRR6202092	9.85	6.76	6.79	SAMN07811859	Metagenomic sequencing of the gut microbiomes of bats with different diets
L11079.1	ERR4398796	9.85	6.76	6.79	SAMEA7112135	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	SRR10572911	9.84	6.76	6.78	SAMN13451431	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR6784536	9.83	6.76	6.77	SAMN06619284	MECFS metagenomics
L11079.1	SRR6058006	9.82	6.76	6.77	SAMN07679370	Impacts of florfenicol on the antimicrobial resistance and community composition of microbiome in aquaculture ecosystem as revealed by metagenomics sequencing
L11079.1	ERR3574725	9.82	6.76	6.77	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3525311	9.82	6.76	6.77	SAMEA5961688	Metagenomic sequencing of the rumen of cattle (Bos Taurus), sheep (Ovis aries), reindeer (Rangifer tarandus) and red deer (Cervus elaphus)
L11079.1	SRR12874596	9.80	6.76	6.75	SAMN16502418	Within-host evolution of Vibrio cholerae using metagenomics
L11079.1	ERR4398788	9.79	6.76	6.75	SAMEA7112127	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	ERR3502027	9.79	6.76	6.75	SAMEA5925640	A cross-sectional study of compositional and functional profiles of gut microbiota in Sardinian centenarians
L11079.1	ERR2245477	9.78	6.76	6.74	SAMEA104467343	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	SRR8925809	9.78	6.76	6.74	SAMN11458246	Metagenome of feedstock samples for 56 full-scale biogas plants in China
L11079.1	ERR3574519	9.74	6.76	6.71	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR1135246	9.74	6.76	6.71	SAMEA3663073	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR3941104	9.68	6.76	6.67	SAMEA6577095	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	SRR4018496	9.67	6.76	6.67	SAMN05442513	freshwater metagenome Raw sequence reads
L11079.1	SRR12711223	9.43	6.76	6.50	SAMN15870983	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR10572901	8.90	6.08	6.14	SAMN13451440	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR6869088	8.87	6.08	6.12	SAMN08738629	Bovine Fecal Metagenomics During Early Life
L11079.1	ERR3574872	8.86	6.08	6.11	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3569474	8.86	6.08	6.11	SAMEA5983454	Demographic and environmental drivers of metagenomic viral diversity in vampire bats
L11079.1	SRR14574034	8.85	6.08	6.10	SAMN19237092	rumen content metagenomics sequencing
L11079.1	SRR8289457	8.84	6.08	6.09	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR2597357	8.83	6.08	6.09	SAMEA4688871	VETII samples
L11079.1	ERR2009463	8.83	6.08	6.09	SAMEA104112267	Human fecal metagenome spiked with Campylobacter jejuni
L11079.1	SRR13760448	8.82	6.08	6.08	SAMN18016884	Antibiotic-driven intestinal dysbiosis in paediatric SBS alters microbiome functions and is associated with gut-derived blood stream infections throughout childhood
L11079.1	SRR12711362	8.81	6.08	6.07	SAMN15871487	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12459264	8.81	6.08	6.07	SAMN15824897	PROMISE Cohort Metagenome sequence data
L11079.1	ERR4398789	8.81	6.08	6.07	SAMEA7112128	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	SRR8925825	8.80	6.08	6.07	SAMN11458263	Metagenome of feedstock samples for 56 full-scale biogas plants in China
L11079.1	SRR8289413	8.79	6.08	6.06	SAMN10508885	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR7109575	8.79	6.08	6.06	SAMN08776111	Enriched fungal communities from goat fecal pellet, Isla Vista, California, United States - Alfalfa, Gen5, Rep 3 metagenome
L11079.1	ERR3574521	8.79	6.08	6.06	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR4657931	8.78	6.08	6.05	SAMEA7372251	gut metagenome of HC, IBS, DEP and COMO
L11079.1	SRR10403546	8.77	6.08	6.04	SAMN13221640	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR12711230	8.71	6.08	6.00	SAMN15870976	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	ERR2380891	8.68	6.08	5.98	SAMEA104674556	EQ.128.130507_meta
L11079.1	ERR4844309	7.90	5.41	5.44	SAMEA7567908	Metagenomics and metatranscriptomics of WT and Down Syndrome model (Ts65Dn) mice fed control and High-fat diet, sequenced with Illumina HiSeq (total RNA and ribodepleted RNA).
L11079.1	SRR8289377	7.89	5.41	5.44	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR5664943	7.89	5.41	5.44	SAMEA8514716	Asymptomatic gut colonization by extended-spectrum beta-lactamase producing Escherichia coli is not associated with an altered gut microbiome or metabolome
L11079.1	DRR330123	7.88	5.41	5.43	SAMD00402951	Monitoring circulating tumor DNA by using panel-specific sequencing to predict recurrence in colorectal cancer after surgical resection
L11079.1	DRR330127	7.88	5.41	5.43	SAMD00402955	Monitoring circulating tumor DNA by using panel-specific sequencing to predict recurrence in colorectal cancer after surgical resection
L11079.1	SRR6058005	7.88	5.41	5.43	SAMN07679371	Impacts of florfenicol on the antimicrobial resistance and community composition of microbiome in aquaculture ecosystem as revealed by metagenomics sequencing
L11079.1	ERR2592254	7.88	5.41	5.43	SAMEA4527616	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR2607434	7.88	5.41	5.43	SAMEA4700755	Global surveillance of antimicrobial resistance
L11079.1	ERR4086545	7.87	5.41	5.42	SAMEA6811483	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	SRR8289330	7.86	5.41	5.42	SAMN10508885	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR2835425	7.86	5.41	5.41	SAMEA4968859	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	DRR330131	7.85	5.41	5.41	SAMD00402959	Monitoring circulating tumor DNA by using panel-specific sequencing to predict recurrence in colorectal cancer after surgical resection
L11079.1	ERR2597348	7.85	5.41	5.41	SAMEA4688862	VETII samples
L11079.1	ERR2243490	7.84	5.41	5.40	SAMEA3932918	Effects of preservation and storage conditions on the fecal microbiome
L11079.1	SRR15686320	7.84	5.41	5.40	SAMN21160204	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR15686321	7.84	5.41	5.40	SAMN21160203	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR15686322	7.84	5.41	5.40	SAMN21160202	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR15686333	7.84	5.41	5.40	SAMN21160207	Metagenomics - Survival E. coli in beach sand
L11079.1	ERR4398769	7.84	5.41	5.40	SAMEA7112108	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	SRR10499541	7.84	5.41	5.40	SAMN13293006	human gut metagenome Metagenome
L11079.1	SRR10572899	7.83	5.41	5.40	SAMN13451442	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572908	7.83	5.41	5.40	SAMN13451434	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	ERR1135216	7.83	5.41	5.39	SAMEA3663043	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	SRR13517631	7.82	5.41	5.39	SAMN17521794	Metagenomics of antimicrobial and heavy metal resistance in the cecal microbiome of fattening pigs raised without antibiotics
L11079.1	ERR2739182	7.82	5.41	5.39	SAMEA4833209	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	SRR8289519	7.69	5.41	5.30	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR10098751	7.61	5.41	5.25	SAMN12727814	Characterization of antimicrobial resistance genes in the enriched Enterobacteriaceae community of suburban mesocarnivores, stray dogs and owned dogs.
L11079.1	SRR6514661	7.61	5.41	5.24	SAMN08379454	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	SRR8289376	7.57	5.41	5.21	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR3176534	7.43	5.41	5.12	SAMN04448871	gut microbe Metagenome
L11079.1	SRR3954030	6.98	4.73	4.81	SAMN05441325	Phage-resistant Synechococcus
L11079.1	SRR10572835	6.91	4.73	4.76	SAMN13451492	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572838	6.91	4.73	4.76	SAMN13451418	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572842	6.91	4.73	4.76	SAMN13451486	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572856	6.91	4.73	4.76	SAMN13451473	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572870	6.91	4.73	4.76	SAMN13451469	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572871	6.91	4.73	4.76	SAMN13451468	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572872	6.91	4.73	4.76	SAMN13451467	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572916	6.91	4.73	4.76	SAMN13451427	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR8288598	6.89	4.73	4.75	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8288677	6.88	4.73	4.74	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR12159126	6.88	4.73	4.74	SAMN15422691	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR8289124	6.88	4.73	4.74	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR6847270	6.88	4.73	4.74	SAMN04330490	Vaginal Microbiome of Pregnancy
L11079.1	ERR3574515	6.88	4.73	4.74	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	SRR12711158	6.88	4.73	4.74	SAMN15871214	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR5678805	6.88	4.73	4.74	SAMN07224804	Metagenome studies of ARG on manure and soil sample
L11079.1	DRR330110	6.88	4.73	4.74	SAMD00402938	Monitoring circulating tumor DNA by using panel-specific sequencing to predict recurrence in colorectal cancer after surgical resection
L11079.1	SRR5377206	6.87	4.73	4.74	SAMN06624499	human gut metagenome Raw sequence reads
L11079.1	SRR12089732	6.87	4.73	4.74	SAMN15366210	Trace amine producing bacteria are widespread in the human skin microbiota
L11079.1	ERR1992809	6.87	4.73	4.73	SAMEA103954416	Semi-synthetic marine metagenomes for metagenomic pipeline assessment
L11079.1	ERR2696420	6.87	4.73	4.73	SAMEA4786491	Semi-synthetic marine metagenomes for metagenomic pipeline assessment
L11079.1	SRR8289497	6.87	4.73	4.73	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR3211774	6.87	4.73	4.73	SAMEA5414419	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR5030995	6.86	4.73	4.73	SAMEA3932884	Effects of preservation and storage conditions on the fecal microbiome
L11079.1	SRR5574344	6.86	4.73	4.73	SAMN07125683	Metagenomic analysis of vegetable soil profiles
L11079.1	ERR4844301	6.86	4.73	4.73	SAMEA7567900	Metagenomics and metatranscriptomics of WT and Down Syndrome model (Ts65Dn) mice fed control and High-fat diet, sequenced with Illumina HiSeq (total RNA and ribodepleted RNA).
L11079.1	ERR4398717	6.86	4.73	4.73	SAMEA7112056	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	ERR1223839	6.86	4.73	4.73	SAMEA3730548	A sampling and metagenomic sequencing-based methodology for monitoring antimicrobial resistance in swine herds
L11079.1	ERR209058	6.86	4.73	4.72	SAMEA2042281	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	SRR16110324	6.85	4.73	4.72	SAMN21894385	sock swab screening for Hepatitis E virus surveillance in pig herds
L11079.1	ERR3525310	6.85	4.73	4.72	SAMEA5961687	Metagenomic sequencing of the rumen of cattle (Bos Taurus), sheep (Ovis aries), reindeer (Rangifer tarandus) and red deer (Cervus elaphus)
L11079.1	SRR3169810	6.85	4.73	4.72	SAMN04448868	gut microbe Metagenome
L11079.1	ERR7130331	6.84	4.73	4.71	SAMEA10021387	Smoking-related dysbiosis and associated metabolites drive cessation-induced weight gain
L11079.1	ERR7159591	6.84	4.73	4.71	SAMEA10021387	Smoking-related dysbiosis and associated metabolites drive cessation-induced weight gain
L11079.1	SRR8925818	6.84	4.73	4.71	SAMN11458198	Metagenomic analysis of 56 full-scale biogas plants in China
L11079.1	ERR3519526	6.84	4.73	4.71	SAMEA5953999	Secrets of the hospital underbelly: abundance of antimicrobial resistance genes in hospital wastewater reflects hospital antimicrobial use and inpatient length of stay
L11079.1	ERR1711743	6.82	4.73	4.70	SAMEA4525165	KCL_twins2
L11079.1	ERR4398779	6.82	4.73	4.70	SAMEA7112118	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	SRR6177793	6.82	4.73	4.70	SAMN07740643	Mycobacterium tuberculosis Genome sequencing and assembly
L11079.1	SRR12711162	6.73	4.73	4.64	SAMN15871211	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR8316595	6.73	4.73	4.64	SAMN10592415	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8288592	6.73	4.73	4.64	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR7533028	6.70	4.73	4.62	SAMN09641548	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR4051758	6.64	4.73	4.57	SAMN03861969	Panchlora gut microbial communities from Gamboa, Panama - Panchlora_hindgut_metagenome
L11079.1	SRR12961173	6.60	4.73	4.55	SAMN16598094	Human gut microbes Metagenome
L11079.1	SRR8289523	6.60	4.73	4.55	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR7723005	6.34	4.73	4.37	SAMN09863661	Influence of early environmental factors on the establishment and development of gut microbiome composition and function and metabolomics profiles in infants at-risk of celiac disease
L11079.1	ERR1135372	5.92	4.05	4.08	SAMEA3663199	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	SRR8288675	5.92	4.05	4.08	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	DRR330104	5.91	4.05	4.07	SAMD00402932	Monitoring circulating tumor DNA by using panel-specific sequencing to predict recurrence in colorectal cancer after surgical resection
L11079.1	SRR4018495	5.91	4.05	4.07	SAMN05442512	freshwater metagenome Raw sequence reads
L11079.1	ERR2367394	5.91	4.05	4.07	SAMEA104562589	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	SRR12234616	5.91	4.05	4.07	SAMN15422042	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	ERR2756791	5.91	4.05	4.07	SAMEA4858894	Metagenomics of viral communities of vampire bats in Peru
L11079.1	SRR12915119	5.90	4.05	4.07	SAMN16546518	Metagenomic sequencing from dairy farm samples
L11079.1	SRR6714210	5.90	4.05	4.06	SAMN04382203	Human feces metagenome 16s rDNA sequencing
L11079.1	SRR8288986	5.90	4.05	4.06	SAMN10508890	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR15732365	5.90	4.05	4.06	SAMN20953132	Sus scrofa Metagenome
L11079.1	ERR3211914	5.89	4.05	4.06	SAMEA5414559	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	DRR330107	5.89	4.05	4.06	SAMD00402935	Monitoring circulating tumor DNA by using panel-specific sequencing to predict recurrence in colorectal cancer after surgical resection
L11079.1	SRR8289464	5.89	4.05	4.06	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8299381	5.89	4.05	4.06	SAMN10561992	Viral diversity in river catchment area
L11079.1	SRR16327203	5.88	4.05	4.05	SAMN22262140	Xylan alleviates dietary fiber deprivation-induced dysbiosis by selectively promoting Bifidobacterium pseudocatenulatum in pigs
L11079.1	SRR13212621	5.88	4.05	4.05	SAMN17023023	Immobilized Enzymes for Nanopore Direct RNA-Seq of Non-Poly(A) Tailed RNA
L11079.1	SRR8289381	5.88	4.05	4.05	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR3574545	5.88	4.05	4.05	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	SRR7533037	5.88	4.05	4.05	SAMN09641624	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR10572869	5.88	4.05	4.05	SAMN13451416	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572885	5.88	4.05	4.05	SAMN13451455	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572918	5.88	4.05	4.05	SAMN13451425	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10828597	5.88	4.05	4.05	SAMN13701970	Metagenomics uncover antibiotic resistance genes in pig and chicken Raw sequence reads
L11079.1	SRR10572874	5.87	4.05	4.05	SAMN13451465	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	ERR2241624	5.87	4.05	4.04	SAMEA104467127	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	SRR14800553	5.87	4.05	4.04	SAMN19685510	Metagenomic raw data of wastewater treatment plants in Xinjiang Uyghur Autonomous Region
L11079.1	ERR3212053	5.86	4.05	4.04	SAMEA5414699	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	SRR7193047	5.86	4.05	4.04	SAMN09235251	Evaluation of porcine fecal microbiomes after exposure to ceftriaxone
L11079.1	SRR12711056	5.85	4.05	4.03	SAMN15871073	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR8288991	5.85	4.05	4.03	SAMN10508890	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8288595	5.85	4.05	4.03	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8288593	5.85	4.05	4.03	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289240	5.85	4.05	4.03	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR2270962	5.75	4.05	3.96	SAMEA104549059	Metagenomic characterization of the human intestinal microbiota in faecal samples from STEC-infected patients
L11079.1	ERR2597347	5.73	4.05	3.95	SAMEA4688861	VETII samples
L11079.1	SRR1612069	5.72	4.05	3.94	SAMN03068463	Wake Forest Vervet Microbiome Project
L11079.1	ERR2239523	5.71	4.05	3.94	SAMEA3613468	American Gut Project
L11079.1	SRR5156061	5.71	4.05	3.94	SAMN06164630	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR6028527	5.71	4.05	3.94	SAMN06164630	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR9030452	5.71	4.05	3.94	SAMN09710967	Wastewater Metagenome
L11079.1	ERR4571405	5.36	4.05	3.70	SAMEA7294522	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	ERR2835536	4.96	3.38	3.42	SAMEA4968970	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	SRR10572873	4.94	3.38	3.40	SAMN13451466	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572921	4.93	3.38	3.40	SAMN13451422	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR8288601	4.92	3.38	3.39	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8288684	4.92	3.38	3.39	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR2597461	4.92	3.38	3.39	SAMEA4688975	VETII samples
L11079.1	SRR8925789	4.91	3.38	3.38	SAMN11458259	Metagenome of feedstock samples for 56 full-scale biogas plants in China
L11079.1	SRR8289455	4.91	3.38	3.38	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR1135381	4.91	3.38	3.38	SAMEA3663208	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	SRR8289378	4.91	3.38	3.38	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR12711118	4.91	3.38	3.38	SAMN15871045	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR6429798	4.90	3.38	3.38	SAMN08275684	wastewater metagenome Metagenome
L11079.1	ERR2241885	4.90	3.38	3.38	SAMEA104467388	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	SRR15276866	4.90	3.38	3.38	SAMN20362771	AMR target-enriched metagenomic and 16S rRNA reads from cows raised in conventional or organic setting
L11079.1	SRR3181120	4.90	3.38	3.38	SAMN04450452	Cattle feces Metagenome
L11079.1	ERR4561579	4.90	3.38	3.38	SAMEA7288477	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR3211785	4.90	3.38	3.37	SAMEA5414430	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR4083631	4.90	3.38	3.37	SAMEA6809464	Large scale metagenome assembly reveals novel animal-associated microbial diversity
L11079.1	SRR10572904	4.89	3.38	3.37	SAMN13451438	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	ERR3211900	4.89	3.38	3.37	SAMEA5414545	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR912092	4.88	3.38	3.36	SAMEA3449287	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR1135683	4.88	3.38	3.36	SAMEA3663215	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR4682427	4.88	3.38	3.36	SAMEA7428334	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	SRR7521234	4.88	3.38	3.36	SAMN09572431	bird metagenome Metagenome
L11079.1	SRR8289238	4.88	3.38	3.36	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR17317419	4.87	3.38	3.36	SAMN24337956	The difference between diarrhea piglets and normal piglets
L11079.1	SRR11489779	4.87	3.38	3.36	SAMN14543228	Global studies of microbial diversity in pig gut
L11079.1	SRR8126734	4.77	3.38	3.29	SAMN10340208	United States National Arboretum Microbial Observatory
L11079.1	ERR4398716	4.76	3.38	3.28	SAMEA7112055	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	SRR8289458	4.67	3.38	3.22	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR12459432	4.63	3.38	3.19	SAMN15824774	PROMISE Cohort Metagenome sequence data
L11079.1	ERR4678596	4.52	3.38	3.11	SAMEA7426296	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	SRR8289506	3.94	2.70	2.72	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR12710929	3.94	2.70	2.72	SAMN15871129	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR10572841	3.94	2.70	2.71	SAMN13451487	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572845	3.94	2.70	2.71	SAMN13451483	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572853	3.94	2.70	2.71	SAMN13451476	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572855	3.94	2.70	2.71	SAMN13451474	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572875	3.94	2.70	2.71	SAMN13451464	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572894	3.94	2.70	2.71	SAMN13451447	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR4018509	3.94	2.70	2.71	SAMN05442497	freshwater metagenome Raw sequence reads
L11079.1	ERR3345692	3.94	2.70	2.71	SAMEA104717261	Metagenomics_of_Environmental_Samples_from_Pit_Latrines
L11079.1	ERR1855544	3.94	2.70	2.71	SAMEA99907918	Metagenomic analysis of gut microbiota in sows and piglets (EBI)
L11079.1	SRR5240750	3.94	2.70	2.71	SAMN06315440	Metagenomic analysis of gut microbiota in sows and piglets
L11079.1	ERR321066	3.93	2.70	2.71	SAMEA2155030	Richness of human gut microbiome correlates with metabolic markers
L11079.1	SRR4051759	3.93	2.70	2.71	SAMN03861969	Panchlora gut microbial communities from Gamboa, Panama - Panchlora_hindgut_metagenome
L11079.1	SRR8288902	3.93	2.70	2.71	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8288993	3.93	2.70	2.71	SAMN10508888	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR14759167	3.93	2.70	2.71	SAMN19581813	Study of microbes related to fiber degradation in gut of pigs
L11079.1	SRR8288894	3.93	2.70	2.71	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8288594	3.93	2.70	2.71	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289244	3.93	2.70	2.71	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289524	3.93	2.70	2.71	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8745604	3.93	2.70	2.71	SAMN11160409	The impact of artificial selection on the mammalian gut microbiota, Shotgun Metagenomics data
L11079.1	SRR9161846	3.93	2.70	2.71	SAMN11878357	Dissecting the functional co-evolution of mammals and their gut microbiota: the role of diet and digestive system's physiology
L11079.1	SRR8289380	3.93	2.70	2.71	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8288591	3.92	2.70	2.70	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8288824	3.92	2.70	2.70	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289496	3.92	2.70	2.70	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR4086540	3.92	2.70	2.70	SAMEA6811483	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	SRR5127632	3.92	2.70	2.70	SAMN06110171	Gut microbial interactions with the inflammatory cytokine production capacity
L11079.1	ERR2241880	3.92	2.70	2.70	SAMEA104467383	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR3211800	3.92	2.70	2.70	SAMEA5414445	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	SRR8288989	3.91	2.70	2.70	SAMN10508889	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8288597	3.91	2.70	2.70	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR1578684	3.91	2.70	2.70	SAMEA4378293	Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease
L11079.1	SRR7533030	3.91	2.70	2.69	SAMN09641547	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	ERR414276	3.91	2.70	2.69	SAMEA2338661	An integrated catalog of reference genes in the human gut microbiome
L11079.1	ERR4678682	3.91	2.70	2.69	SAMEA7426382	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678683	3.91	2.70	2.69	SAMEA7426383	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR3211993	3.91	2.70	2.69	SAMEA5414638	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	SRR14474049	3.91	2.70	2.69	SAMN19078919	Metagenome of pig fecal bacteria
L11079.1	SRR8289210	3.90	2.70	2.69	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289389	3.90	2.70	2.69	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR3574343	3.90	2.70	2.68	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR1950668	3.78	2.70	2.61	SAMEA104032360	Surveillance for prevalence of drug resistance bacteria in Ugandan animal agriculture
L11079.1	DRR330134	3.78	2.70	2.61	SAMD00402962	Monitoring circulating tumor DNA by using panel-specific sequencing to predict recurrence in colorectal cancer after surgical resection
L11079.1	ERR2241794	3.78	2.70	2.61	SAMEA104467297	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR5310804	3.78	2.70	2.61	SAMEA8082484	The TrackCattle Study
L11079.1	SRR8126724	3.77	2.70	2.59	SAMN10340227	United States National Arboretum Microbial Observatory
L11079.1	SRR8289461	3.76	2.70	2.59	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR4425674	3.66	2.70	2.52	SAMN05597091	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	ERR4682849	3.66	2.70	2.52	SAMEA7428491	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR2759396	3.56	2.70	2.45	SAMEA4867848	Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation
L11079.1	ERR3594029	3.56	2.70	2.45	SAMEA6085995	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR4097208	3.56	2.70	2.45	SAMEA6804950	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	SRR5677845	3.56	2.70	2.45	SAMN06019335	viral metagenome Metagenome
L11079.1	SRR12302433	3.56	2.70	2.45	SAMN09515637	infant gut Targeted Locus (Loci)
L11079.1	SRR12302524	3.56	2.70	2.45	SAMN15567819	infant gut Targeted Locus (Loci)
L11079.1	SRR12442209	3.56	2.70	2.45	SAMN15784580	ViroCap enriched viral metagenomic sequences from stool samples of adult transplant patients presenting with GvHD
L11079.1	SRR13697185	3.56	2.70	2.45	SAMN13271621	Microbiota of allo-HSCT patients and in the setting of Autologous Fecal Microbiota Transplant (auto-FMT) at MSKCC Raw sequence reads
L11079.1	SRR13774597	3.56	2.70	2.45	SAMN18040286	Premature infant microbiome Metagenome
L11079.1	SRR14117276	3.56	2.70	2.45	SAMN17717661	Transmission and formation of microbiota in the ealry life
L11079.1	SRR15686330	3.56	2.70	2.45	SAMN21160210	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR413571	3.56	2.70	2.45	SAMN00791916	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR5963407	3.56	2.70	2.45	SAMN07501314	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR6177792	3.56	2.70	2.45	SAMN07740650	Mycobacterium tuberculosis Genome sequencing and assembly
L11079.1	SRR7411257	3.56	2.70	2.45	SAMN09278611	Probiotics in Pregnancy study
L11079.1	SRR8653001	3.56	2.70	2.45	SAMN11031328	Human infant gut virome
L11079.1	ERR3593271	3.55	2.70	2.45	SAMEA6085236	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	SRR5630626	3.55	2.70	2.45	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR8692195	3.55	2.70	2.45	SAMN05788895	infant gut Targeted Locus (Loci)
L11079.1	SRR4101303	3.55	2.70	2.45	SAMN05715933	food contamination metagenome Metagenome
L11079.1	SRR12802609	3.41	2.70	2.35	SAMN16401335	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR8731955	2.97	2.03	2.05	SAMN11130128	Analysis of a 15 th century faecal specimen from Bushman Rock Shelter, South Africa
L11079.1	SRR11236238	2.96	2.03	2.04	SAMN14270973	Human gut microbiome Raw sequence reads
L11079.1	SRR8289507	2.96	2.03	2.04	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289157	2.95	2.03	2.04	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR12710930	2.95	2.03	2.04	SAMN15871128	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	ERR4086543	2.95	2.03	2.03	SAMEA6811483	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	SRR8289385	2.95	2.03	2.03	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR12711058	2.95	2.03	2.03	SAMN15871071	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR6058010	2.95	2.03	2.03	SAMN07679366	Impacts of florfenicol on the antimicrobial resistance and community composition of microbiome in aquaculture ecosystem as revealed by metagenomics sequencing
L11079.1	SRR8288673	2.95	2.03	2.03	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289098	2.95	2.03	2.03	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	DRR330111	2.95	2.03	2.03	SAMD00402939	Monitoring circulating tumor DNA by using panel-specific sequencing to predict recurrence in colorectal cancer after surgical resection
L11079.1	ERR209059	2.95	2.03	2.03	SAMEA2042281	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	SRR8289387	2.95	2.03	2.03	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289278	2.95	2.03	2.03	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR11412752	2.94	2.03	2.03	SAMN14445522	human gut metagenome Metagenome
L11079.1	SRR8289064	2.94	2.03	2.03	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8288602	2.94	2.03	2.03	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8288727	2.94	2.03	2.03	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289399	2.94	2.03	2.03	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR912080	2.94	2.03	2.03	SAMEA3449275	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR3211797	2.94	2.03	2.02	SAMEA5414442	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR3211931	2.94	2.03	2.02	SAMEA5414576	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	SRR12529382	2.94	2.03	2.02	SAMN15829939	An integrated gene catalog and over 10,000 metagenome-assembled genomes from the gastrointestinal microbiome of ruminants
L11079.1	ERR1950672	2.94	2.03	2.02	SAMEA104032364	Surveillance for prevalence of drug resistance bacteria in Ugandan animal agriculture
L11079.1	SRR10572834	2.94	2.03	2.02	SAMN13451493	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR1611553	2.94	2.03	2.02	SAMN03068415	Wake Forest Vervet Microbiome Project
L11079.1	SRR8925750	2.94	2.03	2.02	SAMN11458265	Metagenome of feedstock samples for 56 full-scale biogas plants in China
L11079.1	SRR3053165	2.93	2.03	2.02	SAMN04362347	Beef Production Metagenome Raw sequence reads
L11079.1	SRR8288891	2.93	2.03	2.02	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289222	2.93	2.03	2.02	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	DRR330126	2.93	2.03	2.02	SAMD00402954	Monitoring circulating tumor DNA by using panel-specific sequencing to predict recurrence in colorectal cancer after surgical resection
L11079.1	ERR2241881	2.93	2.03	2.02	SAMEA104467384	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241960	2.93	2.03	2.02	SAMEA104467463	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR3574517	2.93	2.03	2.02	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3574520	2.93	2.03	2.02	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR4682794	2.93	2.03	2.02	SAMEA7428436	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR7197646	2.93	2.03	2.02	SAMEA10535678	Hi-C metagenomics study on faecal microbiomes from 5-5 British low- and high-antimicrobial use pig farms
L11079.1	SRR13517645	2.93	2.03	2.02	SAMN17521793	Metagenomics of antimicrobial and heavy metal resistance in the cecal microbiome of fattening pigs raised without antibiotics
L11079.1	SRR3953989	2.93	2.03	2.02	SAMN05441317	Phage-resistant Synechococcus
L11079.1	SRR8925785	2.93	2.03	2.02	SAMN11458267	Metagenome of feedstock samples for 56 full-scale biogas plants in China
L11079.1	SRR9603015	2.93	2.03	2.02	SAMN12137782	humman gut microbiota metagenome sequensing Raw sequence reads
L11079.1	ERR3211887	2.93	2.03	2.02	SAMEA5414532	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR1135677	2.93	2.03	2.02	SAMEA3663209	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR4571256	2.93	2.03	2.02	SAMEA7294536	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	SRR11615224	2.93	2.03	2.02	SAMN14738226	Integral approach in the resistome characterization on Spanish swine farms.
L11079.1	SRR15604556	2.93	2.03	2.02	SAMN20968415	Adjunctive probiotic Lactobacillus rhamnosus Probio-M9 enhances the effect of anti-PD-1 antitumor therapy via regulating the gut microbiota damaged by antibiotics
L11079.1	SRR11851393	2.93	2.03	2.02	SAMN14986072	human metagenome Raw sequence reads
L11079.1	SRR8288671	2.92	2.03	2.01	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR209910	2.92	2.03	2.01	SAMEA2042281	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	SRR13517625	2.92	2.03	2.01	SAMN17521794	Metagenomics of antimicrobial and heavy metal resistance in the cecal microbiome of fattening pigs raised without antibiotics
L11079.1	ERR3053323	2.82	2.03	1.94	SAMEA5216099	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3521949	2.82	2.03	1.94	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR4406865	2.82	2.03	1.94	SAMEA7097033	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR6002146	2.82	2.03	1.94	SAMEA8899584	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	SRR12302507	2.82	2.03	1.94	SAMN09515595	infant gut Targeted Locus (Loci)
L11079.1	SRR4098583	2.82	2.03	1.94	SAMN05713718	Clinical sequencing Metagenome Metagenomic assembly
L11079.1	SRR5963173	2.82	2.03	1.94	SAMN07501080	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963387	2.82	2.03	1.94	SAMN07501294	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	ERR4682334	2.82	2.03	1.94	SAMEA7428241	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR3857296	2.81	2.03	1.94	SAMEA6512850	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	ERR4682423	2.81	2.03	1.93	SAMEA7428330	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	SRR4018511	2.80	2.03	1.93	SAMN05442499	freshwater metagenome Raw sequence reads
L11079.1	SRR6869079	2.80	2.03	1.93	SAMN08738624	Bovine Fecal Metagenomics During Early Life
L11079.1	ERR4066028	2.79	2.03	1.93	SAMEA6801862	Strain-level analysis of Bifidobacterium spp. from human gut metagenomes of individuals with different lactase persistence genotypes
L11079.1	SRR413750	2.79	2.03	1.92	SAMN00792095	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	DRR174610	2.71	2.03	1.87	SAMD00166385	Generic sample from human gut metagenome
L11079.1	ERR1018236	2.71	2.03	1.87	SAMEA3541520	Metagenomic analysis of fecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
L11079.1	ERR2238578	2.71	2.03	1.87	SAMEA3608670	American Gut Project
L11079.1	ERR5948128	2.71	2.03	1.87	SAMEA4353910	American Gut Project
L11079.1	ERR1711750	2.71	2.03	1.87	SAMEA4525172	KCL_twins2
L11079.1	ERR2198720	2.71	2.03	1.87	SAMEA104393795	WGS data from FMT trial for the treatment of recurrent Clostridium difficile infection
L11079.1	ERR2734390	2.71	2.03	1.87	SAMEA4827165	E. coli diversity in healthy and IBD human gut
L11079.1	ERR2835418	2.71	2.03	1.87	SAMEA4968852	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR3404647	2.71	2.03	1.87	SAMEA5616565	Early_life_microbiota_colonisation
L11079.1	ERR3555316	2.71	2.03	1.87	SAMEA5846977	Optimizing sequencing protocols for leaderboard metagenomics by combining long and short reads
L11079.1	ERR3521908	2.71	2.03	1.87	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521933	2.71	2.03	1.87	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521955	2.71	2.03	1.87	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521962	2.71	2.03	1.87	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3592901	2.71	2.03	1.87	SAMEA6084865	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593552	2.71	2.03	1.87	SAMEA6085517	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593764	2.71	2.03	1.87	SAMEA6085729	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593878	2.71	2.03	1.87	SAMEA6085843	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3594010	2.71	2.03	1.87	SAMEA6085976	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3792772	2.71	2.03	1.87	SAMEA6448833	Optimizing DNA extraction methods for Nanopore sequencing of Neisseria gonorrhoeae direct from urine samples
L11079.1	ERR4091899	2.71	2.03	1.87	SAMEA6811811	Thermus thermophilus DNA can be used as internal control for process monitoring of clinical metagenomic next-generation sequencing of urine samples
L11079.1	ERR4097175	2.71	2.03	1.87	SAMEA6804860	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097266	2.71	2.03	1.87	SAMEA6804928	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097271	2.71	2.03	1.87	SAMEA6804931	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4158311	2.71	2.03	1.87	SAMEA6845190	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4406853	2.71	2.03	1.87	SAMEA7097021	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR6001962	2.71	2.03	1.87	SAMEA8899400	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR526058	2.71	2.03	1.87	SAMEA2580275	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR5283943	2.71	2.03	1.87	SAMEA8023266	Changes in human gut microbiome during the first wave of COVID-19 pandemic in comparison with pre-pandemic travel-related changes
L11079.1	ERR579892	2.71	2.03	1.87	SAMEA2699040	The microbial colonization of the intestine during the first monthsof life constitutes the most important process for the microbiota-induced host-homeostasis.Alterations in this process may entail a high-risk for disease in later life. However, this process the potential factorsaffecting it in the infant are not well known. Moreover, the potential impact of orally administered vaccines, expected to interact with intestinal immune cells eliciting an immune response at mucosal level,upon the establishing microbiome remains unknown.Here we assessed the intestinal microbiome establishmentprocess and evaluated the impact of rotavirus vaccination upon this process. Metagenomic, PCR-DGGE and faecal short chain fatty acids analyses were performed on faecal samples obtained from three infants before and after the administration of each dose of vaccine. We found a high inter-individual variability in the early lifegut microbiota at microbial composition level, but a large similarity between the infants’ microbiomes at functional level. Rotavirus vaccination did not show any major effects upon the infant gut microbiota. Thus, the individual microbiome establishment and development process seems to occur in a defined manner during the first stages of life and it is not affected by oral rotavirus vaccination.
L11079.1	SRR5298201	2.71	2.03	1.87	SAMN06350469	human metagenome Raw sequence reads
L11079.1	SRR10692742	2.71	2.03	1.87	SAMN13246814	human gut metagenome Metagenome
L11079.1	SRR9264563	2.71	2.03	1.87	SAMN12011411	human gut metagenome Metagenome
L11079.1	SRR10427878	2.71	2.03	1.87	SAMN13258124	Gut microbiome changes after bariatric surgery
L11079.1	SRR1201535	2.71	2.03	1.87	SAMN02675510	C.diff FMT
L11079.1	SRR1491193	2.71	2.03	1.87	SAMN02676200	C.diff FMT
L11079.1	SRR12159123	2.71	2.03	1.87	SAMN15422694	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12195337	2.71	2.03	1.87	SAMN15504578	STEC-spiked food
L11079.1	SRR15127910	2.71	2.03	1.87	SAMN20118314	infant gut Targeted Locus (Loci)
L11079.1	SRR13318308	2.71	2.03	1.87	SAMN17171255	Netherland Travelers
L11079.1	SRR13318363	2.71	2.03	1.87	SAMN17171316	Netherland Travelers
L11079.1	SRR13774595	2.71	2.03	1.87	SAMN18040288	Premature infant microbiome Metagenome
L11079.1	SRR14017395	2.71	2.03	1.87	SAMN18385956	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14573980	2.71	2.03	1.87	SAMN19237348	The composition of gut microbiota in biliary atresia
L11079.1	SRR14918145	2.71	2.03	1.87	SAMN18867795	Fecal Metagenomes
L11079.1	SRR6028536	2.71	2.03	1.87	SAMN06164631	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR5274089	2.71	2.03	1.87	SAMN06350025	Mother-infant microbiome vertical transmission
L11079.1	SRR5405612	2.71	2.03	1.87	SAMN06444708	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5963265	2.71	2.03	1.87	SAMN07501172	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963408	2.71	2.03	1.87	SAMN07501315	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR6659564	2.71	2.03	1.87	SAMN08448078	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR8316666	2.71	2.03	1.87	SAMN10592375	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR9879723	2.71	2.03	1.87	SAMN12418360	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR8289384	2.70	2.03	1.86	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR5371393	2.70	2.03	1.86	SAMN06117848	bovine fecal metagenome raw sequence reads
L11079.1	SRR15702578	2.67	2.03	1.84	SAMN21175586	16s and shotgun sequencing from human faecal
L11079.1	SRR6876225	2.67	2.03	1.84	SAMN08707424	Gut microbial profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients
L11079.1	SRR14292252	2.66	2.03	1.83	SAMN18524910	Hi-C metagenomics of gut microbiome in chronically critically ill patients
L11079.1	SRR5831608	2.58	2.03	1.78	SAMN07357512	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	ERR4193923	2.57	2.03	1.77	SAMEA6873568	Pathogenesis of Klebsiella Liver Abscess Syndrome Study (P-KLASS)
L11079.1	SRR12170231	2.57	2.03	1.77	SAMN15471107	Metagenomic Sequencing of Stool Samples in Bangladeshi Infants: Virome Association with Poliovirus Shedding After Oral Poliovirus Vaccination
L11079.1	SRR5371497	2.56	2.03	1.76	SAMN06117796	bovine fecal metagenome raw sequence reads
L11079.1	SRR3313061	2.55	2.03	1.76	SAMN04571717	Human Gut Microbiome in a Multiplex Family Study of Type 1 Diabetes Mellitus
L11079.1	ERR2683277	2.42	2.03	1.67	SAMEA4777534	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2835381	2.42	2.03	1.67	SAMEA4968815	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835451	2.42	2.03	1.67	SAMEA4968885	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR3593311	2.42	2.03	1.67	SAMEA6085276	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593314	2.42	2.03	1.67	SAMEA6085279	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593315	2.42	2.03	1.67	SAMEA6085280	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593569	2.42	2.03	1.67	SAMEA6085534	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR4682372	2.42	2.03	1.67	SAMEA7428279	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	SRR9264570	2.42	2.03	1.67	SAMN12011418	human gut metagenome Metagenome
L11079.1	SRR5630637	2.42	2.03	1.67	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR5630638	2.42	2.03	1.67	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR12234793	2.42	2.03	1.67	SAMN15421934	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12390987	2.42	2.03	1.67	SAMN15733945	Metagenome of wastewater-derived enrichment cultures with different culture media
L11079.1	SRR12390990	2.42	2.03	1.67	SAMN15733934	Metagenome of wastewater-derived enrichment cultures with different culture media
L11079.1	SRR9988182	2.42	2.03	1.67	SAMN12583227	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR15686332	2.42	2.03	1.67	SAMN21160208	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR16481189	2.42	2.03	1.67	SAMN22374897	Luzhou ARGs
L11079.1	SRR16555207	2.42	2.03	1.67	SAMN22445303	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR16555217	2.42	2.03	1.67	SAMN22445294	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR5831595	2.42	2.03	1.67	SAMN07357514	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831615	2.42	2.03	1.67	SAMN07357507	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5963237	2.42	2.03	1.67	SAMN07501144	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963400	2.42	2.03	1.67	SAMN07501307	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	ERR1728112	1.98	1.35	1.36	SAMEA4545542	Subspecies in the global human gut microbiome
L11079.1	ERR2227917	1.98	1.35	1.36	SAMEA104445635	Selective maternal seeding and environment shape the human gut microbiome
L11079.1	ERR2739223	1.98	1.35	1.36	SAMEA4833102	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	ERR2824917	1.98	1.35	1.36	SAMEA4956206	Functional changes after bariatric surgery by shotgun metagenomic sequencing in obese Chilean subjects
L11079.1	ERR3053421	1.98	1.35	1.36	SAMEA5216128	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3474419	1.98	1.35	1.36	SAMEA5858768	iMSMS Baranzini data
L11079.1	ERR6995300	1.98	1.35	1.36	SAMEA10313758	iMSMS Baranzini data
L11079.1	ERR6996243	1.98	1.35	1.36	SAMEA10314653	iMSMS Baranzini data
L11079.1	ERR3342964	1.98	1.35	1.36	SAMEA5665396	Distinct microbiome composition and metabolome exists across subgroups of elite Irish athletes irrespective of diet
L11079.1	ERR3405024	1.98	1.35	1.36	SAMEA5617706	Early_life_microbiota_colonisation
L11079.1	ERR3450803	1.98	1.35	1.36	SAMEA5814043	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3478448	1.98	1.35	1.36	SAMEA5846977	Optimizing sequencing protocols for leaderboard metagenomics by combining long and short reads
L11079.1	ERR3521919	1.98	1.35	1.36	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3593284	1.98	1.35	1.36	SAMEA6085249	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593765	1.98	1.35	1.36	SAMEA6085730	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593876	1.98	1.35	1.36	SAMEA6085841	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR4334098	1.98	1.35	1.36	SAMEA7045183	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4406850	1.98	1.35	1.36	SAMEA7097018	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4406859	1.98	1.35	1.36	SAMEA7097027	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4407171	1.98	1.35	1.36	SAMEA7097339	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR579889	1.98	1.35	1.36	SAMEA2699037	The microbial colonization of the intestine during the first monthsof life constitutes the most important process for the microbiota-induced host-homeostasis.Alterations in this process may entail a high-risk for disease in later life. However, this process the potential factorsaffecting it in the infant are not well known. Moreover, the potential impact of orally administered vaccines, expected to interact with intestinal immune cells eliciting an immune response at mucosal level,upon the establishing microbiome remains unknown.Here we assessed the intestinal microbiome establishmentprocess and evaluated the impact of rotavirus vaccination upon this process. Metagenomic, PCR-DGGE and faecal short chain fatty acids analyses were performed on faecal samples obtained from three infants before and after the administration of each dose of vaccine. We found a high inter-individual variability in the early lifegut microbiota at microbial composition level, but a large similarity between the infants’ microbiomes at functional level. Rotavirus vaccination did not show any major effects upon the infant gut microbiota. Thus, the individual microbiome establishment and development process seems to occur in a defined manner during the first stages of life and it is not affected by oral rotavirus vaccination.
L11079.1	ERR5960134	1.98	1.35	1.36	SAMEA8804636	RNA-Seq data for ecological memory project
L11079.1	ERR719800	1.98	1.35	1.36	SAMEA3182112	The initial state of the human gut microbiome determines its reshaping by antibiotics
L11079.1	ERR7459368	1.98	1.35	1.36	SAMEA104665887	The_human_gut_microbiome_in_alcoholic_liver_disease
L11079.1	SRR10029201	1.98	1.35	1.36	SAMN12645322	Multi-omic analysis of Clostridioides difficile infection and response to therapy in pediatric inflammatory bowel disease
L11079.1	SRR1162573	1.98	1.35	1.36	SAMN01041775	Microbial composition of samples from infant gut
L11079.1	SRR1166576	1.98	1.35	1.36	SAMN00696746	Microbial composition of samples from infant gut
L11079.1	SRR651352	1.98	1.35	1.36	SAMN01779924	Microbial composition of samples from infant gut
L11079.1	SRR652332	1.98	1.35	1.36	SAMN01780057	Microbial composition of samples from infant gut
L11079.1	SRR918491	1.98	1.35	1.36	SAMN01889407	Microbial composition of samples from infant gut
L11079.1	SRR10499516	1.98	1.35	1.36	SAMN13293013	human gut metagenome Metagenome
L11079.1	SRR10692393	1.98	1.35	1.36	SAMN13246943	human gut metagenome Metagenome
L11079.1	SRR10682084	1.98	1.35	1.36	SAMN13252533	viral metagenome Metagenome
L11079.1	SRR12122301	1.98	1.35	1.36	SAMN15397199	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12234409	1.98	1.35	1.36	SAMN15422228	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12395688	1.98	1.35	1.36	SAMN15661760	Kidney stone patient microbiome
L11079.1	SRR12791976	1.98	1.35	1.36	SAMN16393587	Enrichment-based discovery and cataloguing of gut bacteriophages
L11079.1	SRR12802603	1.98	1.35	1.36	SAMN16401212	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR13557302	1.98	1.35	1.36	SAMN17578429	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR17284162	1.98	1.35	1.36	SAMN23963251	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14881733	1.98	1.35	1.36	SAMN07736352	Escherichia coli Genome sequencing and assembly
L11079.1	SRR15541172	1.98	1.35	1.36	SAMN20889858	Fiber Mixture for a Balanced Gut Microbiota and Human Health in Parkinson's Disease
L11079.1	SRR17244137	1.98	1.35	1.36	SAMN24059819	Infant gut microbiom
L11079.1	SRR17244138	1.98	1.35	1.36	SAMN24059810	Infant gut microbiom
L11079.1	SRR1825362	1.98	1.35	1.36	SAMN03281019	Infant fecal microbiome related to eczema
L11079.1	SRR3131796	1.98	1.35	1.36	SAMN04436641	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR4408184	1.98	1.35	1.36	SAMN05827242	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR5165959	1.98	1.35	1.36	SAMN06164939	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR6054469	1.98	1.35	1.36	SAMN06164939	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR5275462	1.98	1.35	1.36	SAMN06328442	Novel gut-microbiota based metagenomic signature for advanced fibrosis in nonalcoholic fatty liver disease
L11079.1	SRR5405614	1.98	1.35	1.36	SAMN06444706	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405642	1.98	1.35	1.36	SAMN06444678	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405646	1.98	1.35	1.36	SAMN06444674	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR7716241	1.98	1.35	1.36	SAMN06909456	Colonization, succession and evolution of the earliest human gastrointestinal microbiome
L11079.1	SRR5963168	1.98	1.35	1.36	SAMN07501075	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963169	1.98	1.35	1.36	SAMN07501076	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963172	1.98	1.35	1.36	SAMN07501079	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963262	1.98	1.35	1.36	SAMN07501169	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR6262326	1.98	1.35	1.36	SAMN07982952	preterm infant gut metagenomes (NIH Y5 Cohort)
L11079.1	SRR6262508	1.98	1.35	1.36	SAMN07983074	preterm infant gut metagenomes (NIH Y5 Cohort)
L11079.1	SRR6456234	1.98	1.35	1.36	SAMN08335081	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR7411292	1.98	1.35	1.36	SAMN09278681	Probiotics in Pregnancy study
L11079.1	SRR8353827	1.98	1.35	1.36	SAMN10615670	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8898678	1.98	1.35	1.36	SAMN11274039	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	ERR209911	1.98	1.35	1.36	SAMEA2042281	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	ERR3573333	1.98	1.35	1.36	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR4334220	1.98	1.35	1.36	SAMEA7045305	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4682856	1.98	1.35	1.36	SAMEA7428498	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	SRR11830714	1.98	1.35	1.36	SAMN14511597	Metatranscriptome of enriched fungal communities from goat fecal pellet, Isla Vista, California, United States - Bagasse, Gen9, Rep 1, Penicillin and Streptomycin
L11079.1	SRR15558298	1.98	1.35	1.36	SAMN20299497	Metagenomic  data of Laiwu pigs and Lulai pigs.
L11079.1	SRR8289160	1.97	1.35	1.36	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289421	1.97	1.35	1.36	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR6465869	1.97	1.35	1.36	SAMEA9533357	The origins and spread of domestic horses from the Western Eurasian steppes
L11079.1	SRR8288988	1.97	1.35	1.36	SAMN10508889	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289501	1.97	1.35	1.36	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR4083889	1.97	1.35	1.36	SAMEA6809388	Large scale metagenome assembly reveals novel animal-associated microbial diversity
L11079.1	SRR12978831	1.97	1.35	1.36	SAMN16633942	Wastewater metagenome Raw sequence reads
L11079.1	SRR7523249	1.97	1.35	1.36	SAMN09631344	NRC - DFO Douglas channel
L11079.1	SRR7497386	1.97	1.35	1.36	SAMN09603907	Necrotizing soft tissue infection tissue biopsy metagenome and metatranscriptome raw sequence reads
L11079.1	SRR7523247	1.97	1.35	1.36	SAMN09631191	NRC - DFO Douglas channel
L11079.1	ERR3097299	1.97	1.35	1.36	SAMEA5245262	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	SRR5371493	1.97	1.35	1.36	SAMN06117798	bovine fecal metagenome raw sequence reads
L11079.1	SRR15429270	1.97	1.35	1.36	SAMN20718331	Mastitis microbiomes of cow and mouse Metagenome
L11079.1	SRR8289066	1.97	1.35	1.36	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR1223837	1.97	1.35	1.36	SAMEA3730546	A sampling and metagenomic sequencing-based methodology for monitoring antimicrobial resistance in swine herds
L11079.1	ERR4405443	1.97	1.35	1.36	SAMEA7055499	Freshwater Metagenomes from European Lakes and Reservoirs (including time-series metagenomes)
L11079.1	SRR12711379	1.97	1.35	1.36	SAMN15871473	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR8288903	1.97	1.35	1.36	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8288899	1.97	1.35	1.35	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289223	1.97	1.35	1.35	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289286	1.96	1.35	1.35	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR6996583	1.96	1.35	1.35	SAMEA10314796	iMSMS Baranzini data
L11079.1	SRR4451543	1.96	1.35	1.35	SAMN05545044	Human gut microbiome with bacterial pathogen challenge
L11079.1	ERR3764804	1.96	1.35	1.35	SAMEA6416063	Gut microbiome response to a fermented milk product in healthy subjects
L11079.1	ERR4571275	1.96	1.35	1.35	SAMEA7294522	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	SRR11805602	1.96	1.35	1.35	SAMN14943478	A health metadata-based management approach for comparative analysis of high-throughput genetic sequences for quantifying antimicrobial resistance reduction in Canadian hog barns (Manure)
L11079.1	SRR14812360	1.96	1.35	1.35	SAMN19686901	Piglet gut and in-barn manure from farms on Raised Without Antibiotics program display a reduced antimicrobial resistance but an increased prevalence of pathogens
L11079.1	ERR2597494	1.96	1.35	1.35	SAMEA4689008	VETII samples
L11079.1	SRR12711052	1.96	1.35	1.35	SAMN15871075	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR7060081	1.96	1.35	1.35	SAMN08976420	Colorado Natural Cattle SCFP Trial
L11079.1	SRR9036418	1.96	1.35	1.35	SAMN11532400	Bovine rumen microbial communities from UC Davis, California, United States - 3_2548_0518 metagenome
L11079.1	ERR2020034	1.96	1.35	1.35	SAMEA104144124	We studied the effect of different zinc sources on the intestinal microbiome in weaned pigs
L11079.1	ERR4330049	1.96	1.35	1.35	SAMEA7041156	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	SRR8288896	1.96	1.35	1.35	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR6465868	1.95	1.35	1.35	SAMEA9533357	The origins and spread of domestic horses from the Western Eurasian steppes
L11079.1	SRR8288672	1.95	1.35	1.35	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR9866671	1.95	1.35	1.35	SAMN12283826	Metagenomic sequencing of Lawsonia intracellularis
L11079.1	ERR3211889	1.95	1.35	1.35	SAMEA5414534	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR3211928	1.95	1.35	1.35	SAMEA5414573	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	SRR10036038	1.95	1.35	1.35	SAMN12647038	A metagenomics-enabled investigation of antimicrobial resistance in an urban watershed
L11079.1	SRR10572890	1.95	1.35	1.35	SAMN13451450	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572905	1.95	1.35	1.35	SAMN13451437	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR10572907	1.95	1.35	1.35	SAMN13451435	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR6512899	1.95	1.35	1.35	SAMN08385657	Bovine Fecal Metagenome
L11079.1	SRR8288606	1.95	1.35	1.35	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8316592	1.95	1.35	1.34	SAMN10592412	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8288994	1.95	1.35	1.34	SAMN10508888	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8428046	1.83	1.35	1.26	SAMN10722590	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	ERR4571145	1.83	1.35	1.26	SAMEA7294522	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	ERR4682886	1.83	1.35	1.26	SAMEA7428528	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	SRR4425660	1.82	1.35	1.25	SAMN05597105	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	ERR5294997	1.81	1.35	1.25	SAMEA8061998	American Gut Project
L11079.1	ERR6996826	1.81	1.35	1.25	SAMEA10315662	iMSMS Baranzini data
L11079.1	ERR3941103	1.81	1.35	1.25	SAMEA6577094	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	SRR14493510	1.81	1.35	1.25	SAMN18868494	16s vs shallowshotgun
L11079.1	SRR8288670	1.81	1.35	1.25	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289460	1.81	1.35	1.25	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289508	1.81	1.35	1.25	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8299379	1.81	1.35	1.25	SAMN10561990	Viral diversity in river catchment area
L11079.1	SRR9655012	1.81	1.35	1.25	SAMN12231061	Shotgun metagenomics of human gut microbiota up to extreme longevity and the increasing role of xenobiotics degradation
L11079.1	SRR8126733	1.81	1.35	1.25	SAMN10340209	United States National Arboretum Microbial Observatory
L11079.1	ERR2835520	1.72	1.35	1.19	SAMEA4968954	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR3317660	1.72	1.35	1.19	SAMEA5599423	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	SRR14573969	1.72	1.35	1.19	SAMN19237335	The composition of gut microbiota in biliary atresia
L11079.1	SRR4783559	1.72	1.35	1.19	SAMN05545089	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR8944124	1.72	1.35	1.19	SAMN11401900	Urban wastewater treatment plant
L11079.1	SRR9866667	1.72	1.35	1.19	SAMN12283820	Metagenomic sequencing of Lawsonia intracellularis
L11079.1	SRR8289219	1.72	1.35	1.19	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR1578680	1.68	1.35	1.16	SAMEA4378289	Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease
L11079.1	ERR2017780	1.68	1.35	1.16	SAMEA104142436	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2505981	1.68	1.35	1.16	SAMEA1069162	Neonatal gut-microbiome-derived 12,13 DiHOME impedes tolerance and predicts childhood atopy and asthma
L11079.1	ERR2505999	1.68	1.35	1.16	SAMEA1069181	Neonatal gut-microbiome-derived 12,13 DiHOME impedes tolerance and predicts childhood atopy and asthma
L11079.1	ERR2683123	1.68	1.35	1.16	SAMEA4777380	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683186	1.68	1.35	1.16	SAMEA4777443	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683267	1.68	1.35	1.16	SAMEA4777524	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR3593201	1.68	1.35	1.16	SAMEA6085165	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR4158112	1.68	1.35	1.16	SAMEA6844991	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4678693	1.68	1.35	1.16	SAMEA7426393	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4682454	1.68	1.35	1.16	SAMEA7428361	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682455	1.68	1.35	1.16	SAMEA7428362	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682835	1.68	1.35	1.16	SAMEA7428477	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682848	1.68	1.35	1.16	SAMEA7428490	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR6002172	1.68	1.35	1.16	SAMEA8899610	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR5917185	1.68	1.35	1.16	SAMEA8740354	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR7439101	1.68	1.35	1.16	SAMEA10813527	Long-term effects of diet on human gut microbiota composition employing shotgun metagenomics data analysis
L11079.1	ERR7599940	1.68	1.35	1.16	SAMEA11358267	Singapore Platinum Metagenomes Project
L11079.1	SRR5298202	1.68	1.35	1.16	SAMN06350467	human metagenome Raw sequence reads
L11079.1	SRR7757674	1.68	1.35	1.16	SAMN09916452	microbial community diversities of gut
L11079.1	SRR9038120	1.68	1.35	1.16	SAMN11616061	feces metagenome Raw sequence reads
L11079.1	SRR10739566	1.68	1.35	1.16	SAMN13632805	Gut microbiome of Thai adults
L11079.1	SRR5630631	1.68	1.35	1.16	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR12122415	1.68	1.35	1.16	SAMN15397090	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12390988	1.68	1.35	1.16	SAMN15733944	Metagenome of wastewater-derived enrichment cultures with different culture media
L11079.1	SRR12390991	1.68	1.35	1.16	SAMN15733933	Metagenome of wastewater-derived enrichment cultures with different culture media
L11079.1	SRR13773558	1.68	1.35	1.16	SAMN18040082	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773661	1.68	1.35	1.16	SAMN18040047	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13826108	1.68	1.35	1.16	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099263	1.68	1.35	1.16	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14292247	1.68	1.35	1.16	SAMN18524912	Hi-C metagenomics of gut microbiome in chronically critically ill patients
L11079.1	SRR14292249	1.68	1.35	1.16	SAMN18524911	Hi-C metagenomics of gut microbiome in chronically critically ill patients
L11079.1	SRR14292250	1.68	1.35	1.16	SAMN18524911	Hi-C metagenomics of gut microbiome in chronically critically ill patients
L11079.1	SRR14292251	1.68	1.35	1.16	SAMN18524910	Hi-C metagenomics of gut microbiome in chronically critically ill patients
L11079.1	SRR16297680	1.68	1.35	1.16	SAMN22107693	PCaF Raw sequence reads
L11079.1	SRR16555201	1.68	1.35	1.16	SAMN22445287	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR16555212	1.68	1.35	1.16	SAMN22445299	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR2220821	1.68	1.35	1.16	SAMN02334124	Fiji COMP
L11079.1	SRR2220882	1.68	1.35	1.16	SAMN02334124	Fiji COMP
L11079.1	SRR2221423	1.68	1.35	1.16	SAMN02334124	Fiji COMP
L11079.1	SRR2221426	1.68	1.35	1.16	SAMN02334124	Fiji COMP
L11079.1	SRR2221442	1.68	1.35	1.16	SAMN02334124	Fiji COMP
L11079.1	SRR2228038	1.68	1.35	1.16	SAMN02334124	Fiji COMP
L11079.1	SRR2244799	1.68	1.35	1.16	SAMN02334124	Fiji COMP
L11079.1	SRR2250853	1.68	1.35	1.16	SAMN02334124	Fiji COMP
L11079.1	SRR2251611	1.68	1.35	1.16	SAMN02334124	Fiji COMP
L11079.1	SRR7193029	1.68	1.35	1.16	SAMN09235261	Evaluation of porcine fecal microbiomes after exposure to ceftriaxone
L11079.1	SRR5298236	1.68	1.35	1.16	SAMN06350397	Metagenome data from infant (PD and ProD) stools samples raw sequence reads
L11079.1	SRR5405790	1.68	1.35	1.16	SAMN06444530	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405796	1.68	1.35	1.16	SAMN06444524	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR6456219	1.68	1.35	1.16	SAMN08335026	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6795035	1.68	1.35	1.16	SAMN08628027	Bangladesh Infant Gut Metagenomes
L11079.1	SRR7532888	1.68	1.35	1.16	SAMN09641575	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532889	1.68	1.35	1.16	SAMN09641576	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532890	1.68	1.35	1.16	SAMN09641577	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7589585	1.68	1.35	1.16	SAMN09690915	Effect of native and acetylated high amylose maize starch on fecal pH, short chain fatty acid concentrations, and microbiota in a cohort of normal and stunted children in southern India
L11079.1	SRR7614695	1.68	1.35	1.16	SAMN09708234	Antarctic marine sediment and animal faeces metagenomes for the purpose of wastewater impact assessment
L11079.1	SRR8427945	1.68	1.35	1.16	SAMN10722489	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428053	1.68	1.35	1.16	SAMN10722597	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428115	1.68	1.35	1.16	SAMN10722659	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8845473	1.68	1.35	1.16	SAMN11311486	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR9330503	1.68	1.35	1.16	SAMN12097503	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9879764	1.68	1.35	1.16	SAMN12418407	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	ERR2238593	1.58	1.35	1.09	SAMEA3608793	American Gut Project
L11079.1	ERR2239156	1.58	1.35	1.09	SAMEA3608793	American Gut Project
L11079.1	ERR2239196	1.58	1.35	1.09	SAMEA3632841	American Gut Project
L11079.1	ERR2242009	1.58	1.35	1.09	SAMEA3608793	American Gut Project
L11079.1	ERR2242057	1.58	1.35	1.09	SAMEA104187391	American Gut Project
L11079.1	ERR5295053	1.58	1.35	1.09	SAMEA8062054	American Gut Project
L11079.1	ERR1190842	1.58	1.35	1.09	SAMEA3708768	Gut microbiome-dependent stratification of patients for anti-diabetic treatment
L11079.1	ERR1191818	1.58	1.35	1.09	SAMEA3712775	Metagenomes
L11079.1	ERR1430397	1.58	1.35	1.09	SAMEA4019151	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1713386	1.58	1.35	1.09	SAMEA4527654	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR184792	1.58	1.35	1.09	SAMEA1712038	Gut microbiomes of Malawian twin pairs discordant for kwashiorkor
L11079.1	ERR2241688	1.58	1.35	1.09	SAMEA104467191	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2367291	1.58	1.35	1.09	SAMEA104562486	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367337	1.58	1.35	1.09	SAMEA104562532	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367345	1.58	1.35	1.09	SAMEA104562540	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367375	1.58	1.35	1.09	SAMEA104562570	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367384	1.58	1.35	1.09	SAMEA104562579	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367464	1.58	1.35	1.09	SAMEA104562656	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367472	1.58	1.35	1.09	SAMEA104562664	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367545	1.58	1.35	1.09	SAMEA104562737	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367582	1.58	1.35	1.09	SAMEA104562774	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367611	1.58	1.35	1.09	SAMEA104562803	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367701	1.58	1.35	1.09	SAMEA104562893	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367998	1.58	1.35	1.09	SAMEA104563190	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368044	1.58	1.35	1.09	SAMEA104563236	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368187	1.58	1.35	1.09	SAMEA104563404	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368208	1.58	1.35	1.09	SAMEA104563431	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368330	1.58	1.35	1.09	SAMEA104563575	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368471	1.58	1.35	1.09	SAMEA104563902	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368524	1.58	1.35	1.09	SAMEA104564194	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368531	1.58	1.35	1.09	SAMEA104564201	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368536	1.58	1.35	1.09	SAMEA104564206	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368555	1.58	1.35	1.09	SAMEA104564562	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2505984	1.58	1.35	1.09	SAMEA1069166	Neonatal gut-microbiome-derived 12,13 DiHOME impedes tolerance and predicts childhood atopy and asthma
L11079.1	ERR2607525	1.58	1.35	1.09	SAMEA4700846	Global surveillance of antimicrobial resistance
L11079.1	ERR2608665	1.58	1.35	1.09	SAMEA4702404	gut metagenome of ASD
L11079.1	ERR2683164	1.58	1.35	1.09	SAMEA4777421	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683238	1.58	1.35	1.09	SAMEA4777495	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR3004171	1.58	1.35	1.09	SAMEA4813969	KOALA cohort metagenome study
L11079.1	ERR2835296	1.58	1.35	1.09	SAMEA4968730	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835353	1.58	1.35	1.09	SAMEA4968787	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835371	1.58	1.35	1.09	SAMEA4968805	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835459	1.58	1.35	1.09	SAMEA4968893	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835466	1.58	1.35	1.09	SAMEA4968900	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835471	1.58	1.35	1.09	SAMEA4968905	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835515	1.58	1.35	1.09	SAMEA4968949	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2832478	1.58	1.35	1.09	SAMEA4964236	Some pathogenic bacteria may go directly to effluent in WWTPs
L11079.1	ERR3053372	1.58	1.35	1.09	SAMEA5216021	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3053412	1.58	1.35	1.09	SAMEA5216185	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3317626	1.58	1.35	1.09	SAMEA5599389	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317644	1.58	1.35	1.09	SAMEA5599407	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317674	1.58	1.35	1.09	SAMEA5599437	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3405060	1.58	1.35	1.09	SAMEA5617725	Early_life_microbiota_colonisation
L11079.1	ERR3405072	1.58	1.35	1.09	SAMEA5617726	Early_life_microbiota_colonisation
L11079.1	ERR3406260	1.58	1.35	1.09	SAMEA5616855	Early_life_microbiota_colonisation
L11079.1	ERR3450867	1.58	1.35	1.09	SAMEA5814081	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3503305	1.58	1.35	1.09	SAMEA5927912	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3503308	1.58	1.35	1.09	SAMEA5927915	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3503312	1.58	1.35	1.09	SAMEA5927919	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3503313	1.58	1.35	1.09	SAMEA5927920	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3521941	1.58	1.35	1.09	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521958	1.58	1.35	1.09	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3562950	1.58	1.35	1.09	SAMEA5982223	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3574793	1.58	1.35	1.09	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3588735	1.58	1.35	1.09	SAMEA6062673	Metagenomic sequencing of faecal extracts from a commercial pig farm with high antimicrobial usage
L11079.1	ERR3593048	1.58	1.35	1.09	SAMEA6085012	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593110	1.58	1.35	1.09	SAMEA6085074	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593355	1.58	1.35	1.09	SAMEA6085320	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593370	1.58	1.35	1.09	SAMEA6085335	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593373	1.58	1.35	1.09	SAMEA6085338	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593377	1.58	1.35	1.09	SAMEA6085342	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593381	1.58	1.35	1.09	SAMEA6085346	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593382	1.58	1.35	1.09	SAMEA6085347	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593387	1.58	1.35	1.09	SAMEA6085352	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593389	1.58	1.35	1.09	SAMEA6085354	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593396	1.58	1.35	1.09	SAMEA6085361	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593410	1.58	1.35	1.09	SAMEA6085375	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593415	1.58	1.35	1.09	SAMEA6085380	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593520	1.58	1.35	1.09	SAMEA6085485	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593530	1.58	1.35	1.09	SAMEA6085495	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593544	1.58	1.35	1.09	SAMEA6085509	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593545	1.58	1.35	1.09	SAMEA6085510	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593566	1.58	1.35	1.09	SAMEA6085531	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593574	1.58	1.35	1.09	SAMEA6085539	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593580	1.58	1.35	1.09	SAMEA6085545	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593581	1.58	1.35	1.09	SAMEA6085546	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593604	1.58	1.35	1.09	SAMEA6085569	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593637	1.58	1.35	1.09	SAMEA6085602	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593638	1.58	1.35	1.09	SAMEA6085603	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593639	1.58	1.35	1.09	SAMEA6085604	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593641	1.58	1.35	1.09	SAMEA6085606	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593644	1.58	1.35	1.09	SAMEA6085609	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593646	1.58	1.35	1.09	SAMEA6085611	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593647	1.58	1.35	1.09	SAMEA6085612	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593664	1.58	1.35	1.09	SAMEA6085629	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593665	1.58	1.35	1.09	SAMEA6085630	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593666	1.58	1.35	1.09	SAMEA6085631	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593667	1.58	1.35	1.09	SAMEA6085632	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593668	1.58	1.35	1.09	SAMEA6085633	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593669	1.58	1.35	1.09	SAMEA6085634	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593992	1.58	1.35	1.09	SAMEA6085958	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3594025	1.58	1.35	1.09	SAMEA6085991	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3594028	1.58	1.35	1.09	SAMEA6085994	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3607272	1.58	1.35	1.09	SAMEA6104866	Human gut microbiome
L11079.1	ERR3941368	1.58	1.35	1.09	SAMEA6577368	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR4083843	1.58	1.35	1.09	SAMEA6809398	Large scale metagenome assembly reveals novel animal-associated microbial diversity
L11079.1	ERR4084087	1.58	1.35	1.09	SAMEA6809398	Large scale metagenome assembly reveals novel animal-associated microbial diversity
L11079.1	ERR414352	1.58	1.35	1.09	SAMEA2338732	An integrated catalog of reference genes in the human gut microbiome
L11079.1	ERR4158310	1.58	1.35	1.09	SAMEA6845189	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4334001	1.58	1.35	1.09	SAMEA7045085	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4398776	1.58	1.35	1.09	SAMEA7112115	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	ERR4398790	1.58	1.35	1.09	SAMEA7112129	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	ERR4407155	1.58	1.35	1.09	SAMEA7097323	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4564281	1.58	1.35	1.09	SAMEA7288549	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4564283	1.58	1.35	1.09	SAMEA7288549	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4565463	1.58	1.35	1.09	SAMEA7289115	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4658033	1.58	1.35	1.09	SAMEA7375420	gut metagenome of HC, IBS, DEP and COMO
L11079.1	ERR4678567	1.58	1.35	1.09	SAMEA7426267	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678597	1.58	1.35	1.09	SAMEA7426297	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678628	1.58	1.35	1.09	SAMEA7426328	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678687	1.58	1.35	1.09	SAMEA7426387	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678691	1.58	1.35	1.09	SAMEA7426391	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4682837	1.58	1.35	1.09	SAMEA7428479	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR6002144	1.58	1.35	1.09	SAMEA8899582	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002255	1.58	1.35	1.09	SAMEA8899693	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR5050398	1.58	1.35	1.09	SAMEA7766628	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050431	1.58	1.35	1.09	SAMEA7766661	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050501	1.58	1.35	1.09	SAMEA7766732	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050518	1.58	1.35	1.09	SAMEA7766749	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050561	1.58	1.35	1.09	SAMEA7766792	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050562	1.58	1.35	1.09	SAMEA7766793	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5194754	1.58	1.35	1.09	SAMEA7874187	FUT2/FUT3 genes sequences and nasopharyngeal shotgun metagenomics from the Microbiota and Health Study
L11079.1	ERR525985	1.58	1.35	1.09	SAMEA2580202	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR5418003	1.58	1.35	1.09	SAMEA8203624	The genetic impact of an Ebola outbreak on a wild gorilla population
L11079.1	ERR579888	1.58	1.35	1.09	SAMEA2699036	The microbial colonization of the intestine during the first monthsof life constitutes the most important process for the microbiota-induced host-homeostasis.Alterations in this process may entail a high-risk for disease in later life. However, this process the potential factorsaffecting it in the infant are not well known. Moreover, the potential impact of orally administered vaccines, expected to interact with intestinal immune cells eliciting an immune response at mucosal level,upon the establishing microbiome remains unknown.Here we assessed the intestinal microbiome establishmentprocess and evaluated the impact of rotavirus vaccination upon this process. Metagenomic, PCR-DGGE and faecal short chain fatty acids analyses were performed on faecal samples obtained from three infants before and after the administration of each dose of vaccine. We found a high inter-individual variability in the early lifegut microbiota at microbial composition level, but a large similarity between the infants’ microbiomes at functional level. Rotavirus vaccination did not show any major effects upon the infant gut microbiota. Thus, the individual microbiome establishment and development process seems to occur in a defined manner during the first stages of life and it is not affected by oral rotavirus vaccination.
L11079.1	ERR579890	1.58	1.35	1.09	SAMEA2699038	The microbial colonization of the intestine during the first monthsof life constitutes the most important process for the microbiota-induced host-homeostasis.Alterations in this process may entail a high-risk for disease in later life. However, this process the potential factorsaffecting it in the infant are not well known. Moreover, the potential impact of orally administered vaccines, expected to interact with intestinal immune cells eliciting an immune response at mucosal level,upon the establishing microbiome remains unknown.Here we assessed the intestinal microbiome establishmentprocess and evaluated the impact of rotavirus vaccination upon this process. Metagenomic, PCR-DGGE and faecal short chain fatty acids analyses were performed on faecal samples obtained from three infants before and after the administration of each dose of vaccine. We found a high inter-individual variability in the early lifegut microbiota at microbial composition level, but a large similarity between the infants’ microbiomes at functional level. Rotavirus vaccination did not show any major effects upon the infant gut microbiota. Thus, the individual microbiome establishment and development process seems to occur in a defined manner during the first stages of life and it is not affected by oral rotavirus vaccination.
L11079.1	ERR589587	1.58	1.35	1.09	SAMEA2737728	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR597409	1.58	1.35	1.09	SAMEA2755597	Kwashiorkor Children have lost Anaerobes-Methanogenic Gut Prokaryotes Mutualism
L11079.1	ERR6749346	1.58	1.35	1.09	SAMEA9943591	Exploring semi-quantitative metagenomics studies using Oxford Nanopore sequencing : a computational and experimental protocol
L11079.1	ERR843962	1.58	1.35	1.09	SAMEA3323669	An analysis of the composition of viruses and bacteria in stool samples from IBD patients and healthy controls.
L11079.1	ERR843964	1.58	1.35	1.09	SAMEA3323671	An analysis of the composition of viruses and bacteria in stool samples from IBD patients and healthy controls.
L11079.1	ERR906921	1.58	1.35	1.09	SAMEA3444296	Expanded Enteric Virome and Altered Bacterial Microbiome in Acquired Immunodeficiency Syndrome
L11079.1	ERR906930	1.58	1.35	1.09	SAMEA3444305	Expanded Enteric Virome and Altered Bacterial Microbiome in Acquired Immunodeficiency Syndrome
L11079.1	SRR1038389	1.58	1.35	1.09	SAMN02297012	The Neonatal Microbiome and Necrotizing Enterocolitis
L11079.1	SRR10098748	1.58	1.35	1.09	SAMN12727817	Characterization of antimicrobial resistance genes in the enriched Enterobacteriaceae community of suburban mesocarnivores, stray dogs and owned dogs.
L11079.1	SRR10121608	1.58	1.35	1.09	SAMN12751428	fecal sample Raw sequence reads
L11079.1	SRR5298196	1.58	1.35	1.09	SAMN06350479	human metagenome Raw sequence reads
L11079.1	SRR5298198	1.58	1.35	1.09	SAMN06350475	human metagenome Raw sequence reads
L11079.1	SRR10691961	1.58	1.35	1.09	SAMN13246232	human gut metagenome Metagenome
L11079.1	SRR10691965	1.58	1.35	1.09	SAMN13246723	human gut metagenome Metagenome
L11079.1	SRR10692098	1.58	1.35	1.09	SAMN13246668	human gut metagenome Metagenome
L11079.1	SRR10692422	1.58	1.35	1.09	SAMN13246209	human gut metagenome Metagenome
L11079.1	SRR10692502	1.58	1.35	1.09	SAMN13247106	human gut metagenome Metagenome
L11079.1	SRR10692605	1.58	1.35	1.09	SAMN13246386	human gut metagenome Metagenome
L11079.1	SRR10692653	1.58	1.35	1.09	SAMN13246862	human gut metagenome Metagenome
L11079.1	SRR10692669	1.58	1.35	1.09	SAMN13246847	human gut metagenome Metagenome
L11079.1	SRR10330972	1.58	1.35	1.09	SAMN13088791	Human gut metagenome Raw sequence reads upon exercise intervention
L11079.1	SRR10423917	1.58	1.35	1.09	SAMN13241759	Human gut microbiome and virome under antibiotic treatment Raw sequence reads
L11079.1	SRR10682250	1.58	1.35	1.09	SAMN13252903	viral metagenome Metagenome
L11079.1	SRR9037928	1.58	1.35	1.09	SAMN11615950	feces metagenome Raw sequence reads
L11079.1	SRR9038092	1.58	1.35	1.09	SAMN11615912	feces metagenome Raw sequence reads
L11079.1	SRR10739580	1.58	1.35	1.09	SAMN13632801	Gut microbiome of Thai adults
L11079.1	SRR5630627	1.58	1.35	1.09	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR11088368	1.58	1.35	1.09	SAMN14069851	ANTIRES - Distribution pathways of antibiotic resistances in municipal wastewater
L11079.1	SRR11125222	1.58	1.35	1.09	SAMN11097770	Pig microbiome
L11079.1	SRR11125228	1.58	1.35	1.09	SAMN11097735	Pig microbiome
L11079.1	SRR11126494	1.58	1.35	1.09	SAMN11097735	Pig microbiome
L11079.1	SRR11183348	1.58	1.35	1.09	SAMN11097770	Pig microbiome
L11079.1	SRR11183667	1.58	1.35	1.09	SAMN11097747	Pig microbiome
L11079.1	SRR11183928	1.58	1.35	1.09	SAMN11097735	Pig microbiome
L11079.1	SRR8960168	1.58	1.35	1.09	SAMN11097747	Pig microbiome
L11079.1	SRR8960245	1.58	1.35	1.09	SAMN11097889	Pig microbiome
L11079.1	SRR8960545	1.58	1.35	1.09	SAMN11097770	Pig microbiome
L11079.1	SRR8960614	1.58	1.35	1.09	SAMN11097735	Pig microbiome
L11079.1	SRR11236206	1.58	1.35	1.09	SAMN14270944	Human gut microbiome Raw sequence reads
L11079.1	SRR11236248	1.58	1.35	1.09	SAMN14271024	Human gut microbiome Raw sequence reads
L11079.1	SRR11236259	1.58	1.35	1.09	SAMN14271014	Human gut microbiome Raw sequence reads
L11079.1	SRR14092340	1.58	1.35	1.09	SAMN13271619	The role of Enterococcus in allo-HCT patient outcome
L11079.1	SRR11489776	1.58	1.35	1.09	SAMN14543231	Global studies of microbial diversity in pig gut
L11079.1	SRR11489787	1.58	1.35	1.09	SAMN14543221	Global studies of microbial diversity in pig gut
L11079.1	SRR11648343	1.58	1.35	1.09	SAMN14775310	Metabolic recovery with eculizumab precision therapy of CHAPLE disease
L11079.1	SRR12115216	1.58	1.35	1.09	SAMN15397073	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12143783	1.58	1.35	1.09	SAMN14943338	IgA deficiency microbiota
L11079.1	SRR12159156	1.58	1.35	1.09	SAMN15422665	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234763	1.58	1.35	1.09	SAMN15421771	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234794	1.58	1.35	1.09	SAMN15421933	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234921	1.58	1.35	1.09	SAMN15421875	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234959	1.58	1.35	1.09	SAMN15422274	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12217750	1.58	1.35	1.09	SAMN15503816	Bovine fecal metagenome from dairy veal calves
L11079.1	SRR12302369	1.58	1.35	1.09	SAMN09515777	infant gut Targeted Locus (Loci)
L11079.1	SRR15127815	1.58	1.35	1.09	SAMN20118692	infant gut Targeted Locus (Loci)
L11079.1	SRR15127828	1.58	1.35	1.09	SAMN20118675	infant gut Targeted Locus (Loci)
L11079.1	SRR15127857	1.58	1.35	1.09	SAMN09515751	infant gut Targeted Locus (Loci)
L11079.1	SRR12324999	1.58	1.35	1.09	SAMN15643064	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12390985	1.58	1.35	1.09	SAMN15733936	Metagenome of wastewater-derived enrichment cultures with different culture media
L11079.1	SRR12557705	1.58	1.35	1.09	SAMN12619381	Reconstruction of ancient microbial genomes from the human gut
L11079.1	SRR1535338	1.58	1.35	1.09	SAMN02930029	Human gut Targeted Locus (Loci)
L11079.1	SRR12710913	1.58	1.35	1.09	SAMN15870964	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12802642	1.58	1.35	1.09	SAMN16401344	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12887164	1.58	1.35	1.09	SAMN16339643	A metagenomic study of CVID in humans
L11079.1	SRR12934113	1.58	1.35	1.09	SAMN16557107	Bugs and Bones
L11079.1	SRR13060944	1.58	1.35	1.09	SAMN16796246	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13060964	1.58	1.35	1.09	SAMN16796228	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13060976	1.58	1.35	1.09	SAMN16796217	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13060983	1.58	1.35	1.09	SAMN16796210	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13060986	1.58	1.35	1.09	SAMN16796208	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13318087	1.58	1.35	1.09	SAMN17171500	Netherland Travelers
L11079.1	SRR13318146	1.58	1.35	1.09	SAMN17171477	Netherland Travelers
L11079.1	SRR13318173	1.58	1.35	1.09	SAMN17171447	Netherland Travelers
L11079.1	SRR13318268	1.58	1.35	1.09	SAMN17171586	Netherland Travelers
L11079.1	SRR13318425	1.58	1.35	1.09	SAMN17171588	Netherland Travelers
L11079.1	SRR13318442	1.58	1.35	1.09	SAMN17171292	Netherland Travelers
L11079.1	SRR13348674	1.58	1.35	1.09	SAMN17127042	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13434638	1.58	1.35	1.09	SAMN17312078	Primate phageomes are structured by superhost phylogeny and environment
L11079.1	SRR13735677	1.58	1.35	1.09	SAMN17976384	Equine feces samples
L11079.1	SRR13826025	1.58	1.35	1.09	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826134	1.58	1.35	1.09	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099289	1.58	1.35	1.09	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099401	1.58	1.35	1.09	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14000889	1.58	1.35	1.09	SAMN18354155	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001042	1.58	1.35	1.09	SAMN18354068	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001098	1.58	1.35	1.09	SAMN18354178	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14117229	1.58	1.35	1.09	SAMN17717674	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14321986	1.58	1.35	1.09	SAMN18868623	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14368346	1.58	1.35	1.09	SAMN18927861	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14369137	1.58	1.35	1.09	SAMN17899687	Weaning Piglet Gut Microbiome
L11079.1	SRR14369189	1.58	1.35	1.09	SAMN17899640	Weaning Piglet Gut Microbiome
L11079.1	SRR14369248	1.58	1.35	1.09	SAMN17899747	Weaning Piglet Gut Microbiome
L11079.1	SRR14369271	1.58	1.35	1.09	SAMN17899726	Weaning Piglet Gut Microbiome
L11079.1	SRR14369276	1.58	1.35	1.09	SAMN17899721	Weaning Piglet Gut Microbiome
L11079.1	SRR14369300	1.58	1.35	1.09	SAMN17899700	Weaning Piglet Gut Microbiome
L11079.1	SRR14474043	1.58	1.35	1.09	SAMN19078913	Metagenome of pig fecal bacteria
L11079.1	SRR14573966	1.58	1.35	1.09	SAMN19237338	The composition of gut microbiota in biliary atresia
L11079.1	SRR15123486	1.58	1.35	1.09	SAMN15803980	Precise quantification and tracking of gut bacterial strains following fecal transplantation demonstrates long-term stable engraftment and predicts outcome
L11079.1	SRR15343559	1.58	1.35	1.09	SAMN20566142	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15595273	1.58	1.35	1.09	SAMN20959291	Metagenomic Microbiota in Celiac Disease
L11079.1	SRR15686319	1.58	1.35	1.09	SAMN21160205	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR15686327	1.58	1.35	1.09	SAMN21160213	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR15686331	1.58	1.35	1.09	SAMN21160209	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR16555195	1.58	1.35	1.09	SAMN22445283	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR413651	1.58	1.35	1.09	SAMN00791996	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413724	1.58	1.35	1.09	SAMN00792069	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR2237501	1.58	1.35	1.09	SAMN02334109	Fiji COMP
L11079.1	SRR2937625	1.58	1.35	1.09	SAMN04261278	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR3053138	1.58	1.35	1.09	SAMN04362337	Beef Production Metagenome Raw sequence reads
L11079.1	SRR3173844	1.58	1.35	1.09	SAMN04448869	gut microbe Metagenome
L11079.1	SRR3181152	1.58	1.35	1.09	SAMN04450484	Cattle feces Metagenome
L11079.1	SRR3181155	1.58	1.35	1.09	SAMN04450487	Cattle feces Metagenome
L11079.1	SRR4305069	1.58	1.35	1.09	SAMN05826618	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305261	1.58	1.35	1.09	SAMN05826790	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305532	1.58	1.35	1.09	SAMN05826585	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408250	1.58	1.35	1.09	SAMN05826991	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4423576	1.58	1.35	1.09	SAMN05544995	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783431	1.58	1.35	1.09	SAMN05545086	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783475	1.58	1.35	1.09	SAMN05545084	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783479	1.58	1.35	1.09	SAMN05545084	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4425673	1.58	1.35	1.09	SAMN05597090	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR4425695	1.58	1.35	1.09	SAMN05597074	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR5127699	1.58	1.35	1.09	SAMN06110357	Gut microbial interactions with the inflammatory cytokine production capacity
L11079.1	SRR5190129	1.58	1.35	1.09	SAMN05720184	Orangutan group fecal microbial communities from Wisconsin, USA - O827 metagenome metagenome
L11079.1	SRR5298228	1.58	1.35	1.09	SAMN06350415	Metagenome data from infant (PD and ProD) stools samples raw sequence reads
L11079.1	SRR5298238	1.58	1.35	1.09	SAMN06350393	Metagenome data from infant (PD and ProD) stools samples raw sequence reads
L11079.1	SRR5298255	1.58	1.35	1.09	SAMN06350287	Metagenome data from infant stools samples raw sequence reads
L11079.1	SRR5679025	1.58	1.35	1.09	SAMN06685520	Farm metagenomes conventional and organic
L11079.1	SRR5831594	1.58	1.35	1.09	SAMN07357513	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831602	1.58	1.35	1.09	SAMN07357524	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831604	1.58	1.35	1.09	SAMN07357529	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831609	1.58	1.35	1.09	SAMN07357505	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831611	1.58	1.35	1.09	SAMN07357503	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831612	1.58	1.35	1.09	SAMN07357504	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5898978	1.58	1.35	1.09	SAMN07448998	Indian Human Gut Microbiome
L11079.1	SRR6426156	1.58	1.35	1.09	SAMN08007087	Wheat flour Raw sequence reads
L11079.1	SRR6784554	1.58	1.35	1.09	SAMN06619266	MECFS metagenomics
L11079.1	SRR6795049	1.58	1.35	1.09	SAMN08628030	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6869077	1.58	1.35	1.09	SAMN08738641	Bovine Fecal Metagenomics During Early Life
L11079.1	SRR6915181	1.58	1.35	1.09	SAMN08813938	Whole-metagenome shotgun sequencing of two Italian fecal CRC cohorts
L11079.1	SRR7162370	1.58	1.35	1.09	SAMN08993488	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7212682	1.58	1.35	1.09	SAMN08993488	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7352035	1.58	1.35	1.09	SAMN09278137	Probiotics in Pregnancy study
L11079.1	SRR7411345	1.58	1.35	1.09	SAMN09278575	Probiotics in Pregnancy study
L11079.1	SRR7589586	1.58	1.35	1.09	SAMN09690914	Effect of native and acetylated high amylose maize starch on fecal pH, short chain fatty acid concentrations, and microbiota in a cohort of normal and stunted children in southern India
L11079.1	SRR7658594	1.58	1.35	1.09	SAMN09781714	Metagenomic sequencing of stool samples from rural communities from north-eastern Madagascar
L11079.1	SRR7658627	1.58	1.35	1.09	SAMN09781739	Metagenomic sequencing of stool samples from rural communities from north-eastern Madagascar
L11079.1	SRR7716745	1.58	1.35	1.09	SAMN07572913	source-separated urine Metagenome
L11079.1	SRR789046	1.58	1.35	1.09	SAMN01983846	Chicken cecal contents Metagenome
L11079.1	SRR8090617	1.58	1.35	1.09	SAMN10275424	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090711	1.58	1.35	1.09	SAMN10275529	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090866	1.58	1.35	1.09	SAMN10275507	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090914	1.58	1.35	1.09	SAMN10275525	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8784367	1.58	1.35	1.09	SAMN11252283	Metagenomic sequencing of stool samples from Ethiopian individuals
L11079.1	SRR8784394	1.58	1.35	1.09	SAMN11252281	Metagenomic sequencing of stool samples from Ethiopian individuals
L11079.1	SRR8316673	1.58	1.35	1.09	SAMN10592370	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8550843	1.58	1.35	1.09	SAMN10888614	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR9670891	1.58	1.35	1.09	SAMN11031451	Human infant gut virome
L11079.1	SRR8845390	1.58	1.35	1.09	SAMN11311810	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8849276	1.58	1.35	1.09	SAMN11342843	Gut microbiota-bile acid-interleukin 22 axis orchestrates polycystic ovary syndrome
L11079.1	SRR9201484	1.58	1.35	1.09	SAMN11958565	Maturation of the infant rhesus macaque (Macaca mulatta) gut microbiome and its role in the development of diarrheal disease
L11079.1	SRR9330642	1.58	1.35	1.09	SAMN12097528	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9866651	1.58	1.35	1.09	SAMN12283841	Metagenomic sequencing of Lawsonia intracellularis
L11079.1	SRR9866669	1.58	1.35	1.09	SAMN12283834	Metagenomic sequencing of Lawsonia intracellularis
L11079.1	ERR1190622	1.57	1.35	1.09	SAMEA3708548	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190669	1.57	1.35	1.09	SAMEA3708595	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1224351	1.57	1.35	1.09	SAMEA3731130	Meta-genomic analysis of toilet waste from long distance flights
L11079.1	ERR1224353	1.57	1.35	1.09	SAMEA3731132	Meta-genomic analysis of toilet waste from long distance flights
L11079.1	ERR1430454	1.57	1.35	1.09	SAMEA4019208	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1620315	1.57	1.35	1.09	SAMEA4431928	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	ERR1713396	1.57	1.35	1.09	SAMEA4527664	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1995262	1.57	1.35	1.09	SAMEA104062435	Gut resistome modulates resilience and recovery of gut microbiota after broad-spectrum antibiotic treatment
L11079.1	ERR2205801	1.57	1.35	1.09	SAMEA104407307	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2607550	1.57	1.35	1.09	SAMEA4700871	Global surveillance of antimicrobial resistance
L11079.1	ERR2608662	1.57	1.35	1.09	SAMEA4702402	gut metagenome of ASD
L11079.1	ERR2619759	1.57	1.35	1.09	SAMEA4719812	Gut metagenomes of rural populations in Cameroon
L11079.1	ERR2683167	1.57	1.35	1.09	SAMEA4777424	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683182	1.57	1.35	1.09	SAMEA4777439	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683191	1.57	1.35	1.09	SAMEA4777448	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683193	1.57	1.35	1.09	SAMEA4777450	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683195	1.57	1.35	1.09	SAMEA4777452	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683265	1.57	1.35	1.09	SAMEA4777522	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683268	1.57	1.35	1.09	SAMEA4777525	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2722765	1.57	1.35	1.09	SAMEA4814144	Impact of antibiotics on the human gut microbiome and resistome
L11079.1	ERR2835343	1.57	1.35	1.09	SAMEA4968777	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835436	1.57	1.35	1.09	SAMEA4968870	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835458	1.57	1.35	1.09	SAMEA4968892	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835504	1.57	1.35	1.09	SAMEA4968938	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2843567	1.57	1.35	1.09	SAMEA4974243	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR3097281	1.57	1.35	1.09	SAMEA5245244	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097389	1.57	1.35	1.09	SAMEA5245352	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3153827	1.57	1.35	1.09	SAMEA5335601	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153842	1.57	1.35	1.09	SAMEA5335616	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153850	1.57	1.35	1.09	SAMEA5335624	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3317630	1.57	1.35	1.09	SAMEA5599393	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3593038	1.57	1.35	1.09	SAMEA6085002	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593063	1.57	1.35	1.09	SAMEA6085027	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593115	1.57	1.35	1.09	SAMEA6085079	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593129	1.57	1.35	1.09	SAMEA6085093	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593133	1.57	1.35	1.09	SAMEA6085097	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593135	1.57	1.35	1.09	SAMEA6085099	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593136	1.57	1.35	1.09	SAMEA6085100	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593137	1.57	1.35	1.09	SAMEA6085101	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593142	1.57	1.35	1.09	SAMEA6085106	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593177	1.57	1.35	1.09	SAMEA6085141	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593180	1.57	1.35	1.09	SAMEA6085144	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593183	1.57	1.35	1.09	SAMEA6085147	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593310	1.57	1.35	1.09	SAMEA6085275	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593312	1.57	1.35	1.09	SAMEA6085277	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593313	1.57	1.35	1.09	SAMEA6085278	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593398	1.57	1.35	1.09	SAMEA6085363	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593420	1.57	1.35	1.09	SAMEA6085385	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593648	1.57	1.35	1.09	SAMEA6085613	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR4097240	1.57	1.35	1.09	SAMEA6804746	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4135141	1.57	1.35	1.09	SAMEA6827974	Human gut microbiome in Korean NAFLD cohort
L11079.1	ERR4158277	1.57	1.35	1.09	SAMEA6845156	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4406900	1.57	1.35	1.09	SAMEA7097068	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4678561	1.57	1.35	1.09	SAMEA7426261	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678581	1.57	1.35	1.09	SAMEA7426281	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678585	1.57	1.35	1.09	SAMEA7426285	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678634	1.57	1.35	1.09	SAMEA7426334	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678643	1.57	1.35	1.09	SAMEA7426343	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678659	1.57	1.35	1.09	SAMEA7426359	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678680	1.57	1.35	1.09	SAMEA7426380	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678688	1.57	1.35	1.09	SAMEA7426388	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4682367	1.57	1.35	1.09	SAMEA7428274	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682449	1.57	1.35	1.09	SAMEA7428356	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682452	1.57	1.35	1.09	SAMEA7428359	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682805	1.57	1.35	1.09	SAMEA7428447	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682833	1.57	1.35	1.09	SAMEA7428475	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682873	1.57	1.35	1.09	SAMEA7428515	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682874	1.57	1.35	1.09	SAMEA7428516	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682878	1.57	1.35	1.09	SAMEA7428520	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682879	1.57	1.35	1.09	SAMEA7428521	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682895	1.57	1.35	1.09	SAMEA7428537	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR5050428	1.57	1.35	1.09	SAMEA7766658	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR528741	1.57	1.35	1.09	SAMEA2582117	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	ERR589442	1.57	1.35	1.09	SAMEA2737651	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589747	1.57	1.35	1.09	SAMEA2737752	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589753	1.57	1.35	1.09	SAMEA2737758	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589789	1.57	1.35	1.09	SAMEA2737794	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	SRR1073800	1.57	1.35	1.09	SAMN00998686	Microbial composition of samples from infant gut
L11079.1	SRR1159250	1.57	1.35	1.09	SAMN00998686	Microbial composition of samples from infant gut
L11079.1	SRR5298199	1.57	1.35	1.09	SAMN06350473	human metagenome Raw sequence reads
L11079.1	SRR5298211	1.57	1.35	1.09	SAMN06350445	human metagenome Raw sequence reads
L11079.1	SRR10692122	1.57	1.35	1.09	SAMN13246419	human gut metagenome Metagenome
L11079.1	SRR10692226	1.57	1.35	1.09	SAMN13246769	human gut metagenome Metagenome
L11079.1	SRR10692325	1.57	1.35	1.09	SAMN13246517	human gut metagenome Metagenome
L11079.1	SRR10692360	1.57	1.35	1.09	SAMN13246324	human gut metagenome Metagenome
L11079.1	SRR10692433	1.57	1.35	1.09	SAMN13246208	human gut metagenome Metagenome
L11079.1	SRR10692525	1.57	1.35	1.09	SAMN13246761	human gut metagenome Metagenome
L11079.1	SRR10692529	1.57	1.35	1.09	SAMN13246757	human gut metagenome Metagenome
L11079.1	SRR10692710	1.57	1.35	1.09	SAMN13246616	human gut metagenome Metagenome
L11079.1	SRR10692714	1.57	1.35	1.09	SAMN13246612	human gut metagenome Metagenome
L11079.1	SRR10692827	1.57	1.35	1.09	SAMN13246576	human gut metagenome Metagenome
L11079.1	SRR10692856	1.57	1.35	1.09	SAMN13246355	human gut metagenome Metagenome
L11079.1	SRR10692889	1.57	1.35	1.09	SAMN13246778	human gut metagenome Metagenome
L11079.1	SRR11412759	1.57	1.35	1.09	SAMN14445747	human gut metagenome Metagenome
L11079.1	SRR11412789	1.57	1.35	1.09	SAMN14445494	human gut metagenome Metagenome
L11079.1	SRR11412817	1.57	1.35	1.09	SAMN14445469	human gut metagenome Metagenome
L11079.1	SRR11412908	1.57	1.35	1.09	SAMN14445584	human gut metagenome Metagenome
L11079.1	SRR11412928	1.57	1.35	1.09	SAMN14445710	human gut metagenome Metagenome
L11079.1	SRR11728436	1.57	1.35	1.09	SAMN14730707	human gut metagenome Metagenome
L11079.1	SRR13836103	1.57	1.35	1.09	SAMN18115870	human gut metagenome Metagenome
L11079.1	SRR5106335	1.57	1.35	1.09	SAMN06115401	human gut metagenome Metagenome
L11079.1	SRR8506090	1.57	1.35	1.09	SAMN10845108	human gut metagenome Metagenome
L11079.1	SRR9264568	1.57	1.35	1.09	SAMN12011416	human gut metagenome Metagenome
L11079.1	SRR9264639	1.57	1.35	1.09	SAMN12011422	human gut metagenome Metagenome
L11079.1	SRR9038021	1.57	1.35	1.09	SAMN11616050	feces metagenome Raw sequence reads
L11079.1	SRR10739576	1.57	1.35	1.09	SAMN13632797	Gut microbiome of Thai adults
L11079.1	SRR10739582	1.57	1.35	1.09	SAMN13632803	Gut microbiome of Thai adults
L11079.1	SRR10901902	1.57	1.35	1.09	SAMN13684543	A metagenome-wide association study of gut microbiota, visceral fat and sleeve gastrectomy
L11079.1	SRR10901929	1.57	1.35	1.09	SAMN13684563	A metagenome-wide association study of gut microbiota, visceral fat and sleeve gastrectomy
L11079.1	SRR5630623	1.57	1.35	1.09	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR5630624	1.57	1.35	1.09	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR5630630	1.57	1.35	1.09	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR5630635	1.57	1.35	1.09	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR5630636	1.57	1.35	1.09	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR5630639	1.57	1.35	1.09	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR10917782	1.57	1.35	1.09	SAMN13893412	Hybrid, extra-deep metagenomic sequencing enables genomic and functional characterization of low-abundance and uncultured species in human gut
L11079.1	SRR11236227	1.57	1.35	1.09	SAMN14270983	Human gut microbiome Raw sequence reads
L11079.1	SRR11276929	1.57	1.35	1.09	SAMN14121839	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR12114424	1.57	1.35	1.09	SAMN15397206	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114427	1.57	1.35	1.09	SAMN15397206	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114749	1.57	1.35	1.09	SAMN15397138	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114963	1.57	1.35	1.09	SAMN15397061	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114973	1.57	1.35	1.09	SAMN15397061	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12159065	1.57	1.35	1.09	SAMN15422746	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234442	1.57	1.35	1.09	SAMN15422198	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234493	1.57	1.35	1.09	SAMN15422153	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12325046	1.57	1.35	1.09	SAMN15643021	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12326621	1.57	1.35	1.09	SAMN15637101	Cassava leaf microbiome and ions
L11079.1	SRR12390983	1.57	1.35	1.09	SAMN15733938	Metagenome of wastewater-derived enrichment cultures with different culture media
L11079.1	SRR12390986	1.57	1.35	1.09	SAMN15733935	Metagenome of wastewater-derived enrichment cultures with different culture media
L11079.1	SRR12576915	1.57	1.35	1.09	SAMN15968287	Interspecies variation in hominid gut microbiota controls host gene regulation
L11079.1	SRR1535337	1.57	1.35	1.09	SAMN02930028	Human gut Targeted Locus (Loci)
L11079.1	SRR12802562	1.57	1.35	1.09	SAMN16401318	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802573	1.57	1.35	1.09	SAMN16401277	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802630	1.57	1.35	1.09	SAMN16401224	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802659	1.57	1.35	1.09	SAMN16401235	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR13279591	1.57	1.35	1.09	SAMN17126273	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13327464	1.57	1.35	1.09	SAMN17126067	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327492	1.57	1.35	1.09	SAMN17126041	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13348602	1.57	1.35	1.09	SAMN17127106	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348880	1.57	1.35	1.09	SAMN17127144	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR14017402	1.57	1.35	1.09	SAMN18385743	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14117017	1.57	1.35	1.09	SAMN17717655	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117074	1.57	1.35	1.09	SAMN17717632	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117095	1.57	1.35	1.09	SAMN17717613	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14130106	1.57	1.35	1.09	SAMN18579112	Shorgun metagenomics of  allergy  patients human gut microbes
L11079.1	SRR14292248	1.57	1.35	1.09	SAMN18524912	Hi-C metagenomics of gut microbiome in chronically critically ill patients
L11079.1	SRR14321949	1.57	1.35	1.09	SAMN18868595	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14321954	1.57	1.35	1.09	SAMN18868652	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14321957	1.57	1.35	1.09	SAMN18868649	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14321962	1.57	1.35	1.09	SAMN18868645	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14368352	1.57	1.35	1.09	SAMN18927855	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14368361	1.57	1.35	1.09	SAMN18927847	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR6066148	1.57	1.35	1.09	SAMN07606190	Human gut microbiota Raw sequence reads
L11079.1	SRR8583493	1.57	1.35	1.09	SAMN10948448	wastewater metagenome Genome sequencing
L11079.1	SRR16178773	1.57	1.35	1.09	SAMN22025961	Metagenomic analysis towards biomarkers and prediction models between intestinal polyp patients and colorectal cancer patients
L11079.1	SRR16555208	1.57	1.35	1.09	SAMN22445302	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR16555216	1.57	1.35	1.09	SAMN22445295	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR413670	1.57	1.35	1.09	SAMN00792015	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413710	1.57	1.35	1.09	SAMN00792055	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR3950471	1.57	1.35	1.09	SAMN05437201	Gut microbiome of TB patients
L11079.1	SRR5298223	1.57	1.35	1.09	SAMN06350430	Metagenome data from infant (PD and ProD) stools samples raw sequence reads
L11079.1	SRR5665103	1.57	1.35	1.09	SAMN07211157	Viral and Bacterial Communities of Colorectal Cancer
L11079.1	SRR5963236	1.57	1.35	1.09	SAMN07501143	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963370	1.57	1.35	1.09	SAMN07501277	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR6439514	1.57	1.35	1.09	SAMN08287516	Banknote metagenomics
L11079.1	SRR6456255	1.57	1.35	1.09	SAMN08335060	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6795044	1.57	1.35	1.09	SAMN08628057	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6837551	1.57	1.35	1.09	SAMN08707535	Antimicrobial resistance of wastewater samples
L11079.1	SRR6837583	1.57	1.35	1.09	SAMN08707569	Antimicrobial resistance of wastewater samples
L11079.1	SRR7217013	1.57	1.35	1.09	SAMN08122837	Metagenomics of Urban Sewage Identifies an Extensively Shared Antibiotic Resistome in China
L11079.1	SRR7280875	1.57	1.35	1.09	SAMN09382581	Strain-level identification of mother-to-child bacterial transmission during the first few months of life
L11079.1	SRR7904267	1.57	1.35	1.09	SAMN10132190	Gut microbiota of biliary atresia
L11079.1	SRR8316665	1.57	1.35	1.09	SAMN10592378	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316686	1.57	1.35	1.09	SAMN10592395	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8560601	1.57	1.35	1.09	SAMN10915310	Antibiotic resistance genes and their associated bacteria in wastewater in gravity sewers
L11079.1	SRR8898466	1.57	1.35	1.09	SAMN11273831	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898501	1.57	1.35	1.09	SAMN11274006	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8925771	1.57	1.35	1.09	SAMN11458238	Metagenome of feedstock samples for 56 full-scale biogas plants in China
L11079.1	SRR9292891	1.57	1.35	1.09	SAMN11977784	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293118	1.57	1.35	1.09	SAMN11977800	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9603016	1.57	1.35	1.09	SAMN12137783	humman gut microbiota metagenome sequensing Raw sequence reads
L11079.1	SRR9879881	1.57	1.35	1.09	SAMN12418457	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR8861909	1.00	0.68	0.69	SAMN10864302	Saline water microbial communities from Organic Lake, Antarctica - #90 metagenome
L11079.1	ERR1135230	0.99	0.68	0.68	SAMEA3663057	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR1135354	0.99	0.68	0.68	SAMEA3663181	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	SRR7011570	0.99	0.68	0.68	SAMN08777311	Soil microbial communities from a riparian zone of the East river system, Colorado, United States – L3c1 metagenome
L11079.1	ERR4398823	0.99	0.68	0.68	SAMEA7112162	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	SRR12053440	0.99	0.68	0.68	SAMN15248701	Lake Baikal summer metagenomes from 5, 20, 300, 390, 1250 and 1350 m of depth
L11079.1	SRR12718069	0.99	0.68	0.68	SAMN16266302	CalCOFI_NCOG_II_2017_2019 Metagenome
L11079.1	SRR5579950	0.99	0.68	0.68	SAMN06343839	Estuarine microbial communities from the Columbia River estuary, USA - metaG S.697 metagenome
L11079.1	ERR3451296	0.99	0.68	0.68	SAMEA5814548	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR4158239	0.99	0.68	0.68	SAMEA6845118	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	SRR14017447	0.99	0.68	0.68	SAMN18385739	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14883815	0.99	0.68	0.68	SAMN19819727	Gut microbiota alternation uhttps://submit.ncbi.nlm.nih.gov/subs/sra/SUB9882549/bp_info#helper_relevance-project_titlender SARS-CoV-2 Infection
L11079.1	SRR3713834	0.99	0.68	0.68	SAMN05290565	Pseudomonas Aeruginosa Early CF Adaptive Changes
L11079.1	SRR5946675	0.99	0.68	0.68	SAMN07521519	Longitudinal Multi'omics of the Human Microbiome in Inflammatory Bowel Disease
L11079.1	SRR6262408	0.99	0.68	0.68	SAMN07983114	preterm infant gut metagenomes (NIH Y5 Cohort)
L11079.1	ERR3574553	0.99	0.68	0.68	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	SRR14000553	0.99	0.68	0.68	SAMN18353468	PreventiOn of DYSbioSis Complications With Autologous FMT in AML Patients (ODYSSEE)
L11079.1	SRR4341020	0.99	0.68	0.68	SAMN05786251	Neotibicen canicularis and symbionts
L11079.1	SRR6451786	0.99	0.68	0.68	SAMN06165258	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR6473829	0.99	0.68	0.68	SAMN08364493	Taxonomic and functional heterogeneity of the gill microbiome in Phacoides pectinatus
L11079.1	ERR3048426	0.99	0.68	0.68	SAMEA5206754	Investigation of the interactions between Brevibacterium aurantiacum strains and Hafnia alvei in a lab scale mini-cheese model using high-throughput RNA sequencing
L11079.1	SRR9184944	0.99	0.68	0.68	SAMN11897502	Gut metagenomic data of old adult male Asian elephant (Elephas maximus)
L11079.1	SRR8288737	0.99	0.68	0.68	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR3097613	0.99	0.68	0.68	SAMEA5150111	The project aims to study the transcriptional response of Pseudomonas veronii 1YdBTEX2 during inoculation, exponential and stationary growth in natural and polluted soils.
L11079.1	ERR3578767	0.99	0.68	0.68	SAMEA5988976	A protein modification introduced by food processing drives growth of a human gut bacterium
L11079.1	ERR4692001	0.99	0.68	0.68	SAMEA7457905	Metatranscriptomic analysis of fecal microbiota from mice to identify the mechanism by which ProBac inhibits VRE colonization
L11079.1	SRR12009560	0.99	0.68	0.68	SAMN15232429	Emerging viruses in British Columbia salmon discovered via a viral immune response biomarker panel and metatranscriptomic sequencing
L11079.1	SRR14828377	0.99	0.68	0.68	SAMN19728648	Metatranscriptomics of shellfish hatchery intake water
L11079.1	SRR6484357	0.99	0.68	0.68	SAMN08235904	Mice caecal content Raw sequence reads
L11079.1	SRR7523306	0.99	0.68	0.68	SAMN09631148	NRC - DFO Douglas channel
L11079.1	SRR7523488	0.99	0.68	0.68	SAMN09631168	NRC - DFO Douglas channel
L11079.1	SRR9118125	0.99	0.68	0.68	SAMN11605815	Gut microbiome in melanoma patients
L11079.1	ERR4692044	0.99	0.68	0.68	SAMEA7457948	Metatranscriptomic analysis of fecal microbiota from mice to identify the mechanism by which ProBac inhibits VRE colonization
L11079.1	SRR7523421	0.99	0.68	0.68	SAMN09631166	NRC - DFO Douglas channel
L11079.1	SRR7497486	0.99	0.68	0.68	SAMN09603822	Necrotizing soft tissue infection tissue biopsy metagenome and metatranscriptome raw sequence reads
L11079.1	ERR3097617	0.99	0.68	0.68	SAMEA5150115	The project aims to study the transcriptional response of Pseudomonas veronii 1YdBTEX2 during inoculation, exponential and stationary growth in natural and polluted soils.
L11079.1	SRR14920286	0.99	0.68	0.68	SAMN19731504	Human liver transcriptome and gut microbiome
L11079.1	SRR5272498	0.98	0.68	0.68	SAMN06267858	Freshwater lake sediment microbial communities from the University of Notre Dame, USA, for methane emissions studies - PLP11 PL metagenome
L11079.1	ERR700645	0.98	0.68	0.68	SAMEA3175279	Dromedary Faecal Metagenome-GI disorder
L11079.1	ERR3771462	0.98	0.68	0.68	SAMEA6426262	Cervids HoloGenomics - deep sequences
L11079.1	ERR4086541	0.98	0.68	0.68	SAMEA6811483	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	SRR14307625	0.98	0.68	0.68	SAMN15183782	freshwater metagenome Raw sequence reads
L11079.1	SRR12711328	0.98	0.68	0.68	SAMN15871518	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR9118110	0.98	0.68	0.68	SAMN11605851	Gut microbiome in melanoma patients
L11079.1	SRR544882	0.98	0.68	0.68	SAMN01057713	Hepatotropic viruses from human plasma using deep sequencing: a new generation diagnostic tool
L11079.1	SRR545931	0.98	0.68	0.68	SAMN01085609	Hepatotropic viruses from human plasma using deep sequencing: a new generation diagnostic tool
L11079.1	SRR6354723	0.98	0.68	0.68	SAMN04088210	Metagenomic Analysis of Microbiome in Colon Tissue from Subjects with Inflammatory Bowel Diseases Reveals Interplay of Viruses and Bacteria
L11079.1	SRR6354724	0.98	0.68	0.68	SAMN04088211	Metagenomic Analysis of Microbiome in Colon Tissue from Subjects with Inflammatory Bowel Diseases Reveals Interplay of Viruses and Bacteria
L11079.1	SRR6354726	0.98	0.68	0.68	SAMN04088213	Metagenomic Analysis of Microbiome in Colon Tissue from Subjects with Inflammatory Bowel Diseases Reveals Interplay of Viruses and Bacteria
L11079.1	ERR1190227	0.98	0.68	0.68	SAMEA3697937	454 ITS pyrosequencing of soil fungi in a subtropical experimental forest in southeast China 2.5 years after establishment (October 2011)
L11079.1	ERR2803947	0.98	0.68	0.68	SAMEA4923067	80 cohort data
L11079.1	SRR3181156	0.98	0.68	0.68	SAMN04450488	Cattle feces Metagenome
L11079.1	SRR8693973	0.98	0.68	0.68	SAMN11053848	Arctic soil viral communities from Stordalen Mire, Sweden - B.10.14.core 1
L11079.1	ERR1724898	0.98	0.68	0.68	SAMEA4535798	Generation of thousands of high-quality, full-length 16S/18S rRNA sequences from complex microbial samples without rRNA primer bias.
L11079.1	ERR1724899	0.98	0.68	0.68	SAMEA4535798	Generation of thousands of high-quality, full-length 16S/18S rRNA sequences from complex microbial samples without rRNA primer bias.
L11079.1	ERR2109472	0.98	0.68	0.68	SAMEA104232799	Retrieval of a million high-quality, full-length SSU rRNA sequences without primer bias
L11079.1	ERR2109474	0.98	0.68	0.68	SAMEA104232814	Retrieval of a million high-quality, full-length SSU rRNA sequences without primer bias
L11079.1	ERR2109475	0.98	0.68	0.68	SAMEA104232805	Retrieval of a million high-quality, full-length SSU rRNA sequences without primer bias
L11079.1	ERR2109476	0.98	0.68	0.68	SAMEA104232806	Retrieval of a million high-quality, full-length SSU rRNA sequences without primer bias
L11079.1	ERR2109477	0.98	0.68	0.68	SAMEA104232810	Retrieval of a million high-quality, full-length SSU rRNA sequences without primer bias
L11079.1	ERR2109478	0.98	0.68	0.68	SAMEA104232800	Retrieval of a million high-quality, full-length SSU rRNA sequences without primer bias
L11079.1	ERR2109479	0.98	0.68	0.68	SAMEA104232811	Retrieval of a million high-quality, full-length SSU rRNA sequences without primer bias
L11079.1	ERR2109481	0.98	0.68	0.68	SAMEA104232802	Retrieval of a million high-quality, full-length SSU rRNA sequences without primer bias
L11079.1	ERR3813854	0.98	0.68	0.68	SAMEA104111258	A method for reconstructing the structure of double-stranded DNA fragments on a single molecule level and its application to Neanderthal DNA
L11079.1	ERR5642558	0.98	0.68	0.68	SAMEA8476810	Sequencing of mtDNA captures of sediments from the Pleistocene layers of Denisova Cave.
L11079.1	SRR13224055	0.98	0.68	0.68	SAMN16845056	3G-ESP Lake Erie 2018
L11079.1	SRR13265317	0.98	0.68	0.68	SAMN17099858	Microbiota-based markers predictive of development of Clostridioides difficile infection
L11079.1	SRR13265364	0.98	0.68	0.68	SAMN17100811	Microbiota-based markers predictive of development of Clostridioides difficile infection
L11079.1	SRR5788179	0.98	0.68	0.68	SAMN07136833	Marine metagenomes from the bioGEOTRACES project
L11079.1	SRR6243052	0.98	0.68	0.68	SAMN07946183	Viral metagenome human tissue sequencing
L11079.1	SRR6373893	0.98	0.68	0.68	SAMN08172480	Baltic Sea Landsort Deep redox gradient metatranscriptome
L11079.1	SRR8288674	0.98	0.68	0.68	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR13740006	0.98	0.68	0.68	SAMN17618834	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR5007313	0.98	0.68	0.68	SAMN05720145	Active sludge microbial communities of municipal wastewater-treating anaerobic digesters from USA - AD_STIC12_MetaG metagenome
L11079.1	SRR10572883	0.98	0.68	0.68	SAMN13451457	PCR amplicon specificity sequencing for a nL-qPCR chip to detect enteric pathogens
L11079.1	SRR14320207	0.98	0.68	0.68	SAMN18864276	16S Ribosonmal RNA sequencing for human gut microbiota
L11079.1	SRR16379874	0.98	0.68	0.68	SAMN22357625	16S Ribosonmal RNA sequencing for human gut microbiota
L11079.1	SRR8289163	0.98	0.68	0.68	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR1726816	0.98	0.68	0.68	SAMEA2623070	Shotgun Sequencing of Tara Oceans DNA samples corresponding to size fractions for protist
L11079.1	ERR4691748	0.98	0.68	0.68	SAMEA2619733	Shotgun Sequencing of Tara Oceans DNA samples corresponding to size fractions for protist
L11079.1	SRR17275369	0.98	0.68	0.68	SAMN24218642	Metagenome sequence of Gigantidas platifrons with different shell lengths
L11079.1	SRR17275380	0.98	0.68	0.68	SAMN24218641	Metagenome sequence of Gigantidas platifrons with different shell lengths
L11079.1	SRR17275391	0.98	0.68	0.68	SAMN24218640	Metagenome sequence of Gigantidas platifrons with different shell lengths
L11079.1	SRR17275406	0.98	0.68	0.68	SAMN24218693	Metagenome sequence of Gigantidas platifrons with different shell lengths
L11079.1	SRR5788410	0.98	0.68	0.68	SAMN07136577	Marine metagenomes from the bioGEOTRACES project
L11079.1	ERR4086538	0.98	0.68	0.68	SAMEA6811483	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4571457	0.98	0.68	0.68	SAMEA7294486	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	SRR10499496	0.98	0.68	0.68	SAMN13292902	human gut metagenome Metagenome
L11079.1	SRR13271677	0.98	0.68	0.68	SAMN17112131	The Influence of the gut microbiome on BCG-induced trained immunity
L11079.1	SRR13318403	0.98	0.68	0.68	SAMN17171424	Netherland Travelers
L11079.1	ERR1719478	0.98	0.68	0.68	SAMEA2623723	Metatranscriptome sequencing from  samples corresponding to size fractions for protists.
L11079.1	SRR8520135	0.98	0.68	0.68	SAMN10740471	Mesoscale eddy marine microbial metatranscriptomes.
L11079.1	ERR1726552	0.98	0.68	0.67	SAMEA2657019	Shotgun Sequencing of Tara Oceans DNA samples corresponding to size fractions for protist
L11079.1	ERR6415107	0.98	0.68	0.67	SAMEA9459693	Microbial quality of the copepod Acartia tonsa for use as live feed for marine larvae
L11079.1	SRR13267227	0.98	0.68	0.67	SAMN17102286	Bacteriome metagenome of Dictyophara multireticulata specimen DICMUL
L11079.1	SRR8549427	0.98	0.68	0.67	SAMN10865510	Metatranscriptome of plant litter microbial communities from Maridalen valley, Oslo, Norway - NLE6
L11079.1	SRR13218817	0.98	0.68	0.67	SAMN17028939	Metagenomic analysis on soil microbial DNA by forest-to-farm land use change in Zambia
L11079.1	ERR1726944	0.98	0.68	0.67	SAMEA2730918	Shotgun Sequencing of Tara Oceans DNA samples corresponding to size fractions for protist
L11079.1	ERR1726954	0.98	0.68	0.67	SAMEA2732613	Shotgun Sequencing of Tara Oceans DNA samples corresponding to size fractions for protist
L11079.1	ERR599268	0.98	0.68	0.67	SAMEA2620888	Shotgun Sequencing of Tara Oceans DNA samples corresponding to size fractions for protist
L11079.1	ERR3185194	0.98	0.68	0.67	SAMEA5366227	Cervids hologenomics - to be completed later
L11079.1	ERR3771452	0.98	0.68	0.67	SAMEA6426252	Cervids HoloGenomics - deep sequences
L11079.1	ERR3771453	0.98	0.68	0.67	SAMEA6426253	Cervids HoloGenomics - deep sequences
L11079.1	ERR3771454	0.98	0.68	0.67	SAMEA6426254	Cervids HoloGenomics - deep sequences
L11079.1	ERR7625363	0.98	0.68	0.67	SAMEA11358308	Singapore Platinum Metagenomes Project
L11079.1	SRR11267077	0.98	0.68	0.67	SAMN13742492	Gut microbiome of honey bees in china
L11079.1	SRR15851163	0.98	0.68	0.67	SAMN21393443	Phyllosphere microbial community of Arundinaria spanostachya, Yushania lineolate and Fargesia ferax Genome sequencing and assembly
L11079.1	SRR5713923	0.98	0.68	0.67	SAMN06642258	Multi-center study of high throughput sequencing for virus detection
L11079.1	SRR8289511	0.98	0.68	0.67	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR9847856	0.98	0.68	0.67	SAMN12384722	Nanopore long read assembly of the human gut metagenome
L11079.1	ERR5024031	0.98	0.68	0.67	SAMEA3932918	Effects of preservation and storage conditions on the fecal microbiome
L11079.1	ERR2739181	0.98	0.68	0.67	SAMEA4833209	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	SRR15988950	0.98	0.68	0.67	SAMN21379711	Pescadero Basin sediment and rock microbial communities Assembly
L11079.1	ERR2455150	0.98	0.68	0.67	SAMEA104724071	Microbial signature of calf diarrheic gut
L11079.1	SRR7535021	0.98	0.68	0.67	SAMN09201395	Metatranscriptome of forest soil microbial communities from Barre Woods Harvard Forest LTER site, Petersham, Massachusetts, United States - Native-BW-C-14-M
L11079.1	SRR7687102	0.98	0.68	0.67	SAMN09094134	Metatranscriptome of freshwater microbial communities from Columbia River, Oregon, United States - Colum_Yuk_RepA_8d
L11079.1	ERR1726941	0.98	0.68	0.67	SAMEA2731933	Shotgun Sequencing of Tara Oceans DNA samples corresponding to size fractions for protist
L11079.1	ERR1992807	0.98	0.68	0.67	SAMEA103954418	Semi-synthetic marine metagenomes for metagenomic pipeline assessment
L11079.1	ERR2696419	0.98	0.68	0.67	SAMEA4786490	Semi-synthetic marine metagenomes for metagenomic pipeline assessment
L11079.1	ERR3574522	0.98	0.68	0.67	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3574527	0.98	0.68	0.67	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3574562	0.98	0.68	0.67	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3988510	0.98	0.68	0.67	SAMEA6618641	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988511	0.98	0.68	0.67	SAMEA6618642	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988512	0.98	0.68	0.67	SAMEA6618643	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988513	0.98	0.68	0.67	SAMEA6618644	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988514	0.98	0.68	0.67	SAMEA6618645	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988515	0.98	0.68	0.67	SAMEA6618646	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988516	0.98	0.68	0.67	SAMEA6618647	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988518	0.98	0.68	0.67	SAMEA6618649	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988519	0.98	0.68	0.67	SAMEA6618650	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988520	0.98	0.68	0.67	SAMEA6618651	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988521	0.98	0.68	0.67	SAMEA6618652	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988522	0.98	0.68	0.67	SAMEA6618653	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988523	0.98	0.68	0.67	SAMEA6618654	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988524	0.98	0.68	0.67	SAMEA6618655	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988525	0.98	0.68	0.67	SAMEA6618656	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988526	0.98	0.68	0.67	SAMEA6618657	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988527	0.98	0.68	0.67	SAMEA6618658	Metagenomics and metatranscriptomics of coral mucus
L11079.1	ERR3988528	0.98	0.68	0.67	SAMEA6618659	Metagenomics and metatranscriptomics of coral mucus
L11079.1	SRR12711102	0.98	0.68	0.67	SAMN15871060	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12711164	0.98	0.68	0.67	SAMN15871209	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12711526	0.98	0.68	0.67	SAMN15871167	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12711536	0.98	0.68	0.67	SAMN15871158	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12711590	0.98	0.68	0.67	SAMN15871138	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12711591	0.98	0.68	0.67	SAMN15871137	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12718044	0.98	0.68	0.67	SAMN16268220	CalCOFI_NCOG_II_2017_2019 Metagenome
L11079.1	SRR8289424	0.98	0.68	0.67	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8289414	0.98	0.68	0.67	SAMN10508895	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	ERR1135223	0.98	0.68	0.67	SAMEA3663050	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR3211929	0.98	0.68	0.67	SAMEA5414574	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	SRR13517647	0.98	0.68	0.67	SAMN17521793	Metagenomics of antimicrobial and heavy metal resistance in the cecal microbiome of fattening pigs raised without antibiotics
L11079.1	SRR5676474	0.98	0.68	0.67	SAMN07190885	samples from sewage Raw sequence reads
L11079.1	ERR1135233	0.97	0.68	0.67	SAMEA3663060	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR1135249	0.97	0.68	0.67	SAMEA3663076	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR3211779	0.97	0.68	0.67	SAMEA5414424	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR3211784	0.97	0.68	0.67	SAMEA5414429	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR3211925	0.97	0.68	0.67	SAMEA5414570	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	SRR10769902	0.97	0.68	0.67	SAMN13474945	Wastewater treatment and land application of swine wastewater Raw sequence reads
L11079.1	SRR11489754	0.97	0.68	0.67	SAMN14543251	Global studies of microbial diversity in pig gut
L11079.1	SRR12349259	0.97	0.68	0.67	SAMN15648638	the microbes of duck faces and shrimp pond
L11079.1	SRR13378556	0.97	0.68	0.67	SAMN17250507	Human Gut Microbiomes from Burkina Faso
L11079.1	SRR9866673	0.97	0.68	0.67	SAMN12283828	Metagenomic sequencing of Lawsonia intracellularis
L11079.1	ERR3857612	0.97	0.68	0.67	SAMEA6512902	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	SRR398108	0.97	0.68	0.67	SAMN00737776	Kansas, Native Prairie metagenome reference core Project
L11079.1	SRR408195	0.97	0.68	0.67	SAMN00737776	Kansas, Native Prairie metagenome reference core Project
L11079.1	SRR9178472	0.97	0.68	0.67	SAMN11874730	HOT ALOHA metagenomic time and depth series
L11079.1	ERR1135680	0.97	0.68	0.67	SAMEA3663212	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	SRR10769560	0.97	0.68	0.67	SAMN13090057	Metagenomic sequencing with spiked primer enrichment (MSSPE)
L11079.1	SRR10769564	0.97	0.68	0.67	SAMN13090069	Metagenomic sequencing with spiked primer enrichment (MSSPE)
L11079.1	SRR10769630	0.97	0.68	0.67	SAMN13090152	Metagenomic sequencing with spiked primer enrichment (MSSPE)
L11079.1	SRR10769635	0.97	0.68	0.67	SAMN13090153	Metagenomic sequencing with spiked primer enrichment (MSSPE)
L11079.1	SRR10769639	0.97	0.68	0.67	SAMN13090157	Metagenomic sequencing with spiked primer enrichment (MSSPE)
L11079.1	SRR10769642	0.97	0.68	0.67	SAMN13090151	Metagenomic sequencing with spiked primer enrichment (MSSPE)
L11079.1	SRR10769681	0.97	0.68	0.67	SAMN13090150	Metagenomic sequencing with spiked primer enrichment (MSSPE)
L11079.1	SRR10769684	0.97	0.68	0.67	SAMN13090149	Metagenomic sequencing with spiked primer enrichment (MSSPE)
L11079.1	SRR10769703	0.97	0.68	0.67	SAMN13090132	Metagenomic sequencing with spiked primer enrichment (MSSPE)
L11079.1	SRR10769750	0.97	0.68	0.67	SAMN13090006	Metagenomic sequencing with spiked primer enrichment (MSSPE)
L11079.1	SRR10769778	0.97	0.68	0.67	SAMN13090158	Metagenomic sequencing with spiked primer enrichment (MSSPE)
L11079.1	SRR10769782	0.97	0.68	0.67	SAMN13090156	Metagenomic sequencing with spiked primer enrichment (MSSPE)
L11079.1	SRR10769786	0.97	0.68	0.67	SAMN13090155	Metagenomic sequencing with spiked primer enrichment (MSSPE)
L11079.1	DRR127752	0.84	0.68	0.58	SAMD00114998	metagenomic data from human fecal samples
L11079.1	DRR171560	0.84	0.68	0.58	SAMD00164870	metagenomic data from human fecal samples
L11079.1	DRR171624	0.84	0.68	0.58	SAMD00164934	metagenomic data from human fecal samples
L11079.1	DRR171668	0.84	0.68	0.58	SAMD00164978	metagenomic data from human fecal samples
L11079.1	DRR171683	0.84	0.68	0.58	SAMD00164993	metagenomic data from human fecal samples
L11079.1	DRR171698	0.84	0.68	0.58	SAMD00165008	metagenomic data from human fecal samples
L11079.1	DRR171860	0.84	0.68	0.58	SAMD00114896	metagenomic data from human fecal samples
L11079.1	DRR171924	0.84	0.68	0.58	SAMD00114978	metagenomic data from human fecal samples
L11079.1	DRR171951	0.84	0.68	0.58	SAMD00115016	metagenomic data from human fecal samples
L11079.1	DRR174598	0.84	0.68	0.58	SAMD00166373	Generic sample from human gut metagenome
L11079.1	DRR232287	0.84	0.68	0.58	SAMD00230327	Bacteroides inhibit adiposity
L11079.1	DRR232288	0.84	0.68	0.58	SAMD00230328	Bacteroides inhibit adiposity
L11079.1	ERR2238605	0.84	0.68	0.58	SAMEA3608869	American Gut Project
L11079.1	ERR2238659	0.84	0.68	0.58	SAMEA104187419	American Gut Project
L11079.1	ERR2238711	0.84	0.68	0.58	SAMEA104187568	American Gut Project
L11079.1	ERR2238715	0.84	0.68	0.58	SAMEA104187580	American Gut Project
L11079.1	ERR2238732	0.84	0.68	0.58	SAMEA104187611	American Gut Project
L11079.1	ERR2239111	0.84	0.68	0.58	SAMEA3608668	American Gut Project
L11079.1	ERR2239116	0.84	0.68	0.58	SAMEA3608679	American Gut Project
L11079.1	ERR2239133	0.84	0.68	0.58	SAMEA3608729	American Gut Project
L11079.1	ERR2239232	0.84	0.68	0.58	SAMEA3633434	American Gut Project
L11079.1	ERR2239274	0.84	0.68	0.58	SAMEA3634059	American Gut Project
L11079.1	ERR2239306	0.84	0.68	0.58	SAMEA3865543	American Gut Project
L11079.1	ERR2239352	0.84	0.68	0.58	SAMEA104187417	American Gut Project
L11079.1	ERR2239353	0.84	0.68	0.58	SAMEA104187419	American Gut Project
L11079.1	ERR2239444	0.84	0.68	0.58	SAMEA3607836	American Gut Project
L11079.1	ERR2242016	0.84	0.68	0.58	SAMEA3608810	American Gut Project
L11079.1	ERR2242041	0.84	0.68	0.58	SAMEA104187349	American Gut Project
L11079.1	ERR2242054	0.84	0.68	0.58	SAMEA104187388	American Gut Project
L11079.1	ERR2242071	0.84	0.68	0.58	SAMEA104187417	American Gut Project
L11079.1	ERR2242072	0.84	0.68	0.58	SAMEA104187419	American Gut Project
L11079.1	ERR2242128	0.84	0.68	0.58	SAMEA104187568	American Gut Project
L11079.1	ERR2242145	0.84	0.68	0.58	SAMEA104187611	American Gut Project
L11079.1	ERR2242519	0.84	0.68	0.58	SAMEA104187611	American Gut Project
L11079.1	ERR2242538	0.84	0.68	0.58	SAMEA104187694	American Gut Project
L11079.1	ERR5294727	0.84	0.68	0.58	SAMEA8061728	American Gut Project
L11079.1	ERR5295044	0.84	0.68	0.58	SAMEA8062045	American Gut Project
L11079.1	ERR5455141	0.84	0.68	0.58	SAMEA8234878	American Gut Project
L11079.1	ERR5947599	0.84	0.68	0.58	SAMEA104162943	American Gut Project
L11079.1	ERR5947804	0.84	0.68	0.58	SAMEA104162943	American Gut Project
L11079.1	ERR1136691	0.84	0.68	0.58	SAMEA3665070	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136986	0.84	0.68	0.58	SAMEA3664924	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136989	0.84	0.68	0.58	SAMEA3664927	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137253	0.84	0.68	0.58	SAMEA3664924	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137376	0.84	0.68	0.58	SAMEA3665112	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137504	0.84	0.68	0.58	SAMEA3665158	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137511	0.84	0.68	0.58	SAMEA3665166	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1121437	0.84	0.68	0.58	SAMEA3648576	Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children
L11079.1	ERR1135185	0.84	0.68	0.58	SAMEA3663012	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR1190612	0.84	0.68	0.58	SAMEA3708538	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190690	0.84	0.68	0.58	SAMEA3708616	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190739	0.84	0.68	0.58	SAMEA3708665	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190751	0.84	0.68	0.58	SAMEA3708677	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190788	0.84	0.68	0.58	SAMEA3708714	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1293058	0.84	0.68	0.58	SAMEA3879500	Reproducibility of associations between the human gut microbiome and colorectal cancer assessed in a patient population from Washington, DC, USA
L11079.1	ERR1293734	0.84	0.68	0.58	SAMEA3879559	Reproducibility of associations between the human gut microbiome and colorectal cancer assessed in a patient population from Washington, DC, USA
L11079.1	ERR1293735	0.84	0.68	0.58	SAMEA3879559	Reproducibility of associations between the human gut microbiome and colorectal cancer assessed in a patient population from Washington, DC, USA
L11079.1	ERR1305907	0.84	0.68	0.58	SAMEA3888895	Roux-en-Y gastric bypass surgery of morbidly obese patients shows swift and persistent changes of the individual gut microbiota
L11079.1	ERR1305908	0.84	0.68	0.58	SAMEA3888915	Roux-en-Y gastric bypass surgery of morbidly obese patients shows swift and persistent changes of the individual gut microbiota
L11079.1	ERR1306537	0.84	0.68	0.58	SAMEA3891235	Experimental trial using phytase in the diet for broiler
L11079.1	ERR1356740	0.84	0.68	0.58	SAMEA3923219	Studying the presence and selection of antibiotic resistance genes
L11079.1	ERR1449720	0.84	0.68	0.58	SAMEA4031704	Gut microbiota of 10 pairs of Chinese infant twins
L11079.1	ERR1578673	0.84	0.68	0.58	SAMEA4378282	Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease
L11079.1	ERR1600426	0.84	0.68	0.58	SAMEA4413037	The antibiotic resistance potential of the preterm infant gut microbiome measured using shotgun metagenomics.
L11079.1	ERR1600427	0.84	0.68	0.58	SAMEA4413038	The antibiotic resistance potential of the preterm infant gut microbiome measured using shotgun metagenomics.
L11079.1	ERR1600593	0.84	0.68	0.58	SAMEA4385451	Using WTP diet to modulate gut microbiota to alleviate human type 2 diabetes
L11079.1	ERR1600739	0.84	0.68	0.58	SAMEA4385597	Using WTP diet to modulate gut microbiota to alleviate human type 2 diabetes
L11079.1	ERR1620296	0.84	0.68	0.58	SAMEA4431909	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	ERR1655259	0.84	0.68	0.58	SAMEA4462186	The Diet and Exercise-Microbiome Paradigm: Distinct Functional Profiles of the Athlete Microbiome Revealed by Metagenomic and Metabolomic  Analysis
L11079.1	ERR1655285	0.84	0.68	0.58	SAMEA4462212	The Diet and Exercise-Microbiome Paradigm: Distinct Functional Profiles of the Athlete Microbiome Revealed by Metagenomic and Metabolomic  Analysis
L11079.1	ERR1711614	0.84	0.68	0.58	SAMEA4525036	KCL_twins2
L11079.1	ERR1711697	0.84	0.68	0.58	SAMEA4525119	KCL_twins2
L11079.1	ERR1713341	0.84	0.68	0.58	SAMEA4527609	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713351	0.84	0.68	0.58	SAMEA4527619	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1725949	0.84	0.68	0.58	SAMEA4527604	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1725984	0.84	0.68	0.58	SAMEA4527634	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR2592343	0.84	0.68	0.58	SAMEA4527679	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1727532	0.84	0.68	0.58	SAMEA4545513	Subspecies in the global human gut microbiome
L11079.1	ERR1727620	0.84	0.68	0.58	SAMEA4545511	Subspecies in the global human gut microbiome
L11079.1	ERR1727904	0.84	0.68	0.58	SAMEA4545509	Subspecies in the global human gut microbiome
L11079.1	ERR1776145	0.84	0.68	0.58	SAMEA39934168	Exploring associations between the gut microbiota and colonic inflammation and assessing sequential changes during exclusive enteral nutrition (EEN) for children with Crohn's disease and comparing them to healthy cohorts as well as their relatives
L11079.1	ERR1776146	0.84	0.68	0.58	SAMEA39936418	Exploring associations between the gut microbiota and colonic inflammation and assessing sequential changes during exclusive enteral nutrition (EEN) for children with Crohn's disease and comparing them to healthy cohorts as well as their relatives
L11079.1	ERR184738	0.84	0.68	0.58	SAMEA1712041	Gut microbiomes of Malawian twin pairs discordant for kwashiorkor
L11079.1	ERR184749	0.84	0.68	0.58	SAMEA1712105	Gut microbiomes of Malawian twin pairs discordant for kwashiorkor
L11079.1	ERR184768	0.84	0.68	0.58	SAMEA1712057	Gut microbiomes of Malawian twin pairs discordant for kwashiorkor
L11079.1	ERR185005	0.84	0.68	0.58	SAMEA1712055	Gut microbiomes of Malawian twin pairs discordant for kwashiorkor
L11079.1	ERR1857005	0.84	0.68	0.58	SAMEA4019772	The role of the intestinal microflora in non-alcoholic fatty liver disease (NAFLD) (FP7)
L11079.1	ERR1857006	0.84	0.68	0.58	SAMEA4019773	The role of the intestinal microflora in non-alcoholic fatty liver disease (NAFLD) (FP7)
L11079.1	ERR1857019	0.84	0.68	0.58	SAMEA4019786	The role of the intestinal microflora in non-alcoholic fatty liver disease (NAFLD) (FP7)
L11079.1	ERR1913108	0.84	0.68	0.58	SAMEA103958138	The fecal microbiota in L-DOPA naive PD patients
L11079.1	ERR1913109	0.84	0.68	0.58	SAMEA103958138	The fecal microbiota in L-DOPA naive PD patients
L11079.1	ERR1913110	0.84	0.68	0.58	SAMEA103958138	The fecal microbiota in L-DOPA naive PD patients
L11079.1	ERR1913300	0.84	0.68	0.58	SAMEA103958138	The fecal microbiota in L-DOPA naive PD patients
L11079.1	ERR1913301	0.84	0.68	0.58	SAMEA103958138	The fecal microbiota in L-DOPA naive PD patients
L11079.1	ERR2017566	0.84	0.68	0.58	SAMEA104142121	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017773	0.84	0.68	0.58	SAMEA104142429	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2020018	0.84	0.68	0.58	SAMEA104144108	We studied the effect of different zinc sources on the intestinal microbiome in weaned pigs
L11079.1	ERR2020036	0.84	0.68	0.58	SAMEA104144126	We studied the effect of different zinc sources on the intestinal microbiome in weaned pigs
L11079.1	ERR209202	0.84	0.68	0.58	SAMEA2042300	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	ERR209555	0.84	0.68	0.58	SAMEA2042837	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	ERR209556	0.84	0.68	0.58	SAMEA1972440	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	ERR209573	0.84	0.68	0.58	SAMEA2042915	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	ERR209584	0.84	0.68	0.58	SAMEA2042923	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	ERR209731	0.84	0.68	0.58	SAMEA2042225	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	ERR209732	0.84	0.68	0.58	SAMEA2042225	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	ERR210407	0.84	0.68	0.58	SAMEA2042837	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	ERR210640	0.84	0.68	0.58	SAMEA2042449	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	ERR2134190	0.84	0.68	0.58	SAMEA104313537	Salt-responsive gut commensal modulates TH17 axis and disease
L11079.1	ERR2182132	0.84	0.68	0.58	SAMEA104359215	Microbiota broiler carcasses
L11079.1	ERR2193780	0.84	0.68	0.58	SAMEA104378548	BBSRC Main Experiment Shotgun Study
L11079.1	ERR2193782	0.84	0.68	0.58	SAMEA104378550	BBSRC Main Experiment Shotgun Study
L11079.1	ERR2193786	0.84	0.68	0.58	SAMEA104378554	BBSRC Main Experiment Shotgun Study
L11079.1	ERR2194138	0.84	0.68	0.58	SAMEA104378902	BBSRC Main Experiment Shotgun Study
L11079.1	ERR2194214	0.84	0.68	0.58	SAMEA104378979	BBSRC Main Experiment Shotgun Study
L11079.1	ERR2194219	0.84	0.68	0.58	SAMEA104378984	BBSRC Main Experiment Shotgun Study
L11079.1	ERR2213721	0.84	0.68	0.58	SAMEA104416240	Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB
L11079.1	ERR2213736	0.84	0.68	0.58	SAMEA104416142	Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB
L11079.1	ERR2235224	0.84	0.68	0.58	SAMEA104416196	Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB
L11079.1	ERR2235240	0.84	0.68	0.58	SAMEA104416208	Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB
L11079.1	ERR2235293	0.84	0.68	0.58	SAMEA104416255	Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB
L11079.1	ERR2226280	0.84	0.68	0.58	SAMEA104443104	Metagenomic reads for the microbiota of premature infant faecal samples
L11079.1	ERR2226281	0.84	0.68	0.58	SAMEA104443105	Metagenomic reads for the microbiota of premature infant faecal samples
L11079.1	ERR2226282	0.84	0.68	0.58	SAMEA104443106	Metagenomic reads for the microbiota of premature infant faecal samples
L11079.1	ERR2226283	0.84	0.68	0.58	SAMEA104443107	Metagenomic reads for the microbiota of premature infant faecal samples
L11079.1	ERR2226285	0.84	0.68	0.58	SAMEA104443109	Metagenomic reads for the microbiota of premature infant faecal samples
L11079.1	ERR2227579	0.84	0.68	0.58	SAMEA104445508	Selective maternal seeding and environment shape the human gut microbiome
L11079.1	ERR2227729	0.84	0.68	0.58	SAMEA104445567	Selective maternal seeding and environment shape the human gut microbiome
L11079.1	ERR2227739	0.84	0.68	0.58	SAMEA104445569	Selective maternal seeding and environment shape the human gut microbiome
L11079.1	ERR2227747	0.84	0.68	0.58	SAMEA104445571	Selective maternal seeding and environment shape the human gut microbiome
L11079.1	ERR2227814	0.84	0.68	0.58	SAMEA104445596	Selective maternal seeding and environment shape the human gut microbiome
L11079.1	ERR2241728	0.84	0.68	0.58	SAMEA104467231	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241824	0.84	0.68	0.58	SAMEA104467327	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241864	0.84	0.68	0.58	SAMEA104467367	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241874	0.84	0.68	0.58	SAMEA104467377	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241895	0.84	0.68	0.58	SAMEA104467398	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241897	0.84	0.68	0.58	SAMEA104467400	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241905	0.84	0.68	0.58	SAMEA104467408	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241950	0.84	0.68	0.58	SAMEA104467453	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241952	0.84	0.68	0.58	SAMEA104467455	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241968	0.84	0.68	0.58	SAMEA104467471	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2262409	0.84	0.68	0.58	SAMEA104500066	Alterations of the intestinal microbiome in patients with retinal artery occlusion
L11079.1	ERR2367189	0.84	0.68	0.58	SAMEA104562384	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367199	0.84	0.68	0.58	SAMEA104562394	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367202	0.84	0.68	0.58	SAMEA104562397	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367214	0.84	0.68	0.58	SAMEA104562409	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367309	0.84	0.68	0.58	SAMEA104562504	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367315	0.84	0.68	0.58	SAMEA104562510	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367397	0.84	0.68	0.58	SAMEA104562592	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367458	0.84	0.68	0.58	SAMEA104562650	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367470	0.84	0.68	0.58	SAMEA104562662	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367471	0.84	0.68	0.58	SAMEA104562663	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367504	0.84	0.68	0.58	SAMEA104562696	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367507	0.84	0.68	0.58	SAMEA104562699	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367509	0.84	0.68	0.58	SAMEA104562701	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367544	0.84	0.68	0.58	SAMEA104562736	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367676	0.84	0.68	0.58	SAMEA104562868	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367680	0.84	0.68	0.58	SAMEA104562872	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367704	0.84	0.68	0.58	SAMEA104562896	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367718	0.84	0.68	0.58	SAMEA104562910	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367734	0.84	0.68	0.58	SAMEA104562926	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367828	0.84	0.68	0.58	SAMEA104563020	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367842	0.84	0.68	0.58	SAMEA104563034	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367851	0.84	0.68	0.58	SAMEA104563043	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367875	0.84	0.68	0.58	SAMEA104563067	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367921	0.84	0.68	0.58	SAMEA104563113	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367939	0.84	0.68	0.58	SAMEA104563131	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367959	0.84	0.68	0.58	SAMEA104563151	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367989	0.84	0.68	0.58	SAMEA104563181	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368063	0.84	0.68	0.58	SAMEA104563255	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368080	0.84	0.68	0.58	SAMEA104563271	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368131	0.84	0.68	0.58	SAMEA104563325	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368161	0.84	0.68	0.58	SAMEA104563367	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368184	0.84	0.68	0.58	SAMEA104563401	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368190	0.84	0.68	0.58	SAMEA104563413	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368196	0.84	0.68	0.58	SAMEA104563419	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368246	0.84	0.68	0.58	SAMEA104563481	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368272	0.84	0.68	0.58	SAMEA104563507	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368369	0.84	0.68	0.58	SAMEA104563648	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368378	0.84	0.68	0.58	SAMEA104563657	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368439	0.84	0.68	0.58	SAMEA104563853	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368443	0.84	0.68	0.58	SAMEA104563857	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368482	0.84	0.68	0.58	SAMEA104564032	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2282056	0.84	0.68	0.58	SAMEA104567039	Study for giant panda gut microbiota and cellulose digestion mechanism
L11079.1	ERR2451926	0.84	0.68	0.58	SAMEA104724996	The impact of AXOS intake was evaluated in a cohort of 15 overweight individuals with signs of metabolic syndrome. The gut microbiome at baseline and endpoint was assessed by shotgun fecal DNA sequencing.
L11079.1	ERR247141	0.84	0.68	0.58	SAMEA2017459	This is a metagenomic study to investigate the microbial community and metabolic functions of Korean twin pairs.
L11079.1	ERR2503347	0.84	0.68	0.58	SAMEA1062326	TBD
L11079.1	ERR2503348	0.84	0.68	0.58	SAMEA1062327	TBD
L11079.1	ERR2505985	0.84	0.68	0.58	SAMEA1069167	Neonatal gut-microbiome-derived 12,13 DiHOME impedes tolerance and predicts childhood atopy and asthma
L11079.1	ERR2505995	0.84	0.68	0.58	SAMEA1069177	Neonatal gut-microbiome-derived 12,13 DiHOME impedes tolerance and predicts childhood atopy and asthma
L11079.1	ERR2587769	0.84	0.68	0.58	SAMEA4670459	BBC study
L11079.1	ERR2587779	0.84	0.68	0.58	SAMEA4670469	BBC study
L11079.1	ERR2597445	0.84	0.68	0.58	SAMEA4688959	VETII samples
L11079.1	ERR2597479	0.84	0.68	0.58	SAMEA4688993	VETII samples
L11079.1	ERR2597518	0.84	0.68	0.58	SAMEA4689032	VETII samples
L11079.1	ERR2607392	0.84	0.68	0.58	SAMEA4700713	Global surveillance of antimicrobial resistance
L11079.1	ERR2607413	0.84	0.68	0.58	SAMEA4700734	Global surveillance of antimicrobial resistance
L11079.1	ERR2607438	0.84	0.68	0.58	SAMEA4700759	Global surveillance of antimicrobial resistance
L11079.1	ERR2607477	0.84	0.68	0.58	SAMEA4700798	Global surveillance of antimicrobial resistance
L11079.1	ERR2607602	0.84	0.68	0.58	SAMEA4700923	Global surveillance of antimicrobial resistance
L11079.1	ERR2608616	0.84	0.68	0.58	SAMEA4702354	gut metagenome of ASD
L11079.1	ERR2608617	0.84	0.68	0.58	SAMEA4702355	gut metagenome of ASD
L11079.1	ERR2608627	0.84	0.68	0.58	SAMEA4702367	gut metagenome of ASD
L11079.1	ERR2608632	0.84	0.68	0.58	SAMEA4702372	gut metagenome of ASD
L11079.1	ERR2608633	0.84	0.68	0.58	SAMEA4702373	gut metagenome of ASD
L11079.1	ERR2619763	0.84	0.68	0.58	SAMEA4719816	Gut metagenomes of rural populations in Cameroon
L11079.1	ERR2676708	0.84	0.68	0.58	SAMEA4588163	Impact-of-Vegetarian-Diet
L11079.1	ERR2683150	0.84	0.68	0.58	SAMEA4777407	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683204	0.84	0.68	0.58	SAMEA4777461	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683227	0.84	0.68	0.58	SAMEA4777484	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683232	0.84	0.68	0.58	SAMEA4777489	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683234	0.84	0.68	0.58	SAMEA4777491	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683278	0.84	0.68	0.58	SAMEA4777535	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2712959	0.84	0.68	0.58	SAMEA4803019	Six-week endurance exercise alters gut metagenome that is not reflected in systemic metabolism in over-weight women
L11079.1	ERR2722810	0.84	0.68	0.58	SAMEA4814189	Impact of antibiotics on the human gut microbiome and resistome
L11079.1	ERR2722811	0.84	0.68	0.58	SAMEA4814190	Impact of antibiotics on the human gut microbiome and resistome
L11079.1	ERR2722812	0.84	0.68	0.58	SAMEA4814191	Impact of antibiotics on the human gut microbiome and resistome
L11079.1	ERR2722813	0.84	0.68	0.58	SAMEA4814192	Impact of antibiotics on the human gut microbiome and resistome
L11079.1	ERR3003400	0.84	0.68	0.58	SAMEA4813817	KOALA cohort metagenome study
L11079.1	ERR3003454	0.84	0.68	0.58	SAMEA4813872	KOALA cohort metagenome study
L11079.1	ERR3004185	0.84	0.68	0.58	SAMEA4813983	KOALA cohort metagenome study
L11079.1	ERR3004205	0.84	0.68	0.58	SAMEA4813793	KOALA cohort metagenome study
L11079.1	ERR3004253	0.84	0.68	0.58	SAMEA4812207	KOALA cohort metagenome study
L11079.1	ERR2726523	0.84	0.68	0.58	SAMEA4817969	Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer.
L11079.1	ERR2729796	0.84	0.68	0.58	SAMEA4812166	Shotgun metagenomic sequencing of NYC raw sewage samples
L11079.1	ERR2835653	0.84	0.68	0.58	SAMEA4969115	E. coli diversity in healthy and IBD human gut
L11079.1	ERR2739235	0.84	0.68	0.58	SAMEA4833145	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	ERR2739236	0.84	0.68	0.58	SAMEA4833145	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	ERR2739237	0.84	0.68	0.58	SAMEA4833145	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	ERR2739244	0.84	0.68	0.58	SAMEA4833149	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	ERR2739245	0.84	0.68	0.58	SAMEA4833149	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	ERR2739246	0.84	0.68	0.58	SAMEA4833149	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	ERR2749525	0.84	0.68	0.58	SAMEA4844806	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2750722	0.84	0.68	0.58	SAMEA4846004	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2750724	0.84	0.68	0.58	SAMEA4846006	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2750733	0.84	0.68	0.58	SAMEA4846015	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2750783	0.84	0.68	0.58	SAMEA4846065	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2835239	0.84	0.68	0.58	SAMEA4968673	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835337	0.84	0.68	0.58	SAMEA4968771	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835363	0.84	0.68	0.58	SAMEA4968797	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835409	0.84	0.68	0.58	SAMEA4968843	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835455	0.84	0.68	0.58	SAMEA4968889	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835467	0.84	0.68	0.58	SAMEA4968901	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835522	0.84	0.68	0.58	SAMEA4968956	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2814647	0.84	0.68	0.58	SAMEA4939799	Resistflow-INF-DNA data
L11079.1	ERR2816295	0.84	0.68	0.58	SAMEA4947621	The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy
L11079.1	ERR2855821	0.84	0.68	0.58	SAMEA4968120	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855864	0.84	0.68	0.58	SAMEA4968272	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855910	0.84	0.68	0.58	SAMEA4968267	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855924	0.84	0.68	0.58	SAMEA4968124	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855930	0.84	0.68	0.58	SAMEA4968132	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR3726302	0.84	0.68	0.58	SAMEA5039762	Human_colon_16S
L11079.1	ERR3015721	0.84	0.68	0.58	SAMEA5192857	The effects of a low residue diet study on gastrointestinal symptoms.
L11079.1	ERR3053356	0.84	0.68	0.58	SAMEA5216134	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3053368	0.84	0.68	0.58	SAMEA5216145	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3053369	0.84	0.68	0.58	SAMEA5216146	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3053381	0.84	0.68	0.58	SAMEA5216157	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3053383	0.84	0.68	0.58	SAMEA5216022	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3053389	0.84	0.68	0.58	SAMEA5216164	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3053391	0.84	0.68	0.58	SAMEA5216166	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3053441	0.84	0.68	0.58	SAMEA5216039	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3053476	0.84	0.68	0.58	SAMEA5216071	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3053492	0.84	0.68	0.58	SAMEA5216085	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3053494	0.84	0.68	0.58	SAMEA5216087	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3077528	0.84	0.68	0.58	SAMEA5228191	N/A
L11079.1	ERR3229786	0.84	0.68	0.58	SAMEA104565334	RLBUHT_Cdiff
L11079.1	ERR3229823	0.84	0.68	0.58	SAMEA104565354	RLBUHT_Cdiff
L11079.1	ERR3229831	0.84	0.68	0.58	SAMEA104565362	RLBUHT_Cdiff
L11079.1	ERR3229835	0.84	0.68	0.58	SAMEA104565366	RLBUHT_Cdiff
L11079.1	ERR3229909	0.84	0.68	0.58	SAMEA104565251	RLBUHT_Cdiff
L11079.1	ERR3229911	0.84	0.68	0.58	SAMEA104565253	RLBUHT_Cdiff
L11079.1	ERR3229940	0.84	0.68	0.58	SAMEA104565284	RLBUHT_Cdiff
L11079.1	ERR3229961	0.84	0.68	0.58	SAMEA104565305	RLBUHT_Cdiff
L11079.1	ERR3229977	0.84	0.68	0.58	SAMEA104565421	RLBUHT_Cdiff
L11079.1	ERR3097532	0.84	0.68	0.58	SAMEA5245495	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3153779	0.84	0.68	0.58	SAMEA5335553	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153809	0.84	0.68	0.58	SAMEA5335583	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3219597	0.84	0.68	0.58	SAMEA5407463	CaPES
L11079.1	ERR321209	0.84	0.68	0.58	SAMEA2153740	Richness of human gut microbiome correlates with metabolic markers
L11079.1	ERR3261721	0.84	0.68	0.58	SAMEA5537483	Drug metabolism by 28 human gut communities
L11079.1	ERR3261722	0.84	0.68	0.58	SAMEA5537484	Drug metabolism by 28 human gut communities
L11079.1	ERR3277221	0.84	0.68	0.58	SAMEA5564365	The Canadian Healthy Infant Longitudinal Development (CHILD) study is a multicenter longitudinal, prospective, general population birth cohort study. This study used a nested case-controlled design to analyze the functional potential of the fecal microbiome in infants enrolled in the CHILD Study. We selected 3-month and 1-year stool samples from an atopy enriched subset of children from one enrollment center (Vancouver). DNA was extracted from stool samples and submitted for shotgun metagenome sequencing.
L11079.1	ERR3277311	0.84	0.68	0.58	SAMEA5564326	The Canadian Healthy Infant Longitudinal Development (CHILD) study is a multicenter longitudinal, prospective, general population birth cohort study. This study used a nested case-controlled design to analyze the functional potential of the fecal microbiome in infants enrolled in the CHILD Study. We selected 3-month and 1-year stool samples from an atopy enriched subset of children from one enrollment center (Vancouver). DNA was extracted from stool samples and submitted for shotgun metagenome sequencing.
L11079.1	ERR3277347	0.84	0.68	0.58	SAMEA5564344	The Canadian Healthy Infant Longitudinal Development (CHILD) study is a multicenter longitudinal, prospective, general population birth cohort study. This study used a nested case-controlled design to analyze the functional potential of the fecal microbiome in infants enrolled in the CHILD Study. We selected 3-month and 1-year stool samples from an atopy enriched subset of children from one enrollment center (Vancouver). DNA was extracted from stool samples and submitted for shotgun metagenome sequencing.
L11079.1	ERR3277355	0.84	0.68	0.58	SAMEA5564446	The Canadian Healthy Infant Longitudinal Development (CHILD) study is a multicenter longitudinal, prospective, general population birth cohort study. This study used a nested case-controlled design to analyze the functional potential of the fecal microbiome in infants enrolled in the CHILD Study. We selected 3-month and 1-year stool samples from an atopy enriched subset of children from one enrollment center (Vancouver). DNA was extracted from stool samples and submitted for shotgun metagenome sequencing.
L11079.1	ERR3317627	0.84	0.68	0.58	SAMEA5599390	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317628	0.84	0.68	0.58	SAMEA5599391	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317634	0.84	0.68	0.58	SAMEA5599397	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317675	0.84	0.68	0.58	SAMEA5599438	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3338978	0.84	0.68	0.58	SAMEA5615050	Duodenal Microbiota in Stunted Undernourished Children with Enteropathy
L11079.1	ERR6995163	0.84	0.68	0.58	SAMEA10313620	iMSMS Baranzini data
L11079.1	ERR6995277	0.84	0.68	0.58	SAMEA10313735	iMSMS Baranzini data
L11079.1	ERR6996213	0.84	0.68	0.58	SAMEA10314623	iMSMS Baranzini data
L11079.1	ERR6996725	0.84	0.68	0.58	SAMEA10315070	iMSMS Baranzini data
L11079.1	ERR6997318	0.84	0.68	0.58	SAMEA10316108	iMSMS Baranzini data
L11079.1	ERR6997980	0.84	0.68	0.58	SAMEA10314683	iMSMS Baranzini data
L11079.1	ERR3348904	0.84	0.68	0.58	SAMEA5683137	Potential roles of gut microbiome commensals & metabolites in modulation of murine ALS
L11079.1	ERR3363670	0.84	0.68	0.58	SAMEA5700154	Gastrointestinal microbiota and immune cells interact closely and display regional specificity, but little is known about how these communities change with location.
L11079.1	ERR3393557	0.84	0.68	0.58	SAMEA5733060	Animal gut microbiome
L11079.1	ERR3404921	0.84	0.68	0.58	SAMEA5617644	Early_life_microbiota_colonisation
L11079.1	ERR3404922	0.84	0.68	0.58	SAMEA5617645	Early_life_microbiota_colonisation
L11079.1	ERR3404945	0.84	0.68	0.58	SAMEA5617646	Early_life_microbiota_colonisation
L11079.1	ERR3404955	0.84	0.68	0.58	SAMEA5617680	Early_life_microbiota_colonisation
L11079.1	ERR3405097	0.84	0.68	0.58	SAMEA5617727	Early_life_microbiota_colonisation
L11079.1	ERR3405143	0.84	0.68	0.58	SAMEA5618387	Early_life_microbiota_colonisation
L11079.1	ERR3405306	0.84	0.68	0.58	SAMEA5618431	Early_life_microbiota_colonisation
L11079.1	ERR3405394	0.84	0.68	0.58	SAMEA5618516	Early_life_microbiota_colonisation
L11079.1	ERR3405395	0.84	0.68	0.58	SAMEA5618517	Early_life_microbiota_colonisation
L11079.1	ERR3405396	0.84	0.68	0.58	SAMEA5618518	Early_life_microbiota_colonisation
L11079.1	ERR3405408	0.84	0.68	0.58	SAMEA5618536	Early_life_microbiota_colonisation
L11079.1	ERR3405409	0.84	0.68	0.58	SAMEA5618537	Early_life_microbiota_colonisation
L11079.1	ERR3405410	0.84	0.68	0.58	SAMEA5618538	Early_life_microbiota_colonisation
L11079.1	ERR3405479	0.84	0.68	0.58	SAMEA5616956	Early_life_microbiota_colonisation
L11079.1	ERR3405633	0.84	0.68	0.58	SAMEA5618124	Early_life_microbiota_colonisation
L11079.1	ERR3405634	0.84	0.68	0.58	SAMEA5618125	Early_life_microbiota_colonisation
L11079.1	ERR3405636	0.84	0.68	0.58	SAMEA5618126	Early_life_microbiota_colonisation
L11079.1	ERR3405642	0.84	0.68	0.58	SAMEA5618123	Early_life_microbiota_colonisation
L11079.1	ERR3405650	0.84	0.68	0.58	SAMEA5618248	Early_life_microbiota_colonisation
L11079.1	ERR3405843	0.84	0.68	0.58	SAMEA5618132	Early_life_microbiota_colonisation
L11079.1	ERR3405852	0.84	0.68	0.58	SAMEA5618188	Early_life_microbiota_colonisation
L11079.1	ERR3405853	0.84	0.68	0.58	SAMEA5618189	Early_life_microbiota_colonisation
L11079.1	ERR3405882	0.84	0.68	0.58	SAMEA5616959	Early_life_microbiota_colonisation
L11079.1	ERR3405910	0.84	0.68	0.58	SAMEA5618134	Early_life_microbiota_colonisation
L11079.1	ERR3405987	0.84	0.68	0.58	SAMEA5618190	Early_life_microbiota_colonisation
L11079.1	ERR3406014	0.84	0.68	0.58	SAMEA5617922	Early_life_microbiota_colonisation
L11079.1	ERR3406029	0.84	0.68	0.58	SAMEA5617908	Early_life_microbiota_colonisation
L11079.1	ERR3406060	0.84	0.68	0.58	SAMEA5618519	Early_life_microbiota_colonisation
L11079.1	ERR3406080	0.84	0.68	0.58	SAMEA5618191	Early_life_microbiota_colonisation
L11079.1	ERR3406086	0.84	0.68	0.58	SAMEA5618474	Early_life_microbiota_colonisation
L11079.1	ERR3406162	0.84	0.68	0.58	SAMEA5618233	Early_life_microbiota_colonisation
L11079.1	ERR3406202	0.84	0.68	0.58	SAMEA5618094	Early_life_microbiota_colonisation
L11079.1	ERR3406210	0.84	0.68	0.58	SAMEA5618196	Early_life_microbiota_colonisation
L11079.1	ERR3406214	0.84	0.68	0.58	SAMEA5618414	Early_life_microbiota_colonisation
L11079.1	ERR3406227	0.84	0.68	0.58	SAMEA5618540	Early_life_microbiota_colonisation
L11079.1	ERR3406252	0.84	0.68	0.58	SAMEA5618391	Early_life_microbiota_colonisation
L11079.1	ERR3406258	0.84	0.68	0.58	SAMEA5618127	Early_life_microbiota_colonisation
L11079.1	ERR3406297	0.84	0.68	0.58	SAMEA5618291	Early_life_microbiota_colonisation
L11079.1	ERR4666119	0.84	0.68	0.58	SAMEA7383167	Changes in the ileal, but not faecal, microbiome in response to increased dietary protein level and enterotoxigenic Escherichia coli exposure in pigs
L11079.1	ERR3452318	0.84	0.68	0.58	SAMEA5767136	Colonbiome pilot: 9 stools, sequenced by shotgun
L11079.1	ERR3450682	0.84	0.68	0.58	SAMEA5814765	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3450687	0.84	0.68	0.58	SAMEA5814403	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3450697	0.84	0.68	0.58	SAMEA5813904	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3450734	0.84	0.68	0.58	SAMEA5814007	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3450751	0.84	0.68	0.58	SAMEA5814209	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3450829	0.84	0.68	0.58	SAMEA5814573	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3450889	0.84	0.68	0.58	SAMEA5814131	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451013	0.84	0.68	0.58	SAMEA5814290	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451058	0.84	0.68	0.58	SAMEA5814276	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451103	0.84	0.68	0.58	SAMEA5814572	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451133	0.84	0.68	0.58	SAMEA5814313	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451134	0.84	0.68	0.58	SAMEA5814314	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451210	0.84	0.68	0.58	SAMEA5814479	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451233	0.84	0.68	0.58	SAMEA5813949	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451279	0.84	0.68	0.58	SAMEA5814620	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451282	0.84	0.68	0.58	SAMEA5814501	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451337	0.84	0.68	0.58	SAMEA5814057	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451341	0.84	0.68	0.58	SAMEA5814592	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451384	0.84	0.68	0.58	SAMEA5814073	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451395	0.84	0.68	0.58	SAMEA5814743	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451450	0.84	0.68	0.58	SAMEA5814456	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451465	0.84	0.68	0.58	SAMEA5814172	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451499	0.84	0.68	0.58	SAMEA5814686	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451509	0.84	0.68	0.58	SAMEA5813947	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451528	0.84	0.68	0.58	SAMEA5814732	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3471112	0.84	0.68	0.58	SAMEA5846977	Optimizing sequencing protocols for leaderboard metagenomics by combining long and short reads
L11079.1	ERR3500829	0.84	0.68	0.58	SAMEA5923316	The results of a first exploratory study testing the use of vaginal microbiome transplantation from healthy donors (VMT), as a therapeutic alternative for patients suffering from symptomatic, intractable and recurrent bacterial vaginosis.
L11079.1	ERR3503293	0.84	0.68	0.58	SAMEA5927900	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3503301	0.84	0.68	0.58	SAMEA5927908	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3519521	0.84	0.68	0.58	SAMEA5953994	Secrets of the hospital underbelly: abundance of antimicrobial resistance genes in hospital wastewater reflects hospital antimicrobial use and inpatient length of stay
L11079.1	ERR3521910	0.84	0.68	0.58	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521928	0.84	0.68	0.58	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521931	0.84	0.68	0.58	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521936	0.84	0.68	0.58	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521940	0.84	0.68	0.58	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521946	0.84	0.68	0.58	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521960	0.84	0.68	0.58	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521961	0.84	0.68	0.58	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521970	0.84	0.68	0.58	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3522029	0.84	0.68	0.58	SAMEA5669781	Ultra-deep shotgun sequencing
L11079.1	ERR3562943	0.84	0.68	0.58	SAMEA5982216	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3563059	0.84	0.68	0.58	SAMEA5982332	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3563093	0.84	0.68	0.58	SAMEA5982366	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3572994	0.84	0.68	0.58	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3573318	0.84	0.68	0.58	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3573553	0.84	0.68	0.58	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3573560	0.84	0.68	0.58	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3573565	0.84	0.68	0.58	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3573567	0.84	0.68	0.58	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3573569	0.84	0.68	0.58	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3573851	0.84	0.68	0.58	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3573853	0.84	0.68	0.58	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3574734	0.84	0.68	0.58	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3574736	0.84	0.68	0.58	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3588744	0.84	0.68	0.58	SAMEA6062682	Metagenomic sequencing of faecal extracts from a commercial pig farm with high antimicrobial usage
L11079.1	ERR3593050	0.84	0.68	0.58	SAMEA6085014	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593357	0.84	0.68	0.58	SAMEA6085322	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593404	0.84	0.68	0.58	SAMEA6085369	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593406	0.84	0.68	0.58	SAMEA6085371	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593408	0.84	0.68	0.58	SAMEA6085373	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593450	0.84	0.68	0.58	SAMEA6085415	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593453	0.84	0.68	0.58	SAMEA6085418	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593505	0.84	0.68	0.58	SAMEA6085470	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593514	0.84	0.68	0.58	SAMEA6085479	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593537	0.84	0.68	0.58	SAMEA6085502	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593555	0.84	0.68	0.58	SAMEA6085520	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593584	0.84	0.68	0.58	SAMEA6085549	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593605	0.84	0.68	0.58	SAMEA6085570	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593630	0.84	0.68	0.58	SAMEA6085595	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593649	0.84	0.68	0.58	SAMEA6085614	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593650	0.84	0.68	0.58	SAMEA6085615	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593656	0.84	0.68	0.58	SAMEA6085621	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593657	0.84	0.68	0.58	SAMEA6085622	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593658	0.84	0.68	0.58	SAMEA6085623	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593659	0.84	0.68	0.58	SAMEA6085624	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593660	0.84	0.68	0.58	SAMEA6085625	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593661	0.84	0.68	0.58	SAMEA6085626	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593662	0.84	0.68	0.58	SAMEA6085627	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593727	0.84	0.68	0.58	SAMEA6085692	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593766	0.84	0.68	0.58	SAMEA6085731	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593774	0.84	0.68	0.58	SAMEA6085739	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593864	0.84	0.68	0.58	SAMEA6085829	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593874	0.84	0.68	0.58	SAMEA6085839	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593957	0.84	0.68	0.58	SAMEA6085923	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593972	0.84	0.68	0.58	SAMEA6085938	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593988	0.84	0.68	0.58	SAMEA6085954	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3594007	0.84	0.68	0.58	SAMEA6085973	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3607290	0.84	0.68	0.58	SAMEA6104892	Human gut microbiome
L11079.1	ERR3607292	0.84	0.68	0.58	SAMEA6104881	Human gut microbiome
L11079.1	ERR3761412	0.84	0.68	0.58	SAMEA6415060	Shotgun sequencing of archaelogical paleofeces and sediments
L11079.1	ERR3792768	0.84	0.68	0.58	SAMEA6448812	Optimizing DNA extraction methods for Nanopore sequencing of Neisseria gonorrhoeae direct from urine samples
L11079.1	ERR3792781	0.84	0.68	0.58	SAMEA6448813	Optimizing DNA extraction methods for Nanopore sequencing of Neisseria gonorrhoeae direct from urine samples
L11079.1	ERR3792866	0.84	0.68	0.58	SAMEA6448819	Optimizing DNA extraction methods for Nanopore sequencing of Neisseria gonorrhoeae direct from urine samples
L11079.1	ERR4363156	0.84	0.68	0.58	SAMEA6448830	Optimizing DNA extraction methods for Nanopore sequencing of Neisseria gonorrhoeae direct from urine samples
L11079.1	ERR3857178	0.84	0.68	0.58	SAMEA6513013	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	ERR3857615	0.84	0.68	0.58	SAMEA6512885	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	ERR3857616	0.84	0.68	0.58	SAMEA6512885	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	ERR3857836	0.84	0.68	0.58	SAMEA6513038	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	ERR3857837	0.84	0.68	0.58	SAMEA6513038	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	ERR3857838	0.84	0.68	0.58	SAMEA6513038	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	ERR3857839	0.84	0.68	0.58	SAMEA6513038	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	ERR3857895	0.84	0.68	0.58	SAMEA6512910	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	ERR3857896	0.84	0.68	0.58	SAMEA6512910	Mediterranean diet intervention in overweight and obese subjects leads to multiple beneficial shifts in gut microbiome and metabolome independently from energy intake
L11079.1	ERR3950424	0.84	0.68	0.58	SAMEA6537522	The urinary tract microbiome in older women exhibits host genetics and environmental influences
L11079.1	ERR3941059	0.84	0.68	0.58	SAMEA6577050	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941065	0.84	0.68	0.58	SAMEA6577056	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941070	0.84	0.68	0.58	SAMEA6577061	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3946701	0.84	0.68	0.58	SAMEA6582098	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3946714	0.84	0.68	0.58	SAMEA6582111	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3946724	0.84	0.68	0.58	SAMEA6582121	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3946737	0.84	0.68	0.58	SAMEA6582134	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3957790	0.84	0.68	0.58	SAMEA6591540	Investigating the health status and microbiota in members of the Irish Travelling community
L11079.1	ERR3957794	0.84	0.68	0.58	SAMEA6591544	Investigating the health status and microbiota in members of the Irish Travelling community
L11079.1	ERR3986564	0.84	0.68	0.58	SAMEA6618436	Identifying frailty-associated markers in Elderly Irish Individuals
L11079.1	ERR3986612	0.84	0.68	0.58	SAMEA6618484	Identifying frailty-associated markers in Elderly Irish Individuals
L11079.1	ERR3986629	0.84	0.68	0.58	SAMEA6618501	Identifying frailty-associated markers in Elderly Irish Individuals
L11079.1	ERR3986745	0.84	0.68	0.58	SAMEA6618617	Identifying frailty-associated markers in Elderly Irish Individuals
L11079.1	ERR4032690	0.84	0.68	0.58	SAMEA6663405	Effects of the menstrual cycle and hormonal contraceptives on the human microbiome
L11079.1	ERR4032708	0.84	0.68	0.58	SAMEA6663424	Effects of the menstrual cycle and hormonal contraceptives on the human microbiome
L11079.1	ERR4065985	0.84	0.68	0.58	SAMEA6801819	Strain-level analysis of Bifidobacterium spp. from human gut metagenomes of individuals with different lactase persistence genotypes
L11079.1	ERR4086711	0.84	0.68	0.58	SAMEA6811046	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4087077	0.84	0.68	0.58	SAMEA6810994	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4087079	0.84	0.68	0.58	SAMEA6810994	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4087777	0.84	0.68	0.58	SAMEA6811344	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4087778	0.84	0.68	0.58	SAMEA6811344	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4087779	0.84	0.68	0.58	SAMEA6811344	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4088844	0.84	0.68	0.58	SAMEA6811258	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4088845	0.84	0.68	0.58	SAMEA6811258	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4088846	0.84	0.68	0.58	SAMEA6811258	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4088847	0.84	0.68	0.58	SAMEA6811258	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4089133	0.84	0.68	0.58	SAMEA6810963	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4089134	0.84	0.68	0.58	SAMEA6810963	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4089135	0.84	0.68	0.58	SAMEA6810963	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4089136	0.84	0.68	0.58	SAMEA6810963	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4089651	0.84	0.68	0.58	SAMEA6811313	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4089652	0.84	0.68	0.58	SAMEA6811313	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4089654	0.84	0.68	0.58	SAMEA6811313	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4089655	0.84	0.68	0.58	SAMEA6811313	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4090279	0.84	0.68	0.58	SAMEA6811363	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4097215	0.84	0.68	0.58	SAMEA6804800	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097216	0.84	0.68	0.58	SAMEA6804871	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097218	0.84	0.68	0.58	SAMEA6804873	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097225	0.84	0.68	0.58	SAMEA6804799	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097230	0.84	0.68	0.58	SAMEA6804801	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097236	0.84	0.68	0.58	SAMEA6804803	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097252	0.84	0.68	0.58	SAMEA6804819	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097254	0.84	0.68	0.58	SAMEA6804815	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097255	0.84	0.68	0.58	SAMEA6804818	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097256	0.84	0.68	0.58	SAMEA6804817	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097258	0.84	0.68	0.58	SAMEA6804811	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097260	0.84	0.68	0.58	SAMEA6804813	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097285	0.84	0.68	0.58	SAMEA6804838	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097286	0.84	0.68	0.58	SAMEA6804837	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097288	0.84	0.68	0.58	SAMEA6804835	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097289	0.84	0.68	0.58	SAMEA6804842	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097292	0.84	0.68	0.58	SAMEA6804839	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR414477	0.84	0.68	0.58	SAMEA2338847	An integrated catalog of reference genes in the human gut microbiome
L11079.1	ERR4158099	0.84	0.68	0.58	SAMEA6844978	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4158186	0.84	0.68	0.58	SAMEA6845065	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4158234	0.84	0.68	0.58	SAMEA6845113	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4158284	0.84	0.68	0.58	SAMEA6845163	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4191876	0.84	0.68	0.58	SAMEA6871668	Chicken gut microbiome
L11079.1	ERR4193886	0.84	0.68	0.58	SAMEA6873531	Pathogenesis of Klebsiella Liver Abscess Syndrome Study (P-KLASS)
L11079.1	ERR4288632	0.84	0.68	0.58	SAMEA7007658	Transcriptome sequencing of D. diazotrophica
L11079.1	ERR4288684	0.84	0.68	0.58	SAMEA7007671	Transcriptome sequencing of D. diazotrophica
L11079.1	ERR4304376	0.84	0.68	0.58	SAMEA5698170	Microbiome_based_prediction_of_vaccine_response_in_elderly_patients
L11079.1	ERR4320066	0.84	0.68	0.58	SAMEA7041100	Gut microbiota of carriers of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae following treatment with oral antibiotics and fecal microbiota transplantation
L11079.1	ERR4333889	0.84	0.68	0.58	SAMEA7041252	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4333974	0.84	0.68	0.58	SAMEA7045058	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4334041	0.84	0.68	0.58	SAMEA7045125	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4334111	0.84	0.68	0.58	SAMEA7045196	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4334137	0.84	0.68	0.58	SAMEA7045222	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4334247	0.84	0.68	0.58	SAMEA7045332	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4335045	0.84	0.68	0.58	SAMEA7045380	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4335162	0.84	0.68	0.58	SAMEA7045497	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4335251	0.84	0.68	0.58	SAMEA7045586	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4341794	0.84	0.68	0.58	SAMEA7045787	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4332552	0.84	0.68	0.58	SAMEA7051315	Multi-omics analysis on overweight subjects under a caloric restriction intervention with fibre supplementation and placebo-controlled.
L11079.1	ERR4368182	0.84	0.68	0.58	SAMEA7082341	Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome is mirrored by changes in gut microbiome
L11079.1	ERR4368197	0.84	0.68	0.58	SAMEA7082342	Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome is mirrored by changes in gut microbiome
L11079.1	ERR4369536	0.84	0.68	0.58	SAMEA7082351	Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome is mirrored by changes in gut microbiome
L11079.1	ERR4383745	0.84	0.68	0.58	SAMEA7082393	Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome is mirrored by changes in gut microbiome
L11079.1	ERR4383992	0.84	0.68	0.58	SAMEA7094264	SKIN MICROBIOTA AND CLINICAL ASSOCIATIONS IN NETHERTON SYNDROME
L11079.1	ERR4398809	0.84	0.68	0.58	SAMEA7112148	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	ERR4406668	0.84	0.68	0.58	SAMEA7096835	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4406670	0.84	0.68	0.58	SAMEA7096837	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4406691	0.84	0.68	0.58	SAMEA7096858	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4406753	0.84	0.68	0.58	SAMEA7096921	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4406754	0.84	0.68	0.58	SAMEA7096922	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4406757	0.84	0.68	0.58	SAMEA7096925	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4406779	0.84	0.68	0.58	SAMEA7096947	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4406866	0.84	0.68	0.58	SAMEA7097034	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4407094	0.84	0.68	0.58	SAMEA7097262	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4407095	0.84	0.68	0.58	SAMEA7097263	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4407096	0.84	0.68	0.58	SAMEA7097264	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4407122	0.84	0.68	0.58	SAMEA7097290	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4407167	0.84	0.68	0.58	SAMEA7097335	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4407172	0.84	0.68	0.58	SAMEA7097340	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4560961	0.84	0.68	0.58	SAMEA7288252	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4560962	0.84	0.68	0.58	SAMEA7288252	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4560963	0.84	0.68	0.58	SAMEA7288252	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561307	0.84	0.68	0.58	SAMEA7288372	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561454	0.84	0.68	0.58	SAMEA7288413	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561455	0.84	0.68	0.58	SAMEA7288413	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561457	0.84	0.68	0.58	SAMEA7288413	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561458	0.84	0.68	0.58	SAMEA7288413	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561460	0.84	0.68	0.58	SAMEA7288413	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561794	0.84	0.68	0.58	SAMEA7288624	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561795	0.84	0.68	0.58	SAMEA7288624	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561796	0.84	0.68	0.58	SAMEA7288624	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561797	0.84	0.68	0.58	SAMEA7288624	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561798	0.84	0.68	0.58	SAMEA7288624	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561810	0.84	0.68	0.58	SAMEA7288628	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4562116	0.84	0.68	0.58	SAMEA7288695	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4562117	0.84	0.68	0.58	SAMEA7288695	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4562118	0.84	0.68	0.58	SAMEA7288695	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4562119	0.84	0.68	0.58	SAMEA7288695	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4562120	0.84	0.68	0.58	SAMEA7288695	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4562360	0.84	0.68	0.58	SAMEA7288745	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4562402	0.84	0.68	0.58	SAMEA7288753	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4562404	0.84	0.68	0.58	SAMEA7288753	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4562405	0.84	0.68	0.58	SAMEA7288753	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563326	0.84	0.68	0.58	SAMEA7288186	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563470	0.84	0.68	0.58	SAMEA7288245	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563917	0.84	0.68	0.58	SAMEA7288462	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563980	0.84	0.68	0.58	SAMEA7288475	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4564048	0.84	0.68	0.58	SAMEA7288494	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4564049	0.84	0.68	0.58	SAMEA7288494	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4564050	0.84	0.68	0.58	SAMEA7288494	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4564051	0.84	0.68	0.58	SAMEA7288494	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4564053	0.84	0.68	0.58	SAMEA7288494	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4564280	0.84	0.68	0.58	SAMEA7288549	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4564282	0.84	0.68	0.58	SAMEA7288549	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4565653	0.84	0.68	0.58	SAMEA7289153	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4678560	0.84	0.68	0.58	SAMEA7426260	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678568	0.84	0.68	0.58	SAMEA7426268	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4682333	0.84	0.68	0.58	SAMEA7428240	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682374	0.84	0.68	0.58	SAMEA7428281	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682383	0.84	0.68	0.58	SAMEA7428290	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682433	0.84	0.68	0.58	SAMEA7428340	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682453	0.84	0.68	0.58	SAMEA7428360	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682773	0.84	0.68	0.58	SAMEA7428414	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682778	0.84	0.68	0.58	SAMEA7428420	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682798	0.84	0.68	0.58	SAMEA7428440	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4686051	0.84	0.68	0.58	SAMEA7449696	Shotgun metagenomics of total DNA isolated from intestinal content of wild and domestic animals
L11079.1	ERR478970	0.84	0.68	0.58	SAMEA2467013	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR478971	0.84	0.68	0.58	SAMEA2467013	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR478972	0.84	0.68	0.58	SAMEA2467013	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR478973	0.84	0.68	0.58	SAMEA2467013	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479128	0.84	0.68	0.58	SAMEA2467018	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479129	0.84	0.68	0.58	SAMEA2467018	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479130	0.84	0.68	0.58	SAMEA2467018	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479131	0.84	0.68	0.58	SAMEA2467018	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479375	0.84	0.68	0.58	SAMEA2467042	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479376	0.84	0.68	0.58	SAMEA2467042	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479390	0.84	0.68	0.58	SAMEA2466927	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR480624	0.84	0.68	0.58	SAMEA2467018	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR480625	0.84	0.68	0.58	SAMEA2467018	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR480627	0.84	0.68	0.58	SAMEA2467018	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR480873	0.84	0.68	0.58	SAMEA2467042	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR4794178	0.84	0.68	0.58	SAMEA7519346	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4794180	0.84	0.68	0.58	SAMEA7519347	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4794185	0.84	0.68	0.58	SAMEA7519350	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4794209	0.84	0.68	0.58	SAMEA7519364	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4794296	0.84	0.68	0.58	SAMEA7519384	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4794300	0.84	0.68	0.58	SAMEA7519387	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4794305	0.84	0.68	0.58	SAMEA7519391	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4794406	0.84	0.68	0.58	SAMEA7519256	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4794448	0.84	0.68	0.58	SAMEA7519266	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4794516	0.84	0.68	0.58	SAMEA7519283	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4794526	0.84	0.68	0.58	SAMEA7519285	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4794534	0.84	0.68	0.58	SAMEA7519287	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4794536	0.84	0.68	0.58	SAMEA7519287	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4794554	0.84	0.68	0.58	SAMEA7519290	Analysis of human fecal metagenomes from adults and infants, to investigate strain persistance, dispersal and purifying selection of bacterial strains.
L11079.1	ERR4803999	0.84	0.68	0.58	SAMEA7535920	Metagenomic Analysis of Sewage for Surveillance of Bacterial Pathogens: A Release Experiment to Determine Sensitivity
L11079.1	ERR4804020	0.84	0.68	0.58	SAMEA7535941	Metagenomic Analysis of Sewage for Surveillance of Bacterial Pathogens: A Release Experiment to Determine Sensitivity
L11079.1	ERR4804029	0.84	0.68	0.58	SAMEA7535950	Metagenomic Analysis of Sewage for Surveillance of Bacterial Pathogens: A Release Experiment to Determine Sensitivity
L11079.1	ERR6001990	0.84	0.68	0.58	SAMEA8899428	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002053	0.84	0.68	0.58	SAMEA8899491	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002070	0.84	0.68	0.58	SAMEA8899508	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002100	0.84	0.68	0.58	SAMEA8899538	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002124	0.84	0.68	0.58	SAMEA8899562	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002229	0.84	0.68	0.58	SAMEA8899667	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002236	0.84	0.68	0.58	SAMEA8899674	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR5035295	0.84	0.68	0.58	SAMEA7756257	Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption
L11079.1	ERR5035325	0.84	0.68	0.58	SAMEA7756287	Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption
L11079.1	ERR5035331	0.84	0.68	0.58	SAMEA7756293	Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption
L11079.1	ERR5050429	0.84	0.68	0.58	SAMEA7766659	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050472	0.84	0.68	0.58	SAMEA7766703	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050485	0.84	0.68	0.58	SAMEA7766716	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050496	0.84	0.68	0.58	SAMEA7766727	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5083824	0.84	0.68	0.58	SAMEA7800722	We investigated the effect of short vs long antibiotic treatments on gut microbiota of patients with Gram-negative bacteremia by whole metagenome shotgun sequencing.
L11079.1	ERR5083899	0.84	0.68	0.58	SAMEA7800797	We investigated the effect of short vs long antibiotic treatments on gut microbiota of patients with Gram-negative bacteremia by whole metagenome shotgun sequencing.
L11079.1	ERR5102917	0.84	0.68	0.58	SAMEA7772032	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5103815	0.84	0.68	0.58	SAMEA7772103	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5169901	0.84	0.68	0.58	SAMEA7772259	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5169904	0.84	0.68	0.58	SAMEA7772260	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5169909	0.84	0.68	0.58	SAMEA7772262	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5169913	0.84	0.68	0.58	SAMEA7772263	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5169919	0.84	0.68	0.58	SAMEA7772265	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5169925	0.84	0.68	0.58	SAMEA7772266	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5261216	0.84	0.68	0.58	SAMEA7772340	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5261218	0.84	0.68	0.58	SAMEA7772341	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5261219	0.84	0.68	0.58	SAMEA7772343	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5261222	0.84	0.68	0.58	SAMEA7772342	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5261231	0.84	0.68	0.58	SAMEA7772344	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5261235	0.84	0.68	0.58	SAMEA7772351	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5261236	0.84	0.68	0.58	SAMEA7772350	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5261239	0.84	0.68	0.58	SAMEA7772353	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5261215	0.84	0.68	0.58	SAMEA7996530	Intestinal VLP reads and predicted phage contigs for at-risk RA individuals
L11079.1	ERR5194758	0.84	0.68	0.58	SAMEA7874188	FUT2/FUT3 genes sequences and nasopharyngeal shotgun metagenomics from the Microbiota and Health Study
L11079.1	ERR525768	0.84	0.68	0.58	SAMEA2579985	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR525769	0.84	0.68	0.58	SAMEA2579986	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR525770	0.84	0.68	0.58	SAMEA2579987	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR525853	0.84	0.68	0.58	SAMEA2580070	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR525950	0.84	0.68	0.58	SAMEA2580167	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR525983	0.84	0.68	0.58	SAMEA2580200	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR526044	0.84	0.68	0.58	SAMEA2580261	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR527121	0.84	0.68	0.58	SAMEA2581951	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	ERR5417990	0.84	0.68	0.58	SAMEA8203611	The genetic impact of an Ebola outbreak on a wild gorilla population
L11079.1	ERR5418035	0.84	0.68	0.58	SAMEA8203656	The genetic impact of an Ebola outbreak on a wild gorilla population
L11079.1	ERR5418047	0.84	0.68	0.58	SAMEA8203668	The genetic impact of an Ebola outbreak on a wild gorilla population
L11079.1	ERR5418048	0.84	0.68	0.58	SAMEA8203669	The genetic impact of an Ebola outbreak on a wild gorilla population
L11079.1	ERR5418055	0.84	0.68	0.58	SAMEA8203676	The genetic impact of an Ebola outbreak on a wild gorilla population
L11079.1	ERR5445744	0.84	0.68	0.58	SAMEA8228457	Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota
L11079.1	ERR5445800	0.84	0.68	0.58	SAMEA8228513	Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota
L11079.1	ERR5664980	0.84	0.68	0.58	SAMEA8514753	Asymptomatic gut colonization by extended-spectrum beta-lactamase producing Escherichia coli is not associated with an altered gut microbiome or metabolome
L11079.1	ERR579887	0.84	0.68	0.58	SAMEA2699035	The microbial colonization of the intestine during the first monthsof life constitutes the most important process for the microbiota-induced host-homeostasis.Alterations in this process may entail a high-risk for disease in later life. However, this process the potential factorsaffecting it in the infant are not well known. Moreover, the potential impact of orally administered vaccines, expected to interact with intestinal immune cells eliciting an immune response at mucosal level,upon the establishing microbiome remains unknown.Here we assessed the intestinal microbiome establishmentprocess and evaluated the impact of rotavirus vaccination upon this process. Metagenomic, PCR-DGGE and faecal short chain fatty acids analyses were performed on faecal samples obtained from three infants before and after the administration of each dose of vaccine. We found a high inter-individual variability in the early lifegut microbiota at microbial composition level, but a large similarity between the infants’ microbiomes at functional level. Rotavirus vaccination did not show any major effects upon the infant gut microbiota. Thus, the individual microbiome establishment and development process seems to occur in a defined manner during the first stages of life and it is not affected by oral rotavirus vaccination.
L11079.1	ERR5845181	0.84	0.68	0.58	SAMEA8653345	Association between age and the human intestinal microbiome
L11079.1	ERR5845210	0.84	0.68	0.58	SAMEA8653375	Association between age and the human intestinal microbiome
L11079.1	ERR5883797	0.84	0.68	0.58	SAMEA8690943	Effect of fecal microbiota transplantation combined with Mediterranean diet on insulin sensitivity in subjects with metabolic syndrome
L11079.1	ERR589529	0.84	0.68	0.58	SAMEA2737671	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589543	0.84	0.68	0.58	SAMEA2737684	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR5917350	0.84	0.68	0.58	SAMEA8740519	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR597418	0.84	0.68	0.58	SAMEA2755606	Kwashiorkor Children have lost Anaerobes-Methanogenic Gut Prokaryotes Mutualism
L11079.1	ERR6170232	0.84	0.68	0.58	SAMEA8945663	VEGA Human Gut Metagenomics
L11079.1	ERR6170290	0.84	0.68	0.58	SAMEA8945717	VEGA Human Gut Metagenomics
L11079.1	ERR6383997	0.84	0.68	0.58	SAMEA8994802	Human and mouse gut metagenome upon fecal microbiota transplantation
L11079.1	ERR6750193	0.84	0.68	0.58	SAMEA9943592	Exploring semi-quantitative metagenomics studies using Oxford Nanopore sequencing : a computational and experimental protocol
L11079.1	ERR6751195	0.84	0.68	0.58	SAMEA9943599	Exploring semi-quantitative metagenomics studies using Oxford Nanopore sequencing : a computational and experimental protocol
L11079.1	ERR6747899	0.84	0.68	0.58	SAMEA9943799	Saccharomyces boulardii CNCM I 745 supplementation modifies the fecal resistome during the Helicobacter pylori eradication therapy
L11079.1	ERR688564	0.84	0.68	0.58	SAMEA3136652	Gut microbiome development along the colorectal adenoma-carcinoma sequence
L11079.1	ERR688567	0.84	0.68	0.58	SAMEA3136753	Gut microbiome development along the colorectal adenoma-carcinoma sequence
L11079.1	ERR6911007	0.84	0.68	0.58	SAMEA9990065	BARIA baseline first 100 individuals, metagenomes
L11079.1	ERR700201	0.84	0.68	0.58	SAMEA3174673	Dromedary Faecal Metagenome-GI disorder
L11079.1	ERR7017691	0.84	0.68	0.58	SAMEA10256232	AMR_metagenomic_sequencing
L11079.1	ERR7017719	0.84	0.68	0.58	SAMEA10256232	AMR_metagenomic_sequencing
L11079.1	ERR7017747	0.84	0.68	0.58	SAMEA10256232	AMR_metagenomic_sequencing
L11079.1	ERR7017775	0.84	0.68	0.58	SAMEA10256232	AMR_metagenomic_sequencing
L11079.1	ERR7017803	0.84	0.68	0.58	SAMEA10256232	AMR_metagenomic_sequencing
L11079.1	ERR7017831	0.84	0.68	0.58	SAMEA10256232	AMR_metagenomic_sequencing
L11079.1	ERR7017859	0.84	0.68	0.58	SAMEA10256232	AMR_metagenomic_sequencing
L11079.1	ERR707010	0.84	0.68	0.58	SAMEA3178640	Dromedary Faecal Metagenomes-Healthy
L11079.1	ERR7130309	0.84	0.68	0.58	SAMEA10021365	Smoking-related dysbiosis and associated metabolites drive cessation-induced weight gain
L11079.1	ERR7159569	0.84	0.68	0.58	SAMEA10021365	Smoking-related dysbiosis and associated metabolites drive cessation-induced weight gain
L11079.1	ERR7197555	0.84	0.68	0.58	SAMEA10535610	Hi-C metagenomics study on faecal microbiomes from 5-5 British low- and high-antimicrobial use pig farms
L11079.1	ERR7197559	0.84	0.68	0.58	SAMEA10535614	Hi-C metagenomics study on faecal microbiomes from 5-5 British low- and high-antimicrobial use pig farms
L11079.1	ERR7197647	0.84	0.68	0.58	SAMEA10535679	Hi-C metagenomics study on faecal microbiomes from 5-5 British low- and high-antimicrobial use pig farms
L11079.1	ERR7197648	0.84	0.68	0.58	SAMEA10535680	Hi-C metagenomics study on faecal microbiomes from 5-5 British low- and high-antimicrobial use pig farms
L11079.1	ERR719008	0.84	0.68	0.58	SAMEA3182094	The initial state of the human gut microbiome determines its reshaping by antibiotics
L11079.1	ERR719075	0.84	0.68	0.58	SAMEA3182097	The initial state of the human gut microbiome determines its reshaping by antibiotics
L11079.1	ERR7256418	0.84	0.68	0.58	SAMEA10886902	Stool samples sorted with microfluidics technique to isolate out individual cells.
L11079.1	ERR7256419	0.84	0.68	0.58	SAMEA10886903	Stool samples sorted with microfluidics technique to isolate out individual cells.
L11079.1	ERR7439210	0.84	0.68	0.58	SAMEA10813639	Long-term effects of diet on human gut microbiota composition employing shotgun metagenomics data analysis
L11079.1	ERR7459284	0.84	0.68	0.58	SAMEA104665992	The_human_gut_microbiome_in_alcoholic_liver_disease
L11079.1	ERR7459342	0.84	0.68	0.58	SAMEA104665919	The_human_gut_microbiome_in_alcoholic_liver_disease
L11079.1	ERR7459377	0.84	0.68	0.58	SAMEA104665869	The_human_gut_microbiome_in_alcoholic_liver_disease
L11079.1	ERR7459381	0.84	0.68	0.58	SAMEA104665864	The_human_gut_microbiome_in_alcoholic_liver_disease
L11079.1	ERR7459391	0.84	0.68	0.58	SAMEA104665854	The_human_gut_microbiome_in_alcoholic_liver_disease
L11079.1	ERR7599944	0.84	0.68	0.58	SAMEA11358278	Singapore Platinum Metagenomes Project
L11079.1	ERR7625357	0.84	0.68	0.58	SAMEA11358278	Singapore Platinum Metagenomes Project
L11079.1	ERR7625404	0.84	0.68	0.58	SAMEA11358302	Singapore Platinum Metagenomes Project
L11079.1	ERR7671939	0.84	0.68	0.58	SAMEA11358278	Singapore Platinum Metagenomes Project
L11079.1	ERR912030	0.84	0.68	0.58	SAMEA3449225	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912033	0.84	0.68	0.58	SAMEA3449228	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912045	0.84	0.68	0.58	SAMEA3449240	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912053	0.84	0.68	0.58	SAMEA3449248	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912058	0.84	0.68	0.58	SAMEA3449253	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912059	0.84	0.68	0.58	SAMEA3449254	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912062	0.84	0.68	0.58	SAMEA3449257	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912076	0.84	0.68	0.58	SAMEA3449271	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912101	0.84	0.68	0.58	SAMEA3449296	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912104	0.84	0.68	0.58	SAMEA3449299	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912108	0.84	0.68	0.58	SAMEA3449303	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	SRR497947	0.84	0.68	0.58	SAMN00829173	Metagenomic Analysis of the Structure and Function of the Human Gut Microbiota in Crohn''s Disease
L11079.1	SRR5548979	0.84	0.68	0.58	SAMN06733434	The Role of the Gut Microbiota in Ulcerative Colitis, functional gene metagenomics
L11079.1	SRR5548980	0.84	0.68	0.58	SAMN06733434	The Role of the Gut Microbiota in Ulcerative Colitis, functional gene metagenomics
L11079.1	SRR4018492	0.84	0.68	0.58	SAMN05442510	freshwater metagenome Raw sequence reads
L11079.1	SRR10029197	0.84	0.68	0.58	SAMN12645325	Multi-omic analysis of Clostridioides difficile infection and response to therapy in pediatric inflammatory bowel disease
L11079.1	SRR10029246	0.84	0.68	0.58	SAMN12645281	Multi-omic analysis of Clostridioides difficile infection and response to therapy in pediatric inflammatory bowel disease
L11079.1	SRR10029248	0.84	0.68	0.58	SAMN12645280	Multi-omic analysis of Clostridioides difficile infection and response to therapy in pediatric inflammatory bowel disease
L11079.1	SRR10029249	0.84	0.68	0.58	SAMN12645279	Multi-omic analysis of Clostridioides difficile infection and response to therapy in pediatric inflammatory bowel disease
L11079.1	SRR1073801	0.84	0.68	0.58	SAMN00002882	Microbial composition of samples from infant gut
L11079.1	SRR1145979	0.84	0.68	0.58	SAMN01773492	Microbial composition of samples from infant gut
L11079.1	SRR1162493	0.84	0.68	0.58	SAMN00990279	Microbial composition of samples from infant gut
L11079.1	SRR605605	0.84	0.68	0.58	SAMN01828277	Microbial composition of samples from infant gut
L11079.1	SRR652317	0.84	0.68	0.58	SAMN01780057	Microbial composition of samples from infant gut
L11079.1	SRR918354	0.84	0.68	0.58	SAMN01795797	Microbial composition of samples from infant gut
L11079.1	SRR918605	0.84	0.68	0.58	SAMN01889407	Microbial composition of samples from infant gut
L11079.1	SRR10058643	0.84	0.68	0.58	SAMN12649869	Fecal microbiome analysis of patients with chronic obstructive pulmonary disease
L11079.1	SRR10059220	0.84	0.68	0.58	SAMN12676722	PIRE- Halting Environmental Antimicrobial Resistance Dissemination (HEARD)
L11079.1	SRR10084767	0.84	0.68	0.58	SAMN12711694	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR15801639	0.84	0.68	0.58	SAMN12730290	Gut virome in VEO-IBD
L11079.1	SRR4140248	0.84	0.68	0.58	SAMN05436723	feces metagenome Metagenome
L11079.1	SRR8402144	0.84	0.68	0.58	SAMN10698501	feces metagenome Metagenome
L11079.1	SRR8402303	0.84	0.68	0.58	SAMN10698511	feces metagenome Metagenome
L11079.1	SRR7124625	0.84	0.68	0.58	SAMN08918304	human gut metagenome Raw sequence reads
L11079.1	SRR10176804	0.84	0.68	0.58	SAMN12837491	Gut Microbiome of Elderly Adults with Advanced Dementia
L11079.1	SRR14570972	0.84	0.68	0.58	SAMN19189065	human metagenome Raw sequence reads
L11079.1	SRR14570973	0.84	0.68	0.58	SAMN19189069	human metagenome Raw sequence reads
L11079.1	SRR14571183	0.84	0.68	0.58	SAMN19188970	human metagenome Raw sequence reads
L11079.1	SRR10499457	0.84	0.68	0.58	SAMN13292922	human gut metagenome Metagenome
L11079.1	SRR10499513	0.84	0.68	0.58	SAMN13293016	human gut metagenome Metagenome
L11079.1	SRR10692054	0.84	0.68	0.58	SAMN13246902	human gut metagenome Metagenome
L11079.1	SRR10692206	0.84	0.68	0.58	SAMN13246863	human gut metagenome Metagenome
L11079.1	SRR10692277	0.84	0.68	0.58	SAMN13246982	human gut metagenome Metagenome
L11079.1	SRR10692305	0.84	0.68	0.58	SAMN13246536	human gut metagenome Metagenome
L11079.1	SRR10692307	0.84	0.68	0.58	SAMN13246534	human gut metagenome Metagenome
L11079.1	SRR10692561	0.84	0.68	0.58	SAMN13246653	human gut metagenome Metagenome
L11079.1	SRR10692563	0.84	0.68	0.58	SAMN13246651	human gut metagenome Metagenome
L11079.1	SRR10692566	0.84	0.68	0.58	SAMN13246648	human gut metagenome Metagenome
L11079.1	SRR10692597	0.84	0.68	0.58	SAMN13246393	human gut metagenome Metagenome
L11079.1	SRR10692703	0.84	0.68	0.58	SAMN13246622	human gut metagenome Metagenome
L11079.1	SRR10692723	0.84	0.68	0.58	SAMN13246604	human gut metagenome Metagenome
L11079.1	SRR10692799	0.84	0.68	0.58	SAMN13246600	human gut metagenome Metagenome
L11079.1	SRR10692833	0.84	0.68	0.58	SAMN13246376	human gut metagenome Metagenome
L11079.1	SRR11412704	0.84	0.68	0.58	SAMN14445566	human gut metagenome Metagenome
L11079.1	SRR11412825	0.84	0.68	0.58	SAMN14445688	human gut metagenome Metagenome
L11079.1	SRR11412943	0.84	0.68	0.58	SAMN14445697	human gut metagenome Metagenome
L11079.1	SRR11728446	0.84	0.68	0.58	SAMN14730715	human gut metagenome Metagenome
L11079.1	SRR13836183	0.84	0.68	0.58	SAMN18115833	human gut metagenome Metagenome
L11079.1	SRR5580327	0.84	0.68	0.58	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR8506062	0.84	0.68	0.58	SAMN10845145	human gut metagenome Metagenome
L11079.1	SRR9264580	0.84	0.68	0.58	SAMN12011382	human gut metagenome Metagenome
L11079.1	SRR9264599	0.84	0.68	0.58	SAMN12011393	human gut metagenome Metagenome
L11079.1	SRR9264651	0.84	0.68	0.58	SAMN12011495	human gut metagenome Metagenome
L11079.1	SRR10313453	0.84	0.68	0.58	SAMN13061249	Gut microbiota related to high altitude adaptation in Tibetan humans and pigs
L11079.1	SRR7124436	0.84	0.68	0.58	SAMN09042631	Human gut metagenome Raw sequence reads upon exercise intervention
L11079.1	SRR7124454	0.84	0.68	0.58	SAMN09042623	Human gut metagenome Raw sequence reads upon exercise intervention
L11079.1	SRR8490385	0.84	0.68	0.58	SAMN10781795	Whole metagenomic analysis of the enteric microbiota in children with autism spectrum disorder: the search for marker genes compositions
L11079.1	SRR8490387	0.84	0.68	0.58	SAMN10781785	Whole metagenomic analysis of the enteric microbiota in children with autism spectrum disorder: the search for marker genes compositions
L11079.1	SRR10423912	0.84	0.68	0.58	SAMN13241759	Human gut microbiome and virome under antibiotic treatment Raw sequence reads
L11079.1	SRR10427835	0.84	0.68	0.58	SAMN13258163	Gut microbiome changes after bariatric surgery
L11079.1	SRR10427849	0.84	0.68	0.58	SAMN13258151	Gut microbiome changes after bariatric surgery
L11079.1	SRR10427882	0.84	0.68	0.58	SAMN13258121	Gut microbiome changes after bariatric surgery
L11079.1	SRR10527840	0.84	0.68	0.58	SAMN13338980	Impact of intrapartum and postnatal antibiotics on the gut microbiome and emergence of antimicrobial resistance in infants
L11079.1	SRR9095181	0.84	0.68	0.58	SAMN11761759	Impact of intrapartum and postnatal antibiotics on the gut microbiome and emergence of antimicrobial resistance in infants
L11079.1	SRR9095197	0.84	0.68	0.58	SAMN11761738	Impact of intrapartum and postnatal antibiotics on the gut microbiome and emergence of antimicrobial resistance in infants
L11079.1	SRR10616327	0.84	0.68	0.58	SAMN13517520	Human Fecal Microbiome Multi-omics
L11079.1	SRR10682394	0.84	0.68	0.58	SAMN13252773	viral metagenome Metagenome
L11079.1	SRR10680599	0.84	0.68	0.58	SAMN13509632	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680672	0.84	0.68	0.58	SAMN13509568	Human gut metagenomes from Hong Kong populations
L11079.1	SRR12817630	0.84	0.68	0.58	SAMN16428227	COSMIC2 - Persistence of birth mode-dependent effects on gut microbiome composition, immune system stimulation and antimicrobial resistance in the first year of life
L11079.1	SRR13303054	0.84	0.68	0.58	SAMN17025441	COSMIC2 - Persistence of birth mode-dependent effects on gut microbiome composition, immune system stimulation and antimicrobial resistance in the first year of life
L11079.1	SRR13303307	0.84	0.68	0.58	SAMN17025721	COSMIC2 - Persistence of birth mode-dependent effects on gut microbiome composition, immune system stimulation and antimicrobial resistance in the first year of life
L11079.1	SRR9037963	0.84	0.68	0.58	SAMN11616088	feces metagenome Raw sequence reads
L11079.1	SRR9038001	0.84	0.68	0.58	SAMN11615944	feces metagenome Raw sequence reads
L11079.1	SRR9038064	0.84	0.68	0.58	SAMN11616106	feces metagenome Raw sequence reads
L11079.1	SRR9038084	0.84	0.68	0.58	SAMN11615817	feces metagenome Raw sequence reads
L11079.1	SRR9038100	0.84	0.68	0.58	SAMN11615928	feces metagenome Raw sequence reads
L11079.1	SRR9038151	0.84	0.68	0.58	SAMN11615974	feces metagenome Raw sequence reads
L11079.1	SRR9038174	0.84	0.68	0.58	SAMN11615739	feces metagenome Raw sequence reads
L11079.1	SRR9098653	0.84	0.68	0.58	SAMN11793164	feces metagenome Raw sequence reads
L11079.1	SRR9098818	0.84	0.68	0.58	SAMN11792819	feces metagenome Raw sequence reads
L11079.1	SRR9128965	0.84	0.68	0.58	SAMN11864574	feces metagenome Raw sequence reads
L11079.1	SRR12404962	0.84	0.68	0.58	SAMN15090775	wastewater Metagenome
L11079.1	SRR10769893	0.84	0.68	0.58	SAMN13474920	Wastewater treatment and land application of swine wastewater Raw sequence reads
L11079.1	SRR10816034	0.84	0.68	0.58	SAMN13705555	Elderly Gut Microbiota FMM
L11079.1	SRR10816035	0.84	0.68	0.58	SAMN13705554	Elderly Gut Microbiota FMM
L11079.1	SRR10816049	0.84	0.68	0.58	SAMN13705541	Elderly Gut Microbiota FMM
L11079.1	SRR10901933	0.84	0.68	0.58	SAMN13684559	A metagenome-wide association study of gut microbiota, visceral fat and sleeve gastrectomy
L11079.1	SRR11047628	0.84	0.68	0.58	SAMN13705430	A Novel Index for Predicting Health Status Using Species-level Gut Microbiome Profiling
L11079.1	SRR11070361	0.84	0.68	0.58	SAMN14001099	Type 1 diabetes in pregnancy and changes in the composition and function of the gut microbiome
L11079.1	SRR11070376	0.84	0.68	0.58	SAMN14001140	Type 1 diabetes in pregnancy and changes in the composition and function of the gut microbiome
L11079.1	SRR11070410	0.84	0.68	0.58	SAMN14001080	Type 1 diabetes in pregnancy and changes in the composition and function of the gut microbiome
L11079.1	SRR11070412	0.84	0.68	0.58	SAMN14001078	Type 1 diabetes in pregnancy and changes in the composition and function of the gut microbiome
L11079.1	SRR11070415	0.84	0.68	0.58	SAMN14001075	Type 1 diabetes in pregnancy and changes in the composition and function of the gut microbiome
L11079.1	SRR13773810	0.84	0.68	0.58	SAMN18022855	Type 1 diabetes in pregnancy and changes in the composition and function of the gut microbiome
L11079.1	SRR11088378	0.84	0.68	0.58	SAMN13976059	ANTIRES - Distribution pathways of antibiotic resistances in municipal wastewater
L11079.1	SRR11088459	0.84	0.68	0.58	SAMN14069885	ANTIRES - Distribution pathways of antibiotic resistances in municipal wastewater
L11079.1	SRR11124686	0.84	0.68	0.58	SAMN11097693	Pig microbiome
L11079.1	SRR11124707	0.84	0.68	0.58	SAMN11097889	Pig microbiome
L11079.1	SRR11124812	0.84	0.68	0.58	SAMN11097722	Pig microbiome
L11079.1	SRR11124908	0.84	0.68	0.58	SAMN11097954	Pig microbiome
L11079.1	SRR11124937	0.84	0.68	0.58	SAMN11097718	Pig microbiome
L11079.1	SRR11124997	0.84	0.68	0.58	SAMN11097701	Pig microbiome
L11079.1	SRR11125098	0.84	0.68	0.58	SAMN11097689	Pig microbiome
L11079.1	SRR11125204	0.84	0.68	0.58	SAMN11097787	Pig microbiome
L11079.1	SRR11125208	0.84	0.68	0.58	SAMN11097783	Pig microbiome
L11079.1	SRR11125272	0.84	0.68	0.58	SAMN11097682	Pig microbiome
L11079.1	SRR11125287	0.84	0.68	0.58	SAMN11097747	Pig microbiome
L11079.1	SRR11125426	0.84	0.68	0.58	SAMN11098006	Pig microbiome
L11079.1	SRR11125485	0.84	0.68	0.58	SAMN11097732	Pig microbiome
L11079.1	SRR11125503	0.84	0.68	0.58	SAMN11097937	Pig microbiome
L11079.1	SRR11125705	0.84	0.68	0.58	SAMN11097747	Pig microbiome
L11079.1	SRR11125807	0.84	0.68	0.58	SAMN11098126	Pig microbiome
L11079.1	SRR11125839	0.84	0.68	0.58	SAMN11097758	Pig microbiome
L11079.1	SRR11125863	0.84	0.68	0.58	SAMN11097701	Pig microbiome
L11079.1	SRR11125918	0.84	0.68	0.58	SAMN11097954	Pig microbiome
L11079.1	SRR11125971	0.84	0.68	0.58	SAMN11098021	Pig microbiome
L11079.1	SRR11126026	0.84	0.68	0.58	SAMN11097682	Pig microbiome
L11079.1	SRR11126032	0.84	0.68	0.58	SAMN11097693	Pig microbiome
L11079.1	SRR11126040	0.84	0.68	0.58	SAMN11097901	Pig microbiome
L11079.1	SRR11126053	0.84	0.68	0.58	SAMN11097889	Pig microbiome
L11079.1	SRR11126058	0.84	0.68	0.58	SAMN11097885	Pig microbiome
L11079.1	SRR11126061	0.84	0.68	0.58	SAMN11097882	Pig microbiome
L11079.1	SRR11126186	0.84	0.68	0.58	SAMN11097783	Pig microbiome
L11079.1	SRR11126190	0.84	0.68	0.58	SAMN11097779	Pig microbiome
L11079.1	SRR11126200	0.84	0.68	0.58	SAMN11097770	Pig microbiome
L11079.1	SRR11126386	0.84	0.68	0.58	SAMN11097849	Pig microbiome
L11079.1	SRR11126401	0.84	0.68	0.58	SAMN11097836	Pig microbiome
L11079.1	SRR11126430	0.84	0.68	0.58	SAMN11097709	Pig microbiome
L11079.1	SRR11126529	0.84	0.68	0.58	SAMN11097675	Pig microbiome
L11079.1	SRR11183330	0.84	0.68	0.58	SAMN11097787	Pig microbiome
L11079.1	SRR11183339	0.84	0.68	0.58	SAMN11097680	Pig microbiome
L11079.1	SRR11183533	0.84	0.68	0.58	SAMN11097709	Pig microbiome
L11079.1	SRR11183635	0.84	0.68	0.58	SAMN11098016	Pig microbiome
L11079.1	SRR11183697	0.84	0.68	0.58	SAMN11097701	Pig microbiome
L11079.1	SRR11183770	0.84	0.68	0.58	SAMN11097952	Pig microbiome
L11079.1	SRR11183882	0.84	0.68	0.58	SAMN11097693	Pig microbiome
L11079.1	SRR11183891	0.84	0.68	0.58	SAMN11097900	Pig microbiome
L11079.1	SRR11183958	0.84	0.68	0.58	SAMN11097689	Pig microbiome
L11079.1	SRR11184012	0.84	0.68	0.58	SAMN11097849	Pig microbiome
L11079.1	SRR11184032	0.84	0.68	0.58	SAMN11097831	Pig microbiome
L11079.1	SRR11184091	0.84	0.68	0.58	SAMN11097675	Pig microbiome
L11079.1	SRR8960080	0.84	0.68	0.58	SAMN11097885	Pig microbiome
L11079.1	SRR8960133	0.84	0.68	0.58	SAMN11097752	Pig microbiome
L11079.1	SRR8960150	0.84	0.68	0.58	SAMN11098083	Pig microbiome
L11079.1	SRR8960209	0.84	0.68	0.58	SAMN11097980	Pig microbiome
L11079.1	SRR8960213	0.84	0.68	0.58	SAMN11097984	Pig microbiome
L11079.1	SRR8960290	0.84	0.68	0.58	SAMN11097796	Pig microbiome
L11079.1	SRR8960296	0.84	0.68	0.58	SAMN11097798	Pig microbiome
L11079.1	SRR8960312	0.84	0.68	0.58	SAMN11097965	Pig microbiome
L11079.1	SRR8960331	0.84	0.68	0.58	SAMN11097864	Pig microbiome
L11079.1	SRR8960338	0.84	0.68	0.58	SAMN11097867	Pig microbiome
L11079.1	SRR8960363	0.84	0.68	0.58	SAMN11097934	Pig microbiome
L11079.1	SRR8960366	0.84	0.68	0.58	SAMN11097937	Pig microbiome
L11079.1	SRR8960370	0.84	0.68	0.58	SAMN11098016	Pig microbiome
L11079.1	SRR8960457	0.84	0.68	0.58	SAMN11097722	Pig microbiome
L11079.1	SRR8960483	0.84	0.68	0.58	SAMN11098006	Pig microbiome
L11079.1	SRR8960493	0.84	0.68	0.58	SAMN11097695	Pig microbiome
L11079.1	SRR8960495	0.84	0.68	0.58	SAMN11097693	Pig microbiome
L11079.1	SRR8960499	0.84	0.68	0.58	SAMN11097689	Pig microbiome
L11079.1	SRR8960513	0.84	0.68	0.58	SAMN11097875	Pig microbiome
L11079.1	SRR8960581	0.84	0.68	0.58	SAMN11098126	Pig microbiome
L11079.1	SRR8960710	0.84	0.68	0.58	SAMN11097954	Pig microbiome
L11079.1	SRR8960711	0.84	0.68	0.58	SAMN11097951	Pig microbiome
L11079.1	SRR8960712	0.84	0.68	0.58	SAMN11097952	Pig microbiome
L11079.1	SRR8960735	0.84	0.68	0.58	SAMN11097708	Pig microbiome
L11079.1	SRR8960740	0.84	0.68	0.58	SAMN11097701	Pig microbiome
L11079.1	SRR8960778	0.84	0.68	0.58	SAMN11097709	Pig microbiome
L11079.1	SRR8960827	0.84	0.68	0.58	SAMN11097902	Pig microbiome
L11079.1	SRR8960829	0.84	0.68	0.58	SAMN11097900	Pig microbiome
L11079.1	SRR8960840	0.84	0.68	0.58	SAMN11098276	Pig microbiome
L11079.1	SRR8960856	0.84	0.68	0.58	SAMN11097787	Pig microbiome
L11079.1	SRR8960860	0.84	0.68	0.58	SAMN11097783	Pig microbiome
L11079.1	SRR8960864	0.84	0.68	0.58	SAMN11097779	Pig microbiome
L11079.1	SRR8960865	0.84	0.68	0.58	SAMN11097780	Pig microbiome
L11079.1	SRR8960918	0.84	0.68	0.58	SAMN11098148	Pig microbiome
L11079.1	SRR8960927	0.84	0.68	0.58	SAMN11097849	Pig microbiome
L11079.1	SRR8960937	0.84	0.68	0.58	SAMN11097682	Pig microbiome
L11079.1	SRR8960939	0.84	0.68	0.58	SAMN11097680	Pig microbiome
L11079.1	SRR11236194	0.84	0.68	0.58	SAMN14270955	Human gut microbiome Raw sequence reads
L11079.1	SRR11236251	0.84	0.68	0.58	SAMN14271021	Human gut microbiome Raw sequence reads
L11079.1	SRR11236253	0.84	0.68	0.58	SAMN14271019	Human gut microbiome Raw sequence reads
L11079.1	SRR11276995	0.84	0.68	0.58	SAMN14121932	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11276999	0.84	0.68	0.58	SAMN14121928	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277001	0.84	0.68	0.58	SAMN14121927	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277019	0.84	0.68	0.58	SAMN14121885	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277175	0.84	0.68	0.58	SAMN14121946	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277194	0.84	0.68	0.58	SAMN14121752	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277301	0.84	0.68	0.58	SAMN14121998	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11363001	0.84	0.68	0.58	SAMN14420304	Functional Microbial Responses to Alcohol Abstinence in Patients with Alcohol Use Disorder
L11079.1	SRR11363015	0.84	0.68	0.58	SAMN14420359	Functional Microbial Responses to Alcohol Abstinence in Patients with Alcohol Use Disorder
L11079.1	SRR14092179	0.84	0.68	0.58	SAMN07560665	The role of Enterococcus in allo-HCT patient outcome
L11079.1	SRR14092302	0.84	0.68	0.58	SAMN07561851	The role of Enterococcus in allo-HCT patient outcome
L11079.1	SRR11482331	0.84	0.68	0.58	SAMN14538522	Farm dust metagenomes in European poultry and pig farms
L11079.1	SRR11569111	0.84	0.68	0.58	SAMN14640556	Detection and genetic characterization of viruses present in free-ranging snow leopards (Panthera uncia)
L11079.1	SRR11575975	0.84	0.68	0.58	SAMN14614837	Shotgun Metagenomics Fecal Microbiome Dysbiosis in Parkinsons Disease
L11079.1	SRR11599146	0.84	0.68	0.58	SAMN14680409	Linking strain engraftment in fecal microbiota transplantation with maintenance of remission in Crohn's disease
L11079.1	SRR11599149	0.84	0.68	0.58	SAMN14680406	Linking strain engraftment in fecal microbiota transplantation with maintenance of remission in Crohn's disease
L11079.1	SRR11599150	0.84	0.68	0.58	SAMN14680405	Linking strain engraftment in fecal microbiota transplantation with maintenance of remission in Crohn's disease
L11079.1	SRR11615226	0.84	0.68	0.58	SAMN14738224	Integral approach in the resistome characterization on Spanish swine farms.
L11079.1	SRR11649943	0.84	0.68	0.58	SAMN14582994	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11649960	0.84	0.68	0.58	SAMN14583019	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11669395	0.84	0.68	0.58	SAMN14786439	Microbiome Signatures of Cavernous Angioma
L11079.1	SRR11679943	0.84	0.68	0.58	SAMN14560210	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679955	0.84	0.68	0.58	SAMN14560199	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11723732	0.84	0.68	0.58	SAMN14846990	Pig gut microbiome and its relationship with host weight
L11079.1	SRR11723734	0.84	0.68	0.58	SAMN14846988	Pig gut microbiome and its relationship with host weight
L11079.1	SRR11822039	0.84	0.68	0.58	SAMN14968310	human viral metagenome Raw sequence reads
L11079.1	SRR11941306	0.84	0.68	0.58	SAMN15156697	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941308	0.84	0.68	0.58	SAMN15156695	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941309	0.84	0.68	0.58	SAMN15156694	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941418	0.84	0.68	0.58	SAMN15156596	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941449	0.84	0.68	0.58	SAMN15156442	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941580	0.84	0.68	0.58	SAMN15156540	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941581	0.84	0.68	0.58	SAMN15156539	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941683	0.84	0.68	0.58	SAMN15156701	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR12114054	0.84	0.68	0.58	SAMN15397128	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114288	0.84	0.68	0.58	SAMN15397155	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114289	0.84	0.68	0.58	SAMN15397155	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114454	0.84	0.68	0.58	SAMN15397205	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114513	0.84	0.68	0.58	SAMN15397129	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114776	0.84	0.68	0.58	SAMN15397078	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114777	0.84	0.68	0.58	SAMN15397078	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114778	0.84	0.68	0.58	SAMN15397078	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114779	0.84	0.68	0.58	SAMN15397078	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114780	0.84	0.68	0.58	SAMN15397078	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114782	0.84	0.68	0.58	SAMN15397078	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114783	0.84	0.68	0.58	SAMN15397078	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114784	0.84	0.68	0.58	SAMN15397078	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114785	0.84	0.68	0.58	SAMN15397078	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114786	0.84	0.68	0.58	SAMN15397078	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114787	0.84	0.68	0.58	SAMN15397077	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114802	0.84	0.68	0.58	SAMN15397077	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114803	0.84	0.68	0.58	SAMN15397077	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114804	0.84	0.68	0.58	SAMN15397077	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114805	0.84	0.68	0.58	SAMN15397077	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114806	0.84	0.68	0.58	SAMN15397077	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114808	0.84	0.68	0.58	SAMN15397077	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114809	0.84	0.68	0.58	SAMN15397077	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114810	0.84	0.68	0.58	SAMN15397077	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114811	0.84	0.68	0.58	SAMN15397077	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114812	0.84	0.68	0.58	SAMN15397077	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114813	0.84	0.68	0.58	SAMN15397077	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114814	0.84	0.68	0.58	SAMN15397077	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114901	0.84	0.68	0.58	SAMN15397063	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114989	0.84	0.68	0.58	SAMN15397079	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114993	0.84	0.68	0.58	SAMN15397079	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114994	0.84	0.68	0.58	SAMN15397079	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114998	0.84	0.68	0.58	SAMN15397079	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115030	0.84	0.68	0.58	SAMN15397076	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115046	0.84	0.68	0.58	SAMN15397076	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115047	0.84	0.68	0.58	SAMN15397076	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115048	0.84	0.68	0.58	SAMN15397076	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115049	0.84	0.68	0.58	SAMN15397076	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115051	0.84	0.68	0.58	SAMN15397076	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115052	0.84	0.68	0.58	SAMN15397076	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115053	0.84	0.68	0.58	SAMN15397076	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115054	0.84	0.68	0.58	SAMN15397076	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115056	0.84	0.68	0.58	SAMN15397076	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115057	0.84	0.68	0.58	SAMN15397076	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115058	0.84	0.68	0.58	SAMN15397076	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115059	0.84	0.68	0.58	SAMN15397078	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115074	0.84	0.68	0.58	SAMN15397078	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115075	0.84	0.68	0.58	SAMN15397078	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115209	0.84	0.68	0.58	SAMN15397073	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12121937	0.84	0.68	0.58	SAMN15397093	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122024	0.84	0.68	0.58	SAMN15397093	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR1211103	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1211668	0.84	0.68	0.58	SAMN02675049	Microbiome study of the RISK cohort
L11079.1	SRR1212193	0.84	0.68	0.58	SAMN02674965	Microbiome study of the RISK cohort
L11079.1	SRR1212227	0.84	0.68	0.58	SAMN02674965	Microbiome study of the RISK cohort
L11079.1	SRR1212497	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1212541	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1212546	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1212554	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1212555	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1212560	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1212726	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1212762	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1214498	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1214562	0.84	0.68	0.58	SAMN02675049	Microbiome study of the RISK cohort
L11079.1	SRR1214730	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1214757	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1214760	0.84	0.68	0.58	SAMN02674965	Microbiome study of the RISK cohort
L11079.1	SRR1214933	0.84	0.68	0.58	SAMN02674965	Microbiome study of the RISK cohort
L11079.1	SRR1214947	0.84	0.68	0.58	SAMN02674965	Microbiome study of the RISK cohort
L11079.1	SRR1214948	0.84	0.68	0.58	SAMN02675049	Microbiome study of the RISK cohort
L11079.1	SRR1215012	0.84	0.68	0.58	SAMN02675049	Microbiome study of the RISK cohort
L11079.1	SRR1215019	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1215293	0.84	0.68	0.58	SAMN02674965	Microbiome study of the RISK cohort
L11079.1	SRR1215509	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1215582	0.84	0.68	0.58	SAMN02675049	Microbiome study of the RISK cohort
L11079.1	SRR1215657	0.84	0.68	0.58	SAMN02674966	Microbiome study of the RISK cohort
L11079.1	SRR1215675	0.84	0.68	0.58	SAMN02674965	Microbiome study of the RISK cohort
L11079.1	SRR1215688	0.84	0.68	0.58	SAMN02675049	Microbiome study of the RISK cohort
L11079.1	SRR1215828	0.84	0.68	0.58	SAMN02674965	Microbiome study of the RISK cohort
L11079.1	SRR1215843	0.84	0.68	0.58	SAMN02674965	Microbiome study of the RISK cohort
L11079.1	SRR1215844	0.84	0.68	0.58	SAMN02675049	Microbiome study of the RISK cohort
L11079.1	SRR1215918	0.84	0.68	0.58	SAMN02675049	Microbiome study of the RISK cohort
L11079.1	SRR1215956	0.84	0.68	0.58	SAMN02675049	Microbiome study of the RISK cohort
L11079.1	SRR1216305	0.84	0.68	0.58	SAMN02675049	Microbiome study of the RISK cohort
L11079.1	SRR1219486	0.84	0.68	0.58	SAMN02675049	Microbiome study of the RISK cohort
L11079.1	SRR12143686	0.84	0.68	0.58	SAMN14943310	IgA deficiency microbiota
L11079.1	SRR12143770	0.84	0.68	0.58	SAMN14943232	IgA deficiency microbiota
L11079.1	SRR12158996	0.84	0.68	0.58	SAMN15422808	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159004	0.84	0.68	0.58	SAMN15422801	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159196	0.84	0.68	0.58	SAMN15422628	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234665	0.84	0.68	0.58	SAMN15421997	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234701	0.84	0.68	0.58	SAMN15421847	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234703	0.84	0.68	0.58	SAMN15421845	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234732	0.84	0.68	0.58	SAMN15421956	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234816	0.84	0.68	0.58	SAMN15422345	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234830	0.84	0.68	0.58	SAMN15422333	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234952	0.84	0.68	0.58	SAMN15422280	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12170235	0.84	0.68	0.58	SAMN15471104	Metagenomic Sequencing of Stool Samples in Bangladeshi Infants: Virome Association with Poliovirus Shedding After Oral Poliovirus Vaccination
L11079.1	SRR12170353	0.84	0.68	0.58	SAMN15471131	Metagenomic Sequencing of Stool Samples in Bangladeshi Infants: Virome Association with Poliovirus Shedding After Oral Poliovirus Vaccination
L11079.1	SRR12179853	0.84	0.68	0.58	SAMN15470485	Gut Metagenomes of South Asian Canadians
L11079.1	SRR12223857	0.84	0.68	0.58	SAMN15536106	Microbial Communities in a Drinking Water Storage Tank Sediment (reactor)
L11079.1	SRR12302339	0.84	0.68	0.58	SAMN09779708	infant gut Targeted Locus (Loci)
L11079.1	SRR12302364	0.84	0.68	0.58	SAMN09515567	infant gut Targeted Locus (Loci)
L11079.1	SRR12302457	0.84	0.68	0.58	SAMN09515625	infant gut Targeted Locus (Loci)
L11079.1	SRR12302548	0.84	0.68	0.58	SAMN05788911	infant gut Targeted Locus (Loci)
L11079.1	SRR12302587	0.84	0.68	0.58	SAMN15567812	infant gut Targeted Locus (Loci)
L11079.1	SRR12302659	0.84	0.68	0.58	SAMN09515792	infant gut Targeted Locus (Loci)
L11079.1	SRR12302685	0.84	0.68	0.58	SAMN04108721	infant gut Targeted Locus (Loci)
L11079.1	SRR12302709	0.84	0.68	0.58	SAMN09515552	infant gut Targeted Locus (Loci)
L11079.1	SRR15127897	0.84	0.68	0.58	SAMN20118555	infant gut Targeted Locus (Loci)
L11079.1	SRR15127944	0.84	0.68	0.58	SAMN20119310	infant gut Targeted Locus (Loci)
L11079.1	SRR15127950	0.84	0.68	0.58	SAMN20119230	infant gut Targeted Locus (Loci)
L11079.1	SRR8692203	0.84	0.68	0.58	SAMN09515554	infant gut Targeted Locus (Loci)
L11079.1	SRR12324970	0.84	0.68	0.58	SAMN15643090	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12324974	0.84	0.68	0.58	SAMN15643087	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12324975	0.84	0.68	0.58	SAMN15643086	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12324978	0.84	0.68	0.58	SAMN15643083	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12324997	0.84	0.68	0.58	SAMN15643066	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12325001	0.84	0.68	0.58	SAMN15643062	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12325006	0.84	0.68	0.58	SAMN15643058	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12325007	0.84	0.68	0.58	SAMN15643057	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12325035	0.84	0.68	0.58	SAMN15643031	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12326803	0.84	0.68	0.58	SAMN15589074	Impact of the gut microbiome and metabolome on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
L11079.1	SRR12326825	0.84	0.68	0.58	SAMN15589066	Impact of the gut microbiome and metabolome on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
L11079.1	SRR12326873	0.84	0.68	0.58	SAMN15589085	Impact of the gut microbiome and metabolome on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
L11079.1	SRR12395655	0.84	0.68	0.58	SAMN15661790	Kidney stone patient microbiome
L11079.1	SRR12395659	0.84	0.68	0.58	SAMN15661787	Kidney stone patient microbiome
L11079.1	SRR12459280	0.84	0.68	0.58	SAMN15824620	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12459288	0.84	0.68	0.58	SAMN15824675	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12459555	0.84	0.68	0.58	SAMN15824864	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12459599	0.84	0.68	0.58	SAMN15824767	PROMISE Cohort Metagenome sequence data
L11079.1	SRR4426299	0.84	0.68	0.58	SAMN05893371	manure metagenome Raw sequence reads
L11079.1	SRR12477602	0.84	0.68	0.58	SAMN15854733	Delivery mode impacts newborn gut colonization efficiency
L11079.1	SRR12477642	0.84	0.68	0.58	SAMN15854726	Delivery mode impacts newborn gut colonization efficiency
L11079.1	SRR12506180	0.84	0.68	0.58	SAMN15890732	gut microbiome shifts associated with Henoch-Schonlein purpura
L11079.1	SRR13429695	0.84	0.68	0.58	SAMN17309614	Unveiling the bifidobacterial resistance mechanism against amoxicillin-clavulanic acid: genetic and ecological insights
L11079.1	SRR13429706	0.84	0.68	0.58	SAMN17309613	Unveiling the bifidobacterial resistance mechanism against amoxicillin-clavulanic acid: genetic and ecological insights
L11079.1	SRR13429719	0.84	0.68	0.58	SAMN17309646	Unveiling the bifidobacterial resistance mechanism against amoxicillin-clavulanic acid: genetic and ecological insights
L11079.1	SRR13429721	0.84	0.68	0.58	SAMN17309644	Unveiling the bifidobacterial resistance mechanism against amoxicillin-clavulanic acid: genetic and ecological insights
L11079.1	SRR13429727	0.84	0.68	0.58	SAMN17309638	Unveiling the bifidobacterial resistance mechanism against amoxicillin-clavulanic acid: genetic and ecological insights
L11079.1	SRR13429737	0.84	0.68	0.58	SAMN17309629	Unveiling the bifidobacterial resistance mechanism against amoxicillin-clavulanic acid: genetic and ecological insights
L11079.1	SRR13429738	0.84	0.68	0.58	SAMN17309628	Unveiling the bifidobacterial resistance mechanism against amoxicillin-clavulanic acid: genetic and ecological insights
L11079.1	SRR13429742	0.84	0.68	0.58	SAMN17309625	Unveiling the bifidobacterial resistance mechanism against amoxicillin-clavulanic acid: genetic and ecological insights
L11079.1	SRR13429746	0.84	0.68	0.58	SAMN17309621	Unveiling the bifidobacterial resistance mechanism against amoxicillin-clavulanic acid: genetic and ecological insights
L11079.1	SRR13429749	0.84	0.68	0.58	SAMN17309618	Unveiling the bifidobacterial resistance mechanism against amoxicillin-clavulanic acid: genetic and ecological insights
L11079.1	SRR12660608	0.84	0.68	0.58	SAMN16198208	Neonatal antibiotic exposure impairs child growth during the first six years of life
L11079.1	SRR12660609	0.84	0.68	0.58	SAMN16198207	Neonatal antibiotic exposure impairs child growth during the first six years of life
L11079.1	SRR1535401	0.84	0.68	0.58	SAMN02930092	Human gut Targeted Locus (Loci)
L11079.1	SRR12736343	0.84	0.68	0.58	SAMN16286572	Gut bacteriophages in Clostridioides difficile patients and fecal microbiota transplantation donors
L11079.1	SRR12762313	0.84	0.68	0.58	SAMN16295564	Metagenomic profiling of antibiotic resistance genes and mobile genetic elements
L11079.1	SRR12762314	0.84	0.68	0.58	SAMN16295563	Metagenomic profiling of antibiotic resistance genes and mobile genetic elements
L11079.1	SRR12771473	0.84	0.68	0.58	SAMN16351768	IDEO Microbiome Study
L11079.1	SRR15732367	0.84	0.68	0.58	SAMN20953122	Sus scrofa Metagenome
L11079.1	SRR12802550	0.84	0.68	0.58	SAMN16401303	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802613	0.84	0.68	0.58	SAMN16401331	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802661	0.84	0.68	0.58	SAMN16401300	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12887156	0.84	0.68	0.58	SAMN16339641	A metagenomic study of CVID in humans
L11079.1	SRR12907720	0.84	0.68	0.58	SAMN16554586	human gut microbiota raw sequences of critically ill patients
L11079.1	SRR12934001	0.84	0.68	0.58	SAMN16557060	Bugs and Bones
L11079.1	SRR12973227	0.84	0.68	0.58	SAMN16630120	Shorgun metagenomics of T2DM human gut microbes associated with FMT
L11079.1	SRR13004638	0.84	0.68	0.58	SAMN16701757	Role of Diet in the Reconstitution of the Human Gut Microbiome and its Metabolome
L11079.1	SRR13004825	0.84	0.68	0.58	SAMN16701589	Role of Diet in the Reconstitution of the Human Gut Microbiome and its Metabolome
L11079.1	SRR13004826	0.84	0.68	0.58	SAMN16701588	Role of Diet in the Reconstitution of the Human Gut Microbiome and its Metabolome
L11079.1	SRR13008407	0.84	0.68	0.58	SAMN16688169	In vitro gut microbiome response to resistant starch
L11079.1	SRR13008506	0.84	0.68	0.58	SAMN16688195	In vitro gut microbiome response to resistant starch
L11079.1	SRR13008529	0.84	0.68	0.58	SAMN16688174	In vitro gut microbiome response to resistant starch
L11079.1	SRR13022250	0.84	0.68	0.58	SAMN16673278	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022251	0.84	0.68	0.58	SAMN16673277	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022252	0.84	0.68	0.58	SAMN16673276	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022254	0.84	0.68	0.58	SAMN16673274	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022255	0.84	0.68	0.58	SAMN16673273	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022257	0.84	0.68	0.58	SAMN16673271	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022258	0.84	0.68	0.58	SAMN16673270	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022259	0.84	0.68	0.58	SAMN16673269	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022298	0.84	0.68	0.58	SAMN16673352	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022320	0.84	0.68	0.58	SAMN16673332	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022322	0.84	0.68	0.58	SAMN16673330	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022439	0.84	0.68	0.58	SAMN16673300	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022440	0.84	0.68	0.58	SAMN16673299	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022442	0.84	0.68	0.58	SAMN16673298	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13022444	0.84	0.68	0.58	SAMN16673296	Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients
L11079.1	SRR13060959	0.84	0.68	0.58	SAMN16796232	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13060968	0.84	0.68	0.58	SAMN16796224	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13077677	0.84	0.68	0.58	SAMN15723198	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077690	0.84	0.68	0.58	SAMN15723024	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077694	0.84	0.68	0.58	SAMN15723020	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077716	0.84	0.68	0.58	SAMN15723106	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077775	0.84	0.68	0.58	SAMN15723050	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077780	0.84	0.68	0.58	SAMN15723046	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077859	0.84	0.68	0.58	SAMN15723166	Gut metagenomes of patients with COVID-19
L11079.1	SRR13697129	0.84	0.68	0.58	SAMN07562012	Microbiota of allo-HSCT patients and in the setting of Autologous Fecal Microbiota Transplant (auto-FMT) at MSKCC Raw sequence reads
L11079.1	SRR13271619	0.84	0.68	0.58	SAMN17112065	The Influence of the gut microbiome on BCG-induced trained immunity
L11079.1	SRR13271697	0.84	0.68	0.58	SAMN17112149	The Influence of the gut microbiome on BCG-induced trained immunity
L11079.1	SRR13279628	0.84	0.68	0.58	SAMN17126308	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13296376	0.84	0.68	0.58	SAMN17149490	Metagenomic sequencing of non-IBD and Crohn's disease fecal samples
L11079.1	SRR13318094	0.84	0.68	0.58	SAMN17171513	Netherland Travelers
L11079.1	SRR13318097	0.84	0.68	0.58	SAMN17171440	Netherland Travelers
L11079.1	SRR13318135	0.84	0.68	0.58	SAMN17171392	Netherland Travelers
L11079.1	SRR13318230	0.84	0.68	0.58	SAMN17171517	Netherland Travelers
L11079.1	SRR13318234	0.84	0.68	0.58	SAMN17171521	Netherland Travelers
L11079.1	SRR13318267	0.84	0.68	0.58	SAMN17171585	Netherland Travelers
L11079.1	SRR13318287	0.84	0.68	0.58	SAMN17171372	Netherland Travelers
L11079.1	SRR13318299	0.84	0.68	0.58	SAMN17171409	Netherland Travelers
L11079.1	SRR13318311	0.84	0.68	0.58	SAMN17171599	Netherland Travelers
L11079.1	SRR13318404	0.84	0.68	0.58	SAMN17171425	Netherland Travelers
L11079.1	SRR13318410	0.84	0.68	0.58	SAMN17171431	Netherland Travelers
L11079.1	SRR13327435	0.84	0.68	0.58	SAMN17126093	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327475	0.84	0.68	0.58	SAMN17126057	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327523	0.84	0.68	0.58	SAMN17126128	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327533	0.84	0.68	0.58	SAMN17126029	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13336906	0.84	0.68	0.58	SAMN17190430	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336924	0.84	0.68	0.58	SAMN17190504	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336926	0.84	0.68	0.58	SAMN17190502	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336927	0.84	0.68	0.58	SAMN17190505	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13348683	0.84	0.68	0.58	SAMN17127034	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348782	0.84	0.68	0.58	SAMN17127232	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13436203	0.84	0.68	0.58	SAMN17006474	human gut microbiome predicts response to MTX treatment
L11079.1	SRR13436279	0.84	0.68	0.58	SAMN17006405	human gut microbiome predicts response to MTX treatment
L11079.1	SRR9988202	0.84	0.68	0.58	SAMN12583225	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR13502375	0.84	0.68	0.58	SAMN17486373	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13502626	0.84	0.68	0.58	SAMN17486429	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13502639	0.84	0.68	0.58	SAMN17486417	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13502681	0.84	0.68	0.58	SAMN17486177	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13502775	0.84	0.68	0.58	SAMN17486092	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13502784	0.84	0.68	0.58	SAMN17486084	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13502908	0.84	0.68	0.58	SAMN17486434	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13502991	0.84	0.68	0.58	SAMN17486233	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13503182	0.84	0.68	0.58	SAMN17486334	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13503183	0.84	0.68	0.58	SAMN17486333	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13557305	0.84	0.68	0.58	SAMN17578420	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13557313	0.84	0.68	0.58	SAMN17578023	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13557421	0.84	0.68	0.58	SAMN17578321	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13557441	0.84	0.68	0.58	SAMN17578206	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13557452	0.84	0.68	0.58	SAMN17578162	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13557716	0.84	0.68	0.58	SAMN17578083	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13508161	0.84	0.68	0.58	SAMN17433660	BaBel Infant Gut Virome Raw Data
L11079.1	SRR13508164	0.84	0.68	0.58	SAMN17433658	BaBel Infant Gut Virome Raw Data
L11079.1	SRR13508168	0.84	0.68	0.58	SAMN17433654	BaBel Infant Gut Virome Raw Data
L11079.1	SRR13508185	0.84	0.68	0.58	SAMN17433585	BaBel Infant Gut Virome Raw Data
L11079.1	SRR13621722	0.84	0.68	0.58	SAMN17765332	IgG4RD and systemic sclerosis
L11079.1	SRR13621969	0.84	0.68	0.58	SAMN17765160	IgG4RD and systemic sclerosis
L11079.1	SRR13621977	0.84	0.68	0.58	SAMN17765153	IgG4RD and systemic sclerosis
L11079.1	SRR13622668	0.84	0.68	0.58	SAMN17763859	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13622683	0.84	0.68	0.58	SAMN17763792	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13622808	0.84	0.68	0.58	SAMN17764099	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13622811	0.84	0.68	0.58	SAMN17764096	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13622947	0.84	0.68	0.58	SAMN17763974	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13694768	0.84	0.68	0.58	SAMN17884067	Vaginal seeding in babies born by caesarean section (ECOBABe trial) - shotgun metagenomics data
L11079.1	SRR13694804	0.84	0.68	0.58	SAMN17884141	Vaginal seeding in babies born by caesarean section (ECOBABe trial) - shotgun metagenomics data
L11079.1	SRR13694807	0.84	0.68	0.58	SAMN17884144	Vaginal seeding in babies born by caesarean section (ECOBABe trial) - shotgun metagenomics data
L11079.1	SRR13695039	0.84	0.68	0.58	SAMN17884688	Intermittent fasting and probiotic supplementation in adults with prediabetes (PROFAST pilot trial ) - shotgun metagenomics data
L11079.1	SRR13765883	0.84	0.68	0.58	SAMN18029486	gut microbiomes of dogs and wolves
L11079.1	SRR13739721	0.84	0.68	0.58	SAMN17618521	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13739797	0.84	0.68	0.58	SAMN17619289	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13739996	0.84	0.68	0.58	SAMN17618843	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13740075	0.84	0.68	0.58	SAMN17618785	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13740102	0.84	0.68	0.58	SAMN17618760	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13740167	0.84	0.68	0.58	SAMN17619372	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13740262	0.84	0.68	0.58	SAMN17619059	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13740349	0.84	0.68	0.58	SAMN17618981	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13740409	0.84	0.68	0.58	SAMN17618505	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13740997	0.84	0.68	0.58	SAMN17976282	Shotgun Metagenome Sequencing of Rectal Swab Samples from Cervical Cancer Patients
L11079.1	SRR13767249	0.84	0.68	0.58	SAMN17266880	Reactor fermentation sample Raw sequence reads Raw sequence reads
L11079.1	SRR13773559	0.84	0.68	0.58	SAMN18040001	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773575	0.84	0.68	0.58	SAMN18040067	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773579	0.84	0.68	0.58	SAMN18040063	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773622	0.84	0.68	0.58	SAMN18040007	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773637	0.84	0.68	0.58	SAMN18040128	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773655	0.84	0.68	0.58	SAMN18040052	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773658	0.84	0.68	0.58	SAMN18040050	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773659	0.84	0.68	0.58	SAMN18040049	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773706	0.84	0.68	0.58	SAMN18040011	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773719	0.84	0.68	0.58	SAMN18040004	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773725	0.84	0.68	0.58	SAMN18040106	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773731	0.84	0.68	0.58	SAMN18040101	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773762	0.84	0.68	0.58	SAMN18040217	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13774426	0.84	0.68	0.58	SAMN18040439	Premature infant microbiome Metagenome
L11079.1	SRR13774462	0.84	0.68	0.58	SAMN18040407	Premature infant microbiome Metagenome
L11079.1	SRR13774464	0.84	0.68	0.58	SAMN18040405	Premature infant microbiome Metagenome
L11079.1	SRR13774549	0.84	0.68	0.58	SAMN18040230	Premature infant microbiome Metagenome
L11079.1	SRR13825972	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825973	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825996	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826159	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099344	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099345	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099368	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099371	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13837292	0.84	0.68	0.58	SAMN18117702	GUT MICROBIOME IN ALLERGIC CHILDREN
L11079.1	SRR13837312	0.84	0.68	0.58	SAMN18117764	GUT MICROBIOME IN ALLERGIC CHILDREN
L11079.1	SRR13837323	0.84	0.68	0.58	SAMN18117754	GUT MICROBIOME IN ALLERGIC CHILDREN
L11079.1	SRR13837336	0.84	0.68	0.58	SAMN18117698	GUT MICROBIOME IN ALLERGIC CHILDREN
L11079.1	SRR13837354	0.84	0.68	0.58	SAMN18117726	GUT MICROBIOME IN ALLERGIC CHILDREN
L11079.1	SRR13837359	0.84	0.68	0.58	SAMN18117722	GUT MICROBIOME IN ALLERGIC CHILDREN
L11079.1	SRR13837386	0.84	0.68	0.58	SAMN18117801	GUT MICROBIOME IN ALLERGIC CHILDREN
L11079.1	SRR13924323	0.84	0.68	0.58	SAMN18206770	Metagenomic sequencing of stool samples from human hematopoietic cell transplantation patients
L11079.1	SRR13928135	0.84	0.68	0.58	SAMN18239585	human stool Metagenome
L11079.1	SRR14000539	0.84	0.68	0.58	SAMN18353422	PreventiOn of DYSbioSis Complications With Autologous FMT in AML Patients (ODYSSEE)
L11079.1	SRR14000554	0.84	0.68	0.58	SAMN18353467	PreventiOn of DYSbioSis Complications With Autologous FMT in AML Patients (ODYSSEE)
L11079.1	SRR14000581	0.84	0.68	0.58	SAMN18353413	PreventiOn of DYSbioSis Complications With Autologous FMT in AML Patients (ODYSSEE)
L11079.1	SRR14000770	0.84	0.68	0.58	SAMN18354176	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000787	0.84	0.68	0.58	SAMN18354036	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000796	0.84	0.68	0.58	SAMN18354325	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000799	0.84	0.68	0.58	SAMN18354322	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000803	0.84	0.68	0.58	SAMN18354318	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000807	0.84	0.68	0.58	SAMN18354315	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000814	0.84	0.68	0.58	SAMN18354200	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000819	0.84	0.68	0.58	SAMN18353999	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000829	0.84	0.68	0.58	SAMN18354187	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000838	0.84	0.68	0.58	SAMN18354308	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000846	0.84	0.68	0.58	SAMN18354301	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000861	0.84	0.68	0.58	SAMN18354288	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000864	0.84	0.68	0.58	SAMN18354286	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000914	0.84	0.68	0.58	SAMN18354132	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000934	0.84	0.68	0.58	SAMN18354055	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000938	0.84	0.68	0.58	SAMN18354051	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000941	0.84	0.68	0.58	SAMN18354048	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000942	0.84	0.68	0.58	SAMN18354047	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001072	0.84	0.68	0.58	SAMN18354024	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001089	0.84	0.68	0.58	SAMN18354251	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001093	0.84	0.68	0.58	SAMN18354183	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017298	0.84	0.68	0.58	SAMN18386043	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017304	0.84	0.68	0.58	SAMN18386038	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017320	0.84	0.68	0.58	SAMN18386023	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017341	0.84	0.68	0.58	SAMN18386005	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017444	0.84	0.68	0.58	SAMN18385912	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017469	0.84	0.68	0.58	SAMN18385737	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017479	0.84	0.68	0.58	SAMN18385880	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017488	0.84	0.68	0.58	SAMN18385872	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017535	0.84	0.68	0.58	SAMN18385731	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017559	0.84	0.68	0.58	SAMN18385729	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017603	0.84	0.68	0.58	SAMN18385725	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14117041	0.84	0.68	0.58	SAMN17717811	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117106	0.84	0.68	0.58	SAMN17717603	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117125	0.84	0.68	0.58	SAMN17717767	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117212	0.84	0.68	0.58	SAMN17717690	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117224	0.84	0.68	0.58	SAMN17717679	Transmission and formation of microbiota in the ealry life
L11079.1	SRR17284136	0.84	0.68	0.58	SAMN23963216	Transmission and formation of microbiota in the ealry life
L11079.1	SRR6066144	0.84	0.68	0.58	SAMN07606266	Human gut microbiota Raw sequence reads
L11079.1	SRR14346248	0.84	0.68	0.58	SAMN18880784	The role of maternal exposures on commensal microbes
L11079.1	SRR14346283	0.84	0.68	0.58	SAMN18880794	The role of maternal exposures on commensal microbes
L11079.1	SRR14369191	0.84	0.68	0.58	SAMN17899638	Weaning Piglet Gut Microbiome
L11079.1	SRR14573983	0.84	0.68	0.58	SAMN19237345	The composition of gut microbiota in biliary atresia
L11079.1	SRR14573986	0.84	0.68	0.58	SAMN19237342	The composition of gut microbiota in biliary atresia
L11079.1	SRR14626405	0.84	0.68	0.58	SAMN19312602	The composition of gut microbiota in biliary atresia
L11079.1	SRR14689329	0.84	0.68	0.58	SAMN19433444	The Probiotic L. casei Zhang Slows the Progression of Acute and Chronic Kidney Disease
L11079.1	SRR14689330	0.84	0.68	0.58	SAMN19433443	The Probiotic L. casei Zhang Slows the Progression of Acute and Chronic Kidney Disease
L11079.1	SRR14763279	0.84	0.68	0.58	SAMN17977824	Longitudinal linked read sequencing reveals ecological and evolutionary responses of a human gut microbiome during antibiotic treatment
L11079.1	SRR14763282	0.84	0.68	0.58	SAMN17977821	Longitudinal linked read sequencing reveals ecological and evolutionary responses of a human gut microbiome during antibiotic treatment
L11079.1	SRR14768671	0.84	0.68	0.58	SAMN19608020	16S rRNA and Metatranscriptomic Sequencing of Neonates at risk for NEC
L11079.1	SRR14768682	0.84	0.68	0.58	SAMN19608019	16S rRNA and Metatranscriptomic Sequencing of Neonates at risk for NEC
L11079.1	SRR14774613	0.84	0.68	0.58	SAMN19612823	Shotgun metagenomic sequencing data of gut microbiome in Duroc pigs
L11079.1	SRR14812367	0.84	0.68	0.58	SAMN19686895	Piglet gut and in-barn manure from farms on Raised Without Antibiotics program display a reduced antimicrobial resistance but an increased prevalence of pathogens
L11079.1	SRR14842375	0.84	0.68	0.58	SAMN19735710	Global Canine Shotgun Microbiomes
L11079.1	SRR14842417	0.84	0.68	0.58	SAMN19735767	Global Canine Shotgun Microbiomes
L11079.1	SRR14881720	0.84	0.68	0.58	SAMN07583777	Escherichia coli Genome sequencing and assembly
L11079.1	SRR14881739	0.84	0.68	0.58	SAMN07736348	Escherichia coli Genome sequencing and assembly
L11079.1	SRR14881764	0.84	0.68	0.58	SAMN07736296	Escherichia coli Genome sequencing and assembly
L11079.1	SRR14881868	0.84	0.68	0.58	SAMN07584090	Escherichia coli Genome sequencing and assembly
L11079.1	SRR14881872	0.84	0.68	0.58	SAMN07584084	Escherichia coli Genome sequencing and assembly
L11079.1	SRR14883772	0.84	0.68	0.58	SAMN19819719	Gut microbiota alternation uhttps://submit.ncbi.nlm.nih.gov/subs/sra/SUB9882549/bp_info#helper_relevance-project_titlender SARS-CoV-2 Infection
L11079.1	SRR14883787	0.84	0.68	0.58	SAMN19819717	Gut microbiota alternation uhttps://submit.ncbi.nlm.nih.gov/subs/sra/SUB9882549/bp_info#helper_relevance-project_titlender SARS-CoV-2 Infection
L11079.1	SRR14883793	0.84	0.68	0.58	SAMN19819747	Gut microbiota alternation uhttps://submit.ncbi.nlm.nih.gov/subs/sra/SUB9882549/bp_info#helper_relevance-project_titlender SARS-CoV-2 Infection
L11079.1	SRR15032256	0.84	0.68	0.58	SAMN20031351	High fermented food, high fiber diet effect on human microbiome and immune system
L11079.1	SRR15051395	0.84	0.68	0.58	SAMN20081895	Identification of unique bile acid metabolizing bacteria from the microbiome of centenarians
L11079.1	SRR15095670	0.84	0.68	0.58	SAMN20163443	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15095797	0.84	0.68	0.58	SAMN20163454	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15095808	0.84	0.68	0.58	SAMN20163444	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15187006	0.84	0.68	0.58	SAMN19188303	High prevalence of co-infecting enteropathogens in alleged rotavirus vaccine breakthrough cases
L11079.1	SRR15204176	0.84	0.68	0.58	SAMN20335697	Metagenomic WGS of Preterm Infant Skin and Stool
L11079.1	SRR15343483	0.84	0.68	0.58	SAMN20566222	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343493	0.84	0.68	0.58	SAMN20566213	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15372868	0.84	0.68	0.58	SAMN20549104	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15372900	0.84	0.68	0.58	SAMN20549075	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15372926	0.84	0.68	0.58	SAMN20549051	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15372936	0.84	0.68	0.58	SAMN20549042	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15372961	0.84	0.68	0.58	SAMN20549323	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15373095	0.84	0.68	0.58	SAMN20549203	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15373100	0.84	0.68	0.58	SAMN20549198	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15373184	0.84	0.68	0.58	SAMN20549122	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15373202	0.84	0.68	0.58	SAMN20549008	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15408517	0.84	0.68	0.58	SAMN20518651	gut microbiome of Myalgic Encephlomyelitis/Chronic Fatigue Syndrome patients
L11079.1	SRR1554967	0.84	0.68	0.58	SAMN02935304	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1554980	0.84	0.68	0.58	SAMN02935302	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577771	0.84	0.68	0.58	SAMN02935305	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577772	0.84	0.68	0.58	SAMN02935306	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577773	0.84	0.68	0.58	SAMN02935307	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577775	0.84	0.68	0.58	SAMN02935324	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577777	0.84	0.68	0.58	SAMN02935326	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577778	0.84	0.68	0.58	SAMN02935327	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577779	0.84	0.68	0.58	SAMN02935328	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577780	0.84	0.68	0.58	SAMN02935329	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577781	0.84	0.68	0.58	SAMN02935330	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577782	0.84	0.68	0.58	SAMN02935331	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577783	0.84	0.68	0.58	SAMN02935332	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577784	0.84	0.68	0.58	SAMN02935333	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577785	0.84	0.68	0.58	SAMN02935334	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577786	0.84	0.68	0.58	SAMN02935335	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577787	0.84	0.68	0.58	SAMN02935336	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1577788	0.84	0.68	0.58	SAMN02935337	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR1595973	0.84	0.68	0.58	SAMN02935303	Synthetic Metagenome. Mix of E.coli, B.proteoclasticus, P.ruminicola, and L.lactis in a defined molar ratio
L11079.1	SRR15595309	0.84	0.68	0.58	SAMN20959284	Metagenomic Microbiota in Celiac Disease
L11079.1	SRR15674186	0.84	0.68	0.58	SAMN21154900	A discovery cohort of 49 normal controls and 48 advanced adenoma patients, and a training cohort of 50 normal controls, 46 advanced adenoma patients and 30 colorectal cancer patients
L11079.1	SRR15674251	0.84	0.68	0.58	SAMN21154953	A discovery cohort of 49 normal controls and 48 advanced adenoma patients, and a training cohort of 50 normal controls, 46 advanced adenoma patients and 30 colorectal cancer patients
L11079.1	SRR15686317	0.84	0.68	0.58	SAMN21160197	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR15686318	0.84	0.68	0.58	SAMN21160196	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR15686323	0.84	0.68	0.58	SAMN21160201	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR15686325	0.84	0.68	0.58	SAMN21160199	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR15686326	0.84	0.68	0.58	SAMN21160198	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR15686328	0.84	0.68	0.58	SAMN21160212	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR16124212	0.84	0.68	0.58	SAMN21877102	Dysbiosis of human gut microbiome in young-onset colorectal cancer
L11079.1	SRR16124325	0.84	0.68	0.58	SAMN21877179	Dysbiosis of human gut microbiome in young-onset colorectal cancer
L11079.1	SRR16124346	0.84	0.68	0.58	SAMN21877160	Dysbiosis of human gut microbiome in young-onset colorectal cancer
L11079.1	SRR15926084	0.84	0.68	0.58	SAMN21462290	Intestinal flora sequencing of Chinese infants
L11079.1	SRR16054213	0.84	0.68	0.58	SAMN21614230	The Mucosally-Adherent Rectal Microbiota Contains Features Unique  to Alcohol-Related Cirrhosis
L11079.1	SRR16054214	0.84	0.68	0.58	SAMN21614229	The Mucosally-Adherent Rectal Microbiota Contains Features Unique  to Alcohol-Related Cirrhosis
L11079.1	SRR16123226	0.84	0.68	0.58	SAMN21899241	Human FMT samples Raw sequence reads
L11079.1	SRR16178799	0.84	0.68	0.58	SAMN22025982	Metagenomic analysis towards biomarkers and prediction models between intestinal polyp patients and colorectal cancer patients
L11079.1	SRR16188895	0.84	0.68	0.58	SAMN22039206	Metagenomic sequencing of UC patients subjected to FMT and FMT-donors
L11079.1	SRR16297693	0.84	0.68	0.58	SAMN22107681	PCaF Raw sequence reads
L11079.1	SRR16297697	0.84	0.68	0.58	SAMN22107677	PCaF Raw sequence reads
L11079.1	SRR16297700	0.84	0.68	0.58	SAMN22107675	PCaF Raw sequence reads
L11079.1	SRR16554720	0.84	0.68	0.58	SAMN22443696	Dietary fiber and probiotics impact the gut microbiome and melanoma immunotherapy response
L11079.1	SRR16555196	0.84	0.68	0.58	SAMN22445282	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR16555204	0.84	0.68	0.58	SAMN22445306	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR16555206	0.84	0.68	0.58	SAMN22445304	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR16555213	0.84	0.68	0.58	SAMN22445298	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR16646018	0.84	0.68	0.58	SAMN22565470	Gut microbiome sequencing
L11079.1	SRR16646100	0.84	0.68	0.58	SAMN22565395	Gut microbiome sequencing
L11079.1	SRR16646116	0.84	0.68	0.58	SAMN22565378	Gut microbiome sequencing
L11079.1	SRR16646117	0.84	0.68	0.58	SAMN22565377	Gut microbiome sequencing
L11079.1	SRR16646138	0.84	0.68	0.58	SAMN22565415	Gut microbiome sequencing
L11079.1	SRR16646144	0.84	0.68	0.58	SAMN22565379	Gut microbiome sequencing
L11079.1	SRR16646194	0.84	0.68	0.58	SAMN22565501	Gut microbiome sequencing
L11079.1	SRR16945666	0.84	0.68	0.58	SAMN22960341	Fecal metagenome Raw sequence reads
L11079.1	SRR17048881	0.84	0.68	0.58	SAMN16797062	Shotgun metagenomic sequencing of stool samples from two South African cohorts
L11079.1	SRR17237850	0.84	0.68	0.58	SAMN24043453	IBS Metagenome
L11079.1	SRR17241872	0.84	0.68	0.58	SAMN23969004	Gut microbiome in obese children treated with butyrate
L11079.1	SRR17243660	0.84	0.68	0.58	SAMN24044232	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243747	0.84	0.68	0.58	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243759	0.84	0.68	0.58	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17317407	0.84	0.68	0.58	SAMN24337978	The difference between diarrhea piglets and normal piglets
L11079.1	SRR17317421	0.84	0.68	0.58	SAMN24337954	The difference between diarrhea piglets and normal piglets
L11079.1	SRR1761697	0.84	0.68	0.58	SAMN03283270	Human Gut Microbiome Metagenome
L11079.1	SRR341658	0.84	0.68	0.58	SAMN00715208	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR341696	0.84	0.68	0.58	SAMN00715246	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413676	0.84	0.68	0.58	SAMN00792021	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413722	0.84	0.68	0.58	SAMN00792067	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413745	0.84	0.68	0.58	SAMN00792090	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR6256383	0.84	0.68	0.58	SAMN07977757	Metagenomes from human infant fecal samples with and without necrotizing enterocolitis
L11079.1	SRR1805215	0.84	0.68	0.58	SAMN03349478	Milk Metagenome
L11079.1	SRR1915838	0.84	0.68	0.58	SAMN03398963	A prospective, longitudinal analysis of the developing gut microbiome in infants en route to type 1 diabetes
L11079.1	SRR1980437	0.84	0.68	0.58	SAMN03398963	A prospective, longitudinal analysis of the developing gut microbiome in infants en route to type 1 diabetes
L11079.1	SRR1980468	0.84	0.68	0.58	SAMN03398963	A prospective, longitudinal analysis of the developing gut microbiome in infants en route to type 1 diabetes
L11079.1	SRR203323	0.84	0.68	0.58	SAMN00265070	DIPP Diabetes Microbiome
L11079.1	SRR2097329	0.84	0.68	0.58	SAMN03856240	Environmental bacteria Raw sequence reads
L11079.1	SRR2220880	0.84	0.68	0.58	SAMN02334124	Fiji COMP
L11079.1	SRR2221421	0.84	0.68	0.58	SAMN02334124	Fiji COMP
L11079.1	SRR2227843	0.84	0.68	0.58	SAMN02334147	Fiji COMP
L11079.1	SRR2237623	0.84	0.68	0.58	SAMN02334124	Fiji COMP
L11079.1	SRR2237744	0.84	0.68	0.58	SAMN02334124	Fiji COMP
L11079.1	SRR2247990	0.84	0.68	0.58	SAMN02334124	Fiji COMP
L11079.1	SRR2249247	0.84	0.68	0.58	SAMN02334124	Fiji COMP
L11079.1	SRR2249321	0.84	0.68	0.58	SAMN02334124	Fiji COMP
L11079.1	SRR2250076	0.84	0.68	0.58	SAMN02334149	Fiji COMP
L11079.1	SRR2565836	0.84	0.68	0.58	SAMN04126253	Intestinal microbiota dynamics in hospitalized patients
L11079.1	SRR2940958	0.84	0.68	0.58	SAMN04281217	Human gut Metagenome
L11079.1	SRR2992951	0.84	0.68	0.58	SAMN04329831	Athlete Microbiome Project (AMP)
L11079.1	SRR2992954	0.84	0.68	0.58	SAMN04329834	Athlete Microbiome Project (AMP)
L11079.1	SRR6714111	0.84	0.68	0.58	SAMN04382297	Human feces metagenome 16s rDNA sequencing
L11079.1	SRR3181148	0.84	0.68	0.58	SAMN04450480	Cattle feces Metagenome
L11079.1	SRR3621973	0.84	0.68	0.58	SAMN05192380	C. difficile exploits a complex metabolic niche associated with microbial dysbiosis in patients with diarrhea
L11079.1	SRR3582160	0.84	0.68	0.58	SAMN05065762	Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn''s disease
L11079.1	SRR3582161	0.84	0.68	0.58	SAMN05065763	Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn''s disease
L11079.1	SRR3582163	0.84	0.68	0.58	SAMN05065765	Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn''s disease
L11079.1	SRR3582166	0.84	0.68	0.58	SAMN05065767	Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn''s disease
L11079.1	SRR3713814	0.84	0.68	0.58	SAMN05290545	Pseudomonas Aeruginosa Early CF Adaptive Changes
L11079.1	SRR3713898	0.84	0.68	0.58	SAMN05290629	Pseudomonas Aeruginosa Early CF Adaptive Changes
L11079.1	SRR3713899	0.84	0.68	0.58	SAMN05290630	Pseudomonas Aeruginosa Early CF Adaptive Changes
L11079.1	SRR5512726	0.84	0.68	0.58	SAMN06887720	Maturation of the Infant Microbiome Community Structure and Function Across Multiple Body Sites
L11079.1	SRR3992955	0.84	0.68	0.58	SAMN05414891	Mongolian Metagenome
L11079.1	SRR3992965	0.84	0.68	0.58	SAMN05414998	Mongolian Metagenome
L11079.1	SRR3992991	0.84	0.68	0.58	SAMN05414923	Mongolian Metagenome
L11079.1	SRR4305031	0.84	0.68	0.58	SAMN05826486	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305058	0.84	0.68	0.58	SAMN05826608	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305082	0.84	0.68	0.58	SAMN05826630	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305083	0.84	0.68	0.58	SAMN05826631	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305095	0.84	0.68	0.58	SAMN05826642	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305100	0.84	0.68	0.58	SAMN05826646	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305204	0.84	0.68	0.58	SAMN05826740	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305206	0.84	0.68	0.58	SAMN05826742	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305278	0.84	0.68	0.58	SAMN05826518	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305312	0.84	0.68	0.58	SAMN05826836	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305447	0.84	0.68	0.58	SAMN05826956	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305468	0.84	0.68	0.58	SAMN05826535	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305479	0.84	0.68	0.58	SAMN05826536	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305482	0.84	0.68	0.58	SAMN05826539	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305487	0.84	0.68	0.58	SAMN05826544	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305493	0.84	0.68	0.58	SAMN05826549	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305506	0.84	0.68	0.58	SAMN05826561	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305508	0.84	0.68	0.58	SAMN05826563	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408036	0.84	0.68	0.58	SAMN05826998	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408160	0.84	0.68	0.58	SAMN05827220	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408168	0.84	0.68	0.58	SAMN05827227	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408187	0.84	0.68	0.58	SAMN05827011	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408196	0.84	0.68	0.58	SAMN05827253	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408215	0.84	0.68	0.58	SAMN05827270	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408221	0.84	0.68	0.58	SAMN05827018	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408252	0.84	0.68	0.58	SAMN05827046	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408260	0.84	0.68	0.58	SAMN05827054	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408288	0.84	0.68	0.58	SAMN05827079	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4423041	0.84	0.68	0.58	SAMN05891488	Shotgun sequencing of the gut microbiome to look at vitamin K biosynthesis
L11079.1	SRR4423043	0.84	0.68	0.58	SAMN05891486	Shotgun sequencing of the gut microbiome to look at vitamin K biosynthesis
L11079.1	SRR4423067	0.84	0.68	0.58	SAMN05891544	Shotgun sequencing of the gut microbiome to look at vitamin K biosynthesis
L11079.1	SRR4423079	0.84	0.68	0.58	SAMN05891504	Shotgun sequencing of the gut microbiome to look at vitamin K biosynthesis
L11079.1	SRR4423595	0.84	0.68	0.58	SAMN05544994	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4423599	0.84	0.68	0.58	SAMN05544994	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4423620	0.84	0.68	0.58	SAMN05544992	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4423654	0.84	0.68	0.58	SAMN05544992	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4423668	0.84	0.68	0.58	SAMN05544998	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4435751	0.84	0.68	0.58	SAMN05545009	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4435788	0.84	0.68	0.58	SAMN05545001	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4435812	0.84	0.68	0.58	SAMN05545004	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4435816	0.84	0.68	0.58	SAMN05545004	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4444746	0.84	0.68	0.58	SAMN05545027	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4444756	0.84	0.68	0.58	SAMN05545018	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4444780	0.84	0.68	0.58	SAMN05545024	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4444824	0.84	0.68	0.58	SAMN05545028	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4444831	0.84	0.68	0.58	SAMN05545029	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4451539	0.84	0.68	0.58	SAMN05545044	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783410	0.84	0.68	0.58	SAMN05545085	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783439	0.84	0.68	0.58	SAMN05545084	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783615	0.84	0.68	0.58	SAMN05545093	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783645	0.84	0.68	0.58	SAMN05545097	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783663	0.84	0.68	0.58	SAMN05545093	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR5056745	0.84	0.68	0.58	SAMN05971586	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR5056823	0.84	0.68	0.58	SAMN05971579	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR5056844	0.84	0.68	0.58	SAMN05971578	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR5056932	0.84	0.68	0.58	SAMN05971451	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR5057085	0.84	0.68	0.58	SAMN05971577	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR5057100	0.84	0.68	0.58	SAMN05971592	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4425675	0.84	0.68	0.58	SAMN05597088	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR4425686	0.84	0.68	0.58	SAMN05597068	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR4435937	0.84	0.68	0.58	SAMN05930836	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435938	0.84	0.68	0.58	SAMN05930837	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435939	0.84	0.68	0.58	SAMN05930832	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435942	0.84	0.68	0.58	SAMN05930835	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435943	0.84	0.68	0.58	SAMN05930828	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435948	0.84	0.68	0.58	SAMN05930825	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435949	0.84	0.68	0.58	SAMN05930822	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435950	0.84	0.68	0.58	SAMN05930823	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435951	0.84	0.68	0.58	SAMN05930820	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435952	0.84	0.68	0.58	SAMN05930821	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435955	0.84	0.68	0.58	SAMN05930826	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435956	0.84	0.68	0.58	SAMN05930827	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435960	0.84	0.68	0.58	SAMN05930839	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435961	0.84	0.68	0.58	SAMN05930838	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435962	0.84	0.68	0.58	SAMN05930841	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR4435963	0.84	0.68	0.58	SAMN05930840	Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients
L11079.1	SRR5008240	0.84	0.68	0.58	SAMN06007643	Evaluation of porcine fecal microbiomes after exposure to ceftriaxone
L11079.1	SRR5008254	0.84	0.68	0.58	SAMN06007682	Evaluation of porcine fecal microbiomes after exposure to ceftriaxone
L11079.1	SRR5008262	0.84	0.68	0.58	SAMN06007662	Evaluation of porcine fecal microbiomes after exposure to ceftriaxone
L11079.1	SRR7193028	0.84	0.68	0.58	SAMN09235260	Evaluation of porcine fecal microbiomes after exposure to ceftriaxone
L11079.1	SRR5091586	0.84	0.68	0.58	SAMN06112004	human gut metagenome in RA
L11079.1	SRR5127779	0.84	0.68	0.58	SAMN06110415	Gut microbial interactions with the inflammatory cytokine production capacity
L11079.1	SRR5155920	0.84	0.68	0.58	SAMN06164781	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR5155961	0.84	0.68	0.58	SAMN06164780	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR6028618	0.84	0.68	0.58	SAMN06164780	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR6028623	0.84	0.68	0.58	SAMN06164781	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR5190122	0.84	0.68	0.58	SAMN05720186	Ring-tailed lemur group fecal microbial communities from Wisconsin, USA - L827 metagenome metagenome
L11079.1	SRR5190303	0.84	0.68	0.58	SAMN05720183	Orangutan group fecal microbial communities from fecal samples from Wisconsin, USA - O1105 metagenome metagenome
L11079.1	SRR5274043	0.84	0.68	0.58	SAMN06350071	Mother-infant microbiome vertical transmission
L11079.1	SRR5275415	0.84	0.68	0.58	SAMN06328491	Novel gut-microbiota based metagenomic signature for advanced fibrosis in nonalcoholic fatty liver disease
L11079.1	SRR5275422	0.84	0.68	0.58	SAMN06328437	Novel gut-microbiota based metagenomic signature for advanced fibrosis in nonalcoholic fatty liver disease
L11079.1	SRR5275440	0.84	0.68	0.58	SAMN06328486	Novel gut-microbiota based metagenomic signature for advanced fibrosis in nonalcoholic fatty liver disease
L11079.1	SRR5275463	0.84	0.68	0.58	SAMN06328441	Novel gut-microbiota based metagenomic signature for advanced fibrosis in nonalcoholic fatty liver disease
L11079.1	SRR5275472	0.84	0.68	0.58	SAMN06328430	Novel gut-microbiota based metagenomic signature for advanced fibrosis in nonalcoholic fatty liver disease
L11079.1	SRR6474234	0.84	0.68	0.58	SAMN08366189	human gut Metagenome
L11079.1	SRR5298241	0.84	0.68	0.58	SAMN06350383	Metagenome data from infant (PD and ProD) stools samples raw sequence reads
L11079.1	SRR5298253	0.84	0.68	0.58	SAMN06350297	Metagenome data from infant stools samples raw sequence reads
L11079.1	SRR5365386	0.84	0.68	0.58	SAMN06622637	Clinical Parameters and Gut Microbiome Changes Before and After Surgery in Thoracic Aortic Dissection in Patients with Gastrointestinal Complications
L11079.1	SRR5405635	0.84	0.68	0.58	SAMN06444685	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405744	0.84	0.68	0.58	SAMN06444576	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405902	0.84	0.68	0.58	SAMN06444418	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405903	0.84	0.68	0.58	SAMN06444417	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405904	0.84	0.68	0.58	SAMN06444416	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405905	0.84	0.68	0.58	SAMN06444415	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405906	0.84	0.68	0.58	SAMN06444414	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405907	0.84	0.68	0.58	SAMN06444413	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405908	0.84	0.68	0.58	SAMN06444412	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405909	0.84	0.68	0.58	SAMN06444411	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405910	0.84	0.68	0.58	SAMN06444410	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405911	0.84	0.68	0.58	SAMN06444409	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5575426	0.84	0.68	0.58	SAMN06909395	Colonization, succession and evolution of the earliest human gastrointestinal microbiome
L11079.1	SRR5650036	0.84	0.68	0.58	SAMN07199875	Longitudinal Stool Study of patients with IBD and controls
L11079.1	SRR5650037	0.84	0.68	0.58	SAMN07199876	Longitudinal Stool Study of patients with IBD and controls
L11079.1	SRR5650038	0.84	0.68	0.58	SAMN07199873	Longitudinal Stool Study of patients with IBD and controls
L11079.1	SRR5650039	0.84	0.68	0.58	SAMN07199874	Longitudinal Stool Study of patients with IBD and controls
L11079.1	SRR5650040	0.84	0.68	0.58	SAMN07199879	Longitudinal Stool Study of patients with IBD and controls
L11079.1	SRR5650041	0.84	0.68	0.58	SAMN07199880	Longitudinal Stool Study of patients with IBD and controls
L11079.1	SRR5650178	0.84	0.68	0.58	SAMN07199881	Longitudinal Stool Study of patients with IBD and controls
L11079.1	SRR5650180	0.84	0.68	0.58	SAMN07199883	Longitudinal Stool Study of patients with IBD and controls
L11079.1	SRR5650181	0.84	0.68	0.58	SAMN07199886	Longitudinal Stool Study of patients with IBD and controls
L11079.1	SRR5650182	0.84	0.68	0.58	SAMN07199885	Longitudinal Stool Study of patients with IBD and controls
L11079.1	SRR5665119	0.84	0.68	0.58	SAMN07211203	Viral and Bacterial Communities of Colorectal Cancer
L11079.1	SRR6277125	0.84	0.68	0.58	SAMN07247683	Infant Microbiota and Probiotic Intake Study (IMPRINT)
L11079.1	SRR5723856	0.84	0.68	0.58	SAMN07259897	human metagenome
L11079.1	SRR8144372	0.84	0.68	0.58	SAMN07560665	High frequency intestinal microbiota sampling in allogeneic bone marrow transplant patients
L11079.1	SRR5866305	0.84	0.68	0.58	SAMN07414243	Whole-Grain rich diet cross-over study
L11079.1	SRR5866306	0.84	0.68	0.58	SAMN07414242	Whole-Grain rich diet cross-over study
L11079.1	SRR5866517	0.84	0.68	0.58	SAMN07414294	Whole-Grain rich diet cross-over study
L11079.1	SRR5866518	0.84	0.68	0.58	SAMN07414295	Whole-Grain rich diet cross-over study
L11079.1	SRR5866520	0.84	0.68	0.58	SAMN07414297	Whole-Grain rich diet cross-over study
L11079.1	SRR5883625	0.84	0.68	0.58	SAMN07427833	NGS approaches to metagenomics of gut microbiome
L11079.1	SRR5898999	0.84	0.68	0.58	SAMN07449019	Indian Human Gut Microbiome
L11079.1	SRR5899003	0.84	0.68	0.58	SAMN07449017	Indian Human Gut Microbiome
L11079.1	SRR5935808	0.84	0.68	0.58	SAMN07509703	Longitudinal Multi'omics of the Human Microbiome in Inflammatory Bowel Disease
L11079.1	SRR5946775	0.84	0.68	0.58	SAMN07521572	Longitudinal Multi'omics of the Human Microbiome in Inflammatory Bowel Disease
L11079.1	SRR5946826	0.84	0.68	0.58	SAMN07521860	Longitudinal Multi'omics of the Human Microbiome in Inflammatory Bowel Disease
L11079.1	SRR5946853	0.84	0.68	0.58	SAMN07521887	Longitudinal Multi'omics of the Human Microbiome in Inflammatory Bowel Disease
L11079.1	SRR5947811	0.84	0.68	0.58	SAMN07424321	Human gut metagenome and metatranscriptome in the inflammatory bowel disease (iHMP/HMP2)
L11079.1	SRR5983414	0.84	0.68	0.58	SAMN07424336	Human gut metagenome and metatranscriptome in the inflammatory bowel disease (iHMP/HMP2)
L11079.1	SRR5963162	0.84	0.68	0.58	SAMN07501069	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963170	0.84	0.68	0.58	SAMN07501077	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963243	0.84	0.68	0.58	SAMN07501150	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963260	0.84	0.68	0.58	SAMN07501167	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963302	0.84	0.68	0.58	SAMN07501209	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963306	0.84	0.68	0.58	SAMN07501213	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963307	0.84	0.68	0.58	SAMN07501214	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963308	0.84	0.68	0.58	SAMN07501215	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963309	0.84	0.68	0.58	SAMN07501216	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963310	0.84	0.68	0.58	SAMN07501217	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963312	0.84	0.68	0.58	SAMN07501219	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963313	0.84	0.68	0.58	SAMN07501220	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963386	0.84	0.68	0.58	SAMN07501293	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963402	0.84	0.68	0.58	SAMN07501309	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963418	0.84	0.68	0.58	SAMN07501325	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963420	0.84	0.68	0.58	SAMN07501327	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963421	0.84	0.68	0.58	SAMN07501328	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR6000946	0.84	0.68	0.58	SAMN07599735	Commensal microbiota associated with anti-PD-1 efficacy in metastatic melanoma patients
L11079.1	SRR6109213	0.84	0.68	0.58	SAMN07660499	gut evolution Raw sequence reads
L11079.1	SRR6131123	0.84	0.68	0.58	SAMN07736353	Hi-C deconvolution of a human gut microbiome yields high-quality draft genomes and reveals plasmid-genome interactions.
L11079.1	SRR9157889	0.84	0.68	0.58	SAMN11885869	Human gut metagenome Targeted loci environmental
L11079.1	SRR6155877	0.84	0.68	0.58	SAMN07740647	Mycobacterium tuberculosis Genome sequencing and assembly
L11079.1	SRR6242968	0.84	0.68	0.58	SAMN07946168	Viral metagenome human tissue sequencing
L11079.1	SRR6262491	0.84	0.68	0.58	SAMN07982921	preterm infant gut metagenomes (NIH Y5 Cohort)
L11079.1	SRR6442997	0.84	0.68	0.58	SAMN08296142	Survey of single and double stranded DNA non-enveloped viruses on the skin of WHIM patients, healthy controls and other immune compromised patients
L11079.1	SRR6760325	0.84	0.68	0.58	SAMN07960030	Homo sapiens Phenotype or Genotype
L11079.1	SRR6897015	0.84	0.68	0.58	SAMN07960245	Homo sapiens Phenotype or Genotype
L11079.1	SRR6451671	0.84	0.68	0.58	SAMN08330745	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456185	0.84	0.68	0.58	SAMN08335114	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456231	0.84	0.68	0.58	SAMN08335076	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456361	0.84	0.68	0.58	SAMN08335919	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6460889	0.84	0.68	0.58	SAMN08143632	Gorilla fecal virome
L11079.1	SRR6468504	0.84	0.68	0.58	SAMN08049760	Gut microbiome structure and metabolic activity in inflammatory bowel disease
L11079.1	SRR6468713	0.84	0.68	0.58	SAMN08049799	Gut microbiome structure and metabolic activity in inflammatory bowel disease
L11079.1	SRR6784525	0.84	0.68	0.58	SAMN06619295	MECFS metagenomics
L11079.1	SRR6784534	0.84	0.68	0.58	SAMN06619286	MECFS metagenomics
L11079.1	SRR6795039	0.84	0.68	0.58	SAMN08628023	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6795043	0.84	0.68	0.58	SAMN08628019	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6795046	0.84	0.68	0.58	SAMN08628033	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6915182	0.84	0.68	0.58	SAMN08813958	Whole-metagenome shotgun sequencing of two Italian fecal CRC cohorts
L11079.1	SRR6915208	0.84	0.68	0.58	SAMN08814034	Whole-metagenome shotgun sequencing of two Italian fecal CRC cohorts
L11079.1	SRR7110576	0.84	0.68	0.58	SAMN08775212	Enriched fungal communities from goat fecal pellet, Isla Vista, California, United States - Reed Canary Grass, Gen10, Rep 3 metagenome
L11079.1	SRR7162391	0.84	0.68	0.58	SAMN08993442	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7162399	0.84	0.68	0.58	SAMN08993510	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7212591	0.84	0.68	0.58	SAMN08993442	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7212627	0.84	0.68	0.58	SAMN08993510	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7217047	0.84	0.68	0.58	SAMN08122855	Metagenomics of Urban Sewage Identifies an Extensively Shared Antibiotic Resistome in China
L11079.1	SRR7217601	0.84	0.68	0.58	SAMN09260198	Infant Diet and Maternal Gestational Weight Gain Influence Functional Maturation of the Infant Gut Microbiome
L11079.1	SRR7217734	0.84	0.68	0.58	SAMN09260203	Infant Diet and Maternal Gestational Weight Gain Influence Functional Maturation of the Infant Gut Microbiome
L11079.1	SRR7217842	0.84	0.68	0.58	SAMN09260221	Infant Diet and Maternal Gestational Weight Gain Influence Functional Maturation of the Infant Gut Microbiome
L11079.1	SRR7227986	0.84	0.68	0.58	SAMN09272210	Effect of bariatric surgery on the faecal metagenome
L11079.1	SRR7280801	0.84	0.68	0.58	SAMN09382505	Strain-level identification of mother-to-child bacterial transmission during the first few months of life
L11079.1	SRR7280856	0.84	0.68	0.58	SAMN09382503	Strain-level identification of mother-to-child bacterial transmission during the first few months of life
L11079.1	SRR7280857	0.84	0.68	0.58	SAMN09382504	Strain-level identification of mother-to-child bacterial transmission during the first few months of life
L11079.1	SRR7280859	0.84	0.68	0.58	SAMN09382506	Strain-level identification of mother-to-child bacterial transmission during the first few months of life
L11079.1	SRR7351630	0.84	0.68	0.58	SAMN09278450	Probiotics in Pregnancy study
L11079.1	SRR7351642	0.84	0.68	0.58	SAMN09278355	Probiotics in Pregnancy study
L11079.1	SRR7351645	0.84	0.68	0.58	SAMN09278149	Probiotics in Pregnancy study
L11079.1	SRR7351646	0.84	0.68	0.58	SAMN09278148	Probiotics in Pregnancy study
L11079.1	SRR7351651	0.84	0.68	0.58	SAMN09278155	Probiotics in Pregnancy study
L11079.1	SRR7351707	0.84	0.68	0.58	SAMN09278421	Probiotics in Pregnancy study
L11079.1	SRR7351781	0.84	0.68	0.58	SAMN09278145	Probiotics in Pregnancy study
L11079.1	SRR7351788	0.84	0.68	0.58	SAMN09278485	Probiotics in Pregnancy study
L11079.1	SRR7351995	0.84	0.68	0.58	SAMN09278217	Probiotics in Pregnancy study
L11079.1	SRR7352003	0.84	0.68	0.58	SAMN09278213	Probiotics in Pregnancy study
L11079.1	SRR7352083	0.84	0.68	0.58	SAMN09278169	Probiotics in Pregnancy study
L11079.1	SRR7352087	0.84	0.68	0.58	SAMN09278406	Probiotics in Pregnancy study
L11079.1	SRR7411320	0.84	0.68	0.58	SAMN09278627	Probiotics in Pregnancy study
L11079.1	SRR7411346	0.84	0.68	0.58	SAMN09278574	Probiotics in Pregnancy study
L11079.1	SRR7411352	0.84	0.68	0.58	SAMN09278672	Probiotics in Pregnancy study
L11079.1	SRR7411367	0.84	0.68	0.58	SAMN09278567	Probiotics in Pregnancy study
L11079.1	SRR7403915	0.84	0.68	0.58	SAMN09464896	Identification of bloodstream pathogens in the gut microbiome
L11079.1	SRR7464879	0.84	0.68	0.58	SAMN09534384	Clostridium Difficile Matched 16S/ITS/Metagenomics/Metatranscriptomics Dataset
L11079.1	SRR7532891	0.84	0.68	0.58	SAMN09641578	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532892	0.84	0.68	0.58	SAMN09641579	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532893	0.84	0.68	0.58	SAMN09641580	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532919	0.84	0.68	0.58	SAMN09641535	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7624261	0.84	0.68	0.58	SAMN09656805	Gut and oral metagenomic signature of fatty liver disease in a pediatric population
L11079.1	SRR7589579	0.84	0.68	0.58	SAMN09690905	Effect of native and acetylated high amylose maize starch on fecal pH, short chain fatty acid concentrations, and microbiota in a cohort of normal and stunted children in southern India
L11079.1	SRR7658592	0.84	0.68	0.58	SAMN09781712	Metagenomic sequencing of stool samples from rural communities from north-eastern Madagascar
L11079.1	SRR7721873	0.84	0.68	0.58	SAMN09864069	Modification of gut microbiota-bile acid-intestinal FXR signaling leads to the clinical benefits of metformin
L11079.1	SRR7880371	0.84	0.68	0.58	SAMN10094481	Gut microbiota profile of vegetarians versus omnivores
L11079.1	SRR7892441	0.84	0.68	0.58	SAMN10080929	Gut virome of Cameroonians living in close proximity with bats
L11079.1	SRR7903719	0.84	0.68	0.58	SAMN10130886	Tyrophagus putrescentiae transcriptome
L11079.1	SRR8086008	0.84	0.68	0.58	SAMN10268311	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8086062	0.84	0.68	0.58	SAMN10268035	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8086092	0.84	0.68	0.58	SAMN10267959	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8086155	0.84	0.68	0.58	SAMN10268019	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8086177	0.84	0.68	0.58	SAMN10268059	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8086193	0.84	0.68	0.58	SAMN10267864	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8086226	0.84	0.68	0.58	SAMN10267898	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8086496	0.84	0.68	0.58	SAMN10268301	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090579	0.84	0.68	0.58	SAMN10275511	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090581	0.84	0.68	0.58	SAMN10275509	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090582	0.84	0.68	0.58	SAMN10275510	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090585	0.84	0.68	0.58	SAMN10275513	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090600	0.84	0.68	0.58	SAMN10275307	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090723	0.84	0.68	0.58	SAMN10275747	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090728	0.84	0.68	0.58	SAMN10275746	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090847	0.84	0.68	0.58	SAMN10275563	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090848	0.84	0.68	0.58	SAMN10275564	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090852	0.84	0.68	0.58	SAMN10275560	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090854	0.84	0.68	0.58	SAMN10275562	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090862	0.84	0.68	0.58	SAMN10275503	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090863	0.84	0.68	0.58	SAMN10275506	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090864	0.84	0.68	0.58	SAMN10275505	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090865	0.84	0.68	0.58	SAMN10275508	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090889	0.84	0.68	0.58	SAMN10275683	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090902	0.84	0.68	0.58	SAMN10275261	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090903	0.84	0.68	0.58	SAMN10275262	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090920	0.84	0.68	0.58	SAMN10275486	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090928	0.84	0.68	0.58	SAMN10275644	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090970	0.84	0.68	0.58	SAMN10275312	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8091065	0.84	0.68	0.58	SAMN10275723	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8108548	0.84	0.68	0.58	SAMN10290225	Comparison of faecal virome composition in cystic fibrosis patients vs. a healthy cohort
L11079.1	SRR8152974	0.84	0.68	0.58	SAMN10364701	The role of the gut microbiome in relation to low-calories artificial sweeteners on gut microbiome
L11079.1	SRR8784361	0.84	0.68	0.58	SAMN11252269	Metagenomic sequencing of stool samples from Ethiopian individuals
L11079.1	SRR8204362	0.84	0.68	0.58	SAMN10433870	Infant gut microbiome meta-transcriptomics
L11079.1	SRR8204363	0.84	0.68	0.58	SAMN10433871	Infant gut microbiome meta-transcriptomics
L11079.1	SRR8204367	0.84	0.68	0.58	SAMN10433852	Infant gut microbiome meta-transcriptomics
L11079.1	SRR8204372	0.84	0.68	0.58	SAMN10433849	Infant gut microbiome meta-transcriptomics
L11079.1	SRR8204373	0.84	0.68	0.58	SAMN10433850	Infant gut microbiome meta-transcriptomics
L11079.1	SRR8204374	0.84	0.68	0.58	SAMN10433851	Infant gut microbiome meta-transcriptomics
L11079.1	SRR8204375	0.84	0.68	0.58	SAMN10433872	Infant gut microbiome meta-transcriptomics
L11079.1	SRR8204378	0.84	0.68	0.58	SAMN10433856	Infant gut microbiome meta-transcriptomics
L11079.1	SRR8204380	0.84	0.68	0.58	SAMN10433873	Infant gut microbiome meta-transcriptomics
L11079.1	SRR8239394	0.84	0.68	0.58	SAMN10456910	Wastewater metagenome and mobilome analysis
L11079.1	SRR8289513	0.84	0.68	0.58	SAMN10508978	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8303194	0.84	0.68	0.58	SAMN10583777	Microbiota changes are associated with acquisition of antibiotic resistant genes among international travelers
L11079.1	SRR8316649	0.84	0.68	0.58	SAMN10592385	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316661	0.84	0.68	0.58	SAMN10592459	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8353584	0.84	0.68	0.58	SAMN10615523	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353587	0.84	0.68	0.58	SAMN10615526	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353590	0.84	0.68	0.58	SAMN10615529	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353592	0.84	0.68	0.58	SAMN10615531	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353595	0.84	0.68	0.58	SAMN10615534	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353597	0.84	0.68	0.58	SAMN10615536	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353618	0.84	0.68	0.58	SAMN10615557	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353620	0.84	0.68	0.58	SAMN10615559	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353622	0.84	0.68	0.58	SAMN10615561	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353623	0.84	0.68	0.58	SAMN10615562	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353626	0.84	0.68	0.58	SAMN10615565	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353627	0.84	0.68	0.58	SAMN10615566	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353633	0.84	0.68	0.58	SAMN10615572	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353658	0.84	0.68	0.58	SAMN10616052	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353706	0.84	0.68	0.58	SAMN10616100	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353725	0.84	0.68	0.58	SAMN10616119	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353733	0.84	0.68	0.58	SAMN10616127	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353785	0.84	0.68	0.58	SAMN10615628	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353815	0.84	0.68	0.58	SAMN10615658	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353817	0.84	0.68	0.58	SAMN10615660	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353920	0.84	0.68	0.58	SAMN10615763	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353921	0.84	0.68	0.58	SAMN10615764	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353953	0.84	0.68	0.58	SAMN10615796	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353958	0.84	0.68	0.58	SAMN10615801	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354032	0.84	0.68	0.58	SAMN10615875	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354034	0.84	0.68	0.58	SAMN10615877	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354041	0.84	0.68	0.58	SAMN10615884	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354045	0.84	0.68	0.58	SAMN10615888	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354070	0.84	0.68	0.58	SAMN10615913	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354086	0.84	0.68	0.58	SAMN10615929	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354153	0.84	0.68	0.58	SAMN10615996	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354185	0.84	0.68	0.58	SAMN10616028	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354188	0.84	0.68	0.58	SAMN10616031	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354189	0.84	0.68	0.58	SAMN10616032	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354192	0.84	0.68	0.58	SAMN10616035	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427557	0.84	0.68	0.58	SAMN10722101	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427608	0.84	0.68	0.58	SAMN10722152	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427636	0.84	0.68	0.58	SAMN10722180	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427879	0.84	0.68	0.58	SAMN10722423	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427885	0.84	0.68	0.58	SAMN10722429	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427967	0.84	0.68	0.58	SAMN10722511	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427979	0.84	0.68	0.58	SAMN10722523	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428093	0.84	0.68	0.58	SAMN10722637	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428103	0.84	0.68	0.58	SAMN10722647	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428169	0.84	0.68	0.58	SAMN10722073	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428191	0.84	0.68	0.58	SAMN10722095	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8387674	0.84	0.68	0.58	SAMN10688648	Gut metagenomic raw sequence reads of cancer patients
L11079.1	SRR8387676	0.84	0.68	0.58	SAMN10688646	Gut metagenomic raw sequence reads of cancer patients
L11079.1	SRR8634364	0.84	0.68	0.58	SAMN11023991	Resistant microbiome underlies antibiotic therapy in pouchitis
L11079.1	SRR8634386	0.84	0.68	0.58	SAMN11024025	Resistant microbiome underlies antibiotic therapy in pouchitis
L11079.1	SRR8638151	0.84	0.68	0.58	SAMN11019930	Military dog macro genome project
L11079.1	SRR8652857	0.84	0.68	0.58	SAMN11031286	Human infant gut virome
L11079.1	SRR8652941	0.84	0.68	0.58	SAMN11031287	Human infant gut virome
L11079.1	SRR8652942	0.84	0.68	0.58	SAMN11031288	Human infant gut virome
L11079.1	SRR8653139	0.84	0.68	0.58	SAMN11031286	Human infant gut virome
L11079.1	SRR8653214	0.84	0.68	0.58	SAMN11031287	Human infant gut virome
L11079.1	SRR8653215	0.84	0.68	0.58	SAMN11031288	Human infant gut virome
L11079.1	SRR9670855	0.84	0.68	0.58	SAMN11031402	Human infant gut virome
L11079.1	SRR9670856	0.84	0.68	0.58	SAMN11031403	Human infant gut virome
L11079.1	SRR9670874	0.84	0.68	0.58	SAMN11031372	Human infant gut virome
L11079.1	SRR9670890	0.84	0.68	0.58	SAMN11031452	Human infant gut virome
L11079.1	SRR9670892	0.84	0.68	0.58	SAMN11031430	Human infant gut virome
L11079.1	SRR9670909	0.84	0.68	0.58	SAMN11031416	Human infant gut virome
L11079.1	SRR9670914	0.84	0.68	0.58	SAMN11031446	Human infant gut virome
L11079.1	SRR9670921	0.84	0.68	0.58	SAMN11031440	Human infant gut virome
L11079.1	SRR9670925	0.84	0.68	0.58	SAMN11031427	Human infant gut virome
L11079.1	SRR8667752	0.84	0.68	0.58	SAMN11052988	Fecal transplant in children with Clostridioides difficile
L11079.1	SRR8845479	0.84	0.68	0.58	SAMN11311782	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845559	0.84	0.68	0.58	SAMN11311761	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845610	0.84	0.68	0.58	SAMN11311679	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845651	0.84	0.68	0.58	SAMN11311539	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8849199	0.84	0.68	0.58	SAMN11342863	Gut microbiota-bile acid-interleukin 22 axis orchestrates polycystic ovary syndrome
L11079.1	SRR8849206	0.84	0.68	0.58	SAMN11342866	Gut microbiota-bile acid-interleukin 22 axis orchestrates polycystic ovary syndrome
L11079.1	SRR8849249	0.84	0.68	0.58	SAMN11342816	Gut microbiota-bile acid-interleukin 22 axis orchestrates polycystic ovary syndrome
L11079.1	SRR8865594	0.84	0.68	0.58	SAMN11355254	Association of Flavonifractor plautii, a flavonoid degrading bacterium, with the gut microbiome of colorectal cancer patients in India
L11079.1	SRR8865598	0.84	0.68	0.58	SAMN11355250	Association of Flavonifractor plautii, a flavonoid degrading bacterium, with the gut microbiome of colorectal cancer patients in India
L11079.1	SRR8882753	0.84	0.68	0.58	SAMN11394083	Infant gut metagenome
L11079.1	SRR8882766	0.84	0.68	0.58	SAMN11394082	Infant gut metagenome
L11079.1	SRR8882781	0.84	0.68	0.58	SAMN11394084	Infant gut metagenome
L11079.1	SRR8890832	0.84	0.68	0.58	SAMN11407862	Gut microbiome differences between wild and captive black rhinoceros – implications for rhino health
L11079.1	SRR8891936	0.84	0.68	0.58	SAMN11408447	PRASCO gut microbiome profile of Pediatric Severe Acute Ulcerative Colitis patients under Antimicrobial treatment
L11079.1	SRR8892030	0.84	0.68	0.58	SAMN11408508	PRASCO gut microbiome profile of Pediatric Severe Acute Ulcerative Colitis patients under Antimicrobial treatment
L11079.1	SRR8898540	0.84	0.68	0.58	SAMN11274029	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898627	0.84	0.68	0.58	SAMN11273970	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898703	0.84	0.68	0.58	SAMN11273991	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898723	0.84	0.68	0.58	SAMN11273985	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR9040422	0.84	0.68	0.58	SAMN11391666	Human Gut Metagenome Raw sequence reads
L11079.1	SRR9040429	0.84	0.68	0.58	SAMN11391668	Human Gut Metagenome Raw sequence reads
L11079.1	SRR9040438	0.84	0.68	0.58	SAMN11391657	Human Gut Metagenome Raw sequence reads
L11079.1	SRR9040448	0.84	0.68	0.58	SAMN11391614	Human Gut Metagenome Raw sequence reads
L11079.1	SRR9040457	0.84	0.68	0.58	SAMN11391638	Human Gut Metagenome Raw sequence reads
L11079.1	SRR9040463	0.84	0.68	0.58	SAMN11391603	Human Gut Metagenome Raw sequence reads
L11079.1	SRR9089485	0.84	0.68	0.58	SAMN11774688	Gut microbiota dysbiosis in spinal cord injury
L11079.1	SRR9201496	0.84	0.68	0.58	SAMN11958555	Maturation of the infant rhesus macaque (Macaca mulatta) gut microbiome and its role in the development of diarrheal disease
L11079.1	SRR9199315	0.84	0.68	0.58	SAMN11954233	Metagenomic Study of Gastrointestinal Tract Microbial Community Change During Long-Term Acute Care
L11079.1	SRR9199318	0.84	0.68	0.58	SAMN11954228	Metagenomic Study of Gastrointestinal Tract Microbial Community Change During Long-Term Acute Care
L11079.1	SRR9199323	0.84	0.68	0.58	SAMN11954235	Metagenomic Study of Gastrointestinal Tract Microbial Community Change During Long-Term Acute Care
L11079.1	SRR9276221	0.84	0.68	0.58	SAMN11664382	Microbiome from diverse natural environments colonize and compete in the mouse gut
L11079.1	SRR9276266	0.84	0.68	0.58	SAMN11664391	Microbiome from diverse natural environments colonize and compete in the mouse gut
L11079.1	SRR9276269	0.84	0.68	0.58	SAMN11664285	Microbiome from diverse natural environments colonize and compete in the mouse gut
L11079.1	SRR9293031	0.84	0.68	0.58	SAMN11977748	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9330506	0.84	0.68	0.58	SAMN12097504	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330516	0.84	0.68	0.58	SAMN12097492	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330549	0.84	0.68	0.58	SAMN12097570	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330559	0.84	0.68	0.58	SAMN12097514	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330567	0.84	0.68	0.58	SAMN12097578	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330582	0.84	0.68	0.58	SAMN12097554	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330584	0.84	0.68	0.58	SAMN12097550	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330585	0.84	0.68	0.58	SAMN12097551	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330599	0.84	0.68	0.58	SAMN12097447	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330612	0.84	0.68	0.58	SAMN12097560	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330631	0.84	0.68	0.58	SAMN12097493	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330635	0.84	0.68	0.58	SAMN12097428	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330638	0.84	0.68	0.58	SAMN12097532	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330639	0.84	0.68	0.58	SAMN12097533	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330657	0.84	0.68	0.58	SAMN12097542	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9674552	0.84	0.68	0.58	SAMN11356521	CARBEPAD
L11079.1	SRR9843927	0.84	0.68	0.58	SAMN12371645	Gut microbiome for the MORDOR I study.
L11079.1	SRR9843935	0.84	0.68	0.58	SAMN12371722	Gut microbiome for the MORDOR I study.
L11079.1	SRR9843936	0.84	0.68	0.58	SAMN12371648	Gut microbiome for the MORDOR I study.
L11079.1	SRR9843983	0.84	0.68	0.58	SAMN12371803	Gut microbiome for the MORDOR I study.
L11079.1	SRR9844167	0.84	0.68	0.58	SAMN12371520	Gut microbiome for the MORDOR I study.
L11079.1	SRR9844214	0.84	0.68	0.58	SAMN12371362	Gut microbiome for the MORDOR I study.
L11079.1	SRR9865437	0.84	0.68	0.58	SAMN09980797	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9865488	0.84	0.68	0.58	SAMN09980729	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9865513	0.84	0.68	0.58	SAMN09980965	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9865531	0.84	0.68	0.58	SAMN09980692	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9865586	0.84	0.68	0.58	SAMN09980974	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9865777	0.84	0.68	0.58	SAMN09980737	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9866670	0.84	0.68	0.58	SAMN12283827	Metagenomic sequencing of Lawsonia intracellularis
L11079.1	SRR9866674	0.84	0.68	0.58	SAMN12283831	Metagenomic sequencing of Lawsonia intracellularis
L11079.1	SRR9879779	0.84	0.68	0.58	SAMN12418490	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR9879835	0.84	0.68	0.58	SAMN12418477	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR9879839	0.84	0.68	0.58	SAMN12418389	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR9879859	0.84	0.68	0.58	SAMN12418363	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR9879875	0.84	0.68	0.58	SAMN12418451	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	DRR070904	0.84	0.68	0.58	SAMD00046786	Shotgun metagenomics of fecal bacterial consortium inhabiting healthy Asian children
L11079.1	DRR070933	0.84	0.68	0.58	SAMD00046815	Shotgun metagenomics of fecal bacterial consortium inhabiting healthy Asian children
L11079.1	DRR171477	0.84	0.68	0.58	SAMD00164756	metagenomic data from human fecal samples
L11079.1	DRR171486	0.84	0.68	0.58	SAMD00164772	metagenomic data from human fecal samples
L11079.1	DRR171492	0.84	0.68	0.58	SAMD00164779	metagenomic data from human fecal samples
L11079.1	DRR171638	0.84	0.68	0.58	SAMD00164948	metagenomic data from human fecal samples
L11079.1	DRR171673	0.84	0.68	0.58	SAMD00164983	metagenomic data from human fecal samples
L11079.1	DRR171827	0.84	0.68	0.58	SAMD00114852	metagenomic data from human fecal samples
L11079.1	DRR171944	0.84	0.68	0.58	SAMD00115006	metagenomic data from human fecal samples
L11079.1	DRR172002	0.84	0.68	0.58	SAMD00115071	metagenomic data from human fecal samples
L11079.1	DRR140159	0.84	0.68	0.58	SAMD00127711	Metagenomic analysis of biological samples collected from patients with Kawasaki disease.
L11079.1	DRR174612	0.84	0.68	0.58	SAMD00166387	Generic sample from human gut metagenome
L11079.1	DRR162216	0.84	0.68	0.58	SAMD00154178	Gut Microbiota dysbiosis leads to the development and progression of multiple sclerosis
L11079.1	DRR162293	0.84	0.68	0.58	SAMD00154255	Gut Microbiota dysbiosis leads to the development and progression of multiple sclerosis
L11079.1	DRR162427	0.84	0.68	0.58	SAMD00149239	Gut metagenome in cardiovascular diseases
L11079.1	DRR173101	0.84	0.68	0.58	SAMD00165646	Metaviromic analyses on crane fecal samples
L11079.1	DRR199878	0.84	0.68	0.58	SAMD00195171	Metagenomic survey and whole genome sequencing of antimicrobial resistant bacteria in Japanese hospital sewage
L11079.1	DRR199879	0.84	0.68	0.58	SAMD00195172	Metagenomic survey and whole genome sequencing of antimicrobial resistant bacteria in Japanese hospital sewage
L11079.1	ERR1018197	0.84	0.68	0.58	SAMEA3541481	Metagenomic analysis of fecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
L11079.1	ERR1018198	0.84	0.68	0.58	SAMEA3541482	Metagenomic analysis of fecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
L11079.1	ERR1018219	0.84	0.68	0.58	SAMEA3541503	Metagenomic analysis of fecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
L11079.1	ERR1018282	0.84	0.68	0.58	SAMEA3541566	Metagenomic analysis of fecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
L11079.1	ERR2239118	0.84	0.68	0.58	SAMEA3633343	American Gut Project
L11079.1	ERR2239305	0.84	0.68	0.58	SAMEA3865537	American Gut Project
L11079.1	ERR2239331	0.84	0.68	0.58	SAMEA104187382	American Gut Project
L11079.1	ERR2239441	0.84	0.68	0.58	SAMEA3609467	American Gut Project
L11079.1	ERR2239635	0.84	0.68	0.58	SAMEA3901120	American Gut Project
L11079.1	ERR2242038	0.84	0.68	0.58	SAMEA104187330	American Gut Project
L11079.1	ERR2242051	0.84	0.68	0.58	SAMEA104187382	American Gut Project
L11079.1	ERR5654403	0.84	0.68	0.58	SAMEA8506685	American Gut Project
L11079.1	ERR5654439	0.84	0.68	0.58	SAMEA8506721	American Gut Project
L11079.1	ERR1110323	0.84	0.68	0.58	SAMEA3646709	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136651	0.84	0.68	0.58	SAMEA3665030	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136833	0.84	0.68	0.58	SAMEA3664631	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136884	0.84	0.68	0.58	SAMEA3664682	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136885	0.84	0.68	0.58	SAMEA3664683	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136923	0.84	0.68	0.58	SAMEA3664682	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137042	0.84	0.68	0.58	SAMEA3664980	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137220	0.84	0.68	0.58	SAMEA3664764	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137320	0.84	0.68	0.58	SAMEA3664980	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137383	0.84	0.68	0.58	SAMEA3665169	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137707	0.84	0.68	0.58	SAMEA3664663	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1190557	0.84	0.68	0.58	SAMEA3708483	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190561	0.84	0.68	0.58	SAMEA3708487	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190618	0.84	0.68	0.58	SAMEA3708544	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190655	0.84	0.68	0.58	SAMEA3708581	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190738	0.84	0.68	0.58	SAMEA3708664	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190761	0.84	0.68	0.58	SAMEA3708687	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190777	0.84	0.68	0.58	SAMEA3708703	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1193331	0.84	0.68	0.58	SAMEA3712872	Metagenomes
L11079.1	ERR1224347	0.84	0.68	0.58	SAMEA3731126	Meta-genomic analysis of toilet waste from long distance flights
L11079.1	ERR1224357	0.84	0.68	0.58	SAMEA3731136	Meta-genomic analysis of toilet waste from long distance flights
L11079.1	ERR1306549	0.84	0.68	0.58	SAMEA3891247	Experimental trial using phytase in the diet for broiler
L11079.1	ERR1430413	0.84	0.68	0.58	SAMEA4019167	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1430448	0.84	0.68	0.58	SAMEA4019202	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1430449	0.84	0.68	0.58	SAMEA4019203	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1430477	0.84	0.68	0.58	SAMEA4019231	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1449732	0.84	0.68	0.58	SAMEA4031714	Gut microbiota of 10 pairs of Chinese infant twins
L11079.1	ERR1514429	0.84	0.68	0.58	SAMEA4062935	Local surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1543942	0.84	0.68	0.58	SAMEA4350108	Evaluating the Potential of using Next-Generation Sequencing for Direct Clinical Diagnostics of Faecal Samples from Patients with Diarrhoea
L11079.1	ERR1578626	0.84	0.68	0.58	SAMEA4378235	Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease
L11079.1	ERR1578664	0.84	0.68	0.58	SAMEA4378273	Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease
L11079.1	ERR1578667	0.84	0.68	0.58	SAMEA4378276	Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease
L11079.1	ERR1578687	0.84	0.68	0.58	SAMEA4378296	Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease
L11079.1	ERR1578699	0.84	0.68	0.58	SAMEA4378308	Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease
L11079.1	ERR1578701	0.84	0.68	0.58	SAMEA4378310	Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease
L11079.1	ERR1578704	0.84	0.68	0.58	SAMEA4378313	Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease
L11079.1	ERR1600709	0.84	0.68	0.58	SAMEA4385567	Using WTP diet to modulate gut microbiota to alleviate human type 2 diabetes
L11079.1	ERR1620268	0.84	0.68	0.58	SAMEA4431881	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	ERR1620271	0.84	0.68	0.58	SAMEA4431884	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	ERR1620291	0.84	0.68	0.58	SAMEA4431904	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	ERR1620308	0.84	0.68	0.58	SAMEA4431921	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	ERR1620361	0.84	0.68	0.58	SAMEA4431974	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	ERR1711691	0.84	0.68	0.58	SAMEA4525113	KCL_twins2
L11079.1	ERR1711715	0.84	0.68	0.58	SAMEA4525137	KCL_twins2
L11079.1	ERR1713338	0.84	0.68	0.58	SAMEA4527606	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713345	0.84	0.68	0.58	SAMEA4527613	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713347	0.84	0.68	0.58	SAMEA4527615	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713369	0.84	0.68	0.58	SAMEA4527637	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713371	0.84	0.68	0.58	SAMEA4527639	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713390	0.84	0.68	0.58	SAMEA4527658	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713402	0.84	0.68	0.58	SAMEA4527670	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713405	0.84	0.68	0.58	SAMEA4527673	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713407	0.84	0.68	0.58	SAMEA4527675	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713408	0.84	0.68	0.58	SAMEA4527676	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1725994	0.84	0.68	0.58	SAMEA4527645	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR2592250	0.84	0.68	0.58	SAMEA4527609	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR2592332	0.84	0.68	0.58	SAMEA4527616	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1728178	0.84	0.68	0.58	SAMEA4545405	Subspecies in the global human gut microbiome
L11079.1	ERR1823591	0.84	0.68	0.58	SAMEA80940418	Analysis of stool samples from sickle cell disease patients and healthy controls
L11079.1	ERR1950666	0.84	0.68	0.58	SAMEA104032358	Surveillance for prevalence of drug resistance bacteria in Ugandan animal agriculture
L11079.1	ERR1981167	0.84	0.68	0.58	SAMEA104075946	Strain-level metagenomic analysis of the fermented dairy beverage nunu highlights potential food safety risks
L11079.1	ERR1981168	0.84	0.68	0.58	SAMEA104075945	Strain-level metagenomic analysis of the fermented dairy beverage nunu highlights potential food safety risks
L11079.1	ERR2014806	0.84	0.68	0.58	SAMEA104075946	Strain-level metagenomic analysis of the fermented dairy beverage nunu highlights potential food safety risks
L11079.1	ERR2014807	0.84	0.68	0.58	SAMEA104075945	Strain-level metagenomic analysis of the fermented dairy beverage nunu highlights potential food safety risks
L11079.1	ERR2013561	0.84	0.68	0.58	SAMEA37062418	Connections between the gut microbiome and gestational diabetes mellitus
L11079.1	ERR2013584	0.84	0.68	0.58	SAMEA37079668	Connections between the gut microbiome and gestational diabetes mellitus
L11079.1	ERR2017414	0.84	0.68	0.58	SAMEA104142371	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017481	0.84	0.68	0.58	SAMEA104142382	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017523	0.84	0.68	0.58	SAMEA104142214	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017526	0.84	0.68	0.58	SAMEA104142219	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017530	0.84	0.68	0.58	SAMEA104142210	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017604	0.84	0.68	0.58	SAMEA104142295	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017609	0.84	0.68	0.58	SAMEA104142299	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017611	0.84	0.68	0.58	SAMEA104142301	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017616	0.84	0.68	0.58	SAMEA104142292	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017621	0.84	0.68	0.58	SAMEA104142277	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017639	0.84	0.68	0.58	SAMEA104142259	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017643	0.84	0.68	0.58	SAMEA104142255	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017663	0.84	0.68	0.58	SAMEA104142245	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017664	0.84	0.68	0.58	SAMEA104142318	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017697	0.84	0.68	0.58	SAMEA104142191	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017715	0.84	0.68	0.58	SAMEA104142310	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017791	0.84	0.68	0.58	SAMEA104142455	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017794	0.84	0.68	0.58	SAMEA104142457	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017800	0.84	0.68	0.58	SAMEA104142460	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2167539	0.84	0.68	0.58	SAMEA104346160	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167540	0.84	0.68	0.58	SAMEA104346161	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167541	0.84	0.68	0.58	SAMEA104346162	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167544	0.84	0.68	0.58	SAMEA104346165	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167735	0.84	0.68	0.58	SAMEA104346160	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167737	0.84	0.68	0.58	SAMEA104346162	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167738	0.84	0.68	0.58	SAMEA104346163	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167740	0.84	0.68	0.58	SAMEA104346165	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167750	0.84	0.68	0.58	SAMEA104346175	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167759	0.84	0.68	0.58	SAMEA104346184	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167789	0.84	0.68	0.58	SAMEA104346214	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167824	0.84	0.68	0.58	SAMEA104346249	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167835	0.84	0.68	0.58	SAMEA104346260	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167837	0.84	0.68	0.58	SAMEA104346262	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167838	0.84	0.68	0.58	SAMEA104346263	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167839	0.84	0.68	0.58	SAMEA104346264	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2167840	0.84	0.68	0.58	SAMEA104346265	A catalog of the Sprague-Dawley (SD) rat gut metagenome
L11079.1	ERR2182420	0.84	0.68	0.58	SAMEA104359224	Microbiota broiler carcasses
L11079.1	ERR2198689	0.84	0.68	0.58	SAMEA104393764	WGS data from FMT trial for the treatment of recurrent Clostridium difficile infection
L11079.1	ERR2198691	0.84	0.68	0.58	SAMEA104393766	WGS data from FMT trial for the treatment of recurrent Clostridium difficile infection
L11079.1	ERR2205768	0.84	0.68	0.58	SAMEA104407274	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2355630	0.84	0.68	0.58	SAMEA104654369	QF.135.091001
L11079.1	ERR2355631	0.84	0.68	0.58	SAMEA104654370	QF.m322.080927
L11079.1	ERR2355699	0.84	0.68	0.58	SAMEA104654437	SY.m210.081125
L11079.1	ERR2359763	0.84	0.68	0.58	SAMEA104658545	JJ.257.130514
L11079.1	ERR2359765	0.84	0.68	0.58	SAMEA104658547	HH.192.090930
L11079.1	ERR2359772	0.84	0.68	0.58	SAMEA104658556	ZZ.109.130808
L11079.1	ERR2360804	0.84	0.68	0.58	SAMEA104665314	JJ.234.130208
L11079.1	ERR2366724	0.84	0.68	0.58	SAMEA104667421	HQ.47.130816
L11079.1	ERR2380888	0.84	0.68	0.58	SAMEA104674554	QQ.98.130411
L11079.1	ERR2505980	0.84	0.68	0.58	SAMEA1069162	Neonatal gut-microbiome-derived 12,13 DiHOME impedes tolerance and predicts childhood atopy and asthma
L11079.1	ERR2505987	0.84	0.68	0.58	SAMEA1069169	Neonatal gut-microbiome-derived 12,13 DiHOME impedes tolerance and predicts childhood atopy and asthma
L11079.1	ERR2505991	0.84	0.68	0.58	SAMEA1069173	Neonatal gut-microbiome-derived 12,13 DiHOME impedes tolerance and predicts childhood atopy and asthma
L11079.1	ERR260151	0.84	0.68	0.58	SAMEA1906571	Gut metagenome in European women with normal, impaired and diabetic glucose control
L11079.1	ERR2607401	0.84	0.68	0.58	SAMEA4700722	Global surveillance of antimicrobial resistance
L11079.1	ERR2607412	0.84	0.68	0.58	SAMEA4700733	Global surveillance of antimicrobial resistance
L11079.1	ERR2607426	0.84	0.68	0.58	SAMEA4700747	Global surveillance of antimicrobial resistance
L11079.1	ERR2607430	0.84	0.68	0.58	SAMEA4700751	Global surveillance of antimicrobial resistance
L11079.1	ERR2607433	0.84	0.68	0.58	SAMEA4700754	Global surveillance of antimicrobial resistance
L11079.1	ERR2607484	0.84	0.68	0.58	SAMEA4700805	Global surveillance of antimicrobial resistance
L11079.1	ERR2607486	0.84	0.68	0.58	SAMEA4700807	Global surveillance of antimicrobial resistance
L11079.1	ERR2607502	0.84	0.68	0.58	SAMEA4700823	Global surveillance of antimicrobial resistance
L11079.1	ERR2607536	0.84	0.68	0.58	SAMEA4700857	Global surveillance of antimicrobial resistance
L11079.1	ERR2607571	0.84	0.68	0.58	SAMEA4700892	Global surveillance of antimicrobial resistance
L11079.1	ERR2607588	0.84	0.68	0.58	SAMEA4700909	Global surveillance of antimicrobial resistance
L11079.1	ERR2607591	0.84	0.68	0.58	SAMEA4700912	Global surveillance of antimicrobial resistance
L11079.1	ERR2607592	0.84	0.68	0.58	SAMEA4700913	Global surveillance of antimicrobial resistance
L11079.1	ERR2608639	0.84	0.68	0.58	SAMEA4702379	gut metagenome of ASD
L11079.1	ERR2608656	0.84	0.68	0.58	SAMEA4702396	gut metagenome of ASD
L11079.1	ERR2619722	0.84	0.68	0.58	SAMEA4719775	Gut metagenomes of rural populations in Cameroon
L11079.1	ERR2619725	0.84	0.68	0.58	SAMEA4719778	Gut metagenomes of rural populations in Cameroon
L11079.1	ERR2619736	0.84	0.68	0.58	SAMEA4719789	Gut metagenomes of rural populations in Cameroon
L11079.1	ERR2619743	0.84	0.68	0.58	SAMEA4719796	Gut metagenomes of rural populations in Cameroon
L11079.1	ERR2619745	0.84	0.68	0.58	SAMEA4719798	Gut metagenomes of rural populations in Cameroon
L11079.1	ERR2619749	0.84	0.68	0.58	SAMEA4719802	Gut metagenomes of rural populations in Cameroon
L11079.1	ERR2619758	0.84	0.68	0.58	SAMEA4719811	Gut metagenomes of rural populations in Cameroon
L11079.1	ERR2683134	0.84	0.68	0.58	SAMEA4777391	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683145	0.84	0.68	0.58	SAMEA4777402	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683151	0.84	0.68	0.58	SAMEA4777408	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683168	0.84	0.68	0.58	SAMEA4777425	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683170	0.84	0.68	0.58	SAMEA4777427	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683178	0.84	0.68	0.58	SAMEA4777435	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683179	0.84	0.68	0.58	SAMEA4777436	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683180	0.84	0.68	0.58	SAMEA4777437	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683184	0.84	0.68	0.58	SAMEA4777441	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683198	0.84	0.68	0.58	SAMEA4777455	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683242	0.84	0.68	0.58	SAMEA4777499	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683249	0.84	0.68	0.58	SAMEA4777506	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683255	0.84	0.68	0.58	SAMEA4777512	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683256	0.84	0.68	0.58	SAMEA4777513	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683261	0.84	0.68	0.58	SAMEA4777518	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683266	0.84	0.68	0.58	SAMEA4777523	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683273	0.84	0.68	0.58	SAMEA4777530	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2722764	0.84	0.68	0.58	SAMEA4814143	Impact of antibiotics on the human gut microbiome and resistome
L11079.1	ERR2722831	0.84	0.68	0.58	SAMEA4814210	Impact of antibiotics on the human gut microbiome and resistome
L11079.1	ERR2722832	0.84	0.68	0.58	SAMEA4814211	Impact of antibiotics on the human gut microbiome and resistome
L11079.1	ERR2739310	0.84	0.68	0.58	SAMEA4833177	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	ERR2739311	0.84	0.68	0.58	SAMEA4833177	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	ERR2739312	0.84	0.68	0.58	SAMEA4833177	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	ERR2739335	0.84	0.68	0.58	SAMEA4833185	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	ERR2739336	0.84	0.68	0.58	SAMEA4833185	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	ERR2739337	0.84	0.68	0.58	SAMEA4833185	Culture-enriched human gut microbiomes reveal core and accessory resistance genes
L11079.1	ERR2749526	0.84	0.68	0.58	SAMEA4844807	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2759380	0.84	0.68	0.58	SAMEA4867832	Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation
L11079.1	ERR2759420	0.84	0.68	0.58	SAMEA4867872	Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation
L11079.1	ERR2835430	0.84	0.68	0.58	SAMEA4968864	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835449	0.84	0.68	0.58	SAMEA4968883	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835472	0.84	0.68	0.58	SAMEA4968906	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835534	0.84	0.68	0.58	SAMEA4968968	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2824913	0.84	0.68	0.58	SAMEA4956202	Functional changes after bariatric surgery by shotgun metagenomic sequencing in obese Chilean subjects
L11079.1	ERR2840920	0.84	0.68	0.58	SAMEA4973177	U.S. immigration westernizes the human gut microbiome
L11079.1	ERR2840921	0.84	0.68	0.58	SAMEA4973178	U.S. immigration westernizes the human gut microbiome
L11079.1	ERR2840923	0.84	0.68	0.58	SAMEA4973180	U.S. immigration westernizes the human gut microbiome
L11079.1	ERR2843558	0.84	0.68	0.58	SAMEA4974185	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2843561	0.84	0.68	0.58	SAMEA4974136	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2843568	0.84	0.68	0.58	SAMEA4974175	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2843577	0.84	0.68	0.58	SAMEA4974158	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2843615	0.84	0.68	0.58	SAMEA4974237	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2843618	0.84	0.68	0.58	SAMEA4974186	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2843620	0.84	0.68	0.58	SAMEA4974142	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2843630	0.84	0.68	0.58	SAMEA4974167	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2843675	0.84	0.68	0.58	SAMEA4974140	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2855820	0.84	0.68	0.58	SAMEA4968269	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855891	0.84	0.68	0.58	SAMEA4968271	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855897	0.84	0.68	0.58	SAMEA4968241	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855900	0.84	0.68	0.58	SAMEA4968188	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855955	0.84	0.68	0.58	SAMEA4968166	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2868405	0.84	0.68	0.58	SAMEA5054172	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868425	0.84	0.68	0.58	SAMEA5054141	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868430	0.84	0.68	0.58	SAMEA5054215	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868434	0.84	0.68	0.58	SAMEA5054095	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868438	0.84	0.68	0.58	SAMEA5054109	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868469	0.84	0.68	0.58	SAMEA5054123	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868485	0.84	0.68	0.58	SAMEA5054105	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868503	0.84	0.68	0.58	SAMEA5054170	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868512	0.84	0.68	0.58	SAMEA5054224	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR3026516	0.84	0.68	0.58	SAMEA5203740	Metagenomic analysis of viruses in toilet waste from long distance flights – A new procedure for global infectious disease surveillance
L11079.1	ERR3229778	0.84	0.68	0.58	SAMEA104565309	RLBUHT_Cdiff
L11079.1	ERR3229779	0.84	0.68	0.58	SAMEA104565327	RLBUHT_Cdiff
L11079.1	ERR3229866	0.84	0.68	0.58	SAMEA104565401	RLBUHT_Cdiff
L11079.1	ERR3229935	0.84	0.68	0.58	SAMEA104565278	RLBUHT_Cdiff
L11079.1	ERR3097286	0.84	0.68	0.58	SAMEA5245249	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097307	0.84	0.68	0.58	SAMEA5245270	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097351	0.84	0.68	0.58	SAMEA5245314	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097456	0.84	0.68	0.58	SAMEA5245419	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097497	0.84	0.68	0.58	SAMEA5245460	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097498	0.84	0.68	0.58	SAMEA5245461	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097540	0.84	0.68	0.58	SAMEA5245503	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3160554	0.84	0.68	0.58	SAMEA5357955	Probiotic Plant Fermentation Extracts Intervention Causes Weight Loss in Obese Patients by Increasing Microbiota-associated Metabolites that Boost Thermogenesis
L11079.1	ERR3160561	0.84	0.68	0.58	SAMEA5357962	Probiotic Plant Fermentation Extracts Intervention Causes Weight Loss in Obese Patients by Increasing Microbiota-associated Metabolites that Boost Thermogenesis
L11079.1	ERR3153748	0.84	0.68	0.58	SAMEA5335522	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153750	0.84	0.68	0.58	SAMEA5335524	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153788	0.84	0.68	0.58	SAMEA5335562	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153823	0.84	0.68	0.58	SAMEA5335597	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153845	0.84	0.68	0.58	SAMEA5335619	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153849	0.84	0.68	0.58	SAMEA5335623	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3201908	0.84	0.68	0.58	SAMEA5407421	CaPES
L11079.1	ERR3201914	0.84	0.68	0.58	SAMEA5407427	CaPES
L11079.1	ERR3201917	0.84	0.68	0.58	SAMEA5407430	CaPES
L11079.1	ERR3201923	0.84	0.68	0.58	SAMEA5407436	CaPES
L11079.1	ERR3201924	0.84	0.68	0.58	SAMEA5407437	CaPES
L11079.1	ERR3201936	0.84	0.68	0.58	SAMEA5407449	CaPES
L11079.1	ERR3209827	0.84	0.68	0.58	SAMEA5410086	Hospital Microbiome
L11079.1	ERR3209833	0.84	0.68	0.58	SAMEA5410092	Hospital Microbiome
L11079.1	ERR3210013	0.84	0.68	0.58	SAMEA5410273	Hospital Microbiome
L11079.1	ERR3213110	0.84	0.68	0.58	SAMEA5416266	Hospital Microbiome
L11079.1	ERR3213111	0.84	0.68	0.58	SAMEA5416267	Hospital Microbiome
L11079.1	ERR3213567	0.84	0.68	0.58	SAMEA5416723	Hospital Microbiome
L11079.1	ERR3213801	0.84	0.68	0.58	SAMEA5416958	Hospital Microbiome
L11079.1	ERR3680156	0.84	0.68	0.58	SAMEA6245281	Hospital Microbiome
L11079.1	ERR321585	0.84	0.68	0.58	SAMEA2153898	Richness of human gut microbiome correlates with metabolic markers
L11079.1	ERR321586	0.84	0.68	0.58	SAMEA2153898	Richness of human gut microbiome correlates with metabolic markers
L11079.1	ERR3212001	0.84	0.68	0.58	SAMEA5414646	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR3261737	0.84	0.68	0.58	SAMEA5537499	Drug metabolism by 28 human gut communities
L11079.1	ERR3277267	0.84	0.68	0.58	SAMEA5564402	The Canadian Healthy Infant Longitudinal Development (CHILD) study is a multicenter longitudinal, prospective, general population birth cohort study. This study used a nested case-controlled design to analyze the functional potential of the fecal microbiome in infants enrolled in the CHILD Study. We selected 3-month and 1-year stool samples from an atopy enriched subset of children from one enrollment center (Vancouver). DNA was extracted from stool samples and submitted for shotgun metagenome sequencing.
L11079.1	ERR3317659	0.84	0.68	0.58	SAMEA5599422	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR6995320	0.84	0.68	0.58	SAMEA10313778	iMSMS Baranzini data
L11079.1	ERR6995416	0.84	0.68	0.58	SAMEA10313840	iMSMS Baranzini data
L11079.1	ERR6995770	0.84	0.68	0.58	SAMEA10313919	iMSMS Baranzini data
L11079.1	ERR6995936	0.84	0.68	0.58	SAMEA10314201	iMSMS Baranzini data
L11079.1	ERR6997758	0.84	0.68	0.58	SAMEA10313920	iMSMS Baranzini data
L11079.1	ERR3345670	0.84	0.68	0.58	SAMEA104717260	Metagenomics_of_Environmental_Samples_from_Pit_Latrines
L11079.1	ERR3405000	0.84	0.68	0.58	SAMEA5616714	Early_life_microbiota_colonisation
L11079.1	ERR3405049	0.84	0.68	0.58	SAMEA5618345	Early_life_microbiota_colonisation
L11079.1	ERR3405116	0.84	0.68	0.58	SAMEA5616715	Early_life_microbiota_colonisation
L11079.1	ERR3405150	0.84	0.68	0.58	SAMEA5617811	Early_life_microbiota_colonisation
L11079.1	ERR3405170	0.84	0.68	0.58	SAMEA5617812	Early_life_microbiota_colonisation
L11079.1	ERR3405331	0.84	0.68	0.58	SAMEA5618443	Early_life_microbiota_colonisation
L11079.1	ERR3405332	0.84	0.68	0.58	SAMEA5618444	Early_life_microbiota_colonisation
L11079.1	ERR3405333	0.84	0.68	0.58	SAMEA5618445	Early_life_microbiota_colonisation
L11079.1	ERR3405390	0.84	0.68	0.58	SAMEA5618488	Early_life_microbiota_colonisation
L11079.1	ERR3405392	0.84	0.68	0.58	SAMEA5618490	Early_life_microbiota_colonisation
L11079.1	ERR3405397	0.84	0.68	0.58	SAMEA5618522	Early_life_microbiota_colonisation
L11079.1	ERR3405570	0.84	0.68	0.58	SAMEA5617948	Early_life_microbiota_colonisation
L11079.1	ERR3405746	0.84	0.68	0.58	SAMEA5616753	Early_life_microbiota_colonisation
L11079.1	ERR3405761	0.84	0.68	0.58	SAMEA5617857	Early_life_microbiota_colonisation
L11079.1	ERR3405765	0.84	0.68	0.58	SAMEA5618421	Early_life_microbiota_colonisation
L11079.1	ERR3405770	0.84	0.68	0.58	SAMEA5617858	Early_life_microbiota_colonisation
L11079.1	ERR3405773	0.84	0.68	0.58	SAMEA5618422	Early_life_microbiota_colonisation
L11079.1	ERR3405947	0.84	0.68	0.58	SAMEA5616755	Early_life_microbiota_colonisation
L11079.1	ERR3406046	0.84	0.68	0.58	SAMEA5618087	Early_life_microbiota_colonisation
L11079.1	ERR3406107	0.84	0.68	0.58	SAMEA5617831	Early_life_microbiota_colonisation
L11079.1	ERR3406212	0.84	0.68	0.58	SAMEA5618381	Early_life_microbiota_colonisation
L11079.1	ERR3406274	0.84	0.68	0.58	SAMEA5618221	Early_life_microbiota_colonisation
L11079.1	ERR3427619	0.84	0.68	0.58	SAMEA5766982	There are 18 ready-to-eat food samples (8 ready-to-eat meat, 7 ready-to-eat vegetables and 3 ready-to-eat fruit) and 6 human faecal samples. The samples were sequenced on the Illumina, NovaSeq PE150.
L11079.1	ERR3427665	0.84	0.68	0.58	SAMEA5767100	There are 18 ready-to-eat food samples (8 ready-to-eat meat, 7 ready-to-eat vegetables and 3 ready-to-eat fruit) and 6 human faecal samples. The samples were sequenced on the Illumina, NovaSeq PE150.
L11079.1	ERR3427667	0.84	0.68	0.58	SAMEA5767102	There are 18 ready-to-eat food samples (8 ready-to-eat meat, 7 ready-to-eat vegetables and 3 ready-to-eat fruit) and 6 human faecal samples. The samples were sequenced on the Illumina, NovaSeq PE150.
L11079.1	ERR3450296	0.84	0.68	0.58	SAMEA5767133	Colonbiome pilot: 9 stools, sequenced by shotgun
L11079.1	ERR3450644	0.84	0.68	0.58	SAMEA5813991	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3450817	0.84	0.68	0.58	SAMEA5814469	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3450873	0.84	0.68	0.58	SAMEA5814396	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3450939	0.84	0.68	0.58	SAMEA5814220	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451002	0.84	0.68	0.58	SAMEA5813848	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3487594	0.84	0.68	0.58	SAMEA5803461	Mother-to-infant transmission of the gut virome and bacterial microbiome
L11079.1	ERR3500828	0.84	0.68	0.58	SAMEA5923315	The results of a first exploratory study testing the use of vaginal microbiome transplantation from healthy donors (VMT), as a therapeutic alternative for patients suffering from symptomatic, intractable and recurrent bacterial vaginosis.
L11079.1	ERR3503287	0.84	0.68	0.58	SAMEA5927894	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3562952	0.84	0.68	0.58	SAMEA5982225	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3562967	0.84	0.68	0.58	SAMEA5982240	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3563021	0.84	0.68	0.58	SAMEA5982294	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3563025	0.84	0.68	0.58	SAMEA5982298	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3563043	0.84	0.68	0.58	SAMEA5982316	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3563048	0.84	0.68	0.58	SAMEA5982321	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3563100	0.84	0.68	0.58	SAMEA5982373	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3563111	0.84	0.68	0.58	SAMEA5982384	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3573307	0.84	0.68	0.58	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3592836	0.84	0.68	0.58	SAMEA6084800	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592838	0.84	0.68	0.58	SAMEA6084802	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592842	0.84	0.68	0.58	SAMEA6084806	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592874	0.84	0.68	0.58	SAMEA6084838	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592875	0.84	0.68	0.58	SAMEA6084839	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592876	0.84	0.68	0.58	SAMEA6084840	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592880	0.84	0.68	0.58	SAMEA6084844	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592884	0.84	0.68	0.58	SAMEA6084848	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592961	0.84	0.68	0.58	SAMEA6084925	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592962	0.84	0.68	0.58	SAMEA6084926	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592972	0.84	0.68	0.58	SAMEA6084936	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592974	0.84	0.68	0.58	SAMEA6084938	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592978	0.84	0.68	0.58	SAMEA6084942	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592984	0.84	0.68	0.58	SAMEA6084948	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592986	0.84	0.68	0.58	SAMEA6084950	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592989	0.84	0.68	0.58	SAMEA6084953	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592993	0.84	0.68	0.58	SAMEA6084957	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592995	0.84	0.68	0.58	SAMEA6084959	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593006	0.84	0.68	0.58	SAMEA6084970	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593010	0.84	0.68	0.58	SAMEA6084974	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593014	0.84	0.68	0.58	SAMEA6084978	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593016	0.84	0.68	0.58	SAMEA6084980	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593017	0.84	0.68	0.58	SAMEA6084981	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593029	0.84	0.68	0.58	SAMEA6084993	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593031	0.84	0.68	0.58	SAMEA6084995	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593033	0.84	0.68	0.58	SAMEA6084997	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593047	0.84	0.68	0.58	SAMEA6085011	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593051	0.84	0.68	0.58	SAMEA6085015	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593061	0.84	0.68	0.58	SAMEA6085025	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593065	0.84	0.68	0.58	SAMEA6085029	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593066	0.84	0.68	0.58	SAMEA6085030	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593077	0.84	0.68	0.58	SAMEA6085041	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593081	0.84	0.68	0.58	SAMEA6085045	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593101	0.84	0.68	0.58	SAMEA6085065	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593138	0.84	0.68	0.58	SAMEA6085102	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593144	0.84	0.68	0.58	SAMEA6085108	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593146	0.84	0.68	0.58	SAMEA6085110	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593147	0.84	0.68	0.58	SAMEA6085111	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593149	0.84	0.68	0.58	SAMEA6085113	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593150	0.84	0.68	0.58	SAMEA6085114	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593175	0.84	0.68	0.58	SAMEA6085139	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593179	0.84	0.68	0.58	SAMEA6085143	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593181	0.84	0.68	0.58	SAMEA6085145	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593182	0.84	0.68	0.58	SAMEA6085146	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593184	0.84	0.68	0.58	SAMEA6085148	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593185	0.84	0.68	0.58	SAMEA6085149	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593186	0.84	0.68	0.58	SAMEA6085150	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593189	0.84	0.68	0.58	SAMEA6085153	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593190	0.84	0.68	0.58	SAMEA6085154	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593191	0.84	0.68	0.58	SAMEA6085155	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593193	0.84	0.68	0.58	SAMEA6085157	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593195	0.84	0.68	0.58	SAMEA6085159	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593196	0.84	0.68	0.58	SAMEA6085160	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593198	0.84	0.68	0.58	SAMEA6085162	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593199	0.84	0.68	0.58	SAMEA6085163	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593200	0.84	0.68	0.58	SAMEA6085164	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593202	0.84	0.68	0.58	SAMEA6085166	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593203	0.84	0.68	0.58	SAMEA6085167	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593204	0.84	0.68	0.58	SAMEA6085169	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593205	0.84	0.68	0.58	SAMEA6085170	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593206	0.84	0.68	0.58	SAMEA6085171	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593207	0.84	0.68	0.58	SAMEA6085172	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593208	0.84	0.68	0.58	SAMEA6085173	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593209	0.84	0.68	0.58	SAMEA6085174	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593210	0.84	0.68	0.58	SAMEA6085175	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593212	0.84	0.68	0.58	SAMEA6085177	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593220	0.84	0.68	0.58	SAMEA6085185	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593223	0.84	0.68	0.58	SAMEA6085188	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593237	0.84	0.68	0.58	SAMEA6085202	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593238	0.84	0.68	0.58	SAMEA6085203	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593239	0.84	0.68	0.58	SAMEA6085204	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593240	0.84	0.68	0.58	SAMEA6085205	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593241	0.84	0.68	0.58	SAMEA6085206	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593242	0.84	0.68	0.58	SAMEA6085207	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593244	0.84	0.68	0.58	SAMEA6085209	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593246	0.84	0.68	0.58	SAMEA6085211	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593247	0.84	0.68	0.58	SAMEA6085212	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593254	0.84	0.68	0.58	SAMEA6085219	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593268	0.84	0.68	0.58	SAMEA6085233	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593269	0.84	0.68	0.58	SAMEA6085234	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593270	0.84	0.68	0.58	SAMEA6085235	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593272	0.84	0.68	0.58	SAMEA6085237	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593274	0.84	0.68	0.58	SAMEA6085239	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593276	0.84	0.68	0.58	SAMEA6085241	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593277	0.84	0.68	0.58	SAMEA6085242	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593278	0.84	0.68	0.58	SAMEA6085243	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593279	0.84	0.68	0.58	SAMEA6085244	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593281	0.84	0.68	0.58	SAMEA6085246	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593282	0.84	0.68	0.58	SAMEA6085247	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593286	0.84	0.68	0.58	SAMEA6085251	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593287	0.84	0.68	0.58	SAMEA6085252	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593288	0.84	0.68	0.58	SAMEA6085253	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593289	0.84	0.68	0.58	SAMEA6085254	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593291	0.84	0.68	0.58	SAMEA6085256	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593292	0.84	0.68	0.58	SAMEA6085257	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593293	0.84	0.68	0.58	SAMEA6085258	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593295	0.84	0.68	0.58	SAMEA6085260	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593297	0.84	0.68	0.58	SAMEA6085262	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593300	0.84	0.68	0.58	SAMEA6085265	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593302	0.84	0.68	0.58	SAMEA6085267	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593303	0.84	0.68	0.58	SAMEA6085268	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593304	0.84	0.68	0.58	SAMEA6085269	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593305	0.84	0.68	0.58	SAMEA6085270	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593306	0.84	0.68	0.58	SAMEA6085271	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593307	0.84	0.68	0.58	SAMEA6085272	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593309	0.84	0.68	0.58	SAMEA6085274	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593440	0.84	0.68	0.58	SAMEA6085405	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593508	0.84	0.68	0.58	SAMEA6085473	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3698116	0.84	0.68	0.58	SAMEA6262700	Associations between the intestinal microbiome and the complement system in age-related macular degeneration
L11079.1	ERR3722016	0.84	0.68	0.58	SAMEA6377494	Clostridium difficile infection patient microbiome
L11079.1	ERR4135165	0.84	0.68	0.58	SAMEA6827998	Human gut microbiome in Korean NAFLD cohort
L11079.1	ERR4139610	0.84	0.68	0.58	SAMEA5338428	Metagenomic_analysis_nasopharyngeal_colonisation
L11079.1	ERR4139621	0.84	0.68	0.58	SAMEA5337812	Metagenomic_analysis_nasopharyngeal_colonisation
L11079.1	ERR4229301	0.84	0.68	0.58	SAMEA5338416	Metagenomic_analysis_nasopharyngeal_colonisation
L11079.1	ERR414289	0.84	0.68	0.58	SAMEA2338673	An integrated catalog of reference genes in the human gut microbiome
L11079.1	ERR414336	0.84	0.68	0.58	SAMEA2338717	An integrated catalog of reference genes in the human gut microbiome
L11079.1	ERR414497	0.84	0.68	0.58	SAMEA2338864	An integrated catalog of reference genes in the human gut microbiome
L11079.1	ERR4158141	0.84	0.68	0.58	SAMEA6845020	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4158304	0.84	0.68	0.58	SAMEA6845183	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4193878	0.84	0.68	0.58	SAMEA6873523	Pathogenesis of Klebsiella Liver Abscess Syndrome Study (P-KLASS)
L11079.1	ERR4193890	0.84	0.68	0.58	SAMEA6873535	Pathogenesis of Klebsiella Liver Abscess Syndrome Study (P-KLASS)
L11079.1	ERR4193901	0.84	0.68	0.58	SAMEA6873546	Pathogenesis of Klebsiella Liver Abscess Syndrome Study (P-KLASS)
L11079.1	ERR4320038	0.84	0.68	0.58	SAMEA7041072	Gut microbiota of carriers of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae following treatment with oral antibiotics and fecal microbiota transplantation
L11079.1	ERR4341885	0.84	0.68	0.58	SAMEA7045878	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4398724	0.84	0.68	0.58	SAMEA7112063	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	ERR4398792	0.84	0.68	0.58	SAMEA7112131	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	ERR4398818	0.84	0.68	0.58	SAMEA7112157	Gut Microbiomes of European Turkey and Veal Calf Herds
L11079.1	ERR4561196	0.84	0.68	0.58	SAMEA7288334	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561197	0.84	0.68	0.58	SAMEA7288334	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561198	0.84	0.68	0.58	SAMEA7288334	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561199	0.84	0.68	0.58	SAMEA7288334	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561200	0.84	0.68	0.58	SAMEA7288334	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563576	0.84	0.68	0.58	SAMEA7288295	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4571328	0.84	0.68	0.58	SAMEA7294485	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	ERR4605534	0.84	0.68	0.58	SAMEA7324888	Liver Cirrhosis cohort
L11079.1	ERR4605536	0.84	0.68	0.58	SAMEA7324888	Liver Cirrhosis cohort
L11079.1	ERR4657996	0.84	0.68	0.58	SAMEA7375383	gut metagenome of HC, IBS, DEP and COMO
L11079.1	ERR4658032	0.84	0.68	0.58	SAMEA7375419	gut metagenome of HC, IBS, DEP and COMO
L11079.1	ERR4678563	0.84	0.68	0.58	SAMEA7426263	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678576	0.84	0.68	0.58	SAMEA7426276	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678580	0.84	0.68	0.58	SAMEA7426280	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678588	0.84	0.68	0.58	SAMEA7426288	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678595	0.84	0.68	0.58	SAMEA7426295	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678616	0.84	0.68	0.58	SAMEA7426316	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678619	0.84	0.68	0.58	SAMEA7426319	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678630	0.84	0.68	0.58	SAMEA7426330	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678631	0.84	0.68	0.58	SAMEA7426331	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678637	0.84	0.68	0.58	SAMEA7426337	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678638	0.84	0.68	0.58	SAMEA7426338	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678641	0.84	0.68	0.58	SAMEA7426341	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678648	0.84	0.68	0.58	SAMEA7426348	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678650	0.84	0.68	0.58	SAMEA7426350	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678655	0.84	0.68	0.58	SAMEA7426355	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678656	0.84	0.68	0.58	SAMEA7426356	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678666	0.84	0.68	0.58	SAMEA7426366	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678673	0.84	0.68	0.58	SAMEA7426373	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678674	0.84	0.68	0.58	SAMEA7426374	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678677	0.84	0.68	0.58	SAMEA7426377	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4682337	0.84	0.68	0.58	SAMEA7428244	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682339	0.84	0.68	0.58	SAMEA7428246	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682347	0.84	0.68	0.58	SAMEA7428254	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682355	0.84	0.68	0.58	SAMEA7428262	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682359	0.84	0.68	0.58	SAMEA7428266	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682360	0.84	0.68	0.58	SAMEA7428267	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682368	0.84	0.68	0.58	SAMEA7428275	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682373	0.84	0.68	0.58	SAMEA7428280	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682380	0.84	0.68	0.58	SAMEA7428287	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682381	0.84	0.68	0.58	SAMEA7428288	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682385	0.84	0.68	0.58	SAMEA7428292	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682396	0.84	0.68	0.58	SAMEA7428303	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682429	0.84	0.68	0.58	SAMEA7428336	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682431	0.84	0.68	0.58	SAMEA7428338	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682441	0.84	0.68	0.58	SAMEA7428348	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682446	0.84	0.68	0.58	SAMEA7428353	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682450	0.84	0.68	0.58	SAMEA7428357	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682786	0.84	0.68	0.58	SAMEA7428428	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682795	0.84	0.68	0.58	SAMEA7428437	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682808	0.84	0.68	0.58	SAMEA7428450	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682821	0.84	0.68	0.58	SAMEA7428463	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682824	0.84	0.68	0.58	SAMEA7428466	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682827	0.84	0.68	0.58	SAMEA7428469	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682832	0.84	0.68	0.58	SAMEA7428474	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682836	0.84	0.68	0.58	SAMEA7428478	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682846	0.84	0.68	0.58	SAMEA7428488	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682847	0.84	0.68	0.58	SAMEA7428489	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682851	0.84	0.68	0.58	SAMEA7428493	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682852	0.84	0.68	0.58	SAMEA7428494	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682866	0.84	0.68	0.58	SAMEA7428508	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682877	0.84	0.68	0.58	SAMEA7428519	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682883	0.84	0.68	0.58	SAMEA7428525	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682894	0.84	0.68	0.58	SAMEA7428536	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682911	0.84	0.68	0.58	SAMEA7428553	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682912	0.84	0.68	0.58	SAMEA7428554	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4796167	0.84	0.68	0.58	SAMEA7529581	Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumor burden in mice
L11079.1	ERR4803941	0.84	0.68	0.58	SAMEA7535862	Metagenomic Analysis of Sewage for Surveillance of Bacterial Pathogens: A Release Experiment to Determine Sensitivity
L11079.1	ERR4803998	0.84	0.68	0.58	SAMEA7535919	Metagenomic Analysis of Sewage for Surveillance of Bacterial Pathogens: A Release Experiment to Determine Sensitivity
L11079.1	ERR6001946	0.84	0.68	0.58	SAMEA8899384	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6001949	0.84	0.68	0.58	SAMEA8899387	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6001954	0.84	0.68	0.58	SAMEA8899392	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002163	0.84	0.68	0.58	SAMEA8899601	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR5194462	0.84	0.68	0.58	SAMEA7874273	FUT2/FUT3 genes sequences and nasopharyngeal shotgun metagenomics from the Microbiota and Health Study
L11079.1	ERR5194602	0.84	0.68	0.58	SAMEA7874134	FUT2/FUT3 genes sequences and nasopharyngeal shotgun metagenomics from the Microbiota and Health Study
L11079.1	ERR5194708	0.84	0.68	0.58	SAMEA7874121	FUT2/FUT3 genes sequences and nasopharyngeal shotgun metagenomics from the Microbiota and Health Study
L11079.1	ERR527034	0.84	0.68	0.58	SAMEA2582006	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	ERR527093	0.84	0.68	0.58	SAMEA2581923	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	ERR528744	0.84	0.68	0.58	SAMEA2582120	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	ERR528749	0.84	0.68	0.58	SAMEA2582125	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	ERR5283964	0.84	0.68	0.58	SAMEA8023287	Changes in human gut microbiome during the first wave of COVID-19 pandemic in comparison with pre-pandemic travel-related changes
L11079.1	ERR5445742	0.84	0.68	0.58	SAMEA8228455	Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota
L11079.1	ERR5445782	0.84	0.68	0.58	SAMEA8228495	Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota
L11079.1	ERR5445784	0.84	0.68	0.58	SAMEA8228497	Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota
L11079.1	ERR5445788	0.84	0.68	0.58	SAMEA8228501	Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota
L11079.1	ERR5445807	0.84	0.68	0.58	SAMEA8228520	Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota
L11079.1	ERR5740693	0.84	0.68	0.58	SAMEA8506298	What is the Burden of Antimicrobial Resistance Genes in Selected Ready-to-Eat Foods?
L11079.1	ERR589746	0.84	0.68	0.58	SAMEA2737751	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589757	0.84	0.68	0.58	SAMEA2737762	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589801	0.84	0.68	0.58	SAMEA2737806	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589831	0.84	0.68	0.58	SAMEA2737836	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589841	0.84	0.68	0.58	SAMEA2737846	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR5917183	0.84	0.68	0.58	SAMEA8740352	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR5917195	0.84	0.68	0.58	SAMEA8740364	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR5917213	0.84	0.68	0.58	SAMEA8740382	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR5917227	0.84	0.68	0.58	SAMEA8740396	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR5917243	0.84	0.68	0.58	SAMEA8740412	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR5917338	0.84	0.68	0.58	SAMEA8740507	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR5917369	0.84	0.68	0.58	SAMEA8740538	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR5917371	0.84	0.68	0.58	SAMEA8740540	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR597371	0.84	0.68	0.58	SAMEA2755559	Kwashiorkor Children have lost Anaerobes-Methanogenic Gut Prokaryotes Mutualism
L11079.1	ERR6050338	0.84	0.68	0.58	SAMEA8912637	Recovery of metagenome-assembled genomes from 110 rice cultivars
L11079.1	ERR6050448	0.84	0.68	0.58	SAMEA8912749	Recovery of metagenome-assembled genomes from 110 rice cultivars
L11079.1	ERR6050558	0.84	0.68	0.58	SAMEA8912859	Recovery of metagenome-assembled genomes from 110 rice cultivars
L11079.1	ERR6384002	0.84	0.68	0.58	SAMEA8994807	Human and mouse gut metagenome upon fecal microbiota transplantation
L11079.1	ERR7017680	0.84	0.68	0.58	SAMEA10256220	AMR_metagenomic_sequencing
L11079.1	ERR7017708	0.84	0.68	0.58	SAMEA10256220	AMR_metagenomic_sequencing
L11079.1	ERR7017736	0.84	0.68	0.58	SAMEA10256220	AMR_metagenomic_sequencing
L11079.1	ERR7017764	0.84	0.68	0.58	SAMEA10256220	AMR_metagenomic_sequencing
L11079.1	ERR7017792	0.84	0.68	0.58	SAMEA10256220	AMR_metagenomic_sequencing
L11079.1	ERR7017820	0.84	0.68	0.58	SAMEA10256220	AMR_metagenomic_sequencing
L11079.1	ERR7017848	0.84	0.68	0.58	SAMEA10256220	AMR_metagenomic_sequencing
L11079.1	ERR720123	0.84	0.68	0.58	SAMEA3182049	The initial state of the human gut microbiome determines its reshaping by antibiotics
L11079.1	ERR720126	0.84	0.68	0.58	SAMEA3182049	The initial state of the human gut microbiome determines its reshaping by antibiotics
L11079.1	ERR7459335	0.84	0.68	0.58	SAMEA104665926	The_human_gut_microbiome_in_alcoholic_liver_disease
L11079.1	ERR7459366	0.84	0.68	0.58	SAMEA104665890	The_human_gut_microbiome_in_alcoholic_liver_disease
L11079.1	ERR7564509	0.84	0.68	0.58	SAMEA10830276	Gut metagenomes of Asian octogenarians from SG90 cohort
L11079.1	ERR7564510	0.84	0.68	0.58	SAMEA10830277	Gut metagenomes of Asian octogenarians from SG90 cohort
L11079.1	ERR7564528	0.84	0.68	0.58	SAMEA10830295	Gut metagenomes of Asian octogenarians from SG90 cohort
L11079.1	ERR7570246	0.84	0.68	0.58	SAMEA10830443	Gut metagenomes of Asian octogenarians from SG90 cohort
L11079.1	ERR7570283	0.84	0.68	0.58	SAMEA10830480	Gut metagenomes of Asian octogenarians from SG90 cohort
L11079.1	ERR7570297	0.84	0.68	0.58	SAMEA10830494	Gut metagenomes of Asian octogenarians from SG90 cohort
L11079.1	ERR7599945	0.84	0.68	0.58	SAMEA11358283	Singapore Platinum Metagenomes Project
L11079.1	ERR7599958	0.84	0.68	0.58	SAMEA11358329	Singapore Platinum Metagenomes Project
L11079.1	ERR7599959	0.84	0.68	0.58	SAMEA11358332	Singapore Platinum Metagenomes Project
L11079.1	ERR7625426	0.84	0.68	0.58	SAMEA11358354	Singapore Platinum Metagenomes Project
L11079.1	ERR7671878	0.84	0.68	0.58	SAMEA11358320	Singapore Platinum Metagenomes Project
L11079.1	ERR7671882	0.84	0.68	0.58	SAMEA11358329	Singapore Platinum Metagenomes Project
L11079.1	ERR7671886	0.84	0.68	0.58	SAMEA11358290	Singapore Platinum Metagenomes Project
L11079.1	ERR7671910	0.84	0.68	0.58	SAMEA11358332	Singapore Platinum Metagenomes Project
L11079.1	ERR7671965	0.84	0.68	0.58	SAMEA11358283	Singapore Platinum Metagenomes Project
L11079.1	ERR7671980	0.84	0.68	0.58	SAMEA11358321	Singapore Platinum Metagenomes Project
L11079.1	ERR7671982	0.84	0.68	0.58	SAMEA11358269	Singapore Platinum Metagenomes Project
L11079.1	ERR844070	0.84	0.68	0.58	SAMEA3323777	An analysis of the composition of viruses and bacteria in stool samples from IBD patients and healthy controls.
L11079.1	ERR953406	0.84	0.68	0.58	SAMEA3475197	Search Engine for Antimicrobial Resistance: a cloud compatible pipeline and web interface for rapidly detecting antimicrobial resistance genes directly from sequence data
L11079.1	SRR5548557	0.84	0.68	0.58	SAMN06733533	The Role of the Gut Microbiota in Ulcerative Colitis, functional gene metagenomics
L11079.1	SRR5548558	0.84	0.68	0.58	SAMN06733533	The Role of the Gut Microbiota in Ulcerative Colitis, functional gene metagenomics
L11079.1	SRR5548565	0.84	0.68	0.58	SAMN06733484	The Role of the Gut Microbiota in Ulcerative Colitis, functional gene metagenomics
L11079.1	SRR5548566	0.84	0.68	0.58	SAMN06733484	The Role of the Gut Microbiota in Ulcerative Colitis, functional gene metagenomics
L11079.1	SRR10002821	0.84	0.68	0.58	SAMN12606837	Shotgun metagenomic sequencing of subway and urban air samples: gCSD17
L11079.1	SRR10002901	0.84	0.68	0.58	SAMN12606665	Shotgun metagenomic sequencing of subway and urban air samples: gCSD17
L11079.1	SRR10025098	0.84	0.68	0.58	SAMN12617476	Temporal variation in the gastrointestinal microbiota of ICU patients
L11079.1	SRR10025099	0.84	0.68	0.58	SAMN12617475	Temporal variation in the gastrointestinal microbiota of ICU patients
L11079.1	SRR10025100	0.84	0.68	0.58	SAMN12617474	Temporal variation in the gastrointestinal microbiota of ICU patients
L11079.1	SRR10029263	0.84	0.68	0.58	SAMN12645266	Multi-omic analysis of Clostridioides difficile infection and response to therapy in pediatric inflammatory bowel disease
L11079.1	SRR10034623	0.84	0.68	0.58	SAMN12650765	Selective concentration for ciprofloxacin resistance in Escherichia coli grown in complex aquatic bacterial biofilms
L11079.1	SRR10034624	0.84	0.68	0.58	SAMN12650762	Selective concentration for ciprofloxacin resistance in Escherichia coli grown in complex aquatic bacterial biofilms
L11079.1	SRR10034626	0.84	0.68	0.58	SAMN12650765	Selective concentration for ciprofloxacin resistance in Escherichia coli grown in complex aquatic bacterial biofilms
L11079.1	SRR10034628	0.84	0.68	0.58	SAMN12650764	Selective concentration for ciprofloxacin resistance in Escherichia coli grown in complex aquatic bacterial biofilms
L11079.1	SRR10034629	0.84	0.68	0.58	SAMN12650764	Selective concentration for ciprofloxacin resistance in Escherichia coli grown in complex aquatic bacterial biofilms
L11079.1	SRR10034634	0.84	0.68	0.58	SAMN12650765	Selective concentration for ciprofloxacin resistance in Escherichia coli grown in complex aquatic bacterial biofilms
L11079.1	SRR1046176	0.84	0.68	0.58	SAMN01828421	Microbial composition of samples from infant gut
L11079.1	SRR1046218	0.84	0.68	0.58	SAMN01828421	Microbial composition of samples from infant gut
L11079.1	SRR1046305	0.84	0.68	0.58	SAMN01828429	Microbial composition of samples from infant gut
L11079.1	SRR1073829	0.84	0.68	0.58	SAMN01041729	Microbial composition of samples from infant gut
L11079.1	SRR1073831	0.84	0.68	0.58	SAMN01780298	Microbial composition of samples from infant gut
L11079.1	SRR1073832	0.84	0.68	0.58	SAMN01041688	Microbial composition of samples from infant gut
L11079.1	SRR1145925	0.84	0.68	0.58	SAMN01041729	Microbial composition of samples from infant gut
L11079.1	SRR1145934	0.84	0.68	0.58	SAMN01041688	Microbial composition of samples from infant gut
L11079.1	SRR1145941	0.84	0.68	0.58	SAMN01780298	Microbial composition of samples from infant gut
L11079.1	SRR1159032	0.84	0.68	0.58	SAMN01041729	Microbial composition of samples from infant gut
L11079.1	SRR1159278	0.84	0.68	0.58	SAMN01041729	Microbial composition of samples from infant gut
L11079.1	SRR1159312	0.84	0.68	0.58	SAMN01795805	Microbial composition of samples from infant gut
L11079.1	SRR1159816	0.84	0.68	0.58	SAMN01041729	Microbial composition of samples from infant gut
L11079.1	SRR1159876	0.84	0.68	0.58	SAMN01041729	Microbial composition of samples from infant gut
L11079.1	SRR1159955	0.84	0.68	0.58	SAMN01780298	Microbial composition of samples from infant gut
L11079.1	SRR1159985	0.84	0.68	0.58	SAMN01041688	Microbial composition of samples from infant gut
L11079.1	SRR1160227	0.84	0.68	0.58	SAMN01774324	Microbial composition of samples from infant gut
L11079.1	SRR1160440	0.84	0.68	0.58	SAMN01780298	Microbial composition of samples from infant gut
L11079.1	SRR1160559	0.84	0.68	0.58	SAMN01774324	Microbial composition of samples from infant gut
L11079.1	SRR1160573	0.84	0.68	0.58	SAMN01795800	Microbial composition of samples from infant gut
L11079.1	SRR1160762	0.84	0.68	0.58	SAMN01780298	Microbial composition of samples from infant gut
L11079.1	SRR1160841	0.84	0.68	0.58	SAMN01041688	Microbial composition of samples from infant gut
L11079.1	SRR1160992	0.84	0.68	0.58	SAMN01795800	Microbial composition of samples from infant gut
L11079.1	SRR1160997	0.84	0.68	0.58	SAMN01780298	Microbial composition of samples from infant gut
L11079.1	SRR1161010	0.84	0.68	0.58	SAMN01041688	Microbial composition of samples from infant gut
L11079.1	SRR1161019	0.84	0.68	0.58	SAMN01780298	Microbial composition of samples from infant gut
L11079.1	SRR1161137	0.84	0.68	0.58	SAMN01041688	Microbial composition of samples from infant gut
L11079.1	SRR1161147	0.84	0.68	0.58	SAMN01041688	Microbial composition of samples from infant gut
L11079.1	SRR1161319	0.84	0.68	0.58	SAMN01041729	Microbial composition of samples from infant gut
L11079.1	SRR1162601	0.84	0.68	0.58	SAMN01773342	Microbial composition of samples from infant gut
L11079.1	SRR1166542	0.84	0.68	0.58	SAMN01773342	Microbial composition of samples from infant gut
L11079.1	SRR1168439	0.84	0.68	0.58	SAMN01773342	Microbial composition of samples from infant gut
L11079.1	SRR1952315	0.84	0.68	0.58	SAMN01773342	Microbial composition of samples from infant gut
L11079.1	SRR1952465	0.84	0.68	0.58	SAMN01774324	Microbial composition of samples from infant gut
L11079.1	SRR1952561	0.84	0.68	0.58	SAMN01795800	Microbial composition of samples from infant gut
L11079.1	SRR649926	0.84	0.68	0.58	SAMN01795782	Microbial composition of samples from infant gut
L11079.1	SRR649937	0.84	0.68	0.58	SAMN01779902	Microbial composition of samples from infant gut
L11079.1	SRR649961	0.84	0.68	0.58	SAMN00001761	Microbial composition of samples from infant gut
L11079.1	SRR649962	0.84	0.68	0.58	SAMN01795782	Microbial composition of samples from infant gut
L11079.1	SRR649967	0.84	0.68	0.58	SAMN01779868	Microbial composition of samples from infant gut
L11079.1	SRR649979	0.84	0.68	0.58	SAMN00001760	Microbial composition of samples from infant gut
L11079.1	SRR649993	0.84	0.68	0.58	SAMN01779868	Microbial composition of samples from infant gut
L11079.1	SRR650243	0.84	0.68	0.58	SAMN01779868	Microbial composition of samples from infant gut
L11079.1	SRR650246	0.84	0.68	0.58	SAMN01779868	Microbial composition of samples from infant gut
L11079.1	SRR650247	0.84	0.68	0.58	SAMN00001760	Microbial composition of samples from infant gut
L11079.1	SRR650252	0.84	0.68	0.58	SAMN01795782	Microbial composition of samples from infant gut
L11079.1	SRR650261	0.84	0.68	0.58	SAMN00001760	Microbial composition of samples from infant gut
L11079.1	SRR650285	0.84	0.68	0.58	SAMN01795801	Microbial composition of samples from infant gut
L11079.1	SRR651261	0.84	0.68	0.58	SAMN00001760	Microbial composition of samples from infant gut
L11079.1	SRR651275	0.84	0.68	0.58	SAMN01779868	Microbial composition of samples from infant gut
L11079.1	SRR651280	0.84	0.68	0.58	SAMN01795782	Microbial composition of samples from infant gut
L11079.1	SRR651312	0.84	0.68	0.58	SAMN01795782	Microbial composition of samples from infant gut
L11079.1	SRR651316	0.84	0.68	0.58	SAMN00001760	Microbial composition of samples from infant gut
L11079.1	SRR651319	0.84	0.68	0.58	SAMN01795782	Microbial composition of samples from infant gut
L11079.1	SRR651359	0.84	0.68	0.58	SAMN01779868	Microbial composition of samples from infant gut
L11079.1	SRR652333	0.84	0.68	0.58	SAMN01780047	Microbial composition of samples from infant gut
L11079.1	SRR653134	0.84	0.68	0.58	SAMN00001760	Microbial composition of samples from infant gut
L11079.1	SRR726569	0.84	0.68	0.58	SAMN01795782	Microbial composition of samples from infant gut
L11079.1	SRR726575	0.84	0.68	0.58	SAMN01779868	Microbial composition of samples from infant gut
L11079.1	SRR726585	0.84	0.68	0.58	SAMN00001760	Microbial composition of samples from infant gut
L11079.1	SRR918020	0.84	0.68	0.58	SAMN01774312	Microbial composition of samples from infant gut
L11079.1	SRR918034	0.84	0.68	0.58	SAMN01774275	Microbial composition of samples from infant gut
L11079.1	SRR918043	0.84	0.68	0.58	SAMN01774312	Microbial composition of samples from infant gut
L11079.1	SRR918118	0.84	0.68	0.58	SAMN01774275	Microbial composition of samples from infant gut
L11079.1	SRR918149	0.84	0.68	0.58	SAMN01774275	Microbial composition of samples from infant gut
L11079.1	SRR918174	0.84	0.68	0.58	SAMN01774275	Microbial composition of samples from infant gut
L11079.1	SRR918176	0.84	0.68	0.58	SAMN01795864	Microbial composition of samples from infant gut
L11079.1	SRR918197	0.84	0.68	0.58	SAMN01774312	Microbial composition of samples from infant gut
L11079.1	SRR918320	0.84	0.68	0.58	SAMN01774312	Microbial composition of samples from infant gut
L11079.1	SRR918346	0.84	0.68	0.58	SAMN01774275	Microbial composition of samples from infant gut
L11079.1	SRR918349	0.84	0.68	0.58	SAMN01774312	Microbial composition of samples from infant gut
L11079.1	SRR918356	0.84	0.68	0.58	SAMN01795864	Microbial composition of samples from infant gut
L11079.1	SRR918404	0.84	0.68	0.58	SAMN01774275	Microbial composition of samples from infant gut
L11079.1	SRR918480	0.84	0.68	0.58	SAMN01779914	Microbial composition of samples from infant gut
L11079.1	SRR918487	0.84	0.68	0.58	SAMN01774312	Microbial composition of samples from infant gut
L11079.1	SRR918584	0.84	0.68	0.58	SAMN01774312	Microbial composition of samples from infant gut
L11079.1	SRR918608	0.84	0.68	0.58	SAMN01795864	Microbial composition of samples from infant gut
L11079.1	SRR918635	0.84	0.68	0.58	SAMN01774275	Microbial composition of samples from infant gut
L11079.1	SRR918642	0.84	0.68	0.58	SAMN01774275	Microbial composition of samples from infant gut
L11079.1	SRR918659	0.84	0.68	0.58	SAMN01774312	Microbial composition of samples from infant gut
L11079.1	SRR12783108	0.84	0.68	0.58	SAMN15889625	Fecal microbiome analysis of patients with chronic obstructive pulmonary disease
L11079.1	SRR10059221	0.84	0.68	0.58	SAMN12676721	PIRE- Halting Environmental Antimicrobial Resistance Dissemination (HEARD)
L11079.1	SRR10084796	0.84	0.68	0.58	SAMN12711667	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084837	0.84	0.68	0.58	SAMN12711630	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10121607	0.84	0.68	0.58	SAMN12751429	fecal sample Raw sequence reads
L11079.1	SRR8402177	0.84	0.68	0.58	SAMN10698577	feces metagenome Metagenome
L11079.1	SRR8402402	0.84	0.68	0.58	SAMN10698583	feces metagenome Metagenome
L11079.1	SRR16643512	0.84	0.68	0.58	SAMN22788899	human gut metagenome Raw sequence reads
L11079.1	SRR16643513	0.84	0.68	0.58	SAMN22788899	human gut metagenome Raw sequence reads
L11079.1	SRR7124830	0.84	0.68	0.58	SAMN08918289	human gut metagenome Raw sequence reads
L11079.1	SRR8803187	0.84	0.68	0.58	SAMN11283181	Homo sapiens Metagenome
L11079.1	SRR5298203	0.84	0.68	0.58	SAMN06350465	human metagenome Raw sequence reads
L11079.1	SRR5298206	0.84	0.68	0.58	SAMN06350459	human metagenome Raw sequence reads
L11079.1	SRR5298208	0.84	0.68	0.58	SAMN06350449	human metagenome Raw sequence reads
L11079.1	SRR1029957	0.84	0.68	0.58	SAMN02401118	Wetland samples Metagenome
L11079.1	SRR10691964	0.84	0.68	0.58	SAMN13246724	human gut metagenome Metagenome
L11079.1	SRR10692015	0.84	0.68	0.58	SAMN13246451	human gut metagenome Metagenome
L11079.1	SRR10692017	0.84	0.68	0.58	SAMN13246449	human gut metagenome Metagenome
L11079.1	SRR10692101	0.84	0.68	0.58	SAMN13246438	human gut metagenome Metagenome
L11079.1	SRR10692118	0.84	0.68	0.58	SAMN13246423	human gut metagenome Metagenome
L11079.1	SRR10692131	0.84	0.68	0.58	SAMN13246411	human gut metagenome Metagenome
L11079.1	SRR10692132	0.84	0.68	0.58	SAMN13246410	human gut metagenome Metagenome
L11079.1	SRR10692145	0.84	0.68	0.58	SAMN13247079	human gut metagenome Metagenome
L11079.1	SRR10692147	0.84	0.68	0.58	SAMN13247077	human gut metagenome Metagenome
L11079.1	SRR10692153	0.84	0.68	0.58	SAMN13247073	human gut metagenome Metagenome
L11079.1	SRR10692217	0.84	0.68	0.58	SAMN13246658	human gut metagenome Metagenome
L11079.1	SRR10692222	0.84	0.68	0.58	SAMN13246654	human gut metagenome Metagenome
L11079.1	SRR10692245	0.84	0.68	0.58	SAMN13246557	human gut metagenome Metagenome
L11079.1	SRR10692247	0.84	0.68	0.58	SAMN13246556	human gut metagenome Metagenome
L11079.1	SRR10692250	0.84	0.68	0.58	SAMN13246553	human gut metagenome Metagenome
L11079.1	SRR10692261	0.84	0.68	0.58	SAMN13246543	human gut metagenome Metagenome
L11079.1	SRR10692271	0.84	0.68	0.58	SAMN13246987	human gut metagenome Metagenome
L11079.1	SRR10692295	0.84	0.68	0.58	SAMN13246256	human gut metagenome Metagenome
L11079.1	SRR10692298	0.84	0.68	0.58	SAMN13246964	human gut metagenome Metagenome
L11079.1	SRR10692304	0.84	0.68	0.58	SAMN13246213	human gut metagenome Metagenome
L11079.1	SRR10692335	0.84	0.68	0.58	SAMN13246508	human gut metagenome Metagenome
L11079.1	SRR10692337	0.84	0.68	0.58	SAMN13246210	human gut metagenome Metagenome
L11079.1	SRR10692346	0.84	0.68	0.58	SAMN13246193	human gut metagenome Metagenome
L11079.1	SRR10692350	0.84	0.68	0.58	SAMN13246333	human gut metagenome Metagenome
L11079.1	SRR10692352	0.84	0.68	0.58	SAMN13246331	human gut metagenome Metagenome
L11079.1	SRR10692381	0.84	0.68	0.58	SAMN13246954	human gut metagenome Metagenome
L11079.1	SRR10692417	0.84	0.68	0.58	SAMN13246501	human gut metagenome Metagenome
L11079.1	SRR10692428	0.84	0.68	0.58	SAMN13246491	human gut metagenome Metagenome
L11079.1	SRR10692449	0.84	0.68	0.58	SAMN13246310	human gut metagenome Metagenome
L11079.1	SRR10692453	0.84	0.68	0.58	SAMN13246190	human gut metagenome Metagenome
L11079.1	SRR10692486	0.84	0.68	0.58	SAMN13246273	human gut metagenome Metagenome
L11079.1	SRR10692491	0.84	0.68	0.58	SAMN13247116	human gut metagenome Metagenome
L11079.1	SRR10692510	0.84	0.68	0.58	SAMN13247098	human gut metagenome Metagenome
L11079.1	SRR10692565	0.84	0.68	0.58	SAMN13246649	human gut metagenome Metagenome
L11079.1	SRR10692576	0.84	0.68	0.58	SAMN13246639	human gut metagenome Metagenome
L11079.1	SRR10692582	0.84	0.68	0.58	SAMN13246200	human gut metagenome Metagenome
L11079.1	SRR10692584	0.84	0.68	0.58	SAMN13246405	human gut metagenome Metagenome
L11079.1	SRR10692630	0.84	0.68	0.58	SAMN13247045	human gut metagenome Metagenome
L11079.1	SRR10692665	0.84	0.68	0.58	SAMN13246851	human gut metagenome Metagenome
L11079.1	SRR10692686	0.84	0.68	0.58	SAMN13246832	human gut metagenome Metagenome
L11079.1	SRR10692691	0.84	0.68	0.58	SAMN13246633	human gut metagenome Metagenome
L11079.1	SRR10692696	0.84	0.68	0.58	SAMN13246628	human gut metagenome Metagenome
L11079.1	SRR10692745	0.84	0.68	0.58	SAMN13246811	human gut metagenome Metagenome
L11079.1	SRR10692768	0.84	0.68	0.58	SAMN13247017	human gut metagenome Metagenome
L11079.1	SRR10692790	0.84	0.68	0.58	SAMN13246997	human gut metagenome Metagenome
L11079.1	SRR10692792	0.84	0.68	0.58	SAMN13246996	human gut metagenome Metagenome
L11079.1	SRR10692857	0.84	0.68	0.58	SAMN13246354	human gut metagenome Metagenome
L11079.1	SRR10692866	0.84	0.68	0.58	SAMN13246346	human gut metagenome Metagenome
L11079.1	SRR10692892	0.84	0.68	0.58	SAMN13246183	human gut metagenome Metagenome
L11079.1	SRR11412666	0.84	0.68	0.58	SAMN14445519	human gut metagenome Metagenome
L11079.1	SRR11412670	0.84	0.68	0.58	SAMN14445515	human gut metagenome Metagenome
L11079.1	SRR11412694	0.84	0.68	0.58	SAMN14445575	human gut metagenome Metagenome
L11079.1	SRR11412717	0.84	0.68	0.58	SAMN14445554	human gut metagenome Metagenome
L11079.1	SRR11412718	0.84	0.68	0.58	SAMN14445553	human gut metagenome Metagenome
L11079.1	SRR11412726	0.84	0.68	0.58	SAMN14445546	human gut metagenome Metagenome
L11079.1	SRR11412731	0.84	0.68	0.58	SAMN14445541	human gut metagenome Metagenome
L11079.1	SRR11412732	0.84	0.68	0.58	SAMN14445540	human gut metagenome Metagenome
L11079.1	SRR11412736	0.84	0.68	0.58	SAMN14445537	human gut metagenome Metagenome
L11079.1	SRR11412737	0.84	0.68	0.58	SAMN14445536	human gut metagenome Metagenome
L11079.1	SRR11412744	0.84	0.68	0.58	SAMN14445431	human gut metagenome Metagenome
L11079.1	SRR11412765	0.84	0.68	0.58	SAMN14445741	human gut metagenome Metagenome
L11079.1	SRR11412769	0.84	0.68	0.58	SAMN14445738	human gut metagenome Metagenome
L11079.1	SRR11412803	0.84	0.68	0.58	SAMN14445481	human gut metagenome Metagenome
L11079.1	SRR11412804	0.84	0.68	0.58	SAMN14445480	human gut metagenome Metagenome
L11079.1	SRR11412805	0.84	0.68	0.58	SAMN14445426	human gut metagenome Metagenome
L11079.1	SRR11412842	0.84	0.68	0.58	SAMN14445672	human gut metagenome Metagenome
L11079.1	SRR11412848	0.84	0.68	0.58	SAMN14445667	human gut metagenome Metagenome
L11079.1	SRR11412881	0.84	0.68	0.58	SAMN14445609	human gut metagenome Metagenome
L11079.1	SRR11412898	0.84	0.68	0.58	SAMN14445593	human gut metagenome Metagenome
L11079.1	SRR11412916	0.84	0.68	0.58	SAMN14445720	human gut metagenome Metagenome
L11079.1	SRR11412917	0.84	0.68	0.58	SAMN14445450	human gut metagenome Metagenome
L11079.1	SRR11412923	0.84	0.68	0.58	SAMN14445715	human gut metagenome Metagenome
L11079.1	SRR11412926	0.84	0.68	0.58	SAMN14445712	human gut metagenome Metagenome
L11079.1	SRR11412927	0.84	0.68	0.58	SAMN14445711	human gut metagenome Metagenome
L11079.1	SRR11412934	0.84	0.68	0.58	SAMN14445705	human gut metagenome Metagenome
L11079.1	SRR11412950	0.84	0.68	0.58	SAMN14445661	human gut metagenome Metagenome
L11079.1	SRR11412977	0.84	0.68	0.58	SAMN14445637	human gut metagenome Metagenome
L11079.1	SRR11412995	0.84	0.68	0.58	SAMN14445765	human gut metagenome Metagenome
L11079.1	SRR11413007	0.84	0.68	0.58	SAMN14445754	human gut metagenome Metagenome
L11079.1	SRR5106273	0.84	0.68	0.58	SAMN06115409	human gut metagenome Metagenome
L11079.1	SRR5106289	0.84	0.68	0.58	SAMN06115430	human gut metagenome Metagenome
L11079.1	SRR5580091	0.84	0.68	0.58	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR6367596	0.84	0.68	0.58	SAMN08159974	human gut metagenome Metagenome
L11079.1	SRR8146975	0.84	0.68	0.58	SAMN10285291	human gut metagenome Metagenome
L11079.1	SRR8146989	0.84	0.68	0.58	SAMN10285304	human gut metagenome Metagenome
L11079.1	SRR8506094	0.84	0.68	0.58	SAMN10845104	human gut metagenome Metagenome
L11079.1	SRR8506095	0.84	0.68	0.58	SAMN10845105	human gut metagenome Metagenome
L11079.1	SRR9264540	0.84	0.68	0.58	SAMN12011436	human gut metagenome Metagenome
L11079.1	SRR9264584	0.84	0.68	0.58	SAMN12011465	human gut metagenome Metagenome
L11079.1	SRR9264603	0.84	0.68	0.58	SAMN12011477	human gut metagenome Metagenome
L11079.1	SRR10330951	0.84	0.68	0.58	SAMN13088784	Human gut metagenome Raw sequence reads upon exercise intervention
L11079.1	SRR10330960	0.84	0.68	0.58	SAMN13088802	Human gut metagenome Raw sequence reads upon exercise intervention
L11079.1	SRR10330966	0.84	0.68	0.58	SAMN13088796	Human gut metagenome Raw sequence reads upon exercise intervention
L11079.1	SRR10333435	0.84	0.68	0.58	SAMN13091313	Human gut metagenome Raw sequence reads upon exercise intervention
L11079.1	SRR10342230	0.84	0.68	0.58	SAMN12874046	UNDERSTANDING THE MICROBIOLOGIC DYNAMICS OF CARBAPENEMASE-PRODUCING ORGANISMS IN HOSPITAL WASTEWATER PREMISE PLUMBING
L11079.1	SRR10394894	0.84	0.68	0.58	SAMN13195585	Metagenomics of human gut microbiota
L11079.1	SRR10403515	0.84	0.68	0.58	SAMN13221642	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403535	0.84	0.68	0.58	SAMN13221599	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403537	0.84	0.68	0.58	SAMN13221597	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403540	0.84	0.68	0.58	SAMN13221594	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403541	0.84	0.68	0.58	SAMN13221593	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403542	0.84	0.68	0.58	SAMN13221592	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403550	0.84	0.68	0.58	SAMN13221636	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403552	0.84	0.68	0.58	SAMN13221634	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403557	0.84	0.68	0.58	SAMN13221630	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10427831	0.84	0.68	0.58	SAMN13258167	Gut microbiome changes after bariatric surgery
L11079.1	SRR10489619	0.84	0.68	0.58	SAMN13326118	United States National Arboretum Microbial Observatory
L11079.1	SRR10489620	0.84	0.68	0.58	SAMN13326117	United States National Arboretum Microbial Observatory
L11079.1	SRR10489621	0.84	0.68	0.58	SAMN13326116	United States National Arboretum Microbial Observatory
L11079.1	SRR10489622	0.84	0.68	0.58	SAMN13326115	United States National Arboretum Microbial Observatory
L11079.1	SRR8126709	0.84	0.68	0.58	SAMN10340219	United States National Arboretum Microbial Observatory
L11079.1	SRR8126710	0.84	0.68	0.58	SAMN10340218	United States National Arboretum Microbial Observatory
L11079.1	SRR8126715	0.84	0.68	0.58	SAMN10340221	United States National Arboretum Microbial Observatory
L11079.1	SRR8126716	0.84	0.68	0.58	SAMN10340220	United States National Arboretum Microbial Observatory
L11079.1	SRR8126721	0.84	0.68	0.58	SAMN10340228	United States National Arboretum Microbial Observatory
L11079.1	SRR8126735	0.84	0.68	0.58	SAMN10340211	United States National Arboretum Microbial Observatory
L11079.1	SRR8126736	0.84	0.68	0.58	SAMN10340210	United States National Arboretum Microbial Observatory
L11079.1	SRR10479026	0.84	0.68	0.58	SAMN13315008	Intestinal microbiota metagenomic sequencing after taking L.p HNU082
L11079.1	SRR10479039	0.84	0.68	0.58	SAMN13314996	Intestinal microbiota metagenomic sequencing after taking L.p HNU082
L11079.1	SRR13205819	0.84	0.68	0.58	SAMN13931179	gut metagenome Raw sequence reads
L11079.1	SRR13205846	0.84	0.68	0.58	SAMN13931201	gut metagenome Raw sequence reads
L11079.1	SRR10507655	0.84	0.68	0.58	SAMN13351580	Gut microbiota composition associated with Clostridium difficile-positive diarrhea and C. difficile type in ICU patients
L11079.1	SRR10672841	0.84	0.68	0.58	SAMN13418693	Infant virome during the first year of life
L11079.1	SRR14770199	0.84	0.68	0.58	SAMN19607308	Infant virome during the first year of life
L11079.1	SRR14770205	0.84	0.68	0.58	SAMN19607302	Infant virome during the first year of life
L11079.1	SRR10681891	0.84	0.68	0.58	SAMN13252615	viral metagenome Metagenome
L11079.1	SRR10681977	0.84	0.68	0.58	SAMN13253245	viral metagenome Metagenome
L11079.1	SRR10682190	0.84	0.68	0.58	SAMN13252353	viral metagenome Metagenome
L11079.1	SRR10682354	0.84	0.68	0.58	SAMN13252387	viral metagenome Metagenome
L11079.1	SRR10682368	0.84	0.68	0.58	SAMN13252797	viral metagenome Metagenome
L11079.1	SRR10682376	0.84	0.68	0.58	SAMN13252385	viral metagenome Metagenome
L11079.1	SRR10682413	0.84	0.68	0.58	SAMN13252756	viral metagenome Metagenome
L11079.1	SRR10682433	0.84	0.68	0.58	SAMN13252739	viral metagenome Metagenome
L11079.1	SRR10682520	0.84	0.68	0.58	SAMN13252372	viral metagenome Metagenome
L11079.1	SRR5677784	0.84	0.68	0.58	SAMN06019337	viral metagenome Metagenome
L11079.1	SRR5677797	0.84	0.68	0.58	SAMN06019314	viral metagenome Metagenome
L11079.1	SRR5677844	0.84	0.68	0.58	SAMN06019312	viral metagenome Metagenome
L11079.1	SRR10680340	0.84	0.68	0.58	SAMN13509693	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680353	0.84	0.68	0.58	SAMN13509739	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680466	0.84	0.68	0.58	SAMN13509752	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680468	0.84	0.68	0.58	SAMN13509750	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680469	0.84	0.68	0.58	SAMN13509749	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680476	0.84	0.68	0.58	SAMN13509685	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680492	0.84	0.68	0.58	SAMN13509672	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680605	0.84	0.68	0.58	SAMN13509483	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680678	0.84	0.68	0.58	SAMN13509302	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680729	0.84	0.68	0.58	SAMN13509296	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680793	0.84	0.68	0.58	SAMN13509588	Human gut metagenomes from Hong Kong populations
L11079.1	SRR9037823	0.84	0.68	0.58	SAMN11615961	feces metagenome Raw sequence reads
L11079.1	SRR9037833	0.84	0.68	0.58	SAMN11615771	feces metagenome Raw sequence reads
L11079.1	SRR9037842	0.84	0.68	0.58	SAMN11616030	feces metagenome Raw sequence reads
L11079.1	SRR9037977	0.84	0.68	0.58	SAMN11615814	feces metagenome Raw sequence reads
L11079.1	SRR9038034	0.84	0.68	0.58	SAMN11615981	feces metagenome Raw sequence reads
L11079.1	SRR9038039	0.84	0.68	0.58	SAMN11615986	feces metagenome Raw sequence reads
L11079.1	SRR9038047	0.84	0.68	0.58	SAMN11615756	feces metagenome Raw sequence reads
L11079.1	SRR9038073	0.84	0.68	0.58	SAMN11616019	feces metagenome Raw sequence reads
L11079.1	SRR9038177	0.84	0.68	0.58	SAMN11615744	feces metagenome Raw sequence reads
L11079.1	SRR9075126	0.84	0.68	0.58	SAMN11664594	feces metagenome Raw sequence reads
L11079.1	SRR9098671	0.84	0.68	0.58	SAMN11792944	feces metagenome Raw sequence reads
L11079.1	SRR9098773	0.84	0.68	0.58	SAMN11792994	feces metagenome Raw sequence reads
L11079.1	SRR9128910	0.84	0.68	0.58	SAMN11864367	feces metagenome Raw sequence reads
L11079.1	SRR9128952	0.84	0.68	0.58	SAMN11864492	feces metagenome Raw sequence reads
L11079.1	SRR9128987	0.84	0.68	0.58	SAMN11864365	feces metagenome Raw sequence reads
L11079.1	SRR10739574	0.84	0.68	0.58	SAMN13632795	Gut microbiome of Thai adults
L11079.1	SRR10744119	0.84	0.68	0.58	SAMN13634758	Toothbrush Microbiome Project
L11079.1	SRR10761724	0.84	0.68	0.58	SAMN13674617	wastewater Metagenome
L11079.1	SRR12404961	0.84	0.68	0.58	SAMN15090776	wastewater Metagenome
L11079.1	SRR10816056	0.84	0.68	0.58	SAMN13705535	Elderly Gut Microbiota FMM
L11079.1	SRR10870012	0.84	0.68	0.58	SAMN13810520	Dysbiosis-induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation (shotgun metagenomics)
L11079.1	SRR10902853	0.84	0.68	0.58	SAMN13871941	Metatranscriptomics raw data of gut microbiota of giant panda
L11079.1	SRR10902858	0.84	0.68	0.58	SAMN13871936	Metatranscriptomics raw data of gut microbiota of giant panda
L11079.1	SRR3928385	0.84	0.68	0.58	SAMN05361753	wastewater metagenome Raw sequence reads
L11079.1	SRR5630628	0.84	0.68	0.58	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR5630640	0.84	0.68	0.58	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR5630642	0.84	0.68	0.58	SAMN05361757	wastewater metagenome Raw sequence reads
L11079.1	SRR10989975	0.84	0.68	0.58	SAMN13938662	Oncom Microbiome
L11079.1	SRR10989976	0.84	0.68	0.58	SAMN13938661	Oncom Microbiome
L11079.1	SRR11036331	0.84	0.68	0.58	SAMN14054044	Metagenome analysis of tempeh
L11079.1	SRR11036332	0.84	0.68	0.58	SAMN14054043	Metagenome analysis of tempeh
L11079.1	SRR11088470	0.84	0.68	0.58	SAMN14069962	ANTIRES - Distribution pathways of antibiotic resistances in municipal wastewater
L11079.1	SRR11073032	0.84	0.68	0.58	SAMN14087325	Comparison of methods to collect fecal samples for microbiome studies using whole-genome shotgun metagenomic sequencing
L11079.1	SRR11146741	0.84	0.68	0.58	SAMN14164010	CRC cohort, Hainan, China
L11079.1	SRR11146743	0.84	0.68	0.58	SAMN14164008	CRC cohort, Hainan, China
L11079.1	SRR11174378	0.84	0.68	0.58	SAMN14144073	CRC shotgun metagenomic sequences, Hainan, China
L11079.1	SRR11174380	0.84	0.68	0.58	SAMN14144071	CRC shotgun metagenomic sequences, Hainan, China
L11079.1	SRR11207283	0.84	0.68	0.58	SAMN14178254	Impact of DNA extraction method on variation in human and built environment microbial community and functional profiles
L11079.1	SRR11236263	0.84	0.68	0.58	SAMN14271010	Human gut microbiome Raw sequence reads
L11079.1	SRR11236276	0.84	0.68	0.58	SAMN14270998	Human gut microbiome Raw sequence reads
L11079.1	SRR11267061	0.84	0.68	0.58	SAMN13742515	Gut microbiome of honey bees in china
L11079.1	SRR11267062	0.84	0.68	0.58	SAMN13742514	Gut microbiome of honey bees in china
L11079.1	SRR11277018	0.84	0.68	0.58	SAMN14121886	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277057	0.84	0.68	0.58	SAMN14121775	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277058	0.84	0.68	0.58	SAMN14121774	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277059	0.84	0.68	0.58	SAMN14121773	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277278	0.84	0.68	0.58	SAMN14121729	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277279	0.84	0.68	0.58	SAMN14121728	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11294824	0.84	0.68	0.58	SAMN14366096	Impact of Intestinal Parasites on Microbiota and Cobalamin Gene Sequences
L11079.1	SRR14092189	0.84	0.68	0.58	SAMN07560402	The role of Enterococcus in allo-HCT patient outcome
L11079.1	SRR14092265	0.84	0.68	0.58	SAMN07491267	The role of Enterococcus in allo-HCT patient outcome
L11079.1	SRR11599077	0.84	0.68	0.58	SAMN14680472	Linking strain engraftment in fecal microbiota transplantation with maintenance of remission in Crohn's disease
L11079.1	SRR11602155	0.84	0.68	0.58	SAMN14652850	Metagenome (DNAseq) of fermented cocoa beans Criollo and Forastero from Mexico
L11079.1	SRR6231153	0.84	0.68	0.58	SAMN07839283	Urban Enviromental Genomics Project
L11079.1	SRR6231169	0.84	0.68	0.58	SAMN07839292	Urban Enviromental Genomics Project
L11079.1	SRR6231178	0.84	0.68	0.58	SAMN07839306	Urban Enviromental Genomics Project
L11079.1	SRR6231185	0.84	0.68	0.58	SAMN07839314	Urban Enviromental Genomics Project
L11079.1	SRR6231191	0.84	0.68	0.58	SAMN07839316	Urban Enviromental Genomics Project
L11079.1	SRR6231194	0.84	0.68	0.58	SAMN07839251	Urban Enviromental Genomics Project
L11079.1	SRR6231213	0.84	0.68	0.58	SAMN07839327	Urban Enviromental Genomics Project
L11079.1	SRR11648354	0.84	0.68	0.58	SAMN14775291	Metabolic recovery with eculizumab precision therapy of CHAPLE disease
L11079.1	SRR11649946	0.84	0.68	0.58	SAMN14582992	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11649972	0.84	0.68	0.58	SAMN14582964	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11649985	0.84	0.68	0.58	SAMN14582935	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11650018	0.84	0.68	0.58	SAMN14582966	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11679820	0.84	0.68	0.58	SAMN14560184	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679833	0.84	0.68	0.58	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679834	0.84	0.68	0.58	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679843	0.84	0.68	0.58	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679852	0.84	0.68	0.58	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679858	0.84	0.68	0.58	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679870	0.84	0.68	0.58	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679879	0.84	0.68	0.58	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679889	0.84	0.68	0.58	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679890	0.84	0.68	0.58	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679897	0.84	0.68	0.58	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679913	0.84	0.68	0.58	SAMN14560237	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679918	0.84	0.68	0.58	SAMN14560233	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11817660	0.84	0.68	0.58	SAMN14968779	Metagenomic sequencing of bio-clogging
L11079.1	SRR11822237	0.84	0.68	0.58	SAMN14968372	human viral metagenome Raw sequence reads
L11079.1	SRR11835830	0.84	0.68	0.58	SAMN15002982	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835839	0.84	0.68	0.58	SAMN15002956	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835845	0.84	0.68	0.58	SAMN15003050	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835848	0.84	0.68	0.58	SAMN15003047	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835858	0.84	0.68	0.58	SAMN15003038	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835882	0.84	0.68	0.58	SAMN15003100	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835884	0.84	0.68	0.58	SAMN15003098	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835886	0.84	0.68	0.58	SAMN15003096	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835893	0.84	0.68	0.58	SAMN15003090	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835896	0.84	0.68	0.58	SAMN15003087	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835912	0.84	0.68	0.58	SAMN15003022	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835926	0.84	0.68	0.58	SAMN15003009	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835930	0.84	0.68	0.58	SAMN15003005	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835935	0.84	0.68	0.58	SAMN15003001	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835957	0.84	0.68	0.58	SAMN15003064	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835962	0.84	0.68	0.58	SAMN15003060	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11927820	0.84	0.68	0.58	SAMN15103581	Dysbiosis in metabolic genes of the gut microbiomes of patients with a Pouch
L11079.1	SRR11927863	0.84	0.68	0.58	SAMN15103542	Dysbiosis in metabolic genes of the gut microbiomes of patients with a Pouch
L11079.1	SRR11927879	0.84	0.68	0.58	SAMN15103527	Dysbiosis in metabolic genes of the gut microbiomes of patients with a Pouch
L11079.1	SRR13759987	0.84	0.68	0.58	SAMN18024160	Dysbiosis in metabolic genes of the gut microbiomes of patients with a Pouch
L11079.1	SRR11941579	0.84	0.68	0.58	SAMN15156541	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941611	0.84	0.68	0.58	SAMN15156512	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941619	0.84	0.68	0.58	SAMN15156504	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR1449325	0.84	0.68	0.58	SAMN02676171	C.diff FMT
L11079.1	SRR1449561	0.84	0.68	0.58	SAMN02676171	C.diff FMT
L11079.1	SRR1462469	0.84	0.68	0.58	SAMN02676169	C.diff FMT
L11079.1	SRR1462494	0.84	0.68	0.58	SAMN02676171	C.diff FMT
L11079.1	SRR1462692	0.84	0.68	0.58	SAMN02676171	C.diff FMT
L11079.1	SRR1491415	0.84	0.68	0.58	SAMN02676171	C.diff FMT
L11079.1	SRR1491526	0.84	0.68	0.58	SAMN02676171	C.diff FMT
L11079.1	SRR1491685	0.84	0.68	0.58	SAMN02676171	C.diff FMT
L11079.1	SRR1491713	0.84	0.68	0.58	SAMN02676171	C.diff FMT
L11079.1	SRR12021143	0.84	0.68	0.58	SAMN15235736	24 samples of metagenomics  sequencing on dairy cows
L11079.1	SRR12021154	0.84	0.68	0.58	SAMN15235735	24 samples of metagenomics  sequencing on dairy cows
L11079.1	SRR12101434	0.84	0.68	0.58	SAMN15357196	Characterizing the gut DNA and RNA viromes in a population of Chinese residents and visiting Pakistanis
L11079.1	SRR12101441	0.84	0.68	0.58	SAMN15357190	Characterizing the gut DNA and RNA viromes in a population of Chinese residents and visiting Pakistanis
L11079.1	SRR6429802	0.84	0.68	0.58	SAMN08275688	wastewater metagenome Metagenome
L11079.1	SRR12113947	0.84	0.68	0.58	SAMN15397151	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12113948	0.84	0.68	0.58	SAMN15397151	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12113949	0.84	0.68	0.58	SAMN15397151	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12113953	0.84	0.68	0.58	SAMN15397151	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12113954	0.84	0.68	0.58	SAMN15397151	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12113974	0.84	0.68	0.58	SAMN15397151	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12113978	0.84	0.68	0.58	SAMN15397151	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114445	0.84	0.68	0.58	SAMN15397206	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114735	0.84	0.68	0.58	SAMN15397060	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114736	0.84	0.68	0.58	SAMN15397060	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114737	0.84	0.68	0.58	SAMN15397060	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114740	0.84	0.68	0.58	SAMN15397060	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114755	0.84	0.68	0.58	SAMN15397060	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114757	0.84	0.68	0.58	SAMN15397060	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114758	0.84	0.68	0.58	SAMN15397060	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114766	0.84	0.68	0.58	SAMN15397060	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114767	0.84	0.68	0.58	SAMN15397061	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114824	0.84	0.68	0.58	SAMN15397137	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114827	0.84	0.68	0.58	SAMN15397065	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114871	0.84	0.68	0.58	SAMN15397083	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114928	0.84	0.68	0.58	SAMN15397174	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114953	0.84	0.68	0.58	SAMN15397174	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114955	0.84	0.68	0.58	SAMN15397066	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115167	0.84	0.68	0.58	SAMN15397137	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12121909	0.84	0.68	0.58	SAMN15397109	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12121982	0.84	0.68	0.58	SAMN15397109	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122019	0.84	0.68	0.58	SAMN15397090	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122061	0.84	0.68	0.58	SAMN15397092	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122085	0.84	0.68	0.58	SAMN15397092	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122151	0.84	0.68	0.58	SAMN15397092	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122181	0.84	0.68	0.58	SAMN15397092	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122187	0.84	0.68	0.58	SAMN15397097	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122188	0.84	0.68	0.58	SAMN15397097	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122189	0.84	0.68	0.58	SAMN15397097	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122190	0.84	0.68	0.58	SAMN15397097	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122191	0.84	0.68	0.58	SAMN15397097	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122192	0.84	0.68	0.58	SAMN15397097	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122193	0.84	0.68	0.58	SAMN15397097	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122194	0.84	0.68	0.58	SAMN15397097	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122195	0.84	0.68	0.58	SAMN15397097	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122196	0.84	0.68	0.58	SAMN15397097	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122198	0.84	0.68	0.58	SAMN15397097	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122199	0.84	0.68	0.58	SAMN15397097	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122254	0.84	0.68	0.58	SAMN15397092	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122259	0.84	0.68	0.58	SAMN15397092	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122299	0.84	0.68	0.58	SAMN15397092	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122311	0.84	0.68	0.58	SAMN15397092	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122312	0.84	0.68	0.58	SAMN15397198	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122317	0.84	0.68	0.58	SAMN15397198	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122351	0.84	0.68	0.58	SAMN15397092	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122356	0.84	0.68	0.58	SAMN15397090	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122374	0.84	0.68	0.58	SAMN15397113	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122376	0.84	0.68	0.58	SAMN15397113	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122378	0.84	0.68	0.58	SAMN15397113	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122379	0.84	0.68	0.58	SAMN15397113	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122382	0.84	0.68	0.58	SAMN15397113	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122398	0.84	0.68	0.58	SAMN15397113	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122401	0.84	0.68	0.58	SAMN15397113	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122402	0.84	0.68	0.58	SAMN15397189	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122403	0.84	0.68	0.58	SAMN15397189	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122404	0.84	0.68	0.58	SAMN15397189	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122408	0.84	0.68	0.58	SAMN15397189	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122410	0.84	0.68	0.58	SAMN15397189	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122423	0.84	0.68	0.58	SAMN15397090	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122449	0.84	0.68	0.58	SAMN15397090	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122467	0.84	0.68	0.58	SAMN15397189	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122468	0.84	0.68	0.58	SAMN15397189	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122469	0.84	0.68	0.58	SAMN15397189	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122470	0.84	0.68	0.58	SAMN15397189	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122487	0.84	0.68	0.58	SAMN15397090	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122496	0.84	0.68	0.58	SAMN15397092	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122514	0.84	0.68	0.58	SAMN15397090	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122585	0.84	0.68	0.58	SAMN15397184	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122592	0.84	0.68	0.58	SAMN15397090	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122605	0.84	0.68	0.58	SAMN15397092	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122617	0.84	0.68	0.58	SAMN15397092	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122627	0.84	0.68	0.58	SAMN15397092	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122671	0.84	0.68	0.58	SAMN15397090	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122714	0.84	0.68	0.58	SAMN15397090	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122761	0.84	0.68	0.58	SAMN15397090	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122769	0.84	0.68	0.58	SAMN15397123	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122801	0.84	0.68	0.58	SAMN15397090	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12120988	0.84	0.68	0.58	SAMN15393542	Gut microbiome of subjects with inflammatory bowel disease undergoing diet intervention
L11079.1	SRR12120999	0.84	0.68	0.58	SAMN15393532	Gut microbiome of subjects with inflammatory bowel disease undergoing diet intervention
L11079.1	SRR12137104	0.84	0.68	0.58	SAMN15428688	FMT for diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma
L11079.1	SRR12149291	0.84	0.68	0.58	SAMN15455273	Shotgun metagenomic sequencing of sludge in A2O and AO processes in a full-scale WWTP
L11079.1	SRR12158959	0.84	0.68	0.58	SAMN15422842	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159060	0.84	0.68	0.58	SAMN15422751	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159076	0.84	0.68	0.58	SAMN15422736	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159151	0.84	0.68	0.58	SAMN15422668	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159222	0.84	0.68	0.58	SAMN15422605	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159251	0.84	0.68	0.58	SAMN15422492	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159253	0.84	0.68	0.58	SAMN15422490	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159258	0.84	0.68	0.58	SAMN15422378	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159260	0.84	0.68	0.58	SAMN15422484	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159283	0.84	0.68	0.58	SAMN15422579	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159351	0.84	0.68	0.58	SAMN15422518	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159352	0.84	0.68	0.58	SAMN15422517	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159355	0.84	0.68	0.58	SAMN15422515	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159389	0.84	0.68	0.58	SAMN15422375	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159434	0.84	0.68	0.58	SAMN15422946	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159442	0.84	0.68	0.58	SAMN15422939	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159460	0.84	0.68	0.58	SAMN15422923	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234414	0.84	0.68	0.58	SAMN15422224	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234415	0.84	0.68	0.58	SAMN15422223	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234475	0.84	0.68	0.58	SAMN15422168	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234508	0.84	0.68	0.58	SAMN15422139	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234520	0.84	0.68	0.58	SAMN15422128	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234591	0.84	0.68	0.58	SAMN15421768	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234627	0.84	0.68	0.58	SAMN15422032	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234639	0.84	0.68	0.58	SAMN15422021	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234642	0.84	0.68	0.58	SAMN15422018	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234807	0.84	0.68	0.58	SAMN15422354	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234860	0.84	0.68	0.58	SAMN15421902	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234903	0.84	0.68	0.58	SAMN15421892	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234974	0.84	0.68	0.58	SAMN15422261	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12170288	0.84	0.68	0.58	SAMN15471055	Metagenomic Sequencing of Stool Samples in Bangladeshi Infants: Virome Association with Poliovirus Shedding After Oral Poliovirus Vaccination
L11079.1	SRR12180960	0.84	0.68	0.58	SAMN15488352	Honeybee gut microbiome
L11079.1	SRR12302539	0.84	0.68	0.58	SAMN04108679	infant gut Targeted Locus (Loci)
L11079.1	SRR12302595	0.84	0.68	0.58	SAMN09515586	infant gut Targeted Locus (Loci)
L11079.1	SRR12302680	0.84	0.68	0.58	SAMN09206805	infant gut Targeted Locus (Loci)
L11079.1	SRR12302699	0.84	0.68	0.58	SAMN15567732	infant gut Targeted Locus (Loci)
L11079.1	SRR12324959	0.84	0.68	0.58	SAMN15643100	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12324980	0.84	0.68	0.58	SAMN15643081	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12325010	0.84	0.68	0.58	SAMN15643054	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12325012	0.84	0.68	0.58	SAMN15643052	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12325031	0.84	0.68	0.58	SAMN15643035	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12325032	0.84	0.68	0.58	SAMN15643034	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12325043	0.84	0.68	0.58	SAMN15643024	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12326578	0.84	0.68	0.58	SAMN15637140	Cassava leaf microbiome and ions
L11079.1	SRR12326579	0.84	0.68	0.58	SAMN15637068	Cassava leaf microbiome and ions
L11079.1	SRR12326580	0.84	0.68	0.58	SAMN15637139	Cassava leaf microbiome and ions
L11079.1	SRR12326581	0.84	0.68	0.58	SAMN15637138	Cassava leaf microbiome and ions
L11079.1	SRR12326583	0.84	0.68	0.58	SAMN15637136	Cassava leaf microbiome and ions
L11079.1	SRR12326584	0.84	0.68	0.58	SAMN15637135	Cassava leaf microbiome and ions
L11079.1	SRR12326588	0.84	0.68	0.58	SAMN15637131	Cassava leaf microbiome and ions
L11079.1	SRR12326590	0.84	0.68	0.58	SAMN15637067	Cassava leaf microbiome and ions
L11079.1	SRR12326591	0.84	0.68	0.58	SAMN15637129	Cassava leaf microbiome and ions
L11079.1	SRR12326595	0.84	0.68	0.58	SAMN15637125	Cassava leaf microbiome and ions
L11079.1	SRR12326596	0.84	0.68	0.58	SAMN15637124	Cassava leaf microbiome and ions
L11079.1	SRR12326597	0.84	0.68	0.58	SAMN15637123	Cassava leaf microbiome and ions
L11079.1	SRR12326601	0.84	0.68	0.58	SAMN15637066	Cassava leaf microbiome and ions
L11079.1	SRR12326602	0.84	0.68	0.58	SAMN15637119	Cassava leaf microbiome and ions
L11079.1	SRR12326603	0.84	0.68	0.58	SAMN15637118	Cassava leaf microbiome and ions
L11079.1	SRR12326604	0.84	0.68	0.58	SAMN15637117	Cassava leaf microbiome and ions
L11079.1	SRR12326606	0.84	0.68	0.58	SAMN15637115	Cassava leaf microbiome and ions
L11079.1	SRR12326607	0.84	0.68	0.58	SAMN15637114	Cassava leaf microbiome and ions
L11079.1	SRR12326613	0.84	0.68	0.58	SAMN15637109	Cassava leaf microbiome and ions
L11079.1	SRR12326617	0.84	0.68	0.58	SAMN15637105	Cassava leaf microbiome and ions
L11079.1	SRR12326618	0.84	0.68	0.58	SAMN15637104	Cassava leaf microbiome and ions
L11079.1	SRR12326619	0.84	0.68	0.58	SAMN15637103	Cassava leaf microbiome and ions
L11079.1	SRR12326620	0.84	0.68	0.58	SAMN15637102	Cassava leaf microbiome and ions
L11079.1	SRR12326622	0.84	0.68	0.58	SAMN15637100	Cassava leaf microbiome and ions
L11079.1	SRR12326624	0.84	0.68	0.58	SAMN15637099	Cassava leaf microbiome and ions
L11079.1	SRR12326628	0.84	0.68	0.58	SAMN15637095	Cassava leaf microbiome and ions
L11079.1	SRR12326629	0.84	0.68	0.58	SAMN15637094	Cassava leaf microbiome and ions
L11079.1	SRR12326630	0.84	0.68	0.58	SAMN15637093	Cassava leaf microbiome and ions
L11079.1	SRR12326631	0.84	0.68	0.58	SAMN15637092	Cassava leaf microbiome and ions
L11079.1	SRR12326645	0.84	0.68	0.58	SAMN15637062	Cassava leaf microbiome and ions
L11079.1	SRR12326650	0.84	0.68	0.58	SAMN15637075	Cassava leaf microbiome and ions
L11079.1	SRR12328921	0.84	0.68	0.58	SAMN15064762	Gut microbiome alterations and longitudinal kinetics in COVID-19 patients
L11079.1	SRR12328940	0.84	0.68	0.58	SAMN15064807	Gut microbiome alterations and longitudinal kinetics in COVID-19 patients
L11079.1	SRR12344402	0.84	0.68	0.58	SAMN15663463	Hi-C and metagenomic sequencing of neutropenic patient microbiomes
L11079.1	SRR12344403	0.84	0.68	0.58	SAMN15663462	Hi-C and metagenomic sequencing of neutropenic patient microbiomes
L11079.1	SRR12344404	0.84	0.68	0.58	SAMN15663461	Hi-C and metagenomic sequencing of neutropenic patient microbiomes
L11079.1	SRR12344405	0.84	0.68	0.58	SAMN15663460	Hi-C and metagenomic sequencing of neutropenic patient microbiomes
L11079.1	SRR12344450	0.84	0.68	0.58	SAMN15663462	Hi-C and metagenomic sequencing of neutropenic patient microbiomes
L11079.1	SRR12344451	0.84	0.68	0.58	SAMN15663461	Hi-C and metagenomic sequencing of neutropenic patient microbiomes
L11079.1	SRR12344453	0.84	0.68	0.58	SAMN15663460	Hi-C and metagenomic sequencing of neutropenic patient microbiomes
L11079.1	SRR12366594	0.84	0.68	0.58	SAMN15501353	A metagenomic survey about rhizosphere and root samples from plantains and bananas
L11079.1	SRR12366598	0.84	0.68	0.58	SAMN15501328	A metagenomic survey about rhizosphere and root samples from plantains and bananas
L11079.1	SRR12459398	0.84	0.68	0.58	SAMN15824805	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12459541	0.84	0.68	0.58	SAMN15824877	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12459582	0.84	0.68	0.58	SAMN15824724	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12459593	0.84	0.68	0.58	SAMN15824714	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12477619	0.84	0.68	0.58	SAMN15854655	Delivery mode impacts newborn gut colonization efficiency
L11079.1	SRR12506185	0.84	0.68	0.58	SAMN15890728	gut microbiome shifts associated with Henoch-Schonlein purpura
L11079.1	SRR12529213	0.84	0.68	0.58	SAMN15830092	An integrated gene catalog and over 10,000 metagenome-assembled genomes from the gastrointestinal microbiome of ruminants
L11079.1	SRR12611921	0.84	0.68	0.58	SAMN15739010	Hydraulically fractured gas well metagenomes
L11079.1	SRR12640727	0.84	0.68	0.58	SAMN16132430	Shotgun metabarcoding of traditional herbal products
L11079.1	SRR12640730	0.84	0.68	0.58	SAMN16132427	Shotgun metabarcoding of traditional herbal products
L11079.1	SRR12632044	0.84	0.68	0.58	SAMN16073638	Treated Wastewater and Soil Meta-genomic Samples
L11079.1	SRR12650320	0.84	0.68	0.58	SAMN16175928	External validation cohorts for CRC-SNP analysis
L11079.1	SRR12650322	0.84	0.68	0.58	SAMN16175926	External validation cohorts for CRC-SNP analysis
L11079.1	SRR12676610	0.84	0.68	0.58	SAMN16175928	External validation cohorts for CRC-SNP analysis
L11079.1	SRR12676612	0.84	0.68	0.58	SAMN16175926	External validation cohorts for CRC-SNP analysis
L11079.1	SRR1535332	0.84	0.68	0.58	SAMN02930023	Human gut Targeted Locus (Loci)
L11079.1	SRR1535356	0.84	0.68	0.58	SAMN02930047	Human gut Targeted Locus (Loci)
L11079.1	SRR1535384	0.84	0.68	0.58	SAMN02930075	Human gut Targeted Locus (Loci)
L11079.1	SRR1535394	0.84	0.68	0.58	SAMN02930085	Human gut Targeted Locus (Loci)
L11079.1	SRR12711231	0.84	0.68	0.58	SAMN15870975	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12730852	0.84	0.68	0.58	SAMN16273814	WGS of feces and saliva of pancreatic cancer patients
L11079.1	SRR12736322	0.84	0.68	0.58	SAMN16286591	Gut bacteriophages in Clostridioides difficile patients and fecal microbiota transplantation donors
L11079.1	SRR12762289	0.84	0.68	0.58	SAMN16295594	Metagenomic profiling of antibiotic resistance genes and mobile genetic elements
L11079.1	SRR12762307	0.84	0.68	0.58	SAMN16295578	Metagenomic profiling of antibiotic resistance genes and mobile genetic elements
L11079.1	SRR12762317	0.84	0.68	0.58	SAMN16295570	Metagenomic profiling of antibiotic resistance genes and mobile genetic elements
L11079.1	SRR12802555	0.84	0.68	0.58	SAMN16401244	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802561	0.84	0.68	0.58	SAMN16401320	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802579	0.84	0.68	0.58	SAMN16401272	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802602	0.84	0.68	0.58	SAMN16401209	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802611	0.84	0.68	0.58	SAMN16401333	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802639	0.84	0.68	0.58	SAMN16401347	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802646	0.84	0.68	0.58	SAMN16401341	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802647	0.84	0.68	0.58	SAMN16401340	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802655	0.84	0.68	0.58	SAMN16401311	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12874582	0.84	0.68	0.58	SAMN16502439	Within-host evolution of Vibrio cholerae using metagenomics
L11079.1	SRR12874586	0.84	0.68	0.58	SAMN16502436	Within-host evolution of Vibrio cholerae using metagenomics
L11079.1	SRR12898783	0.84	0.68	0.58	SAMN16515077	Apis mellifera mellifera Metagenomic assembly
L11079.1	SRR12917028	0.84	0.68	0.58	SAMN16575667	Surveillance of ARGs in Environmental Waters
L11079.1	SRR12917040	0.84	0.68	0.58	SAMN16575660	Surveillance of ARGs in Environmental Waters
L11079.1	SRR12917049	0.84	0.68	0.58	SAMN16575669	Surveillance of ARGs in Environmental Waters
L11079.1	SRR12917052	0.84	0.68	0.58	SAMN16575658	Surveillance of ARGs in Environmental Waters
L11079.1	SRR12961164	0.84	0.68	0.58	SAMN16598102	Human gut microbes Metagenome
L11079.1	SRR12973191	0.84	0.68	0.58	SAMN16630116	Shorgun metagenomics of T2DM human gut microbes associated with FMT
L11079.1	SRR12973198	0.84	0.68	0.58	SAMN16630108	Shorgun metagenomics of T2DM human gut microbes associated with FMT
L11079.1	SRR12973205	0.84	0.68	0.58	SAMN16630122	Shorgun metagenomics of T2DM human gut microbes associated with FMT
L11079.1	SRR13004617	0.84	0.68	0.58	SAMN16701350	Role of Diet in the Reconstitution of the Human Gut Microbiome and its Metabolome
L11079.1	SRR13004936	0.84	0.68	0.58	SAMN16701489	Role of Diet in the Reconstitution of the Human Gut Microbiome and its Metabolome
L11079.1	SRR13004937	0.84	0.68	0.58	SAMN16701488	Role of Diet in the Reconstitution of the Human Gut Microbiome and its Metabolome
L11079.1	SRR13060185	0.84	0.68	0.58	SAMN16679086	Microbiota Restoration Reduces Antibiotic Resistant Bacteria Gut Colonization in Patients with Recurrent Clostridioides difficile Infection from the Open-Label PUNCH CD Study
L11079.1	SRR13061040	0.84	0.68	0.58	SAMN16796253	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13061047	0.84	0.68	0.58	SAMN16796149	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13068830	0.84	0.68	0.58	SAMN16811188	Fecal microbiota transplantation modulates immunotherapy response in refractory metastatic melanoma patients
L11079.1	SRR13068849	0.84	0.68	0.58	SAMN16811197	Fecal microbiota transplantation modulates immunotherapy response in refractory metastatic melanoma patients
L11079.1	SRR13077688	0.84	0.68	0.58	SAMN15723026	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077701	0.84	0.68	0.58	SAMN15723014	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077727	0.84	0.68	0.58	SAMN15723096	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077781	0.84	0.68	0.58	SAMN15723045	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077836	0.84	0.68	0.58	SAMN15723186	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077856	0.84	0.68	0.58	SAMN15722998	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077872	0.84	0.68	0.58	SAMN15723154	Gut metagenomes of patients with COVID-19
L11079.1	SRR13083088	0.84	0.68	0.58	SAMN16830175	Whole-metagenome shotgun sequencing of human feces
L11079.1	SRR13083090	0.84	0.68	0.58	SAMN16830173	Whole-metagenome shotgun sequencing of human feces
L11079.1	SRR13200786	0.84	0.68	0.58	SAMN17005043	Gut virome in necrotizing enterocolitis
L11079.1	SRR13200791	0.84	0.68	0.58	SAMN17004958	Gut virome in necrotizing enterocolitis
L11079.1	SRR13200817	0.84	0.68	0.58	SAMN17005015	Gut virome in necrotizing enterocolitis
L11079.1	SRR13200838	0.84	0.68	0.58	SAMN17004996	Gut virome in necrotizing enterocolitis
L11079.1	SRR13200902	0.84	0.68	0.58	SAMN17005061	Gut virome in necrotizing enterocolitis
L11079.1	SRR13200903	0.84	0.68	0.58	SAMN17005060	Gut virome in necrotizing enterocolitis
L11079.1	SRR13200913	0.84	0.68	0.58	SAMN17005051	Gut virome in necrotizing enterocolitis
L11079.1	SRR13208894	0.84	0.68	0.58	SAMN17016677	Christiansburg WWTP
L11079.1	SRR13697099	0.84	0.68	0.58	SAMN07560774	Microbiota of allo-HSCT patients and in the setting of Autologous Fecal Microbiota Transplant (auto-FMT) at MSKCC Raw sequence reads
L11079.1	SRR13697141	0.84	0.68	0.58	SAMN07560378	Microbiota of allo-HSCT patients and in the setting of Autologous Fecal Microbiota Transplant (auto-FMT) at MSKCC Raw sequence reads
L11079.1	SRR13697192	0.84	0.68	0.58	SAMN07560408	Microbiota of allo-HSCT patients and in the setting of Autologous Fecal Microbiota Transplant (auto-FMT) at MSKCC Raw sequence reads
L11079.1	SRR13279595	0.84	0.68	0.58	SAMN17126278	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279598	0.84	0.68	0.58	SAMN17126281	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279603	0.84	0.68	0.58	SAMN17126286	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279612	0.84	0.68	0.58	SAMN17126294	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279649	0.84	0.68	0.58	SAMN17126327	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279675	0.84	0.68	0.58	SAMN17126187	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279677	0.84	0.68	0.58	SAMN17126189	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279697	0.84	0.68	0.58	SAMN17126209	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279716	0.84	0.68	0.58	SAMN17126173	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279733	0.84	0.68	0.58	SAMN17126242	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13287424	0.84	0.68	0.58	SAMN17132283	environmental microorganisms from municipal WWTP effluent and river
L11079.1	SRR13300677	0.84	0.68	0.58	SAMN17082975	Multi-omics suggest diverse mechanisms for response to biologic therapies in IBD
L11079.1	SRR13300684	0.84	0.68	0.58	SAMN17082937	Multi-omics suggest diverse mechanisms for response to biologic therapies in IBD
L11079.1	SRR13318106	0.84	0.68	0.58	SAMN17171398	Netherland Travelers
L11079.1	SRR13318322	0.84	0.68	0.58	SAMN17171457	Netherland Travelers
L11079.1	SRR13318323	0.84	0.68	0.58	SAMN17171458	Netherland Travelers
L11079.1	SRR13318387	0.84	0.68	0.58	SAMN17171237	Netherland Travelers
L11079.1	SRR13318428	0.84	0.68	0.58	SAMN17171480	Netherland Travelers
L11079.1	SRR13318520	0.84	0.68	0.58	SAMN17170054	Role of synbiotics to prevalence of LRTinfections in infants:gut metagenomic analysis
L11079.1	SRR13327440	0.84	0.68	0.58	SAMN17126026	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327483	0.84	0.68	0.58	SAMN17126049	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327486	0.84	0.68	0.58	SAMN17126047	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327495	0.84	0.68	0.58	SAMN17126021	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327500	0.84	0.68	0.58	SAMN17126034	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327522	0.84	0.68	0.58	SAMN17126030	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327542	0.84	0.68	0.58	SAMN17126112	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327543	0.84	0.68	0.58	SAMN17126111	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13336826	0.84	0.68	0.58	SAMN17190450	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336844	0.84	0.68	0.58	SAMN17190413	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336887	0.84	0.68	0.58	SAMN17190452	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336899	0.84	0.68	0.58	SAMN17190473	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336940	0.84	0.68	0.58	SAMN17190489	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13348578	0.84	0.68	0.58	SAMN17126966	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348714	0.84	0.68	0.58	SAMN17127006	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348720	0.84	0.68	0.58	SAMN17127000	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348808	0.84	0.68	0.58	SAMN17127208	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348867	0.84	0.68	0.58	SAMN17127155	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13355627	0.84	0.68	0.58	SAMN17167479	Comparative shotgun metagenomics used in the assessment of the resistome, pathogens and their ecological control modes in full-scale urban wastewater membrane bioreactor and conventional activated sludge treatment plants
L11079.1	SRR13378555	0.84	0.68	0.58	SAMN17250508	Human Gut Microbiomes from Burkina Faso
L11079.1	SRR13378577	0.84	0.68	0.58	SAMN17250488	Human Gut Microbiomes from Burkina Faso
L11079.1	SRR13378623	0.84	0.68	0.58	SAMN17250429	Human Gut Microbiomes from Burkina Faso
L11079.1	SRR6907999	0.84	0.68	0.58	SAMN08804322	Innate, Transcriptomic, and Microbiomic Correlates of Tuberculosis Infection and Disease
L11079.1	SRR13436228	0.84	0.68	0.58	SAMN17006451	human gut microbiome predicts response to MTX treatment
L11079.1	SRR13502569	0.84	0.68	0.58	SAMN17485773	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13502972	0.84	0.68	0.58	SAMN17486251	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13557685	0.84	0.68	0.58	SAMN17578203	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13612672	0.84	0.68	0.58	SAMN17619793	Shotgun Metagenomic Influent and Effluent WWTP in Malaysia
L11079.1	SRR13621961	0.84	0.68	0.58	SAMN17765167	IgG4RD and systemic sclerosis
L11079.1	SRR13622589	0.84	0.68	0.58	SAMN17763929	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13694823	0.84	0.68	0.58	SAMN17884059	Vaginal seeding in babies born by caesarean section (ECOBABe trial) - shotgun metagenomics data
L11079.1	SRR13740012	0.84	0.68	0.58	SAMN17618828	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13740016	0.84	0.68	0.58	SAMN17618825	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13740222	0.84	0.68	0.58	SAMN17618739	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13740340	0.84	0.68	0.58	SAMN17618989	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13773570	0.84	0.68	0.58	SAMN18040000	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773596	0.84	0.68	0.58	SAMN18040165	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773605	0.84	0.68	0.58	SAMN18040157	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773610	0.84	0.68	0.58	SAMN18040152	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773624	0.84	0.68	0.58	SAMN18040140	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773631	0.84	0.68	0.58	SAMN18040133	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773649	0.84	0.68	0.58	SAMN18040058	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773654	0.84	0.68	0.58	SAMN18040053	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773666	0.84	0.68	0.58	SAMN18040042	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773674	0.84	0.68	0.58	SAMN18040035	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773773	0.84	0.68	0.58	SAMN18040002	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13774546	0.84	0.68	0.58	SAMN18040330	Premature infant microbiome Metagenome
L11079.1	SRR13825942	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825949	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825960	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825967	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825979	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825981	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825985	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825997	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826015	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826032	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826043	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826044	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826047	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826081	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826114	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826141	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826142	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826148	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826153	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826154	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826162	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099269	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099296	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099297	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099303	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099308	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099309	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099314	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099321	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099332	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099339	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099351	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099353	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099357	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099369	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099374	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099391	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099408	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099419	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099420	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099423	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099457	0.84	0.68	0.58	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13844418	0.84	0.68	0.58	SAMN18106059	Fecal microbiota of donors and RCDI patients before and after FMT
L11079.1	SRR13844443	0.84	0.68	0.58	SAMN18106037	Fecal microbiota of donors and RCDI patients before and after FMT
L11079.1	SRR14000967	0.84	0.68	0.58	SAMN18354214	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14117026	0.84	0.68	0.58	SAMN17717647	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117243	0.84	0.68	0.58	SAMN17717722	Transmission and formation of microbiota in the ealry life
L11079.1	SRR17284165	0.84	0.68	0.58	SAMN23963248	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14263120	0.84	0.68	0.58	SAMN18746074	The possible mechanism of Probio-M8 to relieve the symptoms of asthma patients
L11079.1	SRR14263121	0.84	0.68	0.58	SAMN18746073	The possible mechanism of Probio-M8 to relieve the symptoms of asthma patients
L11079.1	SRR14263148	0.84	0.68	0.58	SAMN18746013	The possible mechanism of Probio-M8 to relieve the symptoms of asthma patients
L11079.1	SRR14297772	0.84	0.68	0.58	SAMN18814941	ARGs in wastewater  from hospital
L11079.1	SRR14306866	0.84	0.68	0.58	SAMN18826035	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14306881	0.84	0.68	0.58	SAMN18826022	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14306885	0.84	0.68	0.58	SAMN18826018	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14306898	0.84	0.68	0.58	SAMN18826006	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14306929	0.84	0.68	0.58	SAMN18825978	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14321965	0.84	0.68	0.58	SAMN18868642	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14321967	0.84	0.68	0.58	SAMN18868640	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14322003	0.84	0.68	0.58	SAMN18868590	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14322006	0.84	0.68	0.58	SAMN18868605	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14368312	0.84	0.68	0.58	SAMN18927892	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14368313	0.84	0.68	0.58	SAMN18927891	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14368329	0.84	0.68	0.58	SAMN18927876	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR6066092	0.84	0.68	0.58	SAMN07606194	Human gut microbiota Raw sequence reads
L11079.1	SRR6066137	0.84	0.68	0.58	SAMN07606232	Human gut microbiota Raw sequence reads
L11079.1	SRR6066151	0.84	0.68	0.58	SAMN07606185	Human gut microbiota Raw sequence reads
L11079.1	SRR6066168	0.84	0.68	0.58	SAMN07606180	Human gut microbiota Raw sequence reads
L11079.1	SRR6066171	0.84	0.68	0.58	SAMN07606175	Human gut microbiota Raw sequence reads
L11079.1	SRR6066177	0.84	0.68	0.58	SAMN07606177	Human gut microbiota Raw sequence reads
L11079.1	SRR14338934	0.84	0.68	0.58	SAMN18878909	studies of microbial diversity on human gut
L11079.1	SRR14360626	0.84	0.68	0.58	SAMN18878909	studies of microbial diversity on human gut
L11079.1	SRR14424468	0.84	0.68	0.58	SAMN19016994	Novel biocide resistant Tepidiphilus found in high temperature Orinoquia oil reservoir
L11079.1	SRR14424863	0.84	0.68	0.58	SAMN18710950	The second batch of domestic waste reaction Raw sequence reads Raw sequence reads
L11079.1	SRR14424864	0.84	0.68	0.58	SAMN18710949	The second batch of domestic waste reaction Raw sequence reads Raw sequence reads
L11079.1	SRR8208343	0.84	0.68	0.58	SAMN10430504	wastewater metagenome Genome sequencing
L11079.1	SRR8208349	0.84	0.68	0.58	SAMN10430539	wastewater metagenome Genome sequencing
L11079.1	SRR14469720	0.84	0.68	0.58	SAMN19070975	Metagenome of bean dregs compost
L11079.1	SRR14493506	0.84	0.68	0.58	SAMN18868498	16s vs shallowshotgun
L11079.1	SRR14493508	0.84	0.68	0.58	SAMN18868496	16s vs shallowshotgun
L11079.1	SRR14493004	0.84	0.68	0.58	SAMN19079002	Rapid Absolute Quantification of Pathogen and ARG by Nanopore Sequencing
L11079.1	SRR14573970	0.84	0.68	0.58	SAMN19237357	The composition of gut microbiota in biliary atresia
L11079.1	SRR14574643	0.84	0.68	0.58	SAMN19238790	Genomic adaptations of Escherichia coli strains from patients with inflammatory bowel diseases
L11079.1	SRR14610238	0.84	0.68	0.58	SAMN19290627	Time-series metagenome survey of activated sludge in a full-scale wastewater treatment plant
L11079.1	SRR14689323	0.84	0.68	0.58	SAMN19433449	The Probiotic L. casei Zhang Slows the Progression of Acute and Chronic Kidney Disease
L11079.1	SRR14687453	0.84	0.68	0.58	SAMN19323068	Genome-resolved metagenomics of the chicken gut microbiome
L11079.1	SRR14842329	0.84	0.68	0.58	SAMN19735751	Global Canine Shotgun Microbiomes
L11079.1	SRR14860641	0.84	0.68	0.58	SAMN19769741	Common Vampire Bat Fecal and Gut Microbiomes
L11079.1	SRR14860652	0.84	0.68	0.58	SAMN19769860	Common Vampire Bat Fecal and Gut Microbiomes
L11079.1	SRR14860673	0.84	0.68	0.58	SAMN19769733	Common Vampire Bat Fecal and Gut Microbiomes
L11079.1	SRR14860684	0.84	0.68	0.58	SAMN19769732	Common Vampire Bat Fecal and Gut Microbiomes
L11079.1	SRR14863621	0.84	0.68	0.58	SAMN19775116	FMT in recurrent C. Difficile and or IBD (inflammatory bowel diseases)
L11079.1	SRR14877742	0.84	0.68	0.58	SAMN19769942	Constructed wetlands Raw sequence reads
L11079.1	SRR14877745	0.84	0.68	0.58	SAMN19769942	Constructed wetlands Raw sequence reads
L11079.1	SRR14877748	0.84	0.68	0.58	SAMN19769942	Constructed wetlands Raw sequence reads
L11079.1	SRR14918161	0.84	0.68	0.58	SAMN18867754	Fecal Metagenomes
L11079.1	SRR15008980	0.84	0.68	0.58	SAMN19915233	Ruminal metagenome
L11079.1	SRR15008981	0.84	0.68	0.58	SAMN19915233	Ruminal metagenome
L11079.1	SRR15008982	0.84	0.68	0.58	SAMN19915233	Ruminal metagenome
L11079.1	SRR15008984	0.84	0.68	0.58	SAMN19915233	Ruminal metagenome
L11079.1	SRR15008985	0.84	0.68	0.58	SAMN19915233	Ruminal metagenome
L11079.1	SRR15008986	0.84	0.68	0.58	SAMN19915233	Ruminal metagenome
L11079.1	SRR15008988	0.84	0.68	0.58	SAMN19915233	Ruminal metagenome
L11079.1	SRR15021140	0.84	0.68	0.58	SAMN19971496	Gut microbiota of Kidney Stone patients and live-in partners
L11079.1	SRR15040926	0.84	0.68	0.58	SAMN20058796	Whole genome shotgun metagenome of Parkinson's disease patients and their spouse
L11079.1	SRR15041003	0.84	0.68	0.58	SAMN20058866	Whole genome shotgun metagenome of Parkinson's disease patients and their spouse
L11079.1	SRR15051270	0.84	0.68	0.58	SAMN20081890	Identification of unique bile acid metabolizing bacteria from the microbiome of centenarians
L11079.1	SRR15051277	0.84	0.68	0.58	SAMN20081884	Identification of unique bile acid metabolizing bacteria from the microbiome of centenarians
L11079.1	SRR15051363	0.84	0.68	0.58	SAMN20081923	Identification of unique bile acid metabolizing bacteria from the microbiome of centenarians
L11079.1	SRR15051478	0.84	0.68	0.58	SAMN20081629	Identification of unique bile acid metabolizing bacteria from the microbiome of centenarians
L11079.1	SRR15095504	0.84	0.68	0.58	SAMN20163250	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15095505	0.84	0.68	0.58	SAMN20163249	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15129099	0.84	0.68	0.58	SAMN20204439	Wastewater monitoring for SARS-CoV-2 across the United States (HHS Protect/NWSS/Biobot Analytics)
L11079.1	SRR15647030	0.84	0.68	0.58	SAMN21013789	Wastewater monitoring for SARS-CoV-2 across the United States (HHS Protect/NWSS/Biobot Analytics)
L11079.1	SRR15197192	0.84	0.68	0.58	SAMN20325628	Fecal metagenomes of C. difficile colonized patients
L11079.1	SRR15197247	0.84	0.68	0.58	SAMN20325578	Fecal metagenomes of C. difficile colonized patients
L11079.1	SRR15204179	0.84	0.68	0.58	SAMN20335694	Metagenomic WGS of Preterm Infant Skin and Stool
L11079.1	SRR15343409	0.84	0.68	0.58	SAMN20566127	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343412	0.84	0.68	0.58	SAMN20566124	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15372885	0.84	0.68	0.58	SAMN20549088	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15372944	0.84	0.68	0.58	SAMN20549338	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15372953	0.84	0.68	0.58	SAMN20549330	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR1917936	0.84	0.68	0.58	SAMN03402955	Human microbiome Targeted Locus (Loci)
L11079.1	SRR15595305	0.84	0.68	0.58	SAMN20959303	Metagenomic Microbiota in Celiac Disease
L11079.1	SRR15647981	0.84	0.68	0.58	SAMN21015597	A discovery cohort of 49 normal controls and 48 advanced adenoma patients, and a training cohort of 50 normal controls, 46 advanced adenoma patients and 30 colorectal cancer patients
L11079.1	SRR15674176	0.84	0.68	0.58	SAMN21154909	A discovery cohort of 49 normal controls and 48 advanced adenoma patients, and a training cohort of 50 normal controls, 46 advanced adenoma patients and 30 colorectal cancer patients
L11079.1	SRR15674234	0.84	0.68	0.58	SAMN21154969	A discovery cohort of 49 normal controls and 48 advanced adenoma patients, and a training cohort of 50 normal controls, 46 advanced adenoma patients and 30 colorectal cancer patients
L11079.1	SRR15649873	0.84	0.68	0.58	SAMN21018154	Strain profiling analysis of Klebsiella pneumoniae from clinical metagenome sequencing
L11079.1	SRR15679793	0.84	0.68	0.58	SAMN21019496	Clinical and genetic correlates of the gut  microbiome and relation to cardiometabolic risk
L11079.1	SRR15679903	0.84	0.68	0.58	SAMN21019418	Clinical and genetic correlates of the gut  microbiome and relation to cardiometabolic risk
L11079.1	SRR15702583	0.84	0.68	0.58	SAMN21175581	16s and shotgun sequencing from human faecal
L11079.1	SRR15851075	0.84	0.68	0.58	SAMN21393496	L.casei Zhang improve gut microbiota of patients with allergy
L11079.1	SRR15926044	0.84	0.68	0.58	SAMN21462327	Intestinal flora sequencing of Chinese infants
L11079.1	SRR15926045	0.84	0.68	0.58	SAMN21462326	Intestinal flora sequencing of Chinese infants
L11079.1	SRR15926046	0.84	0.68	0.58	SAMN21462325	Intestinal flora sequencing of Chinese infants
L11079.1	SRR15926051	0.84	0.68	0.58	SAMN21462320	Intestinal flora sequencing of Chinese infants
L11079.1	SRR15926053	0.84	0.68	0.58	SAMN21462318	Intestinal flora sequencing of Chinese infants
L11079.1	SRR15926054	0.84	0.68	0.58	SAMN21462273	Intestinal flora sequencing of Chinese infants
L11079.1	SRR15926067	0.84	0.68	0.58	SAMN21462306	Intestinal flora sequencing of Chinese infants
L11079.1	SRR15926095	0.84	0.68	0.58	SAMN21462280	Intestinal flora sequencing of Chinese infants
L11079.1	SRR16036399	0.84	0.68	0.58	SAMN21544458	silage metagenome Metagenome
L11079.1	SRR16178768	0.84	0.68	0.58	SAMN22025964	Metagenomic analysis towards biomarkers and prediction models between intestinal polyp patients and colorectal cancer patients
L11079.1	SRR16178793	0.84	0.68	0.58	SAMN22025987	Metagenomic analysis towards biomarkers and prediction models between intestinal polyp patients and colorectal cancer patients
L11079.1	SRR16178800	0.84	0.68	0.58	SAMN22025981	Metagenomic analysis towards biomarkers and prediction models between intestinal polyp patients and colorectal cancer patients
L11079.1	SRR16178807	0.84	0.68	0.58	SAMN22025975	Metagenomic analysis towards biomarkers and prediction models between intestinal polyp patients and colorectal cancer patients
L11079.1	SRR16178809	0.84	0.68	0.58	SAMN22025973	Metagenomic analysis towards biomarkers and prediction models between intestinal polyp patients and colorectal cancer patients
L11079.1	SRR1631056	0.84	0.68	0.58	SAMN03025571	Gene-Environment Interactions at the Skin Surface
L11079.1	SRR1632850	0.84	0.68	0.58	SAMN03025667	Gene-Environment Interactions at the Skin Surface
L11079.1	SRR1632856	0.84	0.68	0.58	SAMN03025667	Gene-Environment Interactions at the Skin Surface
L11079.1	SRR3642506	0.84	0.68	0.58	SAMN04999052	Gene-Environment Interactions at the Skin Surface
L11079.1	SRR16297690	0.84	0.68	0.58	SAMN22107684	PCaF Raw sequence reads
L11079.1	SRR16297701	0.84	0.68	0.58	SAMN22107674	PCaF Raw sequence reads
L11079.1	SRR16297704	0.84	0.68	0.58	SAMN22107671	PCaF Raw sequence reads
L11079.1	SRR16297761	0.84	0.68	0.58	SAMN22107699	PCaF Raw sequence reads
L11079.1	SRR16297762	0.84	0.68	0.58	SAMN22107698	PCaF Raw sequence reads
L11079.1	SRR16481185	0.84	0.68	0.58	SAMN22374901	Luzhou ARGs
L11079.1	SRR16555198	0.84	0.68	0.58	SAMN22445290	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR16555200	0.84	0.68	0.58	SAMN22445288	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR16555211	0.84	0.68	0.58	SAMN22445300	Human gut metagenomic sequence Raw sequence reads
L11079.1	SRR16646021	0.84	0.68	0.58	SAMN22565489	Gut microbiome sequencing
L11079.1	SRR16646023	0.84	0.68	0.58	SAMN22565457	Gut microbiome sequencing
L11079.1	SRR16646098	0.84	0.68	0.58	SAMN22565397	Gut microbiome sequencing
L11079.1	SRR16646135	0.84	0.68	0.58	SAMN22565337	Gut microbiome sequencing
L11079.1	SRR16646169	0.84	0.68	0.58	SAMN22565521	Gut microbiome sequencing
L11079.1	SRR16925321	0.84	0.68	0.58	SAMN23016307	No effect of Lactobacillus rhamnosus GG on eradication of colonization by vancomycin resistant Enterococcus faecium or microbiome diversity in hospitalized adult patients
L11079.1	SRR16961797	0.84	0.68	0.58	SAMN23227492	Gut metagenomics in slow transit constipation
L11079.1	SRR17048899	0.84	0.68	0.58	SAMN16797046	Shotgun metagenomic sequencing of stool samples from two South African cohorts
L11079.1	SRR17048905	0.84	0.68	0.58	SAMN16797040	Shotgun metagenomic sequencing of stool samples from two South African cohorts
L11079.1	SRR17048909	0.84	0.68	0.58	SAMN16797037	Shotgun metagenomic sequencing of stool samples from two South African cohorts
L11079.1	SRR17048913	0.84	0.68	0.58	SAMN23441068	Shotgun metagenomic sequencing of stool samples from two South African cohorts
L11079.1	SRR17048946	0.84	0.68	0.58	SAMN16797003	Shotgun metagenomic sequencing of stool samples from two South African cohorts
L11079.1	SRR17049037	0.84	0.68	0.58	SAMN16797072	Shotgun metagenomic sequencing of stool samples from two South African cohorts
L11079.1	SRR17243624	0.84	0.68	0.58	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243625	0.84	0.68	0.58	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243630	0.84	0.68	0.58	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243635	0.84	0.68	0.58	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243637	0.84	0.68	0.58	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243647	0.84	0.68	0.58	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243656	0.84	0.68	0.58	SAMN24044232	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243662	0.84	0.68	0.58	SAMN24044232	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243683	0.84	0.68	0.58	SAMN24044232	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243693	0.84	0.68	0.58	SAMN24044232	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243694	0.84	0.68	0.58	SAMN24044232	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243701	0.84	0.68	0.58	SAMN24044232	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243717	0.84	0.68	0.58	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243722	0.84	0.68	0.58	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR1748608	0.84	0.68	0.58	SAMN03270057	New York City MTA subway samples Metagenome
L11079.1	SRR1748756	0.84	0.68	0.58	SAMN03270145	New York City MTA subway samples Metagenome
L11079.1	SRR1749187	0.84	0.68	0.58	SAMN03270564	New York City MTA subway samples Metagenome
L11079.1	SRR1749188	0.84	0.68	0.58	SAMN03270565	New York City MTA subway samples Metagenome
L11079.1	SRR1749581	0.84	0.68	0.58	SAMN03270958	New York City MTA subway samples Metagenome
L11079.1	SRR2912782	0.84	0.68	0.58	SAMN04209233	Human Gut Microbiome Metagenome
L11079.1	SRR1789035	0.84	0.68	0.58	SAMN03281016	Infant fecal microbiome related to eczema
L11079.1	SRR1791585	0.84	0.68	0.58	SAMN03281016	Infant fecal microbiome related to eczema
L11079.1	SRR1793377	0.84	0.68	0.58	SAMN03281017	Infant fecal microbiome related to eczema
L11079.1	SRR1778451	0.84	0.68	0.58	SAMN00993240	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR341608	0.84	0.68	0.58	SAMN00715158	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR341615	0.84	0.68	0.58	SAMN00715165	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR341661	0.84	0.68	0.58	SAMN00715211	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR341684	0.84	0.68	0.58	SAMN00715234	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413578	0.84	0.68	0.58	SAMN00791923	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413645	0.84	0.68	0.58	SAMN00791990	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413659	0.84	0.68	0.58	SAMN00792004	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413667	0.84	0.68	0.58	SAMN00792012	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413669	0.84	0.68	0.58	SAMN00792014	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413695	0.84	0.68	0.58	SAMN00792040	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413711	0.84	0.68	0.58	SAMN00792056	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413725	0.84	0.68	0.58	SAMN00792070	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413743	0.84	0.68	0.58	SAMN00792088	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413744	0.84	0.68	0.58	SAMN00792089	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413764	0.84	0.68	0.58	SAMN00792109	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413765	0.84	0.68	0.58	SAMN00792110	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR6256382	0.84	0.68	0.58	SAMN07977760	Metagenomes from human infant fecal samples with and without necrotizing enterocolitis
L11079.1	SRR1950743	0.84	0.68	0.58	SAMN03398557	Human Skin Microbiome Metagenome
L11079.1	SRR2135036	0.84	0.68	0.58	SAMN03944621	Waste water metagenome
L11079.1	SRR2145430	0.84	0.68	0.58	SAMN03469442	Inflammation, Antibiotics, and Diet as Concurrent Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease
L11079.1	SRR2145565	0.84	0.68	0.58	SAMN03469566	Inflammation, Antibiotics, and Diet as Concurrent Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease
L11079.1	SRR2145566	0.84	0.68	0.58	SAMN03469567	Inflammation, Antibiotics, and Diet as Concurrent Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease
L11079.1	SRR2187419	0.84	0.68	0.58	SAMN02334051	Fiji COMP
L11079.1	SRR2187661	0.84	0.68	0.58	SAMN02334005	Fiji COMP
L11079.1	SRR2188202	0.84	0.68	0.58	SAMN02333982	Fiji COMP
L11079.1	SRR2188209	0.84	0.68	0.58	SAMN02333970	Fiji COMP
L11079.1	SRR2188458	0.84	0.68	0.58	SAMN02333970	Fiji COMP
L11079.1	SRR2188521	0.84	0.68	0.58	SAMN02333970	Fiji COMP
L11079.1	SRR2188765	0.84	0.68	0.58	SAMN02333996	Fiji COMP
L11079.1	SRR2188835	0.84	0.68	0.58	SAMN02333984	Fiji COMP
L11079.1	SRR2188980	0.84	0.68	0.58	SAMN02334022	Fiji COMP
L11079.1	SRR2189023	0.84	0.68	0.58	SAMN02334042	Fiji COMP
L11079.1	SRR2189681	0.84	0.68	0.58	SAMN02334057	Fiji COMP
L11079.1	SRR2189868	0.84	0.68	0.58	SAMN02334057	Fiji COMP
L11079.1	SRR2189956	0.84	0.68	0.58	SAMN02333969	Fiji COMP
L11079.1	SRR2191931	0.84	0.68	0.58	SAMN02334041	Fiji COMP
L11079.1	SRR2191938	0.84	0.68	0.58	SAMN02334041	Fiji COMP
L11079.1	SRR2192726	0.84	0.68	0.58	SAMN02334056	Fiji COMP
L11079.1	SRR2192778	0.84	0.68	0.58	SAMN02333970	Fiji COMP
L11079.1	SRR2193374	0.84	0.68	0.58	SAMN02334056	Fiji COMP
L11079.1	SRR2193825	0.84	0.68	0.58	SAMN02333970	Fiji COMP
L11079.1	SRR2193826	0.84	0.68	0.58	SAMN02334041	Fiji COMP
L11079.1	SRR2193936	0.84	0.68	0.58	SAMN02334056	Fiji COMP
L11079.1	SRR2193959	0.84	0.68	0.58	SAMN02333966	Fiji COMP
L11079.1	SRR2193961	0.84	0.68	0.58	SAMN02334056	Fiji COMP
L11079.1	SRR2194531	0.84	0.68	0.58	SAMN02334056	Fiji COMP
L11079.1	SRR2194547	0.84	0.68	0.58	SAMN02333966	Fiji COMP
L11079.1	SRR2194585	0.84	0.68	0.58	SAMN02334056	Fiji COMP
L11079.1	SRR2194623	0.84	0.68	0.58	SAMN02334056	Fiji COMP
L11079.1	SRR2194862	0.84	0.68	0.58	SAMN02334042	Fiji COMP
L11079.1	SRR2194924	0.84	0.68	0.58	SAMN02333966	Fiji COMP
L11079.1	SRR2199451	0.84	0.68	0.58	SAMN02334006	Fiji COMP
L11079.1	SRR2221430	0.84	0.68	0.58	SAMN02334140	Fiji COMP
L11079.1	SRR2222373	0.84	0.68	0.58	SAMN02334117	Fiji COMP
L11079.1	SRR2222385	0.84	0.68	0.58	SAMN02334117	Fiji COMP
L11079.1	SRR2222422	0.84	0.68	0.58	SAMN02333966	Fiji COMP
L11079.1	SRR2225822	0.84	0.68	0.58	SAMN02334119	Fiji COMP
L11079.1	SRR2225845	0.84	0.68	0.58	SAMN02334148	Fiji COMP
L11079.1	SRR2225884	0.84	0.68	0.58	SAMN02334148	Fiji COMP
L11079.1	SRR2227287	0.84	0.68	0.58	SAMN02334075	Fiji COMP
L11079.1	SRR2227945	0.84	0.68	0.58	SAMN02334140	Fiji COMP
L11079.1	SRR2227996	0.84	0.68	0.58	SAMN02334075	Fiji COMP
L11079.1	SRR2228581	0.84	0.68	0.58	SAMN02334140	Fiji COMP
L11079.1	SRR2231106	0.84	0.68	0.58	SAMN02334005	Fiji COMP
L11079.1	SRR2231754	0.84	0.68	0.58	SAMN02333970	Fiji COMP
L11079.1	SRR2231799	0.84	0.68	0.58	SAMN02334153	Fiji COMP
L11079.1	SRR2236421	0.84	0.68	0.58	SAMN02334094	Fiji COMP
L11079.1	SRR2237509	0.84	0.68	0.58	SAMN02334135	Fiji COMP
L11079.1	SRR2245561	0.84	0.68	0.58	SAMN02334117	Fiji COMP
L11079.1	SRR2247360	0.84	0.68	0.58	SAMN02334117	Fiji COMP
L11079.1	SRR2248163	0.84	0.68	0.58	SAMN02334150	Fiji COMP
L11079.1	SRR2249518	0.84	0.68	0.58	SAMN02334042	Fiji COMP
L11079.1	SRR2249548	0.84	0.68	0.58	SAMN02333966	Fiji COMP
L11079.1	SRR2249632	0.84	0.68	0.58	SAMN02334117	Fiji COMP
L11079.1	SRR2250006	0.84	0.68	0.58	SAMN02334151	Fiji COMP
L11079.1	SRR2250308	0.84	0.68	0.58	SAMN02333970	Fiji COMP
L11079.1	SRR2250664	0.84	0.68	0.58	SAMN02334093	Fiji COMP
L11079.1	SRR2250806	0.84	0.68	0.58	SAMN02334117	Fiji COMP
L11079.1	SRR2250948	0.84	0.68	0.58	SAMN02334117	Fiji COMP
L11079.1	SRR2251025	0.84	0.68	0.58	SAMN02334005	Fiji COMP
L11079.1	SRR2251605	0.84	0.68	0.58	SAMN02334149	Fiji COMP
L11079.1	SRR3131724	0.84	0.68	0.58	SAMN04436884	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3131856	0.84	0.68	0.58	SAMN04436887	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3131959	0.84	0.68	0.58	SAMN04436885	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132051	0.84	0.68	0.58	SAMN04436657	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132113	0.84	0.68	0.58	SAMN04436747	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132114	0.84	0.68	0.58	SAMN04436747	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132263	0.84	0.68	0.58	SAMN04436658	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132264	0.84	0.68	0.58	SAMN04436658	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132299	0.84	0.68	0.58	SAMN04436886	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132300	0.84	0.68	0.58	SAMN04436886	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132301	0.84	0.68	0.58	SAMN04436888	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132302	0.84	0.68	0.58	SAMN04436888	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132307	0.84	0.68	0.58	SAMN04436889	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132308	0.84	0.68	0.58	SAMN04436889	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132313	0.84	0.68	0.58	SAMN04436746	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132387	0.84	0.68	0.58	SAMN04436723	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132388	0.84	0.68	0.58	SAMN04436723	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3132429	0.84	0.68	0.58	SAMN04436724	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR8942343	0.84	0.68	0.58	SAMN05525460	Maturation of the Infant Microbiome Community Structure and Function Across Multiple Body Sites
L11079.1	SRR3950470	0.84	0.68	0.58	SAMN05437200	Gut microbiome of TB patients
L11079.1	SRR3993058	0.84	0.68	0.58	SAMN05414984	Mongolian Metagenome
L11079.1	SRR4074350	0.84	0.68	0.58	SAMN05710192	Gut microbiota and metagenomic diversity of omnivore, vegetarian and vegan healthy subjects
L11079.1	SRR4305097	0.84	0.68	0.58	SAMN05826644	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305513	0.84	0.68	0.58	SAMN05826567	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408069	0.84	0.68	0.58	SAMN05827001	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408177	0.84	0.68	0.58	SAMN05827235	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR5091536	0.84	0.68	0.58	SAMN06112066	human gut metagenome in RA
L11079.1	SRR5091592	0.84	0.68	0.58	SAMN06111993	human gut metagenome in RA
L11079.1	SRR5130565	0.84	0.68	0.58	SAMN06130179	the gut metagenome of ginat pandas , bears and carnivores Raw sequence reads
L11079.1	SRR5150002	0.84	0.68	0.58	SAMN06185651	wild and captive gut Raw sequence reads
L11079.1	SRR5156011	0.84	0.68	0.58	SAMN06164391	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR5165927	0.84	0.68	0.58	SAMN06164971	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR6028627	0.84	0.68	0.58	SAMN06164391	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR6028628	0.84	0.68	0.58	SAMN06164392	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR6054655	0.84	0.68	0.58	SAMN06164972	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR6054656	0.84	0.68	0.58	SAMN06164971	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR5275456	0.84	0.68	0.58	SAMN06328420	Novel gut-microbiota based metagenomic signature for advanced fibrosis in nonalcoholic fatty liver disease
L11079.1	SRR5275471	0.84	0.68	0.58	SAMN06328474	Novel gut-microbiota based metagenomic signature for advanced fibrosis in nonalcoholic fatty liver disease
L11079.1	SRR5275483	0.84	0.68	0.58	SAMN06328467	Novel gut-microbiota based metagenomic signature for advanced fibrosis in nonalcoholic fatty liver disease
L11079.1	SRR5278470	0.84	0.68	0.58	SAMN06368348	Ecological wastewater treatment
L11079.1	SRR6474282	0.84	0.68	0.58	SAMN08366172	human gut Metagenome
L11079.1	SRR5298234	0.84	0.68	0.58	SAMN06350403	Metagenome data from infant (PD and ProD) stools samples raw sequence reads
L11079.1	SRR5298242	0.84	0.68	0.58	SAMN06350379	Metagenome data from infant stools samples raw sequence reads
L11079.1	SRR5298243	0.84	0.68	0.58	SAMN06350375	Metagenome data from infant stools samples raw sequence reads
L11079.1	SRR5405787	0.84	0.68	0.58	SAMN06444533	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405788	0.84	0.68	0.58	SAMN06444532	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405789	0.84	0.68	0.58	SAMN06444531	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405791	0.84	0.68	0.58	SAMN06444529	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405792	0.84	0.68	0.58	SAMN06444528	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405793	0.84	0.68	0.58	SAMN06444527	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405794	0.84	0.68	0.58	SAMN06444526	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405846	0.84	0.68	0.58	SAMN06444474	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405847	0.84	0.68	0.58	SAMN06444473	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405848	0.84	0.68	0.58	SAMN06444472	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405849	0.84	0.68	0.58	SAMN06444471	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405850	0.84	0.68	0.58	SAMN06444470	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405851	0.84	0.68	0.58	SAMN06444469	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405852	0.84	0.68	0.58	SAMN06444468	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405853	0.84	0.68	0.58	SAMN06444467	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405865	0.84	0.68	0.58	SAMN06444455	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405866	0.84	0.68	0.58	SAMN06444454	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405867	0.84	0.68	0.58	SAMN06444453	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405868	0.84	0.68	0.58	SAMN06444452	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405869	0.84	0.68	0.58	SAMN06444451	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5420285	0.84	0.68	0.58	SAMN06443391	Metagenomes from hospital (NICU) surfaces and sinks
L11079.1	SRR5420287	0.84	0.68	0.58	SAMN06443389	Metagenomes from hospital (NICU) surfaces and sinks
L11079.1	SRR5420293	0.84	0.68	0.58	SAMN06443383	Metagenomes from hospital (NICU) surfaces and sinks
L11079.1	SRR5420294	0.84	0.68	0.58	SAMN06443382	Metagenomes from hospital (NICU) surfaces and sinks
L11079.1	SRR5439748	0.84	0.68	0.58	SAMN06718186	Benchmarking datasets for microbiome profiling
L11079.1	SRR5570991	0.84	0.68	0.58	SAMN07135127	Wastewater, sludge and lake sediment metagenomes Raw sequence reads
L11079.1	SRR5676469	0.84	0.68	0.58	SAMN07190885	samples from sewage Raw sequence reads
L11079.1	SRR5676479	0.84	0.68	0.58	SAMN07190885	samples from sewage Raw sequence reads
L11079.1	SRR5829319	0.84	0.68	0.58	SAMN07326615	The Mid-term plasticity of the Chinese Gut Microbiota
L11079.1	SRR5818488	0.84	0.68	0.58	SAMN07285679	next generation sequencing of feces in HIV-1 patients Raw sequence reads
L11079.1	SRR5818534	0.84	0.68	0.58	SAMN07285647	next generation sequencing of feces in HIV-1 patients Raw sequence reads
L11079.1	SRR5831592	0.84	0.68	0.58	SAMN07357515	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR8144391	0.84	0.68	0.58	SAMN07560378	High frequency intestinal microbiota sampling in allogeneic bone marrow transplant patients
L11079.1	SRR8144437	0.84	0.68	0.58	SAMN07560402	High frequency intestinal microbiota sampling in allogeneic bone marrow transplant patients
L11079.1	SRR5898958	0.84	0.68	0.58	SAMN07449064	Indian Human Gut Microbiome
L11079.1	SRR5898974	0.84	0.68	0.58	SAMN07449003	Indian Human Gut Microbiome
L11079.1	SRR5898988	0.84	0.68	0.58	SAMN07449051	Indian Human Gut Microbiome
L11079.1	SRR5899013	0.84	0.68	0.58	SAMN07449053	Indian Human Gut Microbiome
L11079.1	SRR5903342	0.84	0.68	0.58	SAMN07452484	Gut metagenomes of patients with colorectal cancer
L11079.1	SRR5903352	0.84	0.68	0.58	SAMN07452494	Gut metagenomes of patients with colorectal cancer
L11079.1	SRR5903364	0.84	0.68	0.58	SAMN07452494	Gut metagenomes of patients with colorectal cancer
L11079.1	SRR5903385	0.84	0.68	0.58	SAMN07452484	Gut metagenomes of patients with colorectal cancer
L11079.1	SRR5930508	0.84	0.68	0.58	SAMN07498126	Metagenomic shotgun sequencing of gut microbiomes of melanoma patients receiving immune checkpoint inhibitor therapy
L11079.1	SRR5930535	0.84	0.68	0.58	SAMN07498127	Metagenomic shotgun sequencing of gut microbiomes of melanoma patients receiving immune checkpoint inhibitor therapy
L11079.1	SRR5935874	0.84	0.68	0.58	SAMN07509842	Longitudinal Multi'omics of the Human Microbiome in Inflammatory Bowel Disease
L11079.1	SRR5946942	0.84	0.68	0.58	SAMN07521868	Longitudinal Multi'omics of the Human Microbiome in Inflammatory Bowel Disease
L11079.1	SRR5950598	0.84	0.68	0.58	SAMN07532924	Longitudinal Multi'omics of the Human Microbiome in Inflammatory Bowel Disease
L11079.1	SRR5963238	0.84	0.68	0.58	SAMN07501145	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963246	0.84	0.68	0.58	SAMN07501153	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963249	0.84	0.68	0.58	SAMN07501156	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963256	0.84	0.68	0.58	SAMN07501163	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963257	0.84	0.68	0.58	SAMN07501164	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963258	0.84	0.68	0.58	SAMN07501165	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963339	0.84	0.68	0.58	SAMN07501246	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963340	0.84	0.68	0.58	SAMN07501247	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963371	0.84	0.68	0.58	SAMN07501278	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963376	0.84	0.68	0.58	SAMN07501283	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963377	0.84	0.68	0.58	SAMN07501284	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963403	0.84	0.68	0.58	SAMN07501310	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963404	0.84	0.68	0.58	SAMN07501311	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963406	0.84	0.68	0.58	SAMN07501313	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963428	0.84	0.68	0.58	SAMN07501335	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5974596	0.84	0.68	0.58	SAMN07507533	human and microbial Raw sequence reads in intraocular samples
L11079.1	SRR6060196	0.84	0.68	0.58	SAMN07688541	Microbiome and Worm Infection
L11079.1	SRR6060204	0.84	0.68	0.58	SAMN07688533	Microbiome and Worm Infection
L11079.1	SRR6060207	0.84	0.68	0.58	SAMN07688526	Microbiome and Worm Infection
L11079.1	SRR6060213	0.84	0.68	0.58	SAMN07688530	Microbiome and Worm Infection
L11079.1	SRR6075157	0.84	0.68	0.58	SAMN07612768	Metagenomic analysis of fecal microbiome from patients with gestational diabetes mellitus
L11079.1	SRR6109208	0.84	0.68	0.58	SAMN07660491	gut evolution Raw sequence reads
L11079.1	SRR6145059	0.84	0.68	0.58	SAMN07749901	MTR skin microbiome
L11079.1	SRR6145061	0.84	0.68	0.58	SAMN07749903	MTR skin microbiome
L11079.1	SRR6262275	0.84	0.68	0.58	SAMN07983057	preterm infant gut metagenomes (NIH Y5 Cohort)
L11079.1	SRR6262276	0.84	0.68	0.58	SAMN07983058	preterm infant gut metagenomes (NIH Y5 Cohort)
L11079.1	SRR6262319	0.84	0.68	0.58	SAMN07983056	preterm infant gut metagenomes (NIH Y5 Cohort)
L11079.1	SRR6262473	0.84	0.68	0.58	SAMN07983169	preterm infant gut metagenomes (NIH Y5 Cohort)
L11079.1	SRR6439512	0.84	0.68	0.58	SAMN08287514	Banknote metagenomics
L11079.1	SRR6456199	0.84	0.68	0.58	SAMN08335094	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456201	0.84	0.68	0.58	SAMN08335092	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456205	0.84	0.68	0.58	SAMN08335096	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456209	0.84	0.68	0.58	SAMN08335089	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456213	0.84	0.68	0.58	SAMN08335085	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456220	0.84	0.68	0.58	SAMN08335025	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456240	0.84	0.68	0.58	SAMN08335068	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456252	0.84	0.68	0.58	SAMN08335053	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456357	0.84	0.68	0.58	SAMN08335942	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6468525	0.84	0.68	0.58	SAMN08049684	Gut microbiome structure and metabolic activity in inflammatory bowel disease
L11079.1	SRR6468620	0.84	0.68	0.58	SAMN08049730	Gut microbiome structure and metabolic activity in inflammatory bowel disease
L11079.1	SRR765682	0.84	0.68	0.58	SAMN01892462	Soy Sauce Metagenome
L11079.1	SRR6485349	0.84	0.68	0.58	SAMN07630777	Leachate microbial communities from a municipal landfill in Southern Ontario, Canada - Pumphouse #3 metaG metagenome
L11079.1	SRR6486882	0.84	0.68	0.58	SAMN08375889	Evaluation of Enriched Background Microflora of Wheat flour Spiked with E. coli O157 and E. coli O121 through metagenomics
L11079.1	SRR6517771	0.84	0.68	0.58	SAMN08392133	human gut metagenome Metagenome-Behcet's disease
L11079.1	SRR6517777	0.84	0.68	0.58	SAMN08392148	human gut metagenome Metagenome-Behcet's disease
L11079.1	SRR6517784	0.84	0.68	0.58	SAMN08392156	human gut metagenome Metagenome-Behcet's disease
L11079.1	SRR6701180	0.84	0.68	0.58	SAMN07507533	Infectious Etiology of Age-related Macular Degeneration
L11079.1	SRR6795017	0.84	0.68	0.58	SAMN08628061	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6795032	0.84	0.68	0.58	SAMN08628045	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6795037	0.84	0.68	0.58	SAMN08628025	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6795042	0.84	0.68	0.58	SAMN08628020	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6837581	0.84	0.68	0.58	SAMN08707565	Antimicrobial resistance of wastewater samples
L11079.1	SRR6846471	0.84	0.68	0.58	SAMN08721801	Virome communities in a full-scale wastewater reclamation plant
L11079.1	SRR7162301	0.84	0.68	0.58	SAMN08993449	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7162420	0.84	0.68	0.58	SAMN08993461	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7212648	0.84	0.68	0.58	SAMN08993449	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7212654	0.84	0.68	0.58	SAMN08993461	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7217005	0.84	0.68	0.58	SAMN08122911	Metagenomics of Urban Sewage Identifies an Extensively Shared Antibiotic Resistome in China
L11079.1	SRR7217009	0.84	0.68	0.58	SAMN08122839	Metagenomics of Urban Sewage Identifies an Extensively Shared Antibiotic Resistome in China
L11079.1	SRR7217012	0.84	0.68	0.58	SAMN08122836	Metagenomics of Urban Sewage Identifies an Extensively Shared Antibiotic Resistome in China
L11079.1	SRR7217487	0.84	0.68	0.58	SAMN09260127	Infant Diet and Maternal Gestational Weight Gain Influence Functional Maturation of the Infant Gut Microbiome
L11079.1	SRR7217645	0.84	0.68	0.58	SAMN09260118	Infant Diet and Maternal Gestational Weight Gain Influence Functional Maturation of the Infant Gut Microbiome
L11079.1	SRR7217650	0.84	0.68	0.58	SAMN09260121	Infant Diet and Maternal Gestational Weight Gain Influence Functional Maturation of the Infant Gut Microbiome
L11079.1	SRR7217673	0.84	0.68	0.58	SAMN09260153	Infant Diet and Maternal Gestational Weight Gain Influence Functional Maturation of the Infant Gut Microbiome
L11079.1	SRR7217711	0.84	0.68	0.58	SAMN09260116	Infant Diet and Maternal Gestational Weight Gain Influence Functional Maturation of the Infant Gut Microbiome
L11079.1	SRR7227932	0.84	0.68	0.58	SAMN09272257	Effect of bariatric surgery on the faecal metagenome
L11079.1	SRR7351765	0.84	0.68	0.58	SAMN09278343	Probiotics in Pregnancy study
L11079.1	SRR7495934	0.84	0.68	0.58	SAMN09605439	human stool Raw sequence reads
L11079.1	SRR7532885	0.84	0.68	0.58	SAMN09641582	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532911	0.84	0.68	0.58	SAMN09641588	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532913	0.84	0.68	0.58	SAMN09641586	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532914	0.84	0.68	0.58	SAMN09641585	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532915	0.84	0.68	0.58	SAMN09641584	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532916	0.84	0.68	0.58	SAMN09641583	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532918	0.84	0.68	0.58	SAMN09641591	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532922	0.84	0.68	0.58	SAMN09641528	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532924	0.84	0.68	0.58	SAMN09641530	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532926	0.84	0.68	0.58	SAMN09641524	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532927	0.84	0.68	0.58	SAMN09641523	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532931	0.84	0.68	0.58	SAMN09641531	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532934	0.84	0.68	0.58	SAMN09641553	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532935	0.84	0.68	0.58	SAMN09641554	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532936	0.84	0.68	0.58	SAMN09641559	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532937	0.84	0.68	0.58	SAMN09641560	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532938	0.84	0.68	0.58	SAMN09641557	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532939	0.84	0.68	0.58	SAMN09641558	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532968	0.84	0.68	0.58	SAMN09641521	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532973	0.84	0.68	0.58	SAMN09641565	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532976	0.84	0.68	0.58	SAMN09641570	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532977	0.84	0.68	0.58	SAMN09641569	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532979	0.84	0.68	0.58	SAMN09641571	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532982	0.84	0.68	0.58	SAMN09641658	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532983	0.84	0.68	0.58	SAMN09641657	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7532984	0.84	0.68	0.58	SAMN09641660	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7533015	0.84	0.68	0.58	SAMN09641613	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7533025	0.84	0.68	0.58	SAMN09641550	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7533026	0.84	0.68	0.58	SAMN09641549	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7533053	0.84	0.68	0.58	SAMN09641485	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7533064	0.84	0.68	0.58	SAMN09641595	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7533065	0.84	0.68	0.58	SAMN09641596	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7533066	0.84	0.68	0.58	SAMN09641593	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7533067	0.84	0.68	0.58	SAMN09641594	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7610126	0.84	0.68	0.58	SAMN09711559	Gut microbiome from Piaractus mesopotamicus Metagenome
L11079.1	SRR7638749	0.84	0.68	0.58	SAMN09759346	ARGs-OSP: Online searching platform for antibiotic resistance genes in metagenomic database and bacterial whole genome database
L11079.1	SRR7638760	0.84	0.68	0.58	SAMN09759389	ARGs-OSP: Online searching platform for antibiotic resistance genes in metagenomic database and bacterial whole genome database
L11079.1	SRR7658652	0.84	0.68	0.58	SAMN09781754	Metagenomic sequencing of stool samples from rural communities from north-eastern Madagascar
L11079.1	SRR7721875	0.84	0.68	0.58	SAMN09864065	Modification of gut microbiota-bile acid-intestinal FXR signaling leads to the clinical benefits of metformin
L11079.1	SRR7723047	0.84	0.68	0.58	SAMN09863735	Influence of early environmental factors on the establishment and development of gut microbiome composition and function and metabolomics profiles in infants at-risk of celiac disease
L11079.1	SRR7880200	0.84	0.68	0.58	SAMN10094470	Gut microbiota profile of vegetarians versus omnivores
L11079.1	SRR7904265	0.84	0.68	0.58	SAMN10132198	Gut microbiota of biliary atresia
L11079.1	SRR7905342	0.84	0.68	0.58	SAMN10133259	Arsenic-Impacted Human Gut Metagenome
L11079.1	SRR7943247	0.84	0.68	0.58	SAMN10144995	Comprehensive evaluation of sequencing variation caused by sampling site, sequencer and library preparation method in microbiome research
L11079.1	SRR7943254	0.84	0.68	0.58	SAMN10144994	Comprehensive evaluation of sequencing variation caused by sampling site, sequencer and library preparation method in microbiome research
L11079.1	SRR7943255	0.84	0.68	0.58	SAMN10144993	Comprehensive evaluation of sequencing variation caused by sampling site, sequencer and library preparation method in microbiome research
L11079.1	SRR7943256	0.84	0.68	0.58	SAMN10144992	Comprehensive evaluation of sequencing variation caused by sampling site, sequencer and library preparation method in microbiome research
L11079.1	SRR7943267	0.84	0.68	0.58	SAMN10145010	Comprehensive evaluation of sequencing variation caused by sampling site, sequencer and library preparation method in microbiome research
L11079.1	SRR7943270	0.84	0.68	0.58	SAMN10144970	Comprehensive evaluation of sequencing variation caused by sampling site, sequencer and library preparation method in microbiome research
L11079.1	SRR7943275	0.84	0.68	0.58	SAMN10144971	Comprehensive evaluation of sequencing variation caused by sampling site, sequencer and library preparation method in microbiome research
L11079.1	SRR7943279	0.84	0.68	0.58	SAMN10144976	Comprehensive evaluation of sequencing variation caused by sampling site, sequencer and library preparation method in microbiome research
L11079.1	SRR7943280	0.84	0.68	0.58	SAMN10144979	Comprehensive evaluation of sequencing variation caused by sampling site, sequencer and library preparation method in microbiome research
L11079.1	SRR7943283	0.84	0.68	0.58	SAMN10144978	Comprehensive evaluation of sequencing variation caused by sampling site, sequencer and library preparation method in microbiome research
L11079.1	SRR7943298	0.84	0.68	0.58	SAMN10145002	Comprehensive evaluation of sequencing variation caused by sampling site, sequencer and library preparation method in microbiome research
L11079.1	SRR7989873	0.84	0.68	0.58	SAMN10093246	3G low-gluten cross-over trial - faeces metagenome data
L11079.1	SRR8090611	0.84	0.68	0.58	SAMN10275428	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090744	0.84	0.68	0.58	SAMN10275651	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090891	0.84	0.68	0.58	SAMN10275685	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8239393	0.84	0.68	0.58	SAMN10456909	Wastewater metagenome and mobilome analysis
L11079.1	SRR8247604	0.84	0.68	0.58	SAMN10477976	Metagenomics samples from neuropathic diabetic foot ulcer (DFU) Metagenome
L11079.1	SRR8247605	0.84	0.68	0.58	SAMN10477977	Metagenomics samples from neuropathic diabetic foot ulcer (DFU) Metagenome
L11079.1	SRR8247618	0.84	0.68	0.58	SAMN10477990	Metagenomics samples from neuropathic diabetic foot ulcer (DFU) Metagenome
L11079.1	SRR8247711	0.84	0.68	0.58	SAMN10478083	Metagenomics samples from neuropathic diabetic foot ulcer (DFU) Metagenome
L11079.1	SRR8247712	0.84	0.68	0.58	SAMN10478084	Metagenomics samples from neuropathic diabetic foot ulcer (DFU) Metagenome
L11079.1	SRR8247713	0.84	0.68	0.58	SAMN10478085	Metagenomics samples from neuropathic diabetic foot ulcer (DFU) Metagenome
L11079.1	SRR8247714	0.84	0.68	0.58	SAMN10478086	Metagenomics samples from neuropathic diabetic foot ulcer (DFU) Metagenome
L11079.1	SRR8247716	0.84	0.68	0.58	SAMN10478088	Metagenomics samples from neuropathic diabetic foot ulcer (DFU) Metagenome
L11079.1	SRR8247721	0.84	0.68	0.58	SAMN10478093	Metagenomics samples from neuropathic diabetic foot ulcer (DFU) Metagenome
L11079.1	SRR8247727	0.84	0.68	0.58	SAMN10478099	Metagenomics samples from neuropathic diabetic foot ulcer (DFU) Metagenome
L11079.1	SRR8247731	0.84	0.68	0.58	SAMN10478103	Metagenomics samples from neuropathic diabetic foot ulcer (DFU) Metagenome
L11079.1	SRR8299387	0.84	0.68	0.58	SAMN10561998	Viral diversity in river catchment area
L11079.1	SRR8316610	0.84	0.68	0.58	SAMN10592368	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316627	0.84	0.68	0.58	SAMN10592349	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316631	0.84	0.68	0.58	SAMN10592357	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316646	0.84	0.68	0.58	SAMN10592384	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316691	0.84	0.68	0.58	SAMN10592392	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8353572	0.84	0.68	0.58	SAMN10615511	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353575	0.84	0.68	0.58	SAMN10615514	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353580	0.84	0.68	0.58	SAMN10615519	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353581	0.84	0.68	0.58	SAMN10615520	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353657	0.84	0.68	0.58	SAMN10616051	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353700	0.84	0.68	0.58	SAMN10616094	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353829	0.84	0.68	0.58	SAMN10615672	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353849	0.84	0.68	0.58	SAMN10615692	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353866	0.84	0.68	0.58	SAMN10615709	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353870	0.84	0.68	0.58	SAMN10615713	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353931	0.84	0.68	0.58	SAMN10615774	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353960	0.84	0.68	0.58	SAMN10615803	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354017	0.84	0.68	0.58	SAMN10615860	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354066	0.84	0.68	0.58	SAMN10615909	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354083	0.84	0.68	0.58	SAMN10615926	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354149	0.84	0.68	0.58	SAMN10615992	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427574	0.84	0.68	0.58	SAMN10722118	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427586	0.84	0.68	0.58	SAMN10722130	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427588	0.84	0.68	0.58	SAMN10722132	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427600	0.84	0.68	0.58	SAMN10722144	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427676	0.84	0.68	0.58	SAMN10722220	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427711	0.84	0.68	0.58	SAMN10722255	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427715	0.84	0.68	0.58	SAMN10722259	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427814	0.84	0.68	0.58	SAMN10722358	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427848	0.84	0.68	0.58	SAMN10722392	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427852	0.84	0.68	0.58	SAMN10722396	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427921	0.84	0.68	0.58	SAMN10722465	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427947	0.84	0.68	0.58	SAMN10722491	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427970	0.84	0.68	0.58	SAMN10722514	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427989	0.84	0.68	0.58	SAMN10722533	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427992	0.84	0.68	0.58	SAMN10722536	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428008	0.84	0.68	0.58	SAMN10722552	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428010	0.84	0.68	0.58	SAMN10722554	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428018	0.84	0.68	0.58	SAMN10722562	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428036	0.84	0.68	0.58	SAMN10722580	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428109	0.84	0.68	0.58	SAMN10722653	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428111	0.84	0.68	0.58	SAMN10722655	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428113	0.84	0.68	0.58	SAMN10722657	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428132	0.84	0.68	0.58	SAMN10722676	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428136	0.84	0.68	0.58	SAMN10722680	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428152	0.84	0.68	0.58	SAMN10722056	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428153	0.84	0.68	0.58	SAMN10722057	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428166	0.84	0.68	0.58	SAMN10722070	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428192	0.84	0.68	0.58	SAMN10722096	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8452364	0.84	0.68	0.58	SAMN10766127	Microbiome  study of dietary therapy on chronic enteritis in a canine model
L11079.1	SRR8550830	0.84	0.68	0.58	SAMN10888575	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550906	0.84	0.68	0.58	SAMN10888542	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8566263	0.84	0.68	0.58	SAMN10919937	Gut metagenome of infants in the neonatal intensive care unit
L11079.1	SRR8634432	0.84	0.68	0.58	SAMN11024083	Resistant microbiome underlies antibiotic therapy in pouchitis
L11079.1	SRR8652843	0.84	0.68	0.58	SAMN11031431	Human infant gut virome
L11079.1	SRR8652844	0.84	0.68	0.58	SAMN11031430	Human infant gut virome
L11079.1	SRR8652905	0.84	0.68	0.58	SAMN11031399	Human infant gut virome
L11079.1	SRR8653005	0.84	0.68	0.58	SAMN11031335	Human infant gut virome
L11079.1	SRR8653006	0.84	0.68	0.58	SAMN11031336	Human infant gut virome
L11079.1	SRR8653030	0.84	0.68	0.58	SAMN11031336	Human infant gut virome
L11079.1	SRR8653031	0.84	0.68	0.58	SAMN11031335	Human infant gut virome
L11079.1	SRR8653153	0.84	0.68	0.58	SAMN11031377	Human infant gut virome
L11079.1	SRR8653219	0.84	0.68	0.58	SAMN11031292	Human infant gut virome
L11079.1	SRR8653268	0.84	0.68	0.58	SAMN11031401	Human infant gut virome
L11079.1	SRR9670860	0.84	0.68	0.58	SAMN11031399	Human infant gut virome
L11079.1	SRR9670926	0.84	0.68	0.58	SAMN11031428	Human infant gut virome
L11079.1	SRR8666036	0.84	0.68	0.58	SAMN11046421	Human gut microbial communities from healthy child feces
L11079.1	SRR8715495	0.84	0.68	0.58	SAMN11106800	Israel Pilot-Scale Hospital Wastewater Treatment System Raw sequence reads
L11079.1	SRR8772116	0.84	0.68	0.58	SAMN11166841	Environment microbiome characterization for Powdered Infant formula Production Sites
L11079.1	SRR8791366	0.84	0.68	0.58	SAMN11265230	Metagenomic sequencing of stool samples from Ghanaian individuals
L11079.1	SRR8791382	0.84	0.68	0.58	SAMN11265254	Metagenomic sequencing of stool samples from Ghanaian individuals
L11079.1	SRR8791391	0.84	0.68	0.58	SAMN11265238	Metagenomic sequencing of stool samples from Ghanaian individuals
L11079.1	SRR8791407	0.84	0.68	0.58	SAMN11265223	Metagenomic sequencing of stool samples from Ghanaian individuals
L11079.1	SRR8797760	0.84	0.68	0.58	SAMN11269973	Alzheimers Disease microbiome in elders
L11079.1	SRR8845296	0.84	0.68	0.58	SAMN11311764	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845299	0.84	0.68	0.58	SAMN11311708	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845305	0.84	0.68	0.58	SAMN11311771	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845308	0.84	0.68	0.58	SAMN11311711	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845323	0.84	0.68	0.58	SAMN11311589	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845324	0.84	0.68	0.58	SAMN11311588	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845325	0.84	0.68	0.58	SAMN11311587	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845333	0.84	0.68	0.58	SAMN11311662	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845345	0.84	0.68	0.58	SAMN11311816	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845356	0.84	0.68	0.58	SAMN11311734	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845364	0.84	0.68	0.58	SAMN11311597	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845374	0.84	0.68	0.58	SAMN11311773	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845406	0.84	0.68	0.58	SAMN11311526	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845423	0.84	0.68	0.58	SAMN11311453	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845428	0.84	0.68	0.58	SAMN11311456	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845437	0.84	0.68	0.58	SAMN11311829	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845447	0.84	0.68	0.58	SAMN11311722	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845450	0.84	0.68	0.58	SAMN11311725	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845456	0.84	0.68	0.58	SAMN11311835	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845467	0.84	0.68	0.58	SAMN11311610	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845475	0.84	0.68	0.58	SAMN11311488	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845485	0.84	0.68	0.58	SAMN11311788	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845494	0.84	0.68	0.58	SAMN11311699	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845504	0.84	0.68	0.58	SAMN11311641	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845509	0.84	0.68	0.58	SAMN11311792	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845533	0.84	0.68	0.58	SAMN11311551	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845540	0.84	0.68	0.58	SAMN11311619	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845575	0.84	0.68	0.58	SAMN11311717	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845591	0.84	0.68	0.58	SAMN11311573	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845606	0.84	0.68	0.58	SAMN11311476	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845641	0.84	0.68	0.58	SAMN11311743	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845663	0.84	0.68	0.58	SAMN11311628	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845672	0.84	0.68	0.58	SAMN11311469	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8859383	0.84	0.68	0.58	SAMN11349277	fast halotolerant aerobic granulation
L11079.1	SRR8859386	0.84	0.68	0.58	SAMN11349276	fast halotolerant aerobic granulation
L11079.1	SRR8891655	0.84	0.68	0.58	SAMN11408541	PRASCO gut microbiome profile of Pediatric Severe Acute Ulcerative Colitis patients under Antimicrobial treatment
L11079.1	SRR8891666	0.84	0.68	0.58	SAMN11408472	PRASCO gut microbiome profile of Pediatric Severe Acute Ulcerative Colitis patients under Antimicrobial treatment
L11079.1	SRR8891812	0.84	0.68	0.58	SAMN11408571	PRASCO gut microbiome profile of Pediatric Severe Acute Ulcerative Colitis patients under Antimicrobial treatment
L11079.1	SRR8891878	0.84	0.68	0.58	SAMN11408462	PRASCO gut microbiome profile of Pediatric Severe Acute Ulcerative Colitis patients under Antimicrobial treatment
L11079.1	SRR8891915	0.84	0.68	0.58	SAMN11408499	PRASCO gut microbiome profile of Pediatric Severe Acute Ulcerative Colitis patients under Antimicrobial treatment
L11079.1	SRR8898517	0.84	0.68	0.58	SAMN11274020	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898541	0.84	0.68	0.58	SAMN11274030	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898550	0.84	0.68	0.58	SAMN11273930	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898687	0.84	0.68	0.58	SAMN11273778	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898689	0.84	0.68	0.58	SAMN11273977	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8926242	0.84	0.68	0.58	SAMN11258451	Marked loss of diversity and pathogen domination of the gut microbiota in critically ill patients
L11079.1	SRR8926263	0.84	0.68	0.58	SAMN11258439	Marked loss of diversity and pathogen domination of the gut microbiota in critically ill patients
L11079.1	SRR8926268	0.84	0.68	0.58	SAMN11258444	Marked loss of diversity and pathogen domination of the gut microbiota in critically ill patients
L11079.1	SRR8978457	0.84	0.68	0.58	SAMN11515097	Gut microbiome of humans and wild and captive chimpanzees and gorillas
L11079.1	SRR8978508	0.84	0.68	0.58	SAMN11515102	Gut microbiome of humans and wild and captive chimpanzees and gorillas
L11079.1	SRR9021703	0.84	0.68	0.58	SAMN11533248	Maize rhizosphere microbial communities from greenhouse at UC Davis, California, United States - 322HYB-C-2 metagenome
L11079.1	SRR9026581	0.84	0.68	0.58	SAMN08888812	Metagenomic study of co-metabolic degradation of refractory dye
L11079.1	SRR9026582	0.84	0.68	0.58	SAMN11603254	Metagenomic study of co-metabolic degradation of refractory dye
L11079.1	SRR9089463	0.84	0.68	0.58	SAMN11774703	Gut microbiota dysbiosis in spinal cord injury
L11079.1	SRR9089488	0.84	0.68	0.58	SAMN11774724	Gut microbiota dysbiosis in spinal cord injury
L11079.1	SRR9089489	0.84	0.68	0.58	SAMN11774692	Gut microbiota dysbiosis in spinal cord injury
L11079.1	SRR9089499	0.84	0.68	0.58	SAMN11774709	Gut microbiota dysbiosis in spinal cord injury
L11079.1	SRR9089500	0.84	0.68	0.58	SAMN11774708	Gut microbiota dysbiosis in spinal cord injury
L11079.1	SRR9108961	0.84	0.68	0.58	SAMN11418658	Human gut metagenome Metagenome
L11079.1	SRR9199253	0.84	0.68	0.58	SAMN11954420	Metagenomic Study of Gastrointestinal Tract Microbial Community Change During Long-Term Acute Care
L11079.1	SRR9199254	0.84	0.68	0.58	SAMN11954421	Metagenomic Study of Gastrointestinal Tract Microbial Community Change During Long-Term Acute Care
L11079.1	SRR9292719	0.84	0.68	0.58	SAMN11977834	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9292881	0.84	0.68	0.58	SAMN11977798	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9292991	0.84	0.68	0.58	SAMN11977809	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293007	0.84	0.68	0.58	SAMN11977891	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293223	0.84	0.68	0.58	SAMN11977812	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293236	0.84	0.68	0.58	SAMN11977792	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293288	0.84	0.68	0.58	SAMN11977848	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9302962	0.84	0.68	0.58	SAMN12058486	Different Trophic Status Lakes on Yun-Gui plateau of China
L11079.1	SRR9330519	0.84	0.68	0.58	SAMN12097523	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330623	0.84	0.68	0.58	SAMN12097435	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9654971	0.84	0.68	0.58	SAMN12231073	Shotgun metagenomics of human gut microbiota up to extreme longevity and the increasing role of xenobiotics degradation
L11079.1	SRR9865425	0.84	0.68	0.58	SAMN09980783	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9865426	0.84	0.68	0.58	SAMN09980782	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9865430	0.84	0.68	0.58	SAMN09980779	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9865446	0.84	0.68	0.58	SAMN09980928	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9865676	0.84	0.68	0.58	SAMN09980784	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9865677	0.84	0.68	0.58	SAMN09980785	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9865715	0.84	0.68	0.58	SAMN09980908	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9865718	0.84	0.68	0.58	SAMN09980909	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9878567	0.84	0.68	0.58	SAMN12340440	Microorganisms in anaerobic Biological treatment under different carbon and nitrogen ratios in the EGSB Raw sequence reads
L11079.1	SRR9879705	0.84	0.68	0.58	SAMN12418446	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR9879728	0.84	0.68	0.58	SAMN12418429	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR9879803	0.84	0.68	0.58	SAMN12418416	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR9879847	0.84	0.68	0.58	SAMN12418464	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR9969863	0.84	0.68	0.58	SAMN12574661	cynomolgus macaques gut metagenomic microbial community diversity
L11079.1	ERR3863443	0.74	0.68	0.51	""	""
L11079.1	ERR3863447	0.74	0.68	0.51	""	""
L11079.1	ERR3863450	0.74	0.68	0.51	""	""
L11079.1	ERR3870175	0.74	0.68	0.51	""	""
L11079.1	ERR3870178	0.74	0.68	0.51	""	""
L11079.1	DRR003623	0.74	0.68	0.51	SAMD00011170	Comprehensive Detection of Possible Pathogens Associated with Kawasaki Disease
L11079.1	DRR002667	0.74	0.68	0.51	SAMD00003163	Metgenomic analysis of human gut microbiome in patients with multiple sclerosis (MS).
L11079.1	DRR070852	0.74	0.68	0.51	SAMD00058876	Impacts of Intestinal microbiota on graft-versus-host disease and engraftment after hematopoietic stem cell transplant
L11079.1	DRR070902	0.74	0.68	0.51	SAMD00046784	Shotgun metagenomics of fecal bacterial consortium inhabiting healthy Asian children
L11079.1	DRR070920	0.74	0.68	0.51	SAMD00046802	Shotgun metagenomics of fecal bacterial consortium inhabiting healthy Asian children
L11079.1	DRR174608	0.74	0.68	0.51	SAMD00166383	Generic sample from human gut metagenome
L11079.1	DRR162180	0.74	0.68	0.51	SAMD00154142	Gut Microbiota dysbiosis leads to the development and progression of multiple sclerosis
L11079.1	ERR1018220	0.74	0.68	0.51	SAMEA3541504	Metagenomic analysis of fecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
L11079.1	ERR1018255	0.74	0.68	0.51	SAMEA3541539	Metagenomic analysis of fecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
L11079.1	ERR1018261	0.74	0.68	0.51	SAMEA3541545	Metagenomic analysis of fecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
L11079.1	ERR2238588	0.74	0.68	0.51	SAMEA3608766	American Gut Project
L11079.1	ERR2238697	0.74	0.68	0.51	SAMEA104187534	American Gut Project
L11079.1	ERR2239182	0.74	0.68	0.51	SAMEA3608973	American Gut Project
L11079.1	ERR2239185	0.74	0.68	0.51	SAMEA3608977	American Gut Project
L11079.1	ERR2239207	0.74	0.68	0.51	SAMEA3632926	American Gut Project
L11079.1	ERR2239307	0.74	0.68	0.51	SAMEA3865598	American Gut Project
L11079.1	ERR2239338	0.74	0.68	0.51	SAMEA104187392	American Gut Project
L11079.1	ERR2239653	0.74	0.68	0.51	SAMEA3947587	American Gut Project
L11079.1	ERR2242027	0.74	0.68	0.51	SAMEA3608977	American Gut Project
L11079.1	ERR2242033	0.74	0.68	0.51	SAMEA104187311	American Gut Project
L11079.1	ERR2242111	0.74	0.68	0.51	SAMEA104187534	American Gut Project
L11079.1	ERR2242465	0.74	0.68	0.51	SAMEA104187311	American Gut Project
L11079.1	ERR2242490	0.74	0.68	0.51	SAMEA104187534	American Gut Project
L11079.1	ERR5532596	0.74	0.68	0.51	SAMEA6675800	American Gut Project
L11079.1	ERR5532771	0.74	0.68	0.51	SAMEA6674824	American Gut Project
L11079.1	ERR5532772	0.74	0.68	0.51	SAMEA6674829	American Gut Project
L11079.1	ERR5947568	0.74	0.68	0.51	SAMEA93124918	American Gut Project
L11079.1	ERR1110317	0.74	0.68	0.51	SAMEA3646701	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1110474	0.74	0.68	0.51	SAMEA3646770	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136673	0.74	0.68	0.51	SAMEA3665052	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136746	0.74	0.68	0.51	SAMEA3664543	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136761	0.74	0.68	0.51	SAMEA3664558	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136827	0.74	0.68	0.51	SAMEA3664625	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136847	0.74	0.68	0.51	SAMEA3664645	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136865	0.74	0.68	0.51	SAMEA3664663	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136894	0.74	0.68	0.51	SAMEA3664692	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136939	0.74	0.68	0.51	SAMEA3664837	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136945	0.74	0.68	0.51	SAMEA3664843	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136954	0.74	0.68	0.51	SAMEA3664892	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1136988	0.74	0.68	0.51	SAMEA3664926	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137047	0.74	0.68	0.51	SAMEA3664985	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137105	0.74	0.68	0.51	SAMEA3664801	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137147	0.74	0.68	0.51	SAMEA3664843	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137174	0.74	0.68	0.51	SAMEA3664870	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137278	0.74	0.68	0.51	SAMEA3664764	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137296	0.74	0.68	0.51	SAMEA3664870	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137335	0.74	0.68	0.51	SAMEA3664892	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137380	0.74	0.68	0.51	SAMEA3665116	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137381	0.74	0.68	0.51	SAMEA3665127	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137395	0.74	0.68	0.51	SAMEA3664625	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137432	0.74	0.68	0.51	SAMEA3665120	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137543	0.74	0.68	0.51	SAMEA3665188	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1137689	0.74	0.68	0.51	SAMEA3665271	Towards personalized nutrition by prediction of glycemic responses
L11079.1	ERR1111351	0.74	0.68	0.51	SAMEA3648555	Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children
L11079.1	ERR1121416	0.74	0.68	0.51	SAMEA3648555	Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children
L11079.1	ERR1121417	0.74	0.68	0.51	SAMEA3648556	Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children
L11079.1	ERR1135319	0.74	0.68	0.51	SAMEA3663146	The Pig’s other genome: a reference gene catalogue of the gut microbiome
L11079.1	ERR1190540	0.74	0.68	0.51	SAMEA3708466	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190564	0.74	0.68	0.51	SAMEA3708490	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190565	0.74	0.68	0.51	SAMEA3708491	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190568	0.74	0.68	0.51	SAMEA3708494	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190570	0.74	0.68	0.51	SAMEA3708496	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190590	0.74	0.68	0.51	SAMEA3708516	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190591	0.74	0.68	0.51	SAMEA3708517	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190634	0.74	0.68	0.51	SAMEA3708560	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190642	0.74	0.68	0.51	SAMEA3708568	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190645	0.74	0.68	0.51	SAMEA3708571	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190650	0.74	0.68	0.51	SAMEA3708576	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190677	0.74	0.68	0.51	SAMEA3708603	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190692	0.74	0.68	0.51	SAMEA3708618	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190705	0.74	0.68	0.51	SAMEA3708631	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190720	0.74	0.68	0.51	SAMEA3708646	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190724	0.74	0.68	0.51	SAMEA3708650	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190737	0.74	0.68	0.51	SAMEA3708663	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190753	0.74	0.68	0.51	SAMEA3708679	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190755	0.74	0.68	0.51	SAMEA3708681	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190758	0.74	0.68	0.51	SAMEA3708684	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190759	0.74	0.68	0.51	SAMEA3708685	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190767	0.74	0.68	0.51	SAMEA3708693	Gut microbial dysbiosis in young adults with obesity
L11079.1	ERR1190795	0.74	0.68	0.51	SAMEA3708721	Gut microbiome-dependent stratification of patients for anti-diabetic treatment
L11079.1	ERR1190797	0.74	0.68	0.51	SAMEA3708723	Gut microbiome-dependent stratification of patients for anti-diabetic treatment
L11079.1	ERR1190879	0.74	0.68	0.51	SAMEA3708805	Gut microbiome-dependent stratification of patients for anti-diabetic treatment
L11079.1	ERR1190891	0.74	0.68	0.51	SAMEA3708817	Gut microbiome-dependent stratification of patients for anti-diabetic treatment
L11079.1	ERR1190933	0.74	0.68	0.51	SAMEA3708859	Gut microbiome-dependent stratification of patients for anti-diabetic treatment
L11079.1	ERR1190939	0.74	0.68	0.51	SAMEA3708865	Gut microbiome-dependent stratification of patients for anti-diabetic treatment
L11079.1	ERR1190958	0.74	0.68	0.51	SAMEA3708884	Gut microbiome-dependent stratification of patients for anti-diabetic treatment
L11079.1	ERR1198915	0.74	0.68	0.51	SAMEA3720196	Metatranscriptomes
L11079.1	ERR1224348	0.74	0.68	0.51	SAMEA3731127	Meta-genomic analysis of toilet waste from long distance flights
L11079.1	ERR1224349	0.74	0.68	0.51	SAMEA3731128	Meta-genomic analysis of toilet waste from long distance flights
L11079.1	ERR1224352	0.74	0.68	0.51	SAMEA3731131	Meta-genomic analysis of toilet waste from long distance flights
L11079.1	ERR1293297	0.74	0.68	0.51	SAMEA3879560	Reproducibility of associations between the human gut microbiome and colorectal cancer assessed in a patient population from Washington, DC, USA
L11079.1	ERR1293348	0.74	0.68	0.51	SAMEA3879572	Reproducibility of associations between the human gut microbiome and colorectal cancer assessed in a patient population from Washington, DC, USA
L11079.1	ERR1293740	0.74	0.68	0.51	SAMEA3879560	Reproducibility of associations between the human gut microbiome and colorectal cancer assessed in a patient population from Washington, DC, USA
L11079.1	ERR1293786	0.74	0.68	0.51	SAMEA3879572	Reproducibility of associations between the human gut microbiome and colorectal cancer assessed in a patient population from Washington, DC, USA
L11079.1	ERR1293787	0.74	0.68	0.51	SAMEA3879572	Reproducibility of associations between the human gut microbiome and colorectal cancer assessed in a patient population from Washington, DC, USA
L11079.1	ERR1293788	0.74	0.68	0.51	SAMEA3879572	Reproducibility of associations between the human gut microbiome and colorectal cancer assessed in a patient population from Washington, DC, USA
L11079.1	ERR1293789	0.74	0.68	0.51	SAMEA3879572	Reproducibility of associations between the human gut microbiome and colorectal cancer assessed in a patient population from Washington, DC, USA
L11079.1	ERR1297821	0.74	0.68	0.51	SAMEA3882520	Impact of faecal microbiota transplantation on the intestinal microbiome in metabolic syndrome patients
L11079.1	ERR1297834	0.74	0.68	0.51	SAMEA3882532	Impact of faecal microbiota transplantation on the intestinal microbiome in metabolic syndrome patients
L11079.1	ERR2243243	0.74	0.68	0.51	SAMEA3933832	Effects of preservation and storage conditions on the fecal microbiome
L11079.1	ERR5006376	0.74	0.68	0.51	SAMEA3932983	Effects of preservation and storage conditions on the fecal microbiome
L11079.1	ERR5006626	0.74	0.68	0.51	SAMEA3933980	Effects of preservation and storage conditions on the fecal microbiome
L11079.1	ERR5009346	0.74	0.68	0.51	SAMEA3933832	Effects of preservation and storage conditions on the fecal microbiome
L11079.1	ERR5012230	0.74	0.68	0.51	SAMEA3933832	Effects of preservation and storage conditions on the fecal microbiome
L11079.1	ERR1398070	0.74	0.68	0.51	SAMEA3951690	Hypertension is one of the most prevalent cardiovascular diseases worldwide. Recent findings have identified a link between gut microbiota and blood pressure, yet the contributions of gut microbes and bacterial metabolites towards hypertension remain largely uncharacterized. We carried out metagenomic and metabonomics analyses, in combination with faecal microbiota transplantation, and elucidate that dysbiosis of gut microbiome triggers the pathogenesis of hypertension through altering the metabolic effects.
L11079.1	ERR1398083	0.74	0.68	0.51	SAMEA3951616	Hypertension is one of the most prevalent cardiovascular diseases worldwide. Recent findings have identified a link between gut microbiota and blood pressure, yet the contributions of gut microbes and bacterial metabolites towards hypertension remain largely uncharacterized. We carried out metagenomic and metabonomics analyses, in combination with faecal microbiota transplantation, and elucidate that dysbiosis of gut microbiome triggers the pathogenesis of hypertension through altering the metabolic effects.
L11079.1	ERR1398100	0.74	0.68	0.51	SAMEA3951635	Hypertension is one of the most prevalent cardiovascular diseases worldwide. Recent findings have identified a link between gut microbiota and blood pressure, yet the contributions of gut microbes and bacterial metabolites towards hypertension remain largely uncharacterized. We carried out metagenomic and metabonomics analyses, in combination with faecal microbiota transplantation, and elucidate that dysbiosis of gut microbiome triggers the pathogenesis of hypertension through altering the metabolic effects.
L11079.1	ERR1398113	0.74	0.68	0.51	SAMEA3951622	Hypertension is one of the most prevalent cardiovascular diseases worldwide. Recent findings have identified a link between gut microbiota and blood pressure, yet the contributions of gut microbes and bacterial metabolites towards hypertension remain largely uncharacterized. We carried out metagenomic and metabonomics analyses, in combination with faecal microbiota transplantation, and elucidate that dysbiosis of gut microbiome triggers the pathogenesis of hypertension through altering the metabolic effects.
L11079.1	ERR1398118	0.74	0.68	0.51	SAMEA3951629	Hypertension is one of the most prevalent cardiovascular diseases worldwide. Recent findings have identified a link between gut microbiota and blood pressure, yet the contributions of gut microbes and bacterial metabolites towards hypertension remain largely uncharacterized. We carried out metagenomic and metabonomics analyses, in combination with faecal microbiota transplantation, and elucidate that dysbiosis of gut microbiome triggers the pathogenesis of hypertension through altering the metabolic effects.
L11079.1	ERR1398125	0.74	0.68	0.51	SAMEA3951718	Hypertension is one of the most prevalent cardiovascular diseases worldwide. Recent findings have identified a link between gut microbiota and blood pressure, yet the contributions of gut microbes and bacterial metabolites towards hypertension remain largely uncharacterized. We carried out metagenomic and metabonomics analyses, in combination with faecal microbiota transplantation, and elucidate that dysbiosis of gut microbiome triggers the pathogenesis of hypertension through altering the metabolic effects.
L11079.1	ERR1398208	0.74	0.68	0.51	SAMEA3951724	Hypertension is one of the most prevalent cardiovascular diseases worldwide. Recent findings have identified a link between gut microbiota and blood pressure, yet the contributions of gut microbes and bacterial metabolites towards hypertension remain largely uncharacterized. We carried out metagenomic and metabonomics analyses, in combination with faecal microbiota transplantation, and elucidate that dysbiosis of gut microbiome triggers the pathogenesis of hypertension through altering the metabolic effects.
L11079.1	ERR1398210	0.74	0.68	0.51	SAMEA3951688	Hypertension is one of the most prevalent cardiovascular diseases worldwide. Recent findings have identified a link between gut microbiota and blood pressure, yet the contributions of gut microbes and bacterial metabolites towards hypertension remain largely uncharacterized. We carried out metagenomic and metabonomics analyses, in combination with faecal microbiota transplantation, and elucidate that dysbiosis of gut microbiome triggers the pathogenesis of hypertension through altering the metabolic effects.
L11079.1	ERR1430398	0.74	0.68	0.51	SAMEA4019152	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1430399	0.74	0.68	0.51	SAMEA4019153	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1430401	0.74	0.68	0.51	SAMEA4019155	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1430412	0.74	0.68	0.51	SAMEA4019166	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1430445	0.74	0.68	0.51	SAMEA4019199	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1430453	0.74	0.68	0.51	SAMEA4019207	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1430525	0.74	0.68	0.51	SAMEA4019279	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1430528	0.74	0.68	0.51	SAMEA4019282	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1430529	0.74	0.68	0.51	SAMEA4019283	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1430553	0.74	0.68	0.51	SAMEA4019307	Using two diets to modulate gut  microbiota to alleviate human type 2 diabetes
L11079.1	ERR1449717	0.74	0.68	0.51	SAMEA4031705	Gut microbiota of 10 pairs of Chinese infant twins
L11079.1	ERR1449718	0.74	0.68	0.51	SAMEA4031706	Gut microbiota of 10 pairs of Chinese infant twins
L11079.1	ERR1449722	0.74	0.68	0.51	SAMEA4031708	Gut microbiota of 10 pairs of Chinese infant twins
L11079.1	ERR1449724	0.74	0.68	0.51	SAMEA4031700	Gut microbiota of 10 pairs of Chinese infant twins
L11079.1	ERR1449738	0.74	0.68	0.51	SAMEA4031715	Gut microbiota of 10 pairs of Chinese infant twins
L11079.1	ERR1543947	0.74	0.68	0.51	SAMEA4350113	Evaluating the Potential of using Next-Generation Sequencing for Direct Clinical Diagnostics of Faecal Samples from Patients with Diarrhoea
L11079.1	ERR1543948	0.74	0.68	0.51	SAMEA4350114	Evaluating the Potential of using Next-Generation Sequencing for Direct Clinical Diagnostics of Faecal Samples from Patients with Diarrhoea
L11079.1	ERR1543980	0.74	0.68	0.51	SAMEA4350146	Evaluating the Potential of using Next-Generation Sequencing for Direct Clinical Diagnostics of Faecal Samples from Patients with Diarrhoea
L11079.1	ERR1543983	0.74	0.68	0.51	SAMEA4350149	Evaluating the Potential of using Next-Generation Sequencing for Direct Clinical Diagnostics of Faecal Samples from Patients with Diarrhoea
L11079.1	ERR1543985	0.74	0.68	0.51	SAMEA4350151	Evaluating the Potential of using Next-Generation Sequencing for Direct Clinical Diagnostics of Faecal Samples from Patients with Diarrhoea
L11079.1	ERR1543986	0.74	0.68	0.51	SAMEA4350152	Evaluating the Potential of using Next-Generation Sequencing for Direct Clinical Diagnostics of Faecal Samples from Patients with Diarrhoea
L11079.1	ERR973781	0.74	0.68	0.51	SAMEA3495360	Dissecting effects of community context on a gut pathobiont in a model of childhood undernutrition
L11079.1	ERR973823	0.74	0.68	0.51	SAMEA3495402	Dissecting effects of community context on a gut pathobiont in a model of childhood undernutrition
L11079.1	ERR973860	0.74	0.68	0.51	SAMEA3495439	Dissecting effects of community context on a gut pathobiont in a model of childhood undernutrition
L11079.1	ERR973862	0.74	0.68	0.51	SAMEA3495441	Dissecting effects of community context on a gut pathobiont in a model of childhood undernutrition
L11079.1	ERR1578690	0.74	0.68	0.51	SAMEA4378299	Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease
L11079.1	ERR1600669	0.74	0.68	0.51	SAMEA4385527	Using WTP diet to modulate gut microbiota to alleviate human type 2 diabetes
L11079.1	ERR1600673	0.74	0.68	0.51	SAMEA4385531	Using WTP diet to modulate gut microbiota to alleviate human type 2 diabetes
L11079.1	ERR1600678	0.74	0.68	0.51	SAMEA4385536	Using WTP diet to modulate gut microbiota to alleviate human type 2 diabetes
L11079.1	ERR1600716	0.74	0.68	0.51	SAMEA4385574	Using WTP diet to modulate gut microbiota to alleviate human type 2 diabetes
L11079.1	ERR1600743	0.74	0.68	0.51	SAMEA4385601	Using WTP diet to modulate gut microbiota to alleviate human type 2 diabetes
L11079.1	ERR1606358	0.74	0.68	0.51	SAMEA4413796	Structure and function of the fecal microbiota in diarrhoeic neonatal piglets
L11079.1	ERR1620288	0.74	0.68	0.51	SAMEA4431901	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	ERR1620306	0.74	0.68	0.51	SAMEA4431919	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	ERR1620307	0.74	0.68	0.51	SAMEA4431920	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	ERR1620311	0.74	0.68	0.51	SAMEA4431924	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	ERR1620375	0.74	0.68	0.51	SAMEA4431988	The gut microbiome in Crohn's disease and modulation by exclusive enteral nutrition
L11079.1	ERR1697183	0.74	0.68	0.51	SAMEA4516828	Saliva microbiome of pig in Japan
L11079.1	ERR1711793	0.74	0.68	0.51	SAMEA4525215	KCL_twins2
L11079.1	ERR1713337	0.74	0.68	0.51	SAMEA4527605	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713352	0.74	0.68	0.51	SAMEA4527620	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713353	0.74	0.68	0.51	SAMEA4527621	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713362	0.74	0.68	0.51	SAMEA4527630	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713365	0.74	0.68	0.51	SAMEA4527633	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713378	0.74	0.68	0.51	SAMEA4527646	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713384	0.74	0.68	0.51	SAMEA4527652	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1713410	0.74	0.68	0.51	SAMEA4527678	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1725950	0.74	0.68	0.51	SAMEA4527605	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1725953	0.74	0.68	0.51	SAMEA4527606	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1726031	0.74	0.68	0.51	SAMEA4527678	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1726033	0.74	0.68	0.51	SAMEA4527679	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR2592283	0.74	0.68	0.51	SAMEA4527679	Global surveillance of infectious diseases and antimicrobial resistance from sewage
L11079.1	ERR1727319	0.74	0.68	0.51	SAMEA4545320	Subspecies in the global human gut microbiome
L11079.1	ERR1727321	0.74	0.68	0.51	SAMEA4545320	Subspecies in the global human gut microbiome
L11079.1	ERR1727322	0.74	0.68	0.51	SAMEA4545320	Subspecies in the global human gut microbiome
L11079.1	ERR1727539	0.74	0.68	0.51	SAMEA4545336	Subspecies in the global human gut microbiome
L11079.1	ERR1727740	0.74	0.68	0.51	SAMEA4545434	Subspecies in the global human gut microbiome
L11079.1	ERR1727742	0.74	0.68	0.51	SAMEA4545434	Subspecies in the global human gut microbiome
L11079.1	ERR1728270	0.74	0.68	0.51	SAMEA4545294	Subspecies in the global human gut microbiome
L11079.1	ERR1728271	0.74	0.68	0.51	SAMEA4545294	Subspecies in the global human gut microbiome
L11079.1	ERR1728272	0.74	0.68	0.51	SAMEA4545294	Subspecies in the global human gut microbiome
L11079.1	ERR1728441	0.74	0.68	0.51	SAMEA4545320	Subspecies in the global human gut microbiome
L11079.1	ERR1728442	0.74	0.68	0.51	SAMEA4545320	Subspecies in the global human gut microbiome
L11079.1	ERR1730266	0.74	0.68	0.51	SAMEA4546691	Metagenomic shotgun sequences of human gut microbiota
L11079.1	ERR184745	0.74	0.68	0.51	SAMEA1712155	Gut microbiomes of Malawian twin pairs discordant for kwashiorkor
L11079.1	ERR184777	0.74	0.68	0.51	SAMEA1712137	Gut microbiomes of Malawian twin pairs discordant for kwashiorkor
L11079.1	ERR184839	0.74	0.68	0.51	SAMEA1712162	Gut microbiomes of Malawian twin pairs discordant for kwashiorkor
L11079.1	ERR184919	0.74	0.68	0.51	SAMEA1712143	Gut microbiomes of Malawian twin pairs discordant for kwashiorkor
L11079.1	ERR184984	0.74	0.68	0.51	SAMEA1712142	Gut microbiomes of Malawian twin pairs discordant for kwashiorkor
L11079.1	ERR1855539	0.74	0.68	0.51	SAMEA99904168	Metagenomic analysis of gut microbiota in sows and piglets (EBI)
L11079.1	ERR1995231	0.74	0.68	0.51	SAMEA104062404	Gut resistome modulates resilience and recovery of gut microbiota after broad-spectrum antibiotic treatment
L11079.1	ERR1995247	0.74	0.68	0.51	SAMEA104062419	Gut resistome modulates resilience and recovery of gut microbiota after broad-spectrum antibiotic treatment
L11079.1	ERR1995307	0.74	0.68	0.51	SAMEA104062419	Gut resistome modulates resilience and recovery of gut microbiota after broad-spectrum antibiotic treatment
L11079.1	ERR2013568	0.74	0.68	0.51	SAMEA37067668	Connections between the gut microbiome and gestational diabetes mellitus
L11079.1	ERR2017444	0.74	0.68	0.51	SAMEA104142340	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017467	0.74	0.68	0.51	SAMEA104142231	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017500	0.74	0.68	0.51	SAMEA104142225	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017532	0.74	0.68	0.51	SAMEA104142077	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017552	0.74	0.68	0.51	SAMEA104142134	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017553	0.74	0.68	0.51	SAMEA104142133	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017606	0.74	0.68	0.51	SAMEA104142297	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017651	0.74	0.68	0.51	SAMEA104142315	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017666	0.74	0.68	0.51	SAMEA104142243	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017672	0.74	0.68	0.51	SAMEA104142321	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017677	0.74	0.68	0.51	SAMEA104142317	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017684	0.74	0.68	0.51	SAMEA104142203	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017686	0.74	0.68	0.51	SAMEA104142201	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017736	0.74	0.68	0.51	SAMEA104142085	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2017790	0.74	0.68	0.51	SAMEA104142446	Here we performed a metagenome-wide association study (MWAS) on stools from 218 individuals with atherosclerotic cardiovascular disease (ACVD) and 187 healthy controls.
L11079.1	ERR2019357	0.74	0.68	0.51	SAMEA104143055	Ruminomics EU Project : Deep metagenome sequencing of European cows rumen samples
L11079.1	ERR209332	0.74	0.68	0.51	SAMEA2042490	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	ERR209338	0.74	0.68	0.51	SAMEA2042490	A method for identifying metagenomic species and variable genetic elements by exhaustive co-abundance binning
L11079.1	ERR2162209	0.74	0.68	0.51	SAMEA104335950	Gut microbiome impacts response to PD-1 immunotherapy in melanoma patients
L11079.1	ERR2193648	0.74	0.68	0.51	SAMEA104378408	BBSRC Main Experiment Shotgun Study
L11079.1	ERR2193696	0.74	0.68	0.51	SAMEA104378456	BBSRC Main Experiment Shotgun Study
L11079.1	ERR2194147	0.74	0.68	0.51	SAMEA104378911	BBSRC Main Experiment Shotgun Study
L11079.1	ERR2198616	0.74	0.68	0.51	SAMEA104393691	WGS data from FMT trial for the treatment of recurrent Clostridium difficile infection
L11079.1	ERR2198653	0.74	0.68	0.51	SAMEA104393728	WGS data from FMT trial for the treatment of recurrent Clostridium difficile infection
L11079.1	ERR2198657	0.74	0.68	0.51	SAMEA104393732	WGS data from FMT trial for the treatment of recurrent Clostridium difficile infection
L11079.1	ERR2198658	0.74	0.68	0.51	SAMEA104393733	WGS data from FMT trial for the treatment of recurrent Clostridium difficile infection
L11079.1	ERR2200459	0.74	0.68	0.51	SAMEA4527637	COMPARE global sewage snapshot virome sequencing part
L11079.1	ERR2205744	0.74	0.68	0.51	SAMEA104407250	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205755	0.74	0.68	0.51	SAMEA104407261	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205763	0.74	0.68	0.51	SAMEA104407269	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205774	0.74	0.68	0.51	SAMEA104407280	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205775	0.74	0.68	0.51	SAMEA104407281	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205783	0.74	0.68	0.51	SAMEA104407289	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205784	0.74	0.68	0.51	SAMEA104407290	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205793	0.74	0.68	0.51	SAMEA104407299	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205803	0.74	0.68	0.51	SAMEA104407309	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205804	0.74	0.68	0.51	SAMEA104407310	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205824	0.74	0.68	0.51	SAMEA104407330	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205834	0.74	0.68	0.51	SAMEA104407340	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205835	0.74	0.68	0.51	SAMEA104407341	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205843	0.74	0.68	0.51	SAMEA104407349	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205848	0.74	0.68	0.51	SAMEA104407354	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205856	0.74	0.68	0.51	SAMEA104407362	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205863	0.74	0.68	0.51	SAMEA104407369	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2205864	0.74	0.68	0.51	SAMEA104407370	A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses
L11079.1	ERR2235232	0.74	0.68	0.51	SAMEA104416224	Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB
L11079.1	ERR2241689	0.74	0.68	0.51	SAMEA104467192	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241692	0.74	0.68	0.51	SAMEA104467195	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241701	0.74	0.68	0.51	SAMEA104467204	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241702	0.74	0.68	0.51	SAMEA104467205	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241725	0.74	0.68	0.51	SAMEA104467228	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241762	0.74	0.68	0.51	SAMEA104467265	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241782	0.74	0.68	0.51	SAMEA104467285	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241792	0.74	0.68	0.51	SAMEA104467295	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241818	0.74	0.68	0.51	SAMEA104467321	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241851	0.74	0.68	0.51	SAMEA104467354	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241898	0.74	0.68	0.51	SAMEA104467401	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241907	0.74	0.68	0.51	SAMEA104467410	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241921	0.74	0.68	0.51	SAMEA104467424	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241923	0.74	0.68	0.51	SAMEA104467426	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241935	0.74	0.68	0.51	SAMEA104467438	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241941	0.74	0.68	0.51	SAMEA104467444	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241957	0.74	0.68	0.51	SAMEA104467460	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241972	0.74	0.68	0.51	SAMEA104467475	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2241983	0.74	0.68	0.51	SAMEA104467486	As part of the EFFORT project, we sampled feces from pig and poultry livestock in nine European countries (BE, BG, DK, FR, ES, GE, NL, PL, SP). More than 9000 animals were sampled, across 181 pig and 178 poultry herds to generate herd-level composite fecal samples. Using shotgun metagenomics, we have quantified and characterized the antimicrobial resistance gene pools (resistomes) in Europe's two most intensively raised livestock species.
L11079.1	ERR2262427	0.74	0.68	0.51	SAMEA104500084	Alterations of the intestinal microbiome in patients with retinal artery occlusion
L11079.1	ERR2367182	0.74	0.68	0.51	SAMEA104562377	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367212	0.74	0.68	0.51	SAMEA104562407	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367225	0.74	0.68	0.51	SAMEA104562420	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367229	0.74	0.68	0.51	SAMEA104562424	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367240	0.74	0.68	0.51	SAMEA104562435	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367261	0.74	0.68	0.51	SAMEA104562456	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367270	0.74	0.68	0.51	SAMEA104562465	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367273	0.74	0.68	0.51	SAMEA104562468	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367283	0.74	0.68	0.51	SAMEA104562478	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367286	0.74	0.68	0.51	SAMEA104562481	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367300	0.74	0.68	0.51	SAMEA104562495	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367317	0.74	0.68	0.51	SAMEA104562512	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367325	0.74	0.68	0.51	SAMEA104562520	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367338	0.74	0.68	0.51	SAMEA104562533	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367353	0.74	0.68	0.51	SAMEA104562548	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367357	0.74	0.68	0.51	SAMEA104562552	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367366	0.74	0.68	0.51	SAMEA104562561	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367376	0.74	0.68	0.51	SAMEA104562571	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367379	0.74	0.68	0.51	SAMEA104562574	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367393	0.74	0.68	0.51	SAMEA104562588	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367400	0.74	0.68	0.51	SAMEA104562595	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367420	0.74	0.68	0.51	SAMEA104562613	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367438	0.74	0.68	0.51	SAMEA104562630	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367445	0.74	0.68	0.51	SAMEA104562637	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367475	0.74	0.68	0.51	SAMEA104562667	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367491	0.74	0.68	0.51	SAMEA104562683	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367495	0.74	0.68	0.51	SAMEA104562687	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367516	0.74	0.68	0.51	SAMEA104562708	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367532	0.74	0.68	0.51	SAMEA104562724	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367549	0.74	0.68	0.51	SAMEA104562741	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367567	0.74	0.68	0.51	SAMEA104562759	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367593	0.74	0.68	0.51	SAMEA104562785	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367594	0.74	0.68	0.51	SAMEA104562786	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367604	0.74	0.68	0.51	SAMEA104562796	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367614	0.74	0.68	0.51	SAMEA104562806	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367619	0.74	0.68	0.51	SAMEA104562811	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367640	0.74	0.68	0.51	SAMEA104562832	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367646	0.74	0.68	0.51	SAMEA104562838	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367674	0.74	0.68	0.51	SAMEA104562866	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367695	0.74	0.68	0.51	SAMEA104562887	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367722	0.74	0.68	0.51	SAMEA104562914	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367742	0.74	0.68	0.51	SAMEA104562934	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367743	0.74	0.68	0.51	SAMEA104562935	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367746	0.74	0.68	0.51	SAMEA104562938	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367748	0.74	0.68	0.51	SAMEA104562940	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367751	0.74	0.68	0.51	SAMEA104562943	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367798	0.74	0.68	0.51	SAMEA104562990	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367807	0.74	0.68	0.51	SAMEA104562999	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367809	0.74	0.68	0.51	SAMEA104563001	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367810	0.74	0.68	0.51	SAMEA104563002	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367848	0.74	0.68	0.51	SAMEA104563040	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367850	0.74	0.68	0.51	SAMEA104563042	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367854	0.74	0.68	0.51	SAMEA104563046	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367860	0.74	0.68	0.51	SAMEA104563052	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367868	0.74	0.68	0.51	SAMEA104563060	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367871	0.74	0.68	0.51	SAMEA104563063	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367880	0.74	0.68	0.51	SAMEA104563072	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367882	0.74	0.68	0.51	SAMEA104563074	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367891	0.74	0.68	0.51	SAMEA104563083	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367894	0.74	0.68	0.51	SAMEA104563086	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367899	0.74	0.68	0.51	SAMEA104563091	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367905	0.74	0.68	0.51	SAMEA104563097	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367913	0.74	0.68	0.51	SAMEA104563105	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367929	0.74	0.68	0.51	SAMEA104563121	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367948	0.74	0.68	0.51	SAMEA104563140	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367953	0.74	0.68	0.51	SAMEA104563145	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367960	0.74	0.68	0.51	SAMEA104563152	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367964	0.74	0.68	0.51	SAMEA104563156	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367967	0.74	0.68	0.51	SAMEA104563159	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367968	0.74	0.68	0.51	SAMEA104563160	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367979	0.74	0.68	0.51	SAMEA104563171	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367990	0.74	0.68	0.51	SAMEA104563182	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367997	0.74	0.68	0.51	SAMEA104563189	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2367999	0.74	0.68	0.51	SAMEA104563191	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368003	0.74	0.68	0.51	SAMEA104563195	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368014	0.74	0.68	0.51	SAMEA104563206	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368025	0.74	0.68	0.51	SAMEA104563217	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368051	0.74	0.68	0.51	SAMEA104563243	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368069	0.74	0.68	0.51	SAMEA104563261	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368071	0.74	0.68	0.51	SAMEA104563263	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368076	0.74	0.68	0.51	SAMEA104563267	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368090	0.74	0.68	0.51	SAMEA104563281	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368109	0.74	0.68	0.51	SAMEA104563299	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368142	0.74	0.68	0.51	SAMEA104563336	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368188	0.74	0.68	0.51	SAMEA104563405	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368193	0.74	0.68	0.51	SAMEA104563416	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368201	0.74	0.68	0.51	SAMEA104563424	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368205	0.74	0.68	0.51	SAMEA104563428	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368217	0.74	0.68	0.51	SAMEA104563440	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368225	0.74	0.68	0.51	SAMEA104563448	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368232	0.74	0.68	0.51	SAMEA104563467	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368235	0.74	0.68	0.51	SAMEA104563470	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368244	0.74	0.68	0.51	SAMEA104563479	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368245	0.74	0.68	0.51	SAMEA104563480	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368257	0.74	0.68	0.51	SAMEA104563492	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368264	0.74	0.68	0.51	SAMEA104563499	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368318	0.74	0.68	0.51	SAMEA104563563	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368326	0.74	0.68	0.51	SAMEA104563571	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368338	0.74	0.68	0.51	SAMEA104563589	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368344	0.74	0.68	0.51	SAMEA104563595	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368345	0.74	0.68	0.51	SAMEA104563608	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368348	0.74	0.68	0.51	SAMEA104563611	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368366	0.74	0.68	0.51	SAMEA104563645	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368375	0.74	0.68	0.51	SAMEA104563654	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368376	0.74	0.68	0.51	SAMEA104563655	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368390	0.74	0.68	0.51	SAMEA104563669	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368441	0.74	0.68	0.51	SAMEA104563855	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368449	0.74	0.68	0.51	SAMEA104563874	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368459	0.74	0.68	0.51	SAMEA104563890	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368466	0.74	0.68	0.51	SAMEA104563897	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368498	0.74	0.68	0.51	SAMEA104564138	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368517	0.74	0.68	0.51	SAMEA104564187	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368518	0.74	0.68	0.51	SAMEA104564188	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368519	0.74	0.68	0.51	SAMEA104564189	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2368534	0.74	0.68	0.51	SAMEA104564204	Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children
L11079.1	ERR2391219	0.74	0.68	0.51	SAMEA104679484	A cross-sectional study of compositional and functional profiles of gut microbiota in Sardinian centenarians
L11079.1	ERR2587781	0.74	0.68	0.51	SAMEA4670471	BBC study
L11079.1	ERR2589136	0.74	0.68	0.51	SAMEA4672374	ShotGun BACTERIAL AND FUNCTIONAL DETERMINANTS OF OUTCOME IN FAECAL MICROBIOTA TRANSPLANTATION FOR ACTIVE ULCERATIVE COLITIS
L11079.1	ERR2597417	0.74	0.68	0.51	SAMEA4688931	VETII samples
L11079.1	ERR260221	0.74	0.68	0.51	SAMEA1906530	Gut metagenome in European women with normal, impaired and diabetic glucose control
L11079.1	ERR2607394	0.74	0.68	0.51	SAMEA4700715	Global surveillance of antimicrobial resistance
L11079.1	ERR2607396	0.74	0.68	0.51	SAMEA4700717	Global surveillance of antimicrobial resistance
L11079.1	ERR2607399	0.74	0.68	0.51	SAMEA4700720	Global surveillance of antimicrobial resistance
L11079.1	ERR2607440	0.74	0.68	0.51	SAMEA4700761	Global surveillance of antimicrobial resistance
L11079.1	ERR2607441	0.74	0.68	0.51	SAMEA4700762	Global surveillance of antimicrobial resistance
L11079.1	ERR2607466	0.74	0.68	0.51	SAMEA4700787	Global surveillance of antimicrobial resistance
L11079.1	ERR2607475	0.74	0.68	0.51	SAMEA4700796	Global surveillance of antimicrobial resistance
L11079.1	ERR2607509	0.74	0.68	0.51	SAMEA4700830	Global surveillance of antimicrobial resistance
L11079.1	ERR2607520	0.74	0.68	0.51	SAMEA4700841	Global surveillance of antimicrobial resistance
L11079.1	ERR2607596	0.74	0.68	0.51	SAMEA4700917	Global surveillance of antimicrobial resistance
L11079.1	ERR2607599	0.74	0.68	0.51	SAMEA4700920	Global surveillance of antimicrobial resistance
L11079.1	ERR2607603	0.74	0.68	0.51	SAMEA4700924	Global surveillance of antimicrobial resistance
L11079.1	ERR2607605	0.74	0.68	0.51	SAMEA4700926	Global surveillance of antimicrobial resistance
L11079.1	ERR2608630	0.74	0.68	0.51	SAMEA4702370	gut metagenome of ASD
L11079.1	ERR2608636	0.74	0.68	0.51	SAMEA4702376	gut metagenome of ASD
L11079.1	ERR2608638	0.74	0.68	0.51	SAMEA4702378	gut metagenome of ASD
L11079.1	ERR2608643	0.74	0.68	0.51	SAMEA4702383	gut metagenome of ASD
L11079.1	ERR2608646	0.74	0.68	0.51	SAMEA4702386	gut metagenome of ASD
L11079.1	ERR2608649	0.74	0.68	0.51	SAMEA4702389	gut metagenome of ASD
L11079.1	ERR2608652	0.74	0.68	0.51	SAMEA4702392	gut metagenome of ASD
L11079.1	ERR2608657	0.74	0.68	0.51	SAMEA4702397	gut metagenome of ASD
L11079.1	ERR2608666	0.74	0.68	0.51	SAMEA4702405	gut metagenome of ASD
L11079.1	ERR2608989	0.74	0.68	0.51	SAMEA4702359	gut metagenome of ASD
L11079.1	ERR2619708	0.74	0.68	0.51	SAMEA4719761	Gut metagenomes of rural populations in Cameroon
L11079.1	ERR2619719	0.74	0.68	0.51	SAMEA4719772	Gut metagenomes of rural populations in Cameroon
L11079.1	ERR2619739	0.74	0.68	0.51	SAMEA4719792	Gut metagenomes of rural populations in Cameroon
L11079.1	ERR2641231	0.74	0.68	0.51	SAMEA4731435	Microbiome metagenome analysis of stool samples from individuals with low and high salivary amylase gene copy numbers
L11079.1	ERR2641340	0.74	0.68	0.51	SAMEA4731443	Microbiome metagenome analysis of stool samples from individuals with low and high salivary amylase gene copy numbers
L11079.1	ERR2641387	0.74	0.68	0.51	SAMEA4731422	Microbiome metagenome analysis of stool samples from individuals with low and high salivary amylase gene copy numbers
L11079.1	ERR2641395	0.74	0.68	0.51	SAMEA4731443	Microbiome metagenome analysis of stool samples from individuals with low and high salivary amylase gene copy numbers
L11079.1	ERR2641424	0.74	0.68	0.51	SAMEA4731443	Microbiome metagenome analysis of stool samples from individuals with low and high salivary amylase gene copy numbers
L11079.1	ERR2641462	0.74	0.68	0.51	SAMEA4731435	Microbiome metagenome analysis of stool samples from individuals with low and high salivary amylase gene copy numbers
L11079.1	ERR2641471	0.74	0.68	0.51	SAMEA4731422	Microbiome metagenome analysis of stool samples from individuals with low and high salivary amylase gene copy numbers
L11079.1	ERR2641488	0.74	0.68	0.51	SAMEA4731435	Microbiome metagenome analysis of stool samples from individuals with low and high salivary amylase gene copy numbers
L11079.1	ERR2641497	0.74	0.68	0.51	SAMEA4731422	Microbiome metagenome analysis of stool samples from individuals with low and high salivary amylase gene copy numbers
L11079.1	ERR2641675	0.74	0.68	0.51	SAMEA4731443	Microbiome metagenome analysis of stool samples from individuals with low and high salivary amylase gene copy numbers
L11079.1	ERR2641713	0.74	0.68	0.51	SAMEA4731435	Microbiome metagenome analysis of stool samples from individuals with low and high salivary amylase gene copy numbers
L11079.1	ERR2676677	0.74	0.68	0.51	SAMEA4588094	Impact-of-Vegetarian-Diet
L11079.1	ERR2683116	0.74	0.68	0.51	SAMEA4777373	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683117	0.74	0.68	0.51	SAMEA4777374	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683122	0.74	0.68	0.51	SAMEA4777379	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683135	0.74	0.68	0.51	SAMEA4777392	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683156	0.74	0.68	0.51	SAMEA4777413	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683158	0.74	0.68	0.51	SAMEA4777415	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683163	0.74	0.68	0.51	SAMEA4777420	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683172	0.74	0.68	0.51	SAMEA4777429	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683183	0.74	0.68	0.51	SAMEA4777440	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683187	0.74	0.68	0.51	SAMEA4777444	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683224	0.74	0.68	0.51	SAMEA4777481	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683225	0.74	0.68	0.51	SAMEA4777482	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683236	0.74	0.68	0.51	SAMEA4777493	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683241	0.74	0.68	0.51	SAMEA4777498	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683264	0.74	0.68	0.51	SAMEA4777521	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2683269	0.74	0.68	0.51	SAMEA4777526	Global surveillance of antimicrobial resistance - Batch June 2017
L11079.1	ERR2855776	0.74	0.68	0.51	SAMEA4813874	KOALA cohort metagenome study
L11079.1	ERR3003479	0.74	0.68	0.51	SAMEA4813896	KOALA cohort metagenome study
L11079.1	ERR3004219	0.74	0.68	0.51	SAMEA4813780	KOALA cohort metagenome study
L11079.1	ERR2726452	0.74	0.68	0.51	SAMEA4817929	Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer.
L11079.1	ERR2726582	0.74	0.68	0.51	SAMEA4817929	Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer.
L11079.1	ERR2749155	0.74	0.68	0.51	SAMEA4844435	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2749156	0.74	0.68	0.51	SAMEA4844436	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2749157	0.74	0.68	0.51	SAMEA4844437	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2749168	0.74	0.68	0.51	SAMEA4844448	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2749470	0.74	0.68	0.51	SAMEA4844751	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2749504	0.74	0.68	0.51	SAMEA4844785	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2749520	0.74	0.68	0.51	SAMEA4844801	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2749522	0.74	0.68	0.51	SAMEA4844803	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2749524	0.74	0.68	0.51	SAMEA4844805	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2750526	0.74	0.68	0.51	SAMEA4845808	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2750527	0.74	0.68	0.51	SAMEA4845809	(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics; (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT
L11079.1	ERR2753119	0.74	0.68	0.51	SAMEA4853344	Influence of travel on the gut microbiome of cricketers
L11079.1	ERR2759394	0.74	0.68	0.51	SAMEA4867846	Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation
L11079.1	ERR2759395	0.74	0.68	0.51	SAMEA4867847	Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation
L11079.1	ERR2759404	0.74	0.68	0.51	SAMEA4867856	Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation
L11079.1	ERR2759414	0.74	0.68	0.51	SAMEA4867866	Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation
L11079.1	ERR3021283	0.74	0.68	0.51	SAMEA5202715	Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation
L11079.1	ERR3021307	0.74	0.68	0.51	SAMEA5202739	Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation
L11079.1	ERR3021308	0.74	0.68	0.51	SAMEA5202740	Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation
L11079.1	ERR2784675	0.74	0.68	0.51	SAMEA4888532	Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course.
L11079.1	ERR2835236	0.74	0.68	0.51	SAMEA4968670	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835237	0.74	0.68	0.51	SAMEA4968671	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835238	0.74	0.68	0.51	SAMEA4968672	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835247	0.74	0.68	0.51	SAMEA4968681	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835248	0.74	0.68	0.51	SAMEA4968682	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835251	0.74	0.68	0.51	SAMEA4968685	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835255	0.74	0.68	0.51	SAMEA4968689	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835258	0.74	0.68	0.51	SAMEA4968692	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835270	0.74	0.68	0.51	SAMEA4968704	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835272	0.74	0.68	0.51	SAMEA4968706	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835274	0.74	0.68	0.51	SAMEA4968708	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835276	0.74	0.68	0.51	SAMEA4968710	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835300	0.74	0.68	0.51	SAMEA4968734	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835302	0.74	0.68	0.51	SAMEA4968736	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835304	0.74	0.68	0.51	SAMEA4968738	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835308	0.74	0.68	0.51	SAMEA4968742	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835310	0.74	0.68	0.51	SAMEA4968744	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835317	0.74	0.68	0.51	SAMEA4968751	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835319	0.74	0.68	0.51	SAMEA4968753	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835344	0.74	0.68	0.51	SAMEA4968778	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835347	0.74	0.68	0.51	SAMEA4968781	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835350	0.74	0.68	0.51	SAMEA4968784	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835351	0.74	0.68	0.51	SAMEA4968785	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835355	0.74	0.68	0.51	SAMEA4968789	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835356	0.74	0.68	0.51	SAMEA4968790	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835386	0.74	0.68	0.51	SAMEA4968820	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835389	0.74	0.68	0.51	SAMEA4968823	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835390	0.74	0.68	0.51	SAMEA4968824	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835395	0.74	0.68	0.51	SAMEA4968829	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835397	0.74	0.68	0.51	SAMEA4968831	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835400	0.74	0.68	0.51	SAMEA4968834	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835402	0.74	0.68	0.51	SAMEA4968836	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835413	0.74	0.68	0.51	SAMEA4968847	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835414	0.74	0.68	0.51	SAMEA4968848	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835416	0.74	0.68	0.51	SAMEA4968850	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835420	0.74	0.68	0.51	SAMEA4968854	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835422	0.74	0.68	0.51	SAMEA4968856	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835424	0.74	0.68	0.51	SAMEA4968858	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835435	0.74	0.68	0.51	SAMEA4968869	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835448	0.74	0.68	0.51	SAMEA4968882	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835450	0.74	0.68	0.51	SAMEA4968884	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835454	0.74	0.68	0.51	SAMEA4968888	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835456	0.74	0.68	0.51	SAMEA4968890	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835460	0.74	0.68	0.51	SAMEA4968894	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835462	0.74	0.68	0.51	SAMEA4968896	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835464	0.74	0.68	0.51	SAMEA4968898	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835468	0.74	0.68	0.51	SAMEA4968902	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835473	0.74	0.68	0.51	SAMEA4968907	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835474	0.74	0.68	0.51	SAMEA4968908	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835481	0.74	0.68	0.51	SAMEA4968915	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835485	0.74	0.68	0.51	SAMEA4968919	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835487	0.74	0.68	0.51	SAMEA4968921	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835488	0.74	0.68	0.51	SAMEA4968922	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835494	0.74	0.68	0.51	SAMEA4968928	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835496	0.74	0.68	0.51	SAMEA4968930	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835498	0.74	0.68	0.51	SAMEA4968932	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835503	0.74	0.68	0.51	SAMEA4968937	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835505	0.74	0.68	0.51	SAMEA4968939	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835508	0.74	0.68	0.51	SAMEA4968942	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835510	0.74	0.68	0.51	SAMEA4968944	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835511	0.74	0.68	0.51	SAMEA4968945	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835512	0.74	0.68	0.51	SAMEA4968946	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835523	0.74	0.68	0.51	SAMEA4968957	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835525	0.74	0.68	0.51	SAMEA4968959	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835528	0.74	0.68	0.51	SAMEA4968962	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835541	0.74	0.68	0.51	SAMEA4968975	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835542	0.74	0.68	0.51	SAMEA4968976	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835543	0.74	0.68	0.51	SAMEA4968977	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835546	0.74	0.68	0.51	SAMEA4968980	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835547	0.74	0.68	0.51	SAMEA4968981	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835548	0.74	0.68	0.51	SAMEA4968982	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835549	0.74	0.68	0.51	SAMEA4968983	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2835555	0.74	0.68	0.51	SAMEA4968989	A microbiota-directed complementary food, developed and characterized in gnotobiotic mice and piglets colonized with microbial therapeutic targets, has wide-ranging beneficial effects on biomarkers and mediators of postnatal development in Bangladeshi children with moderate acute malnutrition
L11079.1	ERR2816274	0.74	0.68	0.51	SAMEA4947600	The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy
L11079.1	ERR2821862	0.74	0.68	0.51	SAMEA4952263	Broiler Caecal Metagenome
L11079.1	ERR2840903	0.74	0.68	0.51	SAMEA4973160	U.S. immigration westernizes the human gut microbiome
L11079.1	ERR2840925	0.74	0.68	0.51	SAMEA4973182	U.S. immigration westernizes the human gut microbiome
L11079.1	ERR2840932	0.74	0.68	0.51	SAMEA4973189	U.S. immigration westernizes the human gut microbiome
L11079.1	ERR2840935	0.74	0.68	0.51	SAMEA4973192	U.S. immigration westernizes the human gut microbiome
L11079.1	ERR2840937	0.74	0.68	0.51	SAMEA4973194	U.S. immigration westernizes the human gut microbiome
L11079.1	ERR2840942	0.74	0.68	0.51	SAMEA4973199	U.S. immigration westernizes the human gut microbiome
L11079.1	ERR2843546	0.74	0.68	0.51	SAMEA4974194	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2843547	0.74	0.68	0.51	SAMEA4974164	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2843589	0.74	0.68	0.51	SAMEA4974202	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2843648	0.74	0.68	0.51	SAMEA4974200	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2843661	0.74	0.68	0.51	SAMEA4974228	Meta cooperation project of guangdong provincial hospital of traditional Chinese medicine
L11079.1	ERR2849651	0.74	0.68	0.51	SAMEA4982946	16S rRNA gene amplicon and metagenomic shotgun sequencing reads from a pediatric acute lymphoblastic leukemia cohort. Metagenomic shotgun sequencing reads have been prefiltered to remove any human DNA before uploading to following ethical guidelines for the study.
L11079.1	ERR2855787	0.74	0.68	0.51	SAMEA4968187	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855791	0.74	0.68	0.51	SAMEA4968222	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855799	0.74	0.68	0.51	SAMEA4968133	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855810	0.74	0.68	0.51	SAMEA4968197	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855818	0.74	0.68	0.51	SAMEA4968265	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855869	0.74	0.68	0.51	SAMEA4968207	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855871	0.74	0.68	0.51	SAMEA4968219	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855886	0.74	0.68	0.51	SAMEA4968210	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855905	0.74	0.68	0.51	SAMEA4968273	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855908	0.74	0.68	0.51	SAMEA4968237	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855909	0.74	0.68	0.51	SAMEA4968212	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855922	0.74	0.68	0.51	SAMEA4968185	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855923	0.74	0.68	0.51	SAMEA4968289	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855943	0.74	0.68	0.51	SAMEA4968277	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2855948	0.74	0.68	0.51	SAMEA4968135	A causal role of the gut microbiome in schizophrenia
L11079.1	ERR2867813	0.74	0.68	0.51	SAMEA5065177	Prenatal arsenic exposure and intestinal microbiota in Bangladeshi children
L11079.1	ERR2867822	0.74	0.68	0.51	SAMEA5065186	Prenatal arsenic exposure and intestinal microbiota in Bangladeshi children
L11079.1	ERR2867823	0.74	0.68	0.51	SAMEA5065187	Prenatal arsenic exposure and intestinal microbiota in Bangladeshi children
L11079.1	ERR2867824	0.74	0.68	0.51	SAMEA5065188	Prenatal arsenic exposure and intestinal microbiota in Bangladeshi children
L11079.1	ERR2867880	0.74	0.68	0.51	SAMEA5065244	Prenatal arsenic exposure and intestinal microbiota in Bangladeshi children
L11079.1	ERR2867888	0.74	0.68	0.51	SAMEA5065252	Prenatal arsenic exposure and intestinal microbiota in Bangladeshi children
L11079.1	ERR2867892	0.74	0.68	0.51	SAMEA5065256	Prenatal arsenic exposure and intestinal microbiota in Bangladeshi children
L11079.1	ERR2867906	0.74	0.68	0.51	SAMEA5065270	Prenatal arsenic exposure and intestinal microbiota in Bangladeshi children
L11079.1	ERR2867907	0.74	0.68	0.51	SAMEA5065271	Prenatal arsenic exposure and intestinal microbiota in Bangladeshi children
L11079.1	ERR2867908	0.74	0.68	0.51	SAMEA5065272	Prenatal arsenic exposure and intestinal microbiota in Bangladeshi children
L11079.1	ERR2867928	0.74	0.68	0.51	SAMEA5065292	Prenatal arsenic exposure and intestinal microbiota in Bangladeshi children
L11079.1	ERR2867933	0.74	0.68	0.51	SAMEA5065297	Prenatal arsenic exposure and intestinal microbiota in Bangladeshi children
L11079.1	ERR2868400	0.74	0.68	0.51	SAMEA5054152	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868401	0.74	0.68	0.51	SAMEA5054209	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868409	0.74	0.68	0.51	SAMEA5054175	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868415	0.74	0.68	0.51	SAMEA5054099	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868419	0.74	0.68	0.51	SAMEA5054169	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868420	0.74	0.68	0.51	SAMEA5054129	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868426	0.74	0.68	0.51	SAMEA5054112	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868433	0.74	0.68	0.51	SAMEA5054108	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868436	0.74	0.68	0.51	SAMEA5054132	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868448	0.74	0.68	0.51	SAMEA5054206	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868461	0.74	0.68	0.51	SAMEA5054171	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868465	0.74	0.68	0.51	SAMEA5054117	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868471	0.74	0.68	0.51	SAMEA5054116	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR2868486	0.74	0.68	0.51	SAMEA5054188	Metagenomics wide association studies on multi-autoimmune diseases.( F16HTSNCWLJ1153-F16FTSNCWLJ0140)
L11079.1	ERR3053344	0.74	0.68	0.51	SAMEA5216117	The effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants
L11079.1	ERR3229776	0.74	0.68	0.51	SAMEA104565307	RLBUHT_Cdiff
L11079.1	ERR3229967	0.74	0.68	0.51	SAMEA104565411	RLBUHT_Cdiff
L11079.1	ERR3097280	0.74	0.68	0.51	SAMEA5245243	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097308	0.74	0.68	0.51	SAMEA5245271	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097309	0.74	0.68	0.51	SAMEA5245272	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097334	0.74	0.68	0.51	SAMEA5245297	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097335	0.74	0.68	0.51	SAMEA5245298	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097344	0.74	0.68	0.51	SAMEA5245307	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097345	0.74	0.68	0.51	SAMEA5245308	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097377	0.74	0.68	0.51	SAMEA5245340	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097386	0.74	0.68	0.51	SAMEA5245349	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097420	0.74	0.68	0.51	SAMEA5245383	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097425	0.74	0.68	0.51	SAMEA5245388	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097426	0.74	0.68	0.51	SAMEA5245389	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097442	0.74	0.68	0.51	SAMEA5245405	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097472	0.74	0.68	0.51	SAMEA5245435	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097499	0.74	0.68	0.51	SAMEA5245462	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097502	0.74	0.68	0.51	SAMEA5245465	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097507	0.74	0.68	0.51	SAMEA5245470	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097508	0.74	0.68	0.51	SAMEA5245471	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097518	0.74	0.68	0.51	SAMEA5245481	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097541	0.74	0.68	0.51	SAMEA5245504	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3097542	0.74	0.68	0.51	SAMEA5245505	Human fecal metagenomes of individuals sampled along a small-scale urbanization gradient in Cameroon
L11079.1	ERR3160557	0.74	0.68	0.51	SAMEA5357958	Probiotic Plant Fermentation Extracts Intervention Causes Weight Loss in Obese Patients by Increasing Microbiota-associated Metabolites that Boost Thermogenesis
L11079.1	ERR3160563	0.74	0.68	0.51	SAMEA5357964	Probiotic Plant Fermentation Extracts Intervention Causes Weight Loss in Obese Patients by Increasing Microbiota-associated Metabolites that Boost Thermogenesis
L11079.1	ERR3153735	0.74	0.68	0.51	SAMEA5335509	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153770	0.74	0.68	0.51	SAMEA5335544	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153771	0.74	0.68	0.51	SAMEA5335545	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153778	0.74	0.68	0.51	SAMEA5335552	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153801	0.74	0.68	0.51	SAMEA5335575	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153803	0.74	0.68	0.51	SAMEA5335577	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153811	0.74	0.68	0.51	SAMEA5335585	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153814	0.74	0.68	0.51	SAMEA5335588	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153822	0.74	0.68	0.51	SAMEA5335596	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153828	0.74	0.68	0.51	SAMEA5335602	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153838	0.74	0.68	0.51	SAMEA5335612	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153843	0.74	0.68	0.51	SAMEA5335617	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR3153851	0.74	0.68	0.51	SAMEA5335625	The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes
L11079.1	ERR321186	0.74	0.68	0.51	SAMEA2150283	Richness of human gut microbiome correlates with metabolic markers
L11079.1	ERR321339	0.74	0.68	0.51	SAMEA2153557	Richness of human gut microbiome correlates with metabolic markers
L11079.1	ERR321345	0.74	0.68	0.51	SAMEA2153557	Richness of human gut microbiome correlates with metabolic markers
L11079.1	ERR321533	0.74	0.68	0.51	SAMEA2142793	Richness of human gut microbiome correlates with metabolic markers
L11079.1	ERR3211536	0.74	0.68	0.51	SAMEA5414181	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR3211568	0.74	0.68	0.51	SAMEA5414213	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR3211677	0.74	0.68	0.51	SAMEA5414322	Metagenomic assessment of the effect of sample processing on different microbiomes
L11079.1	ERR3261726	0.74	0.68	0.51	SAMEA5537488	Drug metabolism by 28 human gut communities
L11079.1	ERR3277228	0.74	0.68	0.51	SAMEA5564370	The Canadian Healthy Infant Longitudinal Development (CHILD) study is a multicenter longitudinal, prospective, general population birth cohort study. This study used a nested case-controlled design to analyze the functional potential of the fecal microbiome in infants enrolled in the CHILD Study. We selected 3-month and 1-year stool samples from an atopy enriched subset of children from one enrollment center (Vancouver). DNA was extracted from stool samples and submitted for shotgun metagenome sequencing.
L11079.1	ERR3277272	0.74	0.68	0.51	SAMEA5564407	The Canadian Healthy Infant Longitudinal Development (CHILD) study is a multicenter longitudinal, prospective, general population birth cohort study. This study used a nested case-controlled design to analyze the functional potential of the fecal microbiome in infants enrolled in the CHILD Study. We selected 3-month and 1-year stool samples from an atopy enriched subset of children from one enrollment center (Vancouver). DNA was extracted from stool samples and submitted for shotgun metagenome sequencing.
L11079.1	ERR3277364	0.74	0.68	0.51	SAMEA5564357	The Canadian Healthy Infant Longitudinal Development (CHILD) study is a multicenter longitudinal, prospective, general population birth cohort study. This study used a nested case-controlled design to analyze the functional potential of the fecal microbiome in infants enrolled in the CHILD Study. We selected 3-month and 1-year stool samples from an atopy enriched subset of children from one enrollment center (Vancouver). DNA was extracted from stool samples and submitted for shotgun metagenome sequencing.
L11079.1	ERR3317604	0.74	0.68	0.51	SAMEA5599367	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317607	0.74	0.68	0.51	SAMEA5599370	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317608	0.74	0.68	0.51	SAMEA5599371	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317610	0.74	0.68	0.51	SAMEA5599373	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317613	0.74	0.68	0.51	SAMEA5599376	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317614	0.74	0.68	0.51	SAMEA5599377	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317631	0.74	0.68	0.51	SAMEA5599394	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317632	0.74	0.68	0.51	SAMEA5599395	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317645	0.74	0.68	0.51	SAMEA5599408	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317650	0.74	0.68	0.51	SAMEA5599413	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317657	0.74	0.68	0.51	SAMEA5599420	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317662	0.74	0.68	0.51	SAMEA5599425	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317669	0.74	0.68	0.51	SAMEA5599432	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317671	0.74	0.68	0.51	SAMEA5599434	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317679	0.74	0.68	0.51	SAMEA5599442	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317680	0.74	0.68	0.51	SAMEA5599443	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317681	0.74	0.68	0.51	SAMEA5599444	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317682	0.74	0.68	0.51	SAMEA5599445	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317685	0.74	0.68	0.51	SAMEA5599448	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3317693	0.74	0.68	0.51	SAMEA5599457	The_population_structure_of_commensal_E__coli_in_Vietnamese_children
L11079.1	ERR3338965	0.74	0.68	0.51	SAMEA5615037	Duodenal Microbiota in Stunted Undernourished Children with Enteropathy
L11079.1	ERR3338971	0.74	0.68	0.51	SAMEA5615043	Duodenal Microbiota in Stunted Undernourished Children with Enteropathy
L11079.1	ERR3338975	0.74	0.68	0.51	SAMEA5615047	Duodenal Microbiota in Stunted Undernourished Children with Enteropathy
L11079.1	ERR3338976	0.74	0.68	0.51	SAMEA5615048	Duodenal Microbiota in Stunted Undernourished Children with Enteropathy
L11079.1	ERR3338982	0.74	0.68	0.51	SAMEA5615054	Duodenal Microbiota in Stunted Undernourished Children with Enteropathy
L11079.1	ERR3338983	0.74	0.68	0.51	SAMEA5615055	Duodenal Microbiota in Stunted Undernourished Children with Enteropathy
L11079.1	ERR6995067	0.74	0.68	0.51	SAMEA10313524	iMSMS Baranzini data
L11079.1	ERR6995859	0.74	0.68	0.51	SAMEA10314124	iMSMS Baranzini data
L11079.1	ERR6996024	0.74	0.68	0.51	SAMEA10314290	iMSMS Baranzini data
L11079.1	ERR6996025	0.74	0.68	0.51	SAMEA10314291	iMSMS Baranzini data
L11079.1	ERR6996109	0.74	0.68	0.51	SAMEA10314375	iMSMS Baranzini data
L11079.1	ERR6996178	0.74	0.68	0.51	SAMEA10314587	iMSMS Baranzini data
L11079.1	ERR6996265	0.74	0.68	0.51	SAMEA10314675	iMSMS Baranzini data
L11079.1	ERR6996336	0.74	0.68	0.51	SAMEA10314774	iMSMS Baranzini data
L11079.1	ERR6996337	0.74	0.68	0.51	SAMEA10314775	iMSMS Baranzini data
L11079.1	ERR6996698	0.74	0.68	0.51	SAMEA10315043	iMSMS Baranzini data
L11079.1	ERR6996860	0.74	0.68	0.51	SAMEA10315695	iMSMS Baranzini data
L11079.1	ERR6997542	0.74	0.68	0.51	SAMEA10313524	iMSMS Baranzini data
L11079.1	ERR6997625	0.74	0.68	0.51	SAMEA10313714	iMSMS Baranzini data
L11079.1	ERR6997974	0.74	0.68	0.51	SAMEA10314375	iMSMS Baranzini data
L11079.1	ERR6998023	0.74	0.68	0.51	SAMEA10314774	iMSMS Baranzini data
L11079.1	ERR6998299	0.74	0.68	0.51	SAMEA10316070	iMSMS Baranzini data
L11079.1	ERR6998325	0.74	0.68	0.51	SAMEA10313617	iMSMS Baranzini data
L11079.1	ERR6998335	0.74	0.68	0.51	SAMEA10313713	iMSMS Baranzini data
L11079.1	ERR3342968	0.74	0.68	0.51	SAMEA5665400	Distinct microbiome composition and metabolome exists across subgroups of elite Irish athletes irrespective of diet
L11079.1	ERR3345699	0.74	0.68	0.51	SAMEA104717244	Metagenomics_of_Environmental_Samples_from_Pit_Latrines
L11079.1	ERR3348919	0.74	0.68	0.51	SAMEA5683152	Potential roles of gut microbiome commensals & metabolites in modulation of murine ALS
L11079.1	ERR3404631	0.74	0.68	0.51	SAMEA5616571	Early_life_microbiota_colonisation
L11079.1	ERR3404632	0.74	0.68	0.51	SAMEA5616572	Early_life_microbiota_colonisation
L11079.1	ERR3404692	0.74	0.68	0.51	SAMEA5618325	Early_life_microbiota_colonisation
L11079.1	ERR3404770	0.74	0.68	0.51	SAMEA5617518	Early_life_microbiota_colonisation
L11079.1	ERR3404891	0.74	0.68	0.51	SAMEA5617631	Early_life_microbiota_colonisation
L11079.1	ERR3404925	0.74	0.68	0.51	SAMEA5617655	Early_life_microbiota_colonisation
L11079.1	ERR3404929	0.74	0.68	0.51	SAMEA5617657	Early_life_microbiota_colonisation
L11079.1	ERR3404944	0.74	0.68	0.51	SAMEA5617656	Early_life_microbiota_colonisation
L11079.1	ERR3405054	0.74	0.68	0.51	SAMEA5617724	Early_life_microbiota_colonisation
L11079.1	ERR3405069	0.74	0.68	0.51	SAMEA5617730	Early_life_microbiota_colonisation
L11079.1	ERR3405188	0.74	0.68	0.51	SAMEA5617767	Early_life_microbiota_colonisation
L11079.1	ERR3405206	0.74	0.68	0.51	SAMEA5617768	Early_life_microbiota_colonisation
L11079.1	ERR3405283	0.74	0.68	0.51	SAMEA5617895	Early_life_microbiota_colonisation
L11079.1	ERR3405284	0.74	0.68	0.51	SAMEA5617896	Early_life_microbiota_colonisation
L11079.1	ERR3405285	0.74	0.68	0.51	SAMEA5617897	Early_life_microbiota_colonisation
L11079.1	ERR3405325	0.74	0.68	0.51	SAMEA5618460	Early_life_microbiota_colonisation
L11079.1	ERR3405441	0.74	0.68	0.51	SAMEA5618607	Early_life_microbiota_colonisation
L11079.1	ERR3405443	0.74	0.68	0.51	SAMEA5618609	Early_life_microbiota_colonisation
L11079.1	ERR3405483	0.74	0.68	0.51	SAMEA5617769	Early_life_microbiota_colonisation
L11079.1	ERR3405495	0.74	0.68	0.51	SAMEA5618026	Early_life_microbiota_colonisation
L11079.1	ERR3405774	0.74	0.68	0.51	SAMEA5618455	Early_life_microbiota_colonisation
L11079.1	ERR3405786	0.74	0.68	0.51	SAMEA5618454	Early_life_microbiota_colonisation
L11079.1	ERR3405796	0.74	0.68	0.51	SAMEA5618456	Early_life_microbiota_colonisation
L11079.1	ERR3405802	0.74	0.68	0.51	SAMEA5617992	Early_life_microbiota_colonisation
L11079.1	ERR3405904	0.74	0.68	0.51	SAMEA5617848	Early_life_microbiota_colonisation
L11079.1	ERR3405923	0.74	0.68	0.51	SAMEA5618187	Early_life_microbiota_colonisation
L11079.1	ERR3405925	0.74	0.68	0.51	SAMEA5617787	Early_life_microbiota_colonisation
L11079.1	ERR3405934	0.74	0.68	0.51	SAMEA5617898	Early_life_microbiota_colonisation
L11079.1	ERR3405944	0.74	0.68	0.51	SAMEA5617993	Early_life_microbiota_colonisation
L11079.1	ERR3406009	0.74	0.68	0.51	SAMEA5617849	Early_life_microbiota_colonisation
L11079.1	ERR3406012	0.74	0.68	0.51	SAMEA5617946	Early_life_microbiota_colonisation
L11079.1	ERR3406024	0.74	0.68	0.51	SAMEA5617810	Early_life_microbiota_colonisation
L11079.1	ERR3406039	0.74	0.68	0.51	SAMEA5617955	Early_life_microbiota_colonisation
L11079.1	ERR3406195	0.74	0.68	0.51	SAMEA5617766	Early_life_microbiota_colonisation
L11079.1	ERR3406217	0.74	0.68	0.51	SAMEA5618447	Early_life_microbiota_colonisation
L11079.1	ERR3427598	0.74	0.68	0.51	SAMEA5766444	Pathogen-induced activation of disease-suppressive functions in the endophytic root microbiome
L11079.1	ERR3427605	0.74	0.68	0.51	SAMEA5766451	Pathogen-induced activation of disease-suppressive functions in the endophytic root microbiome
L11079.1	ERR3427608	0.74	0.68	0.51	SAMEA5766454	Pathogen-induced activation of disease-suppressive functions in the endophytic root microbiome
L11079.1	ERR793607	0.74	0.68	0.51	SAMEA3311358	Pathogen-induced activation of disease-suppressive functions in the endophytic root microbiome
L11079.1	ERR3427669	0.74	0.68	0.51	SAMEA5767104	There are 18 ready-to-eat food samples (8 ready-to-eat meat, 7 ready-to-eat vegetables and 3 ready-to-eat fruit) and 6 human faecal samples. The samples were sequenced on the Illumina, NovaSeq PE150.
L11079.1	ERR3450714	0.74	0.68	0.51	SAMEA5814224	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3450773	0.74	0.68	0.51	SAMEA5814045	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3450920	0.74	0.68	0.51	SAMEA5813906	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3450931	0.74	0.68	0.51	SAMEA5813851	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451032	0.74	0.68	0.51	SAMEA5814612	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451092	0.74	0.68	0.51	SAMEA5814114	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451160	0.74	0.68	0.51	SAMEA5814130	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451161	0.74	0.68	0.51	SAMEA5814372	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451241	0.74	0.68	0.51	SAMEA5814511	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451242	0.74	0.68	0.51	SAMEA5814513	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451343	0.74	0.68	0.51	SAMEA5813891	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451477	0.74	0.68	0.51	SAMEA5813907	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3451560	0.74	0.68	0.51	SAMEA5814805	Whole shotgun metagenomic sequencing for 1,004 individuals belonging to the TwinsUK cohort.  Supporting data for: Visconti et al, Interplay between the human gut microbiome and host metabolism
L11079.1	ERR3484149	0.74	0.68	0.51	SAMEA5846977	Optimizing sequencing protocols for leaderboard metagenomics by combining long and short reads
L11079.1	ERR3501186	0.74	0.68	0.51	SAMEA5923455	Hydrogen-based interactions underlie the widespread co-occurrence of the bacterial family Christensenellaceae and methanogens in the human gut
L11079.1	ERR3501624	0.74	0.68	0.51	SAMEA5923455	Hydrogen-based interactions underlie the widespread co-occurrence of the bacterial family Christensenellaceae and methanogens in the human gut
L11079.1	ERR3503276	0.74	0.68	0.51	SAMEA5927883	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3503285	0.74	0.68	0.51	SAMEA5927892	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3503298	0.74	0.68	0.51	SAMEA5927905	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3503307	0.74	0.68	0.51	SAMEA5927914	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3503309	0.74	0.68	0.51	SAMEA5927916	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3503310	0.74	0.68	0.51	SAMEA5927917	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3503311	0.74	0.68	0.51	SAMEA5927918	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3503314	0.74	0.68	0.51	SAMEA5927921	Surveillance of infectious diseases and antimicrobial resistance from sewage in Kibera (Nairobi, Kenya)
L11079.1	ERR3521913	0.74	0.68	0.51	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521918	0.74	0.68	0.51	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521923	0.74	0.68	0.51	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521932	0.74	0.68	0.51	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521938	0.74	0.68	0.51	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521939	0.74	0.68	0.51	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3521964	0.74	0.68	0.51	SAMEA5669780	Ultra-deep shotgun sequencing
L11079.1	ERR3562869	0.74	0.68	0.51	SAMEA5982142	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3562920	0.74	0.68	0.51	SAMEA5982193	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3562959	0.74	0.68	0.51	SAMEA5982232	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3563057	0.74	0.68	0.51	SAMEA5982330	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3563079	0.74	0.68	0.51	SAMEA5982352	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3563107	0.74	0.68	0.51	SAMEA5982380	Long-term temporal stability of the resistome in sewage from Copenhagen
L11079.1	ERR3573328	0.74	0.68	0.51	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3573855	0.74	0.68	0.51	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3574813	0.74	0.68	0.51	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3574864	0.74	0.68	0.51	SAMEA5989477	Detailed study at the genetic level at bacteria in farm animals, human/animal sewage, sewage treatment works and rivers, to work out the complex network of transmission of important antibiotic-resistant bacteria and antibiotic resistance genes
L11079.1	ERR3588736	0.74	0.68	0.51	SAMEA6062674	Metagenomic sequencing of faecal extracts from a commercial pig farm with high antimicrobial usage
L11079.1	ERR3588737	0.74	0.68	0.51	SAMEA6062675	Metagenomic sequencing of faecal extracts from a commercial pig farm with high antimicrobial usage
L11079.1	ERR3592841	0.74	0.68	0.51	SAMEA6084805	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592912	0.74	0.68	0.51	SAMEA6084876	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592913	0.74	0.68	0.51	SAMEA6084877	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592914	0.74	0.68	0.51	SAMEA6084878	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592915	0.74	0.68	0.51	SAMEA6084879	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592916	0.74	0.68	0.51	SAMEA6084880	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592917	0.74	0.68	0.51	SAMEA6084881	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592926	0.74	0.68	0.51	SAMEA6084890	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592949	0.74	0.68	0.51	SAMEA6084913	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592950	0.74	0.68	0.51	SAMEA6084914	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592951	0.74	0.68	0.51	SAMEA6084915	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592952	0.74	0.68	0.51	SAMEA6084916	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592953	0.74	0.68	0.51	SAMEA6084917	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592954	0.74	0.68	0.51	SAMEA6084918	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592955	0.74	0.68	0.51	SAMEA6084919	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592956	0.74	0.68	0.51	SAMEA6084920	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3592999	0.74	0.68	0.51	SAMEA6084963	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593007	0.74	0.68	0.51	SAMEA6084971	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593021	0.74	0.68	0.51	SAMEA6084985	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593024	0.74	0.68	0.51	SAMEA6084988	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593035	0.74	0.68	0.51	SAMEA6084999	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593049	0.74	0.68	0.51	SAMEA6085013	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593058	0.74	0.68	0.51	SAMEA6085022	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593089	0.74	0.68	0.51	SAMEA6085053	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593090	0.74	0.68	0.51	SAMEA6085054	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593091	0.74	0.68	0.51	SAMEA6085055	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593092	0.74	0.68	0.51	SAMEA6085056	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593094	0.74	0.68	0.51	SAMEA6085058	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593096	0.74	0.68	0.51	SAMEA6085060	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593106	0.74	0.68	0.51	SAMEA6085070	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593107	0.74	0.68	0.51	SAMEA6085071	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593120	0.74	0.68	0.51	SAMEA6085084	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593128	0.74	0.68	0.51	SAMEA6085092	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593131	0.74	0.68	0.51	SAMEA6085095	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593132	0.74	0.68	0.51	SAMEA6085096	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593134	0.74	0.68	0.51	SAMEA6085098	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593139	0.74	0.68	0.51	SAMEA6085103	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593140	0.74	0.68	0.51	SAMEA6085104	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593141	0.74	0.68	0.51	SAMEA6085105	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593153	0.74	0.68	0.51	SAMEA6085117	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593154	0.74	0.68	0.51	SAMEA6085118	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593283	0.74	0.68	0.51	SAMEA6085248	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593339	0.74	0.68	0.51	SAMEA6085304	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593340	0.74	0.68	0.51	SAMEA6085305	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593342	0.74	0.68	0.51	SAMEA6085307	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593343	0.74	0.68	0.51	SAMEA6085308	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593344	0.74	0.68	0.51	SAMEA6085309	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593345	0.74	0.68	0.51	SAMEA6085310	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593346	0.74	0.68	0.51	SAMEA6085311	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593348	0.74	0.68	0.51	SAMEA6085313	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593354	0.74	0.68	0.51	SAMEA6085319	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593372	0.74	0.68	0.51	SAMEA6085337	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593378	0.74	0.68	0.51	SAMEA6085343	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593390	0.74	0.68	0.51	SAMEA6085355	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593391	0.74	0.68	0.51	SAMEA6085356	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593392	0.74	0.68	0.51	SAMEA6085357	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593394	0.74	0.68	0.51	SAMEA6085359	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593397	0.74	0.68	0.51	SAMEA6085362	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593401	0.74	0.68	0.51	SAMEA6085366	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593403	0.74	0.68	0.51	SAMEA6085368	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593405	0.74	0.68	0.51	SAMEA6085370	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593407	0.74	0.68	0.51	SAMEA6085372	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593413	0.74	0.68	0.51	SAMEA6085378	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593414	0.74	0.68	0.51	SAMEA6085379	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593416	0.74	0.68	0.51	SAMEA6085381	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593417	0.74	0.68	0.51	SAMEA6085382	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593435	0.74	0.68	0.51	SAMEA6085400	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593442	0.74	0.68	0.51	SAMEA6085407	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593451	0.74	0.68	0.51	SAMEA6085416	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593452	0.74	0.68	0.51	SAMEA6085417	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593455	0.74	0.68	0.51	SAMEA6085420	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593456	0.74	0.68	0.51	SAMEA6085421	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593463	0.74	0.68	0.51	SAMEA6085428	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593468	0.74	0.68	0.51	SAMEA6085433	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593469	0.74	0.68	0.51	SAMEA6085434	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593471	0.74	0.68	0.51	SAMEA6085436	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593474	0.74	0.68	0.51	SAMEA6085439	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593490	0.74	0.68	0.51	SAMEA6085455	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593510	0.74	0.68	0.51	SAMEA6085475	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593512	0.74	0.68	0.51	SAMEA6085477	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593519	0.74	0.68	0.51	SAMEA6085484	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593526	0.74	0.68	0.51	SAMEA6085491	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593535	0.74	0.68	0.51	SAMEA6085500	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593538	0.74	0.68	0.51	SAMEA6085503	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593541	0.74	0.68	0.51	SAMEA6085506	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593542	0.74	0.68	0.51	SAMEA6085507	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593546	0.74	0.68	0.51	SAMEA6085511	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593547	0.74	0.68	0.51	SAMEA6085512	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593550	0.74	0.68	0.51	SAMEA6085515	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593551	0.74	0.68	0.51	SAMEA6085516	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593556	0.74	0.68	0.51	SAMEA6085521	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593557	0.74	0.68	0.51	SAMEA6085522	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593558	0.74	0.68	0.51	SAMEA6085523	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593560	0.74	0.68	0.51	SAMEA6085525	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593563	0.74	0.68	0.51	SAMEA6085528	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593564	0.74	0.68	0.51	SAMEA6085529	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593570	0.74	0.68	0.51	SAMEA6085535	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593571	0.74	0.68	0.51	SAMEA6085536	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593572	0.74	0.68	0.51	SAMEA6085537	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593576	0.74	0.68	0.51	SAMEA6085541	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593582	0.74	0.68	0.51	SAMEA6085547	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593587	0.74	0.68	0.51	SAMEA6085552	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593595	0.74	0.68	0.51	SAMEA6085560	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593597	0.74	0.68	0.51	SAMEA6085562	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593611	0.74	0.68	0.51	SAMEA6085576	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593617	0.74	0.68	0.51	SAMEA6085582	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593618	0.74	0.68	0.51	SAMEA6085583	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593621	0.74	0.68	0.51	SAMEA6085586	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593625	0.74	0.68	0.51	SAMEA6085590	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593626	0.74	0.68	0.51	SAMEA6085591	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593629	0.74	0.68	0.51	SAMEA6085594	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593631	0.74	0.68	0.51	SAMEA6085596	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593632	0.74	0.68	0.51	SAMEA6085597	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593633	0.74	0.68	0.51	SAMEA6085598	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593634	0.74	0.68	0.51	SAMEA6085599	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593635	0.74	0.68	0.51	SAMEA6085600	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593636	0.74	0.68	0.51	SAMEA6085601	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593640	0.74	0.68	0.51	SAMEA6085605	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593642	0.74	0.68	0.51	SAMEA6085607	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593643	0.74	0.68	0.51	SAMEA6085608	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593651	0.74	0.68	0.51	SAMEA6085616	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593663	0.74	0.68	0.51	SAMEA6085628	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593865	0.74	0.68	0.51	SAMEA6085830	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593899	0.74	0.68	0.51	SAMEA6085864	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593912	0.74	0.68	0.51	SAMEA6085877	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593917	0.74	0.68	0.51	SAMEA6085882	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593921	0.74	0.68	0.51	SAMEA6085886	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593922	0.74	0.68	0.51	SAMEA6085887	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593923	0.74	0.68	0.51	SAMEA6085888	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593932	0.74	0.68	0.51	SAMEA6085897	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593935	0.74	0.68	0.51	SAMEA6085900	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593966	0.74	0.68	0.51	SAMEA6085932	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3593971	0.74	0.68	0.51	SAMEA6085937	Predicting antibiotic resistance in clinical infections caused by Enterobacterales from aggregated population-level taxonomy-adjusted AMR estimates derived from quantitative metagenomic analysis of pooled human faecal samples
L11079.1	ERR3597944	0.74	0.68	0.51	SAMEA6087758	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3597945	0.74	0.68	0.51	SAMEA6087758	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3597946	0.74	0.68	0.51	SAMEA6087758	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3597947	0.74	0.68	0.51	SAMEA6087758	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3597948	0.74	0.68	0.51	SAMEA6087759	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3597949	0.74	0.68	0.51	SAMEA6087759	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3597950	0.74	0.68	0.51	SAMEA6087759	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3597951	0.74	0.68	0.51	SAMEA6087759	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3598112	0.74	0.68	0.51	SAMEA6087800	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3598115	0.74	0.68	0.51	SAMEA6087800	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3598116	0.74	0.68	0.51	SAMEA6087801	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3598117	0.74	0.68	0.51	SAMEA6087801	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3598118	0.74	0.68	0.51	SAMEA6087801	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3598119	0.74	0.68	0.51	SAMEA6087801	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610084	0.74	0.68	0.51	SAMEA6087758	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610085	0.74	0.68	0.51	SAMEA6087758	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610086	0.74	0.68	0.51	SAMEA6087758	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610087	0.74	0.68	0.51	SAMEA6087758	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610088	0.74	0.68	0.51	SAMEA6087759	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610089	0.74	0.68	0.51	SAMEA6087759	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610090	0.74	0.68	0.51	SAMEA6087759	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610091	0.74	0.68	0.51	SAMEA6087759	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610252	0.74	0.68	0.51	SAMEA6087800	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610255	0.74	0.68	0.51	SAMEA6087800	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610256	0.74	0.68	0.51	SAMEA6087801	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610257	0.74	0.68	0.51	SAMEA6087801	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610258	0.74	0.68	0.51	SAMEA6087801	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3610259	0.74	0.68	0.51	SAMEA6087801	Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms
L11079.1	ERR3607268	0.74	0.68	0.51	SAMEA6104862	Human gut microbiome
L11079.1	ERR3607285	0.74	0.68	0.51	SAMEA6104890	Human gut microbiome
L11079.1	ERR3607308	0.74	0.68	0.51	SAMEA6104907	Human gut microbiome
L11079.1	ERR3648605	0.74	0.68	0.51	SAMEA6160760	The pig gut microbiome and antibiotic resistome in industrialized feedlots in China
L11079.1	ERR3722027	0.74	0.68	0.51	SAMEA6377505	Clostridium difficile infection patient microbiome
L11079.1	ERR3844212	0.74	0.68	0.51	SAMEA4963467	ETEC_Carriage_in_Bangladesh
L11079.1	ERR3950331	0.74	0.68	0.51	SAMEA6536717	The urinary tract microbiome in older women exhibits host genetics and environmental influences
L11079.1	ERR3941072	0.74	0.68	0.51	SAMEA6577063	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941077	0.74	0.68	0.51	SAMEA6577068	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941093	0.74	0.68	0.51	SAMEA6577084	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941096	0.74	0.68	0.51	SAMEA6577087	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941100	0.74	0.68	0.51	SAMEA6577091	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941102	0.74	0.68	0.51	SAMEA6577093	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941190	0.74	0.68	0.51	SAMEA6577182	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941268	0.74	0.68	0.51	SAMEA6577268	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941269	0.74	0.68	0.51	SAMEA6577269	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941292	0.74	0.68	0.51	SAMEA6577292	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941293	0.74	0.68	0.51	SAMEA6577293	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941309	0.74	0.68	0.51	SAMEA6577309	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3941344	0.74	0.68	0.51	SAMEA6577344	Using metabolomics and microbiome analysis as tools to investigate cheetah liver necrosis syndrome a pilot study
L11079.1	ERR3957705	0.74	0.68	0.51	SAMEA6591455	Investigating the health status and microbiota in members of the Irish Travelling community
L11079.1	ERR3957740	0.74	0.68	0.51	SAMEA6591490	Investigating the health status and microbiota in members of the Irish Travelling community
L11079.1	ERR3986681	0.74	0.68	0.51	SAMEA6618553	Identifying frailty-associated markers in Elderly Irish Individuals
L11079.1	ERR4018400	0.74	0.68	0.51	SAMEA6663698	Study of fecal microbiota in ankylosing spondylitis patients
L11079.1	ERR4032264	0.74	0.68	0.51	SAMEA6662979	Effects of the menstrual cycle and hormonal contraceptives on the human microbiome
L11079.1	ERR4032650	0.74	0.68	0.51	SAMEA6663365	Effects of the menstrual cycle and hormonal contraceptives on the human microbiome
L11079.1	ERR4032727	0.74	0.68	0.51	SAMEA6663443	Effects of the menstrual cycle and hormonal contraceptives on the human microbiome
L11079.1	ERR4066001	0.74	0.68	0.51	SAMEA6801835	Strain-level analysis of Bifidobacterium spp. from human gut metagenomes of individuals with different lactase persistence genotypes
L11079.1	ERR4083744	0.74	0.68	0.51	SAMEA6809415	Large scale metagenome assembly reveals novel animal-associated microbial diversity
L11079.1	ERR4083809	0.74	0.68	0.51	SAMEA6809581	Large scale metagenome assembly reveals novel animal-associated microbial diversity
L11079.1	ERR4086876	0.74	0.68	0.51	SAMEA6811350	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4087368	0.74	0.68	0.51	SAMEA6811616	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4087370	0.74	0.68	0.51	SAMEA6811616	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4088613	0.74	0.68	0.51	SAMEA6811730	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4088618	0.74	0.68	0.51	SAMEA6811730	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4090133	0.74	0.68	0.51	SAMEA6811324	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4090134	0.74	0.68	0.51	SAMEA6811324	Statin treatment reduces the prevalence of gut microbiota dysbiosis in obese individuals
L11079.1	ERR4097111	0.74	0.68	0.51	SAMEA6804748	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097122	0.74	0.68	0.51	SAMEA6804855	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097127	0.74	0.68	0.51	SAMEA6804765	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097152	0.74	0.68	0.51	SAMEA6804896	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097166	0.74	0.68	0.51	SAMEA6804768	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097171	0.74	0.68	0.51	SAMEA6804856	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097172	0.74	0.68	0.51	SAMEA6804857	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097173	0.74	0.68	0.51	SAMEA6804858	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097174	0.74	0.68	0.51	SAMEA6804859	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097176	0.74	0.68	0.51	SAMEA6804861	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097177	0.74	0.68	0.51	SAMEA6804862	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097185	0.74	0.68	0.51	SAMEA6804849	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097195	0.74	0.68	0.51	SAMEA6804769	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097196	0.74	0.68	0.51	SAMEA6804770	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097197	0.74	0.68	0.51	SAMEA6804771	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097204	0.74	0.68	0.51	SAMEA6804938	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097205	0.74	0.68	0.51	SAMEA6804937	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097206	0.74	0.68	0.51	SAMEA6804948	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097207	0.74	0.68	0.51	SAMEA6804947	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097210	0.74	0.68	0.51	SAMEA6804944	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097211	0.74	0.68	0.51	SAMEA6804943	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097212	0.74	0.68	0.51	SAMEA6804946	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097232	0.74	0.68	0.51	SAMEA6804927	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097237	0.74	0.68	0.51	SAMEA6804737	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097238	0.74	0.68	0.51	SAMEA6804736	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097239	0.74	0.68	0.51	SAMEA6804747	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097241	0.74	0.68	0.51	SAMEA6804745	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097242	0.74	0.68	0.51	SAMEA6804744	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097243	0.74	0.68	0.51	SAMEA6804751	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097244	0.74	0.68	0.51	SAMEA6804750	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097245	0.74	0.68	0.51	SAMEA6804749	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097261	0.74	0.68	0.51	SAMEA6804934	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097262	0.74	0.68	0.51	SAMEA6804933	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097264	0.74	0.68	0.51	SAMEA6804926	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097268	0.74	0.68	0.51	SAMEA6804930	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097269	0.74	0.68	0.51	SAMEA6804929	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097270	0.74	0.68	0.51	SAMEA6804932	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097272	0.74	0.68	0.51	SAMEA6804949	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097275	0.74	0.68	0.51	SAMEA6804887	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097276	0.74	0.68	0.51	SAMEA6804945	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097302	0.74	0.68	0.51	SAMEA6804956	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097334	0.74	0.68	0.51	SAMEA6804825	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097335	0.74	0.68	0.51	SAMEA6804826	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097337	0.74	0.68	0.51	SAMEA6804828	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4097338	0.74	0.68	0.51	SAMEA6804821	Assessment of fecal DNA extraction protocols for metagenomic study
L11079.1	ERR4135145	0.74	0.68	0.51	SAMEA6827978	Human gut microbiome in Korean NAFLD cohort
L11079.1	ERR4135148	0.74	0.68	0.51	SAMEA6827981	Human gut microbiome in Korean NAFLD cohort
L11079.1	ERR414245	0.74	0.68	0.51	SAMEA2338636	An integrated catalog of reference genes in the human gut microbiome
L11079.1	ERR414368	0.74	0.68	0.51	SAMEA2338748	An integrated catalog of reference genes in the human gut microbiome
L11079.1	ERR4158077	0.74	0.68	0.51	SAMEA6844956	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4158078	0.74	0.68	0.51	SAMEA6844957	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4158079	0.74	0.68	0.51	SAMEA6844958	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4158177	0.74	0.68	0.51	SAMEA6845056	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4158276	0.74	0.68	0.51	SAMEA6845155	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4158278	0.74	0.68	0.51	SAMEA6845157	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4158283	0.74	0.68	0.51	SAMEA6845162	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4158286	0.74	0.68	0.51	SAMEA6845165	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4158287	0.74	0.68	0.51	SAMEA6845166	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4158309	0.74	0.68	0.51	SAMEA6845188	Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
L11079.1	ERR4191852	0.74	0.68	0.51	SAMEA6871644	Chicken gut microbiome
L11079.1	ERR4191869	0.74	0.68	0.51	SAMEA6871661	Chicken gut microbiome
L11079.1	ERR4193900	0.74	0.68	0.51	SAMEA6873545	Pathogenesis of Klebsiella Liver Abscess Syndrome Study (P-KLASS)
L11079.1	ERR4221520	0.74	0.68	0.51	SAMEA6932246	Whole genome sequencing of human enteroviruses from clinical samples by direct RNA sequencing
L11079.1	ERR4221521	0.74	0.68	0.51	SAMEA6932247	Whole genome sequencing of human enteroviruses from clinical samples by direct RNA sequencing
L11079.1	ERR4233160	0.74	0.68	0.51	SAMEA6869404	Placenta biopsies, saliva samples, vaginal and rectal swabs collected at delivery for babies at term
L11079.1	ERR4288917	0.74	0.68	0.51	SAMEA7007679	Transcriptome sequencing of D. diazotrophica
L11079.1	ERR4289985	0.74	0.68	0.51	SAMEA7007683	Transcriptome sequencing of D. diazotrophica
L11079.1	ERR4304340	0.74	0.68	0.51	SAMEA5698131	Microbiome_based_prediction_of_vaccine_response_in_elderly_patients
L11079.1	ERR4326197	0.74	0.68	0.51	SAMEA5698131	Microbiome_based_prediction_of_vaccine_response_in_elderly_patients
L11079.1	ERR4320084	0.74	0.68	0.51	SAMEA7041118	Gut microbiota of carriers of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae following treatment with oral antibiotics and fecal microbiota transplantation
L11079.1	ERR4320089	0.74	0.68	0.51	SAMEA7041123	Gut microbiota of carriers of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae following treatment with oral antibiotics and fecal microbiota transplantation
L11079.1	ERR4333890	0.74	0.68	0.51	SAMEA7041253	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4334164	0.74	0.68	0.51	SAMEA7045249	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4335270	0.74	0.68	0.51	SAMEA7045605	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4341663	0.74	0.68	0.51	SAMEA7045656	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4341781	0.74	0.68	0.51	SAMEA7045774	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4341795	0.74	0.68	0.51	SAMEA7045788	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4341805	0.74	0.68	0.51	SAMEA7045798	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4341893	0.74	0.68	0.51	SAMEA7045886	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4341942	0.74	0.68	0.51	SAMEA7045936	Microbiome connections with host metabolism and habitual diet from the PREDICT 1 metagenomic study
L11079.1	ERR4332492	0.74	0.68	0.51	SAMEA7051255	Multi-omics analysis on overweight subjects under a caloric restriction intervention with fibre supplementation and placebo-controlled.
L11079.1	ERR4332522	0.74	0.68	0.51	SAMEA7051285	Multi-omics analysis on overweight subjects under a caloric restriction intervention with fibre supplementation and placebo-controlled.
L11079.1	ERR4332523	0.74	0.68	0.51	SAMEA7051286	Multi-omics analysis on overweight subjects under a caloric restriction intervention with fibre supplementation and placebo-controlled.
L11079.1	ERR4406755	0.74	0.68	0.51	SAMEA7096923	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4406946	0.74	0.68	0.51	SAMEA7097114	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4406960	0.74	0.68	0.51	SAMEA7097128	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4406970	0.74	0.68	0.51	SAMEA7097138	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4407010	0.74	0.68	0.51	SAMEA7097178	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4407114	0.74	0.68	0.51	SAMEA7097282	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4407123	0.74	0.68	0.51	SAMEA7097291	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4407166	0.74	0.68	0.51	SAMEA7097334	Longitudinal metagenomic analysis of the gut microbiome in preterm infants diagnosed with necrotising enterocolitis and matched controls
L11079.1	ERR4561334	0.74	0.68	0.51	SAMEA7288379	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4561336	0.74	0.68	0.51	SAMEA7288379	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4562565	0.74	0.68	0.51	SAMEA7288787	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563249	0.74	0.68	0.51	SAMEA7288155	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563386	0.74	0.68	0.51	SAMEA7288208	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563387	0.74	0.68	0.51	SAMEA7288208	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563388	0.74	0.68	0.51	SAMEA7288208	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563389	0.74	0.68	0.51	SAMEA7288208	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563390	0.74	0.68	0.51	SAMEA7288208	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563437	0.74	0.68	0.51	SAMEA7288227	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563444	0.74	0.68	0.51	SAMEA7288234	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563445	0.74	0.68	0.51	SAMEA7288234	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563446	0.74	0.68	0.51	SAMEA7288234	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563634	0.74	0.68	0.51	SAMEA7288316	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563635	0.74	0.68	0.51	SAMEA7288316	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563636	0.74	0.68	0.51	SAMEA7288316	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563637	0.74	0.68	0.51	SAMEA7288316	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563794	0.74	0.68	0.51	SAMEA7288418	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563795	0.74	0.68	0.51	SAMEA7288418	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563796	0.74	0.68	0.51	SAMEA7288418	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4563797	0.74	0.68	0.51	SAMEA7288418	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4564407	0.74	0.68	0.51	SAMEA7288594	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4564552	0.74	0.68	0.51	SAMEA7288891	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4564868	0.74	0.68	0.51	SAMEA7288971	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4565459	0.74	0.68	0.51	SAMEA7289115	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4565461	0.74	0.68	0.51	SAMEA7289115	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4565462	0.74	0.68	0.51	SAMEA7289115	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4565464	0.74	0.68	0.51	SAMEA7289115	Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
L11079.1	ERR4571139	0.74	0.68	0.51	SAMEA7294513	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	ERR4571269	0.74	0.68	0.51	SAMEA7294513	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	ERR4571529	0.74	0.68	0.51	SAMEA7294513	Genomic insights into adaptations of TMA-utilizing methanogens to diverse habitats including the human gut
L11079.1	ERR4622849	0.74	0.68	0.51	SAMEA7336372	Alterations in gut microbiome in cirrhosis as assessed by quantitative metagenomics. Relationship with acute-on-chronic liver failure and mortality and prognosis.
L11079.1	ERR4657910	0.74	0.68	0.51	SAMEA7372230	gut metagenome of HC, IBS, DEP and COMO
L11079.1	ERR4657930	0.74	0.68	0.51	SAMEA7372250	gut metagenome of HC, IBS, DEP and COMO
L11079.1	ERR4657987	0.74	0.68	0.51	SAMEA7375374	gut metagenome of HC, IBS, DEP and COMO
L11079.1	ERR4657989	0.74	0.68	0.51	SAMEA7375376	gut metagenome of HC, IBS, DEP and COMO
L11079.1	ERR4657992	0.74	0.68	0.51	SAMEA7375379	gut metagenome of HC, IBS, DEP and COMO
L11079.1	ERR4657994	0.74	0.68	0.51	SAMEA7375381	gut metagenome of HC, IBS, DEP and COMO
L11079.1	ERR4657995	0.74	0.68	0.51	SAMEA7375382	gut metagenome of HC, IBS, DEP and COMO
L11079.1	ERR4657997	0.74	0.68	0.51	SAMEA7375384	gut metagenome of HC, IBS, DEP and COMO
L11079.1	ERR4657999	0.74	0.68	0.51	SAMEA7375386	gut metagenome of HC, IBS, DEP and COMO
L11079.1	ERR4658000	0.74	0.68	0.51	SAMEA7375387	gut metagenome of HC, IBS, DEP and COMO
L11079.1	ERR4678564	0.74	0.68	0.51	SAMEA7426264	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678565	0.74	0.68	0.51	SAMEA7426265	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678571	0.74	0.68	0.51	SAMEA7426271	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678590	0.74	0.68	0.51	SAMEA7426290	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678598	0.74	0.68	0.51	SAMEA7426298	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678606	0.74	0.68	0.51	SAMEA7426306	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678609	0.74	0.68	0.51	SAMEA7426309	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678614	0.74	0.68	0.51	SAMEA7426314	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678621	0.74	0.68	0.51	SAMEA7426321	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678624	0.74	0.68	0.51	SAMEA7426324	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678629	0.74	0.68	0.51	SAMEA7426329	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678646	0.74	0.68	0.51	SAMEA7426346	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678662	0.74	0.68	0.51	SAMEA7426362	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678667	0.74	0.68	0.51	SAMEA7426367	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678668	0.74	0.68	0.51	SAMEA7426368	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678675	0.74	0.68	0.51	SAMEA7426375	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678679	0.74	0.68	0.51	SAMEA7426379	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678692	0.74	0.68	0.51	SAMEA7426392	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678696	0.74	0.68	0.51	SAMEA7426396	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678697	0.74	0.68	0.51	SAMEA7426397	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4678706	0.74	0.68	0.51	SAMEA7426406	Global surveillance of antimicrobial resistance - batch November 2018
L11079.1	ERR4682332	0.74	0.68	0.51	SAMEA7428239	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682342	0.74	0.68	0.51	SAMEA7428249	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682353	0.74	0.68	0.51	SAMEA7428260	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682361	0.74	0.68	0.51	SAMEA7428268	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682377	0.74	0.68	0.51	SAMEA7428284	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682387	0.74	0.68	0.51	SAMEA7428294	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682404	0.74	0.68	0.51	SAMEA7428311	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682410	0.74	0.68	0.51	SAMEA7428317	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682416	0.74	0.68	0.51	SAMEA7428323	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682422	0.74	0.68	0.51	SAMEA7428329	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682425	0.74	0.68	0.51	SAMEA7428332	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682437	0.74	0.68	0.51	SAMEA7428344	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682462	0.74	0.68	0.51	SAMEA7428369	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682468	0.74	0.68	0.51	SAMEA7428375	Global surveillance of antimicrobial resistance - batch November 2017
L11079.1	ERR4682777	0.74	0.68	0.51	SAMEA7428419	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682796	0.74	0.68	0.51	SAMEA7428438	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682804	0.74	0.68	0.51	SAMEA7428446	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682818	0.74	0.68	0.51	SAMEA7428460	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682820	0.74	0.68	0.51	SAMEA7428462	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682834	0.74	0.68	0.51	SAMEA7428476	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682887	0.74	0.68	0.51	SAMEA7428529	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682889	0.74	0.68	0.51	SAMEA7428531	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682891	0.74	0.68	0.51	SAMEA7428533	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682897	0.74	0.68	0.51	SAMEA7428539	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR4682898	0.74	0.68	0.51	SAMEA7428540	Global surveillance of antimicrobial resistance - batch June 2018
L11079.1	ERR479001	0.74	0.68	0.51	SAMEA2467035	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479002	0.74	0.68	0.51	SAMEA2467035	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479003	0.74	0.68	0.51	SAMEA2467035	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479203	0.74	0.68	0.51	SAMEA2467026	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479206	0.74	0.68	0.51	SAMEA2467026	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479218	0.74	0.68	0.51	SAMEA2466949	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479331	0.74	0.68	0.51	SAMEA2466932	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR479332	0.74	0.68	0.51	SAMEA2466932	Potential of fecal microbiota for early stage detection of colorectal cancer
L11079.1	ERR4775682	0.74	0.68	0.51	SAMEA7501210	Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome
L11079.1	ERR4803927	0.74	0.68	0.51	SAMEA7535848	Metagenomic Analysis of Sewage for Surveillance of Bacterial Pathogens: A Release Experiment to Determine Sensitivity
L11079.1	ERR6001996	0.74	0.68	0.51	SAMEA8899434	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6001997	0.74	0.68	0.51	SAMEA8899435	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002032	0.74	0.68	0.51	SAMEA8899470	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002035	0.74	0.68	0.51	SAMEA8899473	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002037	0.74	0.68	0.51	SAMEA8899475	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002063	0.74	0.68	0.51	SAMEA8899501	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002079	0.74	0.68	0.51	SAMEA8899517	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002113	0.74	0.68	0.51	SAMEA8899551	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002130	0.74	0.68	0.51	SAMEA8899568	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002158	0.74	0.68	0.51	SAMEA8899596	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002174	0.74	0.68	0.51	SAMEA8899612	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002175	0.74	0.68	0.51	SAMEA8899613	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002176	0.74	0.68	0.51	SAMEA8899614	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002178	0.74	0.68	0.51	SAMEA8899616	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002189	0.74	0.68	0.51	SAMEA8899627	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002190	0.74	0.68	0.51	SAMEA8899628	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002192	0.74	0.68	0.51	SAMEA8899630	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR6002202	0.74	0.68	0.51	SAMEA8899640	Different development status of gut microbiome link to the dysbiosis of gut ecosystem in early childhood with atopic dermatitis
L11079.1	ERR4866066	0.74	0.68	0.51	SAMEA7608578	Examining the gut microbial community and genes in children with acute lymphoblastic leukemia that experience different levels of change in serum asparaginase activity during pegaspargase treatment
L11079.1	ERR5011877	0.74	0.68	0.51	SAMEA7729748	Metaomics Reveals Microbiome Based Proteolysis as a Driver of Ulcerative Colitis Severity
L11079.1	ERR5035233	0.74	0.68	0.51	SAMEA7756195	Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption
L11079.1	ERR5035258	0.74	0.68	0.51	SAMEA7756220	Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption
L11079.1	ERR5035307	0.74	0.68	0.51	SAMEA7756269	Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption
L11079.1	ERR5035334	0.74	0.68	0.51	SAMEA7756296	Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption
L11079.1	ERR5050379	0.74	0.68	0.51	SAMEA7766609	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050407	0.74	0.68	0.51	SAMEA7766637	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050412	0.74	0.68	0.51	SAMEA7766642	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050437	0.74	0.68	0.51	SAMEA7766667	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050440	0.74	0.68	0.51	SAMEA7766671	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050441	0.74	0.68	0.51	SAMEA7766672	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050448	0.74	0.68	0.51	SAMEA7766679	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050453	0.74	0.68	0.51	SAMEA7766684	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050457	0.74	0.68	0.51	SAMEA7766688	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050459	0.74	0.68	0.51	SAMEA7766690	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050461	0.74	0.68	0.51	SAMEA7766692	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050465	0.74	0.68	0.51	SAMEA7766696	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050470	0.74	0.68	0.51	SAMEA7766701	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050475	0.74	0.68	0.51	SAMEA7766706	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050480	0.74	0.68	0.51	SAMEA7766711	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050488	0.74	0.68	0.51	SAMEA7766719	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050495	0.74	0.68	0.51	SAMEA7766726	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050506	0.74	0.68	0.51	SAMEA7766737	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050509	0.74	0.68	0.51	SAMEA7766740	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050514	0.74	0.68	0.51	SAMEA7766745	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050519	0.74	0.68	0.51	SAMEA7766750	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050529	0.74	0.68	0.51	SAMEA7766760	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050540	0.74	0.68	0.51	SAMEA7766771	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050541	0.74	0.68	0.51	SAMEA7766772	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050542	0.74	0.68	0.51	SAMEA7766773	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050543	0.74	0.68	0.51	SAMEA7766774	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050550	0.74	0.68	0.51	SAMEA7766781	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050552	0.74	0.68	0.51	SAMEA7766783	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050556	0.74	0.68	0.51	SAMEA7766787	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5050560	0.74	0.68	0.51	SAMEA7766791	Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial
L11079.1	ERR5083829	0.74	0.68	0.51	SAMEA7800727	We investigated the effect of short vs long antibiotic treatments on gut microbiota of patients with Gram-negative bacteremia by whole metagenome shotgun sequencing.
L11079.1	ERR5083834	0.74	0.68	0.51	SAMEA7800732	We investigated the effect of short vs long antibiotic treatments on gut microbiota of patients with Gram-negative bacteremia by whole metagenome shotgun sequencing.
L11079.1	ERR5083848	0.74	0.68	0.51	SAMEA7800746	We investigated the effect of short vs long antibiotic treatments on gut microbiota of patients with Gram-negative bacteremia by whole metagenome shotgun sequencing.
L11079.1	ERR5083880	0.74	0.68	0.51	SAMEA7800778	We investigated the effect of short vs long antibiotic treatments on gut microbiota of patients with Gram-negative bacteremia by whole metagenome shotgun sequencing.
L11079.1	ERR5083882	0.74	0.68	0.51	SAMEA7800780	We investigated the effect of short vs long antibiotic treatments on gut microbiota of patients with Gram-negative bacteremia by whole metagenome shotgun sequencing.
L11079.1	ERR5083886	0.74	0.68	0.51	SAMEA7800784	We investigated the effect of short vs long antibiotic treatments on gut microbiota of patients with Gram-negative bacteremia by whole metagenome shotgun sequencing.
L11079.1	ERR5169890	0.74	0.68	0.51	SAMEA7772257	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5170004	0.74	0.68	0.51	SAMEA7772270	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5170005	0.74	0.68	0.51	SAMEA7772271	Characterizing microbiota-directed fiber snack food prototypes in gnotobiotic mice and humans
L11079.1	ERR5260985	0.74	0.68	0.51	SAMEA7996526	Intestinal VLP reads and predicted phage contigs for at-risk RA individuals
L11079.1	ERR521419	0.74	0.68	0.51	SAMEA2556542	Effects of cholera on the human gut microbiota, and interactions between human gut microbes and Vibrio cholerae.
L11079.1	ERR525739	0.74	0.68	0.51	SAMEA2579956	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR525741	0.74	0.68	0.51	SAMEA2579958	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR525841	0.74	0.68	0.51	SAMEA2580058	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR525916	0.74	0.68	0.51	SAMEA2580133	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR526033	0.74	0.68	0.51	SAMEA2580250	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR526071	0.74	0.68	0.51	SAMEA2580288	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR526072	0.74	0.68	0.51	SAMEA2580289	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR526073	0.74	0.68	0.51	SAMEA2580290	Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
L11079.1	ERR527098	0.74	0.68	0.51	SAMEA2581928	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	ERR527103	0.74	0.68	0.51	SAMEA2581933	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	ERR527150	0.74	0.68	0.51	SAMEA2582028	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	ERR527195	0.74	0.68	0.51	SAMEA2582073	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	ERR527208	0.74	0.68	0.51	SAMEA2582086	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	ERR528736	0.74	0.68	0.51	SAMEA2582112	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	ERR528742	0.74	0.68	0.51	SAMEA2582118	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.
L11079.1	ERR5283938	0.74	0.68	0.51	SAMEA8023261	Changes in human gut microbiome during the first wave of COVID-19 pandemic in comparison with pre-pandemic travel-related changes
L11079.1	ERR5283940	0.74	0.68	0.51	SAMEA8023263	Changes in human gut microbiome during the first wave of COVID-19 pandemic in comparison with pre-pandemic travel-related changes
L11079.1	ERR5283996	0.74	0.68	0.51	SAMEA8023319	Changes in human gut microbiome during the first wave of COVID-19 pandemic in comparison with pre-pandemic travel-related changes
L11079.1	ERR5310765	0.74	0.68	0.51	SAMEA8082445	The TrackCattle Study
L11079.1	ERR5310780	0.74	0.68	0.51	SAMEA8082460	The TrackCattle Study
L11079.1	ERR5310825	0.74	0.68	0.51	SAMEA8082505	The TrackCattle Study
L11079.1	ERR5310841	0.74	0.68	0.51	SAMEA8082521	The TrackCattle Study
L11079.1	ERR5445756	0.74	0.68	0.51	SAMEA8228469	Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota
L11079.1	ERR5445761	0.74	0.68	0.51	SAMEA8228474	Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota
L11079.1	ERR5445799	0.74	0.68	0.51	SAMEA8228512	Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota
L11079.1	ERR5445806	0.74	0.68	0.51	SAMEA8228519	Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota
L11079.1	ERR5845168	0.74	0.68	0.51	SAMEA8653332	Association between age and the human intestinal microbiome
L11079.1	ERR5845178	0.74	0.68	0.51	SAMEA8653342	Association between age and the human intestinal microbiome
L11079.1	ERR5883792	0.74	0.68	0.51	SAMEA8690938	Effect of fecal microbiota transplantation combined with Mediterranean diet on insulin sensitivity in subjects with metabolic syndrome
L11079.1	ERR589551	0.74	0.68	0.51	SAMEA2737692	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589561	0.74	0.68	0.51	SAMEA2737702	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589562	0.74	0.68	0.51	SAMEA2737703	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589574	0.74	0.68	0.51	SAMEA2737715	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589576	0.74	0.68	0.51	SAMEA2737717	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589584	0.74	0.68	0.51	SAMEA2737725	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589588	0.74	0.68	0.51	SAMEA2737729	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589732	0.74	0.68	0.51	SAMEA2737737	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589736	0.74	0.68	0.51	SAMEA2737741	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589744	0.74	0.68	0.51	SAMEA2737749	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589748	0.74	0.68	0.51	SAMEA2737753	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589749	0.74	0.68	0.51	SAMEA2737754	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589758	0.74	0.68	0.51	SAMEA2737763	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589785	0.74	0.68	0.51	SAMEA2737790	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589787	0.74	0.68	0.51	SAMEA2737792	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589792	0.74	0.68	0.51	SAMEA2737797	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589804	0.74	0.68	0.51	SAMEA2737809	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589818	0.74	0.68	0.51	SAMEA2737823	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589828	0.74	0.68	0.51	SAMEA2737833	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589829	0.74	0.68	0.51	SAMEA2737834	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589843	0.74	0.68	0.51	SAMEA2737848	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR589873	0.74	0.68	0.51	SAMEA2737878	Gut and Oral Microbiome Dysbiosis in Rheumatoid Arthritis
L11079.1	ERR5902425	0.74	0.68	0.51	SAMEA8694893	A synbiotic intervention modulates meta-omics signatures of gut redox potential and acidity in elective caesarean born infants
L11079.1	ERR5902426	0.74	0.68	0.51	SAMEA8694894	A synbiotic intervention modulates meta-omics signatures of gut redox potential and acidity in elective caesarean born infants
L11079.1	ERR5917188	0.74	0.68	0.51	SAMEA8740357	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR5917240	0.74	0.68	0.51	SAMEA8740409	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR5917274	0.74	0.68	0.51	SAMEA8740443	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR5917280	0.74	0.68	0.51	SAMEA8740449	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR5917322	0.74	0.68	0.51	SAMEA8740491	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR5917339	0.74	0.68	0.51	SAMEA8740508	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR5917342	0.74	0.68	0.51	SAMEA8740511	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study
L11079.1	ERR597356	0.74	0.68	0.51	SAMEA2755544	Kwashiorkor Children have lost Anaerobes-Methanogenic Gut Prokaryotes Mutualism
L11079.1	ERR597391	0.74	0.68	0.51	SAMEA2755579	Kwashiorkor Children have lost Anaerobes-Methanogenic Gut Prokaryotes Mutualism
L11079.1	ERR597406	0.74	0.68	0.51	SAMEA2755594	Kwashiorkor Children have lost Anaerobes-Methanogenic Gut Prokaryotes Mutualism
L11079.1	ERR597414	0.74	0.68	0.51	SAMEA2755602	Kwashiorkor Children have lost Anaerobes-Methanogenic Gut Prokaryotes Mutualism
L11079.1	ERR597419	0.74	0.68	0.51	SAMEA2755607	Kwashiorkor Children have lost Anaerobes-Methanogenic Gut Prokaryotes Mutualism
L11079.1	ERR843017	0.74	0.68	0.51	SAMEA3322267	Kwashiorkor Children have lost Anaerobes-Methanogenic Gut Prokaryotes Mutualism
L11079.1	ERR843239	0.74	0.68	0.51	SAMEA3322501	Kwashiorkor Children have lost Anaerobes-Methanogenic Gut Prokaryotes Mutualism
L11079.1	ERR636350	0.74	0.68	0.51	SAMEA2784449	Influence of travel on antibiotic resistance
L11079.1	ERR636356	0.74	0.68	0.51	SAMEA2784455	Influence of travel on antibiotic resistance
L11079.1	ERR636366	0.74	0.68	0.51	SAMEA2784465	Influence of travel on antibiotic resistance
L11079.1	ERR636374	0.74	0.68	0.51	SAMEA2784473	Influence of travel on antibiotic resistance
L11079.1	ERR636378	0.74	0.68	0.51	SAMEA2784477	Influence of travel on antibiotic resistance
L11079.1	ERR636390	0.74	0.68	0.51	SAMEA2784489	Influence of travel on antibiotic resistance
L11079.1	ERR636400	0.74	0.68	0.51	SAMEA2784499	Influence of travel on antibiotic resistance
L11079.1	ERR636402	0.74	0.68	0.51	SAMEA2784501	Influence of travel on antibiotic resistance
L11079.1	ERR636403	0.74	0.68	0.51	SAMEA2784502	Influence of travel on antibiotic resistance
L11079.1	ERR636416	0.74	0.68	0.51	SAMEA2784515	Influence of travel on antibiotic resistance
L11079.1	ERR6383981	0.74	0.68	0.51	SAMEA8994786	Human and mouse gut metagenome upon fecal microbiota transplantation
L11079.1	ERR6619100	0.74	0.68	0.51	SAMEA9561691	Fecal microbiota transplantation for treatment of ulcerative colitis
L11079.1	ERR6634864	0.74	0.68	0.51	SAMEA9561738	Fecal microbiota transplantation for treatment of ulcerative colitis
L11079.1	ERR6752171	0.74	0.68	0.51	SAMEA9943621	Exploring semi-quantitative metagenomics studies using Oxford Nanopore sequencing : a computational and experimental protocol
L11079.1	ERR6747870	0.74	0.68	0.51	SAMEA9943770	Saccharomyces boulardii CNCM I 745 supplementation modifies the fecal resistome during the Helicobacter pylori eradication therapy
L11079.1	ERR6747889	0.74	0.68	0.51	SAMEA9943789	Saccharomyces boulardii CNCM I 745 supplementation modifies the fecal resistome during the Helicobacter pylori eradication therapy
L11079.1	ERR6747896	0.74	0.68	0.51	SAMEA9943796	Saccharomyces boulardii CNCM I 745 supplementation modifies the fecal resistome during the Helicobacter pylori eradication therapy
L11079.1	ERR6747912	0.74	0.68	0.51	SAMEA9943812	Saccharomyces boulardii CNCM I 745 supplementation modifies the fecal resistome during the Helicobacter pylori eradication therapy
L11079.1	ERR6747918	0.74	0.68	0.51	SAMEA9943818	Saccharomyces boulardii CNCM I 745 supplementation modifies the fecal resistome during the Helicobacter pylori eradication therapy
L11079.1	ERR6747919	0.74	0.68	0.51	SAMEA9943819	Saccharomyces boulardii CNCM I 745 supplementation modifies the fecal resistome during the Helicobacter pylori eradication therapy
L11079.1	ERR6910949	0.74	0.68	0.51	SAMEA9990007	BARIA baseline first 100 individuals, metagenomes
L11079.1	ERR6910951	0.74	0.68	0.51	SAMEA9990009	BARIA baseline first 100 individuals, metagenomes
L11079.1	ERR6910976	0.74	0.68	0.51	SAMEA9990034	BARIA baseline first 100 individuals, metagenomes
L11079.1	ERR6911016	0.74	0.68	0.51	SAMEA9990074	BARIA baseline first 100 individuals, metagenomes
L11079.1	ERR6929709	0.74	0.68	0.51	SAMEA9992895	seppo horse
L11079.1	ERR6929719	0.74	0.68	0.51	SAMEA9992905	seppo horse
L11079.1	ERR6929727	0.74	0.68	0.51	SAMEA9992913	seppo horse
L11079.1	ERR7017684	0.74	0.68	0.51	SAMEA10256226	AMR_metagenomic_sequencing
L11079.1	ERR7017712	0.74	0.68	0.51	SAMEA10256226	AMR_metagenomic_sequencing
L11079.1	ERR7017740	0.74	0.68	0.51	SAMEA10256226	AMR_metagenomic_sequencing
L11079.1	ERR7017768	0.74	0.68	0.51	SAMEA10256226	AMR_metagenomic_sequencing
L11079.1	ERR7017796	0.74	0.68	0.51	SAMEA10256226	AMR_metagenomic_sequencing
L11079.1	ERR7017824	0.74	0.68	0.51	SAMEA10256226	AMR_metagenomic_sequencing
L11079.1	ERR7017852	0.74	0.68	0.51	SAMEA10256226	AMR_metagenomic_sequencing
L11079.1	ERR719165	0.74	0.68	0.51	SAMEA3182052	The initial state of the human gut microbiome determines its reshaping by antibiotics
L11079.1	ERR720101	0.74	0.68	0.51	SAMEA3182072	The initial state of the human gut microbiome determines its reshaping by antibiotics
L11079.1	ERR7340503	0.74	0.68	0.51	SAMEA10983915	Increasing the diversity of dietary fibres in a daily-consumed bread modifies gut microbiota and metabolic profile in subjects at cardiometabolic risk
L11079.1	ERR7340504	0.74	0.68	0.51	SAMEA10983915	Increasing the diversity of dietary fibres in a daily-consumed bread modifies gut microbiota and metabolic profile in subjects at cardiometabolic risk
L11079.1	ERR7340508	0.74	0.68	0.51	SAMEA10983915	Increasing the diversity of dietary fibres in a daily-consumed bread modifies gut microbiota and metabolic profile in subjects at cardiometabolic risk
L11079.1	ERR7340509	0.74	0.68	0.51	SAMEA10983915	Increasing the diversity of dietary fibres in a daily-consumed bread modifies gut microbiota and metabolic profile in subjects at cardiometabolic risk
L11079.1	ERR7439136	0.74	0.68	0.51	SAMEA10813564	Long-term effects of diet on human gut microbiota composition employing shotgun metagenomics data analysis
L11079.1	ERR7439213	0.74	0.68	0.51	SAMEA10813642	Long-term effects of diet on human gut microbiota composition employing shotgun metagenomics data analysis
L11079.1	ERR7447005	0.74	0.68	0.51	SAMEA11308594	Metatranscriptome analysis of fecal microbiota transplantation in chronic antibiotic resistant pouchitis
L11079.1	ERR7459269	0.74	0.68	0.51	SAMEA104666010	The_human_gut_microbiome_in_alcoholic_liver_disease
L11079.1	ERR7459406	0.74	0.68	0.51	SAMEA104666002	The_human_gut_microbiome_in_alcoholic_liver_disease
L11079.1	ERR7459410	0.74	0.68	0.51	SAMEA104665959	The_human_gut_microbiome_in_alcoholic_liver_disease
L11079.1	ERR7599956	0.74	0.68	0.51	SAMEA11358324	Singapore Platinum Metagenomes Project
L11079.1	ERR7625374	0.74	0.68	0.51	SAMEA11358292	Singapore Platinum Metagenomes Project
L11079.1	ERR7671911	0.74	0.68	0.51	SAMEA11358354	Singapore Platinum Metagenomes Project
L11079.1	ERR7671942	0.74	0.68	0.51	SAMEA11358292	Singapore Platinum Metagenomes Project
L11079.1	ERR866568	0.74	0.68	0.51	SAMEA3360664	Gut microbial succession follows acute secretory diarrhea in humans
L11079.1	ERR866570	0.74	0.68	0.51	SAMEA3360666	Gut microbial succession follows acute secretory diarrhea in humans
L11079.1	ERR866578	0.74	0.68	0.51	SAMEA3360674	Gut microbial succession follows acute secretory diarrhea in humans
L11079.1	ERR866580	0.74	0.68	0.51	SAMEA3360676	Gut microbial succession follows acute secretory diarrhea in humans
L11079.1	ERR866597	0.74	0.68	0.51	SAMEA3360693	Gut microbial succession follows acute secretory diarrhea in humans
L11079.1	ERR906895	0.74	0.68	0.51	SAMEA3444270	Expanded Enteric Virome and Altered Bacterial Microbiome in Acquired Immunodeficiency Syndrome
L11079.1	ERR906899	0.74	0.68	0.51	SAMEA3444274	Expanded Enteric Virome and Altered Bacterial Microbiome in Acquired Immunodeficiency Syndrome
L11079.1	ERR906922	0.74	0.68	0.51	SAMEA3444297	Expanded Enteric Virome and Altered Bacterial Microbiome in Acquired Immunodeficiency Syndrome
L11079.1	ERR906924	0.74	0.68	0.51	SAMEA3444299	Expanded Enteric Virome and Altered Bacterial Microbiome in Acquired Immunodeficiency Syndrome
L11079.1	ERR912001	0.74	0.68	0.51	SAMEA3449196	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912010	0.74	0.68	0.51	SAMEA3449205	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912130	0.74	0.68	0.51	SAMEA3449325	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912152	0.74	0.68	0.51	SAMEA3449347	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR912168	0.74	0.68	0.51	SAMEA3449363	Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome
L11079.1	ERR966030	0.74	0.68	0.51	SAMEA3487582	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR969528	0.74	0.68	0.51	SAMEA3490272	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR969533	0.74	0.68	0.51	SAMEA3490277	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR969539	0.74	0.68	0.51	SAMEA3490283	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR969542	0.74	0.68	0.51	SAMEA3490286	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR969547	0.74	0.68	0.51	SAMEA3490291	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR969551	0.74	0.68	0.51	SAMEA3490295	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR969553	0.74	0.68	0.51	SAMEA3490297	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR969637	0.74	0.68	0.51	SAMEA3490381	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR969647	0.74	0.68	0.51	SAMEA3490391	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR969651	0.74	0.68	0.51	SAMEA3490395	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR969663	0.74	0.68	0.51	SAMEA3490407	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR969675	0.74	0.68	0.51	SAMEA3490419	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR970275	0.74	0.68	0.51	SAMEA3491297	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR970298	0.74	0.68	0.51	SAMEA3491320	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR970303	0.74	0.68	0.51	SAMEA3491325	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR970325	0.74	0.68	0.51	SAMEA3491347	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR970331	0.74	0.68	0.51	SAMEA3491353	Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel
L11079.1	ERR975305	0.74	0.68	0.51	SAMEA3488754	The gut DNA viromes of Malawian twins discordant for severe acute undernutrition
L11079.1	ERR975309	0.74	0.68	0.51	SAMEA3488757	The gut DNA viromes of Malawian twins discordant for severe acute undernutrition
L11079.1	ERR975310	0.74	0.68	0.51	SAMEA3488758	The gut DNA viromes of Malawian twins discordant for severe acute undernutrition
L11079.1	ERR975311	0.74	0.68	0.51	SAMEA3488759	The gut DNA viromes of Malawian twins discordant for severe acute undernutrition
L11079.1	SRR061131	0.74	0.68	0.51	SAMN00040286	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR1564344	0.74	0.68	0.51	SAMN00074762	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR527979	0.74	0.68	0.51	SAMN00069411	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR528012	0.74	0.68	0.51	SAMN00069411	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR528068	0.74	0.68	0.51	SAMN00069411	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR528098	0.74	0.68	0.51	SAMN00069411	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR528136	0.74	0.68	0.51	SAMN00069411	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR528186	0.74	0.68	0.51	SAMN00069411	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR528205	0.74	0.68	0.51	SAMN00069411	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR528319	0.74	0.68	0.51	SAMN00069411	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR528350	0.74	0.68	0.51	SAMN00069411	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR528399	0.74	0.68	0.51	SAMN00069411	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR528474	0.74	0.68	0.51	SAMN00069411	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR528527	0.74	0.68	0.51	SAMN00069411	Human Microbiome Project (HMP) Metagenomic WGS Projects, deeper sequencing of the human microbiome samples: Production Phase
L11079.1	SRR5548648	0.74	0.68	0.51	SAMN06733574	The Role of the Gut Microbiota in Ulcerative Colitis, functional gene metagenomics
L11079.1	SRR10002688	0.74	0.68	0.51	SAMN12606848	Shotgun metagenomic sequencing of subway and urban air samples: gCSD17
L11079.1	SRR10002934	0.74	0.68	0.51	SAMN12606849	Shotgun metagenomic sequencing of subway and urban air samples: gCSD17
L11079.1	SRR10029217	0.74	0.68	0.51	SAMN12645308	Multi-omic analysis of Clostridioides difficile infection and response to therapy in pediatric inflammatory bowel disease
L11079.1	SRR10036064	0.74	0.68	0.51	SAMN12647014	A metagenomics-enabled investigation of antimicrobial resistance in an urban watershed
L11079.1	SRR1145905	0.74	0.68	0.51	SAMN01041783	Microbial composition of samples from infant gut
L11079.1	SRR1159297	0.74	0.68	0.51	SAMN00998686	Microbial composition of samples from infant gut
L11079.1	SRR1159765	0.74	0.68	0.51	SAMN00998686	Microbial composition of samples from infant gut
L11079.1	SRR1159943	0.74	0.68	0.51	SAMN00767973	Microbial composition of samples from infant gut
L11079.1	SRR1162592	0.74	0.68	0.51	SAMN01780015	Microbial composition of samples from infant gut
L11079.1	SRR1162594	0.74	0.68	0.51	SAMN00990327	Microbial composition of samples from infant gut
L11079.1	SRR1166390	0.74	0.68	0.51	SAMN00990279	Microbial composition of samples from infant gut
L11079.1	SRR1166589	0.74	0.68	0.51	SAMN00990327	Microbial composition of samples from infant gut
L11079.1	SRR1166678	0.74	0.68	0.51	SAMN01780015	Microbial composition of samples from infant gut
L11079.1	SRR1166700	0.74	0.68	0.51	SAMN00990327	Microbial composition of samples from infant gut
L11079.1	SRR1952241	0.74	0.68	0.51	SAMN00991577	Microbial composition of samples from infant gut
L11079.1	SRR1952242	0.74	0.68	0.51	SAMN00696746	Microbial composition of samples from infant gut
L11079.1	SRR1952298	0.74	0.68	0.51	SAMN00990327	Microbial composition of samples from infant gut
L11079.1	SRR1952337	0.74	0.68	0.51	SAMN01780015	Microbial composition of samples from infant gut
L11079.1	SRR1952483	0.74	0.68	0.51	SAMN00998645	Microbial composition of samples from infant gut
L11079.1	SRR649946	0.74	0.68	0.51	SAMN01779952	Microbial composition of samples from infant gut
L11079.1	SRR649989	0.74	0.68	0.51	SAMN01780040	Microbial composition of samples from infant gut
L11079.1	SRR650302	0.74	0.68	0.51	SAMN01779924	Microbial composition of samples from infant gut
L11079.1	SRR917982	0.74	0.68	0.51	SAMN01795864	Microbial composition of samples from infant gut
L11079.1	SRR925003	0.74	0.68	0.51	SAMN01828402	Microbial composition of samples from infant gut
L11079.1	SRR12783103	0.74	0.68	0.51	SAMN15889630	Fecal microbiome analysis of patients with chronic obstructive pulmonary disease
L11079.1	SRR10084757	0.74	0.68	0.51	SAMN12711703	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084758	0.74	0.68	0.51	SAMN12711702	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084759	0.74	0.68	0.51	SAMN12711701	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084760	0.74	0.68	0.51	SAMN12711700	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084769	0.74	0.68	0.51	SAMN12711692	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084778	0.74	0.68	0.51	SAMN12711684	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084792	0.74	0.68	0.51	SAMN12711671	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084798	0.74	0.68	0.51	SAMN12711612	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084805	0.74	0.68	0.51	SAMN12711659	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084813	0.74	0.68	0.51	SAMN12711652	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084821	0.74	0.68	0.51	SAMN12711645	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084834	0.74	0.68	0.51	SAMN12711633	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084835	0.74	0.68	0.51	SAMN12711632	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084838	0.74	0.68	0.51	SAMN12711629	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084842	0.74	0.68	0.51	SAMN12711608	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084845	0.74	0.68	0.51	SAMN12711623	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084850	0.74	0.68	0.51	SAMN12711618	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084853	0.74	0.68	0.51	SAMN12711711	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10084854	0.74	0.68	0.51	SAMN12711710	Metagenomics Reveals Impact of Geography, Antibiotics and Acute Diarrhoeal Disease on the Gut Microbiome of Central Indian Populations
L11079.1	SRR10098302	0.74	0.68	0.51	SAMN12691792	Bovine composite fecal metagenome from pre-weaned dairy calves and lactating cows
L11079.1	SRR10098304	0.74	0.68	0.51	SAMN12692662	Bovine composite fecal metagenome from pre-weaned dairy calves and lactating cows
L11079.1	SRR10098307	0.74	0.68	0.51	SAMN12692664	Bovine composite fecal metagenome from pre-weaned dairy calves and lactating cows
L11079.1	SRR10098315	0.74	0.68	0.51	SAMN12692672	Bovine composite fecal metagenome from pre-weaned dairy calves and lactating cows
L11079.1	SRR10098318	0.74	0.68	0.51	SAMN12692674	Bovine composite fecal metagenome from pre-weaned dairy calves and lactating cows
L11079.1	SRR10098320	0.74	0.68	0.51	SAMN12692676	Bovine composite fecal metagenome from pre-weaned dairy calves and lactating cows
L11079.1	SRR10098749	0.74	0.68	0.51	SAMN12727816	Characterization of antimicrobial resistance genes in the enriched Enterobacteriaceae community of suburban mesocarnivores, stray dogs and owned dogs.
L11079.1	SRR10098750	0.74	0.68	0.51	SAMN12727815	Characterization of antimicrobial resistance genes in the enriched Enterobacteriaceae community of suburban mesocarnivores, stray dogs and owned dogs.
L11079.1	SRR10099615	0.74	0.68	0.51	SAMN12730335	Gut virome in VEO-IBD
L11079.1	SRR15801624	0.74	0.68	0.51	SAMN12730287	Gut virome in VEO-IBD
L11079.1	SRR15801635	0.74	0.68	0.51	SAMN12730282	Gut virome in VEO-IBD
L11079.1	SRR10121574	0.74	0.68	0.51	SAMN12751408	fecal sample Raw sequence reads
L11079.1	SRR10121582	0.74	0.68	0.51	SAMN12751407	fecal sample Raw sequence reads
L11079.1	SRR10121599	0.74	0.68	0.51	SAMN12751436	fecal sample Raw sequence reads
L11079.1	SRR10121602	0.74	0.68	0.51	SAMN12751433	fecal sample Raw sequence reads
L11079.1	SRR10121603	0.74	0.68	0.51	SAMN12751432	fecal sample Raw sequence reads
L11079.1	SRR10121604	0.74	0.68	0.51	SAMN12751405	fecal sample Raw sequence reads
L11079.1	SRR10121609	0.74	0.68	0.51	SAMN12751427	fecal sample Raw sequence reads
L11079.1	SRR10121623	0.74	0.68	0.51	SAMN12751414	fecal sample Raw sequence reads
L11079.1	SRR8402091	0.74	0.68	0.51	SAMN10698537	feces metagenome Metagenome
L11079.1	SRR8402137	0.74	0.68	0.51	SAMN10698498	feces metagenome Metagenome
L11079.1	SRR8402145	0.74	0.68	0.51	SAMN10698502	feces metagenome Metagenome
L11079.1	SRR8402157	0.74	0.68	0.51	SAMN10698651	feces metagenome Metagenome
L11079.1	SRR8402166	0.74	0.68	0.51	SAMN10698791	feces metagenome Metagenome
L11079.1	SRR8402212	0.74	0.68	0.51	SAMN10698450	feces metagenome Metagenome
L11079.1	SRR8402266	0.74	0.68	0.51	SAMN10698517	feces metagenome Metagenome
L11079.1	SRR8402312	0.74	0.68	0.51	SAMN10698729	feces metagenome Metagenome
L11079.1	SRR8402322	0.74	0.68	0.51	SAMN10698777	feces metagenome Metagenome
L11079.1	SRR8402340	0.74	0.68	0.51	SAMN10698572	feces metagenome Metagenome
L11079.1	SRR8402378	0.74	0.68	0.51	SAMN10698635	feces metagenome Metagenome
L11079.1	SRR8402393	0.74	0.68	0.51	SAMN10698592	feces metagenome Metagenome
L11079.1	SRR8402414	0.74	0.68	0.51	SAMN10698712	feces metagenome Metagenome
L11079.1	SRR8402427	0.74	0.68	0.51	SAMN10698792	feces metagenome Metagenome
L11079.1	SRR6187066	0.74	0.68	0.51	SAMN07795011	human gut metagenome Raw sequence reads
L11079.1	SRR7124571	0.74	0.68	0.51	SAMN08918301	human gut metagenome Raw sequence reads
L11079.1	SRR7124573	0.74	0.68	0.51	SAMN08918322	human gut metagenome Raw sequence reads
L11079.1	SRR7124664	0.74	0.68	0.51	SAMN08918257	human gut metagenome Raw sequence reads
L11079.1	SRR7124695	0.74	0.68	0.51	SAMN08918079	human gut metagenome Raw sequence reads
L11079.1	SRR7124709	0.74	0.68	0.51	SAMN08918273	human gut metagenome Raw sequence reads
L11079.1	SRR7124744	0.74	0.68	0.51	SAMN08918270	human gut metagenome Raw sequence reads
L11079.1	SRR7124796	0.74	0.68	0.51	SAMN08918300	human gut metagenome Raw sequence reads
L11079.1	SRR7124799	0.74	0.68	0.51	SAMN08918260	human gut metagenome Raw sequence reads
L11079.1	SRR7124847	0.74	0.68	0.51	SAMN08918116	human gut metagenome Raw sequence reads
L11079.1	SRR10158848	0.74	0.68	0.51	SAMN12810835	10x linked-read and Illumina short-read metagenome sequencing for heathy Chinese
L11079.1	SRR10168673	0.74	0.68	0.51	SAMN12826456	Whole Meta-genome shotgun sequencing of stool samples from human treated with antibiotics
L11079.1	SRR8803204	0.74	0.68	0.51	SAMN11283195	Homo sapiens Metagenome
L11079.1	SRR8803206	0.74	0.68	0.51	SAMN11283194	Homo sapiens Metagenome
L11079.1	SRR8803217	0.74	0.68	0.51	SAMN11283192	Homo sapiens Metagenome
L11079.1	SRR8803224	0.74	0.68	0.51	SAMN11283169	Homo sapiens Metagenome
L11079.1	SRR8803228	0.74	0.68	0.51	SAMN11283173	Homo sapiens Metagenome
L11079.1	SRR8803232	0.74	0.68	0.51	SAMN11283203	Homo sapiens Metagenome
L11079.1	SRR8803242	0.74	0.68	0.51	SAMN11283178	Homo sapiens Metagenome
L11079.1	SRR14571172	0.74	0.68	0.51	SAMN19188959	human metagenome Raw sequence reads
L11079.1	SRR5298200	0.74	0.68	0.51	SAMN06350471	human metagenome Raw sequence reads
L11079.1	SRR5298204	0.74	0.68	0.51	SAMN06350463	human metagenome Raw sequence reads
L11079.1	SRR5298210	0.74	0.68	0.51	SAMN06350446	human metagenome Raw sequence reads
L11079.1	SRR5298218	0.74	0.68	0.51	SAMN06350436	human metagenome Raw sequence reads
L11079.1	SRR5298219	0.74	0.68	0.51	SAMN06350435	human metagenome Raw sequence reads
L11079.1	SRR10479842	0.74	0.68	0.51	SAMN13254975	human gut metagenome Metagenome
L11079.1	SRR10499406	0.74	0.68	0.51	SAMN13292756	human gut metagenome Metagenome
L11079.1	SRR10499647	0.74	0.68	0.51	SAMN13292975	human gut metagenome Metagenome
L11079.1	SRR10499697	0.74	0.68	0.51	SAMN13292959	human gut metagenome Metagenome
L11079.1	SRR10499738	0.74	0.68	0.51	SAMN13292951	human gut metagenome Metagenome
L11079.1	SRR10499742	0.74	0.68	0.51	SAMN13292808	human gut metagenome Metagenome
L11079.1	SRR10691959	0.74	0.68	0.51	SAMN13246728	human gut metagenome Metagenome
L11079.1	SRR10691967	0.74	0.68	0.51	SAMN13246721	human gut metagenome Metagenome
L11079.1	SRR10691976	0.74	0.68	0.51	SAMN13246713	human gut metagenome Metagenome
L11079.1	SRR10691978	0.74	0.68	0.51	SAMN13246711	human gut metagenome Metagenome
L11079.1	SRR10691996	0.74	0.68	0.51	SAMN13246468	human gut metagenome Metagenome
L11079.1	SRR10691998	0.74	0.68	0.51	SAMN13246206	human gut metagenome Metagenome
L11079.1	SRR10692007	0.74	0.68	0.51	SAMN13246458	human gut metagenome Metagenome
L11079.1	SRR10692011	0.74	0.68	0.51	SAMN13246455	human gut metagenome Metagenome
L11079.1	SRR10692036	0.74	0.68	0.51	SAMN13246918	human gut metagenome Metagenome
L11079.1	SRR10692040	0.74	0.68	0.51	SAMN13246915	human gut metagenome Metagenome
L11079.1	SRR10692045	0.74	0.68	0.51	SAMN13246910	human gut metagenome Metagenome
L11079.1	SRR10692047	0.74	0.68	0.51	SAMN13246908	human gut metagenome Metagenome
L11079.1	SRR10692048	0.74	0.68	0.51	SAMN13246907	human gut metagenome Metagenome
L11079.1	SRR10692058	0.74	0.68	0.51	SAMN13246898	human gut metagenome Metagenome
L11079.1	SRR10692065	0.74	0.68	0.51	SAMN13246697	human gut metagenome Metagenome
L11079.1	SRR10692067	0.74	0.68	0.51	SAMN13246696	human gut metagenome Metagenome
L11079.1	SRR10692074	0.74	0.68	0.51	SAMN13246689	human gut metagenome Metagenome
L11079.1	SRR10692077	0.74	0.68	0.51	SAMN13246228	human gut metagenome Metagenome
L11079.1	SRR10692079	0.74	0.68	0.51	SAMN13246685	human gut metagenome Metagenome
L11079.1	SRR10692085	0.74	0.68	0.51	SAMN13246679	human gut metagenome Metagenome
L11079.1	SRR10692094	0.74	0.68	0.51	SAMN13246672	human gut metagenome Metagenome
L11079.1	SRR10692099	0.74	0.68	0.51	SAMN13246440	human gut metagenome Metagenome
L11079.1	SRR10692105	0.74	0.68	0.51	SAMN13246435	human gut metagenome Metagenome
L11079.1	SRR10692123	0.74	0.68	0.51	SAMN13246418	human gut metagenome Metagenome
L11079.1	SRR10692133	0.74	0.68	0.51	SAMN13246409	human gut metagenome Metagenome
L11079.1	SRR10692186	0.74	0.68	0.51	SAMN13246880	human gut metagenome Metagenome
L11079.1	SRR10692187	0.74	0.68	0.51	SAMN13246879	human gut metagenome Metagenome
L11079.1	SRR10692211	0.74	0.68	0.51	SAMN13246664	human gut metagenome Metagenome
L11079.1	SRR10692220	0.74	0.68	0.51	SAMN13246656	human gut metagenome Metagenome
L11079.1	SRR10692223	0.74	0.68	0.51	SAMN13246772	human gut metagenome Metagenome
L11079.1	SRR10692228	0.74	0.68	0.51	SAMN13246767	human gut metagenome Metagenome
L11079.1	SRR10692234	0.74	0.68	0.51	SAMN13246567	human gut metagenome Metagenome
L11079.1	SRR10692246	0.74	0.68	0.51	SAMN13246215	human gut metagenome Metagenome
L11079.1	SRR10692265	0.74	0.68	0.51	SAMN13246539	human gut metagenome Metagenome
L11079.1	SRR10692268	0.74	0.68	0.51	SAMN13246990	human gut metagenome Metagenome
L11079.1	SRR10692269	0.74	0.68	0.51	SAMN13246989	human gut metagenome Metagenome
L11079.1	SRR10692273	0.74	0.68	0.51	SAMN13246986	human gut metagenome Metagenome
L11079.1	SRR10692282	0.74	0.68	0.51	SAMN13246977	human gut metagenome Metagenome
L11079.1	SRR10692287	0.74	0.68	0.51	SAMN13246974	human gut metagenome Metagenome
L11079.1	SRR10692289	0.74	0.68	0.51	SAMN13246972	human gut metagenome Metagenome
L11079.1	SRR10692299	0.74	0.68	0.51	SAMN13246963	human gut metagenome Metagenome
L11079.1	SRR10692302	0.74	0.68	0.51	SAMN13246960	human gut metagenome Metagenome
L11079.1	SRR10692321	0.74	0.68	0.51	SAMN13246521	human gut metagenome Metagenome
L11079.1	SRR10692326	0.74	0.68	0.51	SAMN13246211	human gut metagenome Metagenome
L11079.1	SRR10692343	0.74	0.68	0.51	SAMN13246339	human gut metagenome Metagenome
L11079.1	SRR10692345	0.74	0.68	0.51	SAMN13246337	human gut metagenome Metagenome
L11079.1	SRR10692353	0.74	0.68	0.51	SAMN13246330	human gut metagenome Metagenome
L11079.1	SRR10692356	0.74	0.68	0.51	SAMN13246327	human gut metagenome Metagenome
L11079.1	SRR10692357	0.74	0.68	0.51	SAMN13246192	human gut metagenome Metagenome
L11079.1	SRR10692365	0.74	0.68	0.51	SAMN13246319	human gut metagenome Metagenome
L11079.1	SRR10692379	0.74	0.68	0.51	SAMN13246956	human gut metagenome Metagenome
L11079.1	SRR10692387	0.74	0.68	0.51	SAMN13246948	human gut metagenome Metagenome
L11079.1	SRR10692395	0.74	0.68	0.51	SAMN13246941	human gut metagenome Metagenome
L11079.1	SRR10692399	0.74	0.68	0.51	SAMN13246937	human gut metagenome Metagenome
L11079.1	SRR10692418	0.74	0.68	0.51	SAMN13246500	human gut metagenome Metagenome
L11079.1	SRR10692429	0.74	0.68	0.51	SAMN13246490	human gut metagenome Metagenome
L11079.1	SRR10692434	0.74	0.68	0.51	SAMN13246486	human gut metagenome Metagenome
L11079.1	SRR10692435	0.74	0.68	0.51	SAMN13246485	human gut metagenome Metagenome
L11079.1	SRR10692436	0.74	0.68	0.51	SAMN13246484	human gut metagenome Metagenome
L11079.1	SRR10692470	0.74	0.68	0.51	SAMN13246291	human gut metagenome Metagenome
L11079.1	SRR10692483	0.74	0.68	0.51	SAMN13246279	human gut metagenome Metagenome
L11079.1	SRR10692519	0.74	0.68	0.51	SAMN13247090	human gut metagenome Metagenome
L11079.1	SRR10692523	0.74	0.68	0.51	SAMN13246763	human gut metagenome Metagenome
L11079.1	SRR10692524	0.74	0.68	0.51	SAMN13246762	human gut metagenome Metagenome
L11079.1	SRR10692546	0.74	0.68	0.51	SAMN13246742	human gut metagenome Metagenome
L11079.1	SRR10692547	0.74	0.68	0.51	SAMN13246741	human gut metagenome Metagenome
L11079.1	SRR10692558	0.74	0.68	0.51	SAMN13246187	human gut metagenome Metagenome
L11079.1	SRR10692560	0.74	0.68	0.51	SAMN13246177	human gut metagenome Metagenome
L11079.1	SRR10692567	0.74	0.68	0.51	SAMN13246647	human gut metagenome Metagenome
L11079.1	SRR10692568	0.74	0.68	0.51	SAMN13246224	human gut metagenome Metagenome
L11079.1	SRR10692569	0.74	0.68	0.51	SAMN13246646	human gut metagenome Metagenome
L11079.1	SRR10692570	0.74	0.68	0.51	SAMN13246645	human gut metagenome Metagenome
L11079.1	SRR10692572	0.74	0.68	0.51	SAMN13246643	human gut metagenome Metagenome
L11079.1	SRR10692579	0.74	0.68	0.51	SAMN13246223	human gut metagenome Metagenome
L11079.1	SRR10692591	0.74	0.68	0.51	SAMN13246398	human gut metagenome Metagenome
L11079.1	SRR10692599	0.74	0.68	0.51	SAMN13246391	human gut metagenome Metagenome
L11079.1	SRR10692601	0.74	0.68	0.51	SAMN13246389	human gut metagenome Metagenome
L11079.1	SRR10692617	0.74	0.68	0.51	SAMN13246265	human gut metagenome Metagenome
L11079.1	SRR10692622	0.74	0.68	0.51	SAMN13247052	human gut metagenome Metagenome
L11079.1	SRR10692628	0.74	0.68	0.51	SAMN13246264	human gut metagenome Metagenome
L11079.1	SRR10692635	0.74	0.68	0.51	SAMN13247040	human gut metagenome Metagenome
L11079.1	SRR10692636	0.74	0.68	0.51	SAMN13247039	human gut metagenome Metagenome
L11079.1	SRR10692650	0.74	0.68	0.51	SAMN13246262	human gut metagenome Metagenome
L11079.1	SRR10692651	0.74	0.68	0.51	SAMN13247026	human gut metagenome Metagenome
L11079.1	SRR10692660	0.74	0.68	0.51	SAMN13246856	human gut metagenome Metagenome
L11079.1	SRR10692662	0.74	0.68	0.51	SAMN13246854	human gut metagenome Metagenome
L11079.1	SRR10692666	0.74	0.68	0.51	SAMN13246850	human gut metagenome Metagenome
L11079.1	SRR10692675	0.74	0.68	0.51	SAMN13246842	human gut metagenome Metagenome
L11079.1	SRR10692692	0.74	0.68	0.51	SAMN13246632	human gut metagenome Metagenome
L11079.1	SRR10692694	0.74	0.68	0.51	SAMN13246630	human gut metagenome Metagenome
L11079.1	SRR10692700	0.74	0.68	0.51	SAMN13246625	human gut metagenome Metagenome
L11079.1	SRR10692707	0.74	0.68	0.51	SAMN13246618	human gut metagenome Metagenome
L11079.1	SRR10692716	0.74	0.68	0.51	SAMN13246610	human gut metagenome Metagenome
L11079.1	SRR10692738	0.74	0.68	0.51	SAMN13246817	human gut metagenome Metagenome
L11079.1	SRR10692759	0.74	0.68	0.51	SAMN13246798	human gut metagenome Metagenome
L11079.1	SRR10692760	0.74	0.68	0.51	SAMN13246797	human gut metagenome Metagenome
L11079.1	SRR10692769	0.74	0.68	0.51	SAMN13246261	human gut metagenome Metagenome
L11079.1	SRR10692776	0.74	0.68	0.51	SAMN13247010	human gut metagenome Metagenome
L11079.1	SRR10692787	0.74	0.68	0.51	SAMN13247000	human gut metagenome Metagenome
L11079.1	SRR10692795	0.74	0.68	0.51	SAMN13246993	human gut metagenome Metagenome
L11079.1	SRR10692803	0.74	0.68	0.51	SAMN13246219	human gut metagenome Metagenome
L11079.1	SRR10692814	0.74	0.68	0.51	SAMN13246218	human gut metagenome Metagenome
L11079.1	SRR10692819	0.74	0.68	0.51	SAMN13246582	human gut metagenome Metagenome
L11079.1	SRR10692834	0.74	0.68	0.51	SAMN13246375	human gut metagenome Metagenome
L11079.1	SRR10692843	0.74	0.68	0.51	SAMN13246196	human gut metagenome Metagenome
L11079.1	SRR10692848	0.74	0.68	0.51	SAMN13246362	human gut metagenome Metagenome
L11079.1	SRR10692850	0.74	0.68	0.51	SAMN13246360	human gut metagenome Metagenome
L11079.1	SRR10692853	0.74	0.68	0.51	SAMN13246357	human gut metagenome Metagenome
L11079.1	SRR10692864	0.74	0.68	0.51	SAMN13246347	human gut metagenome Metagenome
L11079.1	SRR11412687	0.74	0.68	0.51	SAMN14445428	human gut metagenome Metagenome
L11079.1	SRR11412690	0.74	0.68	0.51	SAMN14445579	human gut metagenome Metagenome
L11079.1	SRR11412710	0.74	0.68	0.51	SAMN14445560	human gut metagenome Metagenome
L11079.1	SRR11412712	0.74	0.68	0.51	SAMN14445559	human gut metagenome Metagenome
L11079.1	SRR11412738	0.74	0.68	0.51	SAMN14445535	human gut metagenome Metagenome
L11079.1	SRR11412745	0.74	0.68	0.51	SAMN14445529	human gut metagenome Metagenome
L11079.1	SRR11412787	0.74	0.68	0.51	SAMN14445496	human gut metagenome Metagenome
L11079.1	SRR11412830	0.74	0.68	0.51	SAMN14445683	human gut metagenome Metagenome
L11079.1	SRR11412831	0.74	0.68	0.51	SAMN14445682	human gut metagenome Metagenome
L11079.1	SRR11412867	0.74	0.68	0.51	SAMN14445620	human gut metagenome Metagenome
L11079.1	SRR11412877	0.74	0.68	0.51	SAMN14445612	human gut metagenome Metagenome
L11079.1	SRR11412884	0.74	0.68	0.51	SAMN14445606	human gut metagenome Metagenome
L11079.1	SRR11412889	0.74	0.68	0.51	SAMN14445601	human gut metagenome Metagenome
L11079.1	SRR11412892	0.74	0.68	0.51	SAMN14445599	human gut metagenome Metagenome
L11079.1	SRR11412901	0.74	0.68	0.51	SAMN14445590	human gut metagenome Metagenome
L11079.1	SRR11412904	0.74	0.68	0.51	SAMN14445588	human gut metagenome Metagenome
L11079.1	SRR11412906	0.74	0.68	0.51	SAMN14445586	human gut metagenome Metagenome
L11079.1	SRR11412912	0.74	0.68	0.51	SAMN14445580	human gut metagenome Metagenome
L11079.1	SRR11412920	0.74	0.68	0.51	SAMN14445718	human gut metagenome Metagenome
L11079.1	SRR11412947	0.74	0.68	0.51	SAMN14445664	human gut metagenome Metagenome
L11079.1	SRR11412953	0.74	0.68	0.51	SAMN14445659	human gut metagenome Metagenome
L11079.1	SRR11412983	0.74	0.68	0.51	SAMN14445463	human gut metagenome Metagenome
L11079.1	SRR11412985	0.74	0.68	0.51	SAMN14445461	human gut metagenome Metagenome
L11079.1	SRR11728430	0.74	0.68	0.51	SAMN14730708	human gut metagenome Metagenome
L11079.1	SRR11728439	0.74	0.68	0.51	SAMN14730722	human gut metagenome Metagenome
L11079.1	SRR11728442	0.74	0.68	0.51	SAMN14730719	human gut metagenome Metagenome
L11079.1	SRR11728445	0.74	0.68	0.51	SAMN14730716	human gut metagenome Metagenome
L11079.1	SRR13836104	0.74	0.68	0.51	SAMN18115869	human gut metagenome Metagenome
L11079.1	SRR13836112	0.74	0.68	0.51	SAMN18115862	human gut metagenome Metagenome
L11079.1	SRR13836124	0.74	0.68	0.51	SAMN18115851	human gut metagenome Metagenome
L11079.1	SRR13836133	0.74	0.68	0.51	SAMN18115929	human gut metagenome Metagenome
L11079.1	SRR13836140	0.74	0.68	0.51	SAMN18115842	human gut metagenome Metagenome
L11079.1	SRR13836171	0.74	0.68	0.51	SAMN18115942	human gut metagenome Metagenome
L11079.1	SRR13836180	0.74	0.68	0.51	SAMN18115933	human gut metagenome Metagenome
L11079.1	SRR5106290	0.74	0.68	0.51	SAMN06115438	human gut metagenome Metagenome
L11079.1	SRR5106292	0.74	0.68	0.51	SAMN06115508	human gut metagenome Metagenome
L11079.1	SRR5106314	0.74	0.68	0.51	SAMN06115529	human gut metagenome Metagenome
L11079.1	SRR5106496	0.74	0.68	0.51	SAMN06115540	human gut metagenome Metagenome
L11079.1	SRR5106498	0.74	0.68	0.51	SAMN06115524	human gut metagenome Metagenome
L11079.1	SRR5106499	0.74	0.68	0.51	SAMN06115444	human gut metagenome Metagenome
L11079.1	SRR5558305	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5558389	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5558391	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5580240	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5580241	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5580242	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5580243	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5580247	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5580258	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5580259	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5580260	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5580314	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5580390	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5580394	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR5580395	0.74	0.68	0.51	SAMN06233224	human gut metagenome Metagenome
L11079.1	SRR8146963	0.74	0.68	0.51	SAMN10285298	human gut metagenome Metagenome
L11079.1	SRR8506098	0.74	0.68	0.51	SAMN10845077	human gut metagenome Metagenome
L11079.1	SRR8506100	0.74	0.68	0.51	SAMN10845075	human gut metagenome Metagenome
L11079.1	SRR8506107	0.74	0.68	0.51	SAMN10845082	human gut metagenome Metagenome
L11079.1	SRR9264544	0.74	0.68	0.51	SAMN12011485	human gut metagenome Metagenome
L11079.1	SRR9264555	0.74	0.68	0.51	SAMN12011406	human gut metagenome Metagenome
L11079.1	SRR9264562	0.74	0.68	0.51	SAMN12011409	human gut metagenome Metagenome
L11079.1	SRR9264564	0.74	0.68	0.51	SAMN12011412	human gut metagenome Metagenome
L11079.1	SRR9264567	0.74	0.68	0.51	SAMN12011415	human gut metagenome Metagenome
L11079.1	SRR9264569	0.74	0.68	0.51	SAMN12011417	human gut metagenome Metagenome
L11079.1	SRR9264590	0.74	0.68	0.51	SAMN12011463	human gut metagenome Metagenome
L11079.1	SRR9264597	0.74	0.68	0.51	SAMN12011395	human gut metagenome Metagenome
L11079.1	SRR9264602	0.74	0.68	0.51	SAMN12011392	human gut metagenome Metagenome
L11079.1	SRR9264619	0.74	0.68	0.51	SAMN12011448	human gut metagenome Metagenome
L11079.1	SRR9264634	0.74	0.68	0.51	SAMN12011503	human gut metagenome Metagenome
L11079.1	SRR9264636	0.74	0.68	0.51	SAMN12011501	human gut metagenome Metagenome
L11079.1	SRR9264637	0.74	0.68	0.51	SAMN12011506	human gut metagenome Metagenome
L11079.1	SRR9264642	0.74	0.68	0.51	SAMN12011423	human gut metagenome Metagenome
L11079.1	SRR9264650	0.74	0.68	0.51	SAMN12011498	human gut metagenome Metagenome
L11079.1	SRR10333460	0.74	0.68	0.51	SAMN13091317	Human gut metagenome Raw sequence reads upon exercise intervention
L11079.1	SRR7124432	0.74	0.68	0.51	SAMN09042589	Human gut metagenome Raw sequence reads upon exercise intervention
L11079.1	SRR7124440	0.74	0.68	0.51	SAMN09042607	Human gut metagenome Raw sequence reads upon exercise intervention
L11079.1	SRR7124442	0.74	0.68	0.51	SAMN09042609	Human gut metagenome Raw sequence reads upon exercise intervention
L11079.1	SRR7124488	0.74	0.68	0.51	SAMN09042598	Human gut metagenome Raw sequence reads upon exercise intervention
L11079.1	SRR7124495	0.74	0.68	0.51	SAMN09042613	Human gut metagenome Raw sequence reads upon exercise intervention
L11079.1	SRR8490389	0.74	0.68	0.51	SAMN10781783	Whole metagenomic analysis of the enteric microbiota in children with autism spectrum disorder: the search for marker genes compositions
L11079.1	SRR10403498	0.74	0.68	0.51	SAMN13221658	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403507	0.74	0.68	0.51	SAMN13221650	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403512	0.74	0.68	0.51	SAMN13221645	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403517	0.74	0.68	0.51	SAMN13221615	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403518	0.74	0.68	0.51	SAMN13221614	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403519	0.74	0.68	0.51	SAMN13221613	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403521	0.74	0.68	0.51	SAMN13221585	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10403532	0.74	0.68	0.51	SAMN13221584	Cross-sectional study of intestinal flora in Parkinson's patients in central China
L11079.1	SRR10418764	0.74	0.68	0.51	SAMN13116668	soil virome
L11079.1	SRR10418766	0.74	0.68	0.51	SAMN13116666	soil virome
L11079.1	SRR10499928	0.74	0.68	0.51	SAMN13255208	Manuscript: IL-17 Inhibition in Spondyloarthritis Associates with Subclinical Gut Microbiome Perturbations and a Distinctive IL-25-Driven Intestinal Inflammation
L11079.1	SRR10499962	0.74	0.68	0.51	SAMN13255237	Manuscript: IL-17 Inhibition in Spondyloarthritis Associates with Subclinical Gut Microbiome Perturbations and a Distinctive IL-25-Driven Intestinal Inflammation
L11079.1	SRR10499963	0.74	0.68	0.51	SAMN13255236	Manuscript: IL-17 Inhibition in Spondyloarthritis Associates with Subclinical Gut Microbiome Perturbations and a Distinctive IL-25-Driven Intestinal Inflammation
L11079.1	SRR10430694	0.74	0.68	0.51	SAMN13256507	Anaerobic Antibiotics and the Risk of Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
L11079.1	SRR10505694	0.74	0.68	0.51	SAMN13344081	gut metagenome Raw sequence reads
L11079.1	SRR10505696	0.74	0.68	0.51	SAMN13344079	gut metagenome Raw sequence reads
L11079.1	SRR10507658	0.74	0.68	0.51	SAMN13351577	Gut microbiota composition associated with Clostridium difficile-positive diarrhea and C. difficile type in ICU patients
L11079.1	SRR10507659	0.74	0.68	0.51	SAMN13351576	Gut microbiota composition associated with Clostridium difficile-positive diarrhea and C. difficile type in ICU patients
L11079.1	SRR10507664	0.74	0.68	0.51	SAMN13351583	Gut microbiota composition associated with Clostridium difficile-positive diarrhea and C. difficile type in ICU patients
L11079.1	SRR10520207	0.74	0.68	0.51	SAMN09091652	Freshwater viral communities from Lake Michigan, USA - Su13.VD.MLB.D.D metagenome
L11079.1	SRR9095188	0.74	0.68	0.51	SAMN11761782	Impact of intrapartum and postnatal antibiotics on the gut microbiome and emergence of antimicrobial resistance in infants
L11079.1	SRR14770221	0.74	0.68	0.51	SAMN19607288	Infant virome during the first year of life
L11079.1	SRR14770235	0.74	0.68	0.51	SAMN19607275	Infant virome during the first year of life
L11079.1	SRR10609879	0.74	0.68	0.51	SAMN13515420	Human gut microbiome response to FOS intake
L11079.1	SRR10609881	0.74	0.68	0.51	SAMN13515422	Human gut microbiome response to FOS intake
L11079.1	SRR10609934	0.74	0.68	0.51	SAMN13515408	Human gut microbiome response to FOS intake
L11079.1	SRR10609978	0.74	0.68	0.51	SAMN13515317	Human gut microbiome response to FOS intake
L11079.1	SRR10609981	0.74	0.68	0.51	SAMN13515315	Human gut microbiome response to FOS intake
L11079.1	SRR10610080	0.74	0.68	0.51	SAMN13515302	Human gut microbiome response to FOS intake
L11079.1	SRR10610252	0.74	0.68	0.51	SAMN13515249	Human gut microbiome response to FOS intake
L11079.1	SRR10610283	0.74	0.68	0.51	SAMN13515217	Human gut microbiome response to FOS intake
L11079.1	SRR10610314	0.74	0.68	0.51	SAMN13515189	Human gut microbiome response to FOS intake
L11079.1	SRR10610316	0.74	0.68	0.51	SAMN13515191	Human gut microbiome response to FOS intake
L11079.1	SRR10610514	0.74	0.68	0.51	SAMN13515370	Human gut microbiome response to FOS intake
L11079.1	SRR10610649	0.74	0.68	0.51	SAMN13515325	Human gut microbiome response to FOS intake
L11079.1	SRR10613491	0.74	0.68	0.51	SAMN13518605	Beijing's airborne particulate matter metagenome
L11079.1	SRR10681886	0.74	0.68	0.51	SAMN13252368	viral metagenome Metagenome
L11079.1	SRR10681925	0.74	0.68	0.51	SAMN13252432	viral metagenome Metagenome
L11079.1	SRR10682086	0.74	0.68	0.51	SAMN13252531	viral metagenome Metagenome
L11079.1	SRR10682171	0.74	0.68	0.51	SAMN13252487	viral metagenome Metagenome
L11079.1	SRR10682198	0.74	0.68	0.51	SAMN13252462	viral metagenome Metagenome
L11079.1	SRR10682207	0.74	0.68	0.51	SAMN13252454	viral metagenome Metagenome
L11079.1	SRR10682234	0.74	0.68	0.51	SAMN13252918	viral metagenome Metagenome
L11079.1	SRR10682254	0.74	0.68	0.51	SAMN13252396	viral metagenome Metagenome
L11079.1	SRR10682292	0.74	0.68	0.51	SAMN13252865	viral metagenome Metagenome
L11079.1	SRR10682302	0.74	0.68	0.51	SAMN13252856	viral metagenome Metagenome
L11079.1	SRR10682303	0.74	0.68	0.51	SAMN13252855	viral metagenome Metagenome
L11079.1	SRR10682314	0.74	0.68	0.51	SAMN13252845	viral metagenome Metagenome
L11079.1	SRR10682322	0.74	0.68	0.51	SAMN13252839	viral metagenome Metagenome
L11079.1	SRR10682323	0.74	0.68	0.51	SAMN13252838	viral metagenome Metagenome
L11079.1	SRR10682362	0.74	0.68	0.51	SAMN13252802	viral metagenome Metagenome
L11079.1	SRR10682401	0.74	0.68	0.51	SAMN13252767	viral metagenome Metagenome
L11079.1	SRR10682429	0.74	0.68	0.51	SAMN13252741	viral metagenome Metagenome
L11079.1	SRR10682436	0.74	0.68	0.51	SAMN13252736	viral metagenome Metagenome
L11079.1	SRR10682483	0.74	0.68	0.51	SAMN13252693	viral metagenome Metagenome
L11079.1	SRR10682575	0.74	0.68	0.51	SAMN13252420	viral metagenome Metagenome
L11079.1	SRR10682739	0.74	0.68	0.51	SAMN13252992	viral metagenome Metagenome
L11079.1	SRR10682797	0.74	0.68	0.51	SAMN13252400	viral metagenome Metagenome
L11079.1	SRR8240708	0.74	0.68	0.51	SAMN10408110	viral metagenome Metagenome
L11079.1	SRR10680320	0.74	0.68	0.51	SAMN13509712	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680373	0.74	0.68	0.51	SAMN13509721	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680384	0.74	0.68	0.51	SAMN13509425	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680386	0.74	0.68	0.51	SAMN13509423	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680397	0.74	0.68	0.51	SAMN13509413	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680467	0.74	0.68	0.51	SAMN13509751	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680475	0.74	0.68	0.51	SAMN13509743	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680488	0.74	0.68	0.51	SAMN13509674	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680499	0.74	0.68	0.51	SAMN13509665	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680530	0.74	0.68	0.51	SAMN13509523	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680666	0.74	0.68	0.51	SAMN13509429	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680669	0.74	0.68	0.51	SAMN13509571	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680711	0.74	0.68	0.51	SAMN13509361	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680775	0.74	0.68	0.51	SAMN13509332	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680777	0.74	0.68	0.51	SAMN13509330	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680784	0.74	0.68	0.51	SAMN13509596	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680839	0.74	0.68	0.51	SAMN13509306	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680844	0.74	0.68	0.51	SAMN13509397	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10680855	0.74	0.68	0.51	SAMN13509387	Human gut metagenomes from Hong Kong populations
L11079.1	SRR10983023	0.74	0.68	0.51	SAMN08516735	gut metagenome Metagenome
L11079.1	SRR10983044	0.74	0.68	0.51	SAMN08516778	gut metagenome Metagenome
L11079.1	SRR9037788	0.74	0.68	0.51	SAMN11616074	feces metagenome Raw sequence reads
L11079.1	SRR9037831	0.74	0.68	0.51	SAMN11615773	feces metagenome Raw sequence reads
L11079.1	SRR9037839	0.74	0.68	0.51	SAMN11615775	feces metagenome Raw sequence reads
L11079.1	SRR9037841	0.74	0.68	0.51	SAMN11616029	feces metagenome Raw sequence reads
L11079.1	SRR9037847	0.74	0.68	0.51	SAMN11616031	feces metagenome Raw sequence reads
L11079.1	SRR9037848	0.74	0.68	0.51	SAMN11616032	feces metagenome Raw sequence reads
L11079.1	SRR9037857	0.74	0.68	0.51	SAMN11615821	feces metagenome Raw sequence reads
L11079.1	SRR9037860	0.74	0.68	0.51	SAMN11616118	feces metagenome Raw sequence reads
L11079.1	SRR9037885	0.74	0.68	0.51	SAMN11615899	feces metagenome Raw sequence reads
L11079.1	SRR9037888	0.74	0.68	0.51	SAMN11615806	feces metagenome Raw sequence reads
L11079.1	SRR9037891	0.74	0.68	0.51	SAMN11615803	feces metagenome Raw sequence reads
L11079.1	SRR9037913	0.74	0.68	0.51	SAMN11615857	feces metagenome Raw sequence reads
L11079.1	SRR9037924	0.74	0.68	0.51	SAMN11615954	feces metagenome Raw sequence reads
L11079.1	SRR9037941	0.74	0.68	0.51	SAMN11615757	feces metagenome Raw sequence reads
L11079.1	SRR9037971	0.74	0.68	0.51	SAMN11615810	feces metagenome Raw sequence reads
L11079.1	SRR9037998	0.74	0.68	0.51	SAMN11615941	feces metagenome Raw sequence reads
L11079.1	SRR9038014	0.74	0.68	0.51	SAMN11615793	feces metagenome Raw sequence reads
L11079.1	SRR9038015	0.74	0.68	0.51	SAMN11615794	feces metagenome Raw sequence reads
L11079.1	SRR9038025	0.74	0.68	0.51	SAMN11616054	feces metagenome Raw sequence reads
L11079.1	SRR9038041	0.74	0.68	0.51	SAMN11615877	feces metagenome Raw sequence reads
L11079.1	SRR9038046	0.74	0.68	0.51	SAMN11615755	feces metagenome Raw sequence reads
L11079.1	SRR9038085	0.74	0.68	0.51	SAMN11615915	feces metagenome Raw sequence reads
L11079.1	SRR9038102	0.74	0.68	0.51	SAMN11615934	feces metagenome Raw sequence reads
L11079.1	SRR9038127	0.74	0.68	0.51	SAMN11615736	feces metagenome Raw sequence reads
L11079.1	SRR9038165	0.74	0.68	0.51	SAMN11615887	feces metagenome Raw sequence reads
L11079.1	SRR9038176	0.74	0.68	0.51	SAMN11615741	feces metagenome Raw sequence reads
L11079.1	SRR9075051	0.74	0.68	0.51	SAMN11664773	feces metagenome Raw sequence reads
L11079.1	SRR9075079	0.74	0.68	0.51	SAMN11664627	feces metagenome Raw sequence reads
L11079.1	SRR9075092	0.74	0.68	0.51	SAMN11664808	feces metagenome Raw sequence reads
L11079.1	SRR9075106	0.74	0.68	0.51	SAMN11664516	feces metagenome Raw sequence reads
L11079.1	SRR9075160	0.74	0.68	0.51	SAMN11664479	feces metagenome Raw sequence reads
L11079.1	SRR9075177	0.74	0.68	0.51	SAMN11664618	feces metagenome Raw sequence reads
L11079.1	SRR9075188	0.74	0.68	0.51	SAMN11664801	feces metagenome Raw sequence reads
L11079.1	SRR9075189	0.74	0.68	0.51	SAMN11664804	feces metagenome Raw sequence reads
L11079.1	SRR9075210	0.74	0.68	0.51	SAMN11664656	feces metagenome Raw sequence reads
L11079.1	SRR9075214	0.74	0.68	0.51	SAMN11664543	feces metagenome Raw sequence reads
L11079.1	SRR9075223	0.74	0.68	0.51	SAMN11664694	feces metagenome Raw sequence reads
L11079.1	SRR9075232	0.74	0.68	0.51	SAMN11664794	feces metagenome Raw sequence reads
L11079.1	SRR9075256	0.74	0.68	0.51	SAMN11664608	feces metagenome Raw sequence reads
L11079.1	SRR9075275	0.74	0.68	0.51	SAMN11664831	feces metagenome Raw sequence reads
L11079.1	SRR9075293	0.74	0.68	0.51	SAMN11664842	feces metagenome Raw sequence reads
L11079.1	SRR9075383	0.74	0.68	0.51	SAMN11664598	feces metagenome Raw sequence reads
L11079.1	SRR9075384	0.74	0.68	0.51	SAMN11664597	feces metagenome Raw sequence reads
L11079.1	SRR9075386	0.74	0.68	0.51	SAMN11664603	feces metagenome Raw sequence reads
L11079.1	SRR9098589	0.74	0.68	0.51	SAMN11792869	feces metagenome Raw sequence reads
L11079.1	SRR9098630	0.74	0.68	0.51	SAMN11792844	feces metagenome Raw sequence reads
L11079.1	SRR9098631	0.74	0.68	0.51	SAMN11792843	feces metagenome Raw sequence reads
L11079.1	SRR9098639	0.74	0.68	0.51	SAMN11793093	feces metagenome Raw sequence reads
L11079.1	SRR9098712	0.74	0.68	0.51	SAMN11793084	feces metagenome Raw sequence reads
L11079.1	SRR9098783	0.74	0.68	0.51	SAMN11793106	feces metagenome Raw sequence reads
L11079.1	SRR9098799	0.74	0.68	0.51	SAMN11792871	feces metagenome Raw sequence reads
L11079.1	SRR9098833	0.74	0.68	0.51	SAMN11793142	feces metagenome Raw sequence reads
L11079.1	SRR9098835	0.74	0.68	0.51	SAMN11793140	feces metagenome Raw sequence reads
L11079.1	SRR9098836	0.74	0.68	0.51	SAMN11793139	feces metagenome Raw sequence reads
L11079.1	SRR9098848	0.74	0.68	0.51	SAMN11792965	feces metagenome Raw sequence reads
L11079.1	SRR9098889	0.74	0.68	0.51	SAMN11793107	feces metagenome Raw sequence reads
L11079.1	SRR9098927	0.74	0.68	0.51	SAMN11792990	feces metagenome Raw sequence reads
L11079.1	SRR9098945	0.74	0.68	0.51	SAMN11793167	feces metagenome Raw sequence reads
L11079.1	SRR9098962	0.74	0.68	0.51	SAMN11792803	feces metagenome Raw sequence reads
L11079.1	SRR9128768	0.74	0.68	0.51	SAMN11864472	feces metagenome Raw sequence reads
L11079.1	SRR9128771	0.74	0.68	0.51	SAMN11864330	feces metagenome Raw sequence reads
L11079.1	SRR9128818	0.74	0.68	0.51	SAMN11864413	feces metagenome Raw sequence reads
L11079.1	SRR9128825	0.74	0.68	0.51	SAMN11864523	feces metagenome Raw sequence reads
L11079.1	SRR9128854	0.74	0.68	0.51	SAMN11864608	feces metagenome Raw sequence reads
L11079.1	SRR9128864	0.74	0.68	0.51	SAMN11864451	feces metagenome Raw sequence reads
L11079.1	SRR9128896	0.74	0.68	0.51	SAMN11864445	feces metagenome Raw sequence reads
L11079.1	SRR9128897	0.74	0.68	0.51	SAMN11864442	feces metagenome Raw sequence reads
L11079.1	SRR9128919	0.74	0.68	0.51	SAMN11864589	feces metagenome Raw sequence reads
L11079.1	SRR9129009	0.74	0.68	0.51	SAMN11864406	feces metagenome Raw sequence reads
L11079.1	SRR9129013	0.74	0.68	0.51	SAMN11864603	feces metagenome Raw sequence reads
L11079.1	SRR9129026	0.74	0.68	0.51	SAMN11864361	feces metagenome Raw sequence reads
L11079.1	SRR9129029	0.74	0.68	0.51	SAMN11864478	feces metagenome Raw sequence reads
L11079.1	SRR9129032	0.74	0.68	0.51	SAMN11864477	feces metagenome Raw sequence reads
L11079.1	SRR9129034	0.74	0.68	0.51	SAMN11864483	feces metagenome Raw sequence reads
L11079.1	SRR10728442	0.74	0.68	0.51	SAMN13578175	C57BL6_NSG_humanFMT
L11079.1	SRR10739568	0.74	0.68	0.51	SAMN13632807	Gut microbiome of Thai adults
L11079.1	SRR10739584	0.74	0.68	0.51	SAMN13632813	Gut microbiome of Thai adults
L11079.1	SRR10901889	0.74	0.68	0.51	SAMN13684598	A metagenome-wide association study of gut microbiota, visceral fat and sleeve gastrectomy
L11079.1	SRR10901924	0.74	0.68	0.51	SAMN13684541	A metagenome-wide association study of gut microbiota, visceral fat and sleeve gastrectomy
L11079.1	SRR10901927	0.74	0.68	0.51	SAMN13684565	A metagenome-wide association study of gut microbiota, visceral fat and sleeve gastrectomy
L11079.1	SRR10901941	0.74	0.68	0.51	SAMN13684552	A metagenome-wide association study of gut microbiota, visceral fat and sleeve gastrectomy
L11079.1	SRR10917774	0.74	0.68	0.51	SAMN13893402	Hybrid, extra-deep metagenomic sequencing enables genomic and functional characterization of low-abundance and uncultured species in human gut
L11079.1	SRR10917775	0.74	0.68	0.51	SAMN13893401	Hybrid, extra-deep metagenomic sequencing enables genomic and functional characterization of low-abundance and uncultured species in human gut
L11079.1	SRR13374488	0.74	0.68	0.51	SAMN17207072	Hybrid, extra-deep metagenomic sequencing enables genomic and functional characterization of low-abundance and uncultured species in human gut
L11079.1	SRR13374492	0.74	0.68	0.51	SAMN17207076	Hybrid, extra-deep metagenomic sequencing enables genomic and functional characterization of low-abundance and uncultured species in human gut
L11079.1	SRR10996932	0.74	0.68	0.51	SAMN13943208	Marine sponge metagenomes Metagenome
L11079.1	SRR11088376	0.74	0.68	0.51	SAMN14069870	ANTIRES - Distribution pathways of antibiotic resistances in municipal wastewater
L11079.1	SRR11088408	0.74	0.68	0.51	SAMN14069931	ANTIRES - Distribution pathways of antibiotic resistances in municipal wastewater
L11079.1	SRR11124661	0.74	0.68	0.51	SAMN11097750	Pig microbiome
L11079.1	SRR11124672	0.74	0.68	0.51	SAMN11097749	Pig microbiome
L11079.1	SRR11124823	0.74	0.68	0.51	SAMN11097721	Pig microbiome
L11079.1	SRR11124873	0.74	0.68	0.51	SAMN11097705	Pig microbiome
L11079.1	SRR11124960	0.74	0.68	0.51	SAMN11098138	Pig microbiome
L11079.1	SRR11125001	0.74	0.68	0.51	SAMN11097985	Pig microbiome
L11079.1	SRR11125121	0.74	0.68	0.51	SAMN11097687	Pig microbiome
L11079.1	SRR11125162	0.74	0.68	0.51	SAMN11098532	Pig microbiome
L11079.1	SRR11125197	0.74	0.68	0.51	SAMN11097793	Pig microbiome
L11079.1	SRR11125389	0.74	0.68	0.51	SAMN11097673	Pig microbiome
L11079.1	SRR11125496	0.74	0.68	0.51	SAMN11097731	Pig microbiome
L11079.1	SRR11125515	0.74	0.68	0.51	SAMN11097926	Pig microbiome
L11079.1	SRR11125523	0.74	0.68	0.51	SAMN11097694	Pig microbiome
L11079.1	SRR11125546	0.74	0.68	0.51	SAMN11098503	Pig microbiome
L11079.1	SRR11125676	0.74	0.68	0.51	SAMN11098503	Pig microbiome
L11079.1	SRR11125746	0.74	0.68	0.51	SAMN11097749	Pig microbiome
L11079.1	SRR11125867	0.74	0.68	0.51	SAMN11097985	Pig microbiome
L11079.1	SRR11125963	0.74	0.68	0.51	SAMN11097705	Pig microbiome
L11079.1	SRR11126019	0.74	0.68	0.51	SAMN11097805	Pig microbiome
L11079.1	SRR11126090	0.74	0.68	0.51	SAMN11097731	Pig microbiome
L11079.1	SRR11126105	0.74	0.68	0.51	SAMN11097721	Pig microbiome
L11079.1	SRR11126116	0.74	0.68	0.51	SAMN11097720	Pig microbiome
L11079.1	SRR11126175	0.74	0.68	0.51	SAMN11097793	Pig microbiome
L11079.1	SRR11126201	0.74	0.68	0.51	SAMN11097769	Pig microbiome
L11079.1	SRR11126214	0.74	0.68	0.51	SAMN11097975	Pig microbiome
L11079.1	SRR11126237	0.74	0.68	0.51	SAMN11097926	Pig microbiome
L11079.1	SRR11126245	0.74	0.68	0.51	SAMN11097694	Pig microbiome
L11079.1	SRR11126268	0.74	0.68	0.51	SAMN11098532	Pig microbiome
L11079.1	SRR11126356	0.74	0.68	0.51	SAMN11097876	Pig microbiome
L11079.1	SRR11126373	0.74	0.68	0.51	SAMN11097861	Pig microbiome
L11079.1	SRR11126387	0.74	0.68	0.51	SAMN11097687	Pig microbiome
L11079.1	SRR11183323	0.74	0.68	0.51	SAMN11097793	Pig microbiome
L11079.1	SRR11183347	0.74	0.68	0.51	SAMN11097771	Pig microbiome
L11079.1	SRR11183396	0.74	0.68	0.51	SAMN11097721	Pig microbiome
L11079.1	SRR11183407	0.74	0.68	0.51	SAMN11097720	Pig microbiome
L11079.1	SRR11183474	0.74	0.68	0.51	SAMN11097714	Pig microbiome
L11079.1	SRR11183534	0.74	0.68	0.51	SAMN11097673	Pig microbiome
L11079.1	SRR11183547	0.74	0.68	0.51	SAMN11097766	Pig microbiome
L11079.1	SRR11183612	0.74	0.68	0.51	SAMN11097749	Pig microbiome
L11079.1	SRR11183621	0.74	0.68	0.51	SAMN11097705	Pig microbiome
L11079.1	SRR11183677	0.74	0.68	0.51	SAMN11098532	Pig microbiome
L11079.1	SRR11183701	0.74	0.68	0.51	SAMN11097985	Pig microbiome
L11079.1	SRR11183712	0.74	0.68	0.51	SAMN11097975	Pig microbiome
L11079.1	SRR11183741	0.74	0.68	0.51	SAMN11098503	Pig microbiome
L11079.1	SRR11183831	0.74	0.68	0.51	SAMN11097926	Pig microbiome
L11079.1	SRR11183839	0.74	0.68	0.51	SAMN11097694	Pig microbiome
L11079.1	SRR11184013	0.74	0.68	0.51	SAMN11097687	Pig microbiome
L11079.1	SRR11184068	0.74	0.68	0.51	SAMN11097731	Pig microbiome
L11079.1	SRR11185229	0.74	0.68	0.51	SAMN11098478	Pig microbiome
L11079.1	SRR11185245	0.74	0.68	0.51	SAMN11098534	Pig microbiome
L11079.1	SRR8960169	0.74	0.68	0.51	SAMN11097748	Pig microbiome
L11079.1	SRR8960206	0.74	0.68	0.51	SAMN11097926	Pig microbiome
L11079.1	SRR8960212	0.74	0.68	0.51	SAMN11097983	Pig microbiome
L11079.1	SRR8960214	0.74	0.68	0.51	SAMN11097985	Pig microbiome
L11079.1	SRR8960267	0.74	0.68	0.51	SAMN11097749	Pig microbiome
L11079.1	SRR8960286	0.74	0.68	0.51	SAMN11097792	Pig microbiome
L11079.1	SRR8960293	0.74	0.68	0.51	SAMN11097793	Pig microbiome
L11079.1	SRR8960332	0.74	0.68	0.51	SAMN11097861	Pig microbiome
L11079.1	SRR8960343	0.74	0.68	0.51	SAMN11098532	Pig microbiome
L11079.1	SRR8960373	0.74	0.68	0.51	SAMN11098013	Pig microbiome
L11079.1	SRR8960390	0.74	0.68	0.51	SAMN11098503	Pig microbiome
L11079.1	SRR8960456	0.74	0.68	0.51	SAMN11097721	Pig microbiome
L11079.1	SRR8960494	0.74	0.68	0.51	SAMN11097694	Pig microbiome
L11079.1	SRR8960504	0.74	0.68	0.51	SAMN11097673	Pig microbiome
L11079.1	SRR8960514	0.74	0.68	0.51	SAMN11097876	Pig microbiome
L11079.1	SRR8960546	0.74	0.68	0.51	SAMN11097769	Pig microbiome
L11079.1	SRR8960558	0.74	0.68	0.51	SAMN11097766	Pig microbiome
L11079.1	SRR8960610	0.74	0.68	0.51	SAMN11097731	Pig microbiome
L11079.1	SRR8960671	0.74	0.68	0.51	SAMN11097932	Pig microbiome
L11079.1	SRR8960688	0.74	0.68	0.51	SAMN11097805	Pig microbiome
L11079.1	SRR8960729	0.74	0.68	0.51	SAMN11097996	Pig microbiome
L11079.1	SRR8960744	0.74	0.68	0.51	SAMN11097705	Pig microbiome
L11079.1	SRR8960809	0.74	0.68	0.51	SAMN11097975	Pig microbiome
L11079.1	SRR8960946	0.74	0.68	0.51	SAMN11097687	Pig microbiome
L11079.1	SRR11207281	0.74	0.68	0.51	SAMN14178254	Impact of DNA extraction method on variation in human and built environment microbial community and functional profiles
L11079.1	SRR11236183	0.74	0.68	0.51	SAMN14270965	Human gut microbiome Raw sequence reads
L11079.1	SRR11236185	0.74	0.68	0.51	SAMN14270963	Human gut microbiome Raw sequence reads
L11079.1	SRR11236187	0.74	0.68	0.51	SAMN14270961	Human gut microbiome Raw sequence reads
L11079.1	SRR11236207	0.74	0.68	0.51	SAMN14270943	Human gut microbiome Raw sequence reads
L11079.1	SRR11236219	0.74	0.68	0.51	SAMN14270990	Human gut microbiome Raw sequence reads
L11079.1	SRR11236223	0.74	0.68	0.51	SAMN14270933	Human gut microbiome Raw sequence reads
L11079.1	SRR11236230	0.74	0.68	0.51	SAMN14270980	Human gut microbiome Raw sequence reads
L11079.1	SRR11236234	0.74	0.68	0.51	SAMN14270932	Human gut microbiome Raw sequence reads
L11079.1	SRR11236260	0.74	0.68	0.51	SAMN14271013	Human gut microbiome Raw sequence reads
L11079.1	SRR11236266	0.74	0.68	0.51	SAMN14271007	Human gut microbiome Raw sequence reads
L11079.1	SRR11236268	0.74	0.68	0.51	SAMN14271006	Human gut microbiome Raw sequence reads
L11079.1	SRR11236269	0.74	0.68	0.51	SAMN14271005	Human gut microbiome Raw sequence reads
L11079.1	SRR11236270	0.74	0.68	0.51	SAMN14271004	Human gut microbiome Raw sequence reads
L11079.1	SRR11236273	0.74	0.68	0.51	SAMN14271001	Human gut microbiome Raw sequence reads
L11079.1	SRR11236274	0.74	0.68	0.51	SAMN14271000	Human gut microbiome Raw sequence reads
L11079.1	SRR12321261	0.74	0.68	0.51	SAMN15502673	Human gut microbiome Raw sequence reads
L11079.1	SRR11276930	0.74	0.68	0.51	SAMN14121838	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277156	0.74	0.68	0.51	SAMN14121963	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277191	0.74	0.68	0.51	SAMN14121755	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277192	0.74	0.68	0.51	SAMN14121754	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11277274	0.74	0.68	0.51	SAMN14121733	Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo
L11079.1	SRR11294814	0.74	0.68	0.51	SAMN14366073	Impact of Intestinal Parasites on Microbiota and Cobalamin Gene Sequences
L11079.1	SRR11294818	0.74	0.68	0.51	SAMN14366069	Impact of Intestinal Parasites on Microbiota and Cobalamin Gene Sequences
L11079.1	SRR11294826	0.74	0.68	0.51	SAMN14366068	Impact of Intestinal Parasites on Microbiota and Cobalamin Gene Sequences
L11079.1	SRR11294830	0.74	0.68	0.51	SAMN14366091	Impact of Intestinal Parasites on Microbiota and Cobalamin Gene Sequences
L11079.1	SRR11294836	0.74	0.68	0.51	SAMN14366085	Impact of Intestinal Parasites on Microbiota and Cobalamin Gene Sequences
L11079.1	SRR11294844	0.74	0.68	0.51	SAMN14366078	Impact of Intestinal Parasites on Microbiota and Cobalamin Gene Sequences
L11079.1	SRR11294845	0.74	0.68	0.51	SAMN14366077	Impact of Intestinal Parasites on Microbiota and Cobalamin Gene Sequences
L11079.1	SRR11294848	0.74	0.68	0.51	SAMN14366066	Impact of Intestinal Parasites on Microbiota and Cobalamin Gene Sequences
L11079.1	SRR11294849	0.74	0.68	0.51	SAMN14366065	Impact of Intestinal Parasites on Microbiota and Cobalamin Gene Sequences
L11079.1	SRR11363012	0.74	0.68	0.51	SAMN14420362	Functional Microbial Responses to Alcohol Abstinence in Patients with Alcohol Use Disorder
L11079.1	SRR11363014	0.74	0.68	0.51	SAMN14420360	Functional Microbial Responses to Alcohol Abstinence in Patients with Alcohol Use Disorder
L11079.1	SRR11363072	0.74	0.68	0.51	SAMN14420307	Functional Microbial Responses to Alcohol Abstinence in Patients with Alcohol Use Disorder
L11079.1	SRR11413585	0.74	0.68	0.51	SAMN14444313	Route of antibiotic administration impacts the microbiota and resistance gene diversity in swine feces
L11079.1	SRR11413679	0.74	0.68	0.51	SAMN14446735	The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1 Immunotherapy in Gastrointestinal Cancer
L11079.1	SRR11413691	0.74	0.68	0.51	SAMN14446724	The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1 Immunotherapy in Gastrointestinal Cancer
L11079.1	SRR14092339	0.74	0.68	0.51	SAMN13271620	The role of Enterococcus in allo-HCT patient outcome
L11079.1	SRR11435973	0.74	0.68	0.51	SAMN14475186	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR11435984	0.74	0.68	0.51	SAMN14475176	Quasimetagenomics sequencing of Salmonella enterica and E. coli O157:H7
L11079.1	SRR11482326	0.74	0.68	0.51	SAMN14538526	Farm dust metagenomes in European poultry and pig farms
L11079.1	SRR11482328	0.74	0.68	0.51	SAMN14538524	Farm dust metagenomes in European poultry and pig farms
L11079.1	SRR11482370	0.74	0.68	0.51	SAMN14538559	Farm dust metagenomes in European poultry and pig farms
L11079.1	SRR11487942	0.74	0.68	0.51	SAMN14524763	DEVELOPING GLOBAL STANDARDS FOR THE MICROBIOME FIELD
L11079.1	SRR11487943	0.74	0.68	0.51	SAMN14524762	DEVELOPING GLOBAL STANDARDS FOR THE MICROBIOME FIELD
L11079.1	SRR11487944	0.74	0.68	0.51	SAMN14524761	DEVELOPING GLOBAL STANDARDS FOR THE MICROBIOME FIELD
L11079.1	SRR11487945	0.74	0.68	0.51	SAMN14524760	DEVELOPING GLOBAL STANDARDS FOR THE MICROBIOME FIELD
L11079.1	SRR11487946	0.74	0.68	0.51	SAMN14524759	DEVELOPING GLOBAL STANDARDS FOR THE MICROBIOME FIELD
L11079.1	SRR11489747	0.74	0.68	0.51	SAMN14543216	Global studies of microbial diversity in pig gut
L11079.1	SRR11489750	0.74	0.68	0.51	SAMN14543213	Global studies of microbial diversity in pig gut
L11079.1	SRR11489757	0.74	0.68	0.51	SAMN14543248	Global studies of microbial diversity in pig gut
L11079.1	SRR11489760	0.74	0.68	0.51	SAMN14543246	Global studies of microbial diversity in pig gut
L11079.1	SRR11489766	0.74	0.68	0.51	SAMN14543240	Global studies of microbial diversity in pig gut
L11079.1	SRR11489767	0.74	0.68	0.51	SAMN14543239	Global studies of microbial diversity in pig gut
L11079.1	SRR11489770	0.74	0.68	0.51	SAMN14543237	Global studies of microbial diversity in pig gut
L11079.1	SRR11489781	0.74	0.68	0.51	SAMN14543227	Global studies of microbial diversity in pig gut
L11079.1	SRR11576013	0.74	0.68	0.51	SAMN14614854	Shotgun Metagenomics Fecal Microbiome Dysbiosis in Parkinsons Disease
L11079.1	SRR11615757	0.74	0.68	0.51	SAMN14734824	Oral capsulized Fecal microbiota transplantation for eradication of carbapenemase-producing Enterobacteriaceae colonization with a metagenomic perspective
L11079.1	SRR11615758	0.74	0.68	0.51	SAMN14734823	Oral capsulized Fecal microbiota transplantation for eradication of carbapenemase-producing Enterobacteriaceae colonization with a metagenomic perspective
L11079.1	SRR6231144	0.74	0.68	0.51	SAMN07839275	Urban Enviromental Genomics Project
L11079.1	SRR6231155	0.74	0.68	0.51	SAMN07839281	Urban Enviromental Genomics Project
L11079.1	SRR11648341	0.74	0.68	0.51	SAMN14775311	Metabolic recovery with eculizumab precision therapy of CHAPLE disease
L11079.1	SRR11648347	0.74	0.68	0.51	SAMN14775306	Metabolic recovery with eculizumab precision therapy of CHAPLE disease
L11079.1	SRR11649932	0.74	0.68	0.51	SAMN14583004	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11649933	0.74	0.68	0.51	SAMN14583003	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11649940	0.74	0.68	0.51	SAMN14582997	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11649942	0.74	0.68	0.51	SAMN14582995	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11649945	0.74	0.68	0.51	SAMN14582939	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11649951	0.74	0.68	0.51	SAMN14583027	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11649971	0.74	0.68	0.51	SAMN14582965	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11649988	0.74	0.68	0.51	SAMN14582950	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11649991	0.74	0.68	0.51	SAMN14582947	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11650006	0.74	0.68	0.51	SAMN14582977	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11650016	0.74	0.68	0.51	SAMN14582968	Shotgun metagenomics of human gut microbiota in China high longevity area
L11079.1	SRR11674015	0.74	0.68	0.51	SAMN14825708	Activated sludge metagenome Genome sequencing and assembly
L11079.1	SRR11674048	0.74	0.68	0.51	SAMN14825681	Activated sludge metagenome Genome sequencing and assembly
L11079.1	SRR11679853	0.74	0.68	0.51	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679856	0.74	0.68	0.51	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679865	0.74	0.68	0.51	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679876	0.74	0.68	0.51	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679878	0.74	0.68	0.51	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679883	0.74	0.68	0.51	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679905	0.74	0.68	0.51	SAMN14776667	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679923	0.74	0.68	0.51	SAMN14560228	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679924	0.74	0.68	0.51	SAMN14560227	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679925	0.74	0.68	0.51	SAMN14560226	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11679949	0.74	0.68	0.51	SAMN14560205	Microbial signature of multiple physical and psychological symptoms in a 135 days oceangoing voyage Metagenome
L11079.1	SRR11702764	0.74	0.68	0.51	SAMN14824819	Microbial sequencing of landfill leachate
L11079.1	SRR11734661	0.74	0.68	0.51	SAMN14775390	Mangrove microbiome Metagenome
L11079.1	SRR11734786	0.74	0.68	0.51	SAMN14850476	Study of microbial diversity of anterior nares swabs from patients colonized by the pathogen Candida auris
L11079.1	SRR11805593	0.74	0.68	0.51	SAMN14943492	A health metadata-based management approach for comparative analysis of high-throughput genetic sequences for quantifying antimicrobial resistance reduction in Canadian hog barns (Fecal-piglet3)
L11079.1	SRR11805609	0.74	0.68	0.51	SAMN14943504	A health metadata-based management approach for comparative analysis of high-throughput genetic sequences for quantifying antimicrobial resistance reduction in Canadian hog barns (Fecal-piglet1
L11079.1	SRR11835836	0.74	0.68	0.51	SAMN15002976	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835897	0.74	0.68	0.51	SAMN15003086	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835914	0.74	0.68	0.51	SAMN15003020	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835928	0.74	0.68	0.51	SAMN15003007	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11835950	0.74	0.68	0.51	SAMN15003071	Genome level reveals the probiotic supplementation can alleviate stress and anxiety symptoms in stressed adults
L11079.1	SRR11880804	0.74	0.68	0.51	SAMN15047046	The gut microbiome of traditional human populations and sympatric nonhuman primates reflects parallel functional adaptations in response to analogous ecological gradients
L11079.1	SRR11927860	0.74	0.68	0.51	SAMN15103518	Dysbiosis in metabolic genes of the gut microbiomes of patients with a Pouch
L11079.1	SRR13759992	0.74	0.68	0.51	SAMN18024173	Dysbiosis in metabolic genes of the gut microbiomes of patients with a Pouch
L11079.1	SRR11941356	0.74	0.68	0.51	SAMN15156653	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941379	0.74	0.68	0.51	SAMN15156632	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941394	0.74	0.68	0.51	SAMN15156618	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941396	0.74	0.68	0.51	SAMN15156616	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941398	0.74	0.68	0.51	SAMN15156614	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941401	0.74	0.68	0.51	SAMN15156612	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941451	0.74	0.68	0.51	SAMN15156440	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941464	0.74	0.68	0.51	SAMN15156428	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941470	0.74	0.68	0.51	SAMN15156423	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941483	0.74	0.68	0.51	SAMN15156411	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941595	0.74	0.68	0.51	SAMN15156526	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941612	0.74	0.68	0.51	SAMN15156511	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR11941660	0.74	0.68	0.51	SAMN15156467	Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)
L11079.1	SRR1197621	0.74	0.68	0.51	SAMN02675501	C.diff FMT
L11079.1	SRR1461854	0.74	0.68	0.51	SAMN02676133	C.diff FMT
L11079.1	SRR1462599	0.74	0.68	0.51	SAMN02676138	C.diff FMT
L11079.1	SRR1491017	0.74	0.68	0.51	SAMN02676137	C.diff FMT
L11079.1	SRR1493052	0.74	0.68	0.51	SAMN02676137	C.diff FMT
L11079.1	SRR1221442	0.74	0.68	0.51	SAMN02673296	Elephant feces Metagenome
L11079.1	SRR12081714	0.74	0.68	0.51	SAMN15357145	Characterizing the gut DNA and RNA viromes in a population of Chinese residents and visiting Pakistanis
L11079.1	SRR12114080	0.74	0.68	0.51	SAMN15397164	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114142	0.74	0.68	0.51	SAMN15397160	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114143	0.74	0.68	0.51	SAMN15397160	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114155	0.74	0.68	0.51	SAMN15397159	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114156	0.74	0.68	0.51	SAMN15397159	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114157	0.74	0.68	0.51	SAMN15397159	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114158	0.74	0.68	0.51	SAMN15397159	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114159	0.74	0.68	0.51	SAMN15397159	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114160	0.74	0.68	0.51	SAMN15397159	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114162	0.74	0.68	0.51	SAMN15397159	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114163	0.74	0.68	0.51	SAMN15397159	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114164	0.74	0.68	0.51	SAMN15397159	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114165	0.74	0.68	0.51	SAMN15397159	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114166	0.74	0.68	0.51	SAMN15397159	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114167	0.74	0.68	0.51	SAMN15397159	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114168	0.74	0.68	0.51	SAMN15397159	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114396	0.74	0.68	0.51	SAMN15397046	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114401	0.74	0.68	0.51	SAMN15397164	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114405	0.74	0.68	0.51	SAMN15397164	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114407	0.74	0.68	0.51	SAMN15397164	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114411	0.74	0.68	0.51	SAMN15397164	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114416	0.74	0.68	0.51	SAMN15397206	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114421	0.74	0.68	0.51	SAMN15397206	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114422	0.74	0.68	0.51	SAMN15397206	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114423	0.74	0.68	0.51	SAMN15397206	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114425	0.74	0.68	0.51	SAMN15397206	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114442	0.74	0.68	0.51	SAMN15397206	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114444	0.74	0.68	0.51	SAMN15397206	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114446	0.74	0.68	0.51	SAMN15397206	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114447	0.74	0.68	0.51	SAMN15397206	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114698	0.74	0.68	0.51	SAMN15397070	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114746	0.74	0.68	0.51	SAMN15397138	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114748	0.74	0.68	0.51	SAMN15397138	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114750	0.74	0.68	0.51	SAMN15397138	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114751	0.74	0.68	0.51	SAMN15397138	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114752	0.74	0.68	0.51	SAMN15397138	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114753	0.74	0.68	0.51	SAMN15397138	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114754	0.74	0.68	0.51	SAMN15397138	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114763	0.74	0.68	0.51	SAMN15397061	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114764	0.74	0.68	0.51	SAMN15397061	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114765	0.74	0.68	0.51	SAMN15397061	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114768	0.74	0.68	0.51	SAMN15397061	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114769	0.74	0.68	0.51	SAMN15397138	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114771	0.74	0.68	0.51	SAMN15397138	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114772	0.74	0.68	0.51	SAMN15397138	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114773	0.74	0.68	0.51	SAMN15397138	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114774	0.74	0.68	0.51	SAMN15397138	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114781	0.74	0.68	0.51	SAMN15397054	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114807	0.74	0.68	0.51	SAMN15397054	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114846	0.74	0.68	0.51	SAMN15397054	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114892	0.74	0.68	0.51	SAMN15397054	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114942	0.74	0.68	0.51	SAMN15397179	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114947	0.74	0.68	0.51	SAMN15397179	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114964	0.74	0.68	0.51	SAMN15397061	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114965	0.74	0.68	0.51	SAMN15397061	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114967	0.74	0.68	0.51	SAMN15397061	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114968	0.74	0.68	0.51	SAMN15397061	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114969	0.74	0.68	0.51	SAMN15397061	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114976	0.74	0.68	0.51	SAMN15397179	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114977	0.74	0.68	0.51	SAMN15397179	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114978	0.74	0.68	0.51	SAMN15397179	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114979	0.74	0.68	0.51	SAMN15397179	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114980	0.74	0.68	0.51	SAMN15397179	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114981	0.74	0.68	0.51	SAMN15397179	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114982	0.74	0.68	0.51	SAMN15397179	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114984	0.74	0.68	0.51	SAMN15397179	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114985	0.74	0.68	0.51	SAMN15397179	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12114987	0.74	0.68	0.51	SAMN15397179	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115055	0.74	0.68	0.51	SAMN15397054	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115090	0.74	0.68	0.51	SAMN15397054	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115111	0.74	0.68	0.51	SAMN15397180	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115129	0.74	0.68	0.51	SAMN15397054	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115155	0.74	0.68	0.51	SAMN15397054	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115165	0.74	0.68	0.51	SAMN15397054	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115186	0.74	0.68	0.51	SAMN15397054	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115203	0.74	0.68	0.51	SAMN15397054	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12115215	0.74	0.68	0.51	SAMN15397073	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122144	0.74	0.68	0.51	SAMN15397117	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122145	0.74	0.68	0.51	SAMN15397117	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122146	0.74	0.68	0.51	SAMN15397117	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122148	0.74	0.68	0.51	SAMN15397117	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122150	0.74	0.68	0.51	SAMN15397117	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122152	0.74	0.68	0.51	SAMN15397117	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122153	0.74	0.68	0.51	SAMN15397117	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122155	0.74	0.68	0.51	SAMN15397117	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122156	0.74	0.68	0.51	SAMN15397117	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122157	0.74	0.68	0.51	SAMN15397117	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122540	0.74	0.68	0.51	SAMN15397090	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122600	0.74	0.68	0.51	SAMN15397195	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122603	0.74	0.68	0.51	SAMN15397195	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122607	0.74	0.68	0.51	SAMN15397195	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122610	0.74	0.68	0.51	SAMN15397195	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122611	0.74	0.68	0.51	SAMN15397195	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122613	0.74	0.68	0.51	SAMN15397195	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR12122702	0.74	0.68	0.51	SAMN15397089	Gut Microbiome and Metabolome in Atopic Eczema Infants
L11079.1	SRR1211531	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1211638	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1212803	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1214034	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1214490	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1214499	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1214542	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1214756	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1214876	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1214922	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1215333	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1215507	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1215581	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1215935	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1215958	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR1219503	0.74	0.68	0.51	SAMN02674885	Microbiome study of the RISK cohort
L11079.1	SRR12106803	0.74	0.68	0.51	SAMN15379492	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12106804	0.74	0.68	0.51	SAMN15379491	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12106806	0.74	0.68	0.51	SAMN15379489	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12106807	0.74	0.68	0.51	SAMN15379488	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12106811	0.74	0.68	0.51	SAMN15379509	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12106817	0.74	0.68	0.51	SAMN15379503	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12106824	0.74	0.68	0.51	SAMN15379497	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12106826	0.74	0.68	0.51	SAMN15379495	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12106827	0.74	0.68	0.51	SAMN15379494	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12106828	0.74	0.68	0.51	SAMN15379493	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113279	0.74	0.68	0.51	SAMN15379456	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113283	0.74	0.68	0.51	SAMN15379452	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113285	0.74	0.68	0.51	SAMN15379450	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113289	0.74	0.68	0.51	SAMN15379470	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113291	0.74	0.68	0.51	SAMN15379468	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113292	0.74	0.68	0.51	SAMN15379467	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113293	0.74	0.68	0.51	SAMN15379449	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113294	0.74	0.68	0.51	SAMN15379466	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113295	0.74	0.68	0.51	SAMN15379465	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113296	0.74	0.68	0.51	SAMN15379464	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113297	0.74	0.68	0.51	SAMN15379463	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113298	0.74	0.68	0.51	SAMN15379462	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113299	0.74	0.68	0.51	SAMN15379461	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113300	0.74	0.68	0.51	SAMN15379460	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113301	0.74	0.68	0.51	SAMN15379459	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113302	0.74	0.68	0.51	SAMN15379458	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113303	0.74	0.68	0.51	SAMN15379457	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12113305	0.74	0.68	0.51	SAMN15379447	Fecal microbiota transplantations reconstitute gut fungal and viral  microbiota in graft-versus-host disease
L11079.1	SRR12143716	0.74	0.68	0.51	SAMN14943282	IgA deficiency microbiota
L11079.1	SRR12143717	0.74	0.68	0.51	SAMN14943281	IgA deficiency microbiota
L11079.1	SRR12143720	0.74	0.68	0.51	SAMN14943278	IgA deficiency microbiota
L11079.1	SRR12143767	0.74	0.68	0.51	SAMN14943234	IgA deficiency microbiota
L11079.1	SRR12143794	0.74	0.68	0.51	SAMN14943328	IgA deficiency microbiota
L11079.1	SRR12158950	0.74	0.68	0.51	SAMN15422850	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159009	0.74	0.68	0.51	SAMN15422796	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159018	0.74	0.68	0.51	SAMN15422788	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159046	0.74	0.68	0.51	SAMN15422764	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159066	0.74	0.68	0.51	SAMN15422404	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159069	0.74	0.68	0.51	SAMN15422743	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159075	0.74	0.68	0.51	SAMN15422737	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159135	0.74	0.68	0.51	SAMN15422683	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159141	0.74	0.68	0.51	SAMN15422677	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159148	0.74	0.68	0.51	SAMN15422671	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159159	0.74	0.68	0.51	SAMN15422662	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159167	0.74	0.68	0.51	SAMN15422655	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159168	0.74	0.68	0.51	SAMN15422654	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159207	0.74	0.68	0.51	SAMN15422618	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159216	0.74	0.68	0.51	SAMN15422610	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159255	0.74	0.68	0.51	SAMN15422488	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159270	0.74	0.68	0.51	SAMN15422475	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159290	0.74	0.68	0.51	SAMN15422573	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159298	0.74	0.68	0.51	SAMN15422386	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159302	0.74	0.68	0.51	SAMN15422563	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159310	0.74	0.68	0.51	SAMN15422385	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159317	0.74	0.68	0.51	SAMN15422549	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159360	0.74	0.68	0.51	SAMN15422510	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159382	0.74	0.68	0.51	SAMN15422462	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159410	0.74	0.68	0.51	SAMN15422436	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159412	0.74	0.68	0.51	SAMN15422435	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159432	0.74	0.68	0.51	SAMN15422948	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159435	0.74	0.68	0.51	SAMN15422424	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159446	0.74	0.68	0.51	SAMN15422423	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159454	0.74	0.68	0.51	SAMN15422928	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159472	0.74	0.68	0.51	SAMN15422912	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159483	0.74	0.68	0.51	SAMN15422902	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159485	0.74	0.68	0.51	SAMN15422900	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159494	0.74	0.68	0.51	SAMN15422892	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159497	0.74	0.68	0.51	SAMN15422889	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159503	0.74	0.68	0.51	SAMN15422884	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12159524	0.74	0.68	0.51	SAMN15422371	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234406	0.74	0.68	0.51	SAMN15422231	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234407	0.74	0.68	0.51	SAMN15422230	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234431	0.74	0.68	0.51	SAMN15422208	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234443	0.74	0.68	0.51	SAMN15422197	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234445	0.74	0.68	0.51	SAMN15422195	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234447	0.74	0.68	0.51	SAMN15422194	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234526	0.74	0.68	0.51	SAMN15422123	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234535	0.74	0.68	0.51	SAMN15421800	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234543	0.74	0.68	0.51	SAMN15422107	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234559	0.74	0.68	0.51	SAMN15422093	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234562	0.74	0.68	0.51	SAMN15422090	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234574	0.74	0.68	0.51	SAMN15422079	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234575	0.74	0.68	0.51	SAMN15422078	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234580	0.74	0.68	0.51	SAMN15422074	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234589	0.74	0.68	0.51	SAMN15422065	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234613	0.74	0.68	0.51	SAMN15421793	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234615	0.74	0.68	0.51	SAMN15422043	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234652	0.74	0.68	0.51	SAMN15422009	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234695	0.74	0.68	0.51	SAMN15421853	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234708	0.74	0.68	0.51	SAMN15421977	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234709	0.74	0.68	0.51	SAMN15421976	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234710	0.74	0.68	0.51	SAMN15421975	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234739	0.74	0.68	0.51	SAMN15421765	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234740	0.74	0.68	0.51	SAMN15421773	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234765	0.74	0.68	0.51	SAMN15422363	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234766	0.74	0.68	0.51	SAMN15422362	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234786	0.74	0.68	0.51	SAMN15421940	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234809	0.74	0.68	0.51	SAMN15422352	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234844	0.74	0.68	0.51	SAMN15421916	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234857	0.74	0.68	0.51	SAMN15421779	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234862	0.74	0.68	0.51	SAMN15421900	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234866	0.74	0.68	0.51	SAMN15421896	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234895	0.74	0.68	0.51	SAMN15422303	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234896	0.74	0.68	0.51	SAMN15422302	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234913	0.74	0.68	0.51	SAMN15421883	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234938	0.74	0.68	0.51	SAMN15422293	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12234976	0.74	0.68	0.51	SAMN15422259	The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes
L11079.1	SRR12170237	0.74	0.68	0.51	SAMN15471102	Metagenomic Sequencing of Stool Samples in Bangladeshi Infants: Virome Association with Poliovirus Shedding After Oral Poliovirus Vaccination
L11079.1	SRR12170320	0.74	0.68	0.51	SAMN15471161	Metagenomic Sequencing of Stool Samples in Bangladeshi Infants: Virome Association with Poliovirus Shedding After Oral Poliovirus Vaccination
L11079.1	SRR12179836	0.74	0.68	0.51	SAMN15470506	Gut Metagenomes of South Asian Canadians
L11079.1	SRR12179842	0.74	0.68	0.51	SAMN15470501	Gut Metagenomes of South Asian Canadians
L11079.1	SRR12180959	0.74	0.68	0.51	SAMN15488353	Honeybee gut microbiome
L11079.1	SRR12180982	0.74	0.68	0.51	SAMN15488332	Honeybee gut microbiome
L11079.1	SRR12180984	0.74	0.68	0.51	SAMN15488330	Honeybee gut microbiome
L11079.1	SRR12181010	0.74	0.68	0.51	SAMN15488306	Honeybee gut microbiome
L11079.1	SRR12195338	0.74	0.68	0.51	SAMN15504577	STEC-spiked food
L11079.1	SRR12195339	0.74	0.68	0.51	SAMN15504576	STEC-spiked food
L11079.1	SRR12203223	0.74	0.68	0.51	SAMN15497282	Parity is associated with maternal gut microbiome composition during pregnancy and offspring microbiome composition in pigs
L11079.1	SRR12203228	0.74	0.68	0.51	SAMN15497277	Parity is associated with maternal gut microbiome composition during pregnancy and offspring microbiome composition in pigs
L11079.1	SRR12261822	0.74	0.68	0.51	SAMN15565829	gut Metagenome of red fox and corsac fox
L11079.1	SRR12302418	0.74	0.68	0.51	SAMN15567710	infant gut Targeted Locus (Loci)
L11079.1	SRR12302546	0.74	0.68	0.51	SAMN15567725	infant gut Targeted Locus (Loci)
L11079.1	SRR12302564	0.74	0.68	0.51	SAMN15567773	infant gut Targeted Locus (Loci)
L11079.1	SRR12302573	0.74	0.68	0.51	SAMN15567725	infant gut Targeted Locus (Loci)
L11079.1	SRR12823601	0.74	0.68	0.51	SAMN09515677	infant gut Targeted Locus (Loci)
L11079.1	SRR15127827	0.74	0.68	0.51	SAMN20118676	infant gut Targeted Locus (Loci)
L11079.1	SRR8692216	0.74	0.68	0.51	SAMN09515582	infant gut Targeted Locus (Loci)
L11079.1	SRR12324960	0.74	0.68	0.51	SAMN15643019	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12324977	0.74	0.68	0.51	SAMN15643084	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12324981	0.74	0.68	0.51	SAMN15643080	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12324992	0.74	0.68	0.51	SAMN15643070	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12325003	0.74	0.68	0.51	SAMN15643060	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12325026	0.74	0.68	0.51	SAMN15643013	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12325028	0.74	0.68	0.51	SAMN15643038	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12325041	0.74	0.68	0.51	SAMN15643026	Factors associated with the microbiome in moderate-late preterm babies - the DIAMOND trial - Shotgun Metagenomic data
L11079.1	SRR12326638	0.74	0.68	0.51	SAMN15637086	Cassava leaf microbiome and ions
L11079.1	SRR12326639	0.74	0.68	0.51	SAMN15637085	Cassava leaf microbiome and ions
L11079.1	SRR12326640	0.74	0.68	0.51	SAMN15637084	Cassava leaf microbiome and ions
L11079.1	SRR12326879	0.74	0.68	0.51	SAMN15589079	Impact of the gut microbiome and metabolome on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
L11079.1	SRR12328950	0.74	0.68	0.51	SAMN15064789	Gut microbiome alterations and longitudinal kinetics in COVID-19 patients
L11079.1	SRR12361993	0.74	0.68	0.51	SAMN15689734	Sequencing depth required for antimicrobial resistance gene detection from metagenomic samples
L11079.1	SRR12361996	0.74	0.68	0.51	SAMN15689731	Sequencing depth required for antimicrobial resistance gene detection from metagenomic samples
L11079.1	SRR12361997	0.74	0.68	0.51	SAMN15689730	Sequencing depth required for antimicrobial resistance gene detection from metagenomic samples
L11079.1	SRR12361998	0.74	0.68	0.51	SAMN15689729	Sequencing depth required for antimicrobial resistance gene detection from metagenomic samples
L11079.1	SRR12361999	0.74	0.68	0.51	SAMN15689728	Sequencing depth required for antimicrobial resistance gene detection from metagenomic samples
L11079.1	SRR12362000	0.74	0.68	0.51	SAMN15689727	Sequencing depth required for antimicrobial resistance gene detection from metagenomic samples
L11079.1	SRR12362001	0.74	0.68	0.51	SAMN15689726	Sequencing depth required for antimicrobial resistance gene detection from metagenomic samples
L11079.1	SRR12390980	0.74	0.68	0.51	SAMN15733941	Metagenome of wastewater-derived enrichment cultures with different culture media
L11079.1	SRR12390989	0.74	0.68	0.51	SAMN15733943	Metagenome of wastewater-derived enrichment cultures with different culture media
L11079.1	SRR12459276	0.74	0.68	0.51	SAMN15824886	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12459330	0.74	0.68	0.51	SAMN15824982	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12459513	0.74	0.68	0.51	SAMN15824844	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12459577	0.74	0.68	0.51	SAMN15824729	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12459587	0.74	0.68	0.51	SAMN15824720	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12459628	0.74	0.68	0.51	SAMN15824741	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12459630	0.74	0.68	0.51	SAMN15824616	PROMISE Cohort Metagenome sequence data
L11079.1	SRR12477457	0.74	0.68	0.51	SAMN15854622	Delivery mode impacts newborn gut colonization efficiency
L11079.1	SRR12477458	0.74	0.68	0.51	SAMN15854621	Delivery mode impacts newborn gut colonization efficiency
L11079.1	SRR12477532	0.74	0.68	0.51	SAMN15854790	Delivery mode impacts newborn gut colonization efficiency
L11079.1	SRR12487007	0.74	0.68	0.51	SAMN15860797	Korean Freshwater Metagenome
L11079.1	SRR12506172	0.74	0.68	0.51	SAMN15890714	gut microbiome shifts associated with Henoch-Schonlein purpura
L11079.1	SRR12506184	0.74	0.68	0.51	SAMN15890711	gut microbiome shifts associated with Henoch-Schonlein purpura
L11079.1	SRR12506196	0.74	0.68	0.51	SAMN15890709	gut microbiome shifts associated with Henoch-Schonlein purpura
L11079.1	SRR12529349	0.74	0.68	0.51	SAMN15829969	An integrated gene catalog and over 10,000 metagenome-assembled genomes from the gastrointestinal microbiome of ruminants
L11079.1	SRR12557706	0.74	0.68	0.51	SAMN12619380	Reconstruction of ancient microbial genomes from the human gut
L11079.1	SRR12557710	0.74	0.68	0.51	SAMN12619405	Reconstruction of ancient microbial genomes from the human gut
L11079.1	SRR12557722	0.74	0.68	0.51	SAMN12619375	Reconstruction of ancient microbial genomes from the human gut
L11079.1	SRR1535307	0.74	0.68	0.51	SAMN02929997	Human gut Targeted Locus (Loci)
L11079.1	SRR1535309	0.74	0.68	0.51	SAMN02929999	Human gut Targeted Locus (Loci)
L11079.1	SRR1535310	0.74	0.68	0.51	SAMN02930000	Human gut Targeted Locus (Loci)
L11079.1	SRR1535339	0.74	0.68	0.51	SAMN02930030	Human gut Targeted Locus (Loci)
L11079.1	SRR1535340	0.74	0.68	0.51	SAMN02930031	Human gut Targeted Locus (Loci)
L11079.1	SRR1535342	0.74	0.68	0.51	SAMN02930033	Human gut Targeted Locus (Loci)
L11079.1	SRR1535346	0.74	0.68	0.51	SAMN02930037	Human gut Targeted Locus (Loci)
L11079.1	SRR1535380	0.74	0.68	0.51	SAMN02930071	Human gut Targeted Locus (Loci)
L11079.1	SRR1535381	0.74	0.68	0.51	SAMN02930072	Human gut Targeted Locus (Loci)
L11079.1	SRR1535382	0.74	0.68	0.51	SAMN02930073	Human gut Targeted Locus (Loci)
L11079.1	SRR1535383	0.74	0.68	0.51	SAMN02930074	Human gut Targeted Locus (Loci)
L11079.1	SRR12711028	0.74	0.68	0.51	SAMN15871271	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12711030	0.74	0.68	0.51	SAMN15871269	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12711069	0.74	0.68	0.51	SAMN15871263	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12711070	0.74	0.68	0.51	SAMN15871262	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12711072	0.74	0.68	0.51	SAMN15871260	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12711073	0.74	0.68	0.51	SAMN15871259	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12711074	0.74	0.68	0.51	SAMN15871258	Metagenomic sequencing of  the digestive tract of buffalo
L11079.1	SRR12793300	0.74	0.68	0.51	SAMN16395786	Xylan alleviates dietary fiber deprivation-induced dysbiosis by selectively promoting Bifidobacterium pseudocatenulatum in pigs
L11079.1	SRR16327188	0.74	0.68	0.51	SAMN22262153	Xylan alleviates dietary fiber deprivation-induced dysbiosis by selectively promoting Bifidobacterium pseudocatenulatum in pigs
L11079.1	SRR1275436	0.74	0.68	0.51	SAMN02767677	Human stool Metagenome
L11079.1	SRR12762308	0.74	0.68	0.51	SAMN16295577	Metagenomic profiling of antibiotic resistance genes and mobile genetic elements
L11079.1	SRR12777864	0.74	0.68	0.51	SAMN16377691	Metagenomic analyses of calf gastrointestinal tract microbiota reveal compositional and functional differences driven by high and low milk allowance diets
L11079.1	SRR12777894	0.74	0.68	0.51	SAMN16377664	Metagenomic analyses of calf gastrointestinal tract microbiota reveal compositional and functional differences driven by high and low milk allowance diets
L11079.1	SRR12795744	0.74	0.68	0.51	SAMN16396838	Fecal microbiota transplantation on necrotizing enterocolitis in preterm piglets
L11079.1	SRR12795745	0.74	0.68	0.51	SAMN16396837	Fecal microbiota transplantation on necrotizing enterocolitis in preterm piglets
L11079.1	SRR12795746	0.74	0.68	0.51	SAMN16396836	Fecal microbiota transplantation on necrotizing enterocolitis in preterm piglets
L11079.1	SRR12795775	0.74	0.68	0.51	SAMN16396831	Fecal microbiota transplantation on necrotizing enterocolitis in preterm piglets
L11079.1	SRR12795781	0.74	0.68	0.51	SAMN16396825	Fecal microbiota transplantation on necrotizing enterocolitis in preterm piglets
L11079.1	SRR12802556	0.74	0.68	0.51	SAMN16401325	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802559	0.74	0.68	0.51	SAMN16401322	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802563	0.74	0.68	0.51	SAMN16401317	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802566	0.74	0.68	0.51	SAMN16401315	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802572	0.74	0.68	0.51	SAMN16401278	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802574	0.74	0.68	0.51	SAMN16401276	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802612	0.74	0.68	0.51	SAMN16401332	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802615	0.74	0.68	0.51	SAMN16401327	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802641	0.74	0.68	0.51	SAMN16401345	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12802644	0.74	0.68	0.51	SAMN16401342	gut dysbiosis in diabetes  used  metagenomic data
L11079.1	SRR12833181	0.74	0.68	0.51	SAMN16457410	metagenomics analysis of intestinal ischemia reperfusion in rats
L11079.1	SRR12844109	0.74	0.68	0.51	SAMN16448828	key fund on straw decomposition
L11079.1	SRR12874564	0.74	0.68	0.51	SAMN16502427	Within-host evolution of Vibrio cholerae using metagenomics
L11079.1	SRR12874567	0.74	0.68	0.51	SAMN16502424	Within-host evolution of Vibrio cholerae using metagenomics
L11079.1	SRR12874578	0.74	0.68	0.51	SAMN16502443	Within-host evolution of Vibrio cholerae using metagenomics
L11079.1	SRR12874589	0.74	0.68	0.51	SAMN16502433	Within-host evolution of Vibrio cholerae using metagenomics
L11079.1	SRR12874591	0.74	0.68	0.51	SAMN16502431	Within-host evolution of Vibrio cholerae using metagenomics
L11079.1	SRR12893985	0.74	0.68	0.51	SAMN16550500	Hong Kong outdoor built environment surface metagenomes
L11079.1	SRR12893990	0.74	0.68	0.51	SAMN16550496	Hong Kong outdoor built environment surface metagenomes
L11079.1	SRR12907727	0.74	0.68	0.51	SAMN16554580	human gut microbiota raw sequences of critically ill patients
L11079.1	SRR12907737	0.74	0.68	0.51	SAMN16554571	human gut microbiota raw sequences of critically ill patients
L11079.1	SRR13566436	0.74	0.68	0.51	SAMN17154517	red swamp crayfish gut Metagenome
L11079.1	SRR12934064	0.74	0.68	0.51	SAMN16557047	Bugs and Bones
L11079.1	SRR12934065	0.74	0.68	0.51	SAMN16557047	Bugs and Bones
L11079.1	SRR12934112	0.74	0.68	0.51	SAMN16557107	Bugs and Bones
L11079.1	SRR12934114	0.74	0.68	0.51	SAMN16557107	Bugs and Bones
L11079.1	SRR12934115	0.74	0.68	0.51	SAMN16557107	Bugs and Bones
L11079.1	SRR12961151	0.74	0.68	0.51	SAMN16598114	Human gut microbes Metagenome
L11079.1	SRR12961163	0.74	0.68	0.51	SAMN16598103	Human gut microbes Metagenome
L11079.1	SRR12961187	0.74	0.68	0.51	SAMN16598064	Human gut microbes Metagenome
L11079.1	SRR12961195	0.74	0.68	0.51	SAMN16598074	Human gut microbes Metagenome
L11079.1	SRR12973195	0.74	0.68	0.51	SAMN16630112	Shorgun metagenomics of T2DM human gut microbes associated with FMT
L11079.1	SRR12973206	0.74	0.68	0.51	SAMN16630105	Shorgun metagenomics of T2DM human gut microbes associated with FMT
L11079.1	SRR12973219	0.74	0.68	0.51	SAMN16630094	Shorgun metagenomics of T2DM human gut microbes associated with FMT
L11079.1	SRR12973231	0.74	0.68	0.51	SAMN16630089	Shorgun metagenomics of T2DM human gut microbes associated with FMT
L11079.1	SRR12973232	0.74	0.68	0.51	SAMN16630082	Shorgun metagenomics of T2DM human gut microbes associated with FMT
L11079.1	SRR12973233	0.74	0.68	0.51	SAMN16630081	Shorgun metagenomics of T2DM human gut microbes associated with FMT
L11079.1	SRR13001969	0.74	0.68	0.51	SAMN16690191	Dairy manure metagenomes with spike-in standard
L11079.1	SRR13004925	0.74	0.68	0.51	SAMN16701498	Role of Diet in the Reconstitution of the Human Gut Microbiome and its Metabolome
L11079.1	SRR13059282	0.74	0.68	0.51	SAMN16794392	Human,  goat, and chicken gut microbiomes and resistomes in urban and rural Bangladesh
L11079.1	SRR13060945	0.74	0.68	0.51	SAMN16796245	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13060949	0.74	0.68	0.51	SAMN16796241	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13060960	0.74	0.68	0.51	SAMN16796231	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13060966	0.74	0.68	0.51	SAMN16796226	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13060991	0.74	0.68	0.51	SAMN16796203	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13061019	0.74	0.68	0.51	SAMN16796178	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13061030	0.74	0.68	0.51	SAMN16796168	Fecal Whole Metagenomic Shotgun Sequencing on Koreans
L11079.1	SRR13077656	0.74	0.68	0.51	SAMN15723217	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077664	0.74	0.68	0.51	SAMN15723209	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077673	0.74	0.68	0.51	SAMN15723201	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077687	0.74	0.68	0.51	SAMN15723027	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077735	0.74	0.68	0.51	SAMN15722990	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077772	0.74	0.68	0.51	SAMN15723053	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077827	0.74	0.68	0.51	SAMN15723193	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077843	0.74	0.68	0.51	SAMN15723179	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077879	0.74	0.68	0.51	SAMN15723148	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077887	0.74	0.68	0.51	SAMN15723140	Gut metagenomes of patients with COVID-19
L11079.1	SRR13077896	0.74	0.68	0.51	SAMN15723132	Gut metagenomes of patients with COVID-19
L11079.1	SRR13083074	0.74	0.68	0.51	SAMN16830187	Whole-metagenome shotgun sequencing of human feces
L11079.1	SRR13083077	0.74	0.68	0.51	SAMN16830185	Whole-metagenome shotgun sequencing of human feces
L11079.1	SRR13099425	0.74	0.68	0.51	SAMN16860728	Interstitial Cystitis Urinary Metagenomics
L11079.1	SRR13377136	0.74	0.68	0.51	SAMN17088346	Multi-omics of the nitrate-reducing iron(II)-oxidizing culture KS
L11079.1	SRR13697100	0.74	0.68	0.51	SAMN07560773	Microbiota of allo-HSCT patients and in the setting of Autologous Fecal Microbiota Transplant (auto-FMT) at MSKCC Raw sequence reads
L11079.1	SRR13271688	0.74	0.68	0.51	SAMN17112141	The Influence of the gut microbiome on BCG-induced trained immunity
L11079.1	SRR13271720	0.74	0.68	0.51	SAMN17112011	The Influence of the gut microbiome on BCG-induced trained immunity
L11079.1	SRR13279599	0.74	0.68	0.51	SAMN17126282	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279624	0.74	0.68	0.51	SAMN17126305	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279629	0.74	0.68	0.51	SAMN17126309	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279648	0.74	0.68	0.51	SAMN17126183	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279676	0.74	0.68	0.51	SAMN17126188	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279688	0.74	0.68	0.51	SAMN17126199	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279701	0.74	0.68	0.51	SAMN17126213	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279703	0.74	0.68	0.51	SAMN17126215	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13279742	0.74	0.68	0.51	SAMN17126250	Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D
L11079.1	SRR13287453	0.74	0.68	0.51	SAMN17132269	environmental microorganisms from municipal WWTP effluent and river
L11079.1	SRR13300704	0.74	0.68	0.51	SAMN17083002	Multi-omics suggest diverse mechanisms for response to biologic therapies in IBD
L11079.1	SRR13318085	0.74	0.68	0.51	SAMN17171498	Netherland Travelers
L11079.1	SRR13318091	0.74	0.68	0.51	SAMN17171511	Netherland Travelers
L11079.1	SRR13318092	0.74	0.68	0.51	SAMN17171512	Netherland Travelers
L11079.1	SRR13318095	0.74	0.68	0.51	SAMN17171514	Netherland Travelers
L11079.1	SRR13318108	0.74	0.68	0.51	SAMN17171400	Netherland Travelers
L11079.1	SRR13318112	0.74	0.68	0.51	SAMN17171328	Netherland Travelers
L11079.1	SRR13318117	0.74	0.68	0.51	SAMN17171530	Netherland Travelers
L11079.1	SRR13318122	0.74	0.68	0.51	SAMN17171534	Netherland Travelers
L11079.1	SRR13318126	0.74	0.68	0.51	SAMN17171380	Netherland Travelers
L11079.1	SRR13318128	0.74	0.68	0.51	SAMN17171382	Netherland Travelers
L11079.1	SRR13318136	0.74	0.68	0.51	SAMN17171240	Netherland Travelers
L11079.1	SRR13318145	0.74	0.68	0.51	SAMN17171476	Netherland Travelers
L11079.1	SRR13318147	0.74	0.68	0.51	SAMN17171478	Netherland Travelers
L11079.1	SRR13318148	0.74	0.68	0.51	SAMN17171226	Netherland Travelers
L11079.1	SRR13318153	0.74	0.68	0.51	SAMN17171526	Netherland Travelers
L11079.1	SRR13318157	0.74	0.68	0.51	SAMN17171556	Netherland Travelers
L11079.1	SRR13318161	0.74	0.68	0.51	SAMN17171258	Netherland Travelers
L11079.1	SRR13318166	0.74	0.68	0.51	SAMN17171228	Netherland Travelers
L11079.1	SRR13318169	0.74	0.68	0.51	SAMN17171233	Netherland Travelers
L11079.1	SRR13318174	0.74	0.68	0.51	SAMN17171448	Netherland Travelers
L11079.1	SRR13318176	0.74	0.68	0.51	SAMN17171450	Netherland Travelers
L11079.1	SRR13318178	0.74	0.68	0.51	SAMN17171452	Netherland Travelers
L11079.1	SRR13318179	0.74	0.68	0.51	SAMN17171246	Netherland Travelers
L11079.1	SRR13318181	0.74	0.68	0.51	SAMN17171304	Netherland Travelers
L11079.1	SRR13318183	0.74	0.68	0.51	SAMN17171306	Netherland Travelers
L11079.1	SRR13318187	0.74	0.68	0.51	SAMN17171290	Netherland Travelers
L11079.1	SRR13318197	0.74	0.68	0.51	SAMN17171502	Netherland Travelers
L11079.1	SRR13318205	0.74	0.68	0.51	SAMN17171334	Netherland Travelers
L11079.1	SRR13318209	0.74	0.68	0.51	SAMN17171338	Netherland Travelers
L11079.1	SRR13318218	0.74	0.68	0.51	SAMN17171416	Netherland Travelers
L11079.1	SRR13318221	0.74	0.68	0.51	SAMN17171244	Netherland Travelers
L11079.1	SRR13318223	0.74	0.68	0.51	SAMN17171434	Netherland Travelers
L11079.1	SRR13318233	0.74	0.68	0.51	SAMN17171520	Netherland Travelers
L11079.1	SRR13318235	0.74	0.68	0.51	SAMN17171522	Netherland Travelers
L11079.1	SRR13318237	0.74	0.68	0.51	SAMN17171544	Netherland Travelers
L11079.1	SRR13318239	0.74	0.68	0.51	SAMN17171546	Netherland Travelers
L11079.1	SRR13318241	0.74	0.68	0.51	SAMN17171256	Netherland Travelers
L11079.1	SRR13318252	0.74	0.68	0.51	SAMN17171460	Netherland Travelers
L11079.1	SRR13318254	0.74	0.68	0.51	SAMN17171462	Netherland Travelers
L11079.1	SRR13318259	0.74	0.68	0.51	SAMN17171484	Netherland Travelers
L11079.1	SRR13318262	0.74	0.68	0.51	SAMN17171580	Netherland Travelers
L11079.1	SRR13318266	0.74	0.68	0.51	SAMN17171584	Netherland Travelers
L11079.1	SRR13318272	0.74	0.68	0.51	SAMN17171282	Netherland Travelers
L11079.1	SRR13318276	0.74	0.68	0.51	SAMN17171286	Netherland Travelers
L11079.1	SRR13318288	0.74	0.68	0.51	SAMN17171238	Netherland Travelers
L11079.1	SRR13318298	0.74	0.68	0.51	SAMN17171408	Netherland Travelers
L11079.1	SRR13318300	0.74	0.68	0.51	SAMN17171410	Netherland Travelers
L11079.1	SRR13318301	0.74	0.68	0.51	SAMN17171536	Netherland Travelers
L11079.1	SRR13318303	0.74	0.68	0.51	SAMN17171538	Netherland Travelers
L11079.1	SRR13318310	0.74	0.68	0.51	SAMN17171598	Netherland Travelers
L11079.1	SRR13318312	0.74	0.68	0.51	SAMN17171600	Netherland Travelers
L11079.1	SRR13318317	0.74	0.68	0.51	SAMN17171332	Netherland Travelers
L11079.1	SRR13318319	0.74	0.68	0.51	SAMN17171454	Netherland Travelers
L11079.1	SRR13318321	0.74	0.68	0.51	SAMN17171456	Netherland Travelers
L11079.1	SRR13318328	0.74	0.68	0.51	SAMN17171471	Netherland Travelers
L11079.1	SRR13318329	0.74	0.68	0.51	SAMN17171472	Netherland Travelers
L11079.1	SRR13318337	0.74	0.68	0.51	SAMN17171344	Netherland Travelers
L11079.1	SRR13318339	0.74	0.68	0.51	SAMN17171346	Netherland Travelers
L11079.1	SRR13318348	0.74	0.68	0.51	SAMN17171562	Netherland Travelers
L11079.1	SRR13318351	0.74	0.68	0.51	SAMN17171565	Netherland Travelers
L11079.1	SRR13318352	0.74	0.68	0.51	SAMN17171566	Netherland Travelers
L11079.1	SRR13318358	0.74	0.68	0.51	SAMN17171296	Netherland Travelers
L11079.1	SRR13318362	0.74	0.68	0.51	SAMN17171300	Netherland Travelers
L11079.1	SRR13318372	0.74	0.68	0.51	SAMN17171264	Netherland Travelers
L11079.1	SRR13318382	0.74	0.68	0.51	SAMN17171274	Netherland Travelers
L11079.1	SRR13318386	0.74	0.68	0.51	SAMN17171278	Netherland Travelers
L11079.1	SRR13318393	0.74	0.68	0.51	SAMN17171368	Netherland Travelers
L11079.1	SRR13318397	0.74	0.68	0.51	SAMN17171420	Netherland Travelers
L11079.1	SRR13318409	0.74	0.68	0.51	SAMN17171430	Netherland Travelers
L11079.1	SRR13318412	0.74	0.68	0.51	SAMN17171487	Netherland Travelers
L11079.1	SRR13318417	0.74	0.68	0.51	SAMN17171492	Netherland Travelers
L11079.1	SRR13318434	0.74	0.68	0.51	SAMN17171310	Netherland Travelers
L11079.1	SRR13318436	0.74	0.68	0.51	SAMN17171312	Netherland Travelers
L11079.1	SRR13318439	0.74	0.68	0.51	SAMN17171314	Netherland Travelers
L11079.1	SRR13318443	0.74	0.68	0.51	SAMN17171230	Netherland Travelers
L11079.1	SRR13318445	0.74	0.68	0.51	SAMN17171294	Netherland Travelers
L11079.1	SRR13318447	0.74	0.68	0.51	SAMN17171302	Netherland Travelers
L11079.1	SRR13318450	0.74	0.68	0.51	SAMN17171386	Netherland Travelers
L11079.1	SRR13318452	0.74	0.68	0.51	SAMN17171388	Netherland Travelers
L11079.1	SRR13318453	0.74	0.68	0.51	SAMN17171548	Netherland Travelers
L11079.1	SRR13318463	0.74	0.68	0.51	SAMN17171353	Netherland Travelers
L11079.1	SRR13637831	0.74	0.68	0.51	SAMN17804184	Netherland Travelers
L11079.1	SRR13318516	0.74	0.68	0.51	SAMN17170059	Role of synbiotics to prevalence of LRTinfections in infants:gut metagenomic analysis
L11079.1	SRR13327430	0.74	0.68	0.51	SAMN17126098	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327456	0.74	0.68	0.51	SAMN17126074	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327459	0.74	0.68	0.51	SAMN17126071	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327467	0.74	0.68	0.51	SAMN17126064	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13327541	0.74	0.68	0.51	SAMN17126113	Shotgun metagenomics data from human stool microorganism Raw sequence reads
L11079.1	SRR13336827	0.74	0.68	0.51	SAMN17190449	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336843	0.74	0.68	0.51	SAMN17190435	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336864	0.74	0.68	0.51	SAMN17190507	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336865	0.74	0.68	0.51	SAMN17190506	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336878	0.74	0.68	0.51	SAMN17190459	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336901	0.74	0.68	0.51	SAMN17190475	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336920	0.74	0.68	0.51	SAMN17190418	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336921	0.74	0.68	0.51	SAMN17190417	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13336929	0.74	0.68	0.51	SAMN17190500	Metagenome-wide association study of gut microbiome revealed potential etiology of Pediatric Ocular Myasthenia Gravis
L11079.1	SRR13348576	0.74	0.68	0.51	SAMN17127129	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348590	0.74	0.68	0.51	SAMN17127117	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348591	0.74	0.68	0.51	SAMN17127116	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348597	0.74	0.68	0.51	SAMN17127110	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348599	0.74	0.68	0.51	SAMN17127108	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348608	0.74	0.68	0.51	SAMN17127100	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348612	0.74	0.68	0.51	SAMN17127097	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348627	0.74	0.68	0.51	SAMN17127083	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348647	0.74	0.68	0.51	SAMN17127065	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348655	0.74	0.68	0.51	SAMN17126959	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348660	0.74	0.68	0.51	SAMN17127053	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348671	0.74	0.68	0.51	SAMN17127045	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348704	0.74	0.68	0.51	SAMN17127015	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348816	0.74	0.68	0.51	SAMN17127201	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348819	0.74	0.68	0.51	SAMN17127198	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348871	0.74	0.68	0.51	SAMN17127151	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13348887	0.74	0.68	0.51	SAMN17126967	Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
L11079.1	SRR13361266	0.74	0.68	0.51	SAMN17217753	Improved microbial community characterization of 16S rRNA via metagenome hybridization capture enrichment
L11079.1	SRR13378550	0.74	0.68	0.51	SAMN17250513	Human Gut Microbiomes from Burkina Faso
L11079.1	SRR13378557	0.74	0.68	0.51	SAMN17250435	Human Gut Microbiomes from Burkina Faso
L11079.1	SRR13378590	0.74	0.68	0.51	SAMN17250432	Human Gut Microbiomes from Burkina Faso
L11079.1	SRR13378616	0.74	0.68	0.51	SAMN17250453	Human Gut Microbiomes from Burkina Faso
L11079.1	SRR6907976	0.74	0.68	0.51	SAMN08804307	Innate, Transcriptomic, and Microbiomic Correlates of Tuberculosis Infection and Disease
L11079.1	SRR6907988	0.74	0.68	0.51	SAMN08804314	Innate, Transcriptomic, and Microbiomic Correlates of Tuberculosis Infection and Disease
L11079.1	SRR6907995	0.74	0.68	0.51	SAMN08804326	Innate, Transcriptomic, and Microbiomic Correlates of Tuberculosis Infection and Disease
L11079.1	SRR6908028	0.74	0.68	0.51	SAMN08804349	Innate, Transcriptomic, and Microbiomic Correlates of Tuberculosis Infection and Disease
L11079.1	SRR6908037	0.74	0.68	0.51	SAMN08804357	Innate, Transcriptomic, and Microbiomic Correlates of Tuberculosis Infection and Disease
L11079.1	SRR13434593	0.74	0.68	0.51	SAMN17312066	Primate phageomes are structured by superhost phylogeny and environment
L11079.1	SRR13434632	0.74	0.68	0.51	SAMN17312202	Primate phageomes are structured by superhost phylogeny and environment
L11079.1	SRR13434633	0.74	0.68	0.51	SAMN17312165	Primate phageomes are structured by superhost phylogeny and environment
L11079.1	SRR13434650	0.74	0.68	0.51	SAMN17312065	Primate phageomes are structured by superhost phylogeny and environment
L11079.1	SRR13434653	0.74	0.68	0.51	SAMN17312062	Primate phageomes are structured by superhost phylogeny and environment
L11079.1	SRR13434658	0.74	0.68	0.51	SAMN17312059	Primate phageomes are structured by superhost phylogeny and environment
L11079.1	SRR13434664	0.74	0.68	0.51	SAMN17312070	Primate phageomes are structured by superhost phylogeny and environment
L11079.1	SRR13436240	0.74	0.68	0.51	SAMN17006440	human gut microbiome predicts response to MTX treatment
L11079.1	SRR8517009	0.74	0.68	0.51	SAMN09833095	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR8517010	0.74	0.68	0.51	SAMN09833119	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR8555085	0.74	0.68	0.51	SAMN10908400	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR8555089	0.74	0.68	0.51	SAMN10908404	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR8555098	0.74	0.68	0.51	SAMN10908413	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR8555101	0.74	0.68	0.51	SAMN10908412	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR8555103	0.74	0.68	0.51	SAMN10908416	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR8555104	0.74	0.68	0.51	SAMN10908427	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR8555105	0.74	0.68	0.51	SAMN10908436	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR8555109	0.74	0.68	0.51	SAMN10908437	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR9988187	0.74	0.68	0.51	SAMN12583234	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR9988190	0.74	0.68	0.51	SAMN12583216	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR9988191	0.74	0.68	0.51	SAMN12583207	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR9988195	0.74	0.68	0.51	SAMN12583211	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR9988197	0.74	0.68	0.51	SAMN12583213	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR9988200	0.74	0.68	0.51	SAMN12583240	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR9988203	0.74	0.68	0.51	SAMN12583226	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR9988210	0.74	0.68	0.51	SAMN12583218	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR9988211	0.74	0.68	0.51	SAMN12583219	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR9988212	0.74	0.68	0.51	SAMN12583220	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR9988213	0.74	0.68	0.51	SAMN12583241	Genome diversity of pathogenic Escherichia coli in Ecuador
L11079.1	SRR13502878	0.74	0.68	0.51	SAMN17486310	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13503077	0.74	0.68	0.51	SAMN17485853	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13557627	0.74	0.68	0.51	SAMN17578285	Inference of association with the gut microbiota in stool, swab and mucosal tissue samples
L11079.1	SRR13570427	0.74	0.68	0.51	SAMN17613208	Metagenome of healthy human feces
L11079.1	SRR13594542	0.74	0.68	0.51	SAMN17719258	Fasting alters the gut microbiome with sustained blood pressure and body weight reduction in metabolic syndrome patients
L11079.1	SRR13838922	0.74	0.68	0.51	SAMN18087723	viral metagenome in soil
L11079.1	SRR13838931	0.74	0.68	0.51	SAMN18087737	viral metagenome in soil
L11079.1	SRR13838940	0.74	0.68	0.51	SAMN18087729	viral metagenome in soil
L11079.1	SRR13838941	0.74	0.68	0.51	SAMN18087728	viral metagenome in soil
L11079.1	SRR13838946	0.74	0.68	0.51	SAMN18087715	viral metagenome in soil
L11079.1	SRR13622639	0.74	0.68	0.51	SAMN17763786	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13622694	0.74	0.68	0.51	SAMN17763791	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13622707	0.74	0.68	0.51	SAMN17764190	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13622748	0.74	0.68	0.51	SAMN17764154	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13622797	0.74	0.68	0.51	SAMN17764109	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13622821	0.74	0.68	0.51	SAMN17764087	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13622855	0.74	0.68	0.51	SAMN17764056	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13622858	0.74	0.68	0.51	SAMN17764054	Early-life metagenomes from human infant fecal samples with matched maternal sample
L11079.1	SRR13694772	0.74	0.68	0.51	SAMN17884074	Vaginal seeding in babies born by caesarean section (ECOBABe trial) - shotgun metagenomics data
L11079.1	SRR13694786	0.74	0.68	0.51	SAMN17884107	Vaginal seeding in babies born by caesarean section (ECOBABe trial) - shotgun metagenomics data
L11079.1	SRR13694788	0.74	0.68	0.51	SAMN17884111	Vaginal seeding in babies born by caesarean section (ECOBABe trial) - shotgun metagenomics data
L11079.1	SRR13712890	0.74	0.68	0.51	SAMN17918396	Donor and recipient stool metagenomes from a fecal microbiota transplantation study
L11079.1	SRR13739794	0.74	0.68	0.51	SAMN17619292	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13739805	0.74	0.68	0.51	SAMN17619282	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13739807	0.74	0.68	0.51	SAMN17619280	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13740121	0.74	0.68	0.51	SAMN17619414	Human gut metagenomes of healthy mothers and their children
L11079.1	SRR13741005	0.74	0.68	0.51	SAMN17976275	Shotgun Metagenome Sequencing of Rectal Swab Samples from Cervical Cancer Patients
L11079.1	SRR13760416	0.74	0.68	0.51	SAMN18016869	Antibiotic-driven intestinal dysbiosis in paediatric SBS alters microbiome functions and is associated with gut-derived blood stream infections throughout childhood
L11079.1	SRR13773572	0.74	0.68	0.51	SAMN18040070	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773573	0.74	0.68	0.51	SAMN18040069	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773590	0.74	0.68	0.51	SAMN18040171	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13773697	0.74	0.68	0.51	SAMN18040190	Metagenomic survey of the gut microbiome of term infants in the United States reveals widespread dysbiosis, absence of B. infantis, and high abundance of antibiotic resistance genes.
L11079.1	SRR13774538	0.74	0.68	0.51	SAMN18040338	Premature infant microbiome Metagenome
L11079.1	SRR13774539	0.74	0.68	0.51	SAMN18040337	Premature infant microbiome Metagenome
L11079.1	SRR13825948	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825952	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825968	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825970	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825978	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825983	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825992	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13825998	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826021	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826024	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826030	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826040	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826050	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826060	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826064	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826067	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826074	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826085	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826092	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826105	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826112	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826115	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826117	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826120	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826125	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826144	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13826150	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099260	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099267	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099270	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099272	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099275	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099280	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099299	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099305	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099320	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099324	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099340	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099342	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099350	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099355	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099364	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099370	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099397	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099400	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099406	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099416	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099426	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099436	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099440	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099443	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099450	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099461	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR14099468	0.74	0.68	0.51	SAMN16925175	Metagenome study of patients with Budd-Chiari syndrome
L11079.1	SRR13837287	0.74	0.68	0.51	SAMN18117787	GUT MICROBIOME IN ALLERGIC CHILDREN
L11079.1	SRR13837346	0.74	0.68	0.51	SAMN18117733	GUT MICROBIOME IN ALLERGIC CHILDREN
L11079.1	SRR13844446	0.74	0.68	0.51	SAMN18106034	Fecal microbiota of donors and RCDI patients before and after FMT
L11079.1	SRR13872425	0.74	0.68	0.51	SAMN18175470	Highly-fermentable diet induces cecal microbial and metabolic perturbations and results in mucosal injuries in sheep
L11079.1	SRR13924250	0.74	0.68	0.51	SAMN18206879	Metagenomic sequencing of stool samples from human hematopoietic cell transplantation patients
L11079.1	SRR13924412	0.74	0.68	0.51	SAMN18206825	Metagenomic sequencing of stool samples from human hematopoietic cell transplantation patients
L11079.1	SRR13938839	0.74	0.68	0.51	SAMN18253902	Gut microbiota of PCa patients and their FMT treated mice
L11079.1	SRR13938845	0.74	0.68	0.51	SAMN18253897	Gut microbiota of PCa patients and their FMT treated mice
L11079.1	SRR13956625	0.74	0.68	0.51	SAMN18273655	Probiotics improved quality of life in stressed adults
L11079.1	SRR14000771	0.74	0.68	0.51	SAMN18354175	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000772	0.74	0.68	0.51	SAMN18354174	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000776	0.74	0.68	0.51	SAMN18354170	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000778	0.74	0.68	0.51	SAMN18354168	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000783	0.74	0.68	0.51	SAMN18354164	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000795	0.74	0.68	0.51	SAMN18354326	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000808	0.74	0.68	0.51	SAMN18354314	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000809	0.74	0.68	0.51	SAMN18354205	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000833	0.74	0.68	0.51	SAMN18354313	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000837	0.74	0.68	0.51	SAMN18354309	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000840	0.74	0.68	0.51	SAMN18354028	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000848	0.74	0.68	0.51	SAMN18354299	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000860	0.74	0.68	0.51	SAMN18354289	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000878	0.74	0.68	0.51	SAMN18354273	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000879	0.74	0.68	0.51	SAMN18354272	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000882	0.74	0.68	0.51	SAMN18354161	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000883	0.74	0.68	0.51	SAMN18354160	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000888	0.74	0.68	0.51	SAMN18354156	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000891	0.74	0.68	0.51	SAMN18354153	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000901	0.74	0.68	0.51	SAMN18354144	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000921	0.74	0.68	0.51	SAMN18354126	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000928	0.74	0.68	0.51	SAMN18354119	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000935	0.74	0.68	0.51	SAMN18354054	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14000961	0.74	0.68	0.51	SAMN18354219	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001010	0.74	0.68	0.51	SAMN18354240	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001016	0.74	0.68	0.51	SAMN18354235	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001017	0.74	0.68	0.51	SAMN18354234	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001034	0.74	0.68	0.51	SAMN18354076	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001039	0.74	0.68	0.51	SAMN18354071	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001040	0.74	0.68	0.51	SAMN18354070	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001074	0.74	0.68	0.51	SAMN18354265	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001075	0.74	0.68	0.51	SAMN18354264	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001076	0.74	0.68	0.51	SAMN18354263	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001078	0.74	0.68	0.51	SAMN18354261	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14001080	0.74	0.68	0.51	SAMN18354259	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017308	0.74	0.68	0.51	SAMN18386034	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017318	0.74	0.68	0.51	SAMN18386025	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017319	0.74	0.68	0.51	SAMN18386024	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017361	0.74	0.68	0.51	SAMN18385987	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017391	0.74	0.68	0.51	SAMN18385744	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017403	0.74	0.68	0.51	SAMN18385949	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017461	0.74	0.68	0.51	SAMN18385897	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017463	0.74	0.68	0.51	SAMN18385895	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017464	0.74	0.68	0.51	SAMN18385894	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017483	0.74	0.68	0.51	SAMN18385877	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017504	0.74	0.68	0.51	SAMN18385858	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017511	0.74	0.68	0.51	SAMN18385851	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017526	0.74	0.68	0.51	SAMN18385838	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017538	0.74	0.68	0.51	SAMN18385827	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017542	0.74	0.68	0.51	SAMN18385823	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017543	0.74	0.68	0.51	SAMN18385822	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017554	0.74	0.68	0.51	SAMN18385814	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017562	0.74	0.68	0.51	SAMN18385807	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017573	0.74	0.68	0.51	SAMN18385797	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017587	0.74	0.68	0.51	SAMN18385784	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017594	0.74	0.68	0.51	SAMN18385778	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017595	0.74	0.68	0.51	SAMN18385777	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14017608	0.74	0.68	0.51	SAMN18385765	COPSAC corhot study of infant gut microbiome
L11079.1	SRR14117058	0.74	0.68	0.51	SAMN17717796	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117064	0.74	0.68	0.51	SAMN17717584	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117065	0.74	0.68	0.51	SAMN17717790	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117079	0.74	0.68	0.51	SAMN17717628	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117091	0.74	0.68	0.51	SAMN17717617	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117128	0.74	0.68	0.51	SAMN17717764	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117140	0.74	0.68	0.51	SAMN17717754	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117161	0.74	0.68	0.51	SAMN17717825	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117166	0.74	0.68	0.51	SAMN17717587	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117182	0.74	0.68	0.51	SAMN17717747	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117205	0.74	0.68	0.51	SAMN17717726	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117218	0.74	0.68	0.51	SAMN17717684	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14117244	0.74	0.68	0.51	SAMN17717721	Transmission and formation of microbiota in the ealry life
L11079.1	SRR17284161	0.74	0.68	0.51	SAMN23963180	Transmission and formation of microbiota in the ealry life
L11079.1	SRR17284175	0.74	0.68	0.51	SAMN23963239	Transmission and formation of microbiota in the ealry life
L11079.1	SRR17284220	0.74	0.68	0.51	SAMN23963175	Transmission and formation of microbiota in the ealry life
L11079.1	SRR17284323	0.74	0.68	0.51	SAMN23963228	Transmission and formation of microbiota in the ealry life
L11079.1	SRR17284335	0.74	0.68	0.51	SAMN23963217	Transmission and formation of microbiota in the ealry life
L11079.1	SRR14160081	0.74	0.68	0.51	SAMN18642133	GO: Gut Microbiome and Oral Fluoropyrimidine Study in Patients with Colorectal Cancer
L11079.1	SRR14263168	0.74	0.68	0.51	SAMN18746030	The possible mechanism of Probio-M8 to relieve the symptoms of asthma patients
L11079.1	SRR14277894	0.74	0.68	0.51	SAMN18792938	Hong Kong pier surface metagenomes
L11079.1	SRR14277941	0.74	0.68	0.51	SAMN18793063	Hong Kong pier surface metagenomes
L11079.1	SRR14277946	0.74	0.68	0.51	SAMN18793059	Hong Kong pier surface metagenomes
L11079.1	SRR14297774	0.74	0.68	0.51	SAMN18814939	ARGs in wastewater  from hospital
L11079.1	SRR14297780	0.74	0.68	0.51	SAMN18814942	ARGs in wastewater  from hospital
L11079.1	SRR14306887	0.74	0.68	0.51	SAMN18826016	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14306913	0.74	0.68	0.51	SAMN18825993	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14306919	0.74	0.68	0.51	SAMN18825987	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14306925	0.74	0.68	0.51	SAMN18825982	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14306928	0.74	0.68	0.51	SAMN18825979	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14306940	0.74	0.68	0.51	SAMN18825968	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14306941	0.74	0.68	0.51	SAMN18825967	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14306942	0.74	0.68	0.51	SAMN18825966	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14321956	0.74	0.68	0.51	SAMN18868650	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14321980	0.74	0.68	0.51	SAMN18868628	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14321983	0.74	0.68	0.51	SAMN18868626	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14321984	0.74	0.68	0.51	SAMN18868625	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14321987	0.74	0.68	0.51	SAMN18868622	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14321988	0.74	0.68	0.51	SAMN18868621	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14321989	0.74	0.68	0.51	SAMN18868620	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14321999	0.74	0.68	0.51	SAMN18868611	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14322000	0.74	0.68	0.51	SAMN18868610	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14322004	0.74	0.68	0.51	SAMN18868607	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14322009	0.74	0.68	0.51	SAMN18868602	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14322010	0.74	0.68	0.51	SAMN18868601	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14322011	0.74	0.68	0.51	SAMN18868600	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14322012	0.74	0.68	0.51	SAMN18868599	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14368311	0.74	0.68	0.51	SAMN18927893	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14368321	0.74	0.68	0.51	SAMN18927830	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14368344	0.74	0.68	0.51	SAMN18927863	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14368358	0.74	0.68	0.51	SAMN18927850	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14368362	0.74	0.68	0.51	SAMN18927846	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14368377	0.74	0.68	0.51	SAMN18927824	Obesity gut microbiome metagenomic sequencing
L11079.1	SRR14318306	0.74	0.68	0.51	SAMN18137953	Study of microbial diversity in human fecal sludge composting
L11079.1	SRR14318310	0.74	0.68	0.51	SAMN18137949	Study of microbial diversity in human fecal sludge composting
L11079.1	SRR6066077	0.74	0.68	0.51	SAMN07606215	Human gut microbiota Raw sequence reads
L11079.1	SRR6066098	0.74	0.68	0.51	SAMN07606196	Human gut microbiota Raw sequence reads
L11079.1	SRR6066100	0.74	0.68	0.51	SAMN07606200	Human gut microbiota Raw sequence reads
L11079.1	SRR6066103	0.74	0.68	0.51	SAMN07606275	Human gut microbiota Raw sequence reads
L11079.1	SRR6066109	0.74	0.68	0.51	SAMN07606211	Human gut microbiota Raw sequence reads
L11079.1	SRR6066125	0.74	0.68	0.51	SAMN07606258	Human gut microbiota Raw sequence reads
L11079.1	SRR6066128	0.74	0.68	0.51	SAMN07606241	Human gut microbiota Raw sequence reads
L11079.1	SRR6066143	0.74	0.68	0.51	SAMN07606269	Human gut microbiota Raw sequence reads
L11079.1	SRR6066146	0.74	0.68	0.51	SAMN07606270	Human gut microbiota Raw sequence reads
L11079.1	SRR6066173	0.74	0.68	0.51	SAMN07606173	Human gut microbiota Raw sequence reads
L11079.1	SRR6066175	0.74	0.68	0.51	SAMN07606179	Human gut microbiota Raw sequence reads
L11079.1	SRR6066176	0.74	0.68	0.51	SAMN07606176	Human gut microbiota Raw sequence reads
L11079.1	SRR14369135	0.74	0.68	0.51	SAMN17899689	Weaning Piglet Gut Microbiome
L11079.1	SRR14369141	0.74	0.68	0.51	SAMN17899683	Weaning Piglet Gut Microbiome
L11079.1	SRR14369142	0.74	0.68	0.51	SAMN17899682	Weaning Piglet Gut Microbiome
L11079.1	SRR14369143	0.74	0.68	0.51	SAMN17899681	Weaning Piglet Gut Microbiome
L11079.1	SRR14369160	0.74	0.68	0.51	SAMN17899666	Weaning Piglet Gut Microbiome
L11079.1	SRR14369161	0.74	0.68	0.51	SAMN17899665	Weaning Piglet Gut Microbiome
L11079.1	SRR14369165	0.74	0.68	0.51	SAMN17899661	Weaning Piglet Gut Microbiome
L11079.1	SRR14369170	0.74	0.68	0.51	SAMN17899657	Weaning Piglet Gut Microbiome
L11079.1	SRR14369171	0.74	0.68	0.51	SAMN17899656	Weaning Piglet Gut Microbiome
L11079.1	SRR14369176	0.74	0.68	0.51	SAMN17899651	Weaning Piglet Gut Microbiome
L11079.1	SRR14369181	0.74	0.68	0.51	SAMN17899647	Weaning Piglet Gut Microbiome
L11079.1	SRR14369187	0.74	0.68	0.51	SAMN17899641	Weaning Piglet Gut Microbiome
L11079.1	SRR14369197	0.74	0.68	0.51	SAMN17899632	Weaning Piglet Gut Microbiome
L11079.1	SRR14369216	0.74	0.68	0.51	SAMN17899776	Weaning Piglet Gut Microbiome
L11079.1	SRR14369217	0.74	0.68	0.51	SAMN17899775	Weaning Piglet Gut Microbiome
L11079.1	SRR14369223	0.74	0.68	0.51	SAMN17899770	Weaning Piglet Gut Microbiome
L11079.1	SRR14369237	0.74	0.68	0.51	SAMN17899757	Weaning Piglet Gut Microbiome
L11079.1	SRR14369243	0.74	0.68	0.51	SAMN17899751	Weaning Piglet Gut Microbiome
L11079.1	SRR14369247	0.74	0.68	0.51	SAMN17899748	Weaning Piglet Gut Microbiome
L11079.1	SRR14369261	0.74	0.68	0.51	SAMN17899735	Weaning Piglet Gut Microbiome
L11079.1	SRR14369265	0.74	0.68	0.51	SAMN17899731	Weaning Piglet Gut Microbiome
L11079.1	SRR14369274	0.74	0.68	0.51	SAMN17899723	Weaning Piglet Gut Microbiome
L11079.1	SRR14369275	0.74	0.68	0.51	SAMN17899722	Weaning Piglet Gut Microbiome
L11079.1	SRR14369298	0.74	0.68	0.51	SAMN17899701	Weaning Piglet Gut Microbiome
L11079.1	SRR14374022	0.74	0.68	0.51	SAMN18736327	METAGENOMIC ANALYSIS OF MEXICAN CHILDHOOD GUT MICROBIOTA
L11079.1	SRR14374031	0.74	0.68	0.51	SAMN18736319	METAGENOMIC ANALYSIS OF MEXICAN CHILDHOOD GUT MICROBIOTA
L11079.1	SRR14374034	0.74	0.68	0.51	SAMN18736316	METAGENOMIC ANALYSIS OF MEXICAN CHILDHOOD GUT MICROBIOTA
L11079.1	SRR14374039	0.74	0.68	0.51	SAMN18736312	METAGENOMIC ANALYSIS OF MEXICAN CHILDHOOD GUT MICROBIOTA
L11079.1	SRR14374040	0.74	0.68	0.51	SAMN18736311	METAGENOMIC ANALYSIS OF MEXICAN CHILDHOOD GUT MICROBIOTA
L11079.1	SRR14374048	0.74	0.68	0.51	SAMN18736303	METAGENOMIC ANALYSIS OF MEXICAN CHILDHOOD GUT MICROBIOTA
L11079.1	SRR14374056	0.74	0.68	0.51	SAMN18736296	METAGENOMIC ANALYSIS OF MEXICAN CHILDHOOD GUT MICROBIOTA
L11079.1	SRR14460534	0.74	0.68	0.51	SAMN18895712	colorectal gut microbiota
L11079.1	SRR14493443	0.74	0.68	0.51	SAMN18868357	16s vs shallowshotgun
L11079.1	SRR14493563	0.74	0.68	0.51	SAMN18868446	16s vs shallowshotgun
L11079.1	SRR14560472	0.74	0.68	0.51	SAMN19228624	Estuarine ecology
L11079.1	SRR14573975	0.74	0.68	0.51	SAMN19237352	The composition of gut microbiota in biliary atresia
L11079.1	SRR14573985	0.74	0.68	0.51	SAMN19237343	The composition of gut microbiota in biliary atresia
L11079.1	SRR14626409	0.74	0.68	0.51	SAMN19312598	The composition of gut microbiota in biliary atresia
L11079.1	SRR14654441	0.74	0.68	0.51	SAMN19315518	Human gut metagenome in male healthy controls and patients with calcium oxalate stone
L11079.1	SRR14654443	0.74	0.68	0.51	SAMN19315518	Human gut metagenome in male healthy controls and patients with calcium oxalate stone
L11079.1	SRR14654448	0.74	0.68	0.51	SAMN19315518	Human gut metagenome in male healthy controls and patients with calcium oxalate stone
L11079.1	SRR14654480	0.74	0.68	0.51	SAMN19340375	Alteration of the Gut Microbiota in Rhesus Monkey with Spontaneous Osteoarthritis
L11079.1	SRR14710633	0.74	0.68	0.51	SAMN19491354	Human gut metagenome in female healthy controls and patients with calcium oxalate stone
L11079.1	SRR14710641	0.74	0.68	0.51	SAMN19491354	Human gut metagenome in female healthy controls and patients with calcium oxalate stone
L11079.1	SRR14710649	0.74	0.68	0.51	SAMN19491354	Human gut metagenome in female healthy controls and patients with calcium oxalate stone
L11079.1	SRR14763288	0.74	0.68	0.51	SAMN17977832	Longitudinal linked read sequencing reveals ecological and evolutionary responses of a human gut microbiome during antibiotic treatment
L11079.1	SRR14774583	0.74	0.68	0.51	SAMN19612850	Shotgun metagenomic sequencing data of gut microbiome in Duroc pigs
L11079.1	SRR14774584	0.74	0.68	0.51	SAMN19612849	Shotgun metagenomic sequencing data of gut microbiome in Duroc pigs
L11079.1	SRR14774588	0.74	0.68	0.51	SAMN19612810	Shotgun metagenomic sequencing data of gut microbiome in Duroc pigs
L11079.1	SRR14774598	0.74	0.68	0.51	SAMN19612836	Shotgun metagenomic sequencing data of gut microbiome in Duroc pigs
L11079.1	SRR14774618	0.74	0.68	0.51	SAMN19612815	Shotgun metagenomic sequencing data of gut microbiome in Duroc pigs
L11079.1	SRR14774621	0.74	0.68	0.51	SAMN19612813	Shotgun metagenomic sequencing data of gut microbiome in Duroc pigs
L11079.1	SRR14812340	0.74	0.68	0.51	SAMN19686884	Piglet gut and in-barn manure from farms on Raised Without Antibiotics program display a reduced antimicrobial resistance but an increased prevalence of pathogens
L11079.1	SRR14812378	0.74	0.68	0.51	SAMN19686876	Piglet gut and in-barn manure from farms on Raised Without Antibiotics program display a reduced antimicrobial resistance but an increased prevalence of pathogens
L11079.1	SRR14842338	0.74	0.68	0.51	SAMN19735743	Global Canine Shotgun Microbiomes
L11079.1	SRR14842341	0.74	0.68	0.51	SAMN19735669	Global Canine Shotgun Microbiomes
L11079.1	SRR14842365	0.74	0.68	0.51	SAMN19735719	Global Canine Shotgun Microbiomes
L11079.1	SRR14842366	0.74	0.68	0.51	SAMN19735718	Global Canine Shotgun Microbiomes
L11079.1	SRR14842369	0.74	0.68	0.51	SAMN19735715	Global Canine Shotgun Microbiomes
L11079.1	SRR14842370	0.74	0.68	0.51	SAMN19735714	Global Canine Shotgun Microbiomes
L11079.1	SRR14842371	0.74	0.68	0.51	SAMN19735713	Global Canine Shotgun Microbiomes
L11079.1	SRR14842384	0.74	0.68	0.51	SAMN19735701	Global Canine Shotgun Microbiomes
L11079.1	SRR14842385	0.74	0.68	0.51	SAMN19735665	Global Canine Shotgun Microbiomes
L11079.1	SRR14842393	0.74	0.68	0.51	SAMN19735693	Global Canine Shotgun Microbiomes
L11079.1	SRR14842395	0.74	0.68	0.51	SAMN19735691	Global Canine Shotgun Microbiomes
L11079.1	SRR14842397	0.74	0.68	0.51	SAMN19735690	Global Canine Shotgun Microbiomes
L11079.1	SRR14842399	0.74	0.68	0.51	SAMN19735688	Global Canine Shotgun Microbiomes
L11079.1	SRR14874088	0.74	0.68	0.51	SAMN19798980	Chesapeake Bay metagenome Raw sequence reads
L11079.1	SRR14874089	0.74	0.68	0.51	SAMN19798979	Chesapeake Bay metagenome Raw sequence reads
L11079.1	SRR14882037	0.74	0.68	0.51	SAMN19697387	Escherichia coli Genome sequencing and assembly
L11079.1	SRR14883805	0.74	0.68	0.51	SAMN19819736	Gut microbiota alternation uhttps://submit.ncbi.nlm.nih.gov/subs/sra/SUB9882549/bp_info#helper_relevance-project_titlender SARS-CoV-2 Infection
L11079.1	SRR14883810	0.74	0.68	0.51	SAMN19819732	Gut microbiota alternation uhttps://submit.ncbi.nlm.nih.gov/subs/sra/SUB9882549/bp_info#helper_relevance-project_titlender SARS-CoV-2 Infection
L11079.1	SRR14918164	0.74	0.68	0.51	SAMN18867778	Fecal Metagenomes
L11079.1	SRR15032209	0.74	0.68	0.51	SAMN20031534	High fermented food, high fiber diet effect on human microbiome and immune system
L11079.1	SRR15032231	0.74	0.68	0.51	SAMN20031288	High fermented food, high fiber diet effect on human microbiome and immune system
L11079.1	SRR15032232	0.74	0.68	0.51	SAMN20031278	High fermented food, high fiber diet effect on human microbiome and immune system
L11079.1	SRR15057927	0.74	0.68	0.51	SAMN20056612	Comparison of viromes and microbiomes of 14 pig fecal samples
L11079.1	SRR15051371	0.74	0.68	0.51	SAMN20081916	Identification of unique bile acid metabolizing bacteria from the microbiome of centenarians
L11079.1	SRR15051377	0.74	0.68	0.51	SAMN20081615	Identification of unique bile acid metabolizing bacteria from the microbiome of centenarians
L11079.1	SRR15123488	0.74	0.68	0.51	SAMN15803979	Precise quantification and tracking of gut bacterial strains following fecal transplantation demonstrates long-term stable engraftment and predicts outcome
L11079.1	SRR15123489	0.74	0.68	0.51	SAMN15803978	Precise quantification and tracking of gut bacterial strains following fecal transplantation demonstrates long-term stable engraftment and predicts outcome
L11079.1	SRR15095407	0.74	0.68	0.51	SAMN20163383	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15095408	0.74	0.68	0.51	SAMN20163382	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15095449	0.74	0.68	0.51	SAMN20163340	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15095450	0.74	0.68	0.51	SAMN20163339	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15095451	0.74	0.68	0.51	SAMN20163338	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15095484	0.74	0.68	0.51	SAMN20163302	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15095485	0.74	0.68	0.51	SAMN20163301	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15095805	0.74	0.68	0.51	SAMN20163446	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15095807	0.74	0.68	0.51	SAMN20163445	Fecal and colon mucosa sequencing of tubular adenoma, serrated, and polyp-free individuals
L11079.1	SRR15186960	0.74	0.68	0.51	SAMN19188303	High prevalence of co-infecting enteropathogens in alleged rotavirus vaccine breakthrough cases
L11079.1	SRR15186961	0.74	0.68	0.51	SAMN19188303	High prevalence of co-infecting enteropathogens in alleged rotavirus vaccine breakthrough cases
L11079.1	SRR15187015	0.74	0.68	0.51	SAMN19188303	High prevalence of co-infecting enteropathogens in alleged rotavirus vaccine breakthrough cases
L11079.1	SRR15187023	0.74	0.68	0.51	SAMN19188303	High prevalence of co-infecting enteropathogens in alleged rotavirus vaccine breakthrough cases
L11079.1	SRR15197207	0.74	0.68	0.51	SAMN20325614	Fecal metagenomes of C. difficile colonized patients
L11079.1	SRR15214366	0.74	0.68	0.51	SAMN20322013	Metagenomics analysis of cultured mucosal bacteria from colorectal cancer and adjacent normal mucosal tissues
L11079.1	SRR15214387	0.74	0.68	0.51	SAMN20321994	Metagenomics analysis of cultured mucosal bacteria from colorectal cancer and adjacent normal mucosal tissues
L11079.1	SRR15221270	0.74	0.68	0.51	SAMN19735968	study the efficiency of preservation
L11079.1	SRR15237458	0.74	0.68	0.51	SAMN20350358	Metagenomics analysis of the CSOs samples
L11079.1	SRR15258675	0.74	0.68	0.51	SAMN20428374	Gut microbiome changes associated with epithelial barrier damage and systemic inflammation during antiretroviral ther-apy of chronic SIV infection
L11079.1	SRR15343405	0.74	0.68	0.51	SAMN20566113	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343408	0.74	0.68	0.51	SAMN20566128	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343431	0.74	0.68	0.51	SAMN20566269	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343445	0.74	0.68	0.51	SAMN20566256	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343463	0.74	0.68	0.51	SAMN20566240	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343465	0.74	0.68	0.51	SAMN20566238	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343470	0.74	0.68	0.51	SAMN20566117	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343487	0.74	0.68	0.51	SAMN20566218	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343495	0.74	0.68	0.51	SAMN20566211	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343503	0.74	0.68	0.51	SAMN20566114	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343506	0.74	0.68	0.51	SAMN20566189	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343530	0.74	0.68	0.51	SAMN20566168	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343550	0.74	0.68	0.51	SAMN20566149	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343552	0.74	0.68	0.51	SAMN20566147	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15343554	0.74	0.68	0.51	SAMN20566105	Shotgun Metagenomic Sequencing to Examine the Gut Microbiome in Konzo
L11079.1	SRR15372915	0.74	0.68	0.51	SAMN20549061	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15373071	0.74	0.68	0.51	SAMN20549224	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15373118	0.74	0.68	0.51	SAMN20549182	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15373158	0.74	0.68	0.51	SAMN20549146	Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in  advanced non-small cell lung cancer patients
L11079.1	SRR15417045	0.74	0.68	0.51	SAMN20711164	Phase I dose-escalation trial of a fructo-oligosaccharide (FOS) prebiotic in hematopoietic stem cell transplantation recipients
L11079.1	SRR15511255	0.74	0.68	0.51	SAMN20837595	Differential effects of western and mediterranean-type diets on gut microbiota: a metagenomics and metabolomics approach
L11079.1	SRR15511256	0.74	0.68	0.51	SAMN20837594	Differential effects of western and mediterranean-type diets on gut microbiota: a metagenomics and metabolomics approach
L11079.1	SRR15595244	0.74	0.68	0.51	SAMN20959300	Metagenomic Microbiota in Celiac Disease
L11079.1	SRR15595267	0.74	0.68	0.51	SAMN20959311	Metagenomic Microbiota in Celiac Disease
L11079.1	SRR15595295	0.74	0.68	0.51	SAMN20959286	Metagenomic Microbiota in Celiac Disease
L11079.1	SRR15595301	0.74	0.68	0.51	SAMN20959304	Metagenomic Microbiota in Celiac Disease
L11079.1	SRR15647901	0.74	0.68	0.51	SAMN21015670	A discovery cohort of 49 normal controls and 48 advanced adenoma patients, and a training cohort of 50 normal controls, 46 advanced adenoma patients and 30 colorectal cancer patients
L11079.1	SRR15647924	0.74	0.68	0.51	SAMN21015649	A discovery cohort of 49 normal controls and 48 advanced adenoma patients, and a training cohort of 50 normal controls, 46 advanced adenoma patients and 30 colorectal cancer patients
L11079.1	SRR15674232	0.74	0.68	0.51	SAMN21154971	A discovery cohort of 49 normal controls and 48 advanced adenoma patients, and a training cohort of 50 normal controls, 46 advanced adenoma patients and 30 colorectal cancer patients
L11079.1	SRR15679825	0.74	0.68	0.51	SAMN21019467	Clinical and genetic correlates of the gut  microbiome and relation to cardiometabolic risk
L11079.1	SRR15686329	0.74	0.68	0.51	SAMN21160211	Metagenomics - Survival E. coli in beach sand
L11079.1	SRR15793034	0.74	0.68	0.51	SAMN21349009	CCFA virome
L11079.1	SRR15851689	0.74	0.68	0.51	SAMN21380775	Distinct metagenomic signatures in the SARS-COV-2 infection
L11079.1	SRR16124180	0.74	0.68	0.51	SAMN21877131	Dysbiosis of human gut microbiome in young-onset colorectal cancer
L11079.1	SRR16124222	0.74	0.68	0.51	SAMN21877048	Dysbiosis of human gut microbiome in young-onset colorectal cancer
L11079.1	SRR16124282	0.74	0.68	0.51	SAMN21877218	Dysbiosis of human gut microbiome in young-onset colorectal cancer
L11079.1	SRR16124331	0.74	0.68	0.51	SAMN21877173	Dysbiosis of human gut microbiome in young-onset colorectal cancer
L11079.1	SRR16124351	0.74	0.68	0.51	SAMN21877155	Dysbiosis of human gut microbiome in young-onset colorectal cancer
L11079.1	SRR16124357	0.74	0.68	0.51	SAMN21877150	Dysbiosis of human gut microbiome in young-onset colorectal cancer
L11079.1	SRR15926040	0.74	0.68	0.51	SAMN21462330	Intestinal flora sequencing of Chinese infants
L11079.1	SRR15926050	0.74	0.68	0.51	SAMN21462321	Intestinal flora sequencing of Chinese infants
L11079.1	SRR15926063	0.74	0.68	0.51	SAMN21462309	Intestinal flora sequencing of Chinese infants
L11079.1	SRR15926098	0.74	0.68	0.51	SAMN21462269	Intestinal flora sequencing of Chinese infants
L11079.1	SRR15966657	0.74	0.68	0.51	SAMN21380292	Metagenomic analysis of gut microbiota of people with depression disorders for determination of the composition of the marker genes.
L11079.1	SRR16681822	0.74	0.68	0.51	SAMN22567050	Metagenomic analysis of gut microbiota of people with depression disorders for determination of the composition of the marker genes.
L11079.1	SRR15973870	0.74	0.68	0.51	SAMN21507543	Bloodstream infections' origins following fecal microbiota transplantation: a strain-level analysis
L11079.1	SRR15973876	0.74	0.68	0.51	SAMN21507534	Bloodstream infections' origins following fecal microbiota transplantation: a strain-level analysis
L11079.1	SRR15973877	0.74	0.68	0.51	SAMN21507533	Bloodstream infections' origins following fecal microbiota transplantation: a strain-level analysis
L11079.1	SRR15973879	0.74	0.68	0.51	SAMN21507532	Bloodstream infections' origins following fecal microbiota transplantation: a strain-level analysis
L11079.1	SRR1612375	0.74	0.68	0.51	SAMN03068495	Wake Forest Vervet Microbiome Project
L11079.1	SRR1612377	0.74	0.68	0.51	SAMN03068495	Wake Forest Vervet Microbiome Project
L11079.1	SRR16054173	0.74	0.68	0.51	SAMN21614207	The Mucosally-Adherent Rectal Microbiota Contains Features Unique  to Alcohol-Related Cirrhosis
L11079.1	SRR16178771	0.74	0.68	0.51	SAMN22026007	Metagenomic analysis towards biomarkers and prediction models between intestinal polyp patients and colorectal cancer patients
L11079.1	SRR16178810	0.74	0.68	0.51	SAMN22025972	Metagenomic analysis towards biomarkers and prediction models between intestinal polyp patients and colorectal cancer patients
L11079.1	SRR16178816	0.74	0.68	0.51	SAMN22025966	Metagenomic analysis towards biomarkers and prediction models between intestinal polyp patients and colorectal cancer patients
L11079.1	SRR16297689	0.74	0.68	0.51	SAMN22107685	PCaF Raw sequence reads
L11079.1	SRR16554704	0.74	0.68	0.51	SAMN22443448	Dietary fiber and probiotics impact the gut microbiome and melanoma immunotherapy response
L11079.1	SRR16554739	0.74	0.68	0.51	SAMN22443384	Dietary fiber and probiotics impact the gut microbiome and melanoma immunotherapy response
L11079.1	SRR16646014	0.74	0.68	0.51	SAMN22565331	Gut microbiome sequencing
L11079.1	SRR16646041	0.74	0.68	0.51	SAMN22565452	Gut microbiome sequencing
L11079.1	SRR16646057	0.74	0.68	0.51	SAMN22565327	Gut microbiome sequencing
L11079.1	SRR16646107	0.74	0.68	0.51	SAMN22565389	Gut microbiome sequencing
L11079.1	SRR16646147	0.74	0.68	0.51	SAMN22565353	Gut microbiome sequencing
L11079.1	SRR16646151	0.74	0.68	0.51	SAMN22565350	Gut microbiome sequencing
L11079.1	SRR16646167	0.74	0.68	0.51	SAMN22565334	Gut microbiome sequencing
L11079.1	SRR16646172	0.74	0.68	0.51	SAMN22565354	Gut microbiome sequencing
L11079.1	SRR16646181	0.74	0.68	0.51	SAMN22565512	Gut microbiome sequencing
L11079.1	SRR16646191	0.74	0.68	0.51	SAMN22565504	Gut microbiome sequencing
L11079.1	SRR16646199	0.74	0.68	0.51	SAMN22565496	Gut microbiome sequencing
L11079.1	SRR16646212	0.74	0.68	0.51	SAMN22565482	Gut microbiome sequencing
L11079.1	SRR16961780	0.74	0.68	0.51	SAMN23227507	Gut metagenomics in slow transit constipation
L11079.1	SRR16961789	0.74	0.68	0.51	SAMN23227499	Gut metagenomics in slow transit constipation
L11079.1	SRR16961795	0.74	0.68	0.51	SAMN23227494	Gut metagenomics in slow transit constipation
L11079.1	SRR16961799	0.74	0.68	0.51	SAMN23227490	Gut metagenomics in slow transit constipation
L11079.1	SRR16961800	0.74	0.68	0.51	SAMN23227489	Gut metagenomics in slow transit constipation
L11079.1	SRR16961803	0.74	0.68	0.51	SAMN23227486	Gut metagenomics in slow transit constipation
L11079.1	SRR16961857	0.74	0.68	0.51	SAMN23227437	Gut metagenomics in slow transit constipation
L11079.1	SRR16961872	0.74	0.68	0.51	SAMN23227529	Gut metagenomics in slow transit constipation
L11079.1	SRR16961880	0.74	0.68	0.51	SAMN23227522	Gut metagenomics in slow transit constipation
L11079.1	SRR16961881	0.74	0.68	0.51	SAMN23227521	Gut metagenomics in slow transit constipation
L11079.1	SRR16961886	0.74	0.68	0.51	SAMN23227516	Gut metagenomics in slow transit constipation
L11079.1	SRR16961890	0.74	0.68	0.51	SAMN23227415	Gut metagenomics in slow transit constipation
L11079.1	SRR17048880	0.74	0.68	0.51	SAMN16797063	Shotgun metagenomic sequencing of stool samples from two South African cohorts
L11079.1	SRR17048882	0.74	0.68	0.51	SAMN16797061	Shotgun metagenomic sequencing of stool samples from two South African cohorts
L11079.1	SRR17048930	0.74	0.68	0.51	SAMN16796973	Shotgun metagenomic sequencing of stool samples from two South African cohorts
L11079.1	SRR17048953	0.74	0.68	0.51	SAMN16796997	Shotgun metagenomic sequencing of stool samples from two South African cohorts
L11079.1	SRR17048960	0.74	0.68	0.51	SAMN16796990	Shotgun metagenomic sequencing of stool samples from two South African cohorts
L11079.1	SRR17048968	0.74	0.68	0.51	SAMN16797135	Shotgun metagenomic sequencing of stool samples from two South African cohorts
L11079.1	SRR17237847	0.74	0.68	0.51	SAMN24043456	IBS Metagenome
L11079.1	SRR17241841	0.74	0.68	0.51	SAMN23969032	Gut microbiome in obese children treated with butyrate
L11079.1	SRR17243680	0.74	0.68	0.51	SAMN24044232	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243682	0.74	0.68	0.51	SAMN24044232	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243687	0.74	0.68	0.51	SAMN24044232	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243688	0.74	0.68	0.51	SAMN24044232	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243709	0.74	0.68	0.51	SAMN24044232	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243727	0.74	0.68	0.51	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243728	0.74	0.68	0.51	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243729	0.74	0.68	0.51	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243749	0.74	0.68	0.51	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17243753	0.74	0.68	0.51	SAMN24044233	Interactions between human gut microbiome dynamics and sub-optimal health symptoms during seafaring expeditions
L11079.1	SRR17317423	0.74	0.68	0.51	SAMN24337950	The difference between diarrhea piglets and normal piglets
L11079.1	SRR1747018	0.74	0.68	0.51	SAMN03275571	Baboon feces Metagenome
L11079.1	SRR1761720	0.74	0.68	0.51	SAMN03283293	Human Gut Microbiome Metagenome
L11079.1	SRR2912786	0.74	0.68	0.51	SAMN04209237	Human Gut Microbiome Metagenome
L11079.1	SRR1766383	0.74	0.68	0.51	SAMN03281010	Infant fecal microbiome related to eczema
L11079.1	SRR1818227	0.74	0.68	0.51	SAMN03281006	Infant fecal microbiome related to eczema
L11079.1	SRR1778455	0.74	0.68	0.51	SAMN00993244	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR341587	0.74	0.68	0.51	SAMN00715137	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR341628	0.74	0.68	0.51	SAMN00715178	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR341644	0.74	0.68	0.51	SAMN00715194	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR341655	0.74	0.68	0.51	SAMN00715205	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR341660	0.74	0.68	0.51	SAMN00715210	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR341725	0.74	0.68	0.51	SAMN00715275	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413573	0.74	0.68	0.51	SAMN00791918	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413608	0.74	0.68	0.51	SAMN00791953	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413631	0.74	0.68	0.51	SAMN00791976	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413639	0.74	0.68	0.51	SAMN00791984	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413700	0.74	0.68	0.51	SAMN00792045	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413705	0.74	0.68	0.51	SAMN00792050	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413713	0.74	0.68	0.51	SAMN00792058	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413736	0.74	0.68	0.51	SAMN00792081	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413753	0.74	0.68	0.51	SAMN00792098	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413754	0.74	0.68	0.51	SAMN00792099	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR413768	0.74	0.68	0.51	SAMN00792113	A metagenome-wide association study of gut microbiota in type 2 diabetes.
L11079.1	SRR1910595	0.74	0.68	0.51	SAMN03401203	A prospective, longitudinal analysis of the developing gut microbiome in infants en route to type 1 diabetes
L11079.1	SRR1910618	0.74	0.68	0.51	SAMN03398705	A prospective, longitudinal analysis of the developing gut microbiome in infants en route to type 1 diabetes
L11079.1	SRR1910678	0.74	0.68	0.51	SAMN03401203	A prospective, longitudinal analysis of the developing gut microbiome in infants en route to type 1 diabetes
L11079.1	SRR1915879	0.74	0.68	0.51	SAMN03398705	A prospective, longitudinal analysis of the developing gut microbiome in infants en route to type 1 diabetes
L11079.1	SRR1916056	0.74	0.68	0.51	SAMN03401203	A prospective, longitudinal analysis of the developing gut microbiome in infants en route to type 1 diabetes
L11079.1	SRR2187356	0.74	0.68	0.51	SAMN02334182	Fiji COMP
L11079.1	SRR2187396	0.74	0.68	0.51	SAMN02334051	Fiji COMP
L11079.1	SRR2187638	0.74	0.68	0.51	SAMN02334051	Fiji COMP
L11079.1	SRR2187959	0.74	0.68	0.51	SAMN02334051	Fiji COMP
L11079.1	SRR2187969	0.74	0.68	0.51	SAMN02334051	Fiji COMP
L11079.1	SRR2188471	0.74	0.68	0.51	SAMN02334040	Fiji COMP
L11079.1	SRR2188775	0.74	0.68	0.51	SAMN02334000	Fiji COMP
L11079.1	SRR2192828	0.74	0.68	0.51	SAMN02334037	Fiji COMP
L11079.1	SRR2193460	0.74	0.68	0.51	SAMN02334058	Fiji COMP
L11079.1	SRR2193666	0.74	0.68	0.51	SAMN02334003	Fiji COMP
L11079.1	SRR2221429	0.74	0.68	0.51	SAMN02334110	Fiji COMP
L11079.1	SRR2221432	0.74	0.68	0.51	SAMN02334110	Fiji COMP
L11079.1	SRR2222387	0.74	0.68	0.51	SAMN02334093	Fiji COMP
L11079.1	SRR2225881	0.74	0.68	0.51	SAMN02334148	Fiji COMP
L11079.1	SRR2227978	0.74	0.68	0.51	SAMN02334223	Fiji COMP
L11079.1	SRR2228047	0.74	0.68	0.51	SAMN02334096	Fiji COMP
L11079.1	SRR2228219	0.74	0.68	0.51	SAMN02334096	Fiji COMP
L11079.1	SRR2228422	0.74	0.68	0.51	SAMN02334096	Fiji COMP
L11079.1	SRR2231290	0.74	0.68	0.51	SAMN02334051	Fiji COMP
L11079.1	SRR2237807	0.74	0.68	0.51	SAMN02334224	Fiji COMP
L11079.1	SRR2243498	0.74	0.68	0.51	SAMN02334181	Fiji COMP
L11079.1	SRR2243831	0.74	0.68	0.51	SAMN02334181	Fiji COMP
L11079.1	SRR2245609	0.74	0.68	0.51	SAMN02334096	Fiji COMP
L11079.1	SRR2247287	0.74	0.68	0.51	SAMN02334181	Fiji COMP
L11079.1	SRR2249215	0.74	0.68	0.51	SAMN02334148	Fiji COMP
L11079.1	SRR2250275	0.74	0.68	0.51	SAMN02334096	Fiji COMP
L11079.1	SRR2250530	0.74	0.68	0.51	SAMN02334096	Fiji COMP
L11079.1	SRR2250547	0.74	0.68	0.51	SAMN02334038	Fiji COMP
L11079.1	SRR2250627	0.74	0.68	0.51	SAMN02334115	Fiji COMP
L11079.1	SRR2545383	0.74	0.68	0.51	SAMN04113045	Gut microbiota from patients with Crohn''s disease
L11079.1	SRR2565933	0.74	0.68	0.51	SAMN04126277	Intestinal microbiota dynamics in hospitalized patients
L11079.1	SRR2565977	0.74	0.68	0.51	SAMN04126314	Intestinal microbiota dynamics in hospitalized patients
L11079.1	SRR2566011	0.74	0.68	0.51	SAMN04126139	Intestinal microbiota dynamics in hospitalized patients
L11079.1	SRR2566012	0.74	0.68	0.51	SAMN04126140	Intestinal microbiota dynamics in hospitalized patients
L11079.1	SRR2568191	0.74	0.68	0.51	SAMN04115964	Fecal microbiota of hospitalised Elderlies with and without Peptoclostridium difficile infection targeted loci
L11079.1	SRR2582241	0.74	0.68	0.51	SAMN04121060	Fecal microbiota of hospitalised Elderlies with and without Peptoclostridium difficile infection metagenome
L11079.1	SRR2937619	0.74	0.68	0.51	SAMN04261270	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2937620	0.74	0.68	0.51	SAMN04261272	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2938122	0.74	0.68	0.51	SAMN04261381	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2938149	0.74	0.68	0.51	SAMN04261163	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2938156	0.74	0.68	0.51	SAMN04261175	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2938171	0.74	0.68	0.51	SAMN04261216	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2938185	0.74	0.68	0.51	SAMN04261239	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2938203	0.74	0.68	0.51	SAMN04261287	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2938248	0.74	0.68	0.51	SAMN04261346	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2938249	0.74	0.68	0.51	SAMN04261347	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2938415	0.74	0.68	0.51	SAMN04261148	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2938463	0.74	0.68	0.51	SAMN04261239	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2938489	0.74	0.68	0.51	SAMN04261288	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2938528	0.74	0.68	0.51	SAMN04261323	Antibiotic resistance exchange between microbiota in resource-poor settings in Latin America
L11079.1	SRR2992956	0.74	0.68	0.51	SAMN04329836	Athlete Microbiome Project (AMP)
L11079.1	SRR4893033	0.74	0.68	0.51	SAMN05969506	iHMP ibdmdb
L11079.1	SRR4893071	0.74	0.68	0.51	SAMN05969332	iHMP ibdmdb
L11079.1	SRR4893072	0.74	0.68	0.51	SAMN05969352	iHMP ibdmdb
L11079.1	SRR4893102	0.74	0.68	0.51	SAMN05969335	iHMP ibdmdb
L11079.1	SRR3053167	0.74	0.68	0.51	SAMN04362331	Beef Production Metagenome Raw sequence reads
L11079.1	SRR6714167	0.74	0.68	0.51	SAMN04382255	Human feces metagenome 16s rDNA sequencing
L11079.1	SRR6714209	0.74	0.68	0.51	SAMN04382204	Human feces metagenome 16s rDNA sequencing
L11079.1	SRR3131758	0.74	0.68	0.51	SAMN04436643	Metagenomic sequencing of preterm infant gut microbiota raw sequence reads
L11079.1	SRR3147681	0.74	0.68	0.51	SAMN04197001	children intestinal bacteria about SFB metagenome
L11079.1	SRR3181113	0.74	0.68	0.51	SAMN04450445	Cattle feces Metagenome
L11079.1	SRR3181117	0.74	0.68	0.51	SAMN04450449	Cattle feces Metagenome
L11079.1	SRR3181128	0.74	0.68	0.51	SAMN04450460	Cattle feces Metagenome
L11079.1	SRR9897362	0.74	0.68	0.51	SAMN12478590	Gut microbiota Raw sequence reads
L11079.1	SRR9897393	0.74	0.68	0.51	SAMN12478600	Gut microbiota Raw sequence reads
L11079.1	SRR9897395	0.74	0.68	0.51	SAMN12478583	Gut microbiota Raw sequence reads
L11079.1	SRR9897403	0.74	0.68	0.51	SAMN12478578	Gut microbiota Raw sequence reads
L11079.1	SRR9897416	0.74	0.68	0.51	SAMN12478561	Gut microbiota Raw sequence reads
L11079.1	SRR3313052	0.74	0.68	0.51	SAMN04571709	Human Gut Microbiome in a Multiplex Family Study of Type 1 Diabetes Mellitus
L11079.1	SRR3501855	0.74	0.68	0.51	SAMN04957396	Integrative community analysis of tropical climate EBPR
L11079.1	SRR3501858	0.74	0.68	0.51	SAMN04957399	Integrative community analysis of tropical climate EBPR
L11079.1	SRR3501859	0.74	0.68	0.51	SAMN04957400	Integrative community analysis of tropical climate EBPR
L11079.1	SRR3582179	0.74	0.68	0.51	SAMN05065779	Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn''s disease
L11079.1	SRR3950469	0.74	0.68	0.51	SAMN05437199	Gut microbiome of TB patients
L11079.1	SRR3950478	0.74	0.68	0.51	SAMN05437207	Gut microbiome of TB patients
L11079.1	SRR3992957	0.74	0.68	0.51	SAMN05414901	Mongolian Metagenome
L11079.1	SRR3992958	0.74	0.68	0.51	SAMN05414991	Mongolian Metagenome
L11079.1	SRR3992964	0.74	0.68	0.51	SAMN05414997	Mongolian Metagenome
L11079.1	SRR3992987	0.74	0.68	0.51	SAMN05414920	Mongolian Metagenome
L11079.1	SRR3992993	0.74	0.68	0.51	SAMN05414925	Mongolian Metagenome
L11079.1	SRR3993045	0.74	0.68	0.51	SAMN05414972	Mongolian Metagenome
L11079.1	SRR4101304	0.74	0.68	0.51	SAMN05715933	food contamination metagenome Metagenome
L11079.1	SRR4101305	0.74	0.68	0.51	SAMN05715933	food contamination metagenome Metagenome
L11079.1	SRR4305074	0.74	0.68	0.51	SAMN05826623	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305179	0.74	0.68	0.51	SAMN05826717	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305180	0.74	0.68	0.51	SAMN05826718	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305255	0.74	0.68	0.51	SAMN05826489	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305269	0.74	0.68	0.51	SAMN05826797	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305327	0.74	0.68	0.51	SAMN05826849	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305341	0.74	0.68	0.51	SAMN05826862	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305387	0.74	0.68	0.51	SAMN05826902	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305407	0.74	0.68	0.51	SAMN05826920	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305420	0.74	0.68	0.51	SAMN05826932	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305433	0.74	0.68	0.51	SAMN05826944	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4305515	0.74	0.68	0.51	SAMN05826569	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408026	0.74	0.68	0.51	SAMN05827105	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408055	0.74	0.68	0.51	SAMN05827132	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408063	0.74	0.68	0.51	SAMN05827139	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408136	0.74	0.68	0.51	SAMN05827198	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408137	0.74	0.68	0.51	SAMN05827199	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408140	0.74	0.68	0.51	SAMN05827202	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408199	0.74	0.68	0.51	SAMN05827255	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408231	0.74	0.68	0.51	SAMN05827027	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408235	0.74	0.68	0.51	SAMN05827031	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4408279	0.74	0.68	0.51	SAMN05827071	A longitudinal analysis of the developing gut microbiome in infants from Finland, Estonia, and Russian Karelia
L11079.1	SRR4423024	0.74	0.68	0.51	SAMN05891553	Shotgun sequencing of the gut microbiome to look at vitamin K biosynthesis
L11079.1	SRR4435755	0.74	0.68	0.51	SAMN05545008	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4435784	0.74	0.68	0.51	SAMN05545011	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4444751	0.74	0.68	0.51	SAMN05545028	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4444762	0.74	0.68	0.51	SAMN05545019	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4444858	0.74	0.68	0.51	SAMN05545021	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4451596	0.74	0.68	0.51	SAMN05545034	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4451665	0.74	0.68	0.51	SAMN05545037	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783407	0.74	0.68	0.51	SAMN05545083	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783425	0.74	0.68	0.51	SAMN05545086	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783426	0.74	0.68	0.51	SAMN05545086	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783440	0.74	0.68	0.51	SAMN05545084	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783467	0.74	0.68	0.51	SAMN05545084	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783468	0.74	0.68	0.51	SAMN05545084	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783469	0.74	0.68	0.51	SAMN05545087	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783471	0.74	0.68	0.51	SAMN05545087	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783472	0.74	0.68	0.51	SAMN05545087	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783473	0.74	0.68	0.51	SAMN05545084	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783474	0.74	0.68	0.51	SAMN05545084	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783476	0.74	0.68	0.51	SAMN05545084	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783477	0.74	0.68	0.51	SAMN05545084	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783480	0.74	0.68	0.51	SAMN05545084	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783494	0.74	0.68	0.51	SAMN05545087	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783496	0.74	0.68	0.51	SAMN05545087	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783527	0.74	0.68	0.51	SAMN05545090	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783528	0.74	0.68	0.51	SAMN05545090	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783530	0.74	0.68	0.51	SAMN05545090	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783531	0.74	0.68	0.51	SAMN05545090	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783532	0.74	0.68	0.51	SAMN05545090	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783533	0.74	0.68	0.51	SAMN05545090	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783534	0.74	0.68	0.51	SAMN05545090	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783535	0.74	0.68	0.51	SAMN05545090	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783536	0.74	0.68	0.51	SAMN05545090	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783552	0.74	0.68	0.51	SAMN05545089	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783553	0.74	0.68	0.51	SAMN05545089	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783555	0.74	0.68	0.51	SAMN05545089	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783556	0.74	0.68	0.51	SAMN05545089	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783557	0.74	0.68	0.51	SAMN05545089	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783562	0.74	0.68	0.51	SAMN05545088	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783563	0.74	0.68	0.51	SAMN05545088	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783565	0.74	0.68	0.51	SAMN05545087	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783569	0.74	0.68	0.51	SAMN05545087	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783570	0.74	0.68	0.51	SAMN05545087	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783584	0.74	0.68	0.51	SAMN05545088	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783591	0.74	0.68	0.51	SAMN05545089	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783593	0.74	0.68	0.51	SAMN05545091	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783595	0.74	0.68	0.51	SAMN05545090	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783597	0.74	0.68	0.51	SAMN05545091	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783598	0.74	0.68	0.51	SAMN05545091	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783601	0.74	0.68	0.51	SAMN05545091	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783603	0.74	0.68	0.51	SAMN05545088	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783653	0.74	0.68	0.51	SAMN05545089	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783655	0.74	0.68	0.51	SAMN05545088	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783656	0.74	0.68	0.51	SAMN05545088	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783659	0.74	0.68	0.51	SAMN05545088	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783660	0.74	0.68	0.51	SAMN05545088	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783661	0.74	0.68	0.51	SAMN05545088	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783662	0.74	0.68	0.51	SAMN05545088	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4783664	0.74	0.68	0.51	SAMN05545087	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR5056921	0.74	0.68	0.51	SAMN05971489	Human gut microbiome with bacterial pathogen challenge
L11079.1	SRR4425681	0.74	0.68	0.51	SAMN05597073	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR4425682	0.74	0.68	0.51	SAMN05597072	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR4425699	0.74	0.68	0.51	SAMN05597121	Composite fecal samples and WWTP biosolids Raw sequence reads
L11079.1	SRR4454604	0.74	0.68	0.51	SAMN05946365	Urban vs. Rural China Microbiome
L11079.1	SRR5008234	0.74	0.68	0.51	SAMN06007669	Evaluation of porcine fecal microbiomes after exposure to ceftriaxone
L11079.1	SRR5008252	0.74	0.68	0.51	SAMN06007667	Evaluation of porcine fecal microbiomes after exposure to ceftriaxone
L11079.1	SRR5032286	0.74	0.68	0.51	SAMN06016350	Human gut microbiome in AS
L11079.1	SRR5032319	0.74	0.68	0.51	SAMN06016398	Human gut microbiome in AS
L11079.1	SRR5032356	0.74	0.68	0.51	SAMN06016417	Human gut microbiome in AS
L11079.1	SRR5091521	0.74	0.68	0.51	SAMN06112021	human gut metagenome in RA
L11079.1	SRR5091544	0.74	0.68	0.51	SAMN06112035	human gut metagenome in RA
L11079.1	SRR5091584	0.74	0.68	0.51	SAMN06112006	human gut metagenome in RA
L11079.1	SRR5091597	0.74	0.68	0.51	SAMN06112024	human gut metagenome in RA
L11079.1	SRR5127508	0.74	0.68	0.51	SAMN06110189	Gut microbial interactions with the inflammatory cytokine production capacity
L11079.1	SRR5127689	0.74	0.68	0.51	SAMN06110292	Gut microbial interactions with the inflammatory cytokine production capacity
L11079.1	SRR5155877	0.74	0.68	0.51	SAMN06164462	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR5156179	0.74	0.68	0.51	SAMN06164631	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR6028586	0.74	0.68	0.51	SAMN06164462	Human gut metagenome and metatranscriptome raw sequence reads.
L11079.1	SRR5190358	0.74	0.68	0.51	SAMN05720181	Eastern black-and-white colobus group fecal microbial communities from Wisconsin, USA - Cm1105 metagenome metagenome
L11079.1	SRR5216657	0.74	0.68	0.51	SAMN06265836	Saline lake microbial communities from Rauer Islands, Antarctica - Metagenome Torckler E11 #897 metagenome
L11079.1	SRR5240742	0.74	0.68	0.51	SAMN06315447	Metagenomic analysis of gut microbiota in sows and piglets
L11079.1	SRR5273944	0.74	0.68	0.51	SAMN06350170	Mother-infant microbiome vertical transmission
L11079.1	SRR5274051	0.74	0.68	0.51	SAMN06350063	Mother-infant microbiome vertical transmission
L11079.1	SRR5279218	0.74	0.68	0.51	SAMN06348199	human gut Metagenome
L11079.1	SRR5279222	0.74	0.68	0.51	SAMN06348195	human gut Metagenome
L11079.1	SRR5279282	0.74	0.68	0.51	SAMN06348135	human gut Metagenome
L11079.1	SRR6474279	0.74	0.68	0.51	SAMN08366175	human gut Metagenome
L11079.1	SRR6474280	0.74	0.68	0.51	SAMN08366178	human gut Metagenome
L11079.1	SRR5298224	0.74	0.68	0.51	SAMN06350425	Metagenome data from infant (PD and ProD) stools samples raw sequence reads
L11079.1	SRR5298225	0.74	0.68	0.51	SAMN06350423	Metagenome data from infant (PD and ProD) stools samples raw sequence reads
L11079.1	SRR5298226	0.74	0.68	0.51	SAMN06350418	Metagenome data from infant (PD and ProD) stools samples raw sequence reads
L11079.1	SRR5298229	0.74	0.68	0.51	SAMN06350412	Metagenome data from infant (PD and ProD) stools samples raw sequence reads
L11079.1	SRR5298235	0.74	0.68	0.51	SAMN06350399	Metagenome data from infant (PD and ProD) stools samples raw sequence reads
L11079.1	SRR5298240	0.74	0.68	0.51	SAMN06350389	Metagenome data from infant (PD and ProD) stools samples raw sequence reads
L11079.1	SRR5298249	0.74	0.68	0.51	SAMN06350321	Metagenome data from infant stools samples raw sequence reads
L11079.1	SRR5298250	0.74	0.68	0.51	SAMN06350315	Metagenome data from infant stools samples raw sequence reads
L11079.1	SRR5298252	0.74	0.68	0.51	SAMN06350303	Metagenome data from infant stools samples raw sequence reads
L11079.1	SRR7428400	0.74	0.68	0.51	SAMN09355625	Human Fecal Metagenome Metagenome
L11079.1	SRR7428423	0.74	0.68	0.51	SAMN09355582	Human Fecal Metagenome Metagenome
L11079.1	SRR5365395	0.74	0.68	0.51	SAMN06622628	Clinical Parameters and Gut Microbiome Changes Before and After Surgery in Thoracic Aortic Dissection in Patients with Gastrointestinal Complications
L11079.1	SRR5371429	0.74	0.68	0.51	SAMN06117830	bovine fecal metagenome raw sequence reads
L11079.1	SRR5371439	0.74	0.68	0.51	SAMN06117825	bovine fecal metagenome raw sequence reads
L11079.1	SRR5405622	0.74	0.68	0.51	SAMN06444698	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405623	0.74	0.68	0.51	SAMN06444697	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405626	0.74	0.68	0.51	SAMN06444694	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405645	0.74	0.68	0.51	SAMN06444675	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405651	0.74	0.68	0.51	SAMN06444669	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5405734	0.74	0.68	0.51	SAMN06444586	preterm infant gut metagenomes (S2_2013 and NIHY2_2012 cohorts)
L11079.1	SRR5519182	0.74	0.68	0.51	SAMN06885155	Mexican childhood obesity Raw sequence reads
L11079.1	SRR5535751	0.74	0.68	0.51	SAMN06899171	Microbial metagenome of urinary tract infection
L11079.1	SRR7716236	0.74	0.68	0.51	SAMN06909449	Colonization, succession and evolution of the earliest human gastrointestinal microbiome
L11079.1	SRR5813195	0.74	0.68	0.51	SAMN07336942	Colon cleanout human gut V4 16S survey & shotgun metagenomic sequencing
L11079.1	SRR5650080	0.74	0.68	0.51	SAMN07199853	Longitudinal Stool Study of patients with IBD and controls
L11079.1	SRR5675759	0.74	0.68	0.51	SAMN07209764	Amazon River Metagenomics
L11079.1	SRR5679042	0.74	0.68	0.51	SAMN06685522	Farm metagenomes conventional and organic
L11079.1	SRR5723849	0.74	0.68	0.51	SAMN07259907	human metagenome
L11079.1	SRR5829262	0.74	0.68	0.51	SAMN07326615	The Mid-term plasticity of the Chinese Gut Microbiota
L11079.1	SRR5829266	0.74	0.68	0.51	SAMN07326615	The Mid-term plasticity of the Chinese Gut Microbiota
L11079.1	SRR5829282	0.74	0.68	0.51	SAMN07326615	The Mid-term plasticity of the Chinese Gut Microbiota
L11079.1	SRR5829295	0.74	0.68	0.51	SAMN07326615	The Mid-term plasticity of the Chinese Gut Microbiota
L11079.1	SRR5829304	0.74	0.68	0.51	SAMN07326615	The Mid-term plasticity of the Chinese Gut Microbiota
L11079.1	SRR5829321	0.74	0.68	0.51	SAMN07326615	The Mid-term plasticity of the Chinese Gut Microbiota
L11079.1	SRR5818481	0.74	0.68	0.51	SAMN07285610	next generation sequencing of feces in HIV-1 patients Raw sequence reads
L11079.1	SRR5818531	0.74	0.68	0.51	SAMN07285620	next generation sequencing of feces in HIV-1 patients Raw sequence reads
L11079.1	SRR5818537	0.74	0.68	0.51	SAMN07285644	next generation sequencing of feces in HIV-1 patients Raw sequence reads
L11079.1	SRR5831590	0.74	0.68	0.51	SAMN07357521	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831591	0.74	0.68	0.51	SAMN07357522	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831593	0.74	0.68	0.51	SAMN07357516	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831596	0.74	0.68	0.51	SAMN07357519	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831598	0.74	0.68	0.51	SAMN07357517	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831599	0.74	0.68	0.51	SAMN07357518	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831600	0.74	0.68	0.51	SAMN07357526	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831601	0.74	0.68	0.51	SAMN07357525	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831603	0.74	0.68	0.51	SAMN07357523	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831606	0.74	0.68	0.51	SAMN07357527	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831607	0.74	0.68	0.51	SAMN07357511	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR5831614	0.74	0.68	0.51	SAMN07357510	Confirmation of Shigella detection in culture negative PCR positive diarrheal cases using a metagenomic approach
L11079.1	SRR585700	0.74	0.68	0.51	SAMN01760908	Symptomatic atherosclerosis gut metagenome
L11079.1	SRR5866314	0.74	0.68	0.51	SAMN07414234	Whole-Grain rich diet cross-over study
L11079.1	SRR5866344	0.74	0.68	0.51	SAMN07414306	Whole-Grain rich diet cross-over study
L11079.1	SRR5866598	0.74	0.68	0.51	SAMN07414399	Whole-Grain rich diet cross-over study
L11079.1	SRR5898921	0.74	0.68	0.51	SAMN07448981	Indian Human Gut Microbiome
L11079.1	SRR5898929	0.74	0.68	0.51	SAMN07449029	Indian Human Gut Microbiome
L11079.1	SRR5898945	0.74	0.68	0.51	SAMN07449031	Indian Human Gut Microbiome
L11079.1	SRR5898954	0.74	0.68	0.51	SAMN07449071	Indian Human Gut Microbiome
L11079.1	SRR5898975	0.74	0.68	0.51	SAMN07449004	Indian Human Gut Microbiome
L11079.1	SRR5903322	0.74	0.68	0.51	SAMN07452495	Gut metagenomes of patients with colorectal cancer
L11079.1	SRR5903354	0.74	0.68	0.51	SAMN07452490	Gut metagenomes of patients with colorectal cancer
L11079.1	SRR5930516	0.74	0.68	0.51	SAMN07498124	Metagenomic shotgun sequencing of gut microbiomes of melanoma patients receiving immune checkpoint inhibitor therapy
L11079.1	SRR5935753	0.74	0.68	0.51	SAMN07509657	Longitudinal Multi'omics of the Human Microbiome in Inflammatory Bowel Disease
L11079.1	SRR5983359	0.74	0.68	0.51	SAMN07424403	Human gut metagenome and metatranscriptome in the inflammatory bowel disease (iHMP/HMP2)
L11079.1	SRR5983420	0.74	0.68	0.51	SAMN07424396	Human gut metagenome and metatranscriptome in the inflammatory bowel disease (iHMP/HMP2)
L11079.1	SRR5983430	0.74	0.68	0.51	SAMN07424483	Human gut metagenome and metatranscriptome in the inflammatory bowel disease (iHMP/HMP2)
L11079.1	SRR5983433	0.74	0.68	0.51	SAMN07424482	Human gut metagenome and metatranscriptome in the inflammatory bowel disease (iHMP/HMP2)
L11079.1	SRR5983448	0.74	0.68	0.51	SAMN07424470	Human gut metagenome and metatranscriptome in the inflammatory bowel disease (iHMP/HMP2)
L11079.1	SRR5963261	0.74	0.68	0.51	SAMN07501168	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963264	0.74	0.68	0.51	SAMN07501171	preterm infant gut metagenomes (NIH Y4 Cohort)
L11079.1	SRR5963488	0.74	0.68	0.51	SAMN07534870	Healthy human fecal metagenomes variably reactivate Irinotecan active metabolite
L11079.1	SRR5963490	0.74	0.68	0.51	SAMN07534978	Healthy human fecal metagenomes variably reactivate Irinotecan active metabolite
L11079.1	SRR6000890	0.74	0.68	0.51	SAMN07599733	Commensal microbiota associated with anti-PD-1 efficacy in metastatic melanoma patients
L11079.1	SRR6000903	0.74	0.68	0.51	SAMN07599739	Commensal microbiota associated with anti-PD-1 efficacy in metastatic melanoma patients
L11079.1	SRR6000912	0.74	0.68	0.51	SAMN07599756	Commensal microbiota associated with anti-PD-1 efficacy in metastatic melanoma patients
L11079.1	SRR6060199	0.74	0.68	0.51	SAMN07688536	Microbiome and Worm Infection
L11079.1	SRR6060201	0.74	0.68	0.51	SAMN07688534	Microbiome and Worm Infection
L11079.1	SRR6060216	0.74	0.68	0.51	SAMN07688544	Microbiome and Worm Infection
L11079.1	SRR6060218	0.74	0.68	0.51	SAMN07688542	Microbiome and Worm Infection
L11079.1	SRR6075155	0.74	0.68	0.51	SAMN07612774	Metagenomic analysis of fecal microbiome from patients with gestational diabetes mellitus
L11079.1	SRR6075178	0.74	0.68	0.51	SAMN07612778	Metagenomic analysis of fecal microbiome from patients with gestational diabetes mellitus
L11079.1	SRR6075181	0.74	0.68	0.51	SAMN07612777	Metagenomic analysis of fecal microbiome from patients with gestational diabetes mellitus
L11079.1	SRR6075183	0.74	0.68	0.51	SAMN07612785	Metagenomic analysis of fecal microbiome from patients with gestational diabetes mellitus
L11079.1	SRR6075210	0.74	0.68	0.51	SAMN07612787	Metagenomic analysis of fecal microbiome from patients with gestational diabetes mellitus
L11079.1	SRR6075212	0.74	0.68	0.51	SAMN07612789	Metagenomic analysis of fecal microbiome from patients with gestational diabetes mellitus
L11079.1	SRR6075259	0.74	0.68	0.51	SAMN07612712	Metagenomic analysis of fecal microbiome from patients with gestational diabetes mellitus
L11079.1	SRR6129542	0.74	0.68	0.51	SAMN07631587	Saline lake microbial communities from Rauer Islands, Antarctica - Metagenome Filla 3 #765 metagenome
L11079.1	SRR6129545	0.74	0.68	0.51	SAMN07631586	Saline lake microbial communities from Rauer Islands, Antarctica - Metagenome Filla 3 #764 metagenome
L11079.1	SRR6129546	0.74	0.68	0.51	SAMN07631588	Saline lake microbial communities from Rauer Islands, Antarctica - Metagenome Filla 3 #767 metagenome
L11079.1	SRR6129769	0.74	0.68	0.51	SAMN07631432	Saline lake microbial communities from Rauer Islands, Antarctica - Metagenome Torckler E11 #899 metagenome
L11079.1	SRR6155026	0.74	0.68	0.51	SAMN07740644	Mycobacterium tuberculosis Genome sequencing and assembly
L11079.1	SRR6185438	0.74	0.68	0.51	SAMN07631560	Saline lake microbial communities from Rauer Islands, Antarctica - Metagenome Torckler E5 #432 metagenome
L11079.1	SRR6186421	0.74	0.68	0.51	SAMN07631436	Saline lake microbial communities from Rauer Islands, Antarctica - Metagenome Filla E10 #628 metagenome
L11079.1	SRR6256454	0.74	0.68	0.51	SAMN07977903	Metagenomic analysis of wild Amur tiger fecal microbiome
L11079.1	SRR6262327	0.74	0.68	0.51	SAMN07982951	preterm infant gut metagenomes (NIH Y5 Cohort)
L11079.1	SRR6262441	0.74	0.68	0.51	SAMN07983096	preterm infant gut metagenomes (NIH Y5 Cohort)
L11079.1	SRR6262442	0.74	0.68	0.51	SAMN07983095	preterm infant gut metagenomes (NIH Y5 Cohort)
L11079.1	SRR6323132	0.74	0.68	0.51	SAMN08010164	A catalogue of chicken gut metagenome and the  microbial responses to antibiotic and plant-derived benzylisoquinoline  alkaloids
L11079.1	SRR6323167	0.74	0.68	0.51	SAMN08009881	A catalogue of chicken gut metagenome and the  microbial responses to antibiotic and plant-derived benzylisoquinoline  alkaloids
L11079.1	SRR6323223	0.74	0.68	0.51	SAMN08009808	A catalogue of chicken gut metagenome and the  microbial responses to antibiotic and plant-derived benzylisoquinoline  alkaloids
L11079.1	SRR6323280	0.74	0.68	0.51	SAMN08009821	A catalogue of chicken gut metagenome and the  microbial responses to antibiotic and plant-derived benzylisoquinoline  alkaloids
L11079.1	SRR6323291	0.74	0.68	0.51	SAMN08009869	A catalogue of chicken gut metagenome and the  microbial responses to antibiotic and plant-derived benzylisoquinoline  alkaloids
L11079.1	SRR6323390	0.74	0.68	0.51	SAMN08010136	A catalogue of chicken gut metagenome and the  microbial responses to antibiotic and plant-derived benzylisoquinoline  alkaloids
L11079.1	SRR6425790	0.74	0.68	0.51	SAMN08242244	Comprehensive Metagenomic
L11079.1	SRR6425792	0.74	0.68	0.51	SAMN08242246	Comprehensive Metagenomic
L11079.1	SRR6425799	0.74	0.68	0.51	SAMN08242251	Comprehensive Metagenomic
L11079.1	SRR6426160	0.74	0.68	0.51	SAMN08007083	Wheat flour Raw sequence reads
L11079.1	SRR6456159	0.74	0.68	0.51	SAMN08335146	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456175	0.74	0.68	0.51	SAMN08335037	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456178	0.74	0.68	0.51	SAMN08335038	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456184	0.74	0.68	0.51	SAMN08335112	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456191	0.74	0.68	0.51	SAMN08335105	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456192	0.74	0.68	0.51	SAMN08335102	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456198	0.74	0.68	0.51	SAMN08335095	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456218	0.74	0.68	0.51	SAMN08335027	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456237	0.74	0.68	0.51	SAMN08335065	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456238	0.74	0.68	0.51	SAMN08335062	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456250	0.74	0.68	0.51	SAMN08335055	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456355	0.74	0.68	0.51	SAMN08335940	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6456359	0.74	0.68	0.51	SAMN08335921	Microbiota Research on Chinses Colorectal Cancer
L11079.1	SRR6468701	0.74	0.68	0.51	SAMN08049669	Gut microbiome structure and metabolic activity in inflammatory bowel disease
L11079.1	SRR6482555	0.74	0.68	0.51	SAMN08018183	Collection of 3,087 bacterial metagenome-assembled genomes recovered from metagenomes available from the Sequence Read Archive.
L11079.1	SRR6514660	0.74	0.68	0.51	SAMN08379455	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	SRR6514662	0.74	0.68	0.51	SAMN08379453	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	SRR6514687	0.74	0.68	0.51	SAMN08379459	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	SRR6514688	0.74	0.68	0.51	SAMN08379460	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	SRR6514689	0.74	0.68	0.51	SAMN08379461	Evaluation of Enriched Background Microflora of Raw Milk Cheese Spiked with E. coli O157:H7 and E. coli O103 using Next-Generation Sequencing Technology
L11079.1	SRR6517776	0.74	0.68	0.51	SAMN08392145	human gut metagenome Metagenome-Behcet's disease
L11079.1	SRR8675879	0.74	0.68	0.51	SAMN11064142	human gut metagenome Metagenome-Behcet's disease
L11079.1	SRR8675894	0.74	0.68	0.51	SAMN11064175	human gut metagenome Metagenome-Behcet's disease
L11079.1	SRR8675901	0.74	0.68	0.51	SAMN11064186	human gut metagenome Metagenome-Behcet's disease
L11079.1	SRR8675918	0.74	0.68	0.51	SAMN11064171	human gut metagenome Metagenome-Behcet's disease
L11079.1	SRR6659416	0.74	0.68	0.51	SAMN08448111	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659417	0.74	0.68	0.51	SAMN08448112	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659418	0.74	0.68	0.51	SAMN08448103	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659419	0.74	0.68	0.51	SAMN08448104	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659420	0.74	0.68	0.51	SAMN08448105	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659421	0.74	0.68	0.51	SAMN08448106	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659422	0.74	0.68	0.51	SAMN08448107	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659423	0.74	0.68	0.51	SAMN08448108	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659424	0.74	0.68	0.51	SAMN08448109	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659425	0.74	0.68	0.51	SAMN08448110	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659436	0.74	0.68	0.51	SAMN08448042	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659437	0.74	0.68	0.51	SAMN08448041	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659438	0.74	0.68	0.51	SAMN08448040	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659439	0.74	0.68	0.51	SAMN08448039	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659440	0.74	0.68	0.51	SAMN08448038	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659441	0.74	0.68	0.51	SAMN08448037	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659442	0.74	0.68	0.51	SAMN08448036	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659443	0.74	0.68	0.51	SAMN08448035	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659444	0.74	0.68	0.51	SAMN08448034	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659445	0.74	0.68	0.51	SAMN08448033	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659447	0.74	0.68	0.51	SAMN08448119	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659448	0.74	0.68	0.51	SAMN08448118	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659449	0.74	0.68	0.51	SAMN08448117	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659450	0.74	0.68	0.51	SAMN08448116	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659451	0.74	0.68	0.51	SAMN08448115	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659452	0.74	0.68	0.51	SAMN08448114	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659453	0.74	0.68	0.51	SAMN08448113	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659466	0.74	0.68	0.51	SAMN08448054	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659467	0.74	0.68	0.51	SAMN08448031	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659468	0.74	0.68	0.51	SAMN08448032	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659477	0.74	0.68	0.51	SAMN08448085	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659478	0.74	0.68	0.51	SAMN08448086	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659481	0.74	0.68	0.51	SAMN08448089	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659482	0.74	0.68	0.51	SAMN08448090	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659483	0.74	0.68	0.51	SAMN08448087	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659484	0.74	0.68	0.51	SAMN08448088	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659485	0.74	0.68	0.51	SAMN08448091	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659486	0.74	0.68	0.51	SAMN08448092	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659495	0.74	0.68	0.51	SAMN08448151	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659497	0.74	0.68	0.51	SAMN08448058	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659498	0.74	0.68	0.51	SAMN08448057	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659499	0.74	0.68	0.51	SAMN08448060	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659500	0.74	0.68	0.51	SAMN08448059	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659502	0.74	0.68	0.51	SAMN08448053	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659503	0.74	0.68	0.51	SAMN08448056	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659504	0.74	0.68	0.51	SAMN08448055	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659506	0.74	0.68	0.51	SAMN08448062	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659507	0.74	0.68	0.51	SAMN08448061	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659508	0.74	0.68	0.51	SAMN08448094	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659509	0.74	0.68	0.51	SAMN08448093	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659510	0.74	0.68	0.51	SAMN08448096	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659511	0.74	0.68	0.51	SAMN08448095	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659512	0.74	0.68	0.51	SAMN08448098	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659513	0.74	0.68	0.51	SAMN08448097	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659514	0.74	0.68	0.51	SAMN08448100	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659515	0.74	0.68	0.51	SAMN08448099	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659516	0.74	0.68	0.51	SAMN08448102	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659517	0.74	0.68	0.51	SAMN08448101	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659536	0.74	0.68	0.51	SAMN08448049	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659537	0.74	0.68	0.51	SAMN08448050	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659538	0.74	0.68	0.51	SAMN08448047	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659539	0.74	0.68	0.51	SAMN08448048	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659540	0.74	0.68	0.51	SAMN08448045	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659541	0.74	0.68	0.51	SAMN08448046	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659542	0.74	0.68	0.51	SAMN08448043	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659543	0.74	0.68	0.51	SAMN08448044	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659544	0.74	0.68	0.51	SAMN08448051	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659545	0.74	0.68	0.51	SAMN08448052	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659558	0.74	0.68	0.51	SAMN08448076	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659559	0.74	0.68	0.51	SAMN08448075	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659560	0.74	0.68	0.51	SAMN08448074	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659561	0.74	0.68	0.51	SAMN08448073	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659565	0.74	0.68	0.51	SAMN08448077	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659576	0.74	0.68	0.51	SAMN08448067	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659577	0.74	0.68	0.51	SAMN08448068	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659578	0.74	0.68	0.51	SAMN08448069	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659579	0.74	0.68	0.51	SAMN08448070	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659580	0.74	0.68	0.51	SAMN08448063	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659581	0.74	0.68	0.51	SAMN08448064	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659582	0.74	0.68	0.51	SAMN08448065	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659583	0.74	0.68	0.51	SAMN08448066	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659584	0.74	0.68	0.51	SAMN08448071	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6659585	0.74	0.68	0.51	SAMN08448072	Quasi-metagenomics study on the recovery of Shigella from field tomatoes
L11079.1	SRR6747976	0.74	0.68	0.51	SAMN03844118	Temporal and Spatial Variation of the Human Microbiota During Pregnancy
L11079.1	SRR6784517	0.74	0.68	0.51	SAMN06619303	MECFS metagenomics
L11079.1	SRR6784544	0.74	0.68	0.51	SAMN06619276	MECFS metagenomics
L11079.1	SRR6795015	0.74	0.68	0.51	SAMN08628052	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6795025	0.74	0.68	0.51	SAMN08628058	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6795033	0.74	0.68	0.51	SAMN08628046	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6795041	0.74	0.68	0.51	SAMN08628021	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6795053	0.74	0.68	0.51	SAMN08628056	Bangladesh Infant Gut Metagenomes
L11079.1	SRR6837566	0.74	0.68	0.51	SAMN08707557	Antimicrobial resistance of wastewater samples
L11079.1	SRR6837569	0.74	0.68	0.51	SAMN08707563	Antimicrobial resistance of wastewater samples
L11079.1	SRR6869399	0.74	0.68	0.51	SAMN08714533	marine biofilm Metagenome
L11079.1	SRR6869087	0.74	0.68	0.51	SAMN08738628	Bovine Fecal Metagenomics During Early Life
L11079.1	SRR6928694	0.74	0.68	0.51	SAMN08848303	Characterizing the cases of HFMD  using RNA-seq
L11079.1	SRR7051675	0.74	0.68	0.51	SAMN08778878	Sediment microbial communities from the Broadkill River, Lewes, Delaware, United States – BRT_10-11_MG metagenome
L11079.1	SRR7060080	0.74	0.68	0.51	SAMN08976419	Colorado Natural Cattle SCFP Trial
L11079.1	SRR7060082	0.74	0.68	0.51	SAMN08976421	Colorado Natural Cattle SCFP Trial
L11079.1	SRR7080745	0.74	0.68	0.51	SAMN08777752	Freshwater microbial communities from subterranean cave lake in Wind Cave National Park, South Dakota, United States - WICALVC2017 metagenome
L11079.1	SRR7162309	0.74	0.68	0.51	SAMN08993552	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7162330	0.74	0.68	0.51	SAMN08993476	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7162345	0.74	0.68	0.51	SAMN08993530	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7162389	0.74	0.68	0.51	SAMN08993444	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7162425	0.74	0.68	0.51	SAMN08993460	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7162428	0.74	0.68	0.51	SAMN08993465	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7212593	0.74	0.68	0.51	SAMN08993444	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7212603	0.74	0.68	0.51	SAMN08993530	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7212632	0.74	0.68	0.51	SAMN08993552	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7212650	0.74	0.68	0.51	SAMN08993465	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7212657	0.74	0.68	0.51	SAMN08993460	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7212660	0.74	0.68	0.51	SAMN08993476	Studies of human gut metagenome Metagenome in breast cancer patients.
L11079.1	SRR7182056	0.74	0.68	0.51	SAMN09209538	PIG GUT RESISTOME
L11079.1	SRR7186486	0.74	0.68	0.51	SAMN08934543	Metagenomic sequencing of  foxtail millet root-associated microbiome
L11079.1	SRR7186528	0.74	0.68	0.51	SAMN08934539	Metagenomic sequencing of  foxtail millet root-associated microbiome
L11079.1	SRR7217020	0.74	0.68	0.51	SAMN08122820	Metagenomics of Urban Sewage Identifies an Extensively Shared Antibiotic Resistome in China
L11079.1	SRR7217046	0.74	0.68	0.51	SAMN08122854	Metagenomics of Urban Sewage Identifies an Extensively Shared Antibiotic Resistome in China
L11079.1	SRR7217055	0.74	0.68	0.51	SAMN08122862	Metagenomics of Urban Sewage Identifies an Extensively Shared Antibiotic Resistome in China
L11079.1	SRR7217056	0.74	0.68	0.51	SAMN08122861	Metagenomics of Urban Sewage Identifies an Extensively Shared Antibiotic Resistome in China
L11079.1	SRR7217512	0.74	0.68	0.51	SAMN09259903	Infant Diet and Maternal Gestational Weight Gain Influence Functional Maturation of the Infant Gut Microbiome
L11079.1	SRR7217522	0.74	0.68	0.51	SAMN09259910	Infant Diet and Maternal Gestational Weight Gain Influence Functional Maturation of the Infant Gut Microbiome
L11079.1	SRR7217593	0.74	0.68	0.51	SAMN09259903	Infant Diet and Maternal Gestational Weight Gain Influence Functional Maturation of the Infant Gut Microbiome
L11079.1	SRR7271174	0.74	0.68	0.51	SAMN09373366	Evaluation of sample extraction and library preparation for short-gun metagenomics
L11079.1	SRR7271177	0.74	0.68	0.51	SAMN09373367	Evaluation of sample extraction and library preparation for short-gun metagenomics
L11079.1	SRR7271184	0.74	0.68	0.51	SAMN09373360	Evaluation of sample extraction and library preparation for short-gun metagenomics
L11079.1	SRR7271185	0.74	0.68	0.51	SAMN09373361	Evaluation of sample extraction and library preparation for short-gun metagenomics
L11079.1	SRR7351722	0.74	0.68	0.51	SAMN09278104	Probiotics in Pregnancy study
L11079.1	SRR7351732	0.74	0.68	0.51	SAMN09278277	Probiotics in Pregnancy study
L11079.1	SRR7351756	0.74	0.68	0.51	SAMN09278240	Probiotics in Pregnancy study
L11079.1	SRR7351758	0.74	0.68	0.51	SAMN09278242	Probiotics in Pregnancy study
L11079.1	SRR7351761	0.74	0.68	0.51	SAMN09278245	Probiotics in Pregnancy study
L11079.1	SRR7351775	0.74	0.68	0.51	SAMN09278147	Probiotics in Pregnancy study
L11079.1	SRR7351808	0.74	0.68	0.51	SAMN09278089	Probiotics in Pregnancy study
L11079.1	SRR7351836	0.74	0.68	0.51	SAMN09278278	Probiotics in Pregnancy study
L11079.1	SRR7351841	0.74	0.68	0.51	SAMN09278479	Probiotics in Pregnancy study
L11079.1	SRR7351844	0.74	0.68	0.51	SAMN09278478	Probiotics in Pregnancy study
L11079.1	SRR7351907	0.74	0.68	0.51	SAMN09278522	Probiotics in Pregnancy study
L11079.1	SRR7351918	0.74	0.68	0.51	SAMN09278521	Probiotics in Pregnancy study
L11079.1	SRR7351966	0.74	0.68	0.51	SAMN09278533	Probiotics in Pregnancy study
L11079.1	SRR7351973	0.74	0.68	0.51	SAMN09278288	Probiotics in Pregnancy study
L11079.1	SRR7352002	0.74	0.68	0.51	SAMN09278214	Probiotics in Pregnancy study
L11079.1	SRR7352011	0.74	0.68	0.51	SAMN09278432	Probiotics in Pregnancy study
L11079.1	SRR7352053	0.74	0.68	0.51	SAMN09278361	Probiotics in Pregnancy study
L11079.1	SRR7352061	0.74	0.68	0.51	SAMN09278253	Probiotics in Pregnancy study
L11079.1	SRR7352082	0.74	0.68	0.51	SAMN09278170	Probiotics in Pregnancy study
L11079.1	SRR7411275	0.74	0.68	0.51	SAMN09278586	Probiotics in Pregnancy study
L11079.1	SRR7411282	0.74	0.68	0.51	SAMN09278601	Probiotics in Pregnancy study
L11079.1	SRR7411309	0.74	0.68	0.51	SAMN09278697	Probiotics in Pregnancy study
L11079.1	SRR7411347	0.74	0.68	0.51	SAMN09278579	Probiotics in Pregnancy study
L11079.1	SRR7411349	0.74	0.68	0.51	SAMN09278671	Probiotics in Pregnancy study
L11079.1	SRR7411384	0.74	0.68	0.51	SAMN09278645	Probiotics in Pregnancy study
L11079.1	SRR7408042	0.74	0.68	0.51	SAMN09467180	Microbiome in Severe Combined Immunodeficiency (X-linked)
L11079.1	SRR7456349	0.74	0.68	0.51	SAMN09519348	Primate Sleeve Gastrectomy
L11079.1	SRR7456356	0.74	0.68	0.51	SAMN09519351	Primate Sleeve Gastrectomy
L11079.1	SRR7495906	0.74	0.68	0.51	SAMN09605435	human stool Raw sequence reads
L11079.1	SRR7495912	0.74	0.68	0.51	SAMN09605429	human stool Raw sequence reads
L11079.1	SRR7495927	0.74	0.68	0.51	SAMN09605427	human stool Raw sequence reads
L11079.1	SRR7635124	0.74	0.68	0.51	SAMN09603381	Nanopore metagenomics
L11079.1	SRR7533011	0.74	0.68	0.51	SAMN09641617	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7533012	0.74	0.68	0.51	SAMN09641618	panda gut metagenome raw sequence reads Raw sequence reads
L11079.1	SRR7589573	0.74	0.68	0.51	SAMN09690922	Effect of native and acetylated high amylose maize starch on fecal pH, short chain fatty acid concentrations, and microbiota in a cohort of normal and stunted children in southern India
L11079.1	SRR7589581	0.74	0.68	0.51	SAMN09690907	Effect of native and acetylated high amylose maize starch on fecal pH, short chain fatty acid concentrations, and microbiota in a cohort of normal and stunted children in southern India
L11079.1	SRR7589590	0.74	0.68	0.51	SAMN09690918	Effect of native and acetylated high amylose maize starch on fecal pH, short chain fatty acid concentrations, and microbiota in a cohort of normal and stunted children in southern India
L11079.1	SRR7615431	0.74	0.68	0.51	SAMN09730607	Etiology of fever in Ugandan children: identification of microbial pathogens using metagenomic next-generation sequencing and IDseq, a platform for unbiased metagenomic analysis
L11079.1	SRR7638719	0.74	0.68	0.51	SAMN09759350	ARGs-OSP: Online searching platform for antibiotic resistance genes in metagenomic database and bacterial whole genome database
L11079.1	SRR7638740	0.74	0.68	0.51	SAMN09759352	ARGs-OSP: Online searching platform for antibiotic resistance genes in metagenomic database and bacterial whole genome database
L11079.1	SRR7638741	0.74	0.68	0.51	SAMN09759351	ARGs-OSP: Online searching platform for antibiotic resistance genes in metagenomic database and bacterial whole genome database
L11079.1	SRR7638750	0.74	0.68	0.51	SAMN09759345	ARGs-OSP: Online searching platform for antibiotic resistance genes in metagenomic database and bacterial whole genome database
L11079.1	SRR7658584	0.74	0.68	0.51	SAMN09781767	Metagenomic sequencing of stool samples from rural communities from north-eastern Madagascar
L11079.1	SRR7658635	0.74	0.68	0.51	SAMN09781726	Metagenomic sequencing of stool samples from rural communities from north-eastern Madagascar
L11079.1	SRR7658656	0.74	0.68	0.51	SAMN09781750	Metagenomic sequencing of stool samples from rural communities from north-eastern Madagascar
L11079.1	SRR7658658	0.74	0.68	0.51	SAMN09781752	Metagenomic sequencing of stool samples from rural communities from north-eastern Madagascar
L11079.1	SRR7658659	0.74	0.68	0.51	SAMN09781773	Metagenomic sequencing of stool samples from rural communities from north-eastern Madagascar
L11079.1	SRR7658664	0.74	0.68	0.51	SAMN09781776	Metagenomic sequencing of stool samples from rural communities from north-eastern Madagascar
L11079.1	SRR7658676	0.74	0.68	0.51	SAMN09781745	Metagenomic sequencing of stool samples from rural communities from north-eastern Madagascar
L11079.1	SRR7658683	0.74	0.68	0.51	SAMN09781693	Metagenomic sequencing of stool samples from rural communities from north-eastern Madagascar
L11079.1	SRR7721867	0.74	0.68	0.51	SAMN09864048	Modification of gut microbiota-bile acid-intestinal FXR signaling leads to the clinical benefits of metformin
L11079.1	SRR7721869	0.74	0.68	0.51	SAMN09864050	Modification of gut microbiota-bile acid-intestinal FXR signaling leads to the clinical benefits of metformin
L11079.1	SRR7721870	0.74	0.68	0.51	SAMN09864049	Modification of gut microbiota-bile acid-intestinal FXR signaling leads to the clinical benefits of metformin
L11079.1	SRR7721883	0.74	0.68	0.51	SAMN09864057	Modification of gut microbiota-bile acid-intestinal FXR signaling leads to the clinical benefits of metformin
L11079.1	SRR7721896	0.74	0.68	0.51	SAMN09864032	Modification of gut microbiota-bile acid-intestinal FXR signaling leads to the clinical benefits of metformin
L11079.1	SRR7721901	0.74	0.68	0.51	SAMN09864029	Modification of gut microbiota-bile acid-intestinal FXR signaling leads to the clinical benefits of metformin
L11079.1	SRR7723086	0.74	0.68	0.51	SAMN09863685	Influence of early environmental factors on the establishment and development of gut microbiome composition and function and metabolomics profiles in infants at-risk of celiac disease
L11079.1	SRR7723087	0.74	0.68	0.51	SAMN09863686	Influence of early environmental factors on the establishment and development of gut microbiome composition and function and metabolomics profiles in infants at-risk of celiac disease
L11079.1	SRR7751833	0.74	0.68	0.51	SAMN09907337	An increased abundance of Clostridiaceae characterizes arthritis in inflammatory bowel disease and rheumatoid arthritis: a cross-sectional study
L11079.1	SRR7751951	0.74	0.68	0.51	SAMN09907266	An increased abundance of Clostridiaceae characterizes arthritis in inflammatory bowel disease and rheumatoid arthritis: a cross-sectional study
L11079.1	SRR7755414	0.74	0.68	0.51	SAMN09812356	Multi-tissues of transcriptomics from Ovis Aries, Capra hircus and Camelus bactrianus. And metagenomics of the rumen contents from Capra hircus during post-natal development. Raw sequence reads
L11079.1	SRR7877884	0.74	0.68	0.51	SAMN10057129	Microbiomes of a pilot-scale advanced water treatment facility and simulated distribution
L11079.1	SRR7880217	0.74	0.68	0.51	SAMN10094496	Gut microbiota profile of vegetarians versus omnivores
L11079.1	SRR7949673	0.74	0.68	0.51	SAMN10162055	Beyond the tip of the iceberg: illuminating bacterial dark matter through a combination of metagenomics and culturomic approaches
L11079.1	SRR8048116	0.74	0.68	0.51	SAMN10229742	Characterisation of the faecal virome of captive and wild Tasmanian devils using virus-like particles metagenomics and meta-transcriptomics
L11079.1	SRR8071855	0.74	0.68	0.51	SAMN10253003	Microbial Tracking 2 - Flights 4, 5
L11079.1	SRR8086138	0.74	0.68	0.51	SAMN10268135	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8086208	0.74	0.68	0.51	SAMN10267963	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8086249	0.74	0.68	0.51	SAMN10267813	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8086366	0.74	0.68	0.51	SAMN10267971	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090517	0.74	0.68	0.51	SAMN10275363	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090606	0.74	0.68	0.51	SAMN10275240	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090612	0.74	0.68	0.51	SAMN10275427	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090631	0.74	0.68	0.51	SAMN10275695	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090650	0.74	0.68	0.51	SAMN10275269	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090661	0.74	0.68	0.51	SAMN10275495	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090825	0.74	0.68	0.51	SAMN10275666	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090842	0.74	0.68	0.51	SAMN10275303	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090892	0.74	0.68	0.51	SAMN10275680	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090905	0.74	0.68	0.51	SAMN10275264	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8090996	0.74	0.68	0.51	SAMN10275578	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8091043	0.74	0.68	0.51	SAMN10275700	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8091056	0.74	0.68	0.51	SAMN10275452	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8091057	0.74	0.68	0.51	SAMN10275453	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8091073	0.74	0.68	0.51	SAMN10275730	Longitudinal gut microbiome sequence data combined from several DIABIMMUNE microbiome studies
L11079.1	SRR8164292	0.74	0.68	0.51	SAMN10383199	Torres Strait Islands Health Surveys, 2016
L11079.1	SRR8164306	0.74	0.68	0.51	SAMN10383148	Torres Strait Islands Health Surveys, 2016
L11079.1	SRR8784369	0.74	0.68	0.51	SAMN11252261	Metagenomic sequencing of stool samples from Ethiopian individuals
L11079.1	SRR8784383	0.74	0.68	0.51	SAMN11252294	Metagenomic sequencing of stool samples from Ethiopian individuals
L11079.1	SRR8784384	0.74	0.68	0.51	SAMN11252276	Metagenomic sequencing of stool samples from Ethiopian individuals
L11079.1	SRR8784397	0.74	0.68	0.51	SAMN11252291	Metagenomic sequencing of stool samples from Ethiopian individuals
L11079.1	SRR8194099	0.74	0.68	0.51	SAMN10411760	Deconvolving Linked-Reads (e.g. 10x Genomics) for Metagenomics
L11079.1	SRR8289067	0.74	0.68	0.51	SAMN10508882	Analytical and Clinical Validation of a Microbial Cell-Free DNA Sequencing Test for Infectious Disease
L11079.1	SRR8316565	0.74	0.68	0.51	SAMN10592469	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316587	0.74	0.68	0.51	SAMN10592484	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316593	0.74	0.68	0.51	SAMN10592409	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316597	0.74	0.68	0.51	SAMN10592413	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316606	0.74	0.68	0.51	SAMN10592362	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316607	0.74	0.68	0.51	SAMN10592361	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316617	0.74	0.68	0.51	SAMN10592443	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316621	0.74	0.68	0.51	SAMN10592439	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316626	0.74	0.68	0.51	SAMN10592350	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316648	0.74	0.68	0.51	SAMN10592386	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316651	0.74	0.68	0.51	SAMN10592379	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316663	0.74	0.68	0.51	SAMN10592461	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316672	0.74	0.68	0.51	SAMN10592369	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316685	0.74	0.68	0.51	SAMN10592394	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8316701	0.74	0.68	0.51	SAMN10592435	Gut metagenomes of Yi and Tibetan population and hypertension patients in China
L11079.1	SRR8353677	0.74	0.68	0.51	SAMN10616071	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353698	0.74	0.68	0.51	SAMN10616092	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353763	0.74	0.68	0.51	SAMN10615606	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353804	0.74	0.68	0.51	SAMN10615647	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353822	0.74	0.68	0.51	SAMN10615665	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8353970	0.74	0.68	0.51	SAMN10615813	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354004	0.74	0.68	0.51	SAMN10615847	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354073	0.74	0.68	0.51	SAMN10615916	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8354173	0.74	0.68	0.51	SAMN10616016	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427579	0.74	0.68	0.51	SAMN10722123	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427611	0.74	0.68	0.51	SAMN10722155	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427645	0.74	0.68	0.51	SAMN10722189	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427720	0.74	0.68	0.51	SAMN10722264	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427727	0.74	0.68	0.51	SAMN10722271	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427744	0.74	0.68	0.51	SAMN10722288	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427752	0.74	0.68	0.51	SAMN10722296	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427821	0.74	0.68	0.51	SAMN10722365	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427824	0.74	0.68	0.51	SAMN10722368	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427843	0.74	0.68	0.51	SAMN10722387	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8427844	0.74	0.68	0.51	SAMN10722388	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428061	0.74	0.68	0.51	SAMN10722605	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428094	0.74	0.68	0.51	SAMN10722638	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8428131	0.74	0.68	0.51	SAMN10722675	The relationship of fecal microbiomes and nutritional status in cystic fibrosis
L11079.1	SRR8387690	0.74	0.68	0.51	SAMN10688598	Gut metagenomic raw sequence reads of cancer patients
L11079.1	SRR8439256	0.74	0.68	0.51	SAMN10351208	Soil microbial communities from agricultural site in Penn Yan, New York, United States - 13C_Glycerol_Day14 metagenome
L11079.1	SRR8452383	0.74	0.68	0.51	SAMN10766086	Microbiome  study of dietary therapy on chronic enteritis in a canine model
L11079.1	SRR8452390	0.74	0.68	0.51	SAMN10766091	Microbiome  study of dietary therapy on chronic enteritis in a canine model
L11079.1	SRR8497112	0.74	0.68	0.51	SAMN10712703	Metagenomes of marine biofilm after the treatments of quorum sensing signals
L11079.1	SRR8526189	0.74	0.68	0.51	SAMN10863942	Saline water microbial communities from Organic Lake, Antarctica - #280 metagenome
L11079.1	SRR8531242	0.74	0.68	0.51	SAMN10872484	Original soil microbial communities
L11079.1	SRR8531315	0.74	0.68	0.51	SAMN10872498	Original soil microbial communities
L11079.1	SRR8550803	0.74	0.68	0.51	SAMN10888599	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550809	0.74	0.68	0.51	SAMN10888607	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550811	0.74	0.68	0.51	SAMN10888527	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550813	0.74	0.68	0.51	SAMN10888521	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550816	0.74	0.68	0.51	SAMN10888520	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550823	0.74	0.68	0.51	SAMN10888619	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550831	0.74	0.68	0.51	SAMN10888574	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550836	0.74	0.68	0.51	SAMN10888569	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550857	0.74	0.68	0.51	SAMN10888517	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550864	0.74	0.68	0.51	SAMN10888516	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550879	0.74	0.68	0.51	SAMN10888563	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550882	0.74	0.68	0.51	SAMN10888562	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550888	0.74	0.68	0.51	SAMN10888531	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550891	0.74	0.68	0.51	SAMN10888536	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550892	0.74	0.68	0.51	SAMN10888535	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550897	0.74	0.68	0.51	SAMN10888547	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550900	0.74	0.68	0.51	SAMN10888544	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550907	0.74	0.68	0.51	SAMN10888590	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8550911	0.74	0.68	0.51	SAMN10888594	Fecal microbiomes from a Zimbabwean pre-school population
L11079.1	SRR8560602	0.74	0.68	0.51	SAMN10915309	Antibiotic resistance genes and their associated bacteria in wastewater in gravity sewers
L11079.1	SRR8581397	0.74	0.68	0.51	SAMN10948891	Metagenomic project data
L11079.1	SRR8581401	0.74	0.68	0.51	SAMN10948895	Metagenomic project data
L11079.1	SRR8581402	0.74	0.68	0.51	SAMN10948894	Metagenomic project data
L11079.1	SRR8634292	0.74	0.68	0.51	SAMN11023915	Resistant microbiome underlies antibiotic therapy in pouchitis
L11079.1	SRR8634296	0.74	0.68	0.51	SAMN11023911	Resistant microbiome underlies antibiotic therapy in pouchitis
L11079.1	SRR8634298	0.74	0.68	0.51	SAMN11023916	Resistant microbiome underlies antibiotic therapy in pouchitis
L11079.1	SRR8634307	0.74	0.68	0.51	SAMN11024032	Resistant microbiome underlies antibiotic therapy in pouchitis
L11079.1	SRR8634359	0.74	0.68	0.51	SAMN11023994	Resistant microbiome underlies antibiotic therapy in pouchitis
L11079.1	SRR8634365	0.74	0.68	0.51	SAMN11023996	Resistant microbiome underlies antibiotic therapy in pouchitis
L11079.1	SRR8634403	0.74	0.68	0.51	SAMN11024002	Resistant microbiome underlies antibiotic therapy in pouchitis
L11079.1	SRR8634427	0.74	0.68	0.51	SAMN11023954	Resistant microbiome underlies antibiotic therapy in pouchitis
L11079.1	SRR8634451	0.74	0.68	0.51	SAMN11023904	Resistant microbiome underlies antibiotic therapy in pouchitis
L11079.1	SRR8638153	0.74	0.68	0.51	SAMN11019910	Military dog macro genome project
L11079.1	SRR8638186	0.74	0.68	0.51	SAMN11019916	Military dog macro genome project
L11079.1	SRR8652841	0.74	0.68	0.51	SAMN11031433	Human infant gut virome
L11079.1	SRR9670857	0.74	0.68	0.51	SAMN11031400	Human infant gut virome
L11079.1	SRR9670897	0.74	0.68	0.51	SAMN11031433	Human infant gut virome
L11079.1	SRR9670900	0.74	0.68	0.51	SAMN11031393	Human infant gut virome
L11079.1	SRR8719679	0.74	0.68	0.51	SAMN11111028	Fecal samples of herders in different regions
L11079.1	SRR8719686	0.74	0.68	0.51	SAMN11111021	Fecal samples of herders in different regions
L11079.1	SRR8719688	0.74	0.68	0.51	SAMN11111023	Fecal samples of herders in different regions
L11079.1	SRR8791369	0.74	0.68	0.51	SAMN11265231	Metagenomic sequencing of stool samples from Ghanaian individuals
L11079.1	SRR8791375	0.74	0.68	0.51	SAMN11265251	Metagenomic sequencing of stool samples from Ghanaian individuals
L11079.1	SRR8791385	0.74	0.68	0.51	SAMN11265258	Metagenomic sequencing of stool samples from Ghanaian individuals
L11079.1	SRR8791389	0.74	0.68	0.51	SAMN11265236	Metagenomic sequencing of stool samples from Ghanaian individuals
L11079.1	SRR8830802	0.74	0.68	0.51	SAMN11303406	Shotgun metagenomics and isolate sequencing for environmental microbial communities
L11079.1	SRR8842856	0.74	0.68	0.51	SAMN11321138	Autistic Symptoms and Gut Microbiota between Two Subgroups of ASD Children Based on ?dT cells- derived IFN-? levels
L11079.1	SRR8842858	0.74	0.68	0.51	SAMN11321116	Autistic Symptoms and Gut Microbiota between Two Subgroups of ASD Children Based on ?dT cells- derived IFN-? levels
L11079.1	SRR8842859	0.74	0.68	0.51	SAMN11321139	Autistic Symptoms and Gut Microbiota between Two Subgroups of ASD Children Based on ?dT cells- derived IFN-? levels
L11079.1	SRR8842863	0.74	0.68	0.51	SAMN11321112	Autistic Symptoms and Gut Microbiota between Two Subgroups of ASD Children Based on ?dT cells- derived IFN-? levels
L11079.1	SRR8845321	0.74	0.68	0.51	SAMN11311591	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845335	0.74	0.68	0.51	SAMN11311668	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845346	0.74	0.68	0.51	SAMN11311817	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845349	0.74	0.68	0.51	SAMN11311812	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845367	0.74	0.68	0.51	SAMN11311592	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845411	0.74	0.68	0.51	SAMN11311525	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845435	0.74	0.68	0.51	SAMN11311827	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845468	0.74	0.68	0.51	SAMN11311483	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845472	0.74	0.68	0.51	SAMN11311487	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845481	0.74	0.68	0.51	SAMN11311784	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845482	0.74	0.68	0.51	SAMN11311787	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845523	0.74	0.68	0.51	SAMN11311569	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845546	0.74	0.68	0.51	SAMN11311521	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845555	0.74	0.68	0.51	SAMN11311531	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845576	0.74	0.68	0.51	SAMN11311716	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845593	0.74	0.68	0.51	SAMN11311575	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845669	0.74	0.68	0.51	SAMN11311464	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8845674	0.74	0.68	0.51	SAMN11311467	Shotgun Metagenomics of 361 post-menopause women reveals gut microbiome change along with the bone loss
L11079.1	SRR8849212	0.74	0.68	0.51	SAMN11342873	Gut microbiota-bile acid-interleukin 22 axis orchestrates polycystic ovary syndrome
L11079.1	SRR8849223	0.74	0.68	0.51	SAMN11342892	Gut microbiota-bile acid-interleukin 22 axis orchestrates polycystic ovary syndrome
L11079.1	SRR8849227	0.74	0.68	0.51	SAMN11342888	Gut microbiota-bile acid-interleukin 22 axis orchestrates polycystic ovary syndrome
L11079.1	SRR8849236	0.74	0.68	0.51	SAMN11342886	Gut microbiota-bile acid-interleukin 22 axis orchestrates polycystic ovary syndrome
L11079.1	SRR8849246	0.74	0.68	0.51	SAMN11342809	Gut microbiota-bile acid-interleukin 22 axis orchestrates polycystic ovary syndrome
L11079.1	SRR8861906	0.74	0.68	0.51	SAMN10864243	Saline water microbial communities from Organic Lake, Antarctica - #88 metagenome
L11079.1	SRR8861994	0.74	0.68	0.51	SAMN10864144	Saline water microbial communities from Organic Lake, Antarctica - #92 metagenome
L11079.1	SRR8861996	0.74	0.68	0.51	SAMN10863946	Saline water microbial communities from Organic Lake, Antarctica - #122 metagenome
L11079.1	SRR8861999	0.74	0.68	0.51	SAMN10863944	Saline water microbial communities from Organic Lake, Antarctica - #177 metagenome
L11079.1	SRR8862018	0.74	0.68	0.51	SAMN10864221	Saline water microbial communities from Organic Lake, Antarctica - #175 metagenome
L11079.1	SRR8862060	0.74	0.68	0.51	SAMN10864207	Saline water microbial communities from Organic Lake, Antarctica - #179 metagenome
L11079.1	SRR8862063	0.74	0.68	0.51	SAMN10864352	Saline water microbial communities from Organic Lake, Antarctica - #437 metagenome
L11079.1	SRR8862070	0.74	0.68	0.51	SAMN10864332	Saline water microbial communities from Organic Lake, Antarctica - #542 metagenome
L11079.1	SRR8862071	0.74	0.68	0.51	SAMN10864062	Saline water microbial communities from Organic Lake, Antarctica - #494 metagenome
L11079.1	SRR8862074	0.74	0.68	0.51	SAMN10864244	Saline water microbial communities from Organic Lake, Antarctica - #594 metagenome
L11079.1	SRR8862075	0.74	0.68	0.51	SAMN10864288	Saline water microbial communities from Organic Lake, Antarctica - #596 metagenome
L11079.1	SRR8862087	0.74	0.68	0.51	SAMN10864129	Saline water microbial communities from Organic Lake, Antarctica - #648 metagenome
L11079.1	SRR8862088	0.74	0.68	0.51	SAMN10864419	Saline water microbial communities from Organic Lake, Antarctica - #650 metagenome
L11079.1	SRR8862126	0.74	0.68	0.51	SAMN10864301	Saline water microbial communities from Organic Lake, Antarctica - #714 metagenome
L11079.1	SRR8862127	0.74	0.68	0.51	SAMN10864060	Saline water microbial communities from Organic Lake, Antarctica - #780 metagenome
L11079.1	SRR8862134	0.74	0.68	0.51	SAMN10864418	Saline water microbial communities from Organic Lake, Antarctica - #1056
L11079.1	SRR8862142	0.74	0.68	0.51	SAMN10864119	Saline water microbial communities from Organic Lake, Antarctica - #991
L11079.1	SRR8865573	0.74	0.68	0.51	SAMN11355274	Association of Flavonifractor plautii, a flavonoid degrading bacterium, with the gut microbiome of colorectal cancer patients in India
L11079.1	SRR8865577	0.74	0.68	0.51	SAMN11355270	Association of Flavonifractor plautii, a flavonoid degrading bacterium, with the gut microbiome of colorectal cancer patients in India
L11079.1	SRR8865580	0.74	0.68	0.51	SAMN11355279	Association of Flavonifractor plautii, a flavonoid degrading bacterium, with the gut microbiome of colorectal cancer patients in India
L11079.1	SRR8887133	0.74	0.68	0.51	SAMN11403404	Metagenome of the gut microbiota in multiple system atrophy patients
L11079.1	SRR8887135	0.74	0.68	0.51	SAMN11403402	Metagenome of the gut microbiota in multiple system atrophy patients
L11079.1	SRR8887139	0.74	0.68	0.51	SAMN11403409	Metagenome of the gut microbiota in multiple system atrophy patients
L11079.1	SRR8887154	0.74	0.68	0.51	SAMN11403395	Metagenome of the gut microbiota in multiple system atrophy patients
L11079.1	SRR8887158	0.74	0.68	0.51	SAMN11403407	Metagenome of the gut microbiota in multiple system atrophy patients
L11079.1	SRR8890831	0.74	0.68	0.51	SAMN11407863	Gut microbiome differences between wild and captive black rhinoceros – implications for rhino health
L11079.1	SRR8891824	0.74	0.68	0.51	SAMN11408596	PRASCO gut microbiome profile of Pediatric Severe Acute Ulcerative Colitis patients under Antimicrobial treatment
L11079.1	SRR8891895	0.74	0.68	0.51	SAMN11408566	PRASCO gut microbiome profile of Pediatric Severe Acute Ulcerative Colitis patients under Antimicrobial treatment
L11079.1	SRR8898506	0.74	0.68	0.51	SAMN11274001	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898509	0.74	0.68	0.51	SAMN11273925	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898510	0.74	0.68	0.51	SAMN11273926	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898515	0.74	0.68	0.51	SAMN11273919	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898533	0.74	0.68	0.51	SAMN11273815	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898536	0.74	0.68	0.51	SAMN11273999	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898538	0.74	0.68	0.51	SAMN11274031	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898559	0.74	0.68	0.51	SAMN11273807	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898594	0.74	0.68	0.51	SAMN11273945	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898622	0.74	0.68	0.51	SAMN11273973	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898654	0.74	0.68	0.51	SAMN11273879	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8898671	0.74	0.68	0.51	SAMN11273968	Pro-inflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus
L11079.1	SRR8926128	0.74	0.68	0.51	SAMN11258345	Marked loss of diversity and pathogen domination of the gut microbiota in critically ill patients
L11079.1	SRR8926313	0.74	0.68	0.51	SAMN11258344	Marked loss of diversity and pathogen domination of the gut microbiota in critically ill patients
L11079.1	SRR8926314	0.74	0.68	0.51	SAMN11258343	Marked loss of diversity and pathogen domination of the gut microbiota in critically ill patients
L11079.1	SRR8978194	0.74	0.68	0.51	SAMN11515111	Gut microbiome of humans and wild and captive chimpanzees and gorillas
L11079.1	SRR8978272	0.74	0.68	0.51	SAMN11515114	Gut microbiome of humans and wild and captive chimpanzees and gorillas
L11079.1	SRR8978277	0.74	0.68	0.51	SAMN11515136	Gut microbiome of humans and wild and captive chimpanzees and gorillas
L11079.1	SRR8978456	0.74	0.68	0.51	SAMN11515096	Gut microbiome of humans and wild and captive chimpanzees and gorillas
L11079.1	SRR8978495	0.74	0.68	0.51	SAMN11515087	Gut microbiome of humans and wild and captive chimpanzees and gorillas
L11079.1	SRR9040456	0.74	0.68	0.51	SAMN11391622	Human Gut Metagenome Raw sequence reads
L11079.1	SRR9089452	0.74	0.68	0.51	SAMN11774733	Gut microbiota dysbiosis in spinal cord injury
L11079.1	SRR9089453	0.74	0.68	0.51	SAMN11774691	Gut microbiota dysbiosis in spinal cord injury
L11079.1	SRR9089482	0.74	0.68	0.51	SAMN11774689	Gut microbiota dysbiosis in spinal cord injury
L11079.1	SRR9089491	0.74	0.68	0.51	SAMN11774696	Gut microbiota dysbiosis in spinal cord injury
L11079.1	SRR9089495	0.74	0.68	0.51	SAMN11774715	Gut microbiota dysbiosis in spinal cord injury
L11079.1	SRR9089507	0.74	0.68	0.51	SAMN11774732	Gut microbiota dysbiosis in spinal cord injury
L11079.1	SRR9108953	0.74	0.68	0.51	SAMN11418654	Human gut metagenome Metagenome
L11079.1	SRR9108958	0.74	0.68	0.51	SAMN11418649	Human gut metagenome Metagenome
L11079.1	SRR9184935	0.74	0.68	0.51	SAMN11897501	Gut metagenomic data of adult female Asian elephant (Elephas maximus)
L11079.1	SRR9184941	0.74	0.68	0.51	SAMN11890360	gastrointestinal metagenomic data of Asian elephant (infant)
L11079.1	SRR9201501	0.74	0.68	0.51	SAMN11958552	Maturation of the infant rhesus macaque (Macaca mulatta) gut microbiome and its role in the development of diarrheal disease
L11079.1	SRR9199262	0.74	0.68	0.51	SAMN11954402	Metagenomic Study of Gastrointestinal Tract Microbial Community Change During Long-Term Acute Care
L11079.1	SRR9199263	0.74	0.68	0.51	SAMN11954401	Metagenomic Study of Gastrointestinal Tract Microbial Community Change During Long-Term Acute Care
L11079.1	SRR9199265	0.74	0.68	0.51	SAMN11954399	Metagenomic Study of Gastrointestinal Tract Microbial Community Change During Long-Term Acute Care
L11079.1	SRR9199266	0.74	0.68	0.51	SAMN11954398	Metagenomic Study of Gastrointestinal Tract Microbial Community Change During Long-Term Acute Care
L11079.1	SRR9199267	0.74	0.68	0.51	SAMN11954397	Metagenomic Study of Gastrointestinal Tract Microbial Community Change During Long-Term Acute Care
L11079.1	SRR9199475	0.74	0.68	0.51	SAMN11954391	Metagenomic Study of Gastrointestinal Tract Microbial Community Change During Long-Term Acute Care
L11079.1	SRR9199476	0.74	0.68	0.51	SAMN11954392	Metagenomic Study of Gastrointestinal Tract Microbial Community Change During Long-Term Acute Care
L11079.1	SRR9199479	0.74	0.68	0.51	SAMN11954395	Metagenomic Study of Gastrointestinal Tract Microbial Community Change During Long-Term Acute Care
L11079.1	SRR9218150	0.74	0.68	0.51	SAMN10877832	Metagenomic Reconstructions of Gut Microbiome in Weanling Pigs
L11079.1	SRR9218171	0.74	0.68	0.51	SAMN10877857	Metagenomic Reconstructions of Gut Microbiome in Weanling Pigs
L11079.1	SRR9218172	0.74	0.68	0.51	SAMN10877856	Metagenomic Reconstructions of Gut Microbiome in Weanling Pigs
L11079.1	SRR9292693	0.74	0.68	0.51	SAMN11977913	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9292747	0.74	0.68	0.51	SAMN11977899	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9292787	0.74	0.68	0.51	SAMN11977805	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9292809	0.74	0.68	0.51	SAMN11977796	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9292960	0.74	0.68	0.51	SAMN11977866	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293071	0.74	0.68	0.51	SAMN11977915	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293096	0.74	0.68	0.51	SAMN11977901	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293125	0.74	0.68	0.51	SAMN11977782	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293136	0.74	0.68	0.51	SAMN11977861	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293165	0.74	0.68	0.51	SAMN11977846	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293281	0.74	0.68	0.51	SAMN11977833	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293373	0.74	0.68	0.51	SAMN11977843	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293393	0.74	0.68	0.51	SAMN11977749	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9293458	0.74	0.68	0.51	SAMN11977741	Cameroon,  U.S. fecal V4 amplicon sequencing of 16S rRNA and shotgun sequencing
L11079.1	SRR9330498	0.74	0.68	0.51	SAMN12097496	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330512	0.74	0.68	0.51	SAMN12097488	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330513	0.74	0.68	0.51	SAMN12097489	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330534	0.74	0.68	0.51	SAMN12097440	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330557	0.74	0.68	0.51	SAMN12097512	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330563	0.74	0.68	0.51	SAMN12097584	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330568	0.74	0.68	0.51	SAMN12097581	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330571	0.74	0.68	0.51	SAMN12097582	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330577	0.74	0.68	0.51	SAMN12097456	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330592	0.74	0.68	0.51	SAMN12097452	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330607	0.74	0.68	0.51	SAMN12097557	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330610	0.74	0.68	0.51	SAMN12097562	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330616	0.74	0.68	0.51	SAMN12097476	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330622	0.74	0.68	0.51	SAMN12097484	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330641	0.74	0.68	0.51	SAMN12097531	South African HIV-exposed, uninfected infant gut microbiomes
L11079.1	SRR9330796	0.74	0.68	0.51	SAMN12097330	Metagenomic sequencing of gut microbiota in women with polycystic ovary syndrome
L11079.1	SRR9639641	0.74	0.68	0.51	SAMN12165897	metagenomic studies of the urban river sediments of Zhengzhou city, China
L11079.1	SRR9674577	0.74	0.68	0.51	SAMN11356513	CARBEPAD
L11079.1	SRR9843718	0.74	0.68	0.51	SAMN12371834	Gut microbiome for the MORDOR I study.
L11079.1	SRR9843778	0.74	0.68	0.51	SAMN12371333	Gut microbiome for the MORDOR I study.
L11079.1	SRR9843834	0.74	0.68	0.51	SAMN12371515	Gut microbiome for the MORDOR I study.
L11079.1	SRR9843883	0.74	0.68	0.51	SAMN12371694	Gut microbiome for the MORDOR I study.
L11079.1	SRR9843998	0.74	0.68	0.51	SAMN12371607	Gut microbiome for the MORDOR I study.
L11079.1	SRR9844093	0.74	0.68	0.51	SAMN12371326	Gut microbiome for the MORDOR I study.
L11079.1	SRR9865435	0.74	0.68	0.51	SAMN09980652	Human infant gut metagenome, infant shotgun sequencing
L11079.1	SRR9866650	0.74	0.68	0.51	SAMN12283840	Metagenomic sequencing of Lawsonia intracellularis
L11079.1	SRR9866652	0.74	0.68	0.51	SAMN12283842	Metagenomic sequencing of Lawsonia intracellularis
L11079.1	SRR9866656	0.74	0.68	0.51	SAMN12283838	Metagenomic sequencing of Lawsonia intracellularis
L11079.1	SRR9866676	0.74	0.68	0.51	SAMN12283833	Metagenomic sequencing of Lawsonia intracellularis
L11079.1	SRR9879751	0.74	0.68	0.51	SAMN12418424	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR9879760	0.74	0.68	0.51	SAMN12418403	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR9879769	0.74	0.68	0.51	SAMN12418410	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR9879789	0.74	0.68	0.51	SAMN12418336	Bacterial colonization reprograms the neonatal gut metabolome
L11079.1	SRR9943745	0.74	0.68	0.51	SAMN12548359	Gut microbiome of Panthera (P. pardus, P. tigris, P. leo)
L11079.1	SRR9943762	0.74	0.68	0.51	SAMN12548365	Gut microbiome of Panthera (P. pardus, P. tigris, P. leo)
L11079.1	SRR9969859	0.74	0.68	0.51	SAMN12574659	cynomolgus macaques gut metagenomic microbial community diversity
L11079.1	SRR9969862	0.74	0.68	0.51	SAMN12574660	cynomolgus macaques gut metagenomic microbial community diversity
